0000313616-19-000148.txt : 20191024 0000313616-19-000148.hdr.sgml : 20191024 20191023185313 ACCESSION NUMBER: 0000313616-19-000148 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 109 CONFORMED PERIOD OF REPORT: 20190927 FILED AS OF DATE: 20191024 DATE AS OF CHANGE: 20191023 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DANAHER CORP /DE/ CENTRAL INDEX KEY: 0000313616 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL [3823] IRS NUMBER: 591995548 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-08089 FILM NUMBER: 191164581 BUSINESS ADDRESS: STREET 1: 2200 PENNSYLVANIA AVE. N.W. STREET 2: SUITE 800W CITY: WASHINGTON STATE: DC ZIP: 20037-1701 BUSINESS PHONE: 2028280850 MAIL ADDRESS: STREET 1: 2200 PENNSYLVANIA AVE. N.W. STREET 2: SUITE 800W CITY: WASHINGTON STATE: DC ZIP: 20037-1701 FORMER COMPANY: FORMER CONFORMED NAME: DMG INC DATE OF NAME CHANGE: 19850221 10-Q 1 dhr-2019927x10q.htm 10-Q Document
false--12-31Q32019000031361604200000400000850000010.6528283000003023300000000.01200000000020000000008179000008350000007015000007182000000.010050.010.005950.005850.010000.005000.010.005030000000000308000000000540000000532000000000600000000210000000600000000080000000008000000000250000000130000000030000000000308000000001300000000540000000532000000001800000000021000000060000000013000000008000000007500000008000000006000000002500000000.0020.003520.0030.00450.0050.00650.00750.010.011250.0120.01350.0170.0180.0250.03350.043750.05000.001200.001250.000300.00040210000000027000000000.0475000150000000165000001650000 0000313616 2019-01-01 2019-09-27 0000313616 dhr:FloatingRateSeniorNotesDue2022Member 2019-01-01 2019-09-27 0000313616 dhr:A0.75SeniorNotesDue2031Member 2019-01-01 2019-09-27 0000313616 us-gaap:PreferredStockMember 2019-01-01 2019-09-27 0000313616 dhr:A1.35SeniorNotesDue2039Member 2019-01-01 2019-09-27 0000313616 dhr:A1.7SeniorNotesDue2022Member 2019-01-01 2019-09-27 0000313616 dhr:A0.2SeniorNotesDue2026Member 2019-01-01 2019-09-27 0000313616 dhr:A0.45SeniorNotesDue2028Member 2019-01-01 2019-09-27 0000313616 dhr:A1.2SeniorNotesDue2027Member 2019-01-01 2019-09-27 0000313616 dhr:A1.8SeniorNotesDue2049Member 2019-01-01 2019-09-27 0000313616 dhr:A2.5SeniorNotesDue2025Member 2019-01-01 2019-09-27 0000313616 us-gaap:CommonStockMember 2019-01-01 2019-09-27 0000313616 2019-10-18 0000313616 2018-12-31 0000313616 2019-09-27 0000313616 2019-09-27 2019-09-27 0000313616 2018-06-30 2018-09-28 0000313616 2019-06-29 2019-09-27 0000313616 2018-01-01 2018-09-28 0000313616 us-gaap:RetainedEarningsMember 2018-01-01 2018-09-28 0000313616 us-gaap:AdditionalPaidInCapitalMember 2018-09-28 0000313616 us-gaap:PreferredStockMember 2018-09-28 0000313616 us-gaap:AdditionalPaidInCapitalMember 2019-09-27 0000313616 us-gaap:CommonStockMember 2019-09-27 0000313616 us-gaap:PreferredStockMember 2019-06-29 2019-09-27 0000313616 us-gaap:AdditionalPaidInCapitalMember 2019-06-29 2019-09-27 0000313616 us-gaap:PreferredStockMember 2018-01-01 2018-09-28 0000313616 us-gaap:NoncontrollingInterestMember 2019-06-29 2019-09-27 0000313616 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000313616 us-gaap:NoncontrollingInterestMember 2018-09-28 0000313616 us-gaap:CommonStockMember 2018-12-31 0000313616 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-09-27 0000313616 us-gaap:RetainedEarningsMember 2018-09-28 0000313616 us-gaap:NoncontrollingInterestMember 2017-12-31 0000313616 us-gaap:NoncontrollingInterestMember 2019-09-27 0000313616 us-gaap:CommonStockMember 2018-06-29 0000313616 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-09-27 0000313616 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 2018-09-28 0000313616 us-gaap:CommonStockMember 2018-09-28 0000313616 us-gaap:RetainedEarningsMember 2019-01-01 2019-09-27 0000313616 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 2018-09-28 0000313616 us-gaap:RetainedEarningsMember 2018-06-30 2018-09-28 0000313616 us-gaap:NoncontrollingInterestMember 2018-06-30 2018-09-28 0000313616 us-gaap:PreferredStockMember 2018-12-31 0000313616 2018-09-28 0000313616 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-09-28 0000313616 us-gaap:CommonStockMember 2017-12-31 0000313616 us-gaap:RetainedEarningsMember 2019-06-28 0000313616 us-gaap:RetainedEarningsMember 2018-06-29 0000313616 us-gaap:RetainedEarningsMember 2018-12-31 0000313616 us-gaap:PreferredStockMember 2019-09-27 0000313616 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-27 0000313616 us-gaap:AdditionalPaidInCapitalMember 2018-06-29 0000313616 us-gaap:AdditionalPaidInCapitalMember 2019-06-28 0000313616 us-gaap:RetainedEarningsMember 2019-09-27 0000313616 us-gaap:NoncontrollingInterestMember 2018-06-29 0000313616 us-gaap:PreferredStockMember 2017-12-31 0000313616 us-gaap:RetainedEarningsMember 2019-06-29 2019-09-27 0000313616 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-09-28 0000313616 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-29 0000313616 us-gaap:CommonStockMember 2019-01-01 2019-09-27 0000313616 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-29 2019-09-27 0000313616 us-gaap:RetainedEarningsMember 2017-12-31 0000313616 us-gaap:NoncontrollingInterestMember 2018-01-01 2018-09-28 0000313616 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-09-27 0000313616 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0000313616 us-gaap:CommonStockMember 2018-06-30 2018-09-28 0000313616 us-gaap:NoncontrollingInterestMember 2019-06-28 0000313616 us-gaap:NoncontrollingInterestMember 2018-12-31 0000313616 us-gaap:PreferredStockMember 2019-06-28 0000313616 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-28 0000313616 us-gaap:CommonStockMember 2019-06-28 0000313616 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-28 0000313616 us-gaap:CommonStockMember 2018-01-01 2018-09-28 0000313616 us-gaap:PreferredStockMember 2019-01-01 2019-09-27 0000313616 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0000313616 us-gaap:PreferredStockMember 2018-06-30 2018-09-28 0000313616 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000313616 us-gaap:CommonStockMember 2019-06-29 2019-09-27 0000313616 us-gaap:PreferredStockMember 2018-06-29 0000313616 2017-12-31 0000313616 dhr:EnvistaMember srt:SubsidiariesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2019-09-27 0000313616 2019-01-01 0000313616 us-gaap:AociAttributableToNoncontrollingInterestMember 2019-06-29 2019-09-27 0000313616 srt:MinimumMember dhr:U.S.DollarDenominatedBondsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2019-06-28 2019-06-28 0000313616 dhr:EnvistaMember srt:SubsidiariesMember us-gaap:ForeignExchangeContractMember 2019-09-27 0000313616 us-gaap:AociAttributableToNoncontrollingInterestMember 2019-01-01 2019-09-27 0000313616 srt:MaximumMember dhr:U.S.DollarDenominatedBondsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2019-06-28 2019-06-28 0000313616 dhr:U.S.DollarDenominatedBondsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2019-06-28 0000313616 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-01-31 0000313616 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-09-28 0000313616 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-12-31 0000313616 us-gaap:AccumulatedTranslationAdjustmentMember 2017-12-31 0000313616 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-01-01 2018-09-28 0000313616 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-09-28 0000313616 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-01-01 0000313616 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-01-01 0000313616 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0000313616 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-01-01 2018-09-28 0000313616 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-01-01 2018-09-28 0000313616 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0000313616 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-09-27 0000313616 us-gaap:AccumulatedTranslationAdjustmentMember 2019-09-27 0000313616 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-01-01 2018-01-01 0000313616 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-09-27 0000313616 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2019-01-01 2019-09-27 0000313616 us-gaap:AociAttributableToNoncontrollingInterestMember 2019-09-27 0000313616 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-12-31 0000313616 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-01-01 2018-09-28 0000313616 us-gaap:AccumulatedTranslationAdjustmentMember 2018-01-01 2018-09-28 0000313616 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-09-27 0000313616 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-09-28 0000313616 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2017-12-31 0000313616 us-gaap:AccumulatedTranslationAdjustmentMember 2018-01-01 2018-01-01 0000313616 us-gaap:AccumulatedTranslationAdjustmentMember 2018-09-28 0000313616 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2019-01-01 2019-09-27 0000313616 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-12-31 0000313616 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-01-01 2018-01-01 0000313616 us-gaap:AccumulatedTranslationAdjustmentMember 2018-01-01 0000313616 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-01-01 2018-01-01 0000313616 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-09-27 0000313616 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2017-12-31 0000313616 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2019-09-27 0000313616 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-09-28 0000313616 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-01-01 0000313616 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-01-01 2018-01-01 0000313616 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-12-31 0000313616 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-01-01 0000313616 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-09-27 0000313616 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-12-31 0000313616 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2019-09-27 0000313616 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2019-06-28 0000313616 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-06-29 2019-09-27 0000313616 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2019-06-29 2019-09-27 0000313616 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-06-30 2018-09-28 0000313616 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-06-29 2019-09-27 0000313616 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-06-30 2018-09-28 0000313616 us-gaap:AccumulatedTranslationAdjustmentMember 2019-06-29 2019-09-27 0000313616 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2019-06-29 2019-09-27 0000313616 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-06-30 2018-09-28 0000313616 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-06-30 2018-09-28 0000313616 us-gaap:AccumulatedTranslationAdjustmentMember 2018-06-30 2018-09-28 0000313616 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-06-29 0000313616 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-06-28 0000313616 us-gaap:AccumulatedTranslationAdjustmentMember 2018-06-29 0000313616 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-06-29 0000313616 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-06-29 0000313616 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-06-29 0000313616 us-gaap:AccumulatedTranslationAdjustmentMember 2019-06-28 0000313616 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-06-28 0000313616 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2019-06-28 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:DentalEnvistaMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:LifeSciencesMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:EnvironmentalAppliedSolutionsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:EnvironmentalAppliedSolutionsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:EnvironmentalAppliedSolutionsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:LifeSciencesMember 2018-06-30 2018-09-28 0000313616 dhr:OtherdevelopedmarketsMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:DiagnosticsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:EnvironmentalAppliedSolutionsMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:DentalEnvistaMember 2019-06-29 2019-09-27 0000313616 dhr:HighgrowthmarketsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:EnvironmentalAppliedSolutionsMember 2018-06-30 2018-09-28 0000313616 dhr:OtherdevelopedmarketsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:LifeSciencesMember 2018-06-30 2018-09-28 0000313616 dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:EnvironmentalAppliedSolutionsMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:DiagnosticsMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:EnvironmentalAppliedSolutionsMember 2018-06-30 2018-09-28 0000313616 dhr:RevenuefromContractwithCustomerMeasurementRecurringMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:DentalEnvistaMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:EnvironmentalAppliedSolutionsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:LifeSciencesMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:DentalEnvistaMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:DentalEnvistaMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:LifeSciencesMember 2019-06-29 2019-09-27 0000313616 srt:NorthAmericaMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:DentalEnvistaMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:DiagnosticsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:DentalEnvistaMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:DiagnosticsMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:LifeSciencesMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:EnvironmentalAppliedSolutionsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:DentalEnvistaMember 2018-06-30 2018-09-28 0000313616 dhr:RevenuefromContractwithCustomerMeasurementRecurringMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:DiagnosticsMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:DentalEnvistaMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:LifeSciencesMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:LifeSciencesMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:LifeSciencesMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:LifeSciencesMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:EnvironmentalAppliedSolutionsMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:DentalEnvistaMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:DiagnosticsMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:DiagnosticsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:DentalEnvistaMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:DiagnosticsMember 2019-06-29 2019-09-27 0000313616 dhr:HighgrowthmarketsMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:LifeSciencesMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:EnvironmentalAppliedSolutionsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:LifeSciencesMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:LifeSciencesMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:DiagnosticsMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:DiagnosticsMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:EnvironmentalAppliedSolutionsMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:DentalEnvistaMember 2019-06-29 2019-09-27 0000313616 srt:NorthAmericaMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:EnvironmentalAppliedSolutionsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:DentalEnvistaMember 2019-06-29 2019-09-27 0000313616 dhr:WesternEuropeMember 2018-06-30 2018-09-28 0000313616 dhr:WesternEuropeMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:DentalEnvistaMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:DiagnosticsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:DiagnosticsMember 2018-06-30 2018-09-28 0000313616 dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:DiagnosticsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:DiagnosticsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:EnvironmentalAppliedSolutionsMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:LifeSciencesMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:DiagnosticsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:DentalEnvistaMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:LifeSciencesMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:EnvironmentalAppliedSolutionsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:DentalEnvistaMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:EnvironmentalAppliedSolutionsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:DiagnosticsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:EnvironmentalAppliedSolutionsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:LifeSciencesMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:EnvironmentalAppliedSolutionsMember 2018-01-01 2018-09-28 0000313616 dhr:RevenuefromContractwithCustomerMeasurementRecurringMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:EnvironmentalAppliedSolutionsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:DiagnosticsMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:EnvironmentalAppliedSolutionsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:LifeSciencesMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:LifeSciencesMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:DiagnosticsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:EnvironmentalAppliedSolutionsMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:EnvironmentalAppliedSolutionsMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:LifeSciencesMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:DentalEnvistaMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:DiagnosticsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:EnvironmentalAppliedSolutionsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:LifeSciencesMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:DiagnosticsMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:DentalEnvistaMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:LifeSciencesMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:LifeSciencesMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:EnvironmentalAppliedSolutionsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:LifeSciencesMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:DentalEnvistaMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:LifeSciencesMember 2019-01-01 2019-09-27 0000313616 dhr:HighgrowthmarketsMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:DentalEnvistaMember 2019-01-01 2019-09-27 0000313616 dhr:OtherdevelopedmarketsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:EnvironmentalAppliedSolutionsMember 2018-01-01 2018-09-28 0000313616 dhr:WesternEuropeMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:DentalEnvistaMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:DentalEnvistaMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:LifeSciencesMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:DiagnosticsMember 2018-01-01 2018-09-28 0000313616 dhr:OtherdevelopedmarketsMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:DentalEnvistaMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:DiagnosticsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:DentalEnvistaMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:DentalEnvistaMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:DiagnosticsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:DiagnosticsMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:LifeSciencesMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:DentalEnvistaMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:DiagnosticsMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:DentalEnvistaMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:DiagnosticsMember 2018-01-01 2018-09-28 0000313616 srt:NorthAmericaMember 2019-01-01 2019-09-27 0000313616 dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:LifeSciencesMember 2019-01-01 2019-09-27 0000313616 dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:LifeSciencesMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:DiagnosticsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:EnvironmentalAppliedSolutionsMember 2018-01-01 2018-09-28 0000313616 dhr:WesternEuropeMember 2019-01-01 2019-09-27 0000313616 us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-09-27 0000313616 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:EnvironmentalAppliedSolutionsMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:DiagnosticsMember 2018-01-01 2018-09-28 0000313616 dhr:HighgrowthmarketsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:EnvironmentalAppliedSolutionsMember 2018-01-01 2018-09-28 0000313616 srt:NorthAmericaMember 2018-01-01 2018-09-28 0000313616 dhr:RevenuefromContractwithCustomerMeasurementRecurringMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:DentalEnvistaMember 2019-01-01 2019-09-27 0000313616 dhr:IDTMember us-gaap:AcquisitionRelatedCostsMember 2018-01-01 2018-12-31 0000313616 dhr:BiopharmaAcquisitionMember 2019-02-25 2019-02-25 0000313616 dhr:BiopharmaAcquisitionMember 2019-09-27 2019-09-27 0000313616 2018-01-01 2018-12-31 0000313616 dhr:BiopharmaAcquisitionMember 2019-02-25 0000313616 dhr:EnvistaMember srt:SubsidiariesMember us-gaap:IPOMember 2019-09-20 2019-09-20 0000313616 dhr:EnvistaMember srt:SubsidiariesMember us-gaap:IPOMember 2019-09-27 0000313616 us-gaap:SubsequentEventMember 2019-10-24 2019-10-24 0000313616 dhr:EnvistaMember srt:SubsidiariesMember us-gaap:IPOMember 2019-09-20 0000313616 dhr:EnvistaMember srt:SubsidiariesMember 2019-09-20 2019-09-27 0000313616 dhr:RedeemedNotesMember us-gaap:SeniorNotesMember us-gaap:SubsequentEventMember 2019-10-24 0000313616 dhr:A5.0SeniorNotesDue2020Member us-gaap:SeniorNotesMember us-gaap:SubsequentEventMember 2019-10-24 0000313616 dhr:A2.4SeniorNotesDue2020Member us-gaap:SeniorNotesMember us-gaap:SubsequentEventMember 2019-10-24 0000313616 srt:MaximumMember 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:DentalEnvistaMember 2018-12-31 0000313616 us-gaap:OperatingSegmentsMember dhr:EnvironmentalAppliedSolutionsMember 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:LifeSciencesMember 2018-12-31 0000313616 us-gaap:OperatingSegmentsMember dhr:DiagnosticsMember 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:LifeSciencesMember 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:DiagnosticsMember 2018-12-31 0000313616 us-gaap:OperatingSegmentsMember dhr:EnvironmentalAppliedSolutionsMember 2018-12-31 0000313616 us-gaap:OperatingSegmentsMember dhr:DentalEnvistaMember 2019-09-27 0000313616 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-09-27 0000313616 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-09-27 0000313616 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2018-12-31 0000313616 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2018-12-31 0000313616 us-gaap:FairValueInputsLevel1Member 2019-09-27 0000313616 us-gaap:FairValueInputsLevel2Member 2019-09-27 0000313616 us-gaap:FairValueInputsLevel3Member 2018-12-31 0000313616 us-gaap:FairValueInputsLevel3Member 2019-09-27 0000313616 us-gaap:FairValueInputsLevel2Member 2018-12-31 0000313616 us-gaap:FairValueInputsLevel1Member 2018-12-31 0000313616 dhr:A0.2SeniorNotesDue2026Member us-gaap:SeniorNotesMember 2019-09-18 2019-09-18 0000313616 dhr:A1.8SeniorNotesDue2049Member us-gaap:SeniorNotesMember 2019-09-18 0000313616 dhr:A0.75SeniorNotesDue2031Member us-gaap:SeniorNotesMember 2019-09-18 0000313616 dhr:A0.45SeniorNotesDue2028Member us-gaap:SeniorNotesMember 2019-09-18 0000313616 dhr:A1.8SeniorNotesDue2049Member us-gaap:SeniorNotesMember 2019-09-18 2019-09-18 0000313616 dhr:A0.45SeniorNotesDue2028Member us-gaap:SeniorNotesMember 2019-09-18 2019-09-18 0000313616 dhr:A0.75SeniorNotesDue2031Member us-gaap:SeniorNotesMember 2019-09-18 2019-09-18 0000313616 dhr:A0.2SeniorNotesDue2026Member us-gaap:SeniorNotesMember 2019-09-18 0000313616 dhr:A1.35SeniorNotesDue2039Member us-gaap:SeniorNotesMember 2019-09-18 0000313616 dhr:A1.35SeniorNotesDue2039Member us-gaap:SeniorNotesMember 2019-09-18 2019-09-18 0000313616 dhr:A2.5SeniorNotesDue2025Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:EnvistaEuroTermLoanFacilityMember us-gaap:UnsecuredDebtMember 2019-09-27 0000313616 dhr:FloatingRateSeniorNotesDue2022Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:EnvistaTermLoanFacilityMember us-gaap:UnsecuredDebtMember 2019-09-27 0000313616 dhr:A5.0SeniorNotesDue2020Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:A0.2SeniorNotesDue2026Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:A1.35SeniorNotesDue2039Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:A0.5BondsDue2023Member us-gaap:BondsMember 2018-12-31 0000313616 dhr:A4.375SeniorNotesDue2045Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:A0.2SeniorNotesDue2026Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:A1.0SeniorNotesDue2019Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:A0.352SeniorNotesDue2021Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:USDollarDenominatedCommercialPaperMember us-gaap:CommercialPaperMember 2019-09-27 0000313616 dhr:EnvistaEuroTermLoanFacilityMember us-gaap:UnsecuredDebtMember 2018-12-31 0000313616 dhr:A5.0SeniorNotesDue2020Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:A0.45SeniorNotesDue2028Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:EnvistaTermLoanFacilityMember us-gaap:UnsecuredDebtMember 2018-12-31 0000313616 dhr:EuroDenominatedCommercialPaperMember us-gaap:CommercialPaperMember 2018-12-31 0000313616 dhr:OtherMember 2019-09-27 0000313616 dhr:A2.4SeniorNotesDue2020Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:A0.75SeniorNotesDue2031Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:A1.35SeniorNotesDue2039Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:A0.352SeniorNotesDue2021Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:A0.65SeniorNotesDue2032Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:OtherMember 2018-12-31 0000313616 dhr:A1.0SeniorNotesDue2019Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:A1.7SeniorNotesDue2022Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:A3.35SeniorNotesDue2025Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:A0.75SeniorNotesDue2031Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:A0.45SeniorNotesDue2028Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:ZeroCouponLYONSDue2021Member us-gaap:ConvertibleDebtMember 2018-12-31 0000313616 dhr:A3.35SeniorNotesDue2025Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:A1.2SeniorNotesDue2027Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:A2.5SeniorNotesDue2025Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:FloatingRateSeniorNotesDue2022Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:A1.7SeniorNotesDue2022Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:A0.3SeniorNotesDue2027Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:A1.8SeniorNotesDue2049Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:A0.5BondsDue2023Member us-gaap:BondsMember 2019-09-27 0000313616 dhr:USDollarDenominatedCommercialPaperMember us-gaap:CommercialPaperMember 2018-12-31 0000313616 dhr:ZeroCouponLYONSDue2021Member us-gaap:ConvertibleDebtMember 2019-09-27 0000313616 dhr:A1.2SeniorNotesDue2027Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:A1.125BondsDue2028Member us-gaap:BondsMember 2018-12-31 0000313616 dhr:A0.3SeniorNotesDue2027Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:A4.375SeniorNotesDue2045Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:A1.125BondsDue2028Member us-gaap:BondsMember 2019-09-27 0000313616 dhr:EuroDenominatedCommercialPaperMember us-gaap:CommercialPaperMember 2019-09-27 0000313616 dhr:A1.8SeniorNotesDue2049Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:A2.4SeniorNotesDue2020Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:A0.65SeniorNotesDue2032Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:EnvistaMember srt:SubsidiariesMember us-gaap:IPOMember 2019-09-01 2019-09-27 0000313616 dhr:BiopharmaEuronotesMember us-gaap:SeniorNotesMember 2019-09-18 2019-09-18 0000313616 dhr:ZeroCouponLYONSDue2021Member us-gaap:ConvertibleDebtMember 2019-01-01 2019-09-27 0000313616 us-gaap:RevolvingCreditFacilityMember dhr:A364DayFacilityMember us-gaap:ShortTermDebtMember 2019-08-27 0000313616 us-gaap:RevolvingCreditFacilityMember dhr:FiveYearFacilityMember us-gaap:LongTermDebtMember 2019-08-27 0000313616 dhr:EnvistaMember srt:SubsidiariesMember dhr:EnvistaTermLoanFacilityMember us-gaap:UnsecuredDebtMember us-gaap:IPOMember 2019-09-27 0000313616 us-gaap:RevolvingCreditFacilityMember dhr:SupersededCreditFacilityMember us-gaap:LongTermDebtMember 2019-08-27 0000313616 us-gaap:RevolvingCreditFacilityMember dhr:A364DayFacilityMember us-gaap:ShortTermDebtMember 2019-08-27 2019-08-27 0000313616 dhr:EnvistaMember srt:SubsidiariesMember dhr:EnvistaEuroTermLoanFacilityMember us-gaap:UnsecuredDebtMember us-gaap:IPOMember 2019-09-27 0000313616 dhr:EnvistaMember srt:SubsidiariesMember us-gaap:RevolvingCreditFacilityMember dhr:EnvistaCreditFacilityMember us-gaap:LongTermDebtMember us-gaap:IPOMember 2019-09-27 0000313616 dhr:A1.0SeniorNotesDue2019Member us-gaap:SeniorNotesMember 2019-07-08 2019-07-08 0000313616 dhr:EuroDenominatedCommercialPaperMember us-gaap:CommercialPaperMember 2019-09-27 2019-09-27 0000313616 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember dhr:A2020CreditFacilitiesMember us-gaap:LongTermDebtMember 2019-08-27 0000313616 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember dhr:A364DayFacilityMember us-gaap:ShortTermDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-08-27 2019-08-27 0000313616 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember dhr:FiveYearFacilityMember us-gaap:LongTermDebtMember 2019-08-27 2019-08-27 0000313616 us-gaap:RevolvingCreditFacilityMember dhr:A364DayFacilityMember us-gaap:ShortTermDebtMember us-gaap:EurodollarMember 2019-08-27 2019-08-27 0000313616 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember dhr:A2020CreditFacilitiesMember us-gaap:LongTermDebtMember 2019-08-27 0000313616 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember dhr:A364DayFacilityMember us-gaap:ShortTermDebtMember 2019-08-27 2019-08-27 0000313616 us-gaap:RevolvingCreditFacilityMember dhr:FiveYearFacilityMember us-gaap:LongTermDebtMember us-gaap:EurodollarMember 2019-08-27 2019-08-27 0000313616 us-gaap:RevolvingCreditFacilityMember dhr:A364DayFacilityMember us-gaap:ShortTermDebtMember us-gaap:FederalFundsEffectiveSwapRateMember 2019-08-27 2019-08-27 0000313616 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember dhr:FiveYearFacilityMember us-gaap:LongTermDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-08-27 2019-08-27 0000313616 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember dhr:FiveYearFacilityMember us-gaap:LongTermDebtMember 2019-08-27 2019-08-27 0000313616 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember dhr:A364DayFacilityMember us-gaap:ShortTermDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-08-27 2019-08-27 0000313616 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember dhr:A364DayFacilityMember us-gaap:ShortTermDebtMember 2019-08-27 2019-08-27 0000313616 us-gaap:RevolvingCreditFacilityMember dhr:FiveYearFacilityMember us-gaap:LongTermDebtMember us-gaap:FederalFundsEffectiveSwapRateMember 2019-08-27 2019-08-27 0000313616 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember dhr:FiveYearFacilityMember us-gaap:LongTermDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-08-27 2019-08-27 0000313616 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:NetInvestmentHedgingMember 2019-09-27 0000313616 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:NetInvestmentHedgingMember 2019-09-27 0000313616 us-gaap:LongTermDebtMember us-gaap:NetInvestmentHedgingMember 2019-09-27 0000313616 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-09-27 0000313616 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2019-09-27 0000313616 dhr:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2019-06-29 2019-09-27 0000313616 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2019-06-29 2019-09-27 0000313616 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2019-01-01 2019-09-27 0000313616 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-01-01 2019-09-27 0000313616 dhr:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2019-09-27 0000313616 dhr:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2019-01-01 2019-09-27 0000313616 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-06-29 2019-09-27 0000313616 dhr:U.S.DollarDenominatedBondsMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-01-31 0000313616 dhr:U.S.DollarDenominatedBondsMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-09-27 0000313616 country:US us-gaap:PensionPlansDefinedBenefitMember 2019-09-27 0000313616 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-09-27 0000313616 country:US us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 2018-09-28 0000313616 country:US us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-09-28 0000313616 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-09-28 0000313616 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-09-27 0000313616 country:US us-gaap:PensionPlansDefinedBenefitMember 2019-06-29 2019-09-27 0000313616 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-29 2019-09-27 0000313616 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 2018-09-28 0000313616 country:US us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-09-27 0000313616 us-gaap:CostOfSalesMember 2018-06-30 2018-09-28 0000313616 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-01-01 2018-09-28 0000313616 us-gaap:CostOfSalesMember 2018-01-01 2018-09-28 0000313616 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-06-30 2018-09-28 0000313616 us-gaap:CostOfSalesMember 2019-01-01 2019-09-27 0000313616 us-gaap:CostOfSalesMember 2019-06-29 2019-09-27 0000313616 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-06-29 2019-09-27 0000313616 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-09-27 0000313616 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-06-29 2019-09-27 0000313616 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-06-30 2018-09-28 0000313616 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-01-01 2018-09-28 0000313616 2017-01-01 2017-12-21 0000313616 2012-01-01 2015-12-31 0000313616 us-gaap:ForeignCountryMember 2013-01-01 2015-12-31 0000313616 us-gaap:ForeignCountryMember 2013-12-10 0000313616 us-gaap:ForeignCountryMember 2010-01-01 2012-12-31 0000313616 2017-12-22 2017-12-31 0000313616 us-gaap:EmployeeStockOptionMember 2018-06-30 2018-09-28 0000313616 us-gaap:EmployeeStockOptionMember 2019-06-29 2019-09-27 0000313616 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-09-27 0000313616 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-09-28 0000313616 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-09-28 0000313616 us-gaap:RestrictedStockUnitsRSUMember 2019-06-29 2019-09-27 0000313616 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-09-27 0000313616 us-gaap:RestrictedStockUnitsRSUMember 2018-06-30 2018-09-28 0000313616 us-gaap:PreferredStockMember 2019-03-01 0000313616 2013-07-16 0000313616 us-gaap:CommonStockMember 2019-03-01 2019-03-01 0000313616 us-gaap:PreferredStockMember 2019-03-01 2019-03-01 0000313616 us-gaap:EmployeeStockOptionMember 2019-09-27 2019-09-27 0000313616 srt:MaximumMember srt:ScenarioForecastMember us-gaap:PreferredStockMember 2022-04-15 0000313616 us-gaap:EmployeeStockOptionMember 2019-09-27 0000313616 us-gaap:RestrictedStockUnitsRSUMember 2019-09-27 2019-09-27 0000313616 us-gaap:CommonStockMember 2019-03-01 0000313616 srt:MinimumMember srt:ScenarioForecastMember us-gaap:PreferredStockMember 2022-04-15 0000313616 us-gaap:RestrictedStockUnitsRSUMember 2019-09-27 0000313616 us-gaap:CorporateNonSegmentMember 2018-06-30 2018-09-28 0000313616 us-gaap:CorporateNonSegmentMember 2019-06-29 2019-09-27 0000313616 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-09-27 0000313616 us-gaap:CorporateNonSegmentMember 2018-01-01 2018-09-28 0000313616 us-gaap:CorporateNonSegmentMember 2019-09-27 0000313616 us-gaap:CorporateNonSegmentMember 2018-12-31 xbrli:shares xbrli:pure iso4217:USD xbrli:shares iso4217:USD iso4217:CHF iso4217:JPY iso4217:EUR dhr:Business_Segments dhr:Business iso4217:DKK
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 ________________________________________________________
FORM 10-Q
 ________________________________________________________
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 27, 2019
OR
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from              to             
Commission File Number: 001-08089
dhrlogofor8ksa26.jpg
DANAHER CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
 
59-1995548
(State of Incorporation)
 
(I.R.S. Employer Identification Number)
 
 
2200 Pennsylvania Avenue, N.W., Suite 800W
 
20037-1701
Washington,
DC
 
(Address of Principal Executive Offices)
 
(Zip Code)
Registrant’s telephone number, including area code: 202-828-0850
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common stock, $0.01 par value
DHR
New York Stock Exchange
4.75% Mandatory Convertible Preferred Stock, Series A, without par value
DHR.PRA
New York Stock Exchange
Floating Rate Senior Notes due 2022
DHR F 06/30/22
New York Stock Exchange
1.700% Senior Notes due 2022
DHR 1.7 01/04/22
New York Stock Exchange
2.500% Senior Notes due 2025
DHR 2.5 07/08/25
New York Stock Exchange
0.200% Senior Notes due 2026
DHR 0.2 03/18/26
New York Stock Exchange
1.200% Senior Notes due 2027
DHR 1.2 06/30/27
New York Stock Exchange
0.450% Senior Notes due 2028
DHR 0.45 03/18/28
New York Stock Exchange
0.750% Senior Notes due 2031
DHR 0.75 09/18/31
New York Stock Exchange
1.350% Senior Notes due 2039
DHR 1.35 09/18/39
New York Stock Exchange
1.800% Senior Notes due 2049
DHR 1.8 09/18/49
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer
 
 
Accelerated Filer
 
 
 
 
 
Non-accelerated Filer
 
 
Smaller Reporting Company
 
 
 
 
 
 
 
 
Emerging Growth Company
 
 
 
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)    Yes      No  ☒
The number of shares of common stock outstanding at October 18, 2019 was 718,281,174.



DANAHER CORPORATION
INDEX
FORM 10-Q
 
 
Page
PART I -
FINANCIAL INFORMATION
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PART II -
OTHER INFORMATION
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 




DANAHER CORPORATION AND SUBSIDIARIES
CONSOLIDATED CONDENSED BALANCE SHEETS
($ and shares in millions, except per share amount)
(unaudited)
 
September 27, 2019
 
December 31, 2018
ASSETS
 
 
 
Current assets:
 
 
 
Cash and equivalents
$
14,252.1

 
$
787.8

Trade accounts receivable, net
3,467.1

 
3,489.6

Inventories:
 
 
 
Finished goods
1,085.2

 
1,031.2

Work in process
335.0

 
313.9

Raw materials
603.5

 
565.0

Total inventories
2,023.7

 
1,910.1

Prepaid expenses and other current assets
610.8

 
906.3

Total current assets
20,353.7

 
7,093.8

Property, plant and equipment, net of accumulated depreciation of $3,023.3 and $2,828.3, respectively
2,519.6

 
2,511.2

Other long-term assets
1,787.1

 
648.4

Goodwill
25,724.8

 
25,906.0

Other intangible assets, net
11,145.9

 
11,673.1

Total assets
$
61,531.1

 
$
47,832.5

LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
Current liabilities:
 
 
 
Notes payable and current portion of long-term debt
$
1,068.6

 
$
51.8

Trade accounts payable
1,606.8

 
1,712.8

Accrued expenses and other liabilities
3,258.6

 
3,076.9

Total current liabilities
5,934.0

 
4,841.5

Other long-term liabilities
5,865.3

 
5,075.8

Long-term debt
16,536.2

 
9,688.5

Stockholders’ equity:
 
 
 
Preferred stock, without par value, 15.0 million shares authorized; 1.65 million shares of 4.75% Mandatory Convertible Preferred Stock, Series A, issued and outstanding at September 27, 2019; no shares issued or outstanding at December 31, 2018
1,599.6

 

Common stock - $0.01 par value, 2.0 billion shares authorized; 835.0 million issued and 718.2 million outstanding at September 27, 2019; 817.9 million issued and 701.5 million outstanding at December 31, 2018
8.3

 
8.2

Additional paid-in capital
7,501.5

 
5,834.3

Retained earnings
26,481.2

 
25,163.0

Accumulated other comprehensive income (loss)
(3,088.3
)
 
(2,791.1
)
Total Danaher stockholders’ equity
32,502.3

 
28,214.4

Noncontrolling interests
693.3

 
12.3

Total stockholders’ equity
33,195.6

 
28,226.7

Total liabilities and stockholders’ equity
$
61,531.1

 
$
47,832.5

See the accompanying Notes to the Consolidated Condensed Financial Statements.

1


DANAHER CORPORATION AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF EARNINGS
($ and shares in millions, except per share amounts)
(unaudited)
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Sales
$
5,037.3

 
$
4,853.1

 
$
15,073.8

 
$
14,529.5

Cost of sales
(2,228.9
)
 
(2,162.6
)
 
(6,670.0
)
 
(6,378.3
)
Gross profit
2,808.4

 
2,690.5

 
8,403.8

 
8,151.2

Operating costs:
 
 
 
 
 
 
 
Selling, general and administrative expenses
(1,654.7
)
 
(1,558.6
)
 
(5,009.9
)
 
(4,798.4
)
Research and development expenses
(318.9
)
 
(301.2
)
 
(951.5
)
 
(911.6
)
Operating profit
834.8

 
830.7

 
2,442.4

 
2,441.2

Nonoperating income (expense):
 
 
 
 
 
 
 
Other income, net
4.4

 
9.1

 
15.9

 
25.2

Interest expense
(26.3
)
 
(41.3
)
 
(70.2
)
 
(123.6
)
Interest income
30.1

 
2.8

 
72.0

 
6.7

Earnings before income taxes
843.0

 
801.3

 
2,460.1

 
2,349.5

Income taxes
(169.1
)
 
(137.6
)
 
(721.1
)
 
(445.4
)
Net earnings
673.9

 
663.7

 
1,739.0

 
1,904.1

Less: net earnings attributable to noncontrolling interests
(5.9
)
 

 
(5.9
)
 

Net earnings attributable to Danaher stockholders
668.0

 
663.7

 
1,733.1

 
1,904.1

Mandatory convertible preferred stock dividends
(19.6
)
 

 
(48.8
)
 

Net earnings attributable to common stockholders
$
648.4

 
$
663.7

 
$
1,684.3

 
$
1,904.1

Net earnings per common share:
 
 
 
 
 
 
 
Basic
$
0.90

 
$
0.95

 
$
2.36

 
$
2.72

Diluted
$
0.89

 
$
0.93

 
$
2.32

 
$
2.68

Average common stock and common equivalent shares outstanding:
 
 
 
 
 
 
 
Basic
718.8

 
701.4

 
714.7

 
700.1

Diluted
729.3

 
710.6

 
725.2

 
709.9


See the accompanying Notes to the Consolidated Condensed Financial Statements.


2


DANAHER CORPORATION AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME
($ in millions)
(unaudited)
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Net earnings
$
673.9

 
$
663.7

 
$
1,739.0

 
$
1,904.1

Other comprehensive income (loss), net of income taxes:
 
 
 
 
 
 
 
Foreign currency translation adjustments
(235.8
)
 
(162.4
)
 
(293.1
)
 
(509.4
)
Pension and postretirement plan benefit adjustments
5.8

 
5.9

 
15.8

 
19.7

Unrealized gain (loss) on available-for-sale securities adjustments
0.5

 

 
1.4

 
(0.6
)
Cash flow hedge adjustments
(41.8
)
 

 
(48.6
)
 

Total other comprehensive income (loss), net of income taxes
(271.3
)
 
(156.5
)
 
(324.5
)
 
(490.3
)
Comprehensive income
402.6

 
507.2

 
1,414.5

 
1,413.8

Less: comprehensive income attributable to noncontrolling interests
(4.7
)
 

 
(4.7
)
 

Comprehensive income attributable to Danaher
$
397.9

 
$
507.2

 
$
1,409.8

 
$
1,413.8

See the accompanying Notes to the Consolidated Condensed Financial Statements.

3


DANAHER CORPORATION AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS’ EQUITY
($ in millions)
(unaudited)
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Preferred stock
 
 
 
 
 
 
 
Balance, beginning of period
$
1,599.6

 
$

 
$

 
$

Issuance of Mandatory Convertible Preferred Stock

 

 
1,599.6

 

Balance, end of period
$
1,599.6

 
$

 
$
1,599.6

 
$

Common stock
 
 
 
 
 
 
 
Balance, beginning of period
$
8.3

 
$
8.2

 
$
8.2

 
$
8.1

Common stock-based award activity

 

 

 
0.1

Issuance of common stock

 

 
0.1

 

Balance, end of period
$
8.3

 
$
8.2

 
$
8.3

 
$
8.2

Additional paid-in capital
 
 
 
 
 
 
 
Balance, beginning of period
$
7,482.6

 
$
5,706.1

 
$
5,834.3

 
$
5,538.2

Common stock-based award activity
77.6

 
66.1

 
253.2

 
194.0

Common stock issued in connection with acquisitions

 

 

 
23.9

Common stock issued in connection with LYONs’ conversions, including tax benefit of $0.4, $0.0, $8.5 and $4.2, respectively
1.3

 

 
30.9

 
16.1

Issuance of common stock

 

 
1,443.1

 

Sale of Envista Holdings Corporation Common Stock
(60.0
)
 

 
(60.0
)
 

Balance, end of period
$
7,501.5

 
$
5,772.2

 
$
7,501.5

 
$
5,772.2

Retained earnings
 
 
 
 
 
 
 
Balance, beginning of period
$
25,955.0

 
$
23,977.2

 
$
25,163.0

 
$
22,806.1

Adoption of accounting standards

 

 

 
154.5

Net earnings attributable to Danaher stockholders
668.0

 
663.7

 
1,733.1

 
1,904.1

Dividends declared
(122.2
)
 
(112.2
)
 
(366.1
)
 
(336.0
)
Mandatory Convertible Preferred Stock cumulative dividends
(19.6
)
 

 
(48.8
)
 

Balance, end of period
$
26,481.2

 
$
24,528.7

 
$
26,481.2

 
$
24,528.7

Accumulated other comprehensive income (loss)
 
 
 
 
 
 
 
Balance, beginning of period
$
(2,844.3
)
 
$
(2,479.2
)
 
$
(2,791.1
)
 
$
(1,994.2
)
Adoption of accounting standards

 

 

 
(151.2
)
Sale of Envista Holdings Corporation Common Stock
26.1

 

 
26.1

 

Other comprehensive income (loss)
(270.1
)
 
(156.5
)
 
(323.3
)
 
(490.3
)
Balance, end of period
$
(3,088.3
)
 
$
(2,635.7
)
 
$
(3,088.3
)
 
$
(2,635.7
)
Noncontrolling interests
 
 
 
 
 
 
 
Balance, beginning of period
$
12.0

 
$
12.1

 
$
12.3

 
$
9.6

Sale of Envista Holdings Corporation Common Stock
676.7

 

 
676.7

 

Change in noncontrolling interests
4.6

 
(0.3
)
 
4.3

 
2.2

Balance, end of period
$
693.3

 
$
11.8

 
$
693.3

 
$
11.8

Total stockholders’ equity, end of period
$
33,195.6

 
$
27,685.2

 
$
33,195.6

 
$
27,685.2

See the accompanying Notes to the Consolidated Condensed Financial Statements.

4


DANAHER CORPORATION AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
($ in millions)
(unaudited)
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
Cash flows from operating activities:
 
 
 
Net earnings
$
1,739.0

 
$
1,904.1

Noncash items:
 
 
 
Depreciation
450.3

 
449.4

Amortization
536.6

 
527.5

Stock-based compensation expense
130.0

 
111.6

Change in trade accounts receivable, net
(26.3
)
 
128.6

Change in inventories
(169.4
)
 
(255.4
)
Change in trade accounts payable
(81.5
)
 
71.5

Change in prepaid expenses and other assets
225.4

 
245.6

Change in accrued expenses and other liabilities
36.3

 
(398.5
)
Net operating cash provided by operating activities
2,840.4

 
2,784.4

Cash flows from investing activities:
 
 
 
Cash paid for acquisitions
(331.1
)
 
(2,173.3
)
Payments for additions to property, plant and equipment
(518.4
)
 
(441.3
)
Proceeds from sales of property, plant and equipment
14.1

 
1.6

Payments for purchases of investments
(165.5
)
 
(61.1
)
Proceeds from sale of investments

 
22.1

All other investing activities
28.9

 

Net operating cash used in investing activities
(972.0
)
 
(2,652.0
)
Cash flows from financing activities:
 
 
 
Proceeds from the issuance of common stock in connection with stock-based compensation
115.0

 
77.3

Proceeds from the sale of common stock, net of issuance costs
1,443.2

 

Proceeds from the sale of preferred stock, net of issuance costs
1,599.6

 

Proceeds from the sale of Envista Holdings Corporation Common Stock, net of issuance costs
643.4

 

Payment of dividends
(385.0
)
 
(321.2
)
Net proceeds from borrowings (maturities of 90 days or less)
744.1

 
882.1

Proceeds from borrowings (maturities longer than 90 days)
8,137.1

 

Net repayments of borrowings (maturities longer than 90 days)
(680.9
)
 
(503.9
)
All other financing activities
(6.0
)
 
(16.6
)
Net operating cash provided by financing activities
11,610.5

 
117.7

Effect of exchange rate changes on cash and equivalents
(14.6
)
 
(104.2
)
Net change in cash and equivalents
13,464.3

 
145.9

Beginning balance of cash and equivalents
787.8

 
630.3

Ending balance of cash and equivalents
$
14,252.1

 
$
776.2

 
 
 
 
Supplemental disclosures:
 
 
 
Cash interest payments
$
112.9

 
$
129.0

Cash income tax payments
494.8

 
502.0

See the accompanying Notes to the Consolidated Condensed Financial Statements.

5


DANAHER CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
(unaudited)

NOTE 1. GENERAL
The Consolidated Condensed Financial Statements included herein have been prepared by Danaher Corporation (“Danaher” or the “Company”) without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In this quarterly report, the terms “Danaher” or the “Company” refer to Danaher Corporation, Danaher Corporation and its consolidated subsidiaries (including Envista Holdings Corporation (“Envista”), unless otherwise indicated or the context otherwise requires) or the consolidated subsidiaries of Danaher Corporation (including Envista, unless otherwise indicated or the context otherwise requires), as the context requires. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted pursuant to SEC rules and regulations; however, the Company believes that the disclosures are adequate to make the information presented not misleading. The Consolidated Condensed Financial Statements included herein should be read in conjunction with the financial statements as of and for the year ended December 31, 2018 and the Notes thereto included in the Company’s 2018 Annual Report on Form 10-K filed on February 21, 2019 (the “2018 Annual Report” or “2018 Annual Report on Form 10-K”).
In the opinion of the Company, the accompanying financial statements contain all adjustments (consisting of only normal recurring accruals) necessary to present fairly the financial position of the Company as of September 27, 2019 and December 31, 2018, its results of operations for the three and nine-month periods ended September 27, 2019 and September 28, 2018 and its cash flows for each of the nine-month periods then ended.
Accounting Standards Recently Adopted
In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842), which requires lessees to recognize a right-of-use (“ROU”) asset and a lease liability for all leases with terms greater than 12 months and also requires disclosures by lessees and lessors about the amount, timing and uncertainty of cash flows arising from leases. The accounting applied by a lessor is largely unchanged from that applied under the prior standard. Subsequent to the issuance of Topic 842, the FASB clarified the guidance through several ASUs; hereinafter the collection of lease guidance is referred to as “ASC 842”.
On January 1, 2019, the Company adopted ASC 842 using the modified retrospective method for all lease arrangements at the beginning of the period of adoption. Results for reporting periods beginning January 1, 2019 are presented under ASC 842, while prior period amounts were not adjusted and continue to be reported in accordance with the Company’s historic accounting under ASC 840, Leases (“ASC 840”). The standard had a material impact on the Company’s Consolidated Condensed Balance Sheet but did not have a significant impact on the Company’s consolidated net earnings and cash flows. The most significant impact was the recognition of ROU assets and lease liabilities for operating leases, while the accounting for finance leases remained substantially unchanged. For leases that commenced before the effective date of ASC 842, the Company elected the permitted practical expedients to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. The Company also elected to include leases with a term of 12 months or less in the recognized ROU assets and lease liabilities.
As a result of the cumulative impact of adopting ASC 842, the Company recorded operating lease ROU assets of $971 million and operating lease liabilities of $1,012 million as of January 1, 2019, primarily related to real estate and automobile leases, based on the present value of the future lease payments on the date of adoption. Refer to Note 5 for the additional disclosures required by ASC 842.
The Company determines if an arrangement is a lease at inception. For leases where the Company is the lessee, ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The ROU asset also consists of any prepaid lease payments, lease incentives received, costs which will be incurred in exiting a lease and the amount of any asset or liability recognized on business combinations relating to favorable or unfavorable lease terms. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as depreciation expense and interest expense using the accelerated interest

6


method of recognition. The Company has lease agreements which require payments for lease and non-lease components and has elected to account for these as a single lease component.
The Company leases Life Sciences, Diagnostics, and Environmental & Applied Solutions equipment to customers in both operating-type lease (“OTL”) and sales-type lease (“STL”) arrangements. Equipment lease revenue for OTL agreements is recognized on a straight-line basis over the life of the lease, and the costs of customer-leased equipment are recorded within property, plant and equipment, net in the accompanying Consolidated Condensed Balance Sheets and depreciated over the equipment’s estimated useful life. Depreciation expense associated with the leased equipment under OTL arrangements is reflected in cost of sales in the accompanying Consolidated Condensed Statements of Earnings. The OTLs are generally not cancellable until after an initial term and may or may not require the customer to purchase a minimum number of consumables or tests throughout the contract term. Certain of the Company’s lease contracts are customized for larger customers and often result in complex terms and conditions that typically require significant judgment in applying the criteria used to evaluate whether the arrangement should be considered an OTL or an STL. An STL results in earlier recognition of equipment revenue as compared to an OTL. Some of the Company’s leases include a purchase option for the customer to purchase the leased asset at the end of the lease arrangement for a purchase price equal to the asset’s fair market value at the time of the purchase. The Company manages its risk on the unguaranteed residual asset for leased equipment through the pricing and term of the leases. In certain geographies, equipment coming off OTL and STL arrangements after the initial lease term may be leased to other customers or used for spare parts.
For lease arrangements with lease and non-lease components where the Company is the lessor, the Company allocates the contract’s transaction price to the lease and non-lease components on a relative standalone selling price basis using the Company’s best estimate of the standalone selling price of each distinct product or service in the contract. The primary method used to estimate standalone selling price is the price observed in standalone sales to customers; however, when prices in standalone sales are not available the Company may use third-party pricing for similar products or services or estimate the standalone selling price. Allocation of the transaction price is determined at the inception of the lease arrangement. The Company’s leases primarily consist of leases with fixed lease payments. For those leases with variable lease payments, the variable lease payment is typically based upon use of the leased equipment or the purchase of consumables used with the leased equipment.
In August 2017, the FASB issued ASU No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities, which expands and refines hedge accounting for both financial and non-financial risk components, aligns the recognition and presentation of the effects of hedging instruments and hedge items in the financial statements and includes certain targeted improvements to ease the application of current guidance related to the assessment of hedge effectiveness. The ASU was effective for public entities for fiscal years beginning after December 15, 2018. In January 2019, the Company entered into approximately $1.9 billion of cross-currency swap derivative contracts to hedge its net investment in foreign operations against adverse changes in the exchange rates between the U.S. dollar and the Danish kroner, Japanese yen, euro and Swiss franc. In June 2019, the Company entered into interest rate swap agreements with a notional amount of $850 million which represents a portion of the amount of U.S. dollar-denominated bonds (with terms ranging from 10 to 30 years) the Company anticipates issuing to finance a portion of the acquisition of the Biopharma Business of General Electric Company (“GE”) Life Sciences (the “GE Biopharma Business” or “GE Biopharma”). These contracts effectively fixed the interest rate for a portion of the Company’s anticipated U.S. dollar-denominated debt issuance equal to the notional amount of the swaps to the rate specified in the interest rate swap agreements. Refer to Note 8 for additional disclosures about the Company’s debt issuances related to the pending GE Biopharma acquisition and Note 9 for additional disclosures about the Company’s hedging activities.
In addition to the cross-currency swaps entered into by the Company in January 2019, in September 2019, Envista entered into $650 million of cross-currency swap derivative contracts with respect to its senior unsecured term loan facility. These contracts effectively convert the senior unsecured term loan facility to an obligation denominated in euro and partially offset the impact of changes in currency rates on Envista’s euro-denominated net investments in foreign operations. In addition, Envista entered into $650 million of interest rate swap derivative contracts to convert the variable interest rate for the senior unsecured term loan facility to a fixed interest rate.
Except for the above accounting policy for leases that was updated as a result of adopting ASC 842, there have been no changes to the Company’s significant accounting policies described in the Annual Report on Form 10-K for the year ended December 31, 2018 that have a material impact on the Company’s Consolidated Condensed Financial Statements and the related Notes.
Accounting Standards Not Yet Adopted
In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which amends the impairment model by requiring entities to use a forward-looking approach

7


based on expected losses rather than incurred losses to estimate credit losses on certain types of financial instruments, including trade receivables. This may result in the earlier recognition of allowances for losses. The ASU is effective for public entities for fiscal years beginning after December 15, 2019, with early adoption permitted. The ASU will be adopted using a modified retrospective transition method, with the adoption impact recognized through a cumulative-effect adjustment to retained earnings in the period of adoption. In November 2018, April 2019 and May 2019, the FASB issued ASU No. 2018-19, Codification Improvements to Topic 326, Financial Instruments-Credit Losses, ASU No. 2019-04, Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments and ASU No. 2019-05, Financial Instruments-Credit Losses (Topic 326): Targeted Transition Relief which provided additional implementation guidance on the previously issued ASU. Management has not yet completed its assessment of the impact of the new standard on the Company’s financial statements. The Company is in the process of implementing changes to its accounting policies and processes for the new standard. Currently, the Company believes that the most notable impact of this ASU will relate to its processes around the assessment of the adequacy of its allowance for doubtful accounts on trade accounts receivable and the recognition of credit losses.
In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820), which modifies the disclosures on fair value measurements by removing the requirement to disclose the amount and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy and the policy for timing of such transfers. The ASU expands the disclosure requirements for Level 3 fair value measurements, primarily focused on changes in unrealized gains and losses included in other comprehensive income (loss). The ASU is effective for public entities for fiscal years beginning after December 15, 2019, with early adoption permitted. Management has not yet completed its assessment of the impact of the new standard on the Company’s financial statements.
In August 2018, the FASB issued ASU No. 2018-14, Disclosure Framework—Changes to the Disclosure Requirements for Defined Benefit Plans, which amends ASC 715, Compensation—Retirement Benefits, to add, remove, and clarify disclosure requirements related to defined benefit pension and other postretirement plans. The ASU is effective for public entities for fiscal years beginning after December 15, 2020, with early adoption permitted. Management has not yet completed its assessment of the impact of the new standard on the Company’s financial statements.

8


Accumulated Other Comprehensive Income (Loss)—Accumulated other comprehensive income (loss) refers to certain gains and losses that under U.S. GAAP are included in comprehensive income (loss) but are excluded from net earnings as these amounts are initially recorded as an adjustment to stockholders’ equity. The changes in accumulated other comprehensive income (loss) by component are summarized below ($ in millions). Foreign currency translation adjustments generally relate to indefinite investments in non-U.S. subsidiaries, as well as the impact from the Company’s hedges of its net investment in foreign operations, including the Company’s cross-currency swap derivatives, net of any tax impacts.
 
Foreign Currency Translation Adjustments
 
Pension & Postretirement Plan Benefit Adjustments
 
Unrealized Gain (Loss) on Available-For-Sale Securities Adjustments
 
Cash Flow Hedge Adjustments
 
Total
 
For the Three-Month Period Ended September 27, 2019:
 
 
 
Balance, June 28, 2019
$
(2,155.4
)
 
$
(681.1
)
 
$
(1.0
)
 
$
(6.8
)
 
$
(2,844.3
)
 
Other comprehensive income (loss) before reclassifications:
 
 
 
 
 
 
 
 
 
 
(Decrease) increase
(226.8
)
 

 
0.6

 
(55.1
)
 
(281.3
)
 
Income tax impact
(9.0
)
 

 
(0.1
)
 
13.3

 
4.2

 
Other comprehensive income (loss) before reclassifications, net of income taxes
(235.8
)
 

 
0.5

 
(41.8
)
 
(277.1
)
 
Amounts reclassified from accumulated other comprehensive income (loss):
 
 
 
 
 
 
 
 
 
 
Increase

 
7.5

(a)

 

 
7.5

 
Income tax impact

 
(1.7
)
 

 

 
(1.7
)
 
Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes

 
5.8

 

 

 
5.8

 
Net current period other comprehensive income (loss), net of income taxes
(235.8
)
 
5.8

 
0.5

 
(41.8
)
 
(271.3
)
(b)
Balance, September 27, 2019
$
(2,391.2
)
 
$
(675.3
)
 
$
(0.5
)
 
$
(48.6
)
 
(3,115.6
)
 
Less: accumulated other comprehensive income attributable to noncontrolling interests
 
(27.3
)
 
Accumulated other comprehensive income attributable to controlling interests
 
$
(3,088.3
)
 
For the Three-Month Period Ended September 28, 2018:
 
 
 
Balance, June 29, 2018
$
(1,812.9
)
 
$
(664.6
)
 
$
(1.7
)
 
$

 
$
(2,479.2
)
 
Other comprehensive income (loss) before reclassifications:
 
 
 
 
 
 
 
 
 
 
Decrease
(162.4
)
 

 

 

 
(162.4
)
 
Income tax impact

 

 

 

 

 
Other comprehensive income (loss) before reclassifications, net of income taxes
(162.4
)
 

 

 

 
(162.4
)
 
Amounts reclassified from accumulated other comprehensive income (loss):
 
 
 
 
 
 
 
 
 
 
Increase

 
7.7

(a)

 

 
7.7

 
Income tax impact

 
(1.8
)
 

 

 
(1.8
)
 
Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes

 
5.9

 

 

 
5.9

 
Net current period other comprehensive income (loss), net of income taxes
(162.4
)
 
5.9

 

 

 
(156.5
)
 
Balance, September 28, 2018
$
(1,975.3
)
 
$
(658.7
)
 
$
(1.7
)
 
$

 
$
(2,635.7
)
 
(a) This accumulated other comprehensive income (loss) component is included in the computation of net periodic pension cost. Refer to Note 10 for additional details.
(b) Accumulated other comprehensive income (loss) for the three-month period ended September 27, 2019 consists of $270.1 million of accumulated other comprehensive loss attributable to controlling interest and $1.2 million of accumulated other comprehensive loss attributable to noncontrolling interest.

9


 
Foreign Currency Translation Adjustments
 
Pension & Postretirement Plan Benefit Adjustments
 
Unrealized Gain (Loss) on Available-For-Sale Securities Adjustments
 
Cash Flow Hedge Adjustments
 
Total
 
For the Nine-Month Period Ended September 27, 2019:
 
 
 
Balance, December 31, 2018
$
(2,098.1
)
 
$
(691.1
)
 
$
(1.9
)
 
$

 
$
(2,791.1
)
 
Other comprehensive income (loss) before reclassifications:
 
 
 
 
 
 
 
 
 
 
(Decrease) increase
(286.0
)
 

 
1.8

 
(64.0
)
 
(348.2
)
 
Income tax impact
(7.1
)
 

 
(0.4
)
 
15.4

 
7.9

 
Other comprehensive income (loss) before reclassifications, net of income taxes
(293.1
)
 

 
1.4

 
(48.6
)
 
(340.3
)
 
Amounts reclassified from accumulated other comprehensive income (loss):
 
 
 
 
 
 
 
 
 
 
Increase

 
20.7

(a)

 

 
20.7

 
Income tax impact

 
(4.9
)
 

 

 
(4.9
)
 
Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes

 
15.8

 

 

 
15.8

 
Net current period other comprehensive income (loss), net of income taxes
(293.1
)
 
15.8

 
1.4

 
(48.6
)
 
(324.5
)
(b)
Balance, September 27, 2019
$
(2,391.2
)
 
$
(675.3
)
 
$
(0.5
)
 
$
(48.6
)
 
(3,115.6
)
 
Less: accumulated other comprehensive income attributable to noncontrolling interests
 
(27.3
)
 
Accumulated other comprehensive income attributable to controlling interests
 
$
(3,088.3
)
 
For the Nine-Month Period Ended September 28, 2018:
 
 
 
Balance, December 31, 2017
$
(1,422.1
)
 
$
(571.2
)
 
$
(0.9
)
 
$

 
$
(1,994.2
)
 
Adoption of accounting standards
(43.8
)
 
(107.2
)
 
(0.2
)
 

 
(151.2
)
 
Balance, January 1, 2018
(1,465.9
)
 
(678.4
)
 
(1.1
)
 

 
(2,145.4
)
 
Other comprehensive income (loss) before reclassifications:
 
 
 
 
 
 
 
 
 
 
Decrease
(509.4
)
 

 
(0.8
)
 

 
(510.2
)
 
Income tax impact

 

 
0.2

 

 
0.2

 
Other comprehensive income (loss) before reclassifications, net of income taxes
(509.4
)
 

 
(0.6
)
 

 
(510.0
)
 
Amounts reclassified from accumulated other comprehensive income (loss):
 
 
 
 
 
 
 
 
 
 
Increase

 
25.8

(a)

 

 
25.8

 
Income tax impact

 
(6.1
)
 

 

 
(6.1
)
 
Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes

 
19.7

 

 

 
19.7

 
Net current period other comprehensive income (loss), net of income taxes
(509.4
)
 
19.7

 
(0.6
)
 

 
(490.3
)
 
Balance, September 28, 2018
$
(1,975.3
)
 
$
(658.7
)
 
$
(1.7
)
 
$

 
$
(2,635.7
)
 

(a) This accumulated other comprehensive income (loss) component is included in the computation of net periodic pension cost. Refer to Note 10 for additional details.
(b) Accumulated other comprehensive income (loss) for the nine-month period ended September 27, 2019 consists of $323.3 million of accumulated other comprehensive loss attributable to controlling interest and $1.2 million of accumulated other comprehensive loss attributable to noncontrolling interest.


10


NOTE 2. REVENUE
The following tables present the Company’s revenues disaggregated by geographical region and revenue type for the three and nine-month periods ended September 27, 2019 and September 28, 2018 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenue.
 
Life Sciences
 
Diagnostics
 
Dental / Envista
 
Environmental & Applied Solutions
 
Total
Three-month period ended September 27, 2019:
 
 
 
 
 
 
 
 
 
Geographical region:
 
 
 
 
 
 
 
 
 
North America
$
637.2

 
$
602.9

 
$
327.7

 
$
465.5

 
$
2,033.3

Western Europe
444.1

 
257.9

 
127.5

 
252.8

 
1,082.3

Other developed markets
149.2

 
108.4

 
45.6

 
32.5

 
335.7

High-growth markets (a)
465.1

 
632.7

 
158.5

 
329.7

 
1,586.0

Total
$
1,695.6

 
$
1,601.9

 
$
659.3

 
$
1,080.5

 
$
5,037.3

 
 
 
 
 
 
 
 
 
 
Revenue type:
 
 
 
 
 
 
 
 
 
Recurring
$
1,084.3

 
$
1,343.2

 
$
479.4

 
$
595.2

 
$
3,502.1

Nonrecurring
611.3

 
258.7

 
179.9

 
485.3

 
1,535.2

Total
$
1,695.6

 
$
1,601.9

 
$
659.3

 
$
1,080.5

 
$
5,037.3

 
 
 
 
 
 
 
 
 
 
Three-month period ended September 28, 2018:
 
 
 
 
 
 
 
 
 
Geographical region:
 
 
 
 
 
 
 
 
 
North America
$
584.0

 
$
574.0

 
$
339.8

 
$
439.7

 
$
1,937.5

Western Europe
447.1

 
262.3

 
137.2

 
257.5

 
1,104.1

Other developed markets
134.5

 
91.8

 
42.5

 
31.0

 
299.8

High-growth markets (a)
431.1

 
574.4

 
160.0

 
346.2

 
1,511.7

Total
$
1,596.7

 
$
1,502.5

 
$
679.5

 
$
1,074.4

 
$
4,853.1

 
 
 
 
 
 
 
 
 
 
Revenue type:
 
 
 
 
 
 
 
 
 
Recurring
$
1,030.9

 
$
1,273.3

 
$
478.2

 
$
571.1

 
$
3,353.5

Nonrecurring
565.8

 
229.2

 
201.3

 
503.3

 
1,499.6

Total
$
1,596.7

 
$
1,502.5

 
$
679.5

 
$
1,074.4

 
$
4,853.1




11



 
Life Sciences
 
Diagnostics
 
Dental / Envista
 
Environmental & Applied Solutions
 
Total
Nine-month period ended September 27, 2019:
 
 
 
 
 
 
 
 
 
Geographical region:
 
 
 
 
 
 
 
 
 
North America
$
1,878.1

 
$
1,836.3

 
$
966.4

 
$
1,403.0

 
$
6,083.8

Western Europe
1,363.7

 
828.5

 
443.7

 
774.1

 
3,410.0

Other developed markets
436.1

 
295.6

 
131.0

 
92.7

 
955.4

High-growth markets (a)
1,357.2

 
1,796.6

 
490.0

 
980.8

 
4,624.6

Total
$
5,035.1

 
$
4,757.0

 
$
2,031.1

 
$
3,250.6

 
$
15,073.8

 
 
 
 
 
 
 
 
 
 
Revenue type:
 
 
 
 
 
 
 
 
 
Recurring
$
3,264.4

 
$
4,047.9

 
$
1,489.3

 
$
1,770.2

 
$
10,571.8

Nonrecurring
1,770.7

 
709.1

 
541.8

 
1,480.4

 
4,502.0

Total
$
5,035.1

 
$
4,757.0

 
$
2,031.1

 
$
3,250.6

 
$
15,073.8

 
 
 
 
 
 
 
 
 
 
Nine-month period ended September 28, 2018:
 
 
 
 
 
 
 
 
 
Geographical region:
 
 
 
 
 
 
 
 
 
North America
$
1,642.4

 
$
1,760.1

 
$
977.2

 
$
1,308.7

 
$
5,688.4

Western Europe
1,346.5

 
861.4

 
483.3

 
785.5

 
3,476.7

Other developed markets
417.9

 
275.3

 
133.5

 
94.9

 
921.6

High-growth markets (a)
1,271.1

 
1,676.3

 
491.5

 
1,003.9

 
4,442.8

Total
$
4,677.9

 
$
4,573.1

 
$
2,085.5

 
$
3,193.0

 
$
14,529.5

 
 
 
 
 
 
 
 
 
 
Revenue type:
 
 
 
 
 
 
 
 
 
Recurring
$
3,057.3

 
$
3,892.8

 
$
1,513.5

 
$
1,702.7

 
$
10,166.3

Nonrecurring
1,620.6

 
680.3

 
572.0

 
1,490.3

 
4,363.2

Total
$
4,677.9

 
$
4,573.1

 
$
2,085.5

 
$
3,193.0

 
$
14,529.5


(a) The Company defines high-growth markets as developing markets of the world experiencing extended periods of accelerated growth in gross domestic product and infrastructure which include Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia). The Company defines developed markets as all markets that are not high-growth markets.
The Company sells equipment to customers as well as consumables, spare parts, software licenses and services, some of which customers purchase on a recurring basis. In most of the Company’s businesses, consumables are typically critical to the use of the equipment and are typically used on a one-time or limited basis, requiring frequent replacement in the customer’s operating cycle. Examples of these consumables include reagents used in diagnostic tests, filters used in filtration, separation and purification processes and cartridges for marking and coding equipment. Additionally, some of the Company’s consumables are used on a standalone basis, such as dental implants and water treatment solutions. The Company separates its goods and services between those sold on a recurring basis and those sold on a nonrecurring basis. Recurring revenue includes revenue from consumables, services, spare parts, software licenses recognized over time, software-as-a-service, sales-and-usage based royalties and OTLs. Nonrecurring revenue includes sales from equipment, software licenses recognized at a point in time and STLs. OTLs and STLs are included in the above revenue amounts. For the three-month periods ended September 27, 2019 and September 28, 2018, revenue accounted for under ASC 842 and ASC 840 was $108 million and $115 million, respectively. For the nine-month periods ended September 27, 2019 and September 28, 2018, revenue accounted for under ASC 842 and ASC 840 was $321 million and $308 million, respectively.
Remaining performance obligations related to Topic 606, Revenue from Contracts with Customers (“ASC 606”) represent the aggregate transaction price allocated to performance obligations with an original contract term greater than one year which are fully or partially unsatisfied at the end of the period. As of September 27, 2019, the aggregate amount of the transaction price allocated to remaining performance obligations was approximately $2.0 billion. The Company expects to recognize revenue on

12


approximately 39% of the remaining performance obligations over the next 12 months, 25% over the subsequent 12 months, and the remainder thereafter.
The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets) and deferred revenue, customer deposits and billings in excess of revenue recognized (contract liabilities) on the Consolidated Condensed Balance Sheets. Most of the Company’s long-term contracts are billed as work progresses in accordance with the contract terms and conditions, either at periodic intervals or upon achievement of certain milestones. Often this results in billing occurring subsequent to revenue recognition resulting in contract assets. Contract assets are generally classified as other current assets in the Consolidated Condensed Balance Sheets. The balance of contract assets as of September 27, 2019 and December 31, 2018 were $77 million and $82 million, respectively.
The Company often receives cash payments from customers in advance of the Company’s performance resulting in contract liabilities. These contract liabilities are classified as either current or long-term in the Consolidated Condensed Balance Sheets based on the timing of when the Company expects to recognize revenue. As of September 27, 2019 and December 31, 2018, contract liabilities were $801 million and $799 million, respectively, and are included within accrued expenses and other liabilities and other long-term liabilities in the accompanying Consolidated Condensed Balance Sheets. Revenue recognized during the nine-month periods ended September 27, 2019 and September 28, 2018 that was included in the contract liability balance on December 31, 2018 and at the date of adoption of ASC 606 on January 1, 2018 was $544 million and $568 million, respectively. Contract assets and liabilities are reported on the accompanying Consolidated Condensed Balance Sheets on a contract-by-contract basis.

NOTE 3. ACQUISITIONS
For a description of the Company’s acquisition activity for the year ended December 31, 2018, reference is made to the financial statements as of and for the year ended December 31, 2018 and Note 3 thereto included in the Company’s 2018 Annual Report.
The Company continually evaluates potential acquisitions that either strategically fit with the Company’s existing portfolio or expand the Company’s portfolio into a new and attractive business area. The Company has completed a number of acquisitions that have been accounted for as purchases and have resulted in the recognition of goodwill in the Company’s financial statements. This goodwill arises because the purchase prices for these businesses reflect a number of factors including the future earnings and cash flow potential of these businesses, the multiple to earnings, cash flow and other factors at which similar businesses have been purchased by other acquirers, the competitive nature of the processes by which the Company acquired the businesses, avoidance of the time and costs which would be required (and the associated risks that would be encountered) to enhance the Company’s existing product offerings to key target markets and enter into new and profitable businesses and the complementary strategic fit and resulting synergies these businesses bring to existing operations.
The Company makes an initial allocation of the purchase price at the date of acquisition based upon its understanding of the fair value of the acquired assets and assumed liabilities. The Company obtains this information during due diligence and through other sources. In the months after closing, as the Company obtains additional information about these assets and liabilities, including through tangible and intangible asset appraisals, and learns more about the newly acquired business, it is able to refine the estimates of fair value and more accurately allocate the purchase price. Only items identified as of the acquisition date are considered for subsequent adjustment. The Company is continuing to evaluate certain pre-acquisition contingencies associated with its 2019 acquisitions and is also in the process of obtaining valuations of acquired intangible assets and certain acquisition-related liabilities in connection with these acquisitions. The Company will make appropriate adjustments to the purchase price allocation prior to completion of the measurement period, as required.
During the nine-month period ended September 27, 2019, the Company acquired five businesses for total consideration of $331 million in cash, net of cash acquired. The businesses acquired complement existing units of the Life Sciences, Diagnostics and Environmental & Applied Solutions segments. The aggregate annual sales of these businesses at the time of their acquisition, based on the companies’ revenues for their last completed fiscal year prior to the acquisition, were $72 million. The Company preliminarily recorded an aggregate of $215 million of goodwill related to these acquisitions.

13


The following summarizes the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition for the acquisitions consummated during the nine-month period ended September 27, 2019 ($ in millions):
Trade accounts receivable
$
8.6

Inventories
8.8

Property, plant and equipment
3.9

Goodwill
214.9

Other intangible assets, primarily customer relationships, trade names and technology
112.3

Trade accounts payable
(2.8
)
Other assets and liabilities, net
(14.6
)
Net cash consideration
$
331.1


Pro Forma Financial Information
The unaudited pro forma information for the periods set forth below gives effect to the 2019 and 2018 acquisitions as if they had occurred as of January 1, 2018. The pro forma information is presented for informational purposes only and is not necessarily indicative of the results of operations that actually would have been achieved had the acquisitions been consummated as of that time ($ in millions, except per share amounts):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Sales
$
5,037.3

 
$
4,873.4

 
$
15,082.6

 
$
14,685.8

Net earnings attributable to common stockholders
648.4

 
658.1

 
1,681.2

 
1,888.5

Diluted net earnings per share
0.89

 
0.93

 
2.32

 
2.66


Acquisition-related transaction costs of $15 million associated with the IDT acquisition were excluded from pro forma earnings in 2018.
Pending Acquisition
On February 25, 2019, the Company entered into an Equity and Asset Purchase Agreement (the “GE Biopharma Purchase Agreement”) with GE to acquire the GE Biopharma Business for a cash purchase price of approximately $21.0 billion, subject to certain adjustments, and the assumption of approximately $0.4 billion of pension liabilities (the “GE Biopharma Acquisition”). The GE Biopharma Business is a leading provider of instruments, consumables and software that support the research, discovery, process development and manufacturing workflows of biopharmaceutical drugs. Based on audited carve-out financial statements provided by GE, the GE Biopharma Business generated revenues of approximately $3.0 billion in 2018. The Company expects to include the GE Biopharma Business within the Life Sciences segment. The GE Biopharma Acquisition is expected to provide additional sales and earnings growth opportunities for the Company’s Life Sciences segment by expanding the business’ geographic and product line diversity, including new product and service offerings that complement the Company’s current biologics workflow solutions. As a condition to obtaining certain regulatory approvals for the closing of the transaction, the Company will be required to divest certain of its existing product lines. In furtherance thereof, on October 18, 2019, the Company signed an agreement to sell certain of its product lines, contingent upon the Company closing the GE Biopharma Acquisition. These product lines had annual revenue in 2018 of $140 million. Though the timing of obtaining the regulatory approvals necessary to close the GE Biopharma Acquisition is uncertain, the Company continues to make progress with respect thereto and expects to close the transaction in the first quarter of 2020.
The Company expects to finance the GE Biopharma Acquisition with approximately $3.0 billion of proceeds from the March 1, 2019 underwritten public offerings of its Common Stock and Mandatory Convertible Preferred Stock (“MCPS”), proceeds from the September 2019 issuance of debt, proceeds from the issuance of additional debt or other borrowings and available cash on hand. Refer to Note 8 for additional information related to the issuance of debt and to Note 14 for additional information related to the March 1, 2019 public offerings.

NOTE 4. ENVISTA INITIAL PUBLIC OFFERING
On September 20, 2019, Envista, a subsidiary of the Company, completed an underwritten initial public offering (the “Envista IPO”) of 30.8 million shares of its common stock, which represents 19.4% of Envista’s outstanding shares, at a public offering

14


price of $22.00 per share (the “IPO price”). Envista shares trade on the New York Stock Exchange under the symbol “NVST”. Envista realized net proceeds of $643 million from the Envista IPO, after deducting underwriting discounts and deal expenses.
In connection with the completion of the Envista IPO, through a series of equity and other transactions, the Company transferred its dental businesses to Envista. In exchange, Envista transferred consideration of approximately $2.0 billion to the Company, which consists primarily of the net proceeds from the Envista IPO and approximately $1.3 billion of proceeds from Envista’s term debt financing. The excess of the net book value of the business transferred to Envista over the net proceeds from the IPO was $60 million and was recorded as a reduction to additional paid-in capital in the accompanying Consolidated Condensed Balance Sheet. Of the Company’s consolidated cash and cash equivalents as of September 27, 2019$193 million is owned by Envista.
Danaher continues to consolidate Envista, as the Company owns 80.6% of Envista’s outstanding common shares and retains control over Envista. The earnings attributable to the noncontrolling interest of Envista for the period from the Envista IPO until September 27, 2019 were $6 million. As of September 27, 2019, the noncontrolling interest of $681 million associated with Envista is reflected in noncontrolling interests in the accompanying Consolidated Condensed Balance Sheet.
Danaher intends to use a portion of the consideration received from Envista to redeem $882 million in aggregate principal amount of outstanding indebtedness in the fourth quarter of 2019 (consisting of the Company’s 2.4% senior unsecured notes due 2020 and 5.0% senior unsecured notes due 2020. The Company expects the make-whole premiums required in connection with the redemption will be $7 million ($5 million after-tax or $0.01 per diluted share). The Company intends to use the balance of the consideration it received from Envista for quarterly cash dividend payments to its shareholders.
The Company intends to make a tax-free distribution to its stockholders of all or a portion of its remaining equity interest in Envista, which may include one or more distributions effected as a dividend to all Danaher stockholders, one or more distributions in exchange for Danaher shares or other securities or any combination thereof (the “Distribution”). The Company has no obligation to pursue or consummate any further dispositions of its ownership interest in Envista, including through the Distribution, by any specified date or at all. If pursued, the Distribution may be subject to various conditions, including receipt of any necessary regulatory or other approvals, the existence of satisfactory market conditions and the receipt of an opinion of counsel to the effect that the separation, together with such Distribution, will be tax-free to Danaher and its stockholders for U.S. federal income tax purposes.

NOTE 5. LEASES
The Company has operating leases for office space, warehouses, distribution centers, research and development facilities, manufacturing locations and certain equipment, primarily automobiles. Many leases include one or more options to renew, some of which include options to extend the leases for up to 30 years, and some leases include options to terminate the leases within 30 days. In certain of the Company’s lease agreements, the rental payments are adjusted periodically to reflect actual charges incurred for common area maintenance, utilities, inflation and/or changes in other indexes. The Company’s finance leases were not material as of September 27, 2019 and for both the three and nine-month periods then ended. ROU assets arising from finance leases are included in property, plant and equipment, net and the liabilities are included in notes payable and current portion of long-term debt and long-term debt in the accompanying Consolidated Condensed Balance Sheets.
The components of operating lease expense were as follows ($ in millions):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 27, 2019
Fixed operating lease expense (a)
$
58.7

 
$
178.1

Variable operating lease expense
13.4

 
38.3

Total operating lease expense
$
72.1

 
$
216.4

(a) Includes short-term leases and sublease income, both of which were immaterial.
Supplemental cash flow information related to the Company’s operating leases for the nine-month period ended September 27, 2019 was as follows ($ in millions):
Cash paid for amounts included in the measurement of operating lease liabilities
$
177.7

ROU assets obtained in exchange for operating lease obligations
165.1


The following table presents the lease balances within the Consolidated Condensed Balance Sheet, weighted average remaining

15


lease term and weighted average discount rates related to the Company’s operating leases as of September 27, 2019 ($ in millions):
Lease Assets and Liabilities
Classification
 
Assets:
 
 
Operating lease ROU assets
Other long-term assets
$
956.1

 
 
 
Liabilities:
 
 
Current:
 
 
Operating lease liabilities
Accrued expenses and other liabilities
$
182.0

Long-term:
 
 
Operating lease liabilities
Other long-term liabilities
817.0

Total operating lease liabilities
 
$
999.0

 
 
 
Weighted average remaining lease term
7 years

Weighted average discount rate
3.1
%

The following table presents the maturity of the Company’s operating lease liabilities as of September 27, 2019 ($ in millions):
Remainder of 2019
$
55.8

2020
197.3

2021
160.4

2022
140.6

2023
122.0

Thereafter
460.3

Total operating lease payments
1,136.4

Less: imputed interest
137.4

Total operating lease liabilities
$
999.0


As of September 27, 2019, the Company had no additional significant operating or finance leases that had not yet commenced.

NOTE 6. GOODWILL
The following is a rollforward of the Company’s goodwill ($ in millions):
Balance, December 31, 2018
$
25,906.0

Attributable to 2019 acquisitions
214.9

Adjustments due to finalization of purchase price allocations
(6.9
)
Foreign currency translation and other
(389.2
)
Balance, September 27, 2019
$
25,724.8


16


The carrying value of goodwill by segment is summarized as follows ($ in millions):
 
September 27, 2019
 
December 31, 2018
Life Sciences
$
13,300.2

 
$
13,311.0

Diagnostics
6,829.9

 
6,925.6

Dental / Envista
3,283.2

 
3,325.5

Environmental & Applied Solutions
2,311.5

 
2,343.9

Total
$
25,724.8

 
$
25,906.0


The Company has not identified any “triggering” events which indicate an impairment of goodwill in the nine-month period ended September 27, 2019.

NOTE 7. FAIR VALUE MEASUREMENTS
Accounting standards define fair value based on an exit price model, establish a framework for measuring fair value where the Company’s assets and liabilities are required to be carried at fair value and provide for certain disclosures related to the valuation methods used within a valuation hierarchy as established within the accounting standards. This hierarchy prioritizes the inputs into three broad levels as follows. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in markets that are not active, or other observable characteristics for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from, or corroborated by, observable market data through correlation. Level 3 inputs are unobservable inputs based on the Company’s assumptions. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement in its entirety.
A summary of financial assets and liabilities that are measured at fair value on a recurring basis were as follows ($ in millions):
 
Quoted Prices in Active Market (Level 1)
 
Significant Other Observable Inputs (Level 2)
 
Significant Unobservable Inputs (Level 3)
 
Total
September 27, 2019:
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
Available-for-sale debt securities
$

 
$
35.7

 
$

 
$
35.7

Investment in equity securities

 

 
314.4

 
314.4

Cross-currency swap derivative contracts

 
36.8

 

 
36.8

Liabilities:
 
 
 
 
 
 
 
Interest rate swap derivative contracts

 
64.0

 

 
64.0

Deferred compensation plans

 
64.6

 

 
64.6

 
 
 
 
 
 
 
 
December 31, 2018:
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
Available-for-sale debt securities
$

 
$
38.3

 
$

 
$
38.3

Investment in equity securities

 

 
148.9

 
148.9

Liabilities:
 
 
 
 
 
 
 
Deferred compensation plans

 
60.9

 

 
60.9


Available-for-sale debt securities, which are included in other long-term assets in the accompanying Consolidated Condensed Balance Sheets, are measured at fair value using quoted prices reported by investment brokers and dealers based on the underlying terms of the security and comparison to similar securities traded on an active market. As of September 27, 2019, available-for-sale debt securities primarily include U.S. Treasury Notes and corporate debt securities, which are valued based on instruments with similar terms traded on an active market.

17


The Company’s investments in equity securities are classified as Level 3 in the fair value hierarchy because the Company estimates the fair value based on the measurement alternative and adjusts for impairments and observable price changes with a same or similar security from the same issuer within net earnings (the “Fair Value Alternative”). The investments in equity securities includes investments that the Company has made as a limited partner in a partnership for which the underlying investments are recorded on a fair value basis.
The cross-currency swap derivative contracts are used to partially hedge the Company’s net investments in foreign operations against adverse movements in exchange rates between the U.S. dollar and the Danish kroner, Japanese yen, euro and Swiss franc. Envista uses cross-currency swap derivative contracts to partially hedge its net investment in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. The cross-currency swap derivative contracts are classified as Level 2 in the fair value hierarchy as they are measured using the income approach with the relevant interest rates and foreign currency current exchange rates and forward curves as inputs. Refer to Note 9 for additional information.
In June 2019, the Company entered into interest rate swap agreements with a notional amount of $850 million which represents a portion of the amount of U.S. dollar-denominated bonds (with terms ranging from 10 to 30 years) the Company anticipates issuing to finance a portion of the GE Biopharma Acquisition. These contracts effectively fixed the interest rate for a portion of the Company’s anticipated U.S. dollar-denominated debt issuance equal to the notional amount of the swaps to the rate specified in the interest rate swap agreements. In September 2019, Envista entered into $650 million of interest rate swap derivative contracts to convert the variable interest rate for the Envista Term Loan Facility to a fixed interest rate. The interest rate swap derivative contracts are classified as Level 2 in the fair value hierarchy as they are measured using the income approach, based on the relevant interest rate yield curves. Refer to Note 8 and Note 9 for additional information.
The Company has established nonqualified contribution and deferred compensation programs that permit the Company to make tax-deferred contributions to officers and certain other employees, and also permit directors, officers and certain other employees to voluntarily defer taxation on a portion of their compensation. All amounts contributed or deferred under such plans are unfunded, unsecured obligations of the Company and are presented as a component of the Company’s compensation and benefits accrual included in other long-term liabilities in the accompanying Consolidated Condensed Balance Sheets. Non-director participants may choose among alternative earning rates for the amounts they defer, which are primarily based on investment options within the Company’s 401(k) program. Changes in the deferred compensation liability under these programs are recognized based on changes in the fair value of the participants’ accounts, which are based on the applicable earnings rates. Amounts voluntarily deferred by directors and amounts unilaterally contributed to participant accounts by the Company are deemed invested in the Company’s common stock and future distributions of such contributions (as well as future distributions of any voluntary deferrals allocated at any time to the Danaher common stock investment option) will be made solely in shares of Company common stock, and therefore are not reflected in the above amounts.
Fair Value of Financial Instruments
The carrying amounts and fair values of the Company’s financial instruments were as follows ($ in millions):
 
September 27, 2019
 
December 31, 2018
 
Carrying Amount
 
Fair Value
 
Carrying Amount
 
Fair Value
Assets:
 
 
 
 
 
 
 
Available-for-sale debt securities
$
35.7

 
$
35.7

 
$
38.3

 
$
38.3

Investment in equity securities
314.4

 
314.4

 
148.9

 
148.9

Cross-currency swap derivative contracts
36.8

 
36.8

 

 

Liabilities:
 
 
 
 
 
 
 
Interest rate swap derivative contracts
64.0

 
64.0

 

 

Notes payable and current portion of long-term debt
1,068.6

 
1,068.6

 
51.8

 
51.8

Long-term debt
16,536.2

 
17,045.5

 
9,688.5

 
9,990.6


As of September 27, 2019 and December 31, 2018, investments in non-marketable equity securities were categorized as Level 3, available-for-sale debt securities, cross-currency swap derivative contracts and interest rate swap derivative contracts were categorized as Level 2 and short and long-term borrowings were categorized as Level 1.

18


The fair value of long-term borrowings was based on quoted market prices. The difference between the fair value and the carrying amounts of long-term borrowings (other than the Company’s Liquid Yield Option Notes due 2021 (the “LYONs”)) is attributable to changes in market interest rates and/or the Company’s credit ratings subsequent to the incurrence of the borrowing. In the case of the LYONs, differences in the fair value from the carrying value are attributable to changes in the price of the Company’s common stock due to the LYONs’ conversion features. The fair values of borrowings with original maturities of one year or less, as well as cash and cash equivalents, trade accounts receivable, net and trade accounts payable approximate their carrying amounts due to the short-term maturities of these instruments.


19


NOTE 8. FINANCING
As of September 27, 2019, the Company was in compliance with all of its debt covenants. The components of the Company’s debt were as follows ($ in millions):
 
September 27, 2019
 
December 31, 2018
U.S. dollar-denominated commercial paper
$

 
$
72.8

Euro-denominated commercial paper (€2.7 billion and €2.1 billion, respectively)
2,933.2

 
2,377.5

1.0% senior unsecured notes due 2019 (€600.0 million aggregate principal amount) (the “2019 Euronotes”)

 
687.0

2.4% senior unsecured notes due 2020
499.2

 
498.5

5.0% senior unsecured notes due 2020 (the “2020 Assumed Pall Notes”)
382.8

 
386.7

Zero-coupon LYONs due 2021
34.6

 
56.2

0.352% senior unsecured notes due 2021 (¥30.0 billion aggregate principal amount) (the “2021 Yen Notes”)
277.6

 
273.2

1.7% senior unsecured notes due 2022 (€800.0 million aggregate principal amount) (the “2022 Euronotes”)
872.6

 
913.2

Floating rate senior unsecured notes due 2022 (€250.0 million aggregate principal amount) (the “Floating Rate 2022 Euronotes”)
272.9

 
285.7

Envista senior unsecured term loan facility due 2022 (the “Envista Term Loan Facility”)
648.6

 

Envista senior unsecured term loan facility due 2022 (€600.0 million aggregate principal amount) (the “Envista Euro Term Loan Facility”)
655.6

 

0.5% senior unsecured bonds due 2023 (CHF 540.0 million aggregate principal amount) (the “2023 CHF Bonds”)
546.0

 
550.7

2.5% senior unsecured notes due 2025 (€800.0 million aggregate principal amount) (the “2025 Euronotes”)
871.7

 
912.6

3.35% senior unsecured notes due 2025
497.1

 
496.8

0.2% senior unsecured notes due 2026 (€1.3 billion aggregate principal amount) (the “2026 Biopharma Euronotes”)
1,357.5

 

0.3% senior unsecured notes due 2027 (¥30.8 billion aggregate principal amount) (the “2027 Yen Notes”)
284.4

 
279.9

1.2% senior unsecured notes due 2027 (€600.0 million aggregate principal amount) (the “2027 Euronotes”)
651.5

 
682.0

0.45% senior unsecured notes due 2028 (€1.3 billion aggregate principal amount) (the “2028 Biopharma Euronotes”)
1,355.6

 

1.125% senior unsecured bonds due 2028 (CHF 210.0 million aggregate principal amount) (the “2028 CHF Bonds”)
216.0

 
218.1

0.75% senior unsecured notes due 2031 (€1.8 billion aggregate principal amount) (the “2031 Biopharma Euronotes”)
1,900.7

 

0.65% senior unsecured notes due 2032 (¥53.2 billion aggregate principal amount) (the “2032 Yen Notes”)
491.1

 
483.4

1.35% senior unsecured notes due 2039 (€1.3 billion aggregate principal amount) (the “2039 Biopharma Euronotes”)
1,349.2

 

4.375% senior unsecured notes due 2045
499.4

 
499.3

1.8% senior unsecured notes due 2049 (€750.0 million aggregate principal amount) (the “2049 Biopharma Euronotes”)
810.3

 

Other
197.2

 
66.7

Total debt
17,604.8

 
9,740.3

Less: currently payable
1,068.6

 
51.8

Long-term debt
$
16,536.2

 
$
9,688.5


For additional details regarding the Company’s debt financing, refer to Note 10 of the Company’s financial statements as of and for the year ended December 31, 2018 included in the Company’s 2018 Annual Report.
The Company satisfies any short-term liquidity needs that are not met through operating cash flow and available cash primarily through issuances of commercial paper under its U.S. dollar and euro-denominated commercial paper programs. Until August

20


27, 2019, credit support for the commercial paper programs was generally provided by the Company’s $4.0 billion unsecured, multi-year revolving credit facility with a syndicate of banks that was scheduled to expire on July 10, 2020 (the “Superseded Credit Facility”), which was also available for working capital and other general corporate purposes. During the duration of the Superseded Credit Facility, no borrowings were outstanding under the Superseded Credit Facility and the Company was in compliance with all covenants thereunder. Effective as of August 27, 2019, credit support for the Company’s U.S. dollar and euro-denominated commercial paper programs is provided by the 2020 Credit Facilities, as described below. In addition, the Company has also entered into reimbursement agreements with various commercial banks to support the issuance of letters of credit.
As of September 27, 2019, borrowings outstanding under the Company’s euro-denominated commercial paper program had a weighted average annual interest rate of negative 0.2% and a weighted average remaining maturity of approximately 42 days. There were no borrowings outstanding under the Company’s U.S. dollar-denominated commercial paper program as of September 27, 2019.
The Company repaid the 600 million aggregate principal amount of the 2019 Euronotes and accrued interest upon their maturity on July 8, 2019 using proceeds from the issuance of euro-denominated commercial paper. The Company has classified the 2.4% senior unsecured notes due 2020 and the 2020 Assumed Pall Notes as short-term debt as of September 27, 2019 since the Company plans to extinguish these obligations in the fourth quarter of 2019 (refer to Note 4 for additional information). The Company has classified approximately $2.9 billion of its borrowings outstanding under the euro-denominated commercial paper program as of September 27, 2019 as long-term debt in the accompanying Consolidated Condensed Balance Sheet as the Company had the intent and ability, as supported by availability under the 2020 Credit Facilities, to refinance these borrowings for at least one year from the balance sheet date.
Debt discounts, premiums and debt issuance costs totaled $86 million and $19 million as of September 27, 2019 and December 31, 2018, respectively, and have been netted against the aggregate principal amounts of the related debt in the components of debt table above.
2019 Debt Issuances
Long-Term Indebtedness Related to the Pending GE Biopharma Acquisition
On September 18, 2019, DH Europe Finance II S.a.r.l. (“Danaher International II”), a wholly-owned finance subsidiary of the Company, completed the underwritten public offering of senior unsecured notes due 2026, 2028, 2031, 2039 and 2049 (collectively the “Biopharma Euronotes”). The following summarizes the key terms of the offering (€ in millions):
 
Aggregate Principal Amount
 
Stated Annual Interest Rate
 
Issue Price (as % of Principal Amount)
 
Maturity Date
 
Interest Payment Dates (in arrears)
2026 Biopharma Euronotes
1,250.0

 
0.200
%
 
99.833
%
 
March 18, 2026
 
March 18
2028 Biopharma Euronotes
1,250.0

 
0.450
%
 
99.751
%
 
March 18, 2028
 
March 18
2031 Biopharma Euronotes
1,750.0

 
0.750
%
 
99.920
%
 
September 18, 2031
 
September 18
2039 Biopharma Euronotes
1,250.0

 
1.350
%
 
99.461
%
 
September 18, 2039
 
September 18
2049 Biopharma Euronotes
750.0

 
1.800
%
 
99.564
%
 
September 18, 2049
 
September 18

The Biopharma Euronotes are fully and unconditionally guaranteed by the Company. The Company received net proceeds from the Biopharma Euronotes, after underwriting discounts and commissions and offering expenses, of approximately 6.2 billion (approximately $6.8 billion based on currency exchange rates as of the date of the pricing of the notes). The Company plans to use the proceeds from the Biopharma Euronotes to fund a portion of the pending GE Biopharma Acquisition. Pending completion of the GE Biopharma Acquisition, the Company has invested the net proceeds in short-term bank deposits and/or interest-bearing, investment-grade securities.
Long-Term Indebtedness Related to Envista
In September 2019, the Company received net cash distributions of approximately $2.0 billion from Envista as consideration for the Company’s contribution of assets to Envista in connection with the Envista IPO. Envista financed these cash payments through the issuance of common stock and proceeds from approximately $1.3 billion of term debt, consisting of $650 million aggregate principal amount of borrowings under a three-year, senior unsecured term loan facility with variable interest rates and 600 million aggregate principal amount of borrowings under a three-year, senior unsecured term loan facility with variable interest rates (together, the “Envista Debt”). In addition, Envista entered into a revolving credit agreement with a syndicate of banks providing for a five-year $250 million senior unsecured revolving credit facility (the “Envista Credit

21


Facility”). Envista had no borrowings outstanding under the Envista Credit Facility as of September 27, 2019. As of September 27, 2019, Danaher owns 80.6% of the common stock of Envista, and as a result, the Company consolidates Envista and therefore the Company’s Consolidated Condensed Balance Sheet as of September 27, 2019 includes the Envista Debt. As of September 27, 2019, Envista was in compliance with all covenants under the Envista Credit Facility.
364-Day and Five-Year Revolving Credit Facilities
On August 27, 2019, the Company replaced the Superseded Credit Facility with a $5.0 billion unsecured revolving credit facility with a syndicate of banks that expires on August 27, 2024, subject to a one-year extension option at the request of the Company with the consent of the lenders (the “Five-Year Facility”). The Five-Year Facility also contains an expansion option permitting Danaher to request up to five increases of up to an aggregate additional $2.5 billion from lenders that elect to make such increase available, upon the satisfaction of certain conditions. At the same time, the Company entered into a $5.0 billion 364-day unsecured revolving credit facility with a syndicate of banks that expires on August 26, 2020 (the “Scheduled Termination Date”) (the “364-Day Facility” and together with the Five-Year Facility, the “2020 Credit Facilities”), to provide additional liquidity support for issuances under the Company’s U.S. dollar and euro-denominated commercial paper programs. The Company may elect, upon the payment of a fee equal to 0.75% of the principal amount of the loans then outstanding and, upon the satisfaction of certain conditions, to convert any loans outstanding on the Scheduled Termination Date into term loans that are due and payable one year following the Scheduled Termination Date. The increase in the size of the Company’s commercial paper programs, as supported by the 2020 Credit Facilities, provides capacity for the Company to use proceeds from the commercial paper programs to fund a portion of the pending GE Biopharma Acquisition.
Borrowings under the Five-Year Facility bear interest as follows: (1) Eurocurrency Rate Committed Loans (as defined in the Five-Year Facility) bear interest at a variable rate equal to the London inter-bank offered rate plus a margin of between 58.5 and 100.0 basis points, depending on Danaher’s long-term debt credit rating; (2) Base Rate Committed Loans and Swing Line Loans (each as defined in the Five-Year Facility) bear interest at a variable rate equal to the highest of (a) the Federal funds rate (as published by the Federal Reserve Bank of New York from time to time) plus 50 basis points; (b) Bank of America’s “prime rate” as publicly announced from time to time and (c) the Eurocurrency Rate (as defined in the Five-Year Facility) plus 100 basis points; and (3) Bid Loans (as defined in the Five-Year Facility) bear interest at the rate bid by the particular lender providing such loan. In addition, Danaher is required to pay a per annum facility fee of between 4.0 and 12.5 basis points (depending on Danaher’s long-term debt credit rating) based on the aggregate commitments under the Five-Year Facility, regardless of usage.
Borrowings under the 364-Day Facility bear interest as follows: (1) Eurodollar Rate Loans (as defined in the 364-Day Facility) bear interest at a variable rate per annum equal to the London inter-bank offered rate plus a margin of between 59.5 and 100.5 basis points, depending on Danaher’s long-term debt credit rating; and (2) Base Rate Loans (as defined in the 364-Day Facility) bear interest at a variable rate per annum equal to the highest of (a) the Federal funds rate (as published by the Federal Reserve Bank of New York from time to time) plus 50 basis points, (b) Bank of America’s “prime rate” as publicly announced from time to time and (c) the Eurodollar Rate (as defined in the 364-Day Facility) plus 100 basis points, plus in each case a margin of up to 0.5 basis points depending on Danaher’s long-term debt credit rating. In addition, Danaher is required to pay a per annum facility fee of between 3.0 and 12.0 basis points (depending on Danaher’s long-term debt credit rating) based on the aggregate commitments under the 364-Day Facility, regardless of usage.
The 2020 Credit Facilities require the Company to maintain a consolidated leverage ratio (as defined in the facilities) of 0.65 to 1.00 or less. Borrowings under the 2020 Credit Facilities are prepayable at the Company’s option at any time in whole or in part without premium or penalty.
The Company’s obligations under the 2020 Credit Facilities are unsecured. The Company has unconditionally and irrevocably guaranteed the obligations of each of its subsidiaries in the event a subsidiary is named a borrower under either of the 2020 Credit Facilities. Each of the 2020 Credit Facilities contain customary representations, warranties, conditions precedent, events of default, indemnities and affirmative and negative covenants. The 2020 Credit Facilities are available for liquidity support for Danaher’s expanded U.S. dollar and euro commercial paper programs, as discussed above, and for general corporate purposes.

22


Guarantors of Debt
The Company has guaranteed long-term debt and commercial paper issued by certain of its wholly-owned subsidiaries. The 2019 Euronotes, 2022 Euronotes, Floating Rate 2022 Euronotes, 2025 Euronotes and 2027 Euronotes were issued by DH Europe Finance S.a.r.l., formerly known as DH Europe Finance S.A. (“Danaher International”). The 2026 Biopharma Euronotes, 2028 Biopharma Euronotes, 2031 Biopharma Euronotes, 2039 Biopharma Euronotes and 2049 Biopharma Euronotes were issued by Danaher International II. The 2023 CHF Bonds and 2028 CHF Bonds were issued by DH Switzerland Finance S.A. (“Danaher Switzerland”). The 2021 Yen Notes, 2027 Yen Notes and 2032 Yen Notes were issued by DH Japan Finance S.A. (“Danaher Japan”). Each of Danaher International, Danaher International II, Danaher Switzerland and Danaher Japan are wholly-owned finance subsidiaries of Danaher Corporation. All of the outstanding and future securities issued by each of these entities, as well as the 2020 Assumed Pall Notes, are or will be fully and unconditionally guaranteed by the Company and these guarantees rank on parity with the Company’s unsecured and unsubordinated indebtedness.
LYONs Redemption
During the nine-month period ended September 27, 2019, holders of certain of the Company’s LYONs converted such LYONs into an aggregate of 891 thousand shares of the Company’s common stock, par value $0.01 per share. The Company’s deferred tax liability of $9 million associated with the book and tax basis difference in the converted LYONs was transferred to additional paid-in capital as a result of the conversions.

NOTE 9. HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS
The Company uses cross-currency swap derivative contracts to partially hedge its net investments in foreign operations against adverse movements in exchange rates between the U.S. dollar and the Danish kroner, Japanese yen, euro and Swiss franc. The cross-currency swap derivative contracts are agreements to exchange fixed-rate payments in one currency for fixed-rate payments in another currency. In January 2019, the Company entered into cross-currency swap derivative contracts with respect to approximately $1.9 billion of its U.S. dollar-denominated bonds and approximately $1.0 billion of these derivative contracts remain outstanding as of September 27, 2019. These contracts effectively convert these U.S. dollar-denominated bonds to obligations denominated in Danish kroner, Japanese yen, euro and Swiss franc, and partially offset the impact of changes in currency rates on foreign currency denominated net investments. The changes in the spot rate of these instruments are recorded in accumulated other comprehensive income (loss) in stockholders’ equity, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in accumulated other comprehensive income (loss) in the Company’s Consolidated Condensed Statements of Stockholders’ Equity. Any ineffective portions of net investment hedges are reclassified from accumulated other comprehensive income (loss) into earnings during the period of change. The interest income or expense from these swaps are recorded in interest expense in the Company’s Consolidated Condensed Statements of Earnings consistent with the classification of interest expense attributable to the underlying debt. These instruments mature on dates ranging up to September 2028.
The Company has also issued foreign currency denominated long-term debt as partial hedges of its net investments in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro, Japanese yen and Swiss franc. These foreign currency denominated long-term debt issuances are designated and qualify as nonderivative hedging instruments. Accordingly, the foreign currency translation of these debt instruments is recorded in accumulated other comprehensive income (loss) in stockholders’ equity in the accompanying Consolidated Condensed Balance Sheets, offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in accumulated other comprehensive income (loss). Any ineffective portions of net investment hedges are reclassified from accumulated other comprehensive income (loss) into earnings during the period of change. These instruments mature on dates ranging from September 2025 to May 2032.
The Company has used interest rate swap agreements to hedge the variability in cash flows due to changes in benchmark interest rates related to a portion of the U.S. debt the Company anticipates issuing to fund the GE Biopharma Acquisition. The interest rate swap agreements are agreements in which the Company agrees to pay a fixed interest rate based on the rate specified in the agreement in exchange for receiving a floating interest rate from a third-party bank based upon a specified benchmark interest rate. In June 2019, the Company entered into interest rate swap agreements with a notional amount of $850 million. These contracts effectively fixed the interest rate for a portion of the Company’s anticipated U.S. dollar-denominated debt issuance equal to the notional amount of the swaps to the rate specified in the interest rate swap agreements. The changes in the fair value of these instruments are recorded in accumulated other comprehensive income (loss) in stockholders’ equity and are subsequently reclassified to interest expense over the life of the related debt.
Envista uses cross-currency swap derivative contracts to partially hedge its net investments in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. The cross-currency swap derivative contracts are

23


agreements to exchange fixed-rate payments in one currency for fixed-rate payments in another currency. In September 2019, Envista entered into cross-currency swap derivative contracts with respect to $650 million of the Envista Term Loan Facility and $650 million of these derivative contracts remain outstanding as of September 27, 2019. These contracts effectively convert the Envista Term Loan Facility to an obligation denominated in euro and partially offset the impact of changes in currency rates on foreign currency denominated net investments. The changes in the fair value of these instruments are recorded in accumulated other comprehensive income (loss) in equity, partially offsetting the foreign currency translation adjustment of Envista’s related net investment that is also recorded in accumulated other comprehensive income (loss). Any ineffective portions of net investment hedges are reclassified from accumulated other comprehensive income (loss) into earnings during the period of change. The interest income or expense from these swaps are recorded in interest expense, consistent with the classification of interest expense attributable to the underlying debt. These instruments mature on dates ranging from September 2020 to September 2022.
Envista issued the euro-denominated Envista Euro Credit Facility as a partial hedge of its net investments in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. This foreign currency denominated long-term debt issuance is designated and qualifies as a nonderivative hedging instrument. Accordingly, the foreign currency translation of this debt instrument is recorded in accumulated other comprehensive income (loss) in stockholders’ equity in the accompanying Consolidated Condensed Balance Sheet, offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in accumulated other comprehensive income (loss). Any ineffective portions of the net investment hedge is reclassified from accumulated other comprehensive income (loss) into earnings during the period of change. This debt matures in September 2022.

In addition to the cross-currency swaps entered into by the Company in January 2019, in September 2019, Envista entered into $650 million of interest rate swap derivative contracts to convert the variable interest rate for the Envista Term Loan Facility to a fixed interest rate. The interest rate swap agreements are agreements in which Envista agrees to pay a fixed interest rate based on the rate specified in the agreement in exchange for receiving a floating interest rate from a third-party bank based upon a specified benchmark interest rate. These contracts effectively fixed the interest rate for the Envista Term Loan Facility. The changes in the fair value of these instruments are recorded in accumulated other comprehensive income (loss) in stockholders’ equity and are subsequently reclassified to interest expense over the life of the Envista Term Loan Facility.
The following table summarizes the notional values as of September 27, 2019 and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive income (“OCI”) for the three and nine-month periods then ended ($ in millions):
 
Notional Amount
 
Gain (Loss) Recognized in OCI
For the Three-Month Period Ended September 27, 2019:
 
 
 
Foreign currency contracts
$
1,650.0

 
$
41.5

Foreign currency denominated debt
8,073.6

 
255.2

Interest rate swaps
1,500.0

 
(55.1
)
Total
$
11,223.6

 
$
241.6

For the Nine-Month Period Ended September 27, 2019:
 
 
 
Foreign currency contracts
$
1,650.0

 
$
36.8

Foreign currency denominated debt
8,073.6

 
263.5

Interest rate swaps
1,500.0

 
(64.0
)
Total
$
11,223.6

 
$
236.3


Gains or losses related to the foreign currency contracts and foreign currency denominated debt are classified as foreign currency translation adjustments in the schedule of changes in OCI in Note 1, as these items are attributable to the Company’s hedges of its net investment in foreign operations. Gains or losses related to the interest rate swaps are classified as cash flow hedge adjustments in the schedule of changes in OCI in Note 1. The Company did not reclassify any deferred gains or losses related to net investment hedges or cash flow hedges from accumulated other comprehensive income (loss) to earnings during the three or nine-month periods ended September 27, 2019. In addition, the Company did not have any ineffectiveness related to net investment hedges or interest rate swaps during the three or nine-month periods ended September 27, 2019. The cash inflows and outflows associated with the Company’s derivative contracts designated as net investment hedges are classified in all other investing activities in the accompanying Consolidated Condensed Statement of Cash Flows. The cash inflows and outflows associated with the Company’s derivative contracts designated as cash flow hedges are classified in cash flows from operating activities in the accompanying Consolidated Condensed Statement of Cash Flows.

24


The Company’s derivative instruments, as well as its nonderivative debt instruments designated and qualifying as net investment hedges, were classified as of September 27, 2019 in the Company’s Consolidated Condensed Balance Sheet as follows ($ in millions):
Derivative assets:
 
Prepaid expenses and other current assets
$
36.8

 
 
Derivative liabilities:
 
Accrued expenses and other liabilities
64.0

 
 
Nonderivative hedging instruments:
 
Long-term debt
8,073.6


Amounts related to the Company’s derivatives expected to be reclassified from accumulated other comprehensive income (loss) to net earnings during the next 12 months are not significant.

NOTE 10. DEFINED BENEFIT PLANS
The following sets forth the components of the Company’s net periodic benefit (cost) of the noncontributory defined benefit pension plans ($ in millions):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
U.S. pension benefits:
 
 
 
 
 
 
 
Service cost
$
(1.6
)
 
$
(1.2
)
 
$
(4.8
)
 
$
(5.4
)
Interest cost
(22.1
)
 
(20.3
)
 
(66.6
)
 
(60.7
)
Expected return on plan assets
31.0

 
33.0

 
94.2

 
99.2

Amortization of actuarial loss
(6.7
)
 
(8.0
)
 
(19.2
)
 
(23.6
)
Amortization of prior service cost
(0.2
)
 
(0.2
)
 
(0.7
)
 
(0.7
)
Net periodic pension benefit
$
0.4


$
3.3


$
2.9


$
8.8

 
 
 
 
 
 
 
 
Non-U.S. pension benefits:
 
 
 
 
 
 
 
Service cost
$
(8.2
)
 
$
(8.6
)
 
$
(24.4
)
 
$
(26.2
)
Interest cost
(6.6
)
 
(6.3
)
 
(19.9
)
 
(19.6
)
Expected return on plan assets
10.9

 
11.6

 
32.7

 
35.6

Amortization of actuarial loss
(3.9
)
 
(1.5
)
 
(3.7
)
 
(4.5
)
Amortization of prior service credit
2.6

 
0.2

 
0.2

 
0.4

Curtailment gain recognized

 

 
1.1

 

Settlement loss recognized
0.1

 
1.2

 

 
0.8

Net periodic pension cost
$
(5.1
)
 
$
(3.4
)
 
$
(14.0
)
 
$
(13.5
)

25


The following sets forth the components of the Company’s net periodic benefit cost of the other postretirement employee benefit plans ($ in millions):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Service cost
$
(0.1
)
 
$

 
$
(0.3
)
 
$
(0.3
)
Interest cost
(1.3
)
 
(1.2
)
 
(3.8
)
 
(3.5
)
Amortization of prior service credit
0.6

 
0.6

 
1.6

 
1.8

Net periodic cost
$
(0.8
)
 
$
(0.6
)
 
$
(2.5
)
 
$
(2.0
)

The net periodic benefit cost of the noncontributory defined benefit pension plans and other postretirement employee benefit plans incurred during the three and nine-month periods ended September 27, 2019 and September 28, 2018 are reflected in the following captions in the accompanying Consolidated Condensed Statements of Earnings ($ in millions):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Service cost:
 
 
 
 
 
 
 
Cost of sales
$
(2.0
)
 
$
(1.6
)
 
$
(6.2
)
 
$
(7.0
)
Selling, general and administrative expenses
(7.9
)
 
(8.2
)
 
(23.3
)
 
(24.9
)
Total service cost
(9.9
)
 
(9.8
)
 
(29.5
)
 
(31.9
)
Other net periodic benefit costs:
 
 
 
 
 
 
 
Other income, net
4.4

 
9.1

 
15.9

 
25.2

Total
$
(5.5
)
 
$
(0.7
)
 
$
(13.6
)
 
$
(6.7
)

Employer Contributions
During 2019, the Company’s cash contribution requirements for its U.S. and non-U.S. defined benefit pension plans are forecasted to be approximately $10 million and $50 million, respectively. The ultimate amounts to be contributed depend upon, among other things, legal requirements, underlying asset returns, the plan’s funded status, the anticipated tax deductibility of the contribution, local practices, market conditions, interest rates and other factors.

NOTE 11. INCOME TAXES
The following table summarizes the Company’s effective tax rate:
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Effective tax rate
20.1
%
 
17.2
%
 
29.3
%
 
19.0
%

The effective tax rate for the three-month period ended September 27, 2019 differs from the U.S. federal statutory rate of 21.0% principally due to the impact of earnings outside the United States which generally are taxed at rates lower than the U.S. federal rate.
The effective tax rate for the nine-month period ended September 27, 2019 differs from the U.S. federal statutory rate of 21.0% principally due to the impact of net discrete charges of $227 million ($0.31 per diluted share) related primarily to changes in estimates associated with prior period uncertain tax positions and audit settlements, net of the release of reserves for uncertain tax positions due to the expiration of statutes of limitation, release of valuation allowances associated with certain foreign tax credits, tax benefits resulting from changes in tax law and excess tax benefits from stock-based compensation. These discrete income tax charges increased the reported tax rate by 9.2% on a net basis.
The Company’s effective tax rates for both the three and nine-month periods ended September 28, 2018 were lower than the U.S. federal statutory rate of 21.0% due principally to the impact of the Company’s earnings outside the United States which overall are taxed at rates lower than the U.S. federal rate. The effective tax rate for the three and nine-month periods ended

26


September 28, 2018 reflects a U.S. corporate income tax rate of 21.0% from the enactment of the Tax Cuts and Jobs Act (“TCJA”), partially offset by a new minimum tax on certain non-U.S. earnings as a result of the TCJA. The effective tax rate for the three-month period ended September 28, 2018 includes net tax benefits of $23 million ($0.03 per diluted share) related primarily to the release of valuation allowances associated with certain foreign operating losses and excess tax benefits from stock-based compensation, which in aggregate reduced the reported tax rate by 2.9%. The effective tax rate for the nine-month period ended September 28, 2018 also includes these benefits, in addition to net tax benefits of $9 million ($0.01 per diluted share) recorded in the second quarter of 2018 related to the release of reserves upon the expiration of statutes of limitation and excess tax benefits from stock-based compensation, which were partially offset by increases in estimates associated with prior period uncertain tax positions.
In the fourth quarter of 2018 and in the first quarter of 2019, the Internal Revenue Service (“IRS”) proposed significant adjustments to the Company’s taxable income for the years 2012 through 2015 with respect to the deferral of tax on certain premium income related to the Company’s self-insurance programs. For income tax purposes, the recognition of premium income has been deferred in accordance with U.S. tax laws related to insurance. The IRS is challenging the deferral of premiums for certain types of insurance policies. The proposed adjustments would increase the Company’s taxable income over the 2012-2015 period by approximately $2.7 billion. Management believes the positions the Company has taken in its U.S. tax returns are in accordance with the relevant tax laws, intends to vigorously defend these positions and is currently considering all of its alternatives. Due to the enactment of the TCJA in 2017 and the resulting reduction in the U.S. corporate tax rate for years after 2017, the Company revalued its deferred tax liabilities related to the temporary differences associated with this deferred premium income from 35.0% to 21.0%. If the Company is not successful in defending these assessments, the taxes owed to the IRS may be computed under the previous 35.0% statutory tax rate and the Company may be required to revalue the related deferred tax liabilities from 21.0% to 35.0%, which in addition to any interest due on the amounts assessed, would require a charge to future earnings. The ultimate resolution of this matter is uncertain, could take many years and could result in a material adverse impact to the Company’s Consolidated Condensed Financial Statements, including its cash flows and effective tax rate.
Tax authorities in Denmark have raised significant issues related to interest accrued by certain of the Company’s subsidiaries. On December 10, 2013, the Company received assessments from the Danish tax authority (“SKAT”) totaling approximately DKK 1.7 billion including interest through September 27, 2019 (approximately $256 million based on the exchange rate as of September 27, 2019), imposing withholding tax relating to interest accrued in Denmark on borrowings from certain of the Company’s subsidiaries for the years 2004-2009. The Company appealed these assessments to the Danish National Tax Tribunal in 2014. The appeal is pending, awaiting the final outcome of other withholding tax cases brought to the Court of Justice of the European Union (“CJEU”). In February 2019, the CJEU decided several other cases related to Danish withholding tax on dividends and interest. In these cases, the CJEU ruled that the exemption of interest payments from withholding taxes provided in the applicable European Union (“EU”) directive should be denied where taxpayers use the directive for abusive or fraudulent purposes, and that it is up to the national courts to make this determination. SKAT has maintained a similar position related to withholding tax on interest accrued in Denmark on borrowings from certain of the Company’s subsidiaries with respect to tax years 2010-2012 and on August 27, 2019, the Company received assessments for these matters totaling approximately DKK 1.0 billion including interest through September 27, 2019 (approximately $152 million based on the exchange rate as of September 27, 2019). The Company is appealing these assessments as well.  The Company remains in discussions with SKAT on similar withholding tax matters for the years 2013-2015 and anticipates receiving additional assessments of approximately DKK 735 million including interest through September 27, 2019 (approximately $108 million based on the exchange rate as of September 27, 2019). Management believes the positions the Company has taken in Denmark are in accordance with the relevant tax laws and is vigorously defending its positions related to the received and anticipated assessments related to the 2004-2009, 2010-2012, and 2013-2015 years. The Company intends on pursuing this matter through the Danish High Court should the appeal to the Danish National Tax Tribunal be unsuccessful. The Company will continue to monitor decisions of both the Danish courts and the CJEU and evaluate the impact of these court rulings on the Company’s tax positions in Denmark. The ultimate resolution of this matter is uncertain, could take many years, and could result in a material adverse impact to the Company’s Consolidated Condensed Financial Statements, including its cash flow and effective tax rate.

NOTE 12. NONOPERATING INCOME (EXPENSE)
The Company disaggregates the service cost component of net periodic benefit costs of the noncontributory defined benefit pension plans and other postretirement employee benefit plans and presents the other components of net periodic benefit cost in other income, net. These other components include the assumed rate of return on plan assets partially offset by amortization of actuarial losses and interest and aggregated to a gain of $4 million and $16 million for the three and nine-month periods ended September 27, 2019, respectively, compared to a gain of $9 million and $25 million for the three and nine-month periods ended September 28, 2018, respectively.

27



NOTE 13. COMMITMENTS AND CONTINGENCIES
For a description of the Company’s litigation and contingencies, refer to Note 17 of the Company’s financial statements as of and for the year ended December 31, 2018 included in the Company’s 2018 Annual Report. The Company reviews the adequacy of its legal reserves on a quarterly basis and establishes reserves for loss contingencies that are both probable and reasonably estimable. During the nine-month period ended September 27, 2019, the Company recorded a provision of $36 million ($29 million after-tax or $0.04 per diluted share) for costs and estimated liabilities related to a legal contingency.
The Company generally accrues estimated warranty costs at the time of sale. In general, manufactured products are warranted against defects in material and workmanship when properly used for their intended purpose, installed correctly and appropriately maintained. Warranty periods depend on the nature of the product and range from the date of such sale up to the life of the product. The amount of the accrued warranty liability is determined based on historical information such as past experience, product failure rates or number of units repaired, estimated cost of material and labor and in certain instances estimated property damage. The accrued warranty liability is reviewed on a quarterly basis and may be adjusted as additional information regarding expected warranty costs becomes known.
The following is a rollforward of the Company’s accrued warranty liability ($ in millions):
Balance, December 31, 2018
$
77.4

Accruals for warranties issued during the period
46.6

Settlements made
(43.7
)
Effect of foreign currency translation
(1.2
)
Balance, September 27, 2019
$
79.1



NOTE 14. STOCK TRANSACTIONS AND STOCK-BASED COMPENSATION
Neither the Company nor any “affiliated purchaser” repurchased any shares of Company common stock during the nine-month period ended September 27, 2019. On July 16, 2013, the Company’s Board of Directors approved a repurchase program (the “Repurchase Program”) authorizing the repurchase of up to 20 million shares of the Company’s common stock from time to time on the open market or in privately negotiated transactions. As of September 27, 2019, 20 million shares remained available for repurchase pursuant to the Repurchase Program.
The following table summarizes the Company’s share activity (shares in millions):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Preferred stock - shares issued:
 
 
 
 
 
 
 
Balance, beginning of period
1.7

 

 

 

Issuance of MCPS

 

 
1.7

 

Balance, end of period
1.7

 

 
1.7

 

 
 
 
 
 
 
 
 
Common stock - shares issued:
 
 
 
 
 
 
 
Balance, beginning of period
834.0

 
816.0

 
817.9

 
812.5

Common stock-based award activity
1.0

 
1.2

 
4.1

 
4.0

Common stock issued in connection with acquisitions

 

 

 
0.2

Common stock issued in connection with LYONs’ conversions

 

 
0.9

 
0.5

Issuance of common stock

 

 
12.1

 

Balance, end of period
835.0

 
817.2

 
835.0

 
817.2


On March 1, 2019, the Company completed the underwritten public offering of 12.1 million shares of Danaher common stock at a price to the public of $123.00 per share (the “Common Stock Offering”), resulting in net proceeds of approximately $1.4 billion, after deducting expenses and the underwriters’ discount of $45 million. Simultaneously, the Company completed the underwritten public offering of 1.65 million shares of its 4.75% MCPS, Series A, without par value and with a liquidation preference of $1,000 per share (the “MCPS Offering”), resulting in net proceeds of approximately $1.6 billion, after deducting expenses and the underwriters’ discount of $50 million. The Company intends to use the net proceeds from the Common Stock

28


Offering and the MCPS Offering to fund a portion of the cash consideration payable for, and certain costs associated with, the GE Biopharma Acquisition. Pending completion of the GE Biopharma Acquisition, the Company has invested the net proceeds in short-term bank deposits and/or interest-bearing, investment-grade securities.
As a result of the dividend paid to shareholders of the Company’s common stock in July 2019, the Company triggered an anti-dilution adjustment pursuant to the terms of the MCPS and after giving affect to this adjustment, each share of MCPS will mandatorily convert on the mandatory conversion date, which is expected to be April 15, 2022, into between 6.6382 and 8.1318 shares of the Company’s common stock, subject to further anti-dilution adjustments. The number of shares of the Company’s common stock issuable upon conversion will be determined based on the average volume-weighted average price per share of the Company’s common stock over the 20 consecutive trading day period beginning on, and including, the 21st scheduled trading day immediately before April 15, 2022. Subject to certain exceptions, at any time prior to April 15, 2022, holders may elect to convert each share of the MCPS into 6.6382 shares of common stock, subject to further anti-dilution adjustments. In the event of a fundamental change, the MCPS will convert at the fundamental change rates specified in the certificate of designations, and the holders of MCPS would be entitled to a fundamental change make-whole dividend.
Holders of MCPS will be entitled to receive, when and if declared by the Company’s Board of Directors, cumulative dividends at the annual rate of 4.75% of the liquidation preference of $1,000 per share (equivalent to $47.50 annually per share), payable in cash or, subject to certain limitations, by delivery of shares of the Company’s common stock or any combination of cash and shares of the Company’s common stock, at the Company’s election. If declared, dividends on the MCPS will be payable quarterly on January 15, April 15, July 15 and October 15 of each year (commencing on July 15, 2019 to, and including, April 15, 2022), to the holders of record of the MCPS as they appear on the Company’s stock register at the close of business on the immediately preceding December 31, March 31, June 30 and September 30, respectively.
If the GE Biopharma Acquisition has not closed on or before 5:00 p.m. (New York City time) on August 25, 2020, the GE Biopharma Purchase Agreement is terminated or the Company’s Board of Directors, in its good faith judgment, determines that the GE Biopharma Acquisition will not occur, the Company has the option to redeem the shares of MCPS, in whole but not in part, subject to certain terms and conditions.
For a full description of the Company’s stock-based compensation programs, refer to Note 18 of the Company’s financial statements as of and for the year ended December 31, 2018 included in the Company’s 2018 Annual Report. As of September 27, 2019, approximately 46 million shares of the Company’s common stock were reserved for issuance under the 2007 Omnibus Incentive Plan.
In connection with the Envista IPO, Envista has adopted a stock-based compensation plan, which provides for grants of stock options, performance stock units (“PSUs”), restricted stock units (“RSUs”) and other stock-based awards denominated in shares of Envista common stock. Envista employees who participated in the Danaher stock compensation program prior to the IPO will continue to participate in such program solely with respect to outstanding compensation awards received prior to the Envista IPO, until the Distribution (at which time such awards will be converted into awards denominated in Envista common stock under the Envista stock compensation plan). From and after the Envista IPO, all equity compensation awarded to Envista associates will be awarded under the Envista stock compensation plan. Stock-based compensation expense for the Envista stock-based compensation plan is included in the Company’s consolidated stock-based compensation expense.

29


The following summarizes the components of the Company’s stock-based compensation expense ($ in millions):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
RSUs/PSUs:
 
 
 
 
 
 
 
Pretax compensation expense
$
27.6

 
$
24.0

 
$
79.8

 
$
69.6

Income tax benefit
(5.7
)
 
(5.0
)
 
(16.6
)
 
(14.6
)
RSU/PSU expense, net of income taxes
21.9

 
19.0

 
63.2

 
55.0

Stock options:
 
 
 
 
 
 
 
Pretax compensation expense
17.0

 
14.2

 
50.2

 
42.0

Income tax benefit
(3.5
)
 
(3.0
)
 
(10.5
)
 
(8.9
)
Stock option expense, net of income taxes
13.5

 
11.2

 
39.7

 
33.1

Total stock-based compensation:
 
 
 
 
 
 
 
Pretax compensation expense
44.6

 
38.2

 
130.0

 
111.6

Income tax benefit
(9.2
)
 
(8.0
)
 
(27.1
)
 
(23.5
)
Total stock-based compensation expense, net of income taxes
$
35.4

 
$
30.2

 
$
102.9

 
$
88.1


Stock-based compensation has been recognized as a component of selling, general and administrative expenses in the accompanying Consolidated Condensed Statements of Earnings. As of September 27, 2019, $192 million of total unrecognized compensation cost related to RSUs/PSUs is expected to be recognized over a weighted average period of approximately two years. As of September 27, 2019, $178 million of total unrecognized compensation cost related to stock options is expected to be recognized over a weighted average period of approximately three years. Future compensation amounts will be adjusted for any changes in estimated forfeitures.

NOTE 15. NET EARNINGS PER SHARE
Basic net earnings per share (“EPS”) is calculated by dividing net earnings attributable to common stockholders by the weighted average number of common shares outstanding for the applicable period. Diluted net EPS is computed based on the weighted average number of common shares outstanding increased by the number of additional shares that would have been outstanding had the potentially dilutive common shares (including subsidiary denominated equity) been issued and reduced by the number of shares the Company could have repurchased with the proceeds from the issuance of the potentially dilutive shares. For both the three and nine-month periods ended September 27, 2019 and the three-month period ended September 28, 2018no options to purchase shares were excluded from the diluted EPS calculation. For the nine-month period ended September 28, 2018, approximately one million options to purchase shares were not included in the diluted EPS calculation as the impact of their inclusion would have been anti-dilutive.
The impact of the MCPS calculated under the if-converted method was anti-dilutive, and as such 12 million shares and 9 million shares underlying the MCPS were excluded from the diluted EPS calculation for the three and nine-month periods ended September 27, 2019, respectively. The inclusion of Envista’s dilutive securities in the calculation of the Company’s net earnings attributable to common stockholders after assumed conversions did not significantly impact the Company’s diluted EPS for the three and nine-month periods ended September 27, 2019, respectively.

30


Information related to the calculation of net earnings per share is summarized as follows ($ and shares in millions, except per share amounts):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Numerator:
 
 
 
 
 
 
 
Net earnings
$
673.9

 
$
663.7

 
$
1,739.0

 
$
1,904.1

Net earnings attributable to noncontrolling interests
(5.9
)
 

 
(5.9
)
 

MCPS dividends
(19.6
)
 

 
(48.8
)
 

Net earnings attributable to common stockholders (used in Basis EPS)
648.4

 
663.7


1,684.3


1,904.1

Adjustment for interest on convertible debentures
0.4

 
0.6

 
1.4

 
1.7

Net earnings attributable to common stockholders after assumed conversions (used in Diluted EPS)
$
648.8

 
$
664.3


$
1,685.7


$
1,905.8

 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
Weighted average common shares outstanding (used in Basic EPS)
718.8

 
701.4

 
714.7

 
700.1

Incremental common shares from:
 
 
 
 
 
 
 
Assumed exercise of dilutive options and vesting of dilutive RSUs and PSUs
9.1

 
6.9

 
8.9

 
7.3

Assumed conversion of the convertible debentures
1.4

 
2.3

 
1.6

 
2.5

Weighted average common shares outstanding (used in Diluted EPS)
729.3

 
710.6

 
725.2

 
709.9

 
 
 
 
 
 
 
 
Basic EPS
$
0.90

 
$
0.95


$
2.36


$
2.72

Diluted EPS
$
0.89

 
$
0.93

 
$
2.32

 
$
2.68



NOTE 16. SEGMENT INFORMATION
The Company operates and reports its results in four separate business segments consisting of the Life Sciences, Diagnostics, Dental/Envista and Environmental & Applied Solutions segments. When determining the reportable segments, the Company 
aggregated operating segments based on their similar economic and operating characteristics. Operating profit represents total revenues less operating expenses, excluding nonoperating income and expense, interest and income taxes. Operating profit amounts in the Other segment consist of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance. Intersegment amounts are not significant and are eliminated to arrive at consolidated totals.

31


Segment results are shown below ($ in millions):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Sales:
 
 
 
 
 
 
 
Life Sciences
$
1,695.6

 
$
1,596.7

 
$
5,035.1

 
$
4,677.9

Diagnostics
1,601.9

 
1,502.5

 
4,757.0

 
4,573.1

Dental / Envista
659.3

 
679.5

 
2,031.1

 
2,085.5

Environmental & Applied Solutions
1,080.5

 
1,074.4

 
3,250.6

 
3,193.0

Total
$
5,037.3

 
$
4,853.1

 
$
15,073.8

 
$
14,529.5

 
 
 
 
 
 
 
 
Operating profit:
 
 
 
 
 
 
 
Life Sciences
$
342.5

 
$
312.8

 
$
995.5

 
$
875.6

Diagnostics
266.0

 
235.1

 
782.0

 
757.4

Dental / Envista
78.7

 
86.1

 
206.4

 
241.8

Environmental & Applied Solutions
256.5

 
254.3

 
761.3

 
732.5

Other
(108.9
)
 
(57.6
)
 
(302.8
)
 
(166.1
)
Total
$
834.8

 
$
830.7

 
$
2,442.4

 
$
2,441.2


Segment identifiable assets are shown below ($ in millions):
 
September 27, 2019
 
December 31, 2018
Life Sciences
$
22,115.0

 
$
22,122.4

Diagnostics
14,175.1

 
14,031.1

Dental / Envista
6,009.5

 
5,897.3

Environmental & Applied Solutions
4,741.3

 
4,637.3

Other
14,490.2

 
1,144.4

Total
$
61,531.1

 
$
47,832.5



NOTE 17. SUBSEQUENT EVENTS
On October 24, 2019, the Company will redeem the $500 million aggregate principal amount of 2.4% Senior Notes due 2020 and the $375 million aggregate principal amount of 5.0% 2020 Assumed Pall Notes, in each case at a redemption price equal to the outstanding principal amount and a make-whole premium as specified in the applicable indenture, plus accrued and unpaid interest. The Company expects the make-whole premiums required in connection with the redemption will be $7 million ($5 million after-tax or $0.01 per diluted share). The payment of the make-whole premiums will be reflected as a loss on early extinguishment of borrowings in the Company’s fourth quarter financial statements, as the extinguishment is expected to occur in the fourth quarter. The Company is funding the redemption using a portion of the cash distribution it received in connection with the Envista IPO.


32


ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is designed to provide a reader of Danaher Corporation’s (“Danaher,” the “Company,” “we,” “us” or “our”) financial statements with a narrative from the perspective of Company management. The Company’s MD&A is divided into five sections:
Information Relating to Forward-Looking Statements
Overview
Results of Operations
Liquidity and Capital Resources
Critical Accounting Estimates
You should read this discussion along with the Company’s MD&A and audited financial statements as of and for the year ended December 31, 2018 and Notes thereto, included in the Company’s 2018 Annual Report on Form 10-K and the Company’s Consolidated Condensed Financial Statements and related Notes as of and for the three and nine-month periods ended September 27, 2019 included in this Report.
Unless otherwise indicated, all financial results in this report refer to continuing operations.

INFORMATION RELATING TO FORWARD-LOOKING STATEMENTS
Certain statements included or incorporated by reference in this quarterly report, in other documents we file with or furnish to the Securities and Exchange Commission, in our press releases, webcasts, conference calls, materials delivered to shareholders and other communications, are “forward-looking statements” within the meaning of the United States federal securities laws. All statements other than historical factual information are forward-looking statements, including without limitation statements regarding: projections of revenue, expenses, profit, profit margins, tax rates, tax provisions, cash flows, pension and benefit obligations and funding requirements, our liquidity position or other projected financial measures; management’s plans and strategies for future operations, including statements relating to anticipated operating performance, cost reductions, restructuring activities, new product and service developments, competitive strengths or market position, acquisitions and the integration thereof (including the pending GE Biopharma Acquisition), divestitures, spin-offs, split-offs or other distributions (including the anticipated Distribution of Envista), strategic opportunities, securities offerings, stock repurchases, dividends and executive compensation; growth, declines and other trends in markets we sell into; new or modified laws, regulations and accounting pronouncements; future regulatory approvals; outstanding claims, legal proceedings, tax audits and assessments and other contingent liabilities; future foreign currency exchange rates and fluctuations in those rates; general economic and capital markets conditions; the anticipated timing of any of the foregoing; assumptions underlying any of the foregoing; and any other statements that address events or developments that Danaher intends or believes will or may occur in the future. Terminology such as “believe,” “anticipate,” “should,” “could,” “intend,” “will,” “plan,” “expect,” “estimate,” “project,” “target,” “may,” “possible,” “potential,” “forecast” and “positioned” and similar references to future periods are intended to identify forward-looking statements, although not all forward-looking statements are accompanied by such words.
Forward-looking statements are based on assumptions and assessments made by our management in light of their experience and perceptions of historical trends, current conditions, expected future developments and other factors. Forward-looking statements are not guarantees of future performance and actual results may differ materially from the results, developments and business decisions contemplated by our forward-looking statements. Accordingly, you should not place undue reliance on any such forward-looking statements. Important factors that in some cases have affected us in the past and that in the future could cause actual results to differ materially from those envisaged in the forward-looking statements include the following:
We may not complete the GE Biopharma Acquisition within the time frame we anticipate or at all; any regulatory approval of the GE Biopharma Acquisition may be subject to conditions; and the GE Biopharma Acquisition could negatively impact our business, financial statements and stock price.
We have outstanding debt, and our debt has increased and will increase as a result of the GE Biopharma Acquisition. Our existing and future indebtedness may limit our operations and our use of our cash flow and negatively impact our credit ratings; and any failure to comply with the covenants that apply to our indebtedness could adversely affect our liquidity and financial statements.

33


We intend to distribute our remaining equity interest in Envista in one or more spin-off and/or split-off transactions. Any or all of these transactions may not be completed on the currently contemplated timeline or at all and may not achieve the intended benefits.
Conditions in the global economy, the particular markets we serve and the financial markets may adversely affect our business and financial statements.
Significant developments or uncertainties stemming from the U.S. administration, including changes in U.S. trade policies, tariffs and the reaction of other countries thereto, could have an adverse effect on our business.
Our growth could suffer if the markets into which we sell our products and services decline, do not grow as anticipated or experience cyclicality.
We face intense competition and if we are unable to compete effectively, we may experience decreased demand and decreased market share. Even if we compete effectively, we may be required to reduce prices for our products and services.
Our growth depends in part on the timely development and commercialization, and customer acceptance, of new and enhanced products and services based on technological innovation.
Our reputation, ability to do business and financial statements may be impaired by improper conduct by any of our employees, agents or business partners.
Certain of our businesses are subject to extensive regulation by the U.S. Food and Drug Administration and by comparable agencies of other countries, as well as laws regulating fraud and abuse in the health care industry and the privacy and security of health information. Failure to comply with those regulations could adversely affect our reputation, ability to do business and financial statements.
Our products are subject to clinical trials, the results of which may be unexpected, or perceived as unfavorable by the market, and could have a material adverse effect on our business, financial condition or results of operations.
The health care industry and related industries that we serve have undergone, and are in the process of undergoing, significant changes in an effort to reduce costs, which could adversely affect our financial statements.
Any inability to consummate acquisitions at our historical rate and at appropriate prices, and to make appropriate investments that support our long-term strategy, could negatively impact our growth rate and stock price.
Our acquisition of businesses, investments, joint ventures and other strategic relationships could negatively impact our financial statements.
The indemnification provisions of acquisition agreements by which we have acquired companies may not fully protect us and as a result we may face unexpected liabilities.
Divestitures or other dispositions could negatively impact our business, and contingent liabilities from businesses that we have disposed could adversely affect our financial statements.
We could incur significant liability if the Envista IPO, any subsequent spin-off and/or split-off of Envista, the 2016 spin-off of Fortive Corporation (“Fortive”) or the 2015 split-off of our communications business is determined to be a taxable transaction.
Potential indemnification and other liabilities in connection with the Envista IPO, any subsequent spin-off and/or split-off of Envista, the 2016 spin-off of Fortive or the 2015 split-off of our communications business could materially and adversely affect our business and financial statements.
A significant disruption in, or breach in security of, our information technology systems or data or violation of data privacy laws could adversely affect our business, reputation and financial statements.
Our operations, products and services expose us to the risk of environmental, health and safety liabilities, costs and violations that could adversely affect our business, reputation and financial statements.
Our businesses are subject to extensive regulation; failure to comply with those regulations could adversely affect our financial statements and our business, including our reputation.

34


Our restructuring actions could have long-term adverse effects on our business.
We may be required to recognize impairment charges for our goodwill and other intangible assets.
Foreign currency exchange rates may adversely affect our financial statements.
Changes in our tax rates or exposure to additional income tax liabilities or assessments could affect our profitability. In addition, audits by tax authorities could result in additional tax payments for prior periods.
Changes in tax law relating to multinational corporations could adversely affect our tax position.
We are subject to a variety of litigation and other legal and regulatory proceedings in the course of our business that could adversely affect our business and financial statements.
If we do not or cannot adequately protect our intellectual property, or if third parties infringe our intellectual property rights, we may suffer competitive injury or expend significant resources enforcing our rights.
Third parties may claim that we are infringing or misappropriating their intellectual property rights and we could suffer significant litigation expenses, losses or licensing expenses or be prevented from selling products or services.
The U.S. government has certain rights to use and disclose some of the intellectual property that we license and could exclusively license it to a third party if we fail to achieve practical application of the intellectual property.
Defects and unanticipated use or inadequate disclosure with respect to our products or services (including software), or allegations thereof, could adversely affect our business, reputation and financial statements.
The manufacture of many of our products is a highly exacting and complex process, and if we directly or indirectly encounter problems manufacturing products, our reputation, business and financial statements could suffer.
Adverse changes in our relationships with, or the financial condition, performance, purchasing patterns or inventory levels of, key distributors and other channel partners could adversely affect our financial statements.
Certain of our businesses rely on relationships with collaborative partners and other third parties for development, supply and marketing of certain products and potential products, and such collaborative partners or other third parties could fail to perform sufficiently.
Our financial results are subject to fluctuations in the cost and availability of commodities that we use in our operations.
If we cannot adjust our manufacturing capacity or the purchases required for our manufacturing activities to reflect changes in market conditions and customer demand, our profitability may suffer. In addition, our reliance upon sole or limited sources of supply for certain materials, components and services could cause production interruptions, delays and inefficiencies.
Changes in laws or governmental regulations may reduce demand for our products or services or increase our expenses.
Work stoppages, union and works council campaigns and other labor disputes could adversely impact our productivity and results of operations.
International economic, political, legal, compliance and business factors could negatively affect our financial statements.
Significant developments stemming from the United Kingdom’s referendum decision to exit the EU could have an adverse effect on our business.
If we suffer loss to our facilities, supply chains, distribution systems or information technology systems due to catastrophe or other events, our operations could be seriously harmed.
Our defined benefit pension plans are subject to financial market risks that could adversely affect our financial statements.
See Part I—Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 and Part II—Item 1A of each of the Company’s Quarterly Reports on Form 10-Q for the quarters ended March 29, 2019 (the “First Quarter 2019 Form 10-Q”) and June 28, 2019 (the “Second Quarter 2019 Form 10-Q”) for further discussion regarding reasons that actual results may differ materially from the results, developments and business decisions contemplated by our forward-looking statements. Forward-looking statements speak only as of the date of the report, document, press release, webcast, call, materials or other communication in which they are made. Except to the extent required by applicable law, we do not assume

35


any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.

OVERVIEW
General
As a result of the Company’s geographic and industry diversity, the Company faces a variety of opportunities and challenges, including rapid technological development (particularly with respect to computing, automation, artificial intelligence, mobile connectivity, communications and digitization) in most of the Company’s served markets, the expansion and evolution of opportunities in high-growth markets, trends and costs associated with a global labor force, consolidation of the Company’s competitors and increasing regulation.  The Company operates in a highly competitive business environment in most markets, and the Company’s long-term growth and profitability will depend in particular on its ability to expand its business in high-growth geographies and high-growth market segments, identify, consummate and integrate appropriate acquisitions, develop innovative and differentiated new products and services with higher gross profit margins, expand and improve the effectiveness of the Company’s sales force, continue to reduce costs and improve operating efficiency and quality, and effectively address the demands of an increasingly regulated environment.  The Company is making significant investments, organically and through acquisitions, to address the rapid pace of technological change in its served markets and to globalize its manufacturing, research and development and customer-facing resources (particularly in high-growth markets) in order to be responsive to the Company’s customers throughout the world and improve the efficiency of the Company’s operations.
Business Performance and Outlook
During the third quarter of 2019, the Company’s revenues increased 4.0% compared to the comparable period of 2018. While differences exist among the Company’s businesses, on an overall basis, demand for the Company’s products and services increased during the third quarter of 2019 compared to the comparable period of 2018. This demand, together with the Company’s continued investments in sales growth initiatives and the other business-specific factors discussed below, contributed to year-over-year core sales growth of 5.0% (for the definition of “core sales” or “core revenue” refer to “—Results of Operations” below). Geographically, both high-growth and developed markets contributed to core sales growth during the third quarter of 2019. Core revenues in high-growth markets increased at a high-single digit rate during the third quarter of 2019 as compared to the comparable period of 2018 led primarily by continued strength in China. High-growth markets represented approximately 31% of the Company’s total sales in the third quarter of 2019. Core revenues in developed markets increased at a mid-single digit rate during the third quarter of 2019 led primarily by growth in North America, Western Europe and Japan. For the nine-month period ended September 27, 2019, sales increased by a total of 3.5%, with 5.5% attributable to core sales growth, as a result of the same factors which drove sales growth for the third quarter of 2019. The Company expects overall year-over-year sales growth for the remainder of 2019 but remains cautious about challenges due to macro-economic and geopolitical uncertainties, including global uncertainties related to trade, tariffs, monetary and fiscal policies. For additional information regarding the Company’s sales by geographical region during the three and nine-month periods ended September 27, 2019 and September 28, 2018, refer to Note 2 to the accompanying Consolidated Condensed Financial Statements.
The Company’s net earnings for the three and nine-month periods ended September 27, 2019 totaled $674 million and approximately $1.7 billion, respectively, compared to $664 million and approximately $1.9 billion, respectively, for the three and nine-month periods ended September 28, 2018. Net earnings attributable to common stockholders for the three and nine-month periods ended September 27, 2019 totaled $648 million or $0.89 per diluted share and approximately $1.7 billion or $2.32 per diluted share, respectively, compared to $664 million or $0.93 per diluted share and approximately $1.9 billion or $2.68 per diluted share, respectively, for the three and nine-month periods ended September 28, 2018. Refer to “—Results of Operations” for further discussion of the drivers in the year-over-year change in net earnings and diluted earnings per share for both the three and nine-month periods ended September 27, 2019. The tax-related charges discussed below in “—Results of Operations—Income Taxes” are the primary drivers of the year-over-year decrease in net earnings and diluted earnings per share for the nine-month period ended September 27, 2019.
Acquisitions and Envista Initial Public Offering
The Company’s growth strategy contemplates future acquisitions. Operations and results can be affected by the rate and extent to which appropriate acquisition opportunities are available and successfully consummated, acquired businesses are effectively integrated and anticipated synergies or cost savings are achieved. For a description of the Company’s pending acquisition of the Biopharma Business of GE Life Sciences and the anticipated financing thereof, refer to Note 3 to the accompanying Consolidated Condensed Financial Statements. For a description of the Company’s Envista initial public offering, refer to Note 4 to the accompanying Consolidated Condensed Financial Statements.

36


During the nine-month period ended September 27, 2019 the Company acquired five businesses for total consideration of $331 million in cash, net of cash acquired. The businesses acquired complement existing units of the Life Sciences, Diagnostics and Environmental & Applied Solutions segments. The aggregate annual sales of these businesses at the time of their acquisition, based on the companies’ revenues for their last completed fiscal year prior to the acquisition, were $72 million.
Currency Exchange Rates
On a year-over-year basis, currency exchange rates negatively impacted reported sales by approximately 1.5% and 3.0% for the three and nine-month periods ended September 27, 2019, compared to the comparable periods of 2018, primarily due to the strength of the U.S. dollar against most major currencies in the first three quarters of 2019. If the currency exchange rates in effect as of September 27, 2019 were to prevail throughout the remainder of 2019, currency exchange rates would reduce the Company’s estimated full year 2019 sales by approximately 2.5% on a year-over-year basis. Any future strengthening of the U.S. dollar against major currencies would adversely impact the Company’s sales and results of operations for the remainder of the year, and any weakening of the U.S. dollar against major currencies would positively impact the Company’s sales and results of operations for the remainder of the year.
UK’s Referendum Decision to Exit the EU (“Brexit”)
In a referendum on June 23, 2016, voters approved for the United Kingdom (“UK”) to exit the EU. The timing of the UK’s exit from the EU remains uncertain; the EU has extended the deadline for the UK to exit the EU until October 31, 2019. The UK and EU have been unable to agree on terms for the UK’s exit from the EU, and the UK has asked the EU for an additional extension of the deadline. It is uncertain whether terms will be agreed and approved before the deadline or if the EU will agree to extend the October 31, 2019 deadline. With the terms of the UK’s withdrawal and the nature of its future relationship with the EU still being decided, the Company continues to monitor the status of the negotiations and plan for potential impacts. To mitigate the potential impact of Brexit on the import and export of goods to and from the UK, the Company has increased its warehouse capacity and the level of inventory within the UK. For goods the Company manufactures within the UK and exports to other countries, the Company has manufactured and shipped additional goods for storage in countries outside the UK in an effort to maintain inventory required to meet customer demand in the event of disruption in shipments from the UK. The ultimate impact of Brexit on the Company’s financial results is uncertain. For additional information, refer to “Item 1A—Risk Factors” of the Company’s 2018 Annual Report on Form 10-K and Part II—Item 1A of each of the First Quarter 2019 Form 10-Q and Second Quarter 2019 Form 10-Q. The Company has 7 manufacturing facilities in the UK, and for the year ended December 31, 2018, less than 5% of our sales were derived from customers located in the UK; however, the impact of Brexit could also impact our sales outside the UK.

RESULTS OF OPERATIONS
Non-GAAP Measures
In this report, references to the non-GAAP measure of core sales (also referred to as core revenues or sales/revenues from existing businesses) refer to sales calculated according to U.S. GAAP, but excluding:
sales from acquired businesses; and
the impact of currency translation.
References to sales or operating profit attributable to acquisitions or acquired businesses refer to sales or operating profit, as applicable, from acquired businesses recorded prior to the first anniversary of the acquisition less the amount of sales and operating profit, as applicable, attributable to divested product lines not considered discontinued operations. The portion of revenue attributable to currency translation is calculated as the difference between:
the period-to-period change in revenue (excluding sales from acquired businesses); and
the period-to-period change in revenue (excluding sales from acquired businesses) after applying current period foreign exchange rates to the prior year period.
Core sales growth should be considered in addition to, and not as a replacement for or superior to, sales, and may not be comparable to similarly titled measures reported by other companies. Management believes that reporting the non-GAAP financial measure of core sales growth provides useful information to investors by helping identify underlying growth trends in Danaher’s business and facilitating comparisons of Danaher’s revenue performance with its performance in prior and future periods and to Danaher’s peers. Management also uses core sales growth to measure the Company’s operating and financial performance, and uses it as one of the performance measures in the Company’s executive short-term cash incentive program.

37


The Company excludes the effect of currency translation from core sales because currency translation is not under management’s control, is subject to volatility and can obscure underlying business trends. The Company excludes the effect of acquisitions and divestiture-related items because the nature, size, timing and number of acquisitions and divestitures can vary dramatically from period-to-period and between the Company and its peers and can also obscure underlying business trends and make comparisons of long-term performance difficult.
Throughout this discussion, references to sales volume refer to the impact of both price and unit sales and references to productivity improvements generally refer to improved cost-efficiencies resulting from the ongoing application of the Danaher Business System.
Core Revenue Growth
 
% Change Three-Month Period Ended September 27, 2019 vs. Comparable 2018 Period
 
% Change Nine- Month Period Ended September 27, 2019 vs. Comparable 2018 Period
Total sales growth (GAAP)
4.0
 %
 
3.5
 %
Less the impact of:
 
 
 
Acquisitions
(0.5
)%
 
(1.0
)%
Currency exchange rates
1.5
 %
 
3.0
 %
Core revenue growth (non-GAAP)
5.0
 %
 
5.5
 %
Operating Profit Performance
Operating profit margins decreased 50 basis points from 17.1% during the three-month period ended September 28, 2018 to 16.6% for the three-month period ended September 27, 2019.
Third quarter 2019 vs. third quarter 2018 operating profit margin comparisons were favorably impacted by:
Higher 2019 core sales volumes, incremental year-over-year cost savings associated with continuing productivity improvement initiatives taken in 2018 and the impact of foreign currency exchange rates, net of incremental year-over-year costs associated with various new product development and sales, service and marketing growth investments in the third quarter of 2019 - 70 basis points
Third quarter 2019 vs. third quarter 2018 operating profit margin comparisons were unfavorably impacted by:
The incremental net dilutive effect in 2019 of acquired businesses - 10 basis points
Transaction costs and integration preparation costs incurred in the third quarter of 2019 related to the anticipated GE Biopharma Acquisition - 60 basis points
Costs incurred in the third quarter of 2019 related to the Envista IPO, including separation related activities and costs related to establishing a new separate company infrastructure, primarily related to incremental salaries, benefits and rent expense - 50 basis points
Operating profit margins decreased 60 basis points from 16.8% during the nine-month period ended September 28, 2018 to 16.2% for the nine-month period ended September 27, 2019.
Year-to-date 2019 vs. year-to-date 2018 operating profit margin comparisons were favorably impacted by:
Higher 2019 core sales volumes and incremental year-over-year cost savings associated with continuing productivity improvement initiatives taken in 2018, net of incremental year-over-year costs associated with various new product development, sales, service and marketing growth investments and the impact of foreign currency exchange rates in the nine-month period in 2019 - 40 basis points
Acquisition-related transaction costs deemed significant and fair value adjustments to inventory incurred in the second quarter of 2018 (the Company deems acquisition-related transaction costs incurred in a given period to be significant (generally relating to the Company’s larger acquisitions) if it determines that such costs exceed the range of acquisition-related transaction costs typical for Danaher in a given period) - 10 basis points

38


Year-to-date 2019 vs. year-to-date 2018 operating profit margin comparisons were unfavorably impacted by:
The incremental net dilutive effect in 2019 of acquired businesses - 10 basis points
Transaction costs and integration preparation costs incurred in 2019 related to the anticipated GE Biopharma Acquisition - 40 basis points
Costs incurred in 2019 related to the Envista IPO, including separation related activities and costs related to establishing a new separate company infrastructure, primarily related to incremental salaries, benefits and rent expense - 30 basis points
First quarter 2019 costs and estimated liabilities related to a legal contingency - 25 basis points.
Second quarter 2018 gain on resolution of acquisition-related matters - 5 basis points
Business Segments
Sales by business segment for each of the periods indicated were as follows ($ in millions):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Life Sciences
$
1,695.6

 
$
1,596.7

 
$
5,035.1

 
$
4,677.9

Diagnostics
1,601.9

 
1,502.5

 
4,757.0

 
4,573.1

Dental / Envista
659.3

 
679.5

 
2,031.1

 
2,085.5

Environmental & Applied Solutions
1,080.5

 
1,074.4

 
3,250.6

 
3,193.0

Total
$
5,037.3

 
$
4,853.1

 
$
15,073.8

 
$
14,529.5

For information regarding the Company’s sales by geographical region during the three and nine-month periods ended September 27, 2019 and September 28, 2018, please refer to Note 2 to the accompanying Consolidated Condensed Financial Statements.

LIFE SCIENCES
The Company’s Life Sciences segment offers a broad range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines.  The segment is also a leading provider of filtration, separation and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics and general industrial sectors.
Life Sciences Selected Financial Data
 
Three-Month Period Ended
 
Nine-Month Period Ended
($ in millions)
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Sales
$
1,695.6

 
$
1,596.7

 
$
5,035.1

 
$
4,677.9

Operating profit
342.5

 
312.8

 
995.5

 
875.6

Depreciation
31.7

 
32.6

 
96.8

 
94.8

Amortization
89.0

 
84.2

 
267.7

 
255.4

Operating profit as a % of sales
20.2
%
 
19.6
%
 
19.8
%
 
18.7
%
Depreciation as a % of sales
1.9
%
 
2.0
%
 
1.9
%
 
2.0
%
Amortization as a % of sales
5.2
%
 
5.3
%
 
5.3
%
 
5.5
%

39


Core Revenue Growth
 
% Change Three-Month Period Ended September 27, 2019 vs. Comparable 2018 Period
 
% Change Nine- Month Period Ended September 27, 2019 vs. Comparable 2018 Period
Total sales growth (GAAP)
6.0
 %
 
7.5
 %
Less the impact of:
 
 
 
Acquisitions
(1.0
)%
 
(3.5
)%
Currency exchange rates
1.5
 %
 
3.0
 %
Core revenue growth (non-GAAP)
6.5
 %
 
7.0
 %
Price increases in the segment contributed 1.0% to sales growth on a year-over-year basis during both the three and nine-month periods ended September 27, 2019, and are reflected as a component of core revenue growth.
Core sales of microscopy products grew during both the three and nine-month periods across most major product lines led by China and Japan in the three-month period and by North America, China, and other Asian markets in the nine-month period. Demand for the business’ flow cytometry and particle counting product lines increased across all major geographies and end-markets in both the three and nine-month periods ended September 27, 2019. Core sales for filtration, separation and purification technologies increased across most major geographies in both the three and nine-month periods in 2019 versus the comparable periods in 2018, led by growth in the biopharmaceutical and aerospace end-markets in both the three and nine-month periods as well as the fluid technology and process end-market in the nine-month period, partially offset by softness in the microelectronics end-market in both the three and nine-month periods. Core sales of the business’ broad range of mass spectrometers declined slightly on a year-over-year basis during the three-month period ended September 27, 2019, as increased demand in high-growth markets was more than offset by lower sales in North America and Western Europe. Core sales in the mass spectrometry business grew during the nine-month period ended September 27, 2019, led by strength in high-growth markets, particularly China, partially offset by lower sales in North America. In the three and nine-month periods, demand for mass spectrometers increased in the pharmaceutical and academic end-markets and for service offerings, offset by lower core sales in the food, environmental and forensics end-markets and the clinical end-market.
Sales growth from acquisitions in the nine-month period is primarily due to the acquisition of IDT in April 2018. IDT provides additional sales and earnings growth opportunities for the segment by expanding the segment’s product line diversity, including new product and service offerings in the area of genomics consumables. During the three and nine-month periods ended September 27, 2019, IDT’s revenues grew on a year-over-year basis with growth across all major product lines and all major geographies served by the business, primarily driven by North America.
In addition, though the timing of obtaining the regulatory approvals necessary to close the GE Biopharma Acquisition is uncertain, the Company continues to make progress with respect thereto and expects to close the transaction in the first quarter of 2020. Upon closing, the Company expects to include the GE Biopharma Business within the Life Sciences segment. The GE Biopharma Acquisition is expected to provide additional sales and earnings growth opportunities for the Company’s Life Sciences segment by expanding the business’ geographic and product line diversity, including new product and service offerings in the areas of process chromatography and consumables, cell culture media, single-use technologies, development instrumentation and consumables that complement the Company’s current biologics workflow solutions.
Operating Profit Performance
Operating profit margins increased 60 basis points during the three-month period ended September 27, 2019 as compared to the comparable period of 2018.
Third quarter 2019 vs. third quarter 2018 operating profit margin comparisons were favorably impacted by:
Higher 2019 core sales volumes, incremental year-over-year cost savings and the impact of foreign currency exchange rates, net of incremental year-over-year costs associated with various new product development and sales and marketing growth investments in the third quarter of 2019 - 100 basis points
Third quarter 2019 vs. third quarter 2018 operating profit margin comparisons were unfavorably impacted by:
The incremental net dilutive effect in 2019 of acquired businesses - 40 basis points

40


Operating profit margins increased 110 basis points during the nine-month period ended September 27, 2019 as compared to the comparable period of 2018.
Year-to-date 2019 vs. year-to-date 2018 operating profit margin comparisons were favorably impacted by:
Higher 2019 core sales volumes and incremental year-over-year cost savings, net of incremental year-over-year costs associated with various new product development, sales and marketing growth investments and the impact of foreign currency exchange rates in the nine-month period in 2019 - 125 basis points
Acquisition-related transaction costs deemed significant and fair value adjustments to inventory incurred in the second quarter of 2018 - 35 basis points
Year-to-date 2019 vs. year-to-date 2018 operating profit margin comparisons were unfavorably impacted by:
The incremental net dilutive effect in 2019 of acquired businesses - 30 basis points
Second quarter 2018 gain on resolution of acquisition-related matters - 20 basis points

DIAGNOSTICS
The Company’s Diagnostics segment offers analytical instruments, reagents, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Diagnostics Selected Financial Data
 
Three-Month Period Ended
 
Nine-Month Period Ended
($ in millions)
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Sales
$
1,601.9

 
$
1,502.5

 
$
4,757.0

 
$
4,573.1

Operating profit
266.0

 
235.1

 
782.0

 
757.4

Depreciation
94.3

 
92.2

 
280.1

 
284.5

Amortization
51.3

 
52.1

 
155.1

 
157.8

Operating profit as a % of sales
16.6
%
 
15.6
%
 
16.4
%
 
16.6
%
Depreciation as a % of sales
5.9
%
 
6.1
%
 
5.9
%
 
6.2
%
Amortization as a % of sales
3.2
%
 
3.5
%
 
3.3
%
 
3.5
%
Core Revenue Growth
 
% Change Three-Month Period Ended September 27, 2019 vs. Comparable 2018 Period
 
% Change Nine- Month Period Ended September 27, 2019 vs. Comparable 2018 Period
Total sales growth (GAAP)
6.5
%
 
4.0
%
Less the impact of:
 
 
 
Currency exchange rates
1.5
%
 
3.0
%
Core revenue growth (non-GAAP)
8.0
%
 
7.0
%
Pricing in the segment did not significantly impact sales growth on a year-over-year basis during the three or nine-month periods ended September 27, 2019.
Core sales in the segment’s clinical lab business increased on a year-over-year basis for both the three and nine-month periods ended September 27, 2019, due to continued demand in high-growth markets, led by China, and in North America, partially offset by modest declines in Western Europe. The immunoassay and chemistry product lines drove the year-over-year core sales growth in both the three and nine-month periods and the automation product line also contributed to the core sales growth in the nine-month period. During both the three and nine-month periods, core sales increased in the molecular diagnostics business on a year-over-year basis in most major product lines, driven by strong demand across all major geographies. Core sales in the acute care diagnostic business increased year-over-year in both the three and nine-month periods ended September 27, 2019, as continued demand for both the blood gas and immunoassay product lines increased core sales,

41


primarily in China, Western Europe, Japan and North America. Increased demand for advanced staining and core histology products, primarily in North America, China, Western Europe and Japan, drove the majority of the year-over-year core sales growth in the pathology business in both the three and nine-month periods ended September 27, 2019.
Operating Profit Performance
Operating profit margins increased 100 basis points during the three-month period ended September 27, 2019 as compared to the comparable period of 2018. The following factors favorably impacted year-over-year operating profit margin comparisons:
Higher 2019 core sales volumes, incremental year-over-year cost savings associated with the restructuring actions and continuing productivity improvement initiatives taken in 2018 and the impact of foreign currency exchange rates, net of incremental year-over-year costs associated with various new product development, sales, service and marketing growth investments and unfavorable product mix in the third quarter of 2019 - 100 basis points
Operating profit margins decreased 20 basis points during the nine-month period ended September 27, 2019 as compared to the comparable period of 2018. The following factors unfavorably impacted year-over-year operating profit margin comparisons:
Incremental year-over-year costs associated with various new product development, sales, service and marketing growth investments, unfavorable product mix and the impact of foreign currency exchange rates in 2019, net of higher 2019 core sales volumes and incremental year-over-year cost savings associated with the restructuring actions and continuing productivity improvement initiatives taken in 2018 - 20 basis points

DENTAL / ENVISTA
On September 20, 2019, Envista completed an underwritten initial public offering of 30.8 million shares of its common stock, which represents 19.4% of Envista’s outstanding shares, at a public offering price of $22.00 per share. Envista shares trade on the New York Stock Exchange under the symbol “NVST”.
Simultaneous with the completion of the Envista IPO, through a series of equity and other transactions, the Company transferred its dental businesses to Envista. In consideration therefor, Envista transferred approximately $2.0 billion to the Company, which consists primarily of the net proceeds from the Envista IPO and approximately $1.3 billion of proceeds from Envista’s term debt financing. Refer to Note 4 to the accompanying Consolidated Condensed Financial Statements for additional information about the Envista IPO. Since the Company continues to control Envista, the operating results of Envista are consolidated with the Company’s operating results and comprise the Company’s Dental segment. Envista provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, as well as to improve the aesthetics of the human smile. With leading brand names, innovative technology and significant market position, the Company is a leading worldwide provider of a broad range of dental consumables, equipment and services, and is dedicated to driving technological innovations that help dental professionals improve clinical outcomes and enhance productivity. The specialty products and technologies business develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The equipment and consumables business develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
Dental / Envista Selected Financial Data
 
Three-Month Period Ended
 
Nine-Month Period Ended
($ in millions)
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Sales
$
659.3

 
$
679.5

 
$
2,031.1

 
$
2,085.5

Operating profit
78.7

 
86.1

 
206.4

 
241.8

Depreciation
10.0

 
9.4

 
29.8

 
29.1

Amortization
22.3

 
22.5

 
67.3

 
68.0

Operating profit as a % of sales
11.9
%
 
12.7
%
 
10.2
%
 
11.6
%
Depreciation as a % of sales
1.5
%
 
1.4
%
 
1.5
%
 
1.4
%
Amortization as a % of sales
3.4
%
 
3.3
%
 
3.3
%
 
3.3
%

42


Core Revenue Growth
 
% Change Three-Month Period Ended September 27, 2019 vs. Comparable 2018 Period
 
% Change Nine- Month Period Ended September 27, 2019 vs. Comparable 2018 Period
Total sales growth (decline) (GAAP)
(3.0
)%
 
(2.5
)%
Less the impact of:
 
 
 
Currency exchange rates
1.5
 %
 
2.5
 %
Core revenue growth (decline) (non-GAAP)
(1.5
)%
 
 %
Price in the segment negatively impacted sales growth by 1.0% on a year-over-year basis during both the three and nine-month periods ended September 27, 2019, and is reflected as a component of core revenue growth (decline).
Core sales of the equipment and consumables business declined in both the three and nine-month periods ended September 27, 2019, as increased demand in China and Japan was more than offset by lower demand in North America and Western Europe. Core revenue growth for the specialty products and technologies business, which consists of implant systems and orthodontic products, was led by the high-growth markets, primarily China, partially offset by declines in Western Europe for both the three and nine-month periods and declines in North America for the three-month period. Core sales growth for the specialty products and technologies business in the three and nine-month periods was driven by demand for orthodontic products due partially to recent product launches, partially offset by lower demand for value implant systems.
Operating Profit Performance
Operating profit margins decreased 80 basis points during the three-month period ended September 27, 2019 as compared to the comparable period of 2018. The following factors unfavorably impacted year-over-year operating profit margin comparisons:
Lower overall pricing and core sales volumes, incremental year-over-year costs associated with sales and marketing growth investments, net of lower spending on productivity initiatives in 2019, cost savings associated with productivity initiatives taken in 2018 and the impact of foreign currency exchange rates in the third quarter of 2019 - 80 basis points
Operating profit margins decreased 140 basis points during the nine-month period ended September 27, 2019 as compared to the comparable period of 2018. The following factors unfavorably impacted year-over-year operating profit margin comparisons:
Lower overall pricing and incremental year-over-year costs associated with sales and marketing growth investments, net of higher 2019 core sales volumes, lower spending on productivity initiatives in 2019, cost savings associated with productivity initiatives taken in 2018 and the impact of foreign currency exchange rates in 2019 - 140 basis points

ENVIRONMENTAL & APPLIED SOLUTIONS
The Company’s Environmental & Applied Solutions segment offers products and services that help protect important resources and keep global food and water supplies safe. The Company’s water quality business provides instrumentation, services and disinfection systems to help analyze, treat and manage the quality of ultra-pure, potable, industrial, waste, ground, source and ocean water in residential, commercial, municipal, industrial and natural resource applications. The Company’s product identification business provides equipment, software, services and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding and traceability applications on consumer, pharmaceutical and industrial products.

43


Environmental & Applied Solutions Selected Financial Data
 
Three-Month Period Ended
 
Nine-Month Period Ended
($ in millions)
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Sales
$
1,080.5

 
$
1,074.4

 
$
3,250.6

 
$
3,193.0

Operating profit
256.5

 
254.3

 
761.3

 
732.5

Depreciation
11.6

 
11.0

 
36.6

 
34.8

Amortization
15.3

 
15.3

 
46.5

 
46.3

Operating profit as a % of sales
23.7
%
 
23.7
%
 
23.4
%
 
22.9
%
Depreciation as a % of sales
1.1
%
 
1.0
%
 
1.1
%
 
1.1
%
Amortization as a % of sales
1.4
%
 
1.4
%
 
1.4
%
 
1.5
%
Core Revenue Growth
 
% Change Three-Month Period Ended September 27, 2019 vs. Comparable 2018 Period
 
% Change Nine- Month Period Ended September 27, 2019 vs. Comparable 2018 Period
Total sales growth (GAAP)
0.5
%
 
2.0
 %
Less the impact of:
 
 
 
Acquisitions
%
 
(0.5
)%
Currency exchange rates
1.5
%
 
2.5
 %
Core revenue growth (non-GAAP)
2.0
%
 
4.0
 %
Price increases in the segment contributed 2.0% and 1.5% to sales growth on a year-over-year basis during the three and nine-month periods ended September 27, 2019, respectively, and are reflected as a component of core revenue growth.
Core sales in the segment’s water quality business increased at a mid-single digit rate during both the three and nine-month periods ended September 27, 2019 as compared to the comparable periods of 2018. Year-over-year core sales in the analytical instrumentation product line grew in both the three and nine-month periods, driven by increased demand in North America and Western Europe, partially offset by lower core sales in China as a result of a difficult prior year comparison. Core revenue growth in the business’ chemical treatment solutions product line for the three and nine-month periods was driven by higher demand in the oil and gas, primary metals, and food and beverage end-markets. Geographically, year-over-year core revenue growth for chemical treatment solutions was driven by increased demand in North America and Latin America. Core sales in the business’ ultraviolet water disinfection product line increased across all major end-markets during the three and nine-month periods, led by the completion of several municipal projects. Geographically, year-over-year core sales growth for ultraviolet water disinfection products was driven by North America and China.
Core sales in the segment’s product identification businesses decreased slightly during the three-month period and increased at a low-single digit rate during the nine-month period ended September 27, 2019 as compared to the comparable periods of 2018. Core sales of marking and coding equipment and related consumables decreased during the three-month period due to a difficult prior year comparison, driven primarily by declines in Western Europe. Core sales for marking and coding equipment and related consumables increased during the nine-month period driven by North America, Western Europe and the high-growth markets. For packaging and color solutions products and services, core sales increased in both the three and nine-month periods. Geographically, year-over-year core revenue growth for packaging and color solutions products and services was driven by North America and Western Europe partially offset by lower sales in high-growth markets.
Operating Profit Performance
Operating profit margins were flat during the three-month period ended September 27, 2019 as compared to the comparable period of 2018.
Third quarter 2019 vs. third quarter 2018 operating profit margin comparisons were favorably impacted by:
Higher 2019 core sales volumes, incremental year-over-year cost savings associated with the restructuring actions and continuing productivity improvement initiatives taken in 2018 and the impact of foreign currency exchange rates in

44


the third quarter of 2019, net of incremental year-over-year costs associated with sales, service and marketing growth investments - 10 basis points
Third quarter 2019 vs. third quarter 2018 operating profit margin comparisons were unfavorably impacted by:
The incremental net dilutive effect in 2019 of acquired businesses - 10 basis points
Operating profit margins increased 50 basis points during the nine-month period ended September 27, 2019 as compared to the comparable period of 2018.
Year-to-date 2019 vs. year-to-date 2018 operating profit margin comparisons were favorably impacted by:
Higher 2019 core sales volumes, incremental year-over-year cost savings associated with the restructuring actions and continuing productivity improvement initiatives taken in 2018 and the impact of foreign currency exchange rates in 2019, net of incremental year-over-year costs associated with sales, service and marketing growth investments - 60 basis points
Year-to-date 2019 vs. year-to-date 2018 operating profit margin comparisons were unfavorably impacted by:
The incremental net dilutive effect in 2019 of acquired businesses - 10 basis points

COST OF SALES AND GROSS PROFIT
 
Three-Month Period Ended
 
Nine-Month Period Ended
($ in millions)
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Sales
$
5,037.3

 
$
4,853.1

 
$
15,073.8

 
$
14,529.5

Cost of sales
(2,228.9
)
 
(2,162.6
)
 
(6,670.0
)
 
(6,378.3
)
Gross profit
$
2,808.4

 
$
2,690.5

 
$
8,403.8

 
$
8,151.2

Gross profit margin
55.8
%
 
55.4
%
 
55.8
%
 
56.1
%
The year-over-year increase in cost of sales during both the three and nine-month periods ended September 27, 2019 as compared to the comparable periods in 2018 was due primarily to the impact of higher year-over-year sales volumes, including sales from recently acquired businesses, partly offset by incremental year-over-year cost savings associated with the restructuring and continued productivity improvement actions taken in 2019 and 2018.
The year-over-year increase in gross profit margin during the three-month period ended September 27, 2019 as compared to the comparable period in 2018, is primarily due to the impact of higher year-over-year sales volumes, including sales from recently acquired businesses, increased leverage of certain manufacturing costs and incremental year-over-year cost savings associated with the restructuring activities and continued productivity improvement actions taken in 2019 and 2018 and the impact of foreign currency exchange rates, partially offset by product mix and higher freight and tariffs costs. The year-over-year decrease in gross profit margin during the nine-month period ended September 27, 2019 as compared to the comparable period in 2018 was due to the impact of foreign currency exchange rates, product mix and higher freight and tariffs costs, partially offset by the impact of higher year-over-year sales volumes, including sales from recently acquired businesses, increased leverage of certain manufacturing costs and incremental year-over-year cost savings associated with the restructuring activities and continued productivity improvement actions taken in 2019 and 2018.

OPERATING EXPENSES
 
Three-Month Period Ended
 
Nine-Month Period Ended
($ in millions)
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Sales
$
5,037.3

 
$
4,853.1

 
$
15,073.8

 
$
14,529.5

Selling, general and administrative (“SG&A”) expenses
1,654.7

 
1,558.6

 
5,009.9

 
4,798.4

Research and development (“R&D”) expenses
318.9

 
301.2

 
951.5

 
911.6

SG&A as a % of sales
32.8
%
 
32.1
%
 
33.2
%
 
33.0
%
R&D as a % of sales
6.3
%
 
6.2
%
 
6.3
%
 
6.3
%

45


The year-over-year increase in SG&A expenses as a percentage of sales for both the three and nine-month periods ended September 27, 2019 as compared to the comparable periods in 2018, was primarily driven by expenses related to the Envista IPO, costs associated with the GE Biopharma Acquisition and investments in sales and marketing growth initiatives, partially offset by the benefit of increased leverage of the Company’s general and administrative cost base resulting from higher 2019 sales volumes. A provision for legal matters of $36 million also contributed to the year-over-year increase in SG&A expenses as a percentage of sales for the nine-month period ended September 27, 2019.
Year-over-year, R&D expenses (consisting principally of internal and contract engineering personnel costs) as a percentage of sales increased slightly for the three-month period and remained constant for the nine-month period ended September 27, 2019 as compared to the comparable periods in 2018, as year-over-year increases in the Company’s new product development initiatives roughly corresponded to the increase in sales.

NONOPERATING INCOME (EXPENSE)
The Company disaggregates the service cost component of net periodic benefit costs of the noncontributory defined benefit pension plans and other postretirement employee benefit plans and presents the other components of net periodic benefit cost in other income, net. These other components include the assumed rate of return on plan assets partially offset by amortization of actuarial losses and interest and aggregated to a gain of $4 million and $16 million for the three and nine-month periods ended September 27, 2019, respectively, compared to a gain of $9 million and $25 million for the three and nine-month periods ended September 28, 2018, respectively.

INTEREST COSTS AND FINANCING
For a discussion of the Company’s outstanding indebtedness, refer to Note 8 to the accompanying Consolidated Condensed Financial Statements.
Interest expense of $26 million and $70 million for the three and nine-month periods ended September 27, 2019, respectively, was $15 million lower and $53 million lower than the comparable periods of 2018, respectively, due primarily to the impact of the Company’s cross-currency swap derivatives, partially offset by interest expense from recent debt issuances. In January 2019, the Company entered into cross-currency swap derivative contracts with respect to approximately $1.9 billion of its U.S. dollar-denominated bonds to effectively convert these U.S. dollar-denominated bonds to obligations denominated in Danish kroner, Japanese yen, euro and Swiss franc. In addition to the cross-currency swaps entered into by the Company in January 2019, in September 2019, Envista entered into cross-currency swap derivative contracts with respect to $650 million of the Envista Term Loan Facility and these derivative contracts remained outstanding as of September 27, 2019. These contracts effectively convert the Envista Term Loan Facility to an obligation denominated in euro. In September 2019, Envista entered into $650 million of interest rate swap derivative contracts to convert the variable interest rate for the Envista Term Loan Facility to fixed interest rate. These contracts effectively fixed the interest rate for the Envista Term Loan Facility.
Interest income of $30 million and $72 million for the three and nine-month periods ended September 27, 2019, respectively, was $27 million higher and $65 million higher than the comparable periods of 2018, respectively, due primarily to higher average cash balances during 2019 attributable to the cash received from the first quarter 2019 Common Stock and Mandatory Convertible Preferred Stock (“MCPS”) Offerings, proceeds from the September 2019 issuance of debt completed in preparation for the GE Biopharma Acquisition and cash received from the third quarter 2019 Envista IPO. In June 2019, the Company entered into interest rate swap agreements with a notional amount of $850 million (with terms ranging from 10 to 30 years) which represents a portion of the amount of U.S. dollar-denominated bonds the Company anticipates issuing to finance a portion of the GE Biopharma Acquisition. These contracts effectively fixed the interest rate for a portion of the Company’s anticipated U.S. dollar-denominated debt issuance equal to the notional amount of the swaps to the rate specified in the interest rate swap agreements and will be reflected in interest expense for this debt once the debt is issued.


46


INCOME TAXES
The following table summarizes the Company’s effective tax rate:
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Effective tax rate
20.1
%
 
17.2
%
 
29.3
%
 
19.0
%
The effective tax rate for the three-month period ended September 27, 2019 differs from the U.S. federal statutory rate of 21.0% principally due to the impact of earnings outside the United States which generally are taxed at rates lower than the U.S. federal rate.
The effective tax rate for the nine-month period ended September 27, 2019 differs from the U.S. federal statutory rate of 21.0% principally due to the impact of net discrete charges of $227 million ($0.31 per diluted share) related primarily to changes in estimates associated with prior period uncertain tax positions and audit settlements, net of the release of reserves for uncertain tax positions due to the expiration of statutes of limitation, release of valuation allowances associated with certain foreign tax credits, tax benefits resulting from changes in tax law and excess tax benefits from stock-based compensation. These discrete income tax charges increased the reported tax rate by 9.2% on a net basis.
The Company’s effective tax rates for both the three and nine-month periods ended September 28, 2018 were lower than the U.S. federal statutory rate of 21.0% due principally to the impact of the Company’s earnings outside the United States which overall are taxed at rates lower than the U.S. federal rate. The effective tax rate for the three and nine-month periods ended September 28, 2018 reflects a U.S. corporate income tax rate of 21.0% from the enactment of the Tax Cuts and Jobs Act (“TCJA”), partially offset by a new minimum tax on certain non-U.S. earnings as a result of the TCJA. The effective tax rate for the three-month period ended September 28, 2018 includes net tax benefits of $23 million ($0.03 per diluted share) related primarily to the release of valuation allowances associated with certain foreign operating losses and excess tax benefits from stock-based compensation, which in aggregate reduced the reported tax rate by 2.9%. The effective tax rate for the nine-month period ended September 28, 2018 also includes these benefits, in addition to net tax benefits of $9 million ($0.01 per diluted share) recorded in the second quarter of 2018 related to the release of reserves upon the expiration of statutes of limitation and excess tax benefits from stock-based compensation, which were partially offset by increases in estimates associated with prior period uncertain tax positions.
The Company conducts business globally, and files numerous consolidated and separate income tax returns in federal, state and foreign jurisdictions. Non-U.S. countries in which the Company has a significant presence include China, Denmark, Germany, Singapore, Switzerland and the United Kingdom. The Company believes that a change in the statutory tax rate of any individual foreign country would not have a material effect on the Company’s financial statements given the geographical dispersion of the Company’s taxable income.
The Company and its subsidiaries are routinely examined by various domestic and international taxing authorities. The IRS has completed the examinations of substantially all of the Company’s federal income tax returns through 2011 and is currently examining certain of the Company’s federal income tax returns for 2012 through 2017. In addition, the Company has subsidiaries in Austria, Belgium, Canada, China, Denmark, France, Germany, India, Japan, New Zealand, Singapore, Sweden, Switzerland and the United Kingdom and various other countries, states and provinces that are currently under audit for years ranging from 2004 through 2017.
In the fourth quarter of 2018 and in the first quarter of 2019, the IRS proposed significant adjustments to the Company’s taxable income for the years 2012 through 2015 with respect to the deferral of tax on certain premium income related to the Company’s self-insurance programs. For income tax purposes, the recognition of premium income has been deferred in accordance with U.S. tax laws related to insurance. The IRS is challenging the deferral of premiums for certain types of insurance policies. The proposed adjustments would increase the Company’s taxable income over the 2012-2015 period by approximately $2.7 billion. Management believes the positions the Company has taken in its U.S. tax returns are in accordance with the relevant tax laws, intends to vigorously defend these positions and is currently considering all of its alternatives. Due to the enactment of the TCJA in 2017 and the resulting reduction in the U.S. corporate tax rate for years after 2017, the Company revalued its deferred tax liabilities related to the temporary differences associated with this deferred premium income from 35.0% to 21.0%. If the Company is not successful in defending these assessments, the taxes owed to the IRS may be computed under the previous 35.0% statutory tax rate and the Company may be required to revalue the related deferred tax liabilities from 21.0% to 35.0%, which in addition to any interest due on the amounts assessed, would require a charge to future earnings. The ultimate resolution of this matter is uncertain, could take many years and could result in a material adverse impact to the Company’s Consolidated Condensed Financial Statements, including its cash flows and effective tax rate.

47


Tax authorities in Denmark have raised significant issues related to interest accrued by certain of the Company’s subsidiaries. On December 10, 2013, the Company received assessments from the Danish tax authority (“SKAT”) totaling approximately DKK 1.7 billion including interest through September 27, 2019 (approximately $256 million based on the exchange rate as of September 27, 2019), imposing withholding tax relating to interest accrued in Denmark on borrowings from certain of the Company’s subsidiaries for the years 2004-2009. The Company appealed these assessments to the Danish National Tax Tribunal in 2014. The appeal is pending, awaiting the final outcome of other withholding tax cases brought to the Court of Justice of the European Union (“CJEU”). In February 2019, the CJEU decided several other cases related to Danish withholding tax on dividends and interest. In these cases, the CJEU ruled that the exemption of interest payments from withholding taxes provided in the applicable EU directive should be denied where taxpayers use the directive for abusive or fraudulent purposes, and that it is up to the national courts to make this determination. In addition, SKAT has maintained a similar position related to withholding tax on interest accrued in Denmark on borrowings from certain of the Company’s subsidiaries with respect to tax years 2010-2012 and on August 27, 2019, the Company received assessments for these matters totaling approximately DKK 1.0 billion including interest through September 27, 2019 (approximately $152 million based on the exchange rate as of September 27, 2019). The Company is appealing these assessments as well.  The Company remains in discussions with SKAT on similar withholding tax matters for the years 2013-2015 and anticipates receiving additional assessments of approximately DKK 735 million including interest through September 27, 2019 (approximately $108 million based on the exchange rate as of September 27, 2019). Management believes the positions the Company has taken in Denmark are in accordance with the relevant tax laws and is vigorously defending its positions related to the received and anticipated assessments related to the 2004-2009, 2010-2012, and 2013-2015 years. The Company intends on pursuing this matter through the Danish High Court should the appeal to the Danish National Tax Tribunal be unsuccessful. The Company will continue to monitor decisions of both the Danish courts and the CJEU and evaluate the impact of these court rulings on the Company’s tax positions in Denmark. The ultimate resolution of this matter is uncertain, could take many years, and could result in a material adverse impact to the Company’s Consolidated Condensed Financial Statements, including its cash flows and effective tax rate.
The Company expects its effective tax rate for the remainder of 2019 to be approximately 20.0%. The Company’s effective tax rate could vary as a result of many factors, including but not limited to the following:
The expected rate for the remainder of 2019 includes the anticipated discrete income tax benefits from excess tax deductions related to the Company’s stock compensation programs, which are reflected as a reduction in tax expense, though the actual benefits (if any) will depend on the Company’s stock price and stock option exercise patterns.
The actual mix of earnings by jurisdiction could fluctuate from the Company’s projection.
The tax effects of other discrete items, including accruals related to tax contingencies, the resolution of worldwide tax matters, tax audit settlements, statute of limitations expirations and changes in tax regulations.
Any future legislative changes or potential tax reform, the impact of future regulations and guidance implementing the TCJA and any related additional tax planning efforts to address these changes.
As a result of the uncertainty in predicting these items, it is reasonably possible that the actual effective tax rate used for financial reporting purposes will change in future periods.

COMPREHENSIVE INCOME
For the three and nine-month periods ended September 27, 2019, comprehensive income attributable to Danaher decreased $109 million and $4 million, respectively, as compared to the comparable periods of 2018, primarily driven by changes in foreign currency translation adjustments and cash flow hedge adjustments in the periods. For the three and nine-month periods ended September 27, 2019, the Company recorded foreign currency translation losses of $236 million and $293 million, respectively, as compared to foreign currency translation losses of $162 million and $509 million for the three and nine-month periods ended September 28, 2018, resulting in an increase in losses from foreign currency translation adjustments of $73 million for the three-month period and a decrease of $216 million for the nine-month period. The Company recorded losses of $42 million and $49 million from cash flow hedge adjustments for the three and nine-month periods ended September 27, 2019, respectively, related to the Company’s interest rate swaps.

INFLATION
The effect of inflation on the Company’s revenues and net earnings was not significant in the three and nine-month periods ended September 27, 2019.


48


LIQUIDITY AND CAPITAL RESOURCES
Management assesses the Company’s liquidity in terms of its ability to generate cash to fund its operating, investing and financing activities. The Company continues to generate substantial cash from operating activities and forecasts that its operating cash flow and other sources of liquidity (including the anticipated financing for the GE Biopharma Acquisition) will be sufficient to allow it to continue investing in existing businesses, consummating strategic acquisitions and investments (including the anticipated GE Biopharma Acquisition), paying interest and servicing debt and managing its capital structure on a short and long-term basis. In addition, as discussed in further detail above, the Company received approximately $2.0 billion from Envista as consideration for the transfer of the Company’s Dental business to Envista, a portion of which consideration the Company intends to use to redeem certain of the Company’s outstanding indebtedness in the fourth quarter of 2019.
Following is an overview of the Company’s cash flows and liquidity ($ in millions):
Overview of Cash Flows and Liquidity
 
Nine-Month Period Ended
($ in millions)
September 27, 2019
 
September 28, 2018
Total operating cash flows
$
2,840.4

 
$
2,784.4

 
 
 
 
Cash paid for acquisitions
$
(331.1
)
 
$
(2,173.3
)
Payments for additions to property, plant and equipment
(518.4
)
 
(441.3
)
Proceeds from sales of property, plant and equipment
14.1

 
1.6

Payments for purchases of investments
(165.5
)
 
(61.1
)
Proceeds from sale of investments

 
22.1

All other investing activities
28.9

 

Net operating cash used in investing activities
$
(972.0
)
 
$
(2,652.0
)
 
 
 
 
Proceeds from the issuance of common stock in connection with stock-based compensation
$
115.0

 
$
77.3

Proceeds from the sale of common stock, net of issuance costs
1,443.2

 

Proceeds from the sale of preferred stock, net of issuance costs
1,599.6

 

Proceeds from the sale of Envista Holdings Corporation Common Stock, net of issuance costs
643.4

 

Payment of dividends
(385.0
)
 
(321.2
)
Net proceeds from borrowings (maturities of 90 days or less)
744.1

 
882.1

Proceeds from borrowings (maturities longer than 90 days)
8,137.1

 

Net repayments of borrowings (maturities longer than 90 days)
(680.9
)
 
(503.9
)
All other financing activities
(6.0
)
 
(16.6
)
Net operating cash provided by financing activities
$
11,610.5

 
$
117.7

Operating cash flows increased $56 million, or approximately 2.0%, during the nine-month period ended September 27, 2019 as compared to the comparable period of 2018, primarily due to higher net earnings (after excluding the noncash discrete income tax charges during the period) and the timing of payments for income taxes, partially offset by higher cash used for funding trade accounts receivable, inventories and accounts payable during the period compared to the prior year.
On March 1, 2019, the Company completed the underwritten public offering of 12.1 million shares of Danaher common stock at a price to the public of $123.00 per share resulting in net proceeds of approximately $1.4 billion after deducting expenses and the underwriters’ discount of $45 million. Simultaneously, the Company completed the underwritten public offering of 1.65 million shares of its MCPS resulting in net proceeds of approximately $1.6 billion, after deducting expenses and the underwriters’ discount. The Company intends to use the net proceeds from the Common Stock Offering and the MCPS Offering to fund a portion of the cash consideration payable for, and certain costs associated with, the GE Biopharma Acquisition.

49


On September 18, 2019 the Company issued approximately €6.2 billion of senior unsecured euronotes (approximately $6.8 billion based on currency exchange rates as of the date of the pricing of the notes). The proceeds from these issuances will be used to fund a portion of the cash consideration payable for the GE Biopharma Acquisition.
On September 20, 2019, Envista borrowed $650 million under a senior unsecured term loan and €600 million under a three-year, senior unsecured term loan facility. Envista transferred the net proceeds from these borrowings along with the net proceeds of $643 million from the Envista IPO to the Company in consideration for the Company’s transfer of the Dental businesses to Envista.
During the nine-month period ended September 27, 2019, the Company invested $166 million in strategic non-marketable equity securities.
As of September 27, 2019, the Company held approximately $14.3 billion of cash and cash equivalents.
Danaher intends to use a portion of the consideration received from Envista to redeem $882 million in aggregate principal amount of outstanding indebtedness in the fourth quarter of 2019. The Company expects the make-whole premiums required in connection with the redemption will be $7 million ($5 million after-tax or $0.01 per diluted share). The Company intends to use the balance of the consideration it received from Envista for quarterly cash dividend payments to its shareholders.

Operating Activities
Cash flows from operating activities can fluctuate significantly from period-to-period as working capital needs and the timing of payments for income taxes, restructuring activities, pension funding and other items impact reported cash flows.
Operating cash flows were approximately $2.8 billion for the first nine months of 2019, an increase of $56 million, or approximately 2.0%, as compared to the comparable period of 2018. The year-over-year change in operating cash flows from 2018 to 2019 was primarily attributable to the following factors:
2019 operating cash flows reflected a decrease of $165 million in net earnings for the first nine months of 2019 as compared to the comparable period in 2018. However, included in net earnings for the first nine months of 2019 are $227 million of net discrete noncash tax charges, which decrease earnings without a corresponding impact to operating cash flows.
Net earnings for the first nine months of 2019 also reflected an increase of $10 million of depreciation and amortization expense as compared to the comparable period of 2018. Amortization expense primarily relates to the amortization of intangible assets acquired in connection with acquisitions and increased due to recently acquired businesses. Depreciation expense relates to both the Company’s manufacturing and operating facilities as well as instrumentation leased to customers under OTL arrangements and increased due primarily to the Company’s increased capital expenditures. Depreciation and amortization are noncash expenses that decrease earnings without a corresponding impact to operating cash flows.
The aggregate of trade accounts receivable, inventories and trade accounts payable used $277 million in operating cash flows during the first nine months of 2019, compared to $55 million of operating cash flows used in the comparable period of 2018. The amount of cash flow generated from or used by the aggregate of trade accounts receivable, inventories and trade accounts payable depends upon how effectively the Company manages the cash conversion cycle, which effectively represents the number of days that elapse from the day it pays for the purchase of raw materials and components to the collection of cash from its customers and can be significantly impacted by the timing of collections and payments in a period.
The aggregate of prepaid expenses and other assets and accrued expenses and other liabilities provided $262 million of operating cash flows during the first nine months of 2019, compared to $153 million of operating cash flows used in the comparable period of 2018. The cash flows provided in the first nine months of 2019 resulted primarily from the noncash discrete tax charges noted above and the timing of cash payments for employee-related liabilities.

Investing Activities
Cash flows relating to investing activities consist of cash used for acquisitions and capital expenditures, including instruments leased to customers, cash used for investments and cash proceeds from divestitures of businesses or assets.

50


Net cash used in investing activities decreased approximately $1.7 billion in the nine-month period ended September 27, 2019 compared to the comparable period of 2018 primarily as a result of the Company’s acquisition of IDT in the second quarter of 2018. For a discussion of the Company’s acquisitions during the first nine months of 2019 refer to “—Overview”.
Capital expenditures are made primarily for increasing capacity, replacing equipment, supporting new product development, improving information technology systems and the manufacture of instruments that are used in OTL arrangements that certain of the Company’s businesses enter into with customers. Capital expenditures increased $77 million on a year-over-year basis for the first nine months of 2019 compared to 2018 due to increased investments in operating assets at newly acquired businesses such as IDT and increased investments in facilities and operating assets across the Company. For the full year 2019, the Company forecasts capital spending to be approximately $750 million, though actual expenditures will ultimately depend on business conditions.

Financing Activities and Indebtedness
Cash flows relating to financing activities consist primarily of cash flows associated with the issuance and repayments of commercial paper, issuance and repayment of notes payable and long-term debt, issuance and repurchases of common stock, issuance of preferred stock, payments of cash dividends to shareholders and proceeds from the Envista IPO. Financing activities provided cash of approximately $11.6 billion during the first nine months of 2019 compared to $118 million of cash provided in the comparable period of 2018. The year-over-year increase in cash provided by financing activities was due primarily to the public offerings of the Company’s common and preferred stock during the first quarter of 2019, the issuance of debt by the Company and by Envista in September 2019 and the proceeds received from the Envista IPO, partially offset by lower net proceeds from commercial paper borrowings in 2019 compared to the comparable 2018 period. The Company intends to use a portion of the consideration received from Envista to redeem certain of the Company’s outstanding indebtedness in the fourth quarter of 2019.
On September 18, 2019, Danaher International II, a wholly-owned finance subsidiary of the Company, completed the underwritten public offering of the Biopharma Euronotes. The Company received net proceeds from the Biopharma Euronotes offering, after underwriting discounts and commissions and offering expenses, of approximately €6.2 billion (approximately $6.8 billion based on currency exchange rates as of the date of the pricing of the notes). The Company plans to use the proceeds from the Biopharma Euronotes offering to fund a portion of the pending GE Biopharma Acquisition.
On September 20, 2019, Envista issued approximately $1.3 billion of term debt, consisting of $650 million aggregate principal amount of borrowings under a three-year, senior unsecured term loan facility with variable interest rates and €600 million aggregate principal amount of borrowings under a three-year, senior unsecured term loan facility with variable interest rates. The net proceeds from these borrowings were paid by Envista to Danaher as partial consideration for the contribution of the Company’s Dental business to Envista.
For a description of the Company’s outstanding debt as of September 27, 2019, and the Company’s commercial paper programs and credit facilities, refer to Note 8 to the accompanying Consolidated Condensed Financial Statements. As of September 27, 2019, each of the Company and Envista was in compliance with all of its respective debt covenants.
As of September 27, 2019, Danaher had the ability to incur an additional approximately $7.1 billion of indebtedness in direct borrowings under the 2020 Credit Facilities, and/or under outstanding commercial paper facilities (based on aggregate amounts available under the 2020 Credit Facilities that were not being used to backstop outstanding commercial paper balances).
For a description of the Company’s financing of the pending GE Biopharma Acquisition, refer to Note 3 and Note 8 to the accompanying Consolidated Condensed Financial Statements.
The Company repaid the €600 million aggregate principal amount of the 2019 Euronotes and accrued interest upon their maturity on July 8, 2019 using proceeds from the issuance of euro-denominated commercial paper. The Company has classified the 2.4% senior unsecured notes due 2020 and the 2020 Assumed Pall Notes as short-term debt as of September 27, 2019 since the Company plans to extinguish these obligations in the fourth quarter of 2019. The Company has classified approximately $2.9 billion of its borrowings outstanding under the euro-denominated commercial paper program as of September 27, 2019 as long-term debt in the accompanying Consolidated Condensed Balance Sheet as the Company had the intent and ability, as supported by availability under the 2020 Credit Facilities, to refinance these borrowings for at least one year from the balance sheet date. As commercial paper obligations mature, the Company may issue additional short-term commercial paper obligations to refinance all or part of these borrowings.

51


Common Stock Offering and MCPS Stock Offering
For a description of the first quarter 2019 Common Stock and MCPS Offerings, refer to Note 14 to the accompanying Consolidated Condensed Financial Statements.

Stock Repurchase Program
For information regarding the Company’s stock repurchase program, please see Part II—Item 2, “Unregistered Sales of Equity Securities and Use of Proceeds”.

Dividends
Aggregate cash payments for dividends on Company common stock during the nine-month period ended September 27, 2019 were $356 million. The increase over the comparable period of 2018 results from an increase in the quarterly dividend rate effective with respect to the dividend paid in the second quarter of 2018 and with respect to the dividend paid in the second quarter of 2019. Aggregate cash payments for dividends on Company MCPS during the nine-month period ended September 27, 2019 were $29 million.
In the third quarter of 2019, the Company declared a regular quarterly dividend of $0.17 per share of Company common stock payable on October 25, 2019 to holders of record as of September 27, 2019, reflecting a 6% increase in the per share amount of the Company’s quarterly dividend compared to the third quarter of 2018. In addition, the Company declared a quarterly cash dividend of $11.875 per MCPS that was paid on October 15, 2019 to holders of record as of September 30, 2019.

Cash and Cash Requirements
As of September 27, 2019, the Company held approximately $14.3 billion of cash and cash equivalents that were held on deposit with financial institutions or invested in highly liquid investment-grade debt instruments with a maturity of 90 days or less with an approximate weighted average annual interest rate of 2.2%. Of this amount, approximately $10.8 billion was held within the United States and approximately $3.5 billion was held outside of the United States. Included in the Company’s cash and cash equivalents is $193 million of cash and cash equivalents of Envista. Envista cash can only be accessed by the Company through the declaration of a dividend by Envista's Board of Directors and settlements of any outstanding agreements between the companies. The Company will continue to have cash requirements to support working capital needs, capital expenditures and acquisitions (including the GE Biopharma Acquisition), pay interest and service debt (including the anticipated redemption of debt using a portion of the consideration received by the Company from Envista), pay taxes and any related interest or penalties, fund its restructuring activities and pension plans as required, pay dividends to shareholders, repurchase shares of the Company’s common stock and support other business needs. For a description of the Company’s anticipated financing of the GE Biopharma Acquisition, please refer to Note 3 to the accompanying Consolidated Condensed Financial Statements.
The Company generally intends to use available cash and internally generated funds to meet these cash requirements, but in the event that additional liquidity is required, particularly in connection with acquisitions (including as noted above in connection with the GE Biopharma Acquisition), the Company may also borrow under its commercial paper programs or the credit facilities, enter into new credit facilities and either borrow directly thereunder or use such credit facilities to backstop additional borrowing capacity under its commercial paper programs and/or access the capital markets. The Company intends to issue additional indebtedness to pay a portion of the purchase price for the Biopharma Business. The Company also may from time to time access the capital markets to take advantage of favorable interest rate environments or other market conditions. With respect to the commercial paper scheduled to mature during the remainder of 2019, the Company expects to repay the principal amounts when due using available cash, proceeds from the issuance of commercial paper and/or proceeds from other debt issuances.
While repatriation of some cash held outside the United States may be restricted by local laws, most of the Company’s foreign cash could be repatriated to the United States. Following enactment of the TCJA and the associated Transition Tax, in general, repatriation of cash to the United States can be completed with no incremental U.S. tax; however, repatriation of cash could subject the Company to non-U.S. taxes on distributions. The cash that the Company’s non-U.S. subsidiaries hold for indefinite reinvestment is generally used to finance foreign operations and investments, including acquisitions. The income taxes, if any, applicable to such earnings including basis differences in our foreign subsidiaries are not readily determinable. As of September 27, 2019, management believes that it has sufficient sources of liquidity to satisfy its cash needs, including its cash needs in the United States.

52


During 2019, the Company’s cash contribution requirements for its U.S. and non-U.S. defined benefit pension plans are forecasted to be approximately $10 million and $50 million, respectively. The ultimate amounts to be contributed depend upon, among other things, legal requirements, underlying asset returns, the plan’s funded status, the anticipated tax deductibility of the contribution, local practices, market conditions, interest rates and other factors.

CRITICAL ACCOUNTING ESTIMATES
There were no material changes to the Company’s critical accounting estimates described in the 2018 Annual Report that have a material impact on the Company’s Consolidated Condensed Financial Statements and the related Notes.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Quantitative and qualitative disclosures about market risk appear in “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Financial Instruments and Risk Management,” in the Company’s 2018 Annual Report. There were no material changes during the quarter ended September 27, 2019 to this information reported in the Company’s 2018 Annual Report.

ITEM 4. CONTROLS AND PROCEDURES
The Company’s management, with the participation of the Company’s President and Chief Executive Officer, and Executive Vice President and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report. Based on such evaluation, the Company’s President and Chief Executive Officer, and Executive Vice President and Chief Financial Officer, have concluded that, as of the end of such period, the Company’s disclosure controls and procedures were effective.
There have been no changes in the Company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the Company’s most recent completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

53


PART II - OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
For additional information regarding legal proceedings, refer to the section titled “Legal Proceedings” in the MD&A section of the Company’s 2018 Annual Report.

ITEM 1A. RISK FACTORS
Except to the extent set forth below, there were no material changes during the quarter ended September 27, 2019 to the risk factors reported in the Company’s 2018 Annual Report, First Quarter 2019 Form 10-Q or Second Quarter 2019 Form 10-Q. Additional information regarding risk factors can be found in “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Information Related to Forward-Looking Statements,” in Part I—Item 2 of this Form 10-Q, in Part I—Item 1A of the Company’s 2018 Annual Report on Form 10-K and in Part II—Item 1A of each of the First Quarter 2019 Form 10-Q and Second Quarter 2019 Form 10-Q.
We may not complete the GE Biopharma Acquisition within the time frame we anticipate or at all; any regulatory approval of the GE Biopharma Acquisition may be subject to conditions; and the GE Biopharma Acquisition could negatively impact our business, financial statements and stock price.
The GE Biopharma Acquisition discussed above would constitute Danaher’s largest acquisition to date based on purchase price, would expand Danaher’s business into new segments and involves a number of financial, accounting, managerial, operational, legal, compliance and other risks and challenges, including the following. Any of these risks or challenges could adversely affect our business, financial statements and stock price.
If the GE Biopharma Acquisition is not completed on the anticipated timetable or at all, or if regulatory approval of the acquisition is subject to conditions, we may fail to realize the anticipated benefits of the GE Biopharma Acquisition on the anticipated timetable or at all.
The GE Biopharma Business could under-perform relative to our expectations and the price that we pay or not perform in accordance with our anticipated timetable, or we could fail to operate such business profitably.
The GE Biopharma Acquisition could cause our financial results to differ from our own or the investment community’s expectations in any given period, or over the long-term.
Pre-closing and post-closing earnings charges related to the GE Biopharma Acquisition could adversely impact operating results in any given period, and the impact may be substantially different from period-to-period.
The GE Biopharma Acquisition could create demands on our management, operational resources and financial and internal control systems that we are unable to effectively address.
The GE Biopharma Acquisition could divert management’s attention and other resources, which could have a negative impact on our ability to manage existing operations or pursue other strategic transactions.
We could experience difficulty or greater-than-anticipated costs in integrating the personnel, operations and financial and other controls and systems of GE Biopharma, and could experience difficulty attracting and retaining key employees and customers.
We may be unable to achieve anticipated cost savings or other synergies on the timetable we expect or at all.
We may assume unknown liabilities, known contingent liabilities that become realized, known liabilities that prove greater than anticipated, internal control deficiencies or exposure to regulatory sanctions resulting from GE Biopharma’s activities and the realization of any of these liabilities or deficiencies may increase our expenses, adversely affect our financial position or cause us to fail to meet our public financial reporting obligations.
The GE Biopharma Purchase Agreement includes provisions relating to purchase price adjustments, which may have unpredictable financial results.
As a result of the GE Biopharma Acquisition, we expect to record significant goodwill and other assets on our balance sheet and if we are not able to realize the value of these assets, we may be required to incur impairment charges.
We have outstanding debt, and our debt will increase as a result of the GE Biopharma Acquisition. Our existing and future indebtedness may limit our operations and our use of our cash flow and negatively impact our credit ratings; and any

54


failure to comply with the covenants that apply to our indebtedness could adversely affect our liquidity and financial statements.
As of September 27, 2019, we had approximately $17.6 billion in outstanding indebtedness and had the ability to incur approximately an additional approximately $7.1 billion of indebtedness in direct borrowings or under our outstanding commercial paper facility based on the amounts available under the Company’s 2020 Credit Facilities which were not being used to backstop outstanding commercial paper balances. We expect to incur approximately $7.0 billion of indebtedness (additional to indebtedness incurred as of September 27, 2019) to fund a portion of the purchase price of the GE Biopharma Acquisition.
Our debt level and related debt service obligations can have negative consequences, including (1) requiring us to dedicate significant cash flow from operations to the payment of principal and interest on our debt, which reduces the funds we have available for other purposes such as acquisitions and other investments; (2) reducing our flexibility in planning for or reacting to changes in our business and market conditions; and (3) exposing us to interest rate risk since a portion of our debt obligations are at variable rates.
We anticipate that the additional indebtedness we expect to incur in connection with the GE Biopharma Acquisition will likely result in a negative change to our credit ratings and a potential downgrading compared to our credit rating prior to the public announcement of the GE Biopharma Acquisition. This anticipated reduction in our credit ratings may limit our ability to borrow at interest rates consistent with the interest rates that have been available to us prior to the GE Biopharma Acquisition. If our credit ratings are further downgraded or put on watch for a further potential downgrade, we may not be able to sell additional debt securities or borrow money in the amounts, at the times or interest rates or upon the more favorable terms and conditions that might be available if our current credit ratings were maintained.
Our 2020 Credit Facilities and long-term debt obligations also impose certain restrictions on us, including certain restrictions on our ability to incur liens on our assets, and a requirement under the 2020 Credit Facilities to maintain a consolidated leverage ratio (the ratio of consolidated indebtedness to consolidated indebtedness plus shareholders’ equity) of 0.65 to 1.0 or less. If we breach any of these restrictions and cannot obtain a waiver from the lenders on favorable terms, subject to applicable cure periods, the outstanding indebtedness (and any other indebtedness with cross-default provisions) could be declared immediately due and payable, which would adversely affect our liquidity and financial statements.
If we add new debt in the future, the risks described above would increase.
Envista completed an initial public offering of shares of its common stock in September 2019, and Danaher could incur liabilities in connection with the separation of Envista. We intend to distribute our remaining equity interest in Envista in one or more spin-off and/or split-off transactions, but the distribution of our remaining equity interest in Envista may not be completed on the currently contemplated timeline or at all and may not achieve the intended benefits.
Envista completed an initial public offering of shares of its common stock in September 2019. In connection with the Envista IPO, we entered into a separation agreement and related agreements with Envista to govern the relationship between the two companies going forward. These agreements provide for specific indemnity and liability obligations of each party and could lead to disputes between us. If we are required to indemnify Envista under the circumstances set forth in these agreements, we may be subject to substantial liabilities. In addition, with respect to the liabilities for which Envista has agreed to indemnify us under these agreements, there can be no assurance that the indemnity rights we have against Envista will be sufficient to protect us against the full amount of the liabilities, or that Envista will be able to fully satisfy its indemnification obligations. It is also possible that a court could disregard the allocation of assets and liabilities agreed to between Danaher and Envista and require Danaher to assume responsibility for obligations allocated to Envista. Each of these risks could negatively affect our business and financial statements.
We intend to distribute our remaining equity interest in Envista in one or more spin-off and/or split-off transactions. Unanticipated developments, including adverse market conditions, possible delays in obtaining regulatory approvals or clearances, uncertainty of the financial markets, changes in the Company’s strategy or challenges in establishing infrastructure or processes, could delay or prevent the anticipated distribution of the remainder of the Company’s equity interest in Envista, or cause such distribution to occur on terms or conditions that are less favorable and/or different than expected. Even if the anticipated distribution is completed, we may not realize some or all of the anticipated benefits therefrom. Expenses incurred to accomplish these transactions may be significantly higher than what we currently anticipate.
Executing the proposed distribution also requires significant time and attention from management, which could distract them from other tasks in operating our business. We cannot assure you that the anticipated distribution, if consummated, will yield greater net benefits to Danaher and its shareholders than if such transaction had not occurred.

55



ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Neither the Company nor any “affiliated purchaser” repurchased any shares of Company common stock during the nine-month period ended September 27, 2019. On July 16, 2013, the Company’s Board of Directors approved a repurchase program (the “Repurchase Program”) authorizing the repurchase of up to 20 million shares of the Company’s common stock from time to time on the open market or in privately negotiated transactions. There is no expiration date for the Repurchase Program, and the timing and amount of any shares repurchased under the program will be determined by the Company’s management based on its evaluation of market conditions and other factors. The Repurchase Program may be suspended or discontinued at any time. Any repurchased shares will be available for use in connection with the Company’s equity compensation plans (or any successor plans) and for other corporate purposes. As of September 27, 2019, 20 million shares remained available for repurchase pursuant to the Repurchase Program. The Company expects to fund any future stock repurchases using the Company’s available cash balances or proceeds from the issuance of debt.
During the third quarter of 2019, holders of certain of the Company’s Liquid Yield Option Notes due 2021 (“LYONS”) converted such LYONS into an aggregate of 37 thousand shares of Danaher common stock, par value $0.01 per share. In each case, the shares of common stock were issued solely to existing security holders upon conversion of the LYONs pursuant to the exemption from registration provided under Section 3(a)(9) of the Securities Act of 1933, as amended.


56


ITEM 6. EXHIBITS
(a)
Exhibits:
2.1

 
 
2.2

 
 
3.1

 
 
3.2

 
 
3.3

 
 
4.1

 
 
4.2

 
 
4.3

 
 
4.4

 
 
10.1

 
 
10.2

 
 
10.3

 
 
10.4

 
 
10.5

 
 
10.6

 
 
10.7


57


 
 
10.8

 
 
10.9

 
 
10.10

 
 
10.11

 
 
10.12

 
 
10.13

 
 
10.14

 
 
10.15

 
 
31.1

 
 
31.2

 
 
32.1

 
 
32.2

 
 
101.INS

Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
 
 
101.SCH

Inline XBRL Taxonomy Extension Schema Document
 
 
101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document
 
 
101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document
 
 
101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document
 
 
101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document
 
 
104

Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)


58


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
DANAHER CORPORATION
 
 
 
 
Date:
October 23, 2019
By:
/s/ Matthew R. McGrew
 
 
 
Matthew R. McGrew
 
 
 
Executive Vice President and Chief Financial Officer
 
 
 
 
Date:
October 23, 2019
By:
/s/ Robert S. Lutz
 
 
 
Robert S. Lutz
 
 
 
Senior Vice President and Chief Accounting Officer

59
EX-10.8 2 dhr-2019927xexx108.htm AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT Exhibit
Exhibit 10.8

AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT
THIS AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”) is made and entered into as of September 20, 2019 by and among DANAHER CORPORATION, a Delaware corporation (the “Company”), each of the Lenders (as defined in the Credit Agreement) party hereto, each of BANK OF AMERICA, N.A. and BANK OF AMERICA, N.A., LONDON BRANCH, each in their respective roles as a Swing Line Lender, and BANK OF AMERICA, N.A., as Administrative Agent (the “Administrative Agent”).
W I T N E S S E T H:
WHEREAS, the Company, the Designated Borrowers from time to time party thereto, the Administrative Agent and the Lenders from time to time party thereto have entered into that certain Second Amended and Restated Credit Agreement dated as of August 27, 2019 (as amended, restated, extended, supplemented or otherwise modified from time to time, the “Credit Agreement”; all capitalized terms not otherwise defined herein shall have the meaning given thereto in the Credit Agreement);
WHEREAS, the Company has requested that the Credit Agreement be amended as set forth herein, and the Lenders and Swing Line Lenders party hereto have agreed to such amendments subject to the conditions set forth herein;
NOW, THEREFORE, in consideration of the premises and the terms hereof, the parties hereto agree as follows:
1.Amendments to Credit Agreement. Subject to the terms and conditions set forth herein, (a) the Credit Agreement is hereby amended by making the changes attached hereto as Exhibit A (with stricken text being deemed deleted and bold/double-underlined text being deemed added), (b) Schedule 2.01 to the Credit Agreement is hereby amended by replacing such schedule in its entirety with the revised version thereof attached hereto as Exhibit B, and (c) Schedule 11.02 to the Credit Agreement is hereby amended by replacing such schedule in its entirety with the revised version thereof attached hereto as Exhibit C.
2.    Effectiveness; Conditions Precedent. This Amendment shall become effective on the first Business Day on which the following conditions are satisfied or waived (such date, the “Effective Date”):
(a)    The Administrative Agent shall have received counterparts of this Amendment, duly executed by the Company, the Administrative Agent, each Swing Line Lender party hereto and the Required Lenders, which counterparts may be delivered by telefacsimile or other electronic means (including .pdf), but such delivery will be promptly followed by the delivery of original signature pages by each Person party hereto unless waived by the Administrative Agent.
(b)    All fees and expenses payable to the Administrative Agent (including the fees and expenses of counsel to the Administrative Agent to the extent due and payable under Section 11.04 of the Credit Agreement) estimated to date and for which invoices have been presented a reasonable period of time prior to the effectiveness hereof shall have been paid in full (without prejudice to final settling of accounts for such fees and expenses).
3.    Representations and Warranties. In order to induce the Administrative Agent and the Lenders to enter into this Amendment, the Company represents and warrants to the Administrative Agent and the Lenders as follows:





(a)    No Default or Event of Default exists as of the date hereof or would result from, or after giving effect to, the amendments contemplated hereby;
(b)    the representations and warranties of (i) the Borrowers contained in Article V of the Credit Agreement and (ii) each Loan Party contained in each other Loan Document are true and correct in all material respects (provided that such materiality qualifier shall not apply to the extent that any such representation or warranty is already qualified or modified by materiality in the text thereof), on and as of the Effective Date, after giving effect to the amendments contemplated hereby, except to the extent that such representations and warranties specifically refer to an earlier date, in which case they are true and correct in all material respects (provided that such materiality qualifier shall not apply to the extent that any such representation or warranty is already qualified or modified by materiality in the text thereof) as of such earlier date, and except that for purposes of this clause (b), (i) the representations and warranties contained in subsections (a) and (b) of Section 5.05 of the Credit Agreement shall be deemed to refer to the most recent statements furnished pursuant to clauses (a) and (b), respectively, of Section 6.01 of the Credit Agreement and (ii) the representations and warranties in subsection (c) of Section 5.05 of the Credit Agreement, subsection (b) of Section 5.06 of the Credit Agreement and Section 5.10 of the Credit Agreement need only be true and correct on and as of the Closing Date;
(c)    it has the legal power and authority to execute and deliver this Amendment;
(d)    the officer executing this Amendment on its behalf has been duly authorized to execute and deliver the same and bind it with respect to the provisions hereof;
(e)    the execution, delivery and performance by the Company of this Amendment have been duly authorized by all necessary corporate or other organizational action, and do not and will not (i) contravene the terms of any of the Company’s Organization Documents; (ii) conflict with or result in any breach or contravention of, or the creation of any Lien under, (A) any Contractual Obligation to which the Company is a party except to the extent that such conflict, breach, contravention, Lien or violation could not reasonably be expected to have a Material Adverse Effect or (B) any order, injunction, writ or decree of any Governmental Authority or any arbitral award to which the Company or its property is subject; or (iii) violate any Law in any material respect;
(f)    this Amendment constitutes its legal, valid and binding obligation, enforceable in accordance with its terms.
4.    Entire Agreement. This Amendment is a Loan Document. This Amendment, together with all the other Loan Documents (collectively, the “Relevant Documents”), sets forth the entire understanding and agreement of the parties hereto in relation to the subject matter hereof and supersedes any prior negotiations and agreements among the parties relating to such subject matter. No promise, condition, representation or warranty, express or implied, not set forth in the Relevant Documents shall bind any party hereto, and no such party has relied on any such promise, condition, representation or warranty. Each of the parties hereto acknowledges that, except as otherwise expressly stated in the Relevant Documents, no representations, warranties or commitments, express or implied, have been made by any party to the other in relation to the subject matter hereof or thereof. None of the terms or conditions of this Amendment may be changed, modified, waived or canceled orally or otherwise, except in writing and in accordance with Section 11.01 of the Credit Agreement.
5.    Full Force and Effect of Credit Agreement. Except as hereby specifically amended, modified or supplemented, the Credit Agreement is hereby confirmed and ratified in all respects and shall
be and remain in full force and effect according to its respective terms.

2



6.    Governing Law. This Amendment shall in all respects be governed by, and construed in accordance with, the laws of the State of New York, and shall be further subject to the provisions of Sections 11.17 and 11.18 of the Credit Agreement.
7.    Enforceability. If any provision of this Amendment is held to be illegal, invalid or unenforceable, (a) the legality, validity and enforceability of the remaining provisions of this Amendment shall not be affected or impaired thereby and (b) the parties shall endeavor in good faith negotiations to replace the illegal, invalid or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the illegal, invalid or unenforceable provisions. The invalidity of a provision in a particular jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction..
8.    References; Interpretation. All references in any of the Loan Documents to the “Credit Agreement” shall mean the Credit Agreement, as amended hereby. The rules of interpretation set forth in Section 1.02 of the Credit Agreement shall be applicable to this Amendment.
9.    Successors and Assigns. This Amendment shall be binding upon and inure to the benefit of the Company, the Administrative Agent and each of the Lenders, and their respective successors, legal representatives, and assignees to the extent such assignees are permitted assignees as provided in Section 11.07 of the Credit Agreement.
10.    No Novation; Reaffirmation. Neither the execution and delivery of this Amendment nor the consummation of any other transaction contemplated hereunder is intended to constitute a novation of the Credit Agreement or of any of the other Loan Documents or any obligations thereunder. The Company hereby (i) affirms and confirms each of the Loan Documents to which it is a party and its Obligations thereunder, (ii) affirms that it has the right, power and authority and has taken all necessary corporate and other action to authorize the execution, delivery and performance of this Amendment and (iii) agrees that, notwithstanding the effectiveness of this Amendment, each Loan Document shall continue to be in full force and effect.
11.    Counterparts. This Amendment may be executed in any number of counterparts, each of which shall be deemed an original as against any party whose signature appears thereon, and all of which shall together constitute one and the same instrument. Delivery of an executed counterpart of a signature page of this Amendment by telecopy or other electronic means (including .pdf) shall be effective as delivery of a manually executed counterpart of this Amendment.
[Remainder of page is intentionally left blank; signature pages follow.]

3



IN WITNESS WHEREOF, the parties have duly executed this Amendment on the day and year first written above.
DANAHER CORPORATION, as the Company
By:     /s/ Frank T. McFaden                
Name:    Frank T. McFaden
Title:    Vice President & Treasurer


Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



ADMINISTRATIVE AGENT:
BANK OF AMERICA, N.A., as Administrative Agent
By:     /s/ Liliana Claar                
Name:     Liliana Claar
Title: Vice President

Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



BANK OF AMERICA, N.A., as a Lender and a Swing Line Lender
By:     /s/ Mukesh Singh                
Name:     Mukesh Singh
Title: Director

Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



BANK OF AMERICA, N.A., LONDON BRANCH,
as a Swing Line Lender
By:     /s/ Fiona Malitsky                
Name:     Fiona Malitsky
Title:     Vice President

Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



BARCLAYS BANK PLC, as a Lender
By:     /s/ May Huang                    
Name:     May Huang
Title:     Assistant Vice President



Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



BNP PARIBAS, as a Lender
By:     /s/ Richard Pace                    
Name:     Richard Pace
Title:     Managing Director


By:     /s/ Melissa Dyki                
Name:     Melissa Dyki
Title:    Director



Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



HSBC BANK USA, NATIONAL ASSOCIATION, as a Lender
By:     /s/ Patrick D. Mueller                
Name:     Patrick D. Mueller
Title:     Managing Director



Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



JPMORGAN CHASE BANK, N.A., as a Lender
By:     /s/ Kyler Eng                        
Name:     Kyler Eng    
Title:     Vice President




Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



U.S. BANK NATIONAL ASSOCIATION, as a Lender
By:     /s/ David C. Mruk                
Name:     David C. Mruk
Title:     SVP



Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



WELLS FARGO BANK, NATIONAL ASSOCIATION, as a Lender
By:     /s/ Darin Mullis                        
Name:     Darin Mullis
Title:     Managing Director



Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



THE BANK OF NOVA SCOTIA, as a Lender
By:     /s/ Winston Lua                    
Name:     Winston Lua
Title:     Director



Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



COMMERZBANK AG, NEW YORK BRANCH, as a Lender
By:     /s/ Michael Ravelo                
Name:     Michael Ravelo
Title:     Managing Director


By:     /s/ Mathew Ward                
Name:     Mathew Ward
Title:     Director




Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, as a Lender
By:     /s/ Judith Smith                    
Name:     Judith Smith
Title:     Authorized Signatory


By:     /s/ Lingzi Huang                
Name:     Lingzi Huan
Title:     Authorized Signatory




Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



GOLDMAN SACHS BANK USA, as a Lender
By:     /s/ Jamie Minieri                
Name:     Jamie Minieri
Title:     Authorized Signatory



Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



INTESA SANPAOLO S.p.A., NEW YORK BRANCH, as a Lender
By:     /s/ Neil Derfler                    
Name:     Neil Derfler
Title:     Relationship Manager


By:     /s/ Alessandro Toigo                
Name:     Alessandro Toigo
Title:     Regional Business Manager
    

Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



LLOYDS BANK CORPORATE MARKETS PLC, as a Lender
By:     /s/ Kamala Basdeo                
Name:     Kamala Basdeo
Title:     Assistant Vice President
Transaction Execution


By:     /s/ Tina Wong                    
Name:     Tina Wong
Title:     Assistant Vice President
Transaction Execution






Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



MORGAN STANLEY BANK, N.A., as a Lender
By:     /s/ Gilroy D’Souza                
Name:     Gilroy D’Souza
Title:     Authorized Signatory




Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



PNC BANK, NATIONAL ASSOCIATION, as a Lender
By:     /s/ Eric H. Williams                
Name:     Eric H. Williams
Title:     Senior Vice President




Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



ROYAL BANK OF CANADA, as a Lender
By:     /s/ Diana Lee                    
Name:     Diana Lee    
Title:     Authorized Signatory




Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



BANCO SANTANDER BANK, S.A., NEW YORK BRANCH, as a Lender
By:     /s/ Juan Galan                    
Name:     Juan Galan
Title:     Managing Director
Banco Santander S.A. New York Branch


By:     /s/ Terence Corcoran                
Name:     Terence Corcoran
Title:     Executive Director




Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



STANDARD CHARTERED BANK, as a Lender
By:     /s/ Guilherme Domingos            
Name:     Guilherme Domingos
Title:     Director



Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



SUMITOMO MITSUI BANKING CORPORATION, as a Lender
By:     /s/ Michael Maguire                
Name:     Michael Maguire
Title:     Executive Director




Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



TORONTO-DOMINION BANK, NEW YORK BRANCH, as a Lender
By:     /s/ Michael Borowiecki                
Name:     MICHAEL BOROWIECKI
Title:     AUTHORIZED SIGNATORY



Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



THE NORTHERN TRUST COMPANY, as a Lender
By:     /s/ Ryan Mulvaney                
Name:     Ryan Mulvaney
Title:     Credit Manager, Officer




Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



BANCO BILBAO VIZCAYA ARGENTARIA, S.A., NEW YORK BRANCH, as a Lender
By:     /s/ Brian Crowley                
Name:     Brian Crowley
Title:     Managing Director


By:     /s/ Luis Ruigomez                
Name:     Luis Ruigomez
Title:     Executive Director



Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



DANSKE BANK A/S, as a Lender
By:     /s/ Corinne Akstrup                
Name:     Corinne Akstrup
Title:     Senior Loan Manager


By:     /s/ Gert Carstens                
Name:     Gert Carstens
Title:     Senior Loan Manager




Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



NORDEA BANK ABP, NEW YORK BRANCH, as a Lender
By:     /s/ Olli Savikko                    
Name:     Olli Savikko
Title:     Senior Vice President


By:     /s/ Leena Parker                    
Name:    Leena Parker     
Title:     Senior Vice President




Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



WESTPAC BANKING CORPORATION, as a Lender
By:     /s/ Richard Yarnold                
Name:     Richard Yarnold
Title:     Senior Relationship Manager
Corporate & Institutional Banking




Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



ICICI BANK LIMITED - NEW YORK BRANCH, as a Lender
By:     /s/ Akashdeep Sarpal                
Name:     Akashdeep Sarpal
Title:     County Head – USA
ICICI Bank Limited



Danaher Corporation
Amendment No. 1 to Second Amended and Restated Credit Agreement
Signature Pages



Exhibit A
(to Amendment No. 1)
[See attached changed pages.]








Execution Version


Published CUSIP Numbers:
Deal: 235854AU0
Revolver: 235854AV8

SECOND AMENDED AND RESTATED CREDIT AGREEMENT

Dated as of August 27, 2019,

(as amended by Amendment No. 1 to Credit Agreement dated as of September 20, 2019)
among
dhrlogofor8ksa27.jpg
DANAHER CORPORATION
and certain of its Subsidiaries,
as Borrowers,

BANK OF AMERICA, N.A.,
as Administrative Agent and a Swing Line Lender,
the other LENDERS party hereto,
CITIBANK, N.A.,
as Syndication Agent,
WELLS FARGO BANK, N.A., MUFG BANK, LTD., BNP PARIBAS, U.S. BANK, NATIONAL ASSOCIATION, HSBC BANK USA, NATIONAL ASSOCIATION, JPMORGAN CHASE BANK, N.A., BARCLAYS BANK PLC and MIZUHO BANK, LTD.,
as Documentation Agents,
and
BofA SECURITIES, INC.,
CITIGROUP GLOBAL MARKETS INC., WELLS FARGO SECURITIES, LLC, MUFG BANK, LTD., BNP PARIBAS SECURITIES CORP., US BANK NATIONAL ASSOCIATION, HSBC SECURITIES (USA) INC., JPMORGAN CHASE BANK, N.A., BARCLAYS BANK PLC





and
MIZUHO BANK, LTD.,
as Joint Lead Arrangers and Joint Bookrunners










TABLE OF CONTENTS
Page

ARTICLE I    DEFINITIONS AND ACCOUNTING TERMS     1
1.01    Defined Terms     1
1.02
Other Interpretive Provisions     2324
1.03
Accounting Terms     2425
1.04
Rounding    25

1.05
References to Agreements and Laws     2526
1.06
Exchange Rates; Currency Equivalents     2526
1.07
Additional Alternative Currencies     2526
1.08
Change of Currency     2627
1.09
Times of Day     2627
1.10    Interest Rates     2627
ARTICLE II        THE COMMITMENTS AND BORROWING     2627
2.01    Committed Loans     2627
2.02
Borrowings, Conversions and Continuations of Committed Loans     2728
2.03
Bid Loans     2829
2.04
Swing Line Loans     3132
2.05
Prepayments    3435

2.06
Termination or Reduction of Commitments     3536
2.07
Repayment of Loans     3536
2.08
Interest     3537
2.09
Fees    3637

2.10    Computation of Interest and Fees     3638
2.11    Evidence of Debt     3738
2.12    Payments Generally     3738
2.13    Sharing of Payments     3940
2.14    Designated Borrowers     3941





2.15    Increase in Commitments     4143
2.16    Defaulting Lenders     4244
2.17    Extension of Maturity Date     4445
ARTICLE III        TAXES, YIELD PROTECTION AND ILLEGALITY     4547
3.01
Taxes     4547
-i-






TABLE OF CONTENTS
(continued)
Page

3.02
Illegality    4849

3.03
Inability to Determine Rates     4850
3.04
Increased Cost and Reduced Return; Capital Adequacy; Reserves on Eurocurrency Rate Loans     5153
3.05
Compensation for Losses     5354
3.06
Matters Applicable to all Requests for Compensation     5355
3.07    Survival     5455 ARTICLE IV        CONDITIONS PRECEDENT TO BORROWINGS     5455
4.01    Conditions to Effectiveness     5455
4.02    Conditions to all Borrowings     5557 ARTICLE V        REPRESENTATIONS AND WARRANTIES     5658
5.01
Existence, Qualification and Power; Compliance with Laws     5658
5.02
Authorization; No Contravention     5658
5.03
Governmental Authorization; Other Consents     5758
5.04
Binding Effect     5758
5.05
Financial Statements; No Material Adverse Effect     5758
5.06
Litigation    5759

5.07
No Default     5759
5.08
Ownership of Property; Liens     5859
5.09
Environmental Compliance     5859
5.10    ERISA Compliance     5859
5.11    Margin Regulations; Investment Company Act     5860
5.12    Foreign Obligor Representations     5960
5.13    OFAC     5961
5.14    Anti-Corruption Laws     5961
5.15
Beneficial Ownership     6061
5.16
EEA Financial Institutions     6061





5.17    Covered Entity     6061 ARTICLE VI        AFFIRMATIVE COVENANTS     6061
6.01    Financial Statements     6062
6.02
Certificates; Other Information     6062
-ii-






TABLE OF CONTENTS
(continued)
Page

6.03
Notices    6263

6.04
Payment of Obligations     6264
6.05
Preservation of Existence, Etc     6264
6.06
Maintenance of Properties     6364
6.07
Compliance with Laws     6364
6.08
Inspection Rights     6365
6.09
Compliance with ERISA     6365
6.10    Use of Proceeds     6365
6.11    Anti-Corruption Laws     6365
ARTICLE VII        NEGATIVE COVENANTS     6365
7.01    Liens     6465
7.02
Fundamental Changes     6567
7.03
Use of Proceeds     6667
7.04
Consolidated Leverage Ratio     6667
7.05
Sanctions     6667
7.06    Anti-Corruption Laws     6668 ARTICLE VIII    EVENTS OF DEFAULT AND REMEDIES     6668
8.01    Events of Default     6668
8.02
Remedies Upon Event of Default     6870
8.03    Application of Funds     6870 ARTICLE IX        ADMINISTRATIVE AGENT     6971
9.01    Appointment and Authority     7071
9.02
Rights as a Lender     7071
9.03
Exculpatory Provisions     7072
9.04
Reliance by Administrative Agent     7172
9.05
Delegation of Duties     7173
9.06
Resignation of Administrative Agent     7173





9.07
Non-Reliance on Administrative Agent and Other Lenders     7274
9.08
No Other Duties, Etc     7374
9.09
Administrative Agent May File Proofs of Claim     7374

-iii-






TABLE OF CONTENTS
(continued)
Page

9.10    Certain ERISA Matters     7375
ARTICLE X        COMPANY GUARANTY     7476
10.01
Guaranty     7476
10.02
Guaranty Absolute     7476
10.03
Waivers and Acknowledgments     7677
10.04
Subrogation    7778

ARTICLE XI    MISCELLANEOUS     7779
11.01
Amendments, Etc     7779
11.02
Notices and Other Communications; Facsimile Copies     7980
11.03
No Waiver; Cumulative Remedies     8182
11.04
Costs and Expenses     8183
11.05
Indemnification by the Company     8283
11.06
Payments Set Aside     8384
11.07
Successors and Assigns     8385
11.08
Confidentiality     8890
11.09
Set-off    8991

11.10    Interest Rate Limitation     9091
11.11    Counterparts    9091

11.12    Integration    9092

11.13    Survival of Representations and Warranties     9092
11.14    Severability    9192

11.15    Tax Forms     9192
11.16    Replacement of Lenders     9394
11.17    Governing Law     9395
11.18    Waiver of Right to Trial by Jury     9495
11.19    Judgment Currency     9496
11.20    No Advisory or Fiduciary Responsibility     9496





11.21    USA PATRIOT Act Notice     9597
11.22    Margin Stock     9597
11.23    Electronic Execution of Assignments and Certain Other Documents     9597

-iv-






TABLE OF CONTENTS
(continued)
Page

11.24    Amendment and Restatement     9697
11.25    Acknowledgement and Consent to Bail-In of EEA Financial Institutions     9698
11.26    Acknowledgement Regarding Any Supported QFCs     9798



























-v-






(c)if such day relates to any interest rate settings as to a Eurocurrency Rate Loan denominated in a currency other than Dollars or Euro, means any such day on which dealings in deposits in the relevant currency are conducted by and between banks in the London or other applicable offshore interbank market for such currency; and

(d)if such day relates to any fundings, disbursements, settlements and payments in a currency other than Dollars or Euro in respect of a Eurocurrency Rate Loan denominated in a currency other than Dollars or Euro, or any other dealings in any currency other than Dollars or Euro to be carried out pursuant to this Agreement in respect of any such Eurocurrency Rate Loan (other than any interest rate settings), means any such day on which banks are open for foreign exchange business in the principal financial center of the country of such currency;

provided that, in the case of any Borrowing of a Swing Line Loan denominated in Euros, a Business Day shall be any TARGET Day on which dealings are also carried on in the London interbank market (without regard to whether commercial banks are authorized to close under the Laws of, or are in fact closed in, the state of New York or such other state where the Administrative Agent’s Office with respect to Obligations denominated in Dollars is located).

Capital Lease” means each lease that has been or is required to be, in accordance with GAAP, classified and accounted for as a capital lease or financing lease.

Change in Law” means the occurrence, after the date of this Agreement, of any of the following:
(a)the adoption or taking effect of any law, rule, regulation or treaty, (b) any change in any law, rule, regulation or treaty or in the administration, interpretation, implementation or application thereof by any Governmental Authority or (c) the making or issuance of any request, rule, guideline or directive (whether or not having the force of law) by any Governmental Authority; provided that notwithstanding anything herein to the contrary, (x) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith or in the implementation thereof and (y) all requests, rules, guidelines or directives promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case pursuant to Basel III, shall in each case be deemed to be a “Change in Law”, regardless of the date enacted, adopted, issued or implemented.

Change of Control” means, with respect to the Company, an event or series of events by which:

(a)    any “person” or “group” (as such terms are used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, but excluding (i) any employee benefit plan of the Company or its Subsidiaries, and any person or entity acting in its capacity as trustee, agent or other fiduciary or administrator of any such plan and (ii) Steven M. Rales and Mitchell P. Rales) becomes the “beneficial owner” (as defined in Rules 13d-3 and 13d-5 under the Securities Exchange Act of 1934, except that a person or group shall be deemed to have “beneficial ownership” of all securities that such person or group has the right to acquire, whether such right is exercisable immediately or only after the passage of time (such right, an “option right”)), directly or indirectly, of more than 50% of the equity securities of the Company entitled to vote for members of the board of directors or equivalent governing body of the Company on a fully diluted basis (and taking into account all such securities that such person or group has the right to acquire pursuant to any option right); or






(b)    during any period of 12 consecutive months, a majority of the members of the board of directors or other equivalent governing body of the Company cease to be composed of individuals (i) who were members of that board or equivalent governing body on the first day of such period, (ii) whose






Eligible Assignee” means any Person that meets the requirements to be an assignee under Section 11.07(b)(iii), (v) and (vii) (subject to such consents, if any, as may be required under Section 11.07(b)(iii)).

Environmental Laws” means any and all Federal, state, local, and foreign statutes, laws, regulations, ordinances, rules, judgments, orders, decrees, permits, concessions, grants, franchises, licenses, agreements or governmental restrictions relating to pollution and the protection of the environment or the release of any materials into the environment, including those related to hazardous substances or wastes, air emissions and discharges to waste or public systems.

Envista Entities” means Envista Holdings Corporation, a Delaware corporation, and each of its Subsidiaries.

ERISA” means the Employee Retirement Income Security Act of 1974, as amended, and the rules and regulations promulgated thereunder.

ERISA Affiliate” means, as of any date of determination, any trade or business (whether or not incorporated) that, as of such date of determination, is under common control with the Company within the meaning of Section 414(b) or (c) of the Code (and Sections 414(m) and (o) of the Code for purposes of provisions relating to Section 412 of the Code).

ERISA Event” means (a) a Reportable Event with respect to a Pension Plan; (b) the withdrawal of the Company or any ERISA Affiliate from a Pension Plan subject to Section 4063 of ERISA during a plan year in which such entity was a “substantial employer” as defined in Section 4001(a)(2) of ERISA or a cessation of operations that is treated as such a withdrawal under Section 4062(e) of ERISA; (c) a complete or partial withdrawal by the Company or any ERISA Affiliate from a Multiemployer Plan or notification that a Multiemployer Plan is in reorganization; (d) the filing of a notice of intent to terminate, the treatment of a Pension Plan amendment as a termination under Section 4041 or 4041A of ERISA; (e) the institution by the PBGC of proceedings to terminate a Pension Plan (other than a Multiemployer Plan) or, to the knowledge of the Company, a Multiemployer Plan; (f) any event or condition which constitutes grounds under Section 4042 of ERISA for the termination of, or the appointment of a trustee to administer, any Pension Plan; (g) the determination that any Pension Plan (other than a Multiemployer Plan) or, to the knowledge of the Company, a Multiemployer Plan is considered an at-risk plan or a plan in endangered or critical status within the meaning of Sections 430, 431 and 432 of the Code or Sections 303, 304 and 305 of ERISA; or (h) the imposition of any liability under Title IV of ERISA, other than for PBGC premiums due but not delinquent under Section 4007 of ERISA, upon the Company or any ERISA Affiliate (where, for Multiemployer Plans, the occurrence of an imposition is to the knowledge of the Company); provided that with respect to a Pension Plan or Multiemployer Plan in which neither the Company nor any Subsidiary is a participating or contributing employer, clauses (a) through (h) shall be to the knowledge of the Company.

EU Bail-In Legislation Schedule” means the EU Bail-In Legislation Schedule published by the Loan Market Association (or any successor person), as in effect from time to time.

Euro” and “EUR” mean the single currency of the Participating Member States.







“Euro Swing Line Rate” means a rate per annum equal to LIBOR for Euros, as published on the applicable Bloomberg screen page (or such other commercially available source providing such quotations as may be designated by the Administrative Agent from time to time) at approximately 11:00 a.m. (London time) for an amount comparable to the amount of that Loan on such day for overnight







deposits in Euros, and, if any such applicable rate is below zero, the Euro Swing Line Rate for such day will be deemed to be zero.

“Euro Swing Line Rate Loan” means a Swing Line Loan denominated in Euros that bears interest based on the Euro Swing Line Rate.

Eurocurrency Bid Margin” means the margin above or below the Eurocurrency Rate to be added to or subtracted from the Eurocurrency Rate, which margin shall be expressed in multiples of 1/100th of one basis point.
Eurocurrency Liabilities” has the meaning assigned to that term in Regulation D of the FRB. “Eurocurrency Margin Bid Loan” means a Bid Loan that bears interest at a rate based upon the
Eurocurrency Rate.

Eurocurrency Rate” means,

(a)with respect to any Loan:

(i)denominated in a LIBOR Quoted Currency, the rate per annum equal to the London Interbank Offered Rate as administered by ICE Benchmark Administration (or any other Person that takes over the administration of such rate) for Dollars for a period equal in length to such Interest Periodthe applicable currency (“LIBOR”) as published on the applicable Bloomberg screen page (or such other commercially available source providing such quotations as may be designated by the Administrative Agent from time to time) at approximately 11:00 a.m., London time, two Business Days prior to the commencement of such Interest Period, for deposits in the relevant currency (for delivery on the first day of such Interest Period) with a term equivalent to such Interest Period; and

(ii)with respect to a Loan denominated in any Non-LIBOR Quoted Currency, the rate per annum as designated by the Company and the Administrative Agent with respect to such Alternative Currency at the time such Alternative Currency is approved by the Administrative Agent and the Lenders pursuant to Section 1.07(a); and

(b)for any interest rate calculation with respect to a Base Rate Loan on any date, the rate per annum equal to LIBOR, at or about 11:00 a.m., London time determined two Business Days prior to such date for Dollar deposits with a term of one month commencing that day; and

(c)if the Eurocurrency Rate shall be less than zero, such rate shall be deemed zero for purposes of this Agreement.







Eurocurrency Rate Committed Loan” means a Committed Loan that bears interest at a rate based on clause (a) of the definition of “Eurocurrency Rate”. Eurocurrency Rate Loans may be denominated in Dollars or in an Alternative Currency. All Committed Loans denominated in an Alternative Currency must be Eurocurrency Rate Loans.

Eurocurrency Rate Loan” means a Eurocurrency Rate Committed Loan or a Eurocurrency Margin Bid Loan.

Event of Default” has the meaning specified in Section 8.01.

Existing Credit Agreement” has the meaning specified in the introductory paragraphs hereto.







(c)net obligations of such Person under any Swap Contract;

(d)all non-contingent obligations of such Person to pay the deferred purchase price of property or services (other than trade accounts payable in the ordinary course of business);

(e)indebtedness (excluding prepaid interest thereon) secured by a Lien on property owned or being purchased by such Person (including indebtedness arising under conditional sales or other title retention agreements), whether or not such indebtedness shall have been assumed by such Person or is limited in recourse;

(f)
Capital Leases and Off Balance Sheet Obligations; and

(g)
all Guarantees of such Person in respect of any of the foregoing.

For all purposes hereof, the Indebtedness of any Person shall include the Indebtedness of any partnership or joint venture (other than a joint venture that is itself a corporation or limited liability company or similar limited liability entity organized under the laws of a jurisdiction other than the United States or a state thereof) in which such Person is a general partner or a joint venturer, unless such Indebtedness is expressly made non-recourse to such Person. The amount of any net obligation under any Swap Contract on any date shall be deemed to be the Swap Termination Value thereof as of such date. The amount of any Capital Lease or Off Balance Sheet Obligation as of any date shall be deemed to be the amount of Attributable Indebtedness in respect thereof as of such date.

Indemnified Liabilities” has the meaning set forth in Section 11.05(a). “Indemnitees” has the meaning set forth in Section 11.05(a). “Information” has the meaning specified in Section 11.08.
Interest Payment Date” means, (a) as to any Loan other than a Base Rate Loan, the last day of each Interest Period applicable to such Loan and the Maturity Date; provided, however, that if any Interest Period for a Eurocurrency Rate Loan exceeds three months, the respective dates that fall every three months after the beginning of such Interest Period shall also be Interest Payment Dates; and (b) as to any Base Rate Loan (includingor a Swing Line Loan), the last Business Day of each March, June, September and December and the Maturity Date.

Interest Period” means, (a) as to each Eurocurrency Rate Loan, the period commencing on the date such Eurocurrency Rate Loan is disbursed or (in the case of any Eurocurrency Rate Committed Loan) converted to or continued as a Eurocurrency Rate Loan and ending on the date one, two, three or six months (or, if agreed by each applicable Lender, twelve months) thereafter (in each case, subject to availability), as selected by the Company in its Committed Loan Notice or Bid Request, as the case may be; and (b) as to each Absolute Rate Loan, a period of not less than 14 days and not more than 180 days as selected by a Borrower in its Bid Request; provided that:







(i)    any Interest Period that would otherwise end on a day that is not a Business Day shall be extended to the next succeeding Business Day unless, in the case of a Eurocurrency Rate Loan, such Business Day falls in another calendar month, in which case such Interest Period shall end on the immediately preceding Business Day;

(ii)    any Interest Period pertaining to a Eurocurrency Rate Loan that begins on the last Business Day of a calendar month (or on a day for which there is no numerically corresponding







Non-Consenting Lender” means any Lender that does not approve any consent, waiver or amendment that (a) requires the approval of all Lenders or all affected Lenders in accordance with the terms of Section 11.01 and (b) has been approved by the Required Lenders.

Non-Defaulting Lender” means, at any time, each Lender that is not a Defaulting Lender at such
time.

Non-LIBOR Quoted Currency” means any currency other than a LIBOR Quoted Currency.

Note” means a promissory note made by a Borrower in favor of a Lender evidencing Loans made by such Lender to such Borrower, substantially in the form of Exhibit C.

Obligations” means all advances to, and debts, liabilities, obligations, covenants and duties of, any Loan Party arising under any Loan Document or otherwise with respect to any Loan, whether direct or indirect (including those acquired by assumption), absolute or contingent, due or to become due, now existing or hereafter arising and including interest and fees that accrue after the commencement by or against any Loan Party or any Affiliate thereof of any proceeding under any Debtor Relief Laws naming such Person as the debtor in such proceeding, regardless of whether such interest and fees are allowed claims in such proceeding. Without limiting the foregoing, the Obligations include the obligation to pay principal, interest, charges, expenses, fees, indemnities and other amounts payable by any Loan Party under, and in accordance with the terms and conditions of, any Loan Document.

OFAC” means the Office of Foreign Assets Control of the United States Department of the Treasury.

Off Balance Sheet Obligation” means the monetary obligation of a Person under (a) a so-called synthetic, off-balance sheet or tax retention lease, (b) an agreement for the use or possession of property creating obligations that do not appear on the balance sheet of such Person but which, upon the insolvency or bankruptcy of such Person, would be characterized as the indebtedness of such Person (without regard to accounting treatment) or (c) an agreement for the sale of receivables or like assets creating obligations that do not appear on the balance sheet of such Person but which, upon the insolvency or bankruptcy of such Person, could be characterized as the indebtedness of such Person (without regard to accounting treatment).

Organization Documents” means, (a) with respect to any corporation, the certificate or articles of incorporation and the bylaws (or equivalent or comparable constitutive documents with respect to any non-U.S. jurisdiction); (b) with respect to any limited liability company, the certificate or articles of formation or organization and operating agreement (or equivalent or comparable constitutive documents with respect to any non-U.S. jurisdiction); and (c) with respect to any partnership, joint venture, trust or other form of business entity, the partnership, joint venture or other applicable agreement of formation or organization and any agreement, instrument, filing or notice with respect thereto filed in connection with its formation or organization with the applicable Governmental Authority in the jurisdiction of its formation or organization and, if applicable, any certificate or articles of formation or organization of such entity.







Other Taxes” has the meaning specified in Section 3.01(b).

Outstanding Amount” means (a) with respect to Committed Loans and Bid Loans on any date, the Dollar Equivalent amount of the aggregate outstanding principal amount thereof after giving effect to any borrowings and prepayments or repayments of such Committed Loans or Bid Loans occurring on such date; and (b) with respect to Swing Line Loans on any date, the aggregate outstanding principal







amount thereof after giving effect to any borrowings and prepayments or repayments of such Swing Line Loans occurring on such date.

Overnight Rate” means, for any day, (a) with respect to any amount denominated in Dollars, the greater of (i) the Federal Funds Rate and (ii) an overnight rate determined by the Administrative Agent or the Swing Line Lender, as the case may be, in accordance with banking industry rules on interbank compensation, and (b) with respect to any amount denominated in an Alternative Currency, the rate of interest per annum at which overnight deposits in the applicable Alternative Currency, in an amount approximately equal to the amount with respect to which such rate is being determined, would be offered for such day by a branch or Affiliate of Bank of America in the applicable offshore interbank market for such currency to major banks in such interbank market.

Participant” has the meaning specified in Section 11.07(d). “Participant Register” has the meaning specified in Section 11.07(d).
Participating Member State” means any member state of the European Union that has the Euro as its lawful currency in accordance with legislation of the European Union relating to Economic and Monetary Union.

PBGC” means the Pension Benefit Guaranty Corporation. “Pension Act” means the Pension Protection Act of 2006.
Pension Funding Rules” means the rules of the Code and ERISA regarding minimum required contributions (including any installment payment thereof) to Pension Plans and set forth in, with respect to plan years ending prior to the effective date of the Pension Act, Section 412 of the Code and Section 302 of ERISA, each as in effect prior to the Pension Act and, thereafter, Section 412, 430, 431, 432 and 436 of the Code and Sections 302, 303, 304 and 305 of ERISA.

Pension Plan” means any “employee pension benefit plan” (as such term is defined in Section 3(2) of ERISA), other than a Multiemployer Plan, that is subject to Title IV of ERISA and is sponsored or maintained by the Company or any ERISA Affiliate or to which the Company or any ERISA Affiliate contributes or has an obligation to contribute, or in the case of a Multiple Employer Plan, has made contributions at any time during the immediately preceding five plan years.

Person” means any natural person, corporation, limited liability company, trust, joint venture, association, company, partnership, Governmental Authority or other entity.

Plan” means any “employee benefit plan” (as such term is defined in Section 3(3) of ERISA) established by the Company or, with respect to any such plan that is subject to the Pension Funding Rules, any ERISA Affiliate.

Platform” has the meaning specified in Section 6.02.







Pro Rata Share” means, with respect to each Lender at any time, a fraction (expressed as a percentage, carried out to the ninth decimal place), the numerator of which is the amount of the Commitment of such Lender at such time and the denominator of which is the amount of the Aggregate Commitments at such time, subject to adjustment as provided in Section 2.16; provided that if the Commitment of each Lender to make Loans has been terminated pursuant to Section 8.02, or if the Aggregate Commitments have expired, then the Pro Rata Share of each Lender shall be determined based







Swing Line” means the revolving credit facility made available by the Swing Line Lenders pursuant to Section 2.04.
Swing Line Borrowing” means a borrowing of a Swing Line Loan pursuant to Section 2.04. “Swing Line Commitment” means as to any Lender (a) the amount set forth opposite such
Lender’s name on Schedule 2.01 hereof or (b) if such Lender has entered into an Assignment and Assumption or has otherwise assumed a Swing Line Commitment after the Closing Date, the amount set forth for such Lender as its Swing Line Commitment in the Register maintained by the Administrative Agent pursuant to Section 11.07(c).

Swing Line Lender” means (a) with respect to Swing Line Loans denominated in Dollars, each of Bank of America and Citi, each in its capacity as a provider of Swing Line Loans denominated in Dollars, and any successor swing line lender hereunder, in anfor Dollars hereunder, and (b) with respect to Swing Line Loans denominated in Euros, Bank of America, N.A. London Branch or one of more other branches or Affiliates of Bank of America acting in such capacity as a provider of Swing Line Loans denominated in Euros, and any successor swing line lender for Euros hereunder, in an aggregate amount up to the Swing Line Commitment.

Swing Line Loan” has the meaning specified in Section 2.04(a).

Swing Line Loan Notice” means a notice of a Swing Line Borrowing pursuant to Section 2.04(b), which shall be substantially in the form of Exhibit A-2 or such other form as approved by the Administrative Agent (including any form on an electronic platform or electronic transmission system as shall be approved by the Administrative Agent), appropriately completed and signed by a Responsible Officer of the Company.

Swing Line Percentage” means, with respect to each Swing Line Lender, 50%.

Swing Line Sublimit” means an amount equal to the lesser of (a) $75,000,000 and (b)(a) with respect to Swing Line Loans denominated in Dollars, $75,000,000 and (b) with respect to Swing Line Loans denominated in Euros, the Alternative Currency Equivalent of $150,000,000; provided that in no event shall the aggregate Swing Line Sublimit exceed the Aggregate Commitments (and if any adjustment is required to the Swing Line Sublimit as a result of the reduction of the Aggregate Commitments, such adjustment shall, unless otherwise agreed among the Swing Line Lenders and the Borrower, be applied pro rata between the portion of the Swing Line Sublimit allocated to Dollars and the portion of the Swing Line Sublimit allocated to Euros, and ratably among the relevant Swing Line Lenders). The Swing Line Sublimit is part of, and not in addition to, the Aggregate Commitments.

TARGET2” means the Trans-European Automated Real-time Gross Settlement Express Transfer payment system which utilizes a single shared platform and which was launched on November 19, 2007.

TARGET Day” means any day on which TARGET2 (or, if such payment system ceases to be operative, such other payment system, if any, determined by the Administrative Agent to be a suitable replacement) is open for the settlement of payments in Euro.







Taxes” has the meaning specified in Section 3.01(a).

Term SOFR” means the forward-looking term rate for any period that is approximately (as determined by the Administrative Agent) as long as any of the Interest Period options set forth in the







than 11:00 a.m., ten Business Days after receipt of such request whether it consents, in its sole discretion, to the making of Eurocurrency Rate Loans in such requested currency.

(c)    Any failure by a Lender to respond to such request within the time period
specified in the preceding sentence shall be deemed to be a refusal by such Lender to permit Eurocurrency Rate Loans to be made in such Requested Currency. If the Administrative Agent and all the Lenders consent to making Eurocurrency Rate Loans in such requested currency, the Administrative Agent shall so notify the Company and such currency shall thereupon be deemed for all purposes to be an Alternative Currency hereunder for purposes of any Committed Borrowings of Eurocurrency Rate Loans. If the Administrative Agent shall fail to obtain consent to any request for an additional currency under this Section 1.07, the Administrative Agent shall promptly so notify the Company.

1.08
Change of Currency.    (a)    Each obligation of the Borrowers to make a payment
denominated in the national currency unit of any member state of the European Union that adopts the Euro as its lawful currency after the date hereof shall be redenominated into Euro at the time of such adoption. If, in relation to the currency of any such member state, the basis of accrual of interest expressed in this Agreement in respect of that currency shall be inconsistent with any convention or practice in the London interbank market for the basis of accrual of interest in respect of the Euro, such expressed basis shall be replaced by such convention or practice with effect from the date on which such member state adopts the Euro as its lawful currency; provided that if any Committed Borrowing in the currency of such member state is outstanding immediately prior to such date, such replacement shall take effect, with respect to such Committed Borrowing, at the end of the then current Interest Period.

(b)
Each provision of this Agreement shall be subject to such reasonable changes of
construction as the Administrative Agent may from time to time specify to be appropriate to reflect the adoption of the Euro by any member state of the European Union and any relevant market conventions or practices relating to the Euro.

(c)
Each provision of this Agreement also shall be subject to such reasonable
changes of construction as the Administrative Agent may from time to time specify to be appropriate to reflect a change in currency of any other country and any relevant market conventions or practices relating to the change in currency.

1.09
Times of Day. Unless otherwise specified, all references herein to times of day shall be
references to Eastern time (daylight or standard, as applicable).

1.10    Interest Rates. The Administrative Agent does not warrant, nor accept responsibility, nor shall the Administrative Agent have any liability with respect to the administration, submission or any other matter related to the rates in the definition of “Eurocurrency Rate” or “Euro Swing Line Rate” or with respect to any rate that is an alternative or replacement for or successor to any of such rate (including, without limitation, any LIBOR Successor Rate) or the effect of any of the foregoing, or of any LIBOR Successor Rate Conforming Changes.

ARTICLE II






THE COMMITMENTS AND BORROWING

2.01    Committed Loans. Subject to the terms and conditions set forth herein, each Lender severally agrees to make loans (each such loan, a “Committed Loan”) to the Company or a Designated Borrower in Dollars or in one or more Alternative Currencies from time to time, on any Business Day during the Availability Period, in an aggregate amount not to exceed at any time outstanding the amount of such Lender’s Commitment; provided, however, that after giving effect to any Committed Borrowing,







accepted for such Interest Period in conformity with the requirements of Section 2.03(e)(iii)) would be to cause the aggregate outstanding principal amount of the applicable Bid Borrowing to exceed the amount specified therefor in the related Bid Request, then, unless otherwise agreed by the Company, the Administrative Agent and such Lenders, such Competitive Bids shall be accepted as nearly as possible in proportion to the amount offered by each such Lender in respect of such Interest Period.

(g)
Notice to Lenders of Acceptance or Rejection of Bids. The Administrative Agent
shall promptly notify each Lender having submitted a Competitive Bid whether or not its offer has been accepted and, if its offer has been accepted, of the amount of the Bid Loan or Bid Loans to be made by it on the date of the applicable Bid Borrowing. Any Competitive Bid or portion thereof that is not accepted by the Company by the applicable time specified in Section 2.03(e) shall be deemed rejected.

(h)
Notice of Eurocurrency Rate. If any Bid Borrowing is to consist of Eurocurrency
Margin Loans, the Administrative Agent shall determine the Eurocurrency Rate for the relevant Interest Period, and promptly after making such determination, shall notify the Company and the Lenders that will be participating in such Bid Borrowing of such Eurocurrency Rate.

(i)
Funding of Bid Loans. Each Lender that has received (A) notice pursuant to
Section 2.03(g) that all or a portion of its Competitive Bid has been accepted by the Company and (B) notice from the Administrative Agent that the conditions set forth in Section 4.02 have been satisfied, shall make the amount of its Bid Loan(s) available directly to the applicable Borrower in immediately available funds at such account as set forth in the related Bid Request not later than 1:00 p.m., in the case of Bid Loans denominated in Dollars, or the Applicable Time, in the case of Bid Loans denominated in an Alternative Currency or a Requested Currency, on the date of the requested Bid Borrowing.

(j)
Payment of Bid Loans. Each Borrower which has received a Bid Loan from a
Lender shall make all payments of principal and interest in respect of such Bid Loan directly to such Lender as provided in Section 2.12(a)(v).

(k)
Notice of Range of Bids. After each Competitive Bid auction pursuant to this
Section 2.03, the Administrative Agent shall notify each Lender that submitted a Competitive Bid in such auction of the ranges of bids submitted (without the bidder’s name) and accepted for each Bid Loan and the aggregate amount of each Bid Borrowing.

2.04
Swing Line Loans.

(a)
The Swing Line.    Subject to the terms and conditions set forth herein, each






applicable Swing Line Lender shall make loans (as applicable) in Dollars or Euros (each such loan, a “Swing Line Loan”) to the Company from time to time on any Business Day during the Availability Period in an aggregate amount not to exceed at any time outstanding the amount of such Swing Line Lender’s Swing Line Percentage of the Swing Line Sublimit applicable to Swing Line Loans in the requested currency, notwithstanding the fact that such Swing Line Loans, when aggregated with the Pro Rata Share of the Outstanding Amount of Committed Loans of each Lender acting as a Swing Line Lender, may exceed the amount of such Lender’s Commitment; provided, however, that (x) after giving effect to any Swing Line Loan, (i) the Total Outstandings shall not exceed the Aggregate Commitments, and (ii) the aggregate Outstanding Amount of the Committed Loans of any Lender, plus such Lender’s Pro Rata Share of the Outstanding Amount of all Swing Line Loans shall not exceed such Lender’s Commitment, (y) that the Company shall not use the proceeds of any Swing Line Loan to refinance any outstanding Swing Line Loan, and (z) anythe applicable Swing Line Lender shall not be under any obligation to make any Swing Line Loan if it shall determine (which determination shall be conclusive and binding absent manifest error) that it has, or by such credit extension may have, Fronting Exposure.







Within the foregoing limits, and subject to the other terms and conditions hereof, the Company may borrow under this Section 2.04, prepay under Section 2.05, and reborrow under this Section 2.04. Each Swing Line Loan denominated in Dollars shall be a Base Rate Loan and each Swing Line Loan denominated in Euros shall be a Euro Swing Line Rate Loan. Immediately upon the making of a Swing Line Loan, each Lender shall be deemed to, and hereby irrevocably and unconditionally agrees to, purchase from the applicable Swing Line Lender a risk participation in such Swing Line Loan in an amount equal to the product of such Lender’s Pro Rata Share times the amountDollar Equivalent of such Swing Line Loan.

(b)    Borrowing Procedures. Each Swing Line Borrowing shall be made only upon the Company’s irrevocable notice to each applicable Swing Line Lender and the Administrative Agent, which may be given by (A) telephone or (B) by a Swing Line Loan Notice; provided that (i) in the case of any Swing Line Borrowing denominated in Euros to be made on a day that is a Business Day for Swing Line Loans denominated in Euros but not for Swing Line Loans denominated in Dollars, the irrevocable notice shall be made in writing (and not by telephone) and shall be provided to each Swing Line Lender providing Swing Line Loans denominated in Euros (with a copy to the Administrative Agent) and (ii) any telephonic notice must be confirmed promptly by delivery to each applicable Swing Line Lender and the Administrative Agent of a Swing Line Loan Notice. Each such notice must be received by each(x) in the case of Swing Line Loans denominated in Dollars, each applicable Swing Line Lender and the Administrative Agent not later than 1:00 p.m. New York City time or (y) in the case of Swing Line Loans denominated in Euros, each applicable Swing Line Lender and the Administrative Agent (or, if such request is made at a time with respect to which proviso (i) of the immediately preceding sentence applies, each applicable Swing Line Lender) not later than 12:00 p.m. Noon London time on the requested borrowing date, and each such notice shall (i) specify (i) the amount to be borrowed, which shall be a minimum of $100,000 or €100,000, andas applicable, (ii) specify the requested borrowing date, which shall be a Business Day, (iii) include a representation from the Company that all of the conditions to the making of a Swing Line Loan (including the provisions of Section 2.04(a) above and of Article IV) are satisfied for the making of such Swing Line Loan and (iv) in the case of Swing Line Loans denominated in Euros’ made at a time with respect to which proviso (i) of the immediately preceding sentence applies, (A) information regarding the Borrower's account for deposit of such Swing Line Loan, (B) a list of authorized signatories for the Borrower with sample signatures for each such authorized Person and (C) contact information for at least two (2) individuals at the Borrower who can be contacted with respect to such request. Promptly after receipt by each applicable Swing Line Lender of any telephonic Swing Line Loan Notice (other than in the case of any telephonic Swing Line Notice with respect to Swing Line Loans denominated in Euros’ made at a time with respect to which proviso (i) of the first sentence of this clause (b) applies), such Swing Line Lender will confirm with the Administrative Agent (by telephone or in writing) that the Administrative Agent has also received such Swing Line Loan Notice and, if not, such Swing Line Lender will notify the Administrative Agent (by telephone or in writing) of the contents thereof. Unless the applicable Swing Line Lenders have received notice from the Administrative Agent (including at the request of any Lender) prior to 2:00 p.m. New York City time on the date of theany proposed Swing Line Borrowing in Dollars or prior to 1:00 p.m. London time on the date of any proposed Swing Line Borrowing in Euros (A) directing the applicable Swing Line Lenders not to make such Swing Line Loan as a result of the limitations set forth in the proviso to the first sentence of Section 2.04(a), or (B) that one or more of the applicable conditions specified in Article IV is not then satisfied, then, subject to the terms and conditions hereof, each applicable Swing Line Lender may, not later than 3:00 p.m. New York City time on the borrowing date specified in such Swing Line Loan Notice in the case of Swing Line Loans denominated in Dollars and 2:00 p.m. London time on the borrowing date specified in such Swing Line Loan Notice in the case of Swing Line Loans denominated in Euros, make the amount of its Swing Line Percentage of the applicable Swing Line Loan available to the Company at its office by (1)







crediting the account of the Company on the books of such Swing Line Lender in Same Day Funds or (2) wire transfer of such funds in accordance with instructions provided to (and reasonably acceptable to) such Swing Line Lender by the Company.

(c)
Refinancing of Swing Line Loans.

(i)
Each applicable Swing Line Lender at any time in its sole and absolute
discretion may request, on behalf of the Company (which hereby irrevocably authorizes each applicable Swing Line Lender to so request on its behalf), that each Lender make a Base Rate Committed Loan for Swing Line Loans denominated in Dollars or a Eurocurrency Rate Loan for Swing Line Loans denominated in Euros, in each case in an amount equal to such Lender’s Pro Rata Share of the amount of Swing Line Loans then outstanding. Such request shall be made in writing (which written request shall be deemed to be a Committed Loan Notice for purposes hereof) and in accordance with the requirements of Section 2.02, without regard to the minimum and multiples specified therein for the principal amount of Base Rate Loans or Eurocurrency Rate Loans, but subject to the unutilized portion of the Aggregate Commitments and the conditions set forth in Section 4.02. The applicable Swing Line Lender shall furnish the Company with a copy of the applicable Committed Loan Notice promptly after delivering such notice to the Administrative Agent. Each Lender shall make an amount equal to its Pro Rata Share of the amount specified in such Committed Loan Notice available to the Administrative Agent in Same Day Funds for the account of the applicable Swing Line Lender at the applicable Administrative Agent’s Office for Dollar-denominated payments not later than 1:00 p.m. New York City time on the day specified in such Committed Loan Notice for Base Rate Committed Loans denominated in Dollars and 1:00 p.m. London time on the date specified in such Committed Loan Notice for Eurocurrency Rate Loans denominated in Euros, whereupon, subject to Section 2.04(c)(ii), each Lender that so makes funds available shall be deemed to have made a Base Rate Committed Loan or Eurocurrency Rate Loan, as applicable, to the Company in such amount. The Administrative Agent shall remit the funds so received to the applicable Swing Line Lender.

(ii)
If for any reason any Swing Line Loan cannot be refinanced by such a
Committed Borrowing in accordance with Section 2.04(c)(i), the request for Base Rate Committed Loans or Eurocurrency Rate Loans submitted by the applicable Swing Line Lender as set forth herein shall be deemed to be a request by such Swing Line Lender that each of the Lenders fund its risk participation in the relevant Swing Line Loan and each Lender’s payment to the Administrative Agent for the account of such Swing Line Lender pursuant to Section 2.04(c)(i) shall be deemed payment in respect of such participation.

(iii)
If any Lender fails to make available to the Administrative Agent for the
account of either Swing Line Lender any amount required to be paid by such Lender pursuant to the foregoing provisions of this Section 2.04(c) by the time specified in Section 2.04(c)(i), the applicable Swing Line Lender shall be entitled to recover from such Lender (acting through the Administrative Agent), on demand, such amount with interest thereon for the period from the date such payment is required to the date on which such payment is immediately available to such Swing Line Lender at






a rate per annum equal to the applicable Overnight Rate from time to time in effect, plus any administrative, processing or similar fees customarily charged by such Swing Line Lender in connection with the foregoing. If such Lender pays such amount (with interest and fees as aforesaid), the amount so paid shall constitute such Lender’s Committed Loan







included in the relevant Committed Borrowing or funded participation in the relevant Swing Line Loan, as the case may be. A certificate of the applicable Swing Line Lender submitted to any Lender (through the Administrative Agent) with respect to any amounts owing under this clause (iii) shall be conclusive absent manifest error.

(iv)
Each Lender’s obligation to make Committed Loans or to purchase and
fund risk participations in Swing Line Loans pursuant to this Section 2.04(c) shall be absolute and unconditional and shall not be affected by any circumstance, including (A) any set-off, counterclaim, recoupment, defense or other right which such Lender may have against any Swing Line Lender, the Company or any other Person for any reason whatsoever, (B) the occurrence or continuance of a Default, or (C) any other occurrence, event or condition, whether or not similar to any of the foregoing; provided, however, that each Lender’s obligation to make Committed Loans pursuant to this Section 2.04(c) is subject to the conditions set forth in Section 4.02. No such funding of risk participations shall relieve or otherwise impair the obligation of the Company to repay Swing Line Loans, together with interest as provided herein.

(d)
Repayment of Participations.

(i)
At any time after any Lender has purchased and funded a risk
participation in a Swing Line Loan, if the applicable Swing Line Lender receives any payment on account of such Swing Line Loan, such Swing Line Lender will distribute to such Lender its Pro Rata Share of such payment (appropriately adjusted, in the case of interest payments, to reflect the period of time during which such Lender’s risk participation was funded) in the same funds as those received by such Swing Line Lender.

(ii)
If any payment received by any Swing Line Lender in respect of
principal or interest on any Swing Line Loan is required to be returned by such Swing Line Lender under any of the circumstances described in Section 11.06 (including pursuant to any settlement entered into by such Swing Line Lender in its discretion), each Lender shall pay to such Swing Line Lender its Pro Rata Share thereof on demand of the Administrative Agent, plus interest thereon from the date of such demand to the date such amount is returned, at a rate per annum equal to the applicable Overnight Rate. The Administrative Agent will make such demand upon the request of such Swing Line Lender. The obligations of the Lenders under this clause shall survive the payment in full of the Obligations and the termination of this Agreement.

(e)
Interest for Account of Swing Line Lender. Each Swing Line Lender shall be
responsible for invoicing the Company for interest on the applicable Swing Line Loans. Until each Lender funds its Base Rate Committed Loan, Eurocurrency Rate Loan or risk participation pursuant to this Section 2.04 to refinance such Lender’s Pro Rata Share of any Swing Line Loan, interest in respect of such Pro Rata Share shall be solely for the account of the applicable Swing Line Lender.







(f)
Payments Directly to Swing Line Lender.    The Company shall make all
payments of principal and interest in respect of the Swing Line Loans directly to the applicable Swing Line Lender.

2.05
Prepayments.    (a)    Each Borrower may, upon notice from the Company to the
Administrative Agent, at any time or from time to time voluntarily prepay Committed Loans in whole or in part without premium or penalty; provided that (i) such notice must be in a form reasonably acceptable







to the Administrative Agent and be received by the Administrative Agent not later than 11:00 a.m. (A) three Business Days prior to any date of prepayment of Eurocurrency Rate Committed Loans denominated in Dollars, (B) four Business Days (or five, in the case of prepayment of Loans denominated in Special Notice Currencies) prior to any date of prepayment of Eurocurrency Rate Loans denominated in Alternative Currencies, and (C) on the date of prepayment of Base Rate Committed Loans; (ii) any prepayment of Eurocurrency Rate Committed Loans denominated in Dollars shall be in a principal amount of $5,000,000 or a whole multiple of $1,000,000 in excess thereof; (iii) any prepayment of Eurocurrency Rate Loans in Alternative Currencies shall be in a minimum principal amount of
$5,000,000 or a whole multiple of $1,000,000 in excess thereof; (iv) any prepayment of Base Rate Committed Loans shall be in a principal amount of $500,000 or a whole multiple of $100,000 in excess thereof or, in each case, if less, the entire principal amount thereof then outstanding; and (v) any such notice may be conditioned upon the effectiveness of other Indebtedness or the occurrence of one or more other transactions or events. Each such notice shall specify the date and amount of such prepayment and the Type(s) of Committed Loans to be prepaid and, if Eurocurrency Loans are to be prepaid, the Interest Period(s) of such Loans. The Administrative Agent will promptly notify each Lender of its receipt of each such notice, and of the amount of such Lender’s Pro Rata Share of such prepayment. If such notice is given by the Company, the applicable Borrower shall irrevocably make such prepayment and the payment amount specified in such notice shall be due and payable on the date specified therein. Any prepayment of a Eurocurrency Rate Loan shall be accompanied by all accrued interest on the amount prepaid, together with any additional amounts required pursuant to Section 3.05. Subject to Section 2.16, each such prepayment shall be applied to the Committed Loans of the Lenders in accordance with their respective Pro Rata Shares.



(b)     No Bid Loan may be prepaid without the prior consent of the applicable Bid Loan Lender.
 

(c)
The Company may, upon notice to each applicable Swing Line Lender (with a
copy to the Administrative Agent), at any time or from time to time, voluntarily prepay Swing Line Loans in whole or in part without premium or penalty; provided that (i) such notice must be received by the Swing Line Lenders and the Administrative Agent not later than 1:00 p.m. New York City time on the date of the prepayment in the case of Swing Line Loans denominated in Dollars and 12:00 p.m. Noon London time on the date of the prepayment in the case of Swing Line Loans denominated in Euros, and (ii) any such prepayment shall be in a minimum principal amount of $100,000.100,000 or €100,000, as applicable. Each such notice shall specify the date and amount of such prepayment. If such notice is given by the Company, the Company shall make such prepayment and the payment amount specified in such notice shall be due and payable on the date specified therein.

(d)
If for any reason the Total Outstandings at any time exceed the Aggregate
Commitments then in effect, the Borrowers shall immediately prepay Loans in an aggregate amount equal to such excess.

(e)
If the Administrative Agent notifies the Company at any time that the
Outstanding Amount of all Loans denominated in Alternative Currencies at such time exceeds an amount equal to 105% of the Alternative Currency Sublimit then in effect, then, within two Business Days after receipt of such notice, the






Borrowers shall prepay Loans in an aggregate amount sufficient to reduce such Outstanding Amount as of such date of payment to an amount not to exceed 100% of the Alternative Currency Sublimit then in effect.

2.06    Termination or Reduction of Commitments. The Company may, upon notice to the Administrative Agent, terminate the Aggregate Commitments, or from time to time permanently reduce the Aggregate Commitments; provided that (i) any such notice shall be received by the Administrative







Agent not later than 11:00 a.m. three (3) Business Days prior to the date of termination or reduction, (ii) any such partial reduction shall be in an aggregate amount of $10,000,000 or any whole multiple of
$1,000,000 in excess thereof, (iii) the Company shall not terminate or reduce the Aggregate Commitments if, after giving effect thereto and to any concurrent prepayments hereunder, the Total Outstandings would exceed the Aggregate Commitments; (iv) if, after giving effect to any reduction of the Aggregate Commitments, the Swing Line Sublimit, the Bid Loan Sublimit or the Bid Loan Requested Currency Sublimit exceeds the amount of the Aggregate Commitments, the Swing Line Sublimit, the Bid Loan Sublimit or the Bid Loan Requested Currency Sublimit, as the case may be, shall be automatically reduced by the amount of such excess; and (v) any such notice may be conditioned upon the effectiveness of other Indebtedness or the occurrence of one or more other transactions or events. The Administrative Agent will promptly notify the Lenders of any such notice of termination or reduction of the Aggregate Commitments. Any reduction of the Aggregate Commitments shall be applied to the Commitment of each Lender according to its Pro Rata Share. All fees accrued until the effective date of any termination of the Aggregate Commitments shall be paid on the effective date of such termination.

2.07
Repayment of Loans. (a) Each Borrower shall repay to the Lenders on the Maturity
Date the aggregate principal amount of Committed Loans made to such Borrower outstanding on such date.

(b)
Each Borrower shall repay each Bid Loan made to such Borrower on the last day
of the Interest Period in respect thereof.

(c)
The Company shall repay each Swing Line Loan on the earlier to occur of (i) the
date ten Business Days after such Loan is made and (ii) the Maturity Date. Swing Line Loans outstanding on the date of a Committed Borrowing shall also be repaid with the proceeds of such borrowing as provided in Section 2.02(b).

2.08    Interest. (a) Subject to the provisions of subsection (b) below, (i) each Eurocurrency Rate Committed Loan shall bear interest on the outstanding principal amount thereof for each Interest Period at a rate per annum equal to the Eurocurrency Rate for such Interest Period plus the Applicable Rate; (ii) each Base Rate Committed Loan shall bear interest on the outstanding principal amount thereof from the applicable borrowing date at a rate per annum equal to the Base Rate plus the Applicable Rate; (iii) each Bid Loan shall bear interest on the outstanding principal amount thereof for the Interest Period therefor at a rate per annum equal to the Eurocurrency Rate for such Interest Period plus (or minus) the Eurocurrency Bid Margin, or at the Absolute Rate for such Interest Period, as the case may be; and (iv) each Swing Line Loan denominated in Dollars shall bear interest on the outstanding principal amount thereof from the applicable borrowing date at a rate per annum equal to the Base Rate plus the Applicable Rate; and (v) each Swing Line Loan denominated in Euros shall bear interest on the outstanding principal amount thereof from the applicable borrowing date at a rate per annum equal to the Euro Swing Line Rate plus the Applicable Rate for Eurocurrency Rate Loans.

(b)    If any amount payable by any Borrower under any Loan Document is not paid when due (after giving effect to any applicable grace periods), whether at stated maturity, by acceleration or otherwise, such overdue amount shall thereafter bear interest at a fluctuating interest rate per annum at all times equal to the Default Rate to the fullest extent permitted by Applicable Laws. Furthermore, upon the request of the Required Lenders, while any other Event of Default exists, each Borrower shall pay interest on the principal amount of all outstanding Obligations at a






fluctuating interest rate per annum at all times equal to the Default Rate to the fullest extent permitted by Applicable Laws. Accrued and unpaid interest on past due amounts (including interest on past due interest) shall be due and payable upon demand.







(d)
Any resignation by Bank of America as Administrative Agent pursuant to this Section
shall also constitute its (and any of its relevant Affiliates’, including the Affiliate acting as Swing Line Lender for Swing Line Loans denominated in Euros) resignation as a Swing Line Lender. If Bank of America (and any of its applicable Affiliates) or any other Lender resigns as a Swing Line Lender, iteach such Person shall retain all the rights of a Swing Line Lender provided for hereunder with respect to Swing Line Loans made by it and outstanding as of the effective date of such resignation, including the right to require the Lenders to make Base Rate Loans or Eurocurrency Rate Loans or fund risk participations in outstanding Swing Line Loans pursuant to Section 2.04(c). Upon the appointment by the Company of an applicable successor Swing Line Lender hereunder (which successor shall in all cases be a Lender other than a Defaulting Lender), (a) such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring Swing Line Lender, and (b) the retiring Swing Line Lender shall be discharged from all of their respective duties and obligations hereunder or under the other Loan Documents.

9.07
Non-Reliance on Administrative Agent and Other Lenders.    Each Lender
acknowledges that it has, independently and without reliance upon the Administrative Agent or any other Lender or any of their Related Parties and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Agreement. Each Lender also acknowledges that it will, independently and without reliance upon the Administrative Agent or any other Lender or any of their Related Parties and based on such documents and information as it shall from time to time deem appropriate, continue to make its own decisions in taking or not taking action under or based upon this Agreement, any other Loan Document or any related agreement or any document furnished hereunder or thereunder.

9.08
No Other Duties, Etc. Anything herein to the contrary notwithstanding, none of the
Bookrunners, Arrangers, syndication agents, documentation agents or other agents listed on the cover page hereof shall have any powers, duties or responsibilities under this Agreement or any of the other Loan Documents, except in its capacity, as applicable, as the Administrative Agent or a Lender hereunder.

9.09
Administrative Agent May File Proofs of Claim. In case of the pendency of any
proceeding under any Debtor Relief Law or any other judicial proceeding relative to any Loan Party, the Administrative Agent (irrespective of whether the principal of any Loan shall then be due and payable as herein expressed or by declaration or otherwise and irrespective of whether the Administrative Agent shall have made any demand on any Borrower) shall be entitled and empowered, by intervention in such proceeding or otherwise:

(a)
to file and prove a claim for the whole amount of the principal and interest owing
and unpaid in respect of the Loans and all other Obligations that are owing and unpaid and to file such other documents as may be necessary or advisable in order to have the claims of the Lenders and the Administrative Agent (including any claim for the reasonable compensation, expenses, disbursements and advances of the Lenders and the Administrative Agent and their respective agents and counsel and all other amounts due the Lenders and the Administrative Agent under Sections 2.09 and 11.04) allowed in such judicial proceeding; and

(b)
to collect and receive any monies or other property payable or deliverable on any






such claims and to distribute the same;

and any custodian, receiver, assignee, trustee, liquidator, sequestrator or other similar official in any such judicial proceeding is hereby authorized by each Lender to make such payments to the Administrative Agent and, in the event that the Administrative Agent shall consent to the making of such payments








(g)
Special Purpose Funding Vehicles. Notwithstanding anything to the contrary
contained herein, any Lender (a “Granting Lender”) may grant to a special purpose funding vehicle identified as such in writing from time to time by the Granting Lender to the Administrative Agent and the Company (an “SPC”) the option to provide all or any part of any Committed Loan that such Granting Lender would otherwise be obligated to make pursuant to this Agreement; provided that (i) nothing herein shall constitute a commitment by any SPC to fund any Committed Loan, and (ii) if an SPC elects not to exercise such option or otherwise fails to make all or any part of such Committed Loan, the Granting Lender shall be obligated to make such Committed Loan pursuant to the terms hereof or, if it fails to do so, to make such payment to the Administrative Agent as is required under Section 2.12(c)(ii). Each party hereto hereby agrees that (i) neither the grant to any SPC nor the exercise by any SPC of such option shall increase the costs or expenses or otherwise increase or change the obligations of the Borrowers under this Agreement (including its obligations under Section 3.01 and Section 3.04), (ii) no SPC shall be liable for any indemnity or similar payment obligation under this Agreement for which a Lender would be liable, and (iii) the Granting Lender shall for all purposes, including the approval of any amendment, waiver or other modification of any provision of any Loan Document, remain the lender of record hereunder. The making of a Committed Loan by an SPC hereunder shall utilize the Commitment of the Granting Lender to the same extent, and as if, such Committed Loan were made by such Granting Lender. In furtherance of the foregoing, each party hereto hereby agrees (which agreement shall survive the termination of this Agreement) that, prior to the date that is one year and one day after the payment in full of all outstanding commercial paper or other senior debt of any SPC, it will not institute against, or join any other Person in instituting against, such SPC any bankruptcy, reorganization, arrangement, insolvency, or liquidation proceeding under the laws of the United States or any State thereof. Notwithstanding anything to the contrary contained herein, any SPC may (i) with notice to, but without prior consent of the Company and the Administrative Agent and with the payment of a processing fee in the amount of $3,500 (which processing fee may be waived by the Administrative Agent in its sole discretion), assign all or any portion of its right to receive payment with respect to any Committed Loan to the Granting Lender and (ii) disclose on a confidential basis any non-public information relating to its funding of Committed Loans to any rating agency, commercial paper dealer or provider of any surety or Guarantee or credit or liquidity enhancement to such SPC.

(h)
Resignation as Swing Line Lender after Assignment. Notwithstanding anything
to the contrary contained herein, if at any time any Swing Line Lender assigns all of its Commitment and Loans pursuant to subsection (b) above, such Swing Line Lender may, upon 30 days’ notice to the Company and the Lenders, resign as Swing Line Lender. In the event of any such resignation as Swing Line Lender, the Company shall be entitled to appoint from among the Lenders a successor Swing Line Lender hereunder; provided, however, that no failure by the Company to appoint any such successor shall affect the resignation of the applicable Swing Line Lender as Swing Line Lender. If any Swing Line Lender resigns as Swing Line Lender, it shall retain all the rights of a Swing Line Lender provided for hereunder with respect to Swing Line Loans made by it and outstanding as of the effective date of such resignation, including the right to require the Lenders to make Base Rate Committed Loans or Eurocurrency Rate Loans or fund risk participations in outstanding Swing Line Loans pursuant to Section 2.04(c). Upon the appointment of a successor Swing Line Lender, such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring Swing Line Lender.

(i)
Designated Affiliates.    Notwithstanding anything to the contrary contained
herein, a Granting Lender may grant to an Affiliate of such Granting Lender identified as such in writing from time to time by the Granting Lender to the Administrative Agent and the Company (a “Designated Affiliate”) the option to provide all or any part of any Committed Loan that such Granting Lender would otherwise be obligated to make to a Designated Borrower not organized under the laws of the United States or any State thereof pursuant to this Agreement;






provided, however, that if a Designated Affiliate elects not to exercise such option or otherwise fails to make all or any part of such Committed Loan, the







Exhibit B
(to Amendment No. 1)
SCHEDULE 2.01
COMMITMENTS
AND PRO RATA SHARES





Lender
Commitment
Pro Rata Share
Swing Line Commitment (for Dollars)
Swing Line Commitment (for Euros)
Bank of America, N.A.
$
200,000,000.00

4.000000000
%

$37,500,000.00

 
Bank of America, N.A., London Branch
--
--
 

$150,000,000.00

Barclays Bank PLC
$
200,000,000.00

4.000000000
%
 
 
BNP Paribas
$
200,000,000.00

4.000000000
%
 
 
Citibank, N.A.
$
200,000,000.00

4.000000000
%

$37,500,000.00

 
HSBC Bank USA, National Association
$
200,000,000.00

4.000000000
%
 
 
JPMorgan Chase Bank, N.A.
$
200,000,000.00

4.000000000
%
 
 
Mizuho Bank, LTD
$
200,000,000.00

4.000000000
%
 
 
MUFG Bank, Ltd.
$
200,000,000.00

4.000000000
%
 
 
U.S. Bank National Association
$
200,000,000.00

4.000000000
%
 
 
Wells Fargo Bank, National Association
$
200,000,000.00

4.000000000
%
 
 
The Bank of Nova Scotia
$
172,500,000.00

3.450000000
%
 
 
Commerzbank AG, New York Branch
$
172,500,000.00

3.450000000
%
 
 
Credit Suisse AG, Cayman Islands Branch
$
172,500,000.00

3.450000000
%
 
 
Deutsche Bank AG, New York Branch
$
172,500,000.00

3.450000000
%
 
 
Goldman Sachs Bank USA
$
172,500,000.00

3.450000000
%
 
 
Intesa Sanpaolo S.p.A., New York Branch
$
172,500,000.00

3.450000000
%
 
 
Lloyds Bank Corporate Markets plc
$
172,500,000.00

3.450000000
%
 
 
PNC Bank, National Association
$
172,500,000.00

3.450000000
%
 
 
Royal Bank of Canada
$
172,500,000.00

3.450000000
%
 
 
Banco Santander, S.A., New York Branch
$
172,500,000.00

3.450000000
%
 
 
Standard Chartered Bank
$
172,500,000.00

3.450000000
%
 
 
Sumitomo Mitsui Banking Corporation
$
172,500,000.00

3.450000000
%
 
 
Toronto-Dominion Bank, New York Branch
$
172,500,000.00

3.450000000
%
 
 
Morgan Stanley Bank, N.A.
$
122,500,000.00

2.450000000
%
 
 
The Northern Trust Company
$
115,000,000.00

2.300000000
%
 
 
Banco Bilbao Vizcaya Argentaria S.A., New York Branch
$
70,000,000.00

1.400000000
%
 
 
The Bank of New York Mellon
$
70,000,000.00

1.400000000
%
 
 
Danske Bank A/S
$
70,000,000.00

1.400000000
%
 
 
DBS Bank Ltd.
$
70,000,000.00

1.400000000
%
 
 
Nordea Bank Abp, New York Branch
$
70,000,000.00

1.400000000
%
 
 
Westpac Banking Corporation
$
70,000,000.00

1.400000000
%
 
 
ICICI Bank Limited, New York Branch
$
50,000,000.00

1.000000000
%
 
 
Morgan Stanley Senior Funding Inc.
$
50,000,000.00

1.000000000
%
 
 
Total

$5,000,000,000.00

100.000000000
%

$75,000,000.00


$150,000,000.00


Exhibit C
(to Amendment No. 1)





SCHEDULE 11.02
ADMINISTRATIVE AGENT’S OFFICE;
CERTAIN ADDRESSES FOR NOTICES
DANAHER CORPORATION
and DESIGNATED BORROWERS:
Danaher Corporation
2200 Pennsylvania Avenue, N.W., Suite 800W
Washington, D.C. 20037-1701
Website Address: www.danaher.com
U.S. Taxpayer Identification Number: 59-1995548

Attention:
Vice President and Treasurer
Telephone:    
Facsimile:    
E-Mail:     

Attention: Executive Vice President, Chief Financial Officer
Telephone:
Facsimile:
E-Mail:

Attention: Vice President, Associate General Counsel
Telephone:
Facsimile:
E-Mail:






ADMINISTRATIVE AGENT:
Administrative Agent’s Office (for payments and Requests for Borrowings):
Bank of America, N.A.
900 W. Trade Street
Mail Code: NC1-026-06-04
Charlotte, North Carolina 28255
Attention:     Donna Barron
Telephone:     
Facsimile:     
E-Mail:     

Account No. (for Dollars):
Reference: Danaher Corp.
ABA Number:    026009593

Account No. (for Euro):
Reference: Danaher Corp.
Swift Code: BOFAGB22
IBAN

Account No. (for Sterling):
Reference: Danaher Corp.
Swift Code: BOFAGB22
IBAN

Account No. (for Yen):
Reference: Danaher Corp.
Swift Code: BOFAJPJX

Other Notices as Administrative Agent:
Bank of America, N.A.
Agency Management
555 California Street, 4
th Floor
Mail Code: CA5-705-04-09
San Francisco, California 94104
Attention:     Liliana B. Claar
Telephone:     
Facsimile:     
E-Mail:     







SWING LINE LENDERS:
Bank of America, N.A.
900 W. Trade Street
Mail Code: NC1-026-06-04
Charlotte, North Carolina 28255
Attention:     Donna Barron
Telephone:     
Facsimile:     
E-Mail:     

Account No.:
Reference:
Danaher Corp.
ABA No.:
026009593

Citibank, N.A.
Name: Loan Administration
Address: CITIBANK NA
1615 Brett Road, Building III
New Castle, DE 19720
Telephone:
Fax:
E-mail Address:

ABA #021000089
Account #
Account Name:  SSB
Reference:  Danaher Corporation

SWING LINE LENDERS (for Swing Line Loans in Euros on non-Business Day in U.S.):

Bank of America, N.A., London Branch

Team:

Adi Khambata                    E-Mail:     





Telephone:    
Facsimile:    

Miraj Mothi                    E-Mail:     
Telephone:    
Facsimile:    

Shirley Brown                    E-Mail:     
Telephone:    
Facsimile:    

Michelle Stanley            E-Mail:     
Telephone:    
Facsimile:    







EX-10.9 3 dhr-2019927xexx109.htm AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT Exhibit
Exhibit 10.9

AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT
THIS AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”) is made and entered into as of October 7, 2019 by and among DANAHER CORPORATION, a Delaware corporation (the “Company”), each of the Lenders (as defined in the Credit Agreement) party hereto, each of BANK OF AMERICA, N.A., LONDON BRANCH, CITIBANK, N.A.,, and WELLS FARGO BANK, NATIONAL ASSOCIATION each in their respective roles as a Swing Line Lender, and BANK OF AMERICA, N.A., as Administrative Agent (the “Administrative Agent”).
W I T N E S S E T H:
WHEREAS, the Company, the Designated Borrowers from time to time party thereto, the Administrative Agent and the Lenders from time to time party thereto have entered into that certain Second Amended and Restated Credit Agreement dated as of August 27, 2019 (as amended, restated, extended, supplemented or otherwise modified from time to time, the “Credit Agreement”; all capitalized terms not otherwise defined herein shall have the meaning given thereto in the Credit Agreement);
WHEREAS, the Company has requested that the Credit Agreement be amended as set forth herein, and the Lenders and Swing Line Lenders party hereto have agreed to such amendments subject to the conditions set forth herein;
NOW, THEREFORE, in consideration of the premises and the terms hereof, the parties hereto agree as follows:
1.Amendments to Credit Agreement. Subject to the terms and conditions set forth herein:
(a)    Section 1.01 to the Credit Agreement is hereby amended by:
(i)    The definition of “Swing Line Lender” is hereby deleted in its entirety and replaced with:
““Swing Line Lender” means (a) with respect to Swing Line Loans denominated in Dollars, each of Citi and Wells Fargo Bank, National Association, each in its capacity as a provider of Swing Line Loans denominated in Dollars, and any successor swing line lender for Dollars hereunder, and (b) with respect to Swing Line Loans denominated in Euros, Bank of America, N.A. London Branch or one of more other branches or Affiliates of Bank of America acting in such capacity as a provider of Swing Line Loans denominated in Euros, and any successor swing line lender for Euros hereunder, in an aggregate amount up to the Swing Line Commitment.”
(ii)    The definition of “Swing Line Percentage” is hereby deleted in its entirety and replaced with:
““Swing Line Percentage” means, with respect to each Swing Line Lender and with respect to each Swing Line Sublimit, the corresponding percentage to such Swing Line Lender’s Swing Line Commitment.”
(iii)    The definition of “Swing Line Sublimit” is hereby deleted in its entirety and replaced with:
““Swing Line Sublimit” means (a) with respect to Swing Line Loans denominated in Dollars, $250,000,000 and (b) with respect to Swing Line Loans denominated in Euros, the





Alternative Currency Equivalent of $250,000,000; provided that in no event shall the aggregate Swing Line Sublimit exceed the Aggregate Commitments (and if any adjustment is required to the Swing Line Sublimit as a result of the reduction of the Aggregate Commitments, such adjustment shall, unless otherwise agreed among the Swing Line Lenders and the Borrower, be applied pro rata between the portion of the Swing Line Sublimit allocated to Dollars and the portion of the Swing Line Sublimit allocated to Euros, and ratably among the relevant Swing Line Lenders). The Swing Line Sublimit is part of, and not in addition to, the Aggregate Commitments.”
(b)    Section 2.04(a) to the Credit Agreement is hereby amended by deleting it in its entirety and replacing it with the following:
“(a)    The Swing Line. Subject to the terms and conditions set forth herein, each applicable Swing Line Lender shall make loans (as applicable) in Dollars or Euros (each such loan, a “Swing Line Loan”) to the Company from time to time on any Business Day during the Availability Period in an aggregate amount not to exceed at any time outstanding the amount of such Swing Line Lender’s Swing Line Percentage of the Swing Line Sublimit applicable to Swing Line Loans in the requested currency; provided, however, that (i) after giving effect to any Swing Line Loan, (x) the Total Outstandings shall not exceed the Aggregate Commitments, and (y) the aggregate Outstanding Amount of the Committed Loans of any Lender, plus such Lender’s Pro Rata Share of the Outstanding Amount of all Swing Line Loans shall not exceed such Lender’s Commitment, (ii) that the Company shall not use the proceeds of any Swing Line Loan to refinance any outstanding Swing Line Loan, (iii) the applicable Swing Line Lender shall not be under any obligation to make any Swing Line Loan if it shall determine (which determination shall be conclusive and binding absent manifest error) that it has, or by such credit extension may have, Fronting Exposure and (iv) such Swing Line Loans, when aggregated with the Pro Rata Share of the Outstanding Amount of Committed Loans of each Lender acting as a Swing Line Lender and its Affiliates, does not exceed the greater of (x) such Lender’s Commitment and (y) such Lender’s Swing Line Sublimit. Within the foregoing limits, and subject to the other terms and conditions hereof, the Company may borrow under this Section 2.04, prepay under Section 2.05, and reborrow under this Section 2.04. Each Swing Line Loan denominated in Dollars shall be a Base Rate Loan and each Swing Line Loan denominated in Euros shall be a Euro Swing Line Rate Loan. Immediately upon the making of a Swing Line Loan, each Lender shall be deemed to, and hereby irrevocably and unconditionally agrees to, purchase from the applicable Swing Line Lender a risk participation in such Swing Line Loan in an amount equal to the product of such Lender’s Pro Rata Share times the Dollar Equivalent of such Swing Line Loan.”
(c)    Schedule 2.01 to the Credit Agreement is hereby amended by replacing such schedule in its entirety with the revised version thereof attached hereto as Exhibit A, and (c) Schedule 11.02 to the Credit Agreement is hereby amended by replacing such schedule in its entirety with the revised version thereof attached hereto as Exhibit B.
2.    Effectiveness; Conditions Precedent. This Amendment shall become effective on the first Business Day on which the following conditions are satisfied or waived (such date, the “Effective Date”):
(a)    The Administrative Agent shall have received counterparts of this Amendment, duly executed by the Company, the Administrative Agent, each Swing Line Lender party hereto and the Required Lenders, which counterparts may be delivered by telefacsimile or other electronic means (including .pdf), but such delivery will be promptly followed by the delivery of original signature pages by each Person party hereto unless waived by the Administrative Agent.

2






(b)    All fees and expenses payable to the Administrative Agent (including the fees and expenses of counsel to the Administrative Agent to the extent due and payable under Section 11.04 of the Credit Agreement) estimated to date and for which invoices have been presented a reasonable period of time prior to the effectiveness hereof shall have been paid in full (without prejudice to final settling of accounts for such fees and expenses).
3.    Representations and Warranties. In order to induce the Administrative Agent and the Lenders to enter into this Amendment, the Company represents and warrants to the Administrative Agent and the Lenders as follows:
(a)    No Default or Event of Default exists as of the date hereof or would result from, or after giving effect to, the amendments contemplated hereby;
(b)    the representations and warranties of (i) the Borrowers contained in Article V of the Credit Agreement and (ii) each Loan Party contained in each other Loan Document are true and correct in all material respects (provided that such materiality qualifier shall not apply to the extent that any such representation or warranty is already qualified or modified by materiality in the text thereof), on and as of the Effective Date, after giving effect to the amendments contemplated hereby, except to the extent that such representations and warranties specifically refer to an earlier date, in which case they are true and correct in all material respects (provided that such materiality qualifier shall not apply to the extent that any such representation or warranty is already qualified or modified by materiality in the text thereof) as of such earlier date, and except that for purposes of this clause (b), (i) the representations and warranties contained in subsections (a) and (b) of Section 5.05 of the Credit Agreement shall be deemed to refer to the most recent statements furnished pursuant to clauses (a) and (b), respectively, of Section 6.01 of the Credit Agreement and (ii) the representations and warranties in subsection (c) of Section 5.05 of the Credit Agreement, subsection (b) of Section 5.06 of the Credit Agreement and Section 5.10 of the Credit Agreement need only be true and correct on and as of the Closing Date;
(c)    it has the legal power and authority to execute and deliver this Amendment;
(d)    the officer executing this Amendment on its behalf has been duly authorized to execute and deliver the same and bind it with respect to the provisions hereof;
(e)    the execution, delivery and performance by the Company of this Amendment have been duly authorized by all necessary corporate or other organizational action, and do not and will not (i) contravene the terms of any of the Company’s Organization Documents; (ii) conflict with or result in any breach or contravention of, or the creation of any Lien under, (A) any Contractual Obligation to which the Company is a party except to the extent that such conflict, breach, contravention, Lien or violation could not reasonably be expected to have a Material Adverse Effect or (B) any order, injunction, writ or decree of any Governmental Authority or any arbitral award to which the Company or its property is subject; or (iii) violate any Law in any material respect;
(f)    this Amendment constitutes its legal, valid and binding obligation, enforceable in accordance with its terms.
4.    Entire Agreement. This Amendment is a Loan Document. This Amendment, together with all the other Loan Documents (collectively, the “Relevant Documents”), sets forth the entire understanding and agreement of the parties hereto in relation to the subject matter hereof and supersedes any prior negotiations and agreements among the parties relating to such subject matter. No promise, condition, representation or warranty, express or implied, not set forth in the Relevant Documents shall bind any party hereto, and no such party has relied on any such promise, condition, representation or warranty. Each of the parties hereto acknowledges that, except as otherwise expressly stated

3






in the Relevant Documents, no representations, warranties or commitments, express or implied, have been made by any party to the other in relation to the subject matter hereof or thereof. None of the terms or conditions of this Amendment may be changed, modified, waived or canceled orally or otherwise, except in writing and in accordance with Section 11.01 of the Credit Agreement.
5.    Full Force and Effect of Credit Agreement. Except as hereby specifically amended, modified or supplemented, the Credit Agreement is hereby confirmed and ratified in all respects and shall be and remain in full force and effect according to its respective terms.
6.    Governing Law. This Amendment shall in all respects be governed by, and construed in accordance with, the laws of the State of New York, and shall be further subject to the provisions of Sections 11.17 and 11.18 of the Credit Agreement.
7.    Enforceability. If any provision of this Amendment is held to be illegal, invalid or unenforceable, (a) the legality, validity and enforceability of the remaining provisions of this Amendment shall not be affected or impaired thereby and (b) the parties shall endeavor in good faith negotiations to replace the illegal, invalid or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the illegal, invalid or unenforceable provisions. The invalidity of a provision in a particular jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction..
8.    References; Interpretation. All references in any of the Loan Documents to the “Credit Agreement” shall mean the Credit Agreement, as amended hereby. The rules of interpretation set forth in Section 1.02 of the Credit Agreement shall be applicable to this Amendment.
9.    Successors and Assigns. This Amendment shall be binding upon and inure to the benefit of the Company, the Administrative Agent and each of the Lenders, and their respective successors, legal representatives, and assignees to the extent such assignees are permitted assignees as provided in Section 11.07 of the Credit Agreement.
10.    No Novation; Reaffirmation. Neither the execution and delivery of this Amendment nor the consummation of any other transaction contemplated hereunder is intended to constitute a novation of the Credit Agreement or of any of the other Loan Documents or any obligations thereunder. The Company hereby (i) affirms and confirms each of the Loan Documents to which it is a party and its Obligations thereunder, (ii) affirms that it has the right, power and authority and has taken all necessary corporate and other action to authorize the execution, delivery and performance of this Amendment and (iii) agrees that, notwithstanding the effectiveness of this Amendment, each Loan Document shall continue to be in full force and effect.
11.    Counterparts. This Amendment may be executed in any number of counterparts, each of which shall be deemed an original as against any party whose signature appears thereon, and all of which shall together constitute one and the same instrument. Delivery of an executed counterpart of a signature page of this Amendment by telecopy or other electronic means (including .pdf) shall be effective as delivery of a manually executed counterpart of this Amendment.
[Remainder of page is intentionally left blank; signature pages follow.]

4






IN WITNESS WHEREOF, the parties have duly executed this Amendment on the day and year first written above.
DANAHER CORPORATION, as the Company
By:     /s/ Frank T. McFaden                
Name:    Frank T. McFaden
Title:    Vice President & Treasurer


Danaher Corporation
Amendment No. 2 to Second Amended and Restated Credit Agreement
Signature Pages



ADMINISTRATIVE AGENT:
BANK OF AMERICA, N.A., as Administrative Agent
By:     /s/ Liliana Claar                
Name:     Liliana Claar
Title: Vice President

Danaher Corporation
Amendment No. 2 to Second Amended and Restated Credit Agreement
Signature Pages



BANK OF AMERICA, N.A., as a Lender and a Swing Line Lender
By:     /s/ Mukesh Singh                
Name:     Mukesh Singh
Title: Director

Danaher Corporation
Amendment No. 2 to Second Amended and Restated Credit Agreement
Signature Pages



BANK OF AMERICA, N.A., LONDON BRANCH,
as a Swing Line Lender
By:     /s/ Fiona Malitsky                
Name:     Fiona Malitsky
Title:     Vice President

Danaher Corporation
Amendment No. 2 to Second Amended and Restated Credit Agreement
Signature Pages



CITIBANK, N.A., as a Lender and a Swing Line Lender
By:     /s/ Susan Olsen                    
Name:     Susan Olsen
Title:    Vice President
    

Danaher Corporation
Amendment No. 2 to Second Amended and Restated Credit Agreement
Signature Pages



BARCLAYS BANK PLC, as a Lender
By:     /s/ Jake Lam                    
Name:     Jake Lam
Title:     Assistant Vice President



Danaher Corporation
Amendment No. 2 to Second Amended and Restated Credit Agreement
Signature Pages



BNP PARIBAS, as a Lender
By:     /s/ Melissa Dyki                
Name:     Melissa Dyki
Title:    Director

By:     /s/ Richard Pace                    
Name:     Richard Pace
Title:     Managing Director




Danaher Corporation
Amendment No. 2 to Second Amended and Restated Credit Agreement
Signature Pages



JPMORGAN CHASE BANK, N.A., as a Lender
By:     /s/ Kyler Eng                        
Name:     Kyler Eng
Title:     Vice President
    

Danaher Corporation
Amendment No. 2 to Second Amended and Restated Credit Agreement
Signature Pages



U.S. BANK NATIONAL ASSOCIATION, as a Lender
By:     /s/ David C. Mruk                
Name:     David C. Mruk
Title:     SVP
    

Danaher Corporation
Amendment No. 2 to Second Amended and Restated Credit Agreement
Signature Pages



WELLS FARGO BANK, NATIONAL ASSOCIATION, as a Lender and a Swing Line Lender
By:     /s/ Darin Mullis                        
Name:     Darin Mullis
Title:     Managing Director



Danaher Corporation
Amendment No. 2 to Second Amended and Restated Credit Agreement
Signature Pages



THE BANK OF NOVA SCOTIA, as a Lender
By:     /s/ Winston Lua                    
Name:     Winston Lua
Title:     Director



Danaher Corporation
Amendment No. 2 to Second Amended and Restated Credit Agreement
Signature Pages



COMMERZBANK AG, NEW YORK BRANCH, as a Lender
By:     /s/ Michael Ravelo                
Name:     Michael Ravelo
Title:     Managing Director


By:     /s/ John W. Deegan                
Name:     John W. Deegan
Title:     Director




Danaher Corporation
Amendment No. 2 to Second Amended and Restated Credit Agreement
Signature Pages



GOLDMAN SACHS BANK USA, as a Lender
By:     /s/ Jamie Minieri                
Name:     Jamie Minieri
Title:     Authorized Signatory



Danaher Corporation
Amendment No. 2 to Second Amended and Restated Credit Agreement
Signature Pages



INTESA SANPAOLO S.p.A., NEW YORK BRANCH, as a Lender
By:     /s/ Neil Derfler                    
Name:     Neil Derfler
Title:     Relationship Manager


By:     /s/ Alessandro Toigo                
Name:     Alessandro Toigo
Title:     Regional Business Manager
    

Danaher Corporation
Amendment No. 2 to Second Amended and Restated Credit Agreement
Signature Pages



LLOYDS BANK CORPORATE MARKETS PLC, as a Lender
By:     /s/ Kamala Basdeo                
Name:     Kamala Basdeo
Title:     Assistant Vice President
Transaction Execution


By:     /s/ Allen McGuire                
Name:     Allen McGuire
Title:     Assistant Vice President
Transaction Execution






Danaher Corporation
Amendment No. 2 to Second Amended and Restated Credit Agreement
Signature Pages



MORGAN STANLEY BANK, N.A., as a Lender
By:     /s/ Jackson Eng                
Name:     Jackson Eng
Title:     Authorized Signatory




Danaher Corporation
Amendment No. 2 to Second Amended and Restated Credit Agreement
Signature Pages



PNC BANK, NATIONAL ASSOCIATION, as a Lender
By:     /s/ Stephanie Lalos                
Name:     Stephanie Lalos
Title:     Assistant Vice President




Danaher Corporation
Amendment No. 2 to Second Amended and Restated Credit Agreement
Signature Pages



ROYAL BANK OF CANADA, as a Lender
By:     /s/ Diana Lee                    
Name:     Diana Lee    
Title:     Authorized Signatory




Danaher Corporation
Amendment No. 2 to Second Amended and Restated Credit Agreement
Signature Pages



BANCO BILBAO VIZCAYA ARGENTARIA, S.A., NEW YORK BRANCH, as a Lender
By:     /s/ Brian Crowley                
Name:     Brian Crowley
Title:     Managing Director
    


By:     /s/ Miriam Trautman                
Name:     Miriam Trautman
Title:     Senior Vice President
        


Danaher Corporation
Amendment No. 2 to Second Amended and Restated Credit Agreement
Signature Pages




BANCO SANTANDER BANK, S.A., NEW YORK BRANCH, as a Lender
By:     /s/ Rita Walz-Cuccioli                
Name:     Rita Walz-Cuccioli
Title:     Executive Director
Banco Santander S.A. New York Branch


By:     /s/ Terence Corcoran                
Name:     Terence Corcoran
Title:     Executive Director
Banco Santander S.A. New York Branch



24





STANDARD CHARTERED BANK, as a Lender
By:     /s/ James Beck                
Name:     James Beck
Title:     Associate Director



Danaher Corporation
Amendment No. 2 to Second Amended and Restated Credit Agreement
Signature Pages



SUMITOMO MITSUI BANKING CORPORATION, as a Lender
By:     /s/ Michael Maguire                
Name:     Michael Maguire
Title:     Executive Director




Danaher Corporation
Amendment No. 2 to Second Amended and Restated Credit Agreement
Signature Pages



TORONTO-DOMINION BANK, NEW YORK BRANCH, as a Lender
By:     /s/ Michael Borowiecki                
Name:     MICHAEL BOROWIECKI
Title:     AUTHORIZED SIGNATORY



Danaher Corporation
Amendment No. 2 to Second Amended and Restated Credit Agreement
Signature Pages



THE NORTHERN TRUST COMPANY, as a Lender
By:     /s/ Kimberly A. Crotty                
Name:     Kimberly A. Crotty
Title:     VP




Danaher Corporation
Amendment No. 2 to Second Amended and Restated Credit Agreement
Signature Pages



DBS BANK LTD., as a Lender
By:     /s/ Yeo How Ngee                
Name:     Yeo How Ngee
Title:     Managing Director





Danaher Corporation
Amendment No. 2 to Second Amended and Restated Credit Agreement
Signature Pages



NORDEA BANK ABP, NEW YORK BRANCH, as a Lender
By:     /s/ Olli Savikko                    
Name:     Olli Savikko
Title:     Senior Vice President


By:     /s/ Leena Parker                    
Name:    Leena Parker     
Title:     Senior Vice President




Danaher Corporation
Amendment No. 2 to Second Amended and Restated Credit Agreement
Signature Pages



WESTPAC BANKING CORPORATION, as a Lender
By:     /s/ Richard Yarnold                
Name:     Richard Yarnold
Title:     Director




Danaher Corporation
Amendment No. 2 to Second Amended and Restated Credit Agreement
Signature Pages



Exhibit A
(to Amendment No. 2)
SCHEDULE 2.01
COMMITMENTS
AND PRO RATA SHARES

121841766_2




Lender
Commitment
Pro Rata Share
Swing Line Commitment (for Dollars)
Swing Line Commitment (for Euros)
Bank of America, N.A.
$
200,000,000.00

4.000000000
%
 
 
Bank of America, N.A., London Branch
--
--
 

$250,000,000.00

Barclays Bank PLC
$
200,000,000.00

4.000000000
%
 
 
BNP Paribas
$
200,000,000.00

4.000000000
%
 
 
Citibank, N.A.
$
200,000,000.00

4.000000000
%

$125,000,000.00

 
HSBC Bank USA, National Association
$
200,000,000.00

4.000000000
%
 
 
JPMorgan Chase Bank, N.A.
$
200,000,000.00

4.000000000
%
 
 
Mizuho Bank, LTD
$
200,000,000.00

4.000000000
%
 
 
MUFG Bank, Ltd.
$
200,000,000.00

4.000000000
%
 
 
U.S. Bank National Association
$
200,000,000.00

4.000000000
%
 
 
Wells Fargo Bank, National Association
$
200,000,000.00

4.000000000
%

$125,000,000.00

 
The Bank of Nova Scotia
$
172,500,000.00

3.450000000
%
 
 
Commerzbank AG, New York Branch
$
172,500,000.00

3.450000000
%
 
 
Credit Suisse AG, Cayman Islands Branch
$
172,500,000.00

3.450000000
%
 
 
Deutsche Bank AG, New York Branch
$
172,500,000.00

3.450000000
%
 
 
Goldman Sachs Bank USA
$
172,500,000.00

3.450000000
%
 
 
Intesa Sanpaolo S.p.A., New York Branch
$
172,500,000.00

3.450000000
%
 
 
Lloyds Bank Corporate Markets plc
$
172,500,000.00

3.450000000
%
 
 
PNC Bank, National Association
$
172,500,000.00

3.450000000
%
 
 
Royal Bank of Canada
$
172,500,000.00

3.450000000
%
 
 
Banco Santander, S.A., New York Branch
$
172,500,000.00

3.450000000
%
 
 
Standard Chartered Bank
$
172,500,000.00

3.450000000
%
 
 
Sumitomo Mitsui Banking Corporation
$
172,500,000.00

3.450000000
%
 
 
Toronto-Dominion Bank, New York Branch
$
172,500,000.00

3.450000000
%
 
 
Morgan Stanley Bank, N.A.
$
122,500,000.00

2.450000000
%
 
 
The Northern Trust Company
$
115,000,000.00

2.300000000
%
 
 
Banco Bilbao Vizcaya Argentaria S.A., New York Branch
$
70,000,000.00

1.400000000
%
 
 
The Bank of New York Mellon
$
70,000,000.00

1.400000000
%
 
 
Danske Bank A/S
$
70,000,000.00

1.400000000
%
 
 
DBS Bank Ltd.
$
70,000,000.00

1.400000000
%
 
 
Nordea Bank Abp, New York Branch
$
70,000,000.00

1.400000000
%
 
 
Westpac Banking Corporation
$
70,000,000.00

1.400000000
%
 
 
ICICI Bank Limited, New York Branch
$
50,000,000.00

1.000000000
%
 
 
Morgan Stanley Senior Funding Inc.
$
50,000,000.00

1.000000000
%
 
 
Total

$5,000,000,000.00

100.000000000
%

$250,000,000.00


$250,000,000.00


Exhibit B
(to Amendment No. 2)

121841766_2




SCHEDULE 11.02
ADMINISTRATIVE AGENT’S OFFICE;
CERTAIN ADDRESSES FOR NOTICES
DANAHER CORPORATION
and DESIGNATED BORROWERS:
Danaher Corporation
2200 Pennsylvania Avenue, N.W., Suite 800W
Washington, D.C. 20037-1701
Website Address: www.danaher.com
U.S. Taxpayer Identification Number: 59-1995548

Attention:
Vice President and Treasurer
Telephone:    
Facsimile:    
E-Mail:     

Attention: Executive Vice President, Chief Financial Officer
Telephone:
Facsimile:
E-Mail:

Attention: Vice President, Associate General Counsel
Telephone:
Facsimile:
E-Mail:


121841766_2




ADMINISTRATIVE AGENT:
Administrative Agent’s Office (for payments and Requests for Borrowings):
Bank of America, N.A.
900 W. Trade Street
Mail Code: NC1-026-06-04
Charlotte, North Carolina 28255
Attention:     
Telephone:     
Facsimile:     
E-Mail:     

Account No. (for Dollars):
Reference: Danaher Corp.
ABA Number:    026009593

Account No. (for Euro):
Reference: Danaher Corp.
Swift Code: BOFAGB22


Account No. (for Sterling):
Reference: Danaher Corp.
Swift Code: BOFAGB22


Account No. (for Yen):
Reference: Danaher Corp.
Swift Code: BOFAJPJX

Other Notices as Administrative Agent:
Bank of America, N.A.
Agency Management
555 California Street, 4
th Floor
Mail Code: CA5-705-04-09
San Francisco, California 94104
Attention:     
Telephone:     
Facsimile:     
E-Mail:     

121841766_2






SWING LINE LENDERS:
Bank of America, N.A.
900 W. Trade Street
Mail Code: NC1-026-06-04
Charlotte, North Carolina 28255
Attention:     
Telephone:     
Facsimile:     
E-Mail:     

Account No.:
Reference: Danaher Corp.
ABA No.: 026009593

Citibank, N.A.
Name: Loan Administration
Address: CITIBANK NA
1615 Brett Road, Building III
New Castle, DE 19720
Telephone:
Fax:
E-mail Address:

ABA #021000089
Account #
Account Name:  SSB
Reference:  Danaher Corporation
Wells Fargo Bank, National Association
711 Plantation Road
Roanoke, Virginia 24019
Attention:
Telephone:
Facsimile:
Email:

ABA #121000248

121841766_2




Account No.:
Account Name: Roanoke In/Out Wire Account
Attention: MCTNA


SWING LINE LENDERS (for Swing Line Loans in Euros on non-Business Day in U.S.):

Bank of America, N.A., London Branch

Team:

E-Mail:     
Telephone:    
Facsimile:    

E-Mail:     
Telephone:    
Facsimile:    

E-Mail:     
Telephone:    
Facsimile:    

E-Mail:     
Telephone:    
Facsimile:    






121841766_2

EX-10.12 4 dhr-2019927xexx1012.htm AMENDED AND RESTATED DANAHER CORPORATION DEFERRED COMPENSATION PLAN Exhibit
EXHIBIT 10.12

 
DANAHER DEFERRED COMPENSATION PLAN
EFFECTIVE JANUARY 1, 2019






TABLE OF CONTENTS
 
 
ARTICLE I DEFINITIONS
3

ARTICLE II PARTICIPATION
5

ARTICLE III CREDITING OF ACCOUNTS
6

ARTICLE IV VESTING OF ACCOUNTS
8

ARTICLE V DISTRIBUTION OF BENEFITS
9

ARTICLE VI CLAIMS AND ADMINISTRATION
12

ARTICLE VII STATUS OF PLAN
14

ARTICLE VIII PLAN AMENDMENT OR TERMINATION
15

ARTICLE IX MISCELLANEOUS
16
























1


DANAHER DEFERRED COMPENSATION PLAN
WHEREAS, Danaher Corporation sponsors the Danaher Corporation & Subsidiaries Executive Deferred Incentive Program which allowed a select group of management and highly compensated employees of Danaher Corporation and its subsidiaries an opportunity to defer compensation before January 1, 2019; and
WHEREAS, as of January 1, 2019, this Danaher Deferred Compensation Plan (the “Plan”) is established to allow a select group of management and highly compensated employees of Danaher Corporation and its subsidiaries to defer salary and annual incentive compensation.
NOW, THEREFORE, in order to accomplish such purpose, the Plan Sponsor has adopted, by appropriate resolutions, this Plan effective as of January 1, 2019. It is intended that this Plan shall be unfunded for purposes of the Code and shall constitute an unfunded pension plan maintained for a select group of management and highly compensated employees for purposes of Title I of ERISA, and shall comply with Code section 409A and all formal regulations, rulings, and guidance issued thereunder.
























2


ARTICLE I
DEFINITIONS
As used in this Plan, each of the following terms shall have the respective meaning set forth below unless a different meaning is plainly required by the content.
1.1    Account. The total amount held in a bookkeeping account under the Plan for a Participant, consisting of his or her Deferral Account(s).
1.2    Administrator. The individual or committee appointed by the Plan Sponsor to administer the Plan.
1.3    Beneficiary. An individual or entity entitled to receive any benefits under this Plan that are payable upon a Participant's death.
1.4    Bonus. With respect to a Participant for a Plan Year, the amount for the Plan Year that shall be determined to have been earned by the Participant in accordance with the Employer's annual cash incentive program.
1.5    Bonus Deferral Amount. With respect to a Participant for a Plan Year, an amount of the Participant's Bonus for the applicable Plan Year that the Participant has elected to defer pursuant to Section 3.1.
1.6    Code. The Internal Revenue Code of 1986, as it may be amended from time to time.
1.7    Common Stock. The common stock of the Plan Sponsor.
1.8    Common Stock Price. With respect to a specified date as of which the price of shares of Common Stock shall be determined, the closing sale price on that date or, if the given date is not a trading day, the closing sale price for the immediately preceding trading day.
1.9    Deferral Account. A bookkeeping account established under Section 5.1 to which a Participant’s Salary Deferral Amounts and Bonus Deferral Amounts are allocated. Each Participant’s Account shall contain one (1) Deferral Account for each Plan Year with respect to which the Participant deferred Salary Deferral Amounts or Bonus Amounts.
1.10    Earnings Crediting Rate. With respect to a Participant, the rate at which nominal earnings shall be credited to, or nominal losses shall be deducted from, all or a designated portion of the Participant's Account, as determined pursuant to Section 3.2 of the Plan.
1.11    Effective Date. January 1, 2019.
1.12    Eligible Employee. An Employee who, pursuant to a determination made by the Administrator, in its sole discretion, prior to the first day of an applicable Plan Year, is an Eligible Employee with respect to such Plan Year. The Administrator may, in its sole discretion, designate any newly hired Employee as an Eligible Employee under the Plan, but only to the extent the Administrator determines such newly hired Employee belongs in a select group of management or highly compensated employees within the meaning of ERISA sections 201(2), 301(a)(3) and 401(a)(1). Notwithstanding the foregoing, an active participant in the Danaher Corporation & Subsidiaries Executive Deferred Incentive Program shall not be an Eligible Employee.
1.13    Employee. An Employee is an employee who performs services for an Employer.
1.14    Employer. (a) The Plan Sponsor or (b) an employer that is a member of the Plan Sponsor's "controlled group of corporations, trades, or businesses," as such term shall be defined in Code Sections 414(b) and 414(c), and that has adopted this Plan with the approval of the Plan Sponsor.
1.15    Employment Termination Date. With respect to a Participant, the date that the Participant separates from service with all Employers, whether by death, retirement, or other termination of employment, in a manner consistent with the definition in Treasury Regulation section 1.409A-1(h).
1.16    ERISA. The Employee Retirement Income Security Act of 1974, as it may be amended from time to time.
1.17    Participant. An Eligible Employee or former Eligible Employee who is participating in this Plan pursuant to Article II.
1.18    Participation Date. With respect to an Eligible Employee, the date (if any) as of which the Eligible Employee shall initially become a Participant as determined pursuant to Section 2.1.

3


1.19    Payroll Period. With respect to an Eligible Employee, a period with respect to which the Eligible Employee receives a pay check or otherwise is paid for services that he or she performs during the period for an Employer.
1.20    Plan. The Danaher Deferred Compensation Plan, as it is set forth herein and as it may be amended from time to time.
1.21    Plan Sponsor. Danaher Corporation.
1.22    Plan Year. The calendar year.
1.23    Salary. With respect to a Participant for a Payroll Period, the total cash compensation (if any) that is payable to the Participant by any Employer during the Payroll Period and that would be reportable on the Participant's federal income tax withholding statement (Form W-2) or would be reportable but such amount is not includible in the gross income of the Participant under Code Sections 125, 132(f)(4), or 402(e)(3), including but not limited to salary and overtime pay, plus remuneration as defined in Code Section 3401(a)(8)(A) to the extent not otherwise reported on the Participant's Form W-2 (excluding housing, COLA, tax equalization, hardship and special allowances); but excluding amounts attributable to Bonuses, hiring bonuses, long-term incentive awards, equity awards, exercised stock options, severance benefits or other variable compensation.
1.24    Salary Deferral Amount. With respect to a Participant for a Plan Year, an amount of the Participant's Salary for a Payroll Period during the Plan Year that the Participant has elected to defer pursuant to Section 3.1.
1.25    Valuation Date. The monthly or other periodic date selected by the Administrator to value Participants’ Accounts.
1.26    Year of Service. With respect to a Participant, a Year of Service has the same meaning as defined in the Danaher Corporation & Subsidiaries Savings Plan, as it may be amended from time to time.





















4


ARTICLE II
PARTICIPATION
2.1    Commencement of Participation. An Eligible Employee shall become a Participant as of the date that is the first (1st) day of a month and that coincides with or follows the later of January 1, 2019, or the date that the individual became an Eligible Employee.
2.2    Termination of Participation. A Participant who ceases being an Employee or an Eligible Employee shall cease being a Participant as of the earlier of the Participant’s date of death or the date as of which the Participant’s vested portion of his or her Account (as determined subsequent to any crediting of his or her Account under the Plan) equals zero (0).




























5


ARTICLE III
CREDITING OF ACCOUNTS
3.1    Deferral Accounts.
(a)Election to Defer. Subject to this Section 3.1:
(i)Bonus Deferral Amounts. A Participant who is an Eligible Employee may elect to have a percentage of his or her Bonus for a Plan Year deferred as a Bonus Deferral Amount for the applicable Plan Year; provided that the actual amount deferred shall not exceed eighty-five percent (85%) of such Bonus for the Plan Year.
(ii)Salary Deferral Amounts. A Participant who is an Eligible Employee may elect to have an amount of his or her Salary for each Payroll Period in a Plan Year deferred as a Salary Deferral Amount. A Participant may only elect to have deferred as a Salary Deferral Amount a whole percentage not to exceed eighty-five percent (85%) of such Salary for a Payroll Period.
(b)Election Procedures. Subject to any further procedures established by the Administrator pursuant to Article V, any election made by a Participant pursuant to Subsection (a) above shall be subject to the procedures described in Paragraphs (i) through (iv) below:
(i)Initial Opportunity to Defer.
(A)Bonus Deferral Amounts. A Participant may, in the Administrator’s sole discretion, elect to have a Bonus Deferral Amount deferred on his or her behalf with respect to the Participant's Bonus for the Plan Year in which the Participant's Participation Date occurs by so indicating on the enrollment form provided by the Administrator, which shall be consistent with the requirements of Treasury Regulation section 1.409A-2(a)(7).
(B)Salary Deferral Amounts. A Participant may, in the Administrator’s sole discretion, elect to have Salary Deferral Amounts deferred on his or her behalf with respect to the Participant's Salary for the Plan Year in which the Participant's Participation Date occurs by so indicating on the enrollment form provided by the Administrator, which shall be consistent with the requirements of Treasury Regulation section 1.409A-2(a)(7). Such election shall be effective for Payroll Periods during such Plan Year or the remainder of such Plan Year, as applicable, beginning as soon as administratively possible on or after the latest of (I) the Participant's Participation Date, or (II) the date that the Participant files the properly completed enrollment form with the Administrator.
(ii)Annual Opportunities to Defer.
(A)Bonus Deferral Amounts. A Participant may elect to have a Bonus Deferral Amount deferred on his or her behalf with respect to the Participant's Bonus for a Plan Year by properly completing an election form provided by the Administrator and filing the form with the Administrator in accordance with the Administrator’s procedures prior to the first (1st) day of such Plan Year.
(B)Salary Deferral Amounts. A Participant may elect to have Salary Deferral Amounts deferred on his or her behalf with respect to the Participant's Salary for a Plan Year by properly completing an election form provided by the Administrator and filing the form with the Administrator in accordance with the Administrator’s procedures prior to the first (1st) day of such Plan Year.
(iii)No Revocations. A Participant may not, at any time, revoke a previous election with respect to a Bonus Deferral Amount or Salary Deferral Amounts.
(iv)Termination of Election. A Participant's election concerning a Bonus Deferral Amount or Salary Deferral Amounts shall terminate on the date as of which the last amount or the only amount, as applicable, designated to be withheld under such election shall be withheld. Notwithstanding the foregoing, a Participant’s election concerning a Bonus Deferral Amount or Salary Deferral Amounts shall terminate (i) upon the date an in-service distribution is made to the Participant of all or a part of his Account in the event that the Participant has an unforeseeable emergency pursuant to Section 5.3, or (ii) upon the date a hardship distribution is made to the Participant within the meaning of Treasury Regulation section 1.401(k)-1(d)(3). A Participant’s election concerning a Bonus Deferral Amount or Salary Deferral Amounts shall apply only with respect to Bonus Deferral Amount or Salary Deferral Amounts earned in the Plan Year designated on the enrollment form or election form provided by the Administrator and shall not apply to amounts earned in any other Plan Year.

6


(c)Crediting of Deferral Amounts. A Participant’s Salary Deferral Amounts and Bonus Deferral Amounts with respect to a Plan Year shall be credited to the Participant’s Deferral Account established for such Plan Year. Such Salary Deferral Amounts and Bonus Deferral Amounts shall be credited as soon as administratively practicable after the time such Salary Deferral Amounts and Bonus Deferral Amounts would have otherwise been paid to the Participant.
3.2    Crediting of Earnings.
(a)Elections. A Participant may elect the Earnings Crediting Rate that shall apply to all or a designated portion of the Participant’s Account from the investment options that the Administrator shall from time to time designate, in accordance with rules established by the Administrator. A Participant makes his or her initial election of the Earnings Crediting Rate(s) that shall apply to the Participant's Account by properly completing an investment option form and filing it with the Administrator. A Participant who has filed an investment option form with the Administrator may elect to change his or her investment election with respect to either the investment of future amounts credited to the Participant's Account and/or the investment of all or a designated portion of the current balance of the Participant's Account by so designating on a new investment option form and filing the form with the Administrator or, in accordance with procedures adopted by the Administrator, by so notifying the Administrator in any manner acceptable to the Administrator; provided, however, that a Participant may not change his or her investment election with respect to any portion of his or her Account deemed invested in notional shares of Common Stock and any such election of notional shares of Common Stock as an investment option shall be irrevocable and remain in effect until the Participant's Account is distributed pursuant to the terms of the Plan. Except as otherwise provided by the Administrator with respect to one (1) or more investment options, any initial investment election made pursuant to this Paragraph shall be effective as soon as administratively possible, and any subsequent investment election made pursuant to this Paragraph shall be effective as soon as administratively possible after the date that the Participant files the investment option form with the Administrator or otherwise notifies the Administrator of his or her election, and each investment election shall continue in effect until the effective date of a subsequent investment election properly made. Notwithstanding the foregoing, with respect to any Participant who is required to file reports with the Securities and Exchange Commission under Section 16 of the Securities Exchange Act of 1934, and the rules promulgated thereunder, if the Participant has elected notional shares of Common Stock as an investment option that shall apply to all or a portion of his or her Account, such investment option and Earnings Crediting Rate shall not become effective with respect to any amounts deferred until the earliest of the last Friday (or if such Friday is a New York Stock Exchange holiday, the immediately preceding day that is not a holiday or weekend day for purposes of the New York Stock Exchange) of the month of April, July, October, or January immediately following the date such amounts were deferred, and during the period from the date of deferral until such April, July, October, or January date, as applicable, the investment options and Earnings Crediting Rate that shall apply to such deferred amounts shall be the fixed income fund investment option, or such other investment option as the Administrator shall determine.
The Administrator shall adopt and may amend procedures to be followed by Participants in electing Earnings Crediting Rate(s) and, pursuant thereto, the Administrator may, among other actions, format investment option forms and establish deadlines for elections.
(b)No Election. The Administrator shall from time to time designate a fixed income fund or other investment option that shall be used to establish the Earnings Crediting Rate that shall apply to the Account of any Participant who has not made an investment option election.
(c)Earnings Credits. As of each Valuation Date, the Administrator shall determine the earnings credit applicable to the Account of each Participant since the prior Valuation Date.
(d)Accounting. The value of each Participant's Account will be adjusted as of each Valuation Date to reflect contributions, earnings, interest, gains, losses, distributions, and expenses experienced since the prior Valuation Date.








7


ARTICLE IV
VESTING OF ACCOUNTS
4.1    Vesting. A Participant's interest in his or her Account will be nonforfeitable.
































8


ARTICLE V
DISTRIBUTION OF BENEFITS
5.1    Establishment of Accounts.
A Deferral Account shall be established for a Participant for each Plan Year with respect to which the Participant completes an enrollment form or election form in accordance with Section 3.1. At such time, the Participant shall designate the time and form of payment of such Deferral Account from among the following available options:
(a)Timing. Subject to Section 5.1(d) below, the Participant shall designate the Deferral Account to be paid or commence payment upon one of the following payment events:
(i)Upon the Participant’s Employment Termination Date, with the payment commencing on the first day of the month following such date below as elected by the Participant:
(A) the Participant’s Employment Termination Date;
(B)the last day of the six (6) month period commencing on the Participant’s Employment Termination Date;
(C)the last day of the twelve (12) month period commencing on the Participant’s Employment Termination Date; or
(D)the last day of the twenty-four (24) month period commencing on the Participant’s Employment Termination Date.
(ii)Upon a fixed date not less than three (3) years following the year the Deferral Account is established.
Notwithstanding the foregoing, if the Participant designates his or her Deferral Account to be paid or commence payment upon a fixed date, and his or her Employment Termination Date occurs prior to such fixed date, the Deferral Account shall be paid upon the payment event designated by the Participant pursuant to subsection (i) above or, if the Participant has not made such a designation, upon the first day of the month following the Participant’s Employment Termination Date.
If the Administrator determines that the Participant has not properly designated a time of payment for a Deferral Account in accordance with the terms of this Section 5.1 or the procedures established by the Administrator, such Participant shall be deemed to have designated the Deferral Account to be payable upon the first day of the month following the Participant’s Employment Termination Date.
(b)Form. With respect to each payment event described in Section 5.1(a), the Participant may designate the Deferral Account to be paid upon such payment event as either:
(i)A lump sum; or
(ii)In annual installments over no more than ten (10) years.
If the Administrator determines that the Participant has not properly designated a form of payment for a Deferral Account in accordance with the terms of this Section 5.1 or the procedures established by the Administrator, such Participant shall be deemed to have designated the Deferral Account to be payable in a lump sum.
If a Deferral Account is to be distributed in installments, the first installment shall be made on the applicable date described in Section 5.1(a) (including any delay in payment pursuant to Section 5.1(d), if applicable), and each subsequent installment thereafter shall be made on the anniversary of the first installment until all installment payments of the amount have been paid to the Participant. The amount of each installment payment shall equal the quotient of (A) the total remaining balance in the Deferral Account as of the Valuation Date immediately prior to the date on which such installment payment is scheduled to be paid, divided by (B) the number of installment payments remaining in the applicable period of annual installments. The entitlement to a series of installment payments under this Plan shall be treated as the entitlement to a single payment, and each such installment payment shall not be considered a separate payment hereunder.

9


(c)Medium. Any portion of a Participant’s Deferral Account that is deemed invested in shares of Common Stock shall be paid in shares of Common Stock. Any portion of a Participant’s Deferral Account that is not deemed invested in shares of Common Stock shall be paid in cash.
(d)Special Payment Rule for Specified Employees. Notwithstanding the foregoing, distributions may not be made to a Specified Employee due to the Participant’s Employment Termination Date other than on account of death before the first day of the month following the last day of the six (6) month period commencing on the Participant’s Employment Termination Date, or, if earlier, the Participant’s date of death. Installment payments that would have commenced during the period of delay will commence as of the next monthly payment date following the period of delay.
For purposes of the Plan, “Specified Employee” shall mean an Employee who is a “key employee” as such term is defined in Code section 416(i) without regard to Code section 416(i)(5). For purposes of determining which Employees are key employees, an Employee is a key employee if the Employee meets the requirements of Code section 416(i)(A)(i), (ii) or (iii) (applied in accordance with the regulations thereunder and disregarding Code section 416(i)(5)) at any time during the 12-month period ending on an identification date (which shall be December 31st of each calendar year); provided, however, that all Employees who are nonresident aliens during the entire 12-month period ending with the relevant identification date shall be excluded in any such determination.
5.2    Distributions upon Death.
(a)Acceleration of Payment. Upon the death of a Participant, the Beneficiary or Beneficiaries of the deceased Participant shall receive the remaining unpaid portion of the Participant’s Account as a lump sum as soon as practicable following the Participant’s death, but no later than the last day of the first Plan Year following the Plan Year in which the Participant’s death occurred.
(b)Beneficiaries. The Administrator shall provide to each new Participant a form on which he or she may designate (i) one or more Beneficiaries who shall receive all or a portion of the Participant’s Account upon the Participant's death, including any Beneficiary who shall receive any such amount only in the event of the death of another Beneficiary; and (ii) the percentages to be paid to each such Beneficiary (if there is more than one). A Participant may change his or her or her Beneficiary designation from time to time by filing a new form with the Administrator. No such Beneficiary designation shall be effective unless and until the Participant has properly filed the completed form with the Administrator in accordance with procedures established by the Administrator. A Beneficiary designation form that designates the spouse of a Participant as his or her Beneficiary (whether or not any other Beneficiary is also designated) shall be void with respect to the designation of the spouse upon the divorce of the Participant and the spouse with the result that the Participant's former spouse shall not be a Beneficiary unless the Participant files a new form with the Administrator and designates his or her former spouse as a Beneficiary. If a deceased Participant is not survived by a designated Beneficiary or if no Beneficiary was effectively designated, the Participant's Beneficiary shall be deemed to be the Participant's spouse and, if there is no spouse, the Participant's estate. If a designated Beneficiary is living at the death of the Participant but dies before receiving any or all of the portion of the Account to which the Beneficiary was entitled, such remaining portion shall be paid in a lump sum to the estate of the deceased Beneficiary as soon as practicable following the Beneficiary’s death, but no later than the last day of the first Plan Year following the Plan Year in which the Beneficiary’s death occurred.
5.3    In-Service Distribution for Unforeseeable Emergency. The Administrator may, but shall not be required to, establish procedures under which an in-service distribution may be made to a Participant of all or a part of his Account in the event that the Participant has an unforeseeable emergency, as described in Subsection (a) below, and the distribution is reasonably needed to satisfy the unforeseeable emergency, as described in Subsection (b) below, and the distribution complies with Treasury Regulation section 1.409A-3(a)(6):
(a)Unforeseeable Emergency. With respect to a Participant, an unforeseeable emergency is severe financial hardship to the Participant resulting from a sudden and unexpected illness or accident of the Participant or of a "dependent" of the Participant, as such term shall be defined in Code Section 152(a); loss of the Participant's property due to casualty; or another similar extraordinary and unforeseeable set of circumstances arising as a result of events beyond the control of the Participant.
(b)Distribution Reasonably Necessary to Satisfy Emergency. A distribution shall be deemed to be reasonably necessary to satisfy a Participant's unforeseeable emergency if the following requirements are met and the distribution otherwise complies with Treasury Regulation section 1.409A-3(i)(3)(ii):
(i)The distribution does not exceed the amount of the Participant's financial need plus amounts necessary to pay any income taxes or penalties reasonably anticipated to result from the distribution;
(ii)The Participant's financial need cannot be relieved:

10


(A)Through reimbursement or compensation by insurance or otherwise,
(B)By liquidation of the Participant's assets, to the extent that such liquidation would not itself cause severe financial hardship, or
(C)By the termination of the Participant’s election (if any) with respect to a Bonus Deferral Amount or Salary Deferral Amounts.
5.4    Subsequent Changes in Time of Payment and Form of Distribution. A Participant may elect to delay a payment of a Deferral Account or to change the form of distribution of a Deferral Account provided that the following conditions are met:
(a)Any election under this Section 5.4 shall not take effect until a date that is at least twelve (12) months after the date on which the election is made.
(b)The payment with respect to which an election under this Section 5.4 is made shall be deferred for a period of not less than five (5) years from the date such payment would otherwise have been paid.
(c)Any election under this Section 5.4 shall be made on a date that is not less than twelve (12) months prior to the date the payment is originally scheduled to be made.
A Participant’s election under this Section 5.4 shall only apply to the Deferral Account(s) that are specifically identified by the Participant in the election. The election will apply to all payment events elected for the applicable Deferral Account(s), unless the election specifies otherwise.
5.5    Permitted Payment Delays. To the extent compliant with Code section 409A, payment of a Participant’s Account may be delayed to a date after the designated payment date under either of the following two circumstances:
(a)Where the Plan Sponsor reasonably anticipates that an Employer’s deduction with respect to the payment of an amount would otherwise be limited or eliminated by application of Code section 162(m); provided, however, that such payment shall be made to the Participant (i) during the Participant's first taxable year in which the Plan Sponsor reasonably anticipates that the deduction of such payment will not be limited or eliminated by the application of Code section 162(m), or, if later, (ii) during the period beginning with the Participant’s Employment Termination Date and ending on the later of (A) the last day of the taxable year of the Plan Sponsor in which the Participant's Employment Termination Date occurs or (B) the fifteenth (15th) day of the third month following the Participant's Employment Termination Date.
(b)Where the Plan Sponsor reasonably anticipates that the making of the payment of the amount will violate Federal Securities laws or other applicable law; provided, however, that such payment will be made to the Participant at the earliest date at which the Plan Sponsor reasonably anticipates that the making of such payment will not cause such violation.
5.6    Permitted Payment Accelerations. The Administrator may, in its sole discretion, accelerate the payment timing of all or a portion of a Participant’s Account to the extent permissible under Treasury Regulation section 1.409A-3(j)(4).












11


ARTICLE VI
CLAIMS AND ADMINISTRATION
6.1    Applications. A Participant or the Beneficiary of a deceased Participant who is or may be entitled to benefits under this Plan shall apply for such benefits in writing if and as required by the Administrator, in his or her sole discretion.
6.2    Information and Proof. A Participant or the Beneficiary of a deceased Participant shall furnish all information and proof required by the Administrator for the determination of any issue arising under the Plan including, but not limited to, proof of marriage to a Participant or a certified copy of the death certificate of a Participant. The failure by a Participant or the Beneficiary of a deceased Participant to furnish such information or proof promptly and in good faith, or the furnishing of false or fraudulent information or proof by the Participant or Beneficiary, shall be sufficient reason for the denial, suspension, or discontinuance of benefits thereto and the recovery of any benefits paid in reliance thereon.
6.3    Notice of Address Change. Each Participant and any Beneficiary of a deceased Participant who is or may be entitled to benefits under this Plan shall notify the Administrator in writing of any change of his or her address.
6.4    Claims Procedure.
(a)Claim Denial. The Administrator shall provide adequate notice in writing to any Participant or Beneficiary of a deceased Participant whose application for benefits has been wholly or partially denied. Such notice shall include the reason(s) for denial, including references, when appropriate, to specific Plan provisions; a description of any additional information necessary for the claimant to perfect the claim, if applicable and an explanation of why such information is necessary; and a description of the claimant's right to appeal under Subsection (b) below.
The Administrator shall furnish such notice of a claim denial within ninety (90) days after the date that the Administrator received the claim. If special circumstances require an extension of time for deciding a claim, the Administrator shall notify the claimant in writing thereof within such ninety (90)-day period and shall specify the date a decision on the claim shall be made, which shall not be more than one hundred eighty (180) days after the date that the Administrator received the claim. Then, the Administrator shall furnish any denial notice on the claim by the later date so specified.
(b)Appeal Procedure. A claimant or his or her duly authorized representative shall have the right to file a written request for review of a claim denial within sixty (60) days after receipt of the denial, to review pertinent documents, records and other information relevant to his or her claim without charge (including items used in the determination, even if not relied upon in making the final determination and items demonstrating consistent application and compliance with this Plan's administrative processes and safeguards), and to submit comments, documents, records, and other information relating to the claim, even if the information was not submitted or considered in the initial determination.
(c)Decision Upon Appeal. In considering an appeal made in accordance with Subsection (b) above, the Administrator shall review and consider any written comments, documents, records, and other information relating to the claim, even if the information was not submitted or considered in the initial determination by the claimant or his or her duly authorized representative. The claimant or his or her representative shall not be entitled to appear in person before any representative of the Administrator.
The Administrator shall issue a written decision on an appeal within sixty (60) days after the date the Administrator receives the appeal together with any written comments relating thereto. If special circumstances require an extension of time for a decision on an appeal, the Administrator shall notify the claimant in writing thereof within such sixty (60)-day period. Then, the Administrator shall furnish a written decision on the appeal as soon as possible but no later than one hundred twenty (120) days after the date that the Administrator received the appeal. The decision on the appeal shall be written in a manner calculated to be understood by the claimant and shall include specific references to the pertinent Plan provisions on which the decision is based. If the claimant loses on appeal, the decision shall include the following information provided in a manner calculated to be understood by the claimant: (1) the specific reason(s) for the adverse determination; (2) reference to the specific Plan provisions on which the determination is based; (3) a statement of the claimant's right to receive at no cost information and copies of documents relevant to the claim, even if such information was not relied upon in making determinations; and (4) a statement of the claimant's rights to sue under ERISA.
6.5    Status, Responsibilities, Authority and Immunity of Administrator.
(a)Appointment and Status of Administrator. The Plan Sponsor shall appoint the Administrator. The Plan Sponsor may remove the Administrator and appoint another Administrator or, if the Administrator is a committee, the Plan Sponsor

12


may remove any or all members of the committee and appoint new members. The Administrator shall be the "administrator" of the Plan, as such term shall be defined in Section 3(16)(A) of ERISA.
(b)Responsibilities and Discretionary Authority. The Administrator shall have absolute and exclusive discretion to manage the Plan and to determine all issues and questions arising in the administration, interpretation, and application of the Plan, including, but not limited to, issues and questions relating to a Participant's eligibility for Plan benefits and to the nature, amount, conditions, and duration of any Plan benefits. Furthermore, the Administrator shall have absolute and exclusive discretion to formulate and to adopt any and all standards for use in calculations required in connection with the Plan and rules, regulations, and procedures that he or she deems necessary or desirable to effectuate the terms of the Plan; provided, however, that the Administrator shall not adopt a rule, regulation, or procedure that shall conflict with this Plan. Subject to the terms of any applicable contract or agreement, any interpretation or application of this Plan by the Administrator, or any rules, regulations, and procedures duly adopted by the Administrator, shall be final and binding upon Employees, Participants, Beneficiaries, and any and all other persons dealing with the Plan.
(c)Delegation of Authority and Reliance on Agents. The Administrator may, in his or her discretion, allocate ministerial duties and responsibilities for the operation and administration of the Plan to one or more persons, who may or may not be Employees, and employ or retain one or more persons, including accountants and attorneys, to render advice with regard to any responsibility of the Administrator.
(d)Reliance on Documents. The Administrator shall incur no liability in relying or in acting upon any instrument, application, notice, request, letter, or other paper or document believed by the Administrator to be genuine, to contain a true statement of facts, and to have been executed or sent by the proper person.
(e)Immunity and Indemnification of Administrator. The Administrator shall not be liable for any of his or her acts or omissions, or the acts or omissions of any employee or agent authorized or retained pursuant to Subsection (c) above by the Administrator, except any act of the Administrator or any such person as constitutes gross negligence or willful misconduct. The Plan Sponsor shall indemnify the Administrator, to the fullest extent permitted by law, if the Administrator is ever made a party or is threatened to be made a party to any threatened, pending, or completed action, suit, claim, or proceeding, whether civil, criminal, administrative, or investigative (including, but not limited to, any action by or in the right of the Plan Sponsor), by reason of the fact that the Administrator is or was, or relating to the Administrator's actions as, the Administrator, against any expenses (including attorneys' fees), judgments, fines, and amounts paid in settlement that the Administrator incurs as a result of, or in connection with, such action, suit, claim, or proceeding, provided that the Administrator had no reasonable cause to believe that his or her conduct was unlawful.
6.6    Enrollment, Deferral Election and Other Procedures. The Administrator shall adopt and may amend procedures to be followed by Eligible Employees and Participants in electing to participate in this Plan, in electing to have Bonus Deferral Amounts and Salary Deferral Amounts made on their behalf, in selecting a form of distribution of any amount, and in taking any other actions required thereby under this Plan.
6.7    Correction of Prior Incorrect Allocations. Notwithstanding any other provisions of this Plan, in the event that an adjustment to a Deferral Account shall be required to correct an incorrect allocation to such account, the Administrator shall take such actions as he or she deems, in his or her sole discretion, to be necessary or desirable to correct such prior incorrect allocation.
6.8    Facility of Payment. If the Administrator shall determine that a Participant or the Beneficiary of a deceased Participant to whom a benefit is payable is unable to care for his or her affairs because of illness, accident or other incapacity, the Administrator may, in his or her discretion, direct that any payment otherwise due to the Participant or Beneficiary be paid to the legal guardian or other representative of the Participant or Beneficiary. Furthermore, the Administrator may, in his or her discretion, direct that any payment otherwise due to a minor Participant or Beneficiary of a deceased Participant be paid to the guardian of the minor or the person having custody of the minor. Any payment made in accordance with this Section 6.8 to a person other than a Participant or the Beneficiary of a deceased Participant shall, to the extent thereof, be a complete discharge of the Plan's obligation to the Participant or Beneficiary.
6.9    Unclaimed Benefits. If the Administrator cannot locate a Participant or the Beneficiary of a deceased Participant to whom payment of benefits under this Plan shall be required, following a diligent effort by the Administrator to locate the Participant or Beneficiary, such benefit shall be forfeited.



13


ARTICLE VII
STATUS OF PLAN
7.1    Unfunded Status of Plan. The Plan constitutes a mere promise by the Plan Sponsor to pay benefits in accordance with the terms of the Plan, and, to the extent that any person acquires a right to receive benefits from the Plan Sponsor under this Plan, such right shall be no greater than any right of any unsecured general creditor of the Plan Sponsor. Nothing contained in this Plan and no action taken pursuant to the provisions of this Plan shall create or be construed so as to create a trust of any kind, or a fiduciary relationship between the Plan Sponsor and any Participant, Beneficiary, or other person.
7.2    Shares to be Issued. Subject to adjustment as provided in this Section 7.2, the aggregate number of shares of Common Stock that may be issued to satisfy the obligations under the Plan shall be 2,000,000 shares. The Common Stock may come from treasury shares, authorized but unissued shares, or previously issued shares that the Plan Sponsor reacquires, including shares it purchases on the open market.
Subject to any required action by the Plan Sponsor (which it shall promptly take) or its stockholders, and subject to the provisions of applicable corporate law, if the outstanding shares of Common Stock increase or decrease or change into or are exchanged for a different number or kind of security by reason of any recapitalization, reclassification, stock split, reverse stock split, combination of shares, exchange of shares, stock dividend, or other distribution payable in capital stock, or some other increase or decrease in the Common Stock occurs without the Plan Sponsor’s receiving consideration, the Administrator shall make an equitable adjustment as the Administrator in its sole discretion deems to be appropriate to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan to the aggregate number of shares of Common Stock that may be issued to satisfy obligations under the Plan, number and kind of shares of Common Stock credited to each Participant’s Account under the Plan, and the Common Stock Price.
In the event of a declaration of an extraordinary dividend on the Common Stock payable in a form other than Common Stock in an amount that has a material effect on the price of the Common Stock, the Administrator shall make an equitable adjustment as the Administrator in its sole discretion deems to be appropriate to the items set forth in the preceding paragraph in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan.
Any issue by the Plan Sponsor of any class of preferred stock, or securities convertible into shares of common or preferred stock of any class, will not affect, and no adjustment by reason thereof will be made with respect to, the number of shares of Common Stock credited to each Participant’s Account under the Plan, or the Common Stock Price, except as this Section 7.2 specifically provides. The crediting of a share of Common Stock under the Plan will not affect in any way the right or power of the Plan Sponsor to make adjustments, reclassifications, reorganizations or changes of its capital or business structure, or to merge or to consolidate, or to dissolve, liquidate, sell, or transfer all or any part of its business or assets.















14


ARTCILE VIII
PLAN AMENDMENT OR TERMINATION
8.1    Right to Amend. The Plan Sponsor reserves the right to amend the Plan, by action duly taken by its Board of Directors, at any time and from time to time to any extent that the Plan Sponsor may deem advisable, and any such amendment shall take the form of an instrument in writing duly executed by one or more individuals duly authorized by the Board of Directors. Without limiting the generality of the foregoing, the Plan Sponsor specifically reserves the right to amend the Plan retroactively as may be deemed necessary. Notwithstanding the foregoing sentences, the Plan Sponsor shall not amend the Plan so as to reduce the balance in the Account of any Participant, or to reduce any Participant’s vested interest in his or her Account, in either case as of the date that such an amendment would otherwise be effective; unless any such amendment shall be reasonably required to comply with applicable law or to preserve the tax treatment of benefits provided under the Plan or is consented to by the affected Participant.
8.2    Right to Terminate. The Plan Sponsor reserves the right to terminate the Plan, by action duly taken by its Board of Directors, at any time as the Plan Sponsor may deem advisable. Upon termination of the Plan, the Plan Sponsor shall pay or provide for the payment of all liabilities with respect to Participants and Beneficiaries of deceased Participants by distributing amounts to and on behalf of such Participants and Beneficiaries. Notwithstanding the foregoing, the termination of the Plan shall not accelerate the time and form of payment of any amount except when the Plan Sponsor elects to terminate the Plan in accordance with one of the following:
(a)The Plan Sponsor elects to terminate the Plan within twelve (12) months of a corporate dissolution taxed under Code section 331 or with the approval of a bankruptcy court pursuant to 11 U.S.C. §503(b)(1)(A), provided that the amounts are included in Participants’ gross incomes in the latest of (a) the calendar year in which the Plan termination occurs, (b) the calendar year in which the amount is no longer subject to a substantial risk of forfeiture, or (c) the first calendar year in which the payment of the amount is administratively practical.
(b)The Plan Sponsor elects to terminate the Plan under the following conditions: (i) the Employer terminates all arrangements sponsored by the Employer that would be aggregated with any terminated arrangements under the regulations promulgated under Code section 409A if the same Participant had deferrals of compensation under all such terminated arrangements; (ii) no payments (other than payments that would be payable under the terms of the arrangements if the termination had not occurred) are made within twelve (12) months of the termination of the arrangements; (iii) all payments are made within twenty-four (24) months of the termination of the arrangements; and (iv) no Employer adopts a new arrangement that would be aggregated with any terminated arrangement under the regulations promulgated under Code section 409A if the same Participant participated in both arrangements, at any time within five (5) years following the date of termination of the Plan.
(c)The Plan Sponsor elects to terminate the Plan in accordance with any such other events and conditions that the Commissioner of the Internal Revenue Service may prescribe in generally applicable guidance published in the Internal Revenue Bulletin.













15


ARTICLE IX
MISCELLANEOUS
9.1    No Guarantee of Employment. Nothing contained in this Plan shall be construed as a contract of employment between any Employee and the Plan Sponsor or any Employer, as a right of any Employee to be continued in any employment position with, or the employment of, the Plan Sponsor or any Employer, or as a limitation of the right of the Plan Sponsor or any Employer to discharge any Employee.
9.2    Nonalienation of Benefits. Any benefits or rights to benefits payable under this Plan shall not be subject in any manner to anticipation, alienation, sale, transfer, assignment, pledge, encumbrance, charge, garnishment, execution, or levy of any kind, either voluntary or involuntary, including any such liability that is for alimony or other payments for the support of a Beneficiary or former Beneficiary, or for the support of any other relative, before payment thereof is received by the Participant, Beneficiary of a deceased Participant, or other person entitled to the benefit under the Plan; and any attempt to anticipate, alienate, sell, transfer, assign, pledge, encumber, charge, or otherwise dispose of any right to benefits payable under this Plan shall be void.
9.3    Taxes. Neither the Plan Sponsor nor any Employer represents or guarantees that any particular federal, state, or local income, payroll, personal property or other tax consequence will result from participation in this Plan or payment of benefits under this Plan. Notwithstanding anything in this Plan to the contrary, the Administrator may, in his or her sole discretion, deduct and withhold applicable taxes from any payment of benefits under this Plan. For the avoidance of doubt, each Participant and Beneficiary shall be responsible for any and all taxes, interest, and penalties. The Administrator also may permit such obligations to be satisfied by the transfer to the Plan Sponsor or any Employer of cash, shares of Common Stock, or other property.
9.4    Not Compensation Under Other Benefit Plans. No amounts in a Participant's Account shall be deemed to be salary or compensation for purposes of the Danaher Corporation & Subsidiaries Savings Plan or any other employee benefit plan of the Plan Sponsor or any Employer except as and to the extent otherwise specifically provided in any such plan.
9.5    Merger or Consolidation of Plan Sponsor. If the Plan Sponsor is merged or consolidated with another organization, or another organization acquires all or substantially all of the Plan Sponsor's assets, such organization may become the "Plan Sponsor" hereunder by action of its board of directors and by action of the board of directors of the Plan Sponsor if still existent. Such change in plan sponsors shall not be deemed to be a termination of this Plan.
9.6    Savings Clause. If any term, covenant, or condition of this Plan, or the application thereof to any person or circumstance, shall to any extent be held to be invalid or unenforceable, the remainder of this Plan, or the application of any such term, covenant, or condition to persons or circumstances other than those as to which it has been held to be invalid or unenforceable, shall not be affected thereby, and, except to the extent of any such invalidity or unenforceability, this Plan and each term, covenant, and condition hereof shall be valid and shall be enforced to the fullest extent permitted by law.
9.7    Governing Law. This Plan shall be construed, regulated and administered under the laws of the State of Delaware to the extent not pre-empted by ERISA or any other federal law.
9.8    Construction. As used in this Plan, the masculine and feminine gender shall be deemed to include the neuter gender, as appropriate, and the singular or plural number shall be deemed to include the other, as appropriate, unless the context clearly indicates to the contrary.
9.9    Headings No Part of Agreement. Headings of articles, sections and subsections of this Plan are inserted for convenience of reference; they constitute no part of the Plan and are not to be considered in the construction of the Plan.
 



16
EX-10.13 5 dhr-2019927xexx1013.htm AMENDMENT TO DANAHER CORPORATION DEFERRED COMPENSATION PLAN Exhibit
Exhibit 10.13

AMENDMENT
TO
DANAHER DEFERRED COMPENSATION PLAN

This is an Amendment to the Danaher Deferred Compensation Plan, which was adopted effective January 1, 2019 (the "Plan"). Under Section 8.1 of the Plan, Danaher Corporation (the "Plan Sponsor") has reserved unto itself the right to amend the Plan. Accordingly, pursuant to Section 8.1, the Plan Sponsor hereby amends the Plan in the following particulars, to be effective January 1, 2020:

1.
Add a new Appendix A to read as follows:

APPENDIX A
TRANSFER OF LIABILITIES TO
ENVISTA DEFERRED COMPENSATION PLAN

At a future date, certain Employers, including Envista Holdings Corporation and its subsidiaries (“Envista”), are intended to separate from the Danaher Corporation controlled group. In anticipation of such event, the Plan liabilities and benefits related to those Participants who are employed by Envista (“Envista Participants”), will be transferred to the Envista Deferred Compensation Plan (“Envista DCP”), effective as of January 1, 2020. After the transfer of the Plan liabilities to the Envista DCP on January 1, 2020, the Plan Sponsor, the Plan, any directors, officers, or employees of the Plan Sponsor, and any successors thereto, shall have no further obligation or liability to any such individual with respect to any benefit, amount, or right due under the Plan.

On and after the transfer of the Plan liabilities to the Envista DCP on January 1, 2020, the Employers that are intended to separate from the Danaher Corporation controlled group shall cease to participate in the Plan.

On and after the transfer of the Plan liabilities to the Envista DCP on January 1, 2020, Envista Participants shall cease participation in the Plan, but shall participate in the Envista DCP in accordance with the terms therein; provided, that any irrevocable deferral election for 2019 in effect under the Plan for an Envista Participant at the time of such transfer will remain in effect under the Envista DCP with respect to 2019 compensation, and provided further that any distribution election applicable to the Plan benefit of an Envista Participant immediately before the transfer will continue to apply to the liabilities and benefits transferred to the Envista DCP, in accordance with the terms therein.
2.
All other parts of the Plan not inconsistent herewith are hereby ratified and confirmed.




EX-10.14 6 dhr-2019927xexx1014.htm AMENDMENT TO DANAHER CORPORATION EXECUTIVE DEFERRED INCENTIVE PROGRAM Exhibit
Exhibit 10.14

AMENDMENT
TO
DANAHER CORPORATION & SUBSIDIARIES
EXECUTIVE DEFERRED INCENTIVE PROGRAM
This is an Amendment to the Danaher Corporation & Subsidiaries Executive Deferred Incentive Program, which was amended and restated effective January 1, 2019 (the "Plan"). Under Section 7.1 of the Plan, Danaher Corporation (the "Plan Sponsor") has reserved unto itself the right to amend the Plan. Accordingly, pursuant to Section 7.1, the Plan Sponsor hereby amends the Plan in the following particulars to be effective January 1, 2020:

1.
Add a new Appendix D to read as follows:

APPENDIX D
TRANSFER OF LIABILITIES TO
ENVISTA EXECUTIVE DEFERRED INCENTIVE PROGRAM AS ESTABLISHED AS A SUB-PLAN UNDER THE ENVISTA 2019 OMNIBUS INCENTIVE PLAN

At a future date, certain Employers, including Envista Holdings Corporation and its subsidiaries (“Envista”), are intended to separate from the Danaher Corporation controlled group. In anticipation of such event, the Plan liabilities and benefits related to those Participants who are employed by Envista (“Envista Participants”), including amounts not subject to Code Section 409A (i.e., amounts deferred and vested prior to January 1, 2005, and earnings related thereto), will be transferred to the Envista Executive Deferred Incentive Program as Established as a Sub-Plan Under the Envista 2019 Omnibus Incentive Plan (“Envista EDIP”), effective as of January 1, 2020. After the transfer of the Plan liabilities to the Envista EDIP on January 1, 2020, the Plan Sponsor, the Plan, any directors, officers, or employees of the Plan Sponsor, and any successors thereto, shall have no further obligation or liability to any such individual with respect to any benefit, amount, or right due under the Plan.

On and after the transfer of the Plan liabilities to the Envista EDIP on January 1, 2020, the Employers that are intended to separate from the Danaher Corporation controlled group shall cease to participate in the Plan.

On and after the transfer of the Plan liabilities to the Envista EDIP on January 1, 2020, Envista Participants shall cease participation in the Plan, but shall participate in the Envista EDIP in accordance with the terms therein; provided, that any distribution election applicable to the Plan benefit of an Envista Participant immediately before the transfer will continue to apply to the liabilities and benefits transferred to the Envista EDIP, in accordance with the terms therein.

2.
All other parts of the Plan not inconsistent herewith are hereby ratified and confirmed.





EX-10.15 7 dhr-2019927xexx1015.htm AMENDMENT TO DANAHER CORPORATION EXCESS CONTRIBUTION PROGRAM Exhibit
Exhibit 10.15

AMENDMENT
TO
DANAHER EXCESS CONTRIBUTION PROGRAM
AS ESTABLISHED AS A SUB-PLAN UNDER THE
DANAHER CORPORATION 2007 OMNIBUS INCENTIVE PLAN,
AS AMENDED AND RESTATED

This is an Amendment to the Danaher Excess Contribution Program as Established as a Sub-Plan Under the Danaher Corporation 2007 Omnibus Incentive Plan, as Amended and Restated, which was amended and restated effective January 1, 2019 (the "Program"). Under Section 8.1 of the Program, Danaher Corporation (the "Program Sponsor") has reserved unto itself the right to amend the Program. Accordingly, pursuant to Section 8.1, the Program Sponsor hereby amends the Program in the following particulars, to be effective January 1, 2020:

1.
Add a new Appendix A to read as follows:

APPENDIX A
TRANSFER OF LIABILITIES TO
ENVISTA EXCESS CONTRIBUTION PROGRAM AS ESTABLISHED AS A SUB-PLAN UNDER THE ENVISTA 2019 OMNIBUS INCENTIVE PLAN

At a future date, certain Employers, including Envista Holdings Corporation and its subsidiaries (“Envista”), are intended to separate from the Danaher Corporation controlled group. In anticipation of such event, the Program liabilities and benefits related to those Participants who will be employed by Envista (“Envista Participants”), will be transferred to the Envista Excess Contribution Program as Established as a Sub-Plan Under the Envista 2019 Omnibus Incentive Plan (“Envista ECP”), effective as of January 1, 2020. After the transfer of the Program liabilities to the Envista ECP on January 1, 2020, the Program Sponsor, the Program, any directors, officers, or employees of the Program Sponsor, and any successors thereto, shall have no further obligation or liability to any such individual with respect to any benefit, amount, or right due under the Program.

On and after the transfer of the Program liabilities to the Envista ECP on January 1, 2020, the Employers that are intended to separate from the Danaher Corporation controlled group shall cease to participate in the Program.

On and after the transfer of the Program liabilities to the Envista ECP on January 1, 2020, Envista Participants shall cease participation in the Program, but shall participate in the Envista ECP in accordance with the terms therein.

2.
All other parts of the Program not inconsistent herewith are hereby ratified and confirmed.




EX-31.1 8 dhr-2019927xexx311.htm CERTIFICATION OF CEO PURSUANT TO SECTION 302 Exhibit
Exhibit 31.1

Certification

I, Thomas P. Joyce, Jr., certify that:
1.
I have reviewed this Quarterly Report on Form 10-Q of Danaher Corporation;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.
disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a.
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:
October 23, 2019
By:
/s/ Thomas P. Joyce, Jr.
 
 
 
Thomas P. Joyce, Jr.
 
 
 
President and Chief Executive Officer


EX-31.2 9 dhr-2019927xexx312.htm CERTIFICATION OF CFO PURSUANT TO SECTION 302 Exhibit
Exhibit 31.2

Certification

I, Matthew R. McGrew, certify that:
1.
I have reviewed this Quarterly Report on Form 10-Q of Danaher Corporation;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.
disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a.
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
Date:
October 23, 2019
By:
/s/ Matthew R. McGrew
 
 
 
Matthew R. McGrew
 
 
 
Executive Vice President and Chief Financial Officer



EX-32.1 10 dhr-2019927xexx321.htm CERTIFICATION OF CEO PURSUANT TO SECTION 906 Exhibit
Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Thomas P. Joyce, Jr., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge, Danaher Corporation’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 27, 2019 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Danaher Corporation.
 
Date:
October 23, 2019
By:
/s/ Thomas P. Joyce, Jr.
 
 
 
Thomas P. Joyce, Jr.
 
 
 
President and Chief Executive Officer

This certification accompanies the Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section. This certification shall not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that Danaher Corporation specifically incorporates it by reference.




EX-32.2 11 dhr-2019927xexx322.htm CERTIFICATION OF CFO PURSUANT TO SECTION 906 Exhibit
Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Matthew R. McGrew, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge, Danaher Corporation’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 27, 2019 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Danaher Corporation.
 
Date:
October 23, 2019
By:
/s/ Matthew R. McGrew
 
 
 
Matthew R. McGrew
 
 
 
Executive Vice President and Chief Financial Officer

This certification accompanies the Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section. This certification shall not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that Danaher Corporation specifically incorporates it by reference.


EX-101.SCH 12 dhr-20190927.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2105100 - Disclosure - Acquisitions link:presentationLink link:calculationLink link:definitionLink 2405404 - Disclosure - Acquisitions (Fair Values Of The Assets Acquired And Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Acquisitions (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2405406 - Disclosure - Acquisitions (Pending Acquisition) (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2405405 - Disclosure - Acquisitions (Pro Forma Financial Information) (Details) link:presentationLink link:calculationLink link:definitionLink 2405403 - Disclosure - Acquisitions (Pro Forma Financial Information) (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Acquisitions (Tables) link:presentationLink link:calculationLink link:definitionLink 2119100 - Disclosure - Commitments And Contingencies link:presentationLink link:calculationLink link:definitionLink 2419402 - Disclosure - Commitments And Contingencies (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2319301 - Disclosure - Commitments And Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 2419403 - Disclosure - Commitments And Contingencies (Warranty Accrual) (Details) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Consolidated Condensed Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1001001 - Statement - Consolidated Condensed Balance Sheets Consolidated Condensed Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Consolidated Condensed Statement Of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 1004001 - Statement - Consolidated Condensed Statement Of Stockholders' Equity Consolidated Condensed Statement Of Stockholders' Equity (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - Consolidated Condensed Statements Of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Consolidated Condensed Statements Of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Consolidated Condensed Statements Of Earnings link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 2115100 - Disclosure - Defined Benefit Plans link:presentationLink link:calculationLink link:definitionLink 2415403 - Disclosure - Defined Benefit Plans (Components of Net Periodic Benefit Cost of Defined Benefit Pension Pans) (Details) link:presentationLink link:calculationLink link:definitionLink 2415404 - Disclosure - Defined Benefit Plans (Components of Net Periodic Benefit Cost of Other Postretirement Benefit Pension Pans) (Details) link:presentationLink link:calculationLink link:definitionLink 2415405 - Disclosure - Defined Benefit Plans (Components of Net Periodic Benefit Cost Reflected in the Consolidated Condensed Statement of Earnings) (Details) link:presentationLink link:calculationLink link:definitionLink 2415402 - Disclosure - Defined Benefit Plans (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2315301 - Disclosure - Defined Benefit Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 2406401 - Disclosure - Envista Initial Public Offering (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Envista Initial Public Offering (Notes) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2411404 - Disclosure - Fair Value Measurements (Carrying Amounts and Fair Values of Financial Instruments) (Details) link:presentationLink link:calculationLink link:definitionLink 2411403 - Disclosure - Fair Value Measurements (Financial Assets and Liabilities Carried at Fair Value) (Details) link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - Fair Value Measurements (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - Financing link:presentationLink link:calculationLink link:definitionLink 2412403 - Disclosure - Financing (Components Of Debt) (Details) link:presentationLink link:calculationLink link:definitionLink 2412404 - Disclosure - Financing (Key Terms Of Offering) (Details) link:presentationLink link:calculationLink link:definitionLink 2412402 - Disclosure - Financing (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2312301 - Disclosure - Financing (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - General link:presentationLink link:calculationLink link:definitionLink 2401404 - Disclosure - General (Components of Accumulated Other Comprehensive Income) (Details) link:presentationLink link:calculationLink link:definitionLink 2401403 - Disclosure - General (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2201202 - Disclosure - General (Policies) link:presentationLink link:calculationLink link:definitionLink 2301301 - Disclosure - General (Tables) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - Goodwill link:presentationLink link:calculationLink link:definitionLink 2409403 - Disclosure - Goodwill (Goodwill by Segment) (Details) link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - Goodwill (Rollforward of Goodwill) (Details) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - Goodwill (Tables) link:presentationLink link:calculationLink link:definitionLink 2414404 - Disclosure - Hedging Transactions And Derivative Financial Instruments (Derivative and Nonderivative Debt Instruments) (Details) link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - Hedging Transactions And Derivative Financial Instruments (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - Hedging Transactions And Derivative Financial Instruments (Notes) link:presentationLink link:calculationLink link:definitionLink 2414403 - Disclosure - Hedging Transactions And Derivative Financial Instruments (Summary of Notional Values and Pretax Impact in Fair Values of Net Investment Hedges) (Details) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - Hedging Transactions And Derivative Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2417402 - Disclosure - Income Taxes (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2417403 - Disclosure - Income Taxes (Summary Of Danaher's Effective Income Tax Rate) (Details) link:presentationLink link:calculationLink link:definitionLink 2317301 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - Leases (Components of Lease Expense) (Details) link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Leases (Lease Arrangements) (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2408406 - Disclosure - Leases (Maturities of Lease Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Leases (Notes) link:presentationLink link:calculationLink link:definitionLink 2408405 - Disclosure - Leases (Supplemental Balance Sheet Inofrmation) (Details) link:presentationLink link:calculationLink link:definitionLink 2408404 - Disclosure - Leases (Supplemental Cash Flow Information) (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 2121100 - Disclosure - Net Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 2421403 - Disclosure - Net Earnings Per Share (Components of Basic and Diluted Earnings per Share) (Details) link:presentationLink link:calculationLink link:definitionLink 2421402 - Disclosure - Net Earnings Per Share (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2321301 - Disclosure - Net Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - Nonoperating Income (Expense) link:presentationLink link:calculationLink link:definitionLink 2418401 - Disclosure - Nonoperating Income (Expense) (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2403403 - Disclosure - Revenue (Disaggregation of Revenue by Geographical Region) (Details) link:presentationLink link:calculationLink link:definitionLink 2403404 - Disclosure - Revenue (Disaggregation of Revenue by Revenue Type) (Details) link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - Revenue (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - Revenue (Notes) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 2122100 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 2422402 - Disclosure - Segment Information (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2422403 - Disclosure - Segment Information (Segment Results) (Details) link:presentationLink link:calculationLink link:definitionLink 2322301 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2120100 - Disclosure - Stock Transactions And Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 2420404 - Disclosure - Stock Transactions And Stock-Based Compensation (Components of Stock-Based Compensation Program) (Details) link:presentationLink link:calculationLink link:definitionLink 2420402 - Disclosure - Stock Transactions And Stock-Based Compensation (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2420403 - Disclosure - Stock Transactions And Stock-Based Compensation (Summary of Share Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 2320301 - Disclosure - Stock Transactions And Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 2423401 - Disclosure - Subsequent Event (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2123100 - Disclosure - Subsequent Event (Notes) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 13 dhr-20190927_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 14 dhr-20190927_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 15 dhr-20190927_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Business Combinations [Abstract] Acquisitions Business Combination Disclosure [Text Block] Revenue from Contract with Customer [Abstract] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Operating segments Operating Segments [Member] Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] Life Sciences Life Sciences [Member] Life Sciences [Member] Diagnostics Diagnostics [Member] Diagnostics [Member] Dental / Envista Dental / Envista [Member] Dental [Member] Environmental & Applied Solutions Environmental & Applied Solutions [Member] Environmental & Applied Solutions [Member] Product and Service [Axis] Product and Service [Axis] Product and Service [Domain] Product and Service [Domain] Recurring revenue Revenue from Contract with Customer, Measurement, Recurring [Member] Revenue from Contract with Customer, Measurement, Recurring [Member] Nonrecurring revenue Revenue from Contract with Customer, Measurement, Nonrecurring [Member] Revenue from Contract with Customer, Measurement, Nonrecurring [Member] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Sales Revenue from Contract with Customer, Excluding Assessed Tax Fair Value Disclosures [Abstract] Statement [Table] Statement [Table] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] U.S. dollar-denominated bonds U.S. Dollar-Denominated Bonds [Member] U.S. Dollar-Denominated Bonds [Member] Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] Envista Envista [Member] Envista [Member] Consolidated Entities [Axis] Consolidated Entities [Axis] Consolidated Entities [Domain] Consolidated Entities [Domain] Subsidiaries Subsidiaries [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Interest rate swap agreements Interest Rate Swap [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Hedging Relationship [Domain] Hedging Relationship [Domain] Cash flow hedging Cash Flow Hedging [Member] Statistical Measurement [Axis] Statistical Measurement [Axis] Statistical Measurement [Domain] Statistical Measurement [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Statement [Line Items] Statement [Line Items] Derivative, notional amount Derivative, Notional Amount Derivative, term of contract Derivative, Term of Contract Share-based Payment Arrangement [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Award Type [Axis] Award Type [Axis] Award Type [Domain] Award Type [Domain] Restricted stock units (“RSUs”)/performance stock units (“PSUs”) Restricted Stock Units (RSUs) [Member] Stock options Share-based Payment Arrangement, Option [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Pretax compensation expense Share-based Payment Arrangement, Expense Income tax benefit Share-based Payment Arrangement, Expense, Tax Benefit Stock-based compensation expense, net of income taxes Share-based Payment Arrangement, Expense, after Tax Organization, Consolidation and Presentation of Financial Statements [Abstract] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Foreign Currency Translation Adjustments Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Pension & Postretirement Plan Benefit Adjustments Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Unrealized Gain (Loss) on Available-For-Sale Securities Adjustments AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member] Cash Flow Hedge Adjustments Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member] AOCI Including Portion Attributable to Noncontrolling Interest [Member] AOCI Including Portion Attributable to Noncontrolling Interest [Member] AOCI attributable to controlling interest AOCI Attributable to Parent [Member] AOCI attributable to noncontrolling interest AOCI Attributable to Noncontrolling Interest [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Beginning balance Accumulated Other Comprehensive Income (Loss), Net of Tax Adoption of accounting standards Cumulative Effect of New Accounting Principle in Period of Adoption, Increase (Decrease) to AOCI Cumulative Effect of New Accounting Principle in Period of Adoption, Increase (Decrease) to AOCI. Increase (decrease) Other Comprehensive Income (Loss), before Reclassifications, before Tax Income tax impact Other Comprehensive Income (Loss) before Reclassifications, Tax Other comprehensive income (loss) before reclassifications, net of income taxes Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Increase (decrease) Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Income tax impact Reclassification from AOCI, Current Period, Tax Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Total other comprehensive income (loss), net of income taxes Other Comprehensive Income (Loss), Net of Tax Ending balance Retirement Benefits [Abstract] Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Retirement Plan Type [Axis] Retirement Plan Type [Axis] Retirement Plan Type [Domain] Retirement Plan Type [Domain] Defined benefit pension plans Pension Plan [Member] Retirement Plan Sponsor Location [Axis] Retirement Plan Sponsor Location [Axis] Retirement Plan Sponsor Location [Domain] Retirement Plan Sponsor Location [Domain] U.S. pension benefits UNITED STATES Non-U.S. pension benefits Foreign Plan [Member] Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Service cost Defined Benefit Plan, Service Cost Interest cost Defined Benefit Plan, Interest Cost Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Amortization of actuarial loss Defined Benefit Plan, Amortization of Gain (Loss) Amortization of prior service (cost) credit Defined Benefit Plan, Amortization of Prior Service Cost (Credit) Curtailment gain recognized Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment Settlement loss recognized Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement Net periodic benefit (cost) Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Income Statement [Abstract] Cost of sales Cost of Goods and Services Sold Gross profit Gross Profit Operating costs: Costs and Expenses [Abstract] Selling, general and administrative expenses Selling, General and Administrative Expense Research and development expenses Research and Development Expense Operating profit Operating Income (Loss) Nonoperating income (expense): Nonoperating Income (Expense) [Abstract] Other income, net Other Nonoperating Income Interest expense Interest Expense Interest income Investment Income, Interest Earnings before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Income taxes Income Tax Expense (Benefit) Net earnings Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Less: net earnings attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Net earnings attributable to Danaher stockholders Net Income (Loss) Attributable to Parent Mandatory convertible preferred stock dividends Preferred Stock Dividends, Income Statement Impact Net earnings attributable to common stockholders Net Income (Loss) Available to Common Stockholders, Basic Net earnings per common share: Earnings Per Share [Abstract] Basic Earnings Per Share, Basic Diluted Earnings Per Share, Diluted Average common stock and common equivalent shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Basic Weighted Average Number of Shares Outstanding, Basic Diluted Weighted Average Number of Shares Outstanding, Diluted Number of businesses acquired Number of Businesses Acquired Net cash consideration Business Combination, Consideration Transferred Revenue reported by acquired entity for last annual period Business Acquisition, Revenue Reported by Acquired Entity for Last Annual Period Goodwill Goodwill, Acquired During Period Subsequent Events [Abstract] Subsequent Event [Table] Subsequent Event [Table] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Senior notes Senior Notes [Member] 2.4% senior notes due 2020 2.4% Senior Notes Due 2020 [Member] 2.4% Senior Notes Due 2020 [Member] 5.0% senior notes due 2020 5.0% Senior Notes Due 2020 [Member] 5.0% Senior Notes 2020 [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent event Subsequent Event [Member] Subsequent Event [Line Items] Subsequent Event [Line Items] Aggregate principal amount Debt Instrument, Face Amount Interest rate of debt instrument Debt Instrument, Interest Rate, Stated Percentage Make-whole premiums Payment for Debt Extinguishment or Debt Prepayment Cost Make-whole premiums, after-tax Payments Of Debt Extinguishment Costs, After-Tax Payments Of Debt Extinguishment Costs, After-Tax Make-whole premiums, per diluted share Payments Of Debt Extinguishment Costs, Per Diluted Share Payments Of Debt Extinguishment Costs, Per Diluted Share Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Other Income and Expenses [Abstract] Leases [Abstract] Lessee, Lease Costs Lease, Cost [Table Text Block] Lessee, Assets and Liabilities Lessee, Assets and Liabilities [Table Text Block] Lessee, Assets and Liabilities[Table Text Block] Lessee, Operating Lease, Liability, Maturity Lessee, Operating Lease, Liability, Maturity [Table Text Block] Goodwill and Intangible Assets Disclosure [Abstract] Rollforward Of Goodwill Schedule of Goodwill [Table Text Block] Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Lessee, operating lease, renewal term Lessee, Operating Lease, Renewal Term Lessee, operating lease, option to terminate, term Lessee, Operating Lease, Option to Terminate, Term Lessee, Operating Lease, Option to Terminate, Term Subsequent Events Subsequent Events [Text Block] Cash paid for amounts included in the measurement of operating lease liabilities Operating Lease, Payments ROU assets obtained in exchange for operating lease obligations Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Preferred stock Preferred Stock [Member] Common stock Common Stock [Member] Scenario [Axis] Scenario [Axis] Scenario [Domain] Scenario [Domain] Scenario, forecast Forecast [Member] Stock repurchase program, authorized shares to be repurchased, shares Stock Repurchase Program, Number of Shares Authorized to be Repurchased Stock repurchase program, remaining number of shares authorized to be repurchased, shares Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased Issuance of stock Stock Issued During Period, Shares, New Issues Common stock issued, price per share Shares Issued, Price Per Share Common stock, proceeds from issuance Proceeds from Issuance of Common Stock Payments of stock issuance costs Payments of Stock Issuance Costs Preferred stock, shares issued Preferred Stock, Shares Issued Preferred stock, dividend rate, percent Preferred Stock, Dividend Rate, Percentage Preferred stock, liquidation preference per share Preferred Stock, Liquidation Preference Per Share Preferred stock, proceeds from the issuance Proceeds from Issuance of Preferred Stock and Preference Stock Convertible preferred stock, shares issued upon conversion Convertible Preferred Stock, Shares Issued upon Conversion Convertible preferred stock, threshold consecutive trading days Debt Instrument, Convertible, Threshold Consecutive Trading Days Preferred stock, annual liquidation preference, per share Preferred Stock, Dividend Rate, Per-Dollar-Amount Common shares reserved for issuance under the 2007 Omnibus Incentive Plan, shares Common Stock, Capital Shares Reserved for Future Issuance Total unrecognized compensation cost Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Weighted average period for cost to be recognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Income Tax Disclosure [Abstract] Income Taxes Income Tax Disclosure [Text Block] Components Of Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative [Table] Derivative [Table] Net investment hedging Net Investment Hedging [Member] Foreign currency contracts Foreign Exchange Contract [Member] Interest rate swaps Derivative [Line Items] Derivative [Line Items] Nonoperating Income (Expense) Other Income and Other Expense Disclosure [Text Block] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Biopharma Acquisition Biopharma Acquisition [Member] Biopharma Acquisition [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Pending acquisition, purchase price Pending acquisition, pension liabilities to be assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other Pending acquisition, revenue for last annual period Pending divestiture, revenue Disposal Group, Including Discontinued Operation, Revenue Proceeds from issuance of common stock and preferred stock, proceeds from issuance of debt and available cash Proceeds from Underwritten Public Offerings of Common Stock and Mandatory Convertible Preferred Stock, Proceeds from Issuance of Debt, and Available Cash Proceeds from Underwritten Public Offerings of Common Stock and Mandatory Convertible Preferred Stock, Proceeds from Issuance of Debt, and Available Cash Statement of Cash Flows [Abstract] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Net earnings Noncash items: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation Depreciation Amortization Amortization Stock-based compensation expense Share-based Payment Arrangement, Noncash Expense Change in trade accounts receivable, net Increase (Decrease) in Accounts Receivable Change in inventories Increase (Decrease) in Inventories Change in trade accounts payable Increase (Decrease) in Accounts Payable Change in prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Change in accrued expenses and other liabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Net operating cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Cash paid for acquisitions Payments to Acquire Businesses, Net of Cash Acquired Payments for additions to property, plant and equipment Payments to Acquire Property, Plant, and Equipment Proceeds from sales of property, plant and equipment Proceeds from Sale of Property, Plant, and Equipment Payments for purchases of investments Payments to Acquire Investments Proceeds from sale of investments Proceeds from Sale and Maturity of Marketable Securities All other investing activities Payments for (Proceeds from) Other Investing Activities Net operating cash used in investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Proceeds from the issuance of common stock in connection with stock-based compensation Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised Proceeds from the sale of common stock, net of issuance costs Proceeds from the sale of preferred stock, net of issuance costs Proceeds from the sale of Envista Holdings Corporation Common Stock, net of issuance costs Proceeds from Issuance or Sale of Equity Payment of dividends Payments of Dividends Net proceeds from borrowings (maturities of 90 days or less) Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less Proceeds from borrowings (maturities longer than 90 days) Proceeds from Issuance of Long-term Debt Net repayments of borrowings (maturities longer than 90 days) Repayments of Long-term Debt All other financing activities Proceeds from (Payments for) Other Financing Activities Net operating cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rate changes on cash and equivalents Effect of Exchange Rate on Cash and Cash Equivalents Net change in cash and equivalents Cash and Cash Equivalents, Period Increase (Decrease) Beginning balance of cash and equivalents Cash and Cash Equivalents, at Carrying Value Ending balance of cash and equivalents Supplemental disclosures: Supplemental Cash Flow Information [Abstract] Cash interest payments Interest Paid, Excluding Capitalized Interest, Operating Activities Cash income tax payments Income Taxes Paid, Net Debt Disclosure [Abstract] Components Of Debt Schedule of Long-term Debt Instruments [Table Text Block] Financial Assets And Liabilities Carried At Fair Value Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Carrying Amounts And Fair Values Of Financial Instruments Fair Value, by Balance Sheet Grouping [Table Text Block] Income Tax Examination [Table] Income Tax Examination [Table] Income Tax Authority [Axis] Income Tax Authority [Axis] Income Tax Authority [Domain] Income Tax Authority [Domain] Foreign tax authority Foreign Tax Authority [Member] Income Tax Examination [Line Items] Income Tax Examination [Line Items] Federal statutory income tax rate, percent Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Net tax benefits, impact, amount Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount Net tax benefits, impact, per diluted share Effective Income Tax Rate Reconciliation, Other Reconciling Items, Per Diluted Share Amount Effective Income Tax Rate Reconciliation, Other Reconciling Items, Per Diluted Share Amount Net tax benefits, impact, percent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent Income tax examination, proposed adjustments to taxable income Income Tax Examination, Self-insurance Programs, Proposed Adjustments to Taxable Income Income Tax Examination, Self-insurance Programs, Proposed Adjustments to Taxable Income Income tax examination, amount of tax assessments Income Tax Examination, Amount of Tax Assessments Income tax assessment received imposing withholding tax and interest related to accrued interest on borrowings. Income tax examination, amount of potential additional tax assessments Income Tax Examination, Amount of Potential Additional Tax Assessments Income Tax Examination, Amount of Potential Additional Tax Assessments Statement of Financial Position [Abstract] ASSETS Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and equivalents Trade accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Inventories: Inventory, Net [Abstract] Finished goods Inventory, Finished Goods, Gross Work in process Inventory, Work in Process, Gross Raw materials Inventory, Raw Materials, Gross Total inventories Inventory, Gross Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Total current assets Assets, Current Property, plant and equipment, net of accumulated depreciation of $3,023.3 and $2,828.3, respectively Property, Plant and Equipment, Net Other long-term assets Other Assets, Noncurrent Goodwill Goodwill Other intangible assets, net Intangible Assets, Net (Excluding Goodwill) Total assets Assets LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Notes payable and current portion of long-term debt Debt, Current Trade accounts payable Accounts Payable, Trade, Current Accrued expenses and other liabilities Accrued Liabilities, Current Total current liabilities Liabilities, Current Other long-term liabilities Other Liabilities, Noncurrent Long-term debt Long-term Debt, Excluding Current Maturities Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Stockholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Preferred stock, without par value, 15.0 million shares authorized; 1.65 million shares of 4.75% Mandatory Convertible Preferred Stock, Series A, issued and outstanding at September 27, 2019; no shares issued or outstanding at December 31, 2018 Preferred Stock, Value, Issued Common stock - $0.01 par value, 2.0 billion shares authorized; 835.0 million issued and 718.2 million outstanding at September 27, 2019; 817.9 million issued and 701.5 million outstanding at December 31, 2018 Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital, Common Stock Retained earnings Retained Earnings (Accumulated Deficit) Accumulated other comprehensive income (loss) Total Danaher stockholders’ equity Stockholders' Equity Attributable to Parent Noncontrolling interests Stockholders' Equity Attributable to Noncontrolling Interest Total stockholders’ equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Total liabilities and stockholders’ equity Liabilities and Equity Numerator Earnings Per Share Reconciliation [Abstract] Net earnings attributable to noncontrolling interest MCPS dividends Adjustment for interest on convertible debentures Interest on Convertible Debt, Net of Tax Net earnings attributable to common stockholders after assumed conversions (used in Diluted EPS) Net Income (Loss) Available to Common Stockholders, Diluted Denominator Weighted average common shares outstanding (used in Basic EPS) Assumed exercise of dilutive options and vesting of dilutive RSUs and PSUs Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Assumed conversion of the convertible debentures Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities Weighted average common shares outstanding (used in Diluted EPS) Basic EPS Diluted EPS Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] North America North America [Member] Western Europe Western Europe [Member] Western Europe [Member] Other developed markets Other developed markets [Member] Other developed markets [Member] High-growth markets High-growth markets [Member] The Company defines high-growth markets as developing markets of the world experiencing extended periods of accelerated growth in gross domestic product and infrastructure which includes Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia). Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] 0.2% senior notes due 2026 0.2% Senior Notes Due 2026 [Member] 0.2% Senior Notes Due 2026 [Member] 0.45% senior notes due 2028 0.45% Senior Notes Due 2028 [Member] 0.45% Senior Notes Due 2028 [Member] 0.75% senior notes due 2031 0.75% Senior Notes Due 2031 [Member] 0.75% Senior Notes Due 2031 [Member] 1.35% senior notes due 2039 1.35% Senior Notes Due 2039 [Member] 1.35% Senior Notes Due 2039 [Member] 1.8% senior notes due 2049 1.8% Senior Notes Due 2049 [Member] 1.8% Senior Notes Due 2049 [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Debt instrument, redemption price, percent Debt Instrument, Redemption Price, Percentage Property, plant and equipment, net of accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Preferred stock, no par value Preferred Stock, No Par Value Preferred stock, shares authorized Preferred Stock, Shares Authorized Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Common stock, par value Common Stock, Par or Stated Value Per Share Common stock, shares authorized Common Stock, Shares Authorized Common stock, shares issued Common Stock, Shares, Issued Common stock, shares outstanding Common Stock, Shares, Outstanding Trade accounts receivable Business Combination, Acquired Receivable, Fair Value Inventories Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Property, plant and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Other intangible assets, primarily customer relationships, trade names and technology Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Trade accounts payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Other assets and liabilities, net Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets And Liabilities, Net Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets And Liabilities, Net Segment Reporting [Abstract] Segment Information Segment Reporting Disclosure [Text Block] Hedging Transactions and Derivative Financial Instruments Derivative Instruments and Hedging Activities Disclosure [Text Block] Fair Value Measurements Fair Value Disclosures [Text Block] Fixed operating lease expense Operating Lease, Cost Variable operating lease expense Variable Lease, Cost Total operating lease expense Lease, Cost Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table] Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table] IDT IDT [Member] IDT Nonrecurring Adjustment [Axis] Nonrecurring Adjustment [Axis] Nonrecurring Adjustment [Domain] Nonrecurring Adjustment [Domain] Fair value adjustment to inventory Fair Value Adjustment to Inventory [Member] Acquisition-related transaction costs Acquisition-related Costs [Member] Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items] Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items] Pro forma earnings, adjustments Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Foreign currency denominated debt Foreign Currency Denominated Debt [Member] Foreign Currency Denominated debt [Member] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Derivatives, notional amount Nonderivative, notional amount Nonderivative Hedging Instruments Nonderivative Hedging Instruments Derivative and nonderivative, notional amount Derivative and Nonderivative, Notional Amount Derivative and Nonderivative, Notional Amount Derivative, gain (loss) recognized in OCI Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax Nonderivative, gain (loss) recognized in OCI Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Nonderivatives Arising During Period, Before Tax Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Nonderivatives Arising During Period, Before Tax Derivative and nonderivative, gain (loss) recognized in OCI Other Comprehensive Income Unrealized Gain Loss On Derivatives And Nonderivatives Arising During Period Before Tax Other Comprehensive Income Unrealized Gain Loss On Derivatives And Nonderivatives Arising During Period Before Tax Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive securities excluded from computation of earnings per share, amount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Schedule of Goodwill [Table] Schedule of Goodwill [Table] Goodwill [Line Items] Goodwill [Line Items] Total goodwill Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Balance, beginning of period Shares, Issued Common stock-based award activity Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture Common stock issued in connection with acquisitions Stock Issued During Period, Shares, Acquisitions Common stock issued in connection with LYONs’ conversions Stock Issued During Period, Shares, Conversion of Convertible Securities Balance, end of period Summary Of Effective Income Tax Rate Summary Of Danaher's Effective Income Tax Rate [Table Text Block] Summary Of Danaher's Effective Income Tax Rate [Table Text Block] Statement of Stockholders' Equity [Abstract] Debt conversion, converted instrument, tax benefit Debt Conversion, Converted Instrument, Tax Benefit (Expense) Debt Conversion, Converted Instrument, Tax Benefit (Expense) Defined Benefit Plans Pension and Other Postretirement Benefits Disclosure [Text Block] Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward] Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward] December 31, 2018 Standard and Extended Product Warranty Accrual Accruals for warranties issued during the period Standard and Extended Product Warranty Accrual, Increase for Warranties Issued Settlements made Standard and Extended Product Warranty Accrual, Decrease for Payments Effect of foreign currency translation Standard and Extended Product Warranty Accrual, Foreign Currency Translation Gain (Loss) September 27, 2019 Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Quoted Prices in Active Market (Level 1) Fair Value, Inputs, Level 1 [Member] Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Significant Unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Assets: Assets, Fair Value Disclosure [Abstract] Available-for-sale debt securities Debt Securities, Available-for-sale Investment in equity securities Equity Securities, FV-NI Cross-currency swap derivative contracts Foreign Currency Contract, Asset, Fair Value Disclosure Liabilities: Liabilities, Fair Value Disclosure [Abstract] Interest rate swap derivative contracts Interest Rate Swap, Liability, Fair Value Disclosure Interest Rate Swap, Liability, Fair Value Disclosure Deferred compensation plans Deferred Compensation Liability, Classified, Noncurrent Statement, Equity Components [Axis] Common stock Additional paid-in capital Additional Paid-in Capital [Member] Retained earnings Retained Earnings [Member] Accumulated other comprehensive income (loss) Noncontrolling interests Noncontrolling Interest [Member] Balance, beginning of period Issuance of stock Stock Issued During Period, Value, New Issues Sale of Envista Holdings Corporation Stock Noncontrolling Interest, Increase from Subsidiary Equity Issuance Common stock-based award activity Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Common stock issued in connection with acquisitions Stock Issued During Period, Value, Acquisitions Common stock issued in connection with LYONs’ conversions Stock Issued During Period, Value, Conversion of Convertible Securities Adoption of accounting standards Cumulative Effect of New Accounting Principle in Period of Adoption Dividends declared Dividends, Common Stock, Cash Mandatory convertible preferred stock cumulative dividends Dividends, Preferred Stock, Cash Other comprehensive income (loss) Change in noncontrolling interests Noncontrolling Interest, Period Increase (Decrease) Balance, end of period Effective tax rate Effective Income Tax Rate Reconciliation, Percent Commercial paper Commercial Paper [Member] Unsecured debt Unsecured Debt [Member] Convertible debt Convertible Debt [Member] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Revolving credit facility Revolving Credit Facility [Member] Superseded credit facility Superseded Credit Facility [Member] Superseded Credit Facility [Member] Euro-denominated commercial paper Euro-Denominated Commercial Paper [Member] Euro-Denominated Commercial Paper [Member] U.S. dollar-denominated commercial paper US Dollar-Denominated Commercial Paper [Member] US Dollar Denominated Commercial Paper [Member] 1.0% senior notes due 2019 1.0% Senior Notes Due 2019 [Member] 1.0% Senior Notes Due 2019 [Member] Biopharma euronotes Biopharma Euronotes [Member] Biopharma Euronotes [Member] Envista term loan facility Envista Term Loan Facility [Member] Envista Term Loan Facility Envista euro term loan facility Envista Euro Term Loan Facility [Member] Envista Euro Term Loan Facility [Member] Envista credit facility Envista Credit Facility [Member] Envista Credit Facility [Member] Five-year facility Five-Year Facility [Member] Five-Year Facility [Member] 364-day facility 364-Day Facility [Member] 364-Day Facility [Member] Zero-coupon LYONs due 2021 Zero-Coupon LYONS Due 2021 [Member] Zero-Coupon LYONS Due 2021 [Member] 2020 credit facilities 2020 Credit Facilities [Member] 2020 Credit Facilities Financial Instrument [Axis] Financial Instrument [Axis] Financial Instruments [Domain] Financial Instruments [Domain] Long-term debt Long-term Debt [Member] Short-term debt Short-term Debt [Member] Sale of Stock [Axis] Sale of Stock [Axis] Sale of Stock [Domain] Sale of Stock [Domain] IPO IPO [Member] Variable Rate [Axis] Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] LIBOR London Interbank Offered Rate (LIBOR) [Member] Federal funds rate Fed Funds Effective Rate Overnight Index Swap Rate [Member] Eurocurrency rate Eurodollar [Member] Line of credit Line of Credit Facility, Maximum Borrowing Capacity Additional borrowing capacity expansion Line of Credit Facility, Additional Borrowing Capacity Line of Credit Facility Additional Borrowing Capacity Line of credit facility, amount outstanding Long-term Line of Credit Weighted average interest rate of long-term debt, interest rate Long-term Debt, Weighted Average Interest Rate, at Point in Time Weighted average maturity of long-term debt, at point in time Long-term Debt, Weighted Average Maturity, at Point in Time Long-term Debt, Weighted Average Maturity, at Point in Time Long-term debt Long-term Debt Repayment of debt Repayments of Debt Debt discounts, premiums and debt issuance costs Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Proceeds from term debt Proceeds from Issuance of Debt Consideration transfered and proceeds from issuance of debt Sale of Stock Transactions, Consideration Transfered and Proceeds from Issuance of Debt Sale of Stock Transactions, Consideration Transfered and Proceeds from Issuance of Debt Sale of stock, ownership after transaction, percent Sale of Stock, Percentage of Ownership after Transaction Debt instrument, basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Per annum fee Line of Credit Facility, Commitment Fee Percentage Debt instrument, leverage ratio, maximum Debt Instrument, Covenants, Conversion Fee, Percent Debt Instrument, Covenants, Conversion Fee, Percent Shares issued under debt conversion, shares Debt Conversion, Converted Instrument, Shares Issued Leverage ratio Debt Instrument, Covenants, Leverage Ratio Debt Instrument, Covenants, Leverage Ratio Number of segments reported Number of Reportable Segments Other postretirement benefit plans Other Postretirement Benefits Plan [Member] Schedule of Net Benefit Costs Schedule of Net Benefit Costs [Table Text Block] Schedule of Defined Benefit Plans Disclosures Schedule of Defined Benefit Plans Disclosures [Table Text Block] Revenue, OTLs and STLs Operating-type Lease And Sales-type Lease, Revenues Amount of operating-type lease and sales-type lease revenues. Revenue, remaining performance obligation Revenue, Remaining Performance Obligation, Amount Revenue, remaining performance obligation, expected satisfaction in next 12 months, percent Revenue, Remaining Performance Obligation, Expected Satisfaction in The Next 12 Months, Percent Revenue, Remaining Performance Obligation, Expected Satisfaction in The Next 12 Months, Percent Revenue, remaining performance obligation, expected satisfaction in subsequent 12 months, percent Revenue, Remaining Performance Obligation, Expected Satisfaction in Year Two, Percent Revenue, Remaining Performance Obligation, Expected Satisfaction in Year Two, Percent Contract with customer, asset, net Contract with Customer, Asset, after Allowance for Credit Loss Contract with customer, liability Contract with Customer, Liability Contract with customer, liability, revenue recognized Contract with Customer, Liability, Revenue Recognized Segment Results Schedule of Segment Reporting Information, by Segment [Table Text Block] Goodwill Goodwill Disclosure [Text Block] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Other Corporate, Non-Segment [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Operating profit Identifiable assets Components Of Basic And Diluted Earnings Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Fair Values Of The Assets Acquired And Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Results Of Operations If Acquisition Was Consummated Business Acquisition, Pro Forma Information [Table Text Block] Financing Debt Disclosure [Text Block] Revenue from Contract with Customer Revenue from Contract with Customer [Text Block] Stock Transactions And Stock-Based Compensation Share-based Payment Arrangement [Text Block] Bonds Bonds [Member] 0.352% senior notes due 2021 0.352% Senior Notes Due 2021 [Member] 0.352% Senior Notes Due 2021 [Member] 1.7% senior notes due 2022 1.7% Senior Notes Due 2022 [Member] 1.7% Senior Notes Due 2022 [Member] Floating rate senior notes due 2022 Floating Rate Senior Notes Due 2022 [Member] Floating Rate Senior Notes Due 2022 Member [Member] 0.5% senior bonds due 2023 0.5% Bonds Due 2023 [Member] 0.5% Bonds Due 2023 [Member] 2.5% senior notes due 2025 2.5% Senior Notes Due 2025 [Member] 2.5% Senior Notes Due 2025 [Member] 3.35% senior notes due 2025 3.35% Senior Notes Due 2025 [Member] 3.35% Senior Notes Due 2025 [Member] 0.3% senior notes due 2027 0.3% Senior Notes Due 2027 [Member] 0.3% Senior Unsecured Notes Due 2027 [Member] 1.2% senior notes due 2027 1.2% Senior Notes Due 2027 [Member] 1.2% Senior Notes Due 2027 [Member] 1.125% senior bonds due 2028 1.125% Bonds Due 2028 [Member] 1.125% Bonds Due 2028 [Member] 0.65% senior notes due 2032 0.65% Senior Notes Due 2032 [Member] 0.65% Senior Notes Due 2032 [Member] 4.375% senior notes due 2045 4.375% Senior Notes Due 2045 [Member] 4.375% Senior Unsecured Notes Due 2045 [Member] Other Other [Member] Other [Member] Long-term debt Less: currently payable Long-term debt excluding currently payable Goodwill [Roll Forward] Goodwill [Roll Forward] Balance, December 31, 2018 Attributable to 2019 acquisitions Adjustments due to finalization of purchase price allocations Goodwill, Purchase Accounting Adjustments Foreign currency translation and other Goodwill, Foreign Currency Translation Gain (Loss) Balance, September 27, 2019 Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Cost of sales Cost of Sales [Member] Selling, general and administrative expenses Selling, General and Administrative Expenses [Member] Total service cost Other income, net Defined Benefit Plan, Other Cost (Credit) Derivative Instruments, Gain (Loss) [Table Text Block] Derivative Instruments, Gain (Loss) [Table Text Block] Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Schedule of Derivative Instruments in Statement of Financial Position, Fair Value Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Net periodic benefit (cost) Operating lease ROU assets Operating Lease, Right-of-Use Asset Total operating lease liabilities Operating Lease, Liability Operating lease ROU assets, other long term assets Operating lease liabilities, accrued expenses and other liabilities Operating Lease, Liability, Current Operating lease liabilities, other long-term liabilities Operating Lease, Liability, Noncurrent Total operating lease liabilities Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Prepaid expenses and other current assets Prepaid Expenses and Other Current Assets [Member] Accrued expenses and other liabilities Accounts Payable and Accrued Liabilities [Member] Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Derivative assets Derivative Asset Derivative liabilities Derivative Liability Nonderivative hedging instruments Cover page. Cover Page [Table] Entities [Table] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Entity Information [Line Items] Entity Information [Line Items] Document type Document Type Document quarterly report Document Quarterly Report Document period end date Document Period End Date Document transition report Document Transition Report Entity file number Entity File Number Entity registrant name Entity Registrant Name Amendment flag Amendment Flag Document fiscal year focus Document Fiscal Year Focus Document fiscal period focus Document Fiscal Period Focus Current fiscal year end date Current Fiscal Year End Date Entity central index key Entity Central Index Key Entity incorporation, state code Entity Incorporation, State or Country Code Entity tax identification number Entity Tax Identification Number Entity address, address line one Entity Address, Address Line One Entity address, city Entity Address, City or Town Entity address, state Entity Address, State or Province Entity address, postal zip code Entity Address, Postal Zip Code City area code City Area Code Local phone number Local Phone Number Title of 12(b) security Title of 12(b) Security Trading symbol Trading Symbol Security exchange name Security Exchange Name Entity current reporting status Entity Current Reporting Status Entity interactive data current Entity Interactive Data Current Entity filer category Entity Filer Category Entity small business Entity Small Business Entity emerging growth company Entity Emerging Growth Company Entity shell company Entity Shell Company Entity common stock, shares outstanding Entity Common Stock, Shares Outstanding Net Earnings Per Share Earnings Per Share [Text Block] Leases Lessee, Operating Leases [Text Block] Warranty Accrual Schedule of Product Warranty Liability [Table Text Block] Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Measurement Basis [Axis] Measurement Basis [Axis] Fair Value Measurement [Domain] Fair Value Measurement [Domain] Portion at Fair Value Measurement [Member] Portion at Fair Value Measurement [Member] Carrying Amount Reported Value Measurement [Member] Fair Value Estimate of Fair Value Measurement [Member] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Assets: Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] Liabilities: Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract] Notes payable and current portion of long-term debt Short-term Debt, Fair Value Long-term debt Long-term Debt, Fair Value Loss contingency accrual, period increase Loss Contingency Accrual, Period Increase (Decrease) Loss contingency accrual, period increase, after-tax Loss Contingency Accrual, Period Increase (Decrease), After-tax Loss Contingency Accrual, Period Increase (Decrease), After-tax Loss contingency accrual, period increase, per diluted share Loss Contingency Accrual, Period Increase (Decrease), Per Diluted Share Loss Contingency Accrual, Period Increase (Decrease), Per Diluted Share Equity [Abstract] Envista Initial Public Offering Stockholders' Equity Note Disclosure [Text Block] New accounting standards New Accounting Pronouncements, Policy [Policy Text Block] Summary of Share Activity Schedule of Stock by Class [Table Text Block] Components Of Stock-Based Compensation Program Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block] Lessee, Operating Lease, Liability, Payment, Due [Abstract] Lessee, Operating Lease, Liability, Payment, Due [Abstract] Remainder of fiscal year Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year Due in year two Lessee, Operating Lease, Liability, Payments, Due Year Two Due in year three Lessee, Operating Lease, Liability, Payments, Due Year Three Due in year four Lessee, Operating Lease, Liability, Payments, Due Year Four Due in year five Lessee, Operating Lease, Liability, Payments, Due Year Five Due thereafter Lessee, Operating Lease, Liability, Payments, Due after Year Five Total operating lease payments Lessee, Operating Lease, Liability, Payments, Due Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Redeemed notes Redeemed Notes [Member] Redeemed Notes [Member] Subsidiary, Sale of Stock [Line Items] Subsidiary, Sale of Stock [Line Items] Number of shares issued in transaction Sale of Stock, Number of Shares Issued in Transaction Ownership percentage by noncontrolling owners Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners IPO price Sale of Stock, Price Per Share Net earnings attributable to noncontrolling interest Statement of Comprehensive Income [Abstract] Other comprehensive income (loss), net of income taxes: Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Pension and postretirement plan benefit adjustments Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Unrealized gain (loss) on available-for-sale securities adjustments Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax Cash flow hedge adjustments Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax Comprehensive income Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Less: comprehensive income attributable to noncontrolling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive income attributable to Danaher Comprehensive Income (Loss), Net of Tax, Attributable to Parent Sales Business Acquisition, Pro Forma Revenue Net earnings attributable to common stockholders Business Acquisition, Pro Forma Net Income (Loss) Diluted net earnings per share Business Acquisition, Pro Forma Earnings Per Share, Diluted Expected future employer contributions, current fiscal year Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year General Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] EX-101.PRE 16 dhr-20190927_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 17 dhrlogofor8ksa26.jpg begin 644 dhrlogofor8ksa26.jpg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end GRAPHIC 18 dhrlogofor8ksa27.jpg begin 644 dhrlogofor8ksa27.jpg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end XML 19 R33.htm IDEA: XBRL DOCUMENT v3.19.3
Financing (Tables)
9 Months Ended
Sep. 27, 2019
Debt Disclosure [Abstract]  
Components Of Debt The following summarizes the key terms of the offering (€ in millions):
 
Aggregate Principal Amount
 
Stated Annual Interest Rate
 
Issue Price (as % of Principal Amount)
 
Maturity Date
 
Interest Payment Dates (in arrears)
2026 Biopharma Euronotes
1,250.0

 
0.200
%
 
99.833
%
 
March 18, 2026
 
March 18
2028 Biopharma Euronotes
1,250.0

 
0.450
%
 
99.751
%
 
March 18, 2028
 
March 18
2031 Biopharma Euronotes
1,750.0

 
0.750
%
 
99.920
%
 
September 18, 2031
 
September 18
2039 Biopharma Euronotes
1,250.0

 
1.350
%
 
99.461
%
 
September 18, 2039
 
September 18
2049 Biopharma Euronotes
750.0

 
1.800
%
 
99.564
%
 
September 18, 2049
 
September 18

The components of the Company’s debt were as follows ($ in millions):
 
September 27, 2019
 
December 31, 2018
U.S. dollar-denominated commercial paper
$

 
$
72.8

Euro-denominated commercial paper (€2.7 billion and €2.1 billion, respectively)
2,933.2

 
2,377.5

1.0% senior unsecured notes due 2019 (€600.0 million aggregate principal amount) (the “2019 Euronotes”)

 
687.0

2.4% senior unsecured notes due 2020
499.2

 
498.5

5.0% senior unsecured notes due 2020 (the “2020 Assumed Pall Notes”)
382.8

 
386.7

Zero-coupon LYONs due 2021
34.6

 
56.2

0.352% senior unsecured notes due 2021 (¥30.0 billion aggregate principal amount) (the “2021 Yen Notes”)
277.6

 
273.2

1.7% senior unsecured notes due 2022 (€800.0 million aggregate principal amount) (the “2022 Euronotes”)
872.6

 
913.2

Floating rate senior unsecured notes due 2022 (€250.0 million aggregate principal amount) (the “Floating Rate 2022 Euronotes”)
272.9

 
285.7

Envista senior unsecured term loan facility due 2022 (the “Envista Term Loan Facility”)
648.6

 

Envista senior unsecured term loan facility due 2022 (€600.0 million aggregate principal amount) (the “Envista Euro Term Loan Facility”)
655.6

 

0.5% senior unsecured bonds due 2023 (CHF 540.0 million aggregate principal amount) (the “2023 CHF Bonds”)
546.0

 
550.7

2.5% senior unsecured notes due 2025 (€800.0 million aggregate principal amount) (the “2025 Euronotes”)
871.7

 
912.6

3.35% senior unsecured notes due 2025
497.1

 
496.8

0.2% senior unsecured notes due 2026 (€1.3 billion aggregate principal amount) (the “2026 Biopharma Euronotes”)
1,357.5

 

0.3% senior unsecured notes due 2027 (¥30.8 billion aggregate principal amount) (the “2027 Yen Notes”)
284.4

 
279.9

1.2% senior unsecured notes due 2027 (€600.0 million aggregate principal amount) (the “2027 Euronotes”)
651.5

 
682.0

0.45% senior unsecured notes due 2028 (€1.3 billion aggregate principal amount) (the “2028 Biopharma Euronotes”)
1,355.6

 

1.125% senior unsecured bonds due 2028 (CHF 210.0 million aggregate principal amount) (the “2028 CHF Bonds”)
216.0

 
218.1

0.75% senior unsecured notes due 2031 (€1.8 billion aggregate principal amount) (the “2031 Biopharma Euronotes”)
1,900.7

 

0.65% senior unsecured notes due 2032 (¥53.2 billion aggregate principal amount) (the “2032 Yen Notes”)
491.1

 
483.4

1.35% senior unsecured notes due 2039 (€1.3 billion aggregate principal amount) (the “2039 Biopharma Euronotes”)
1,349.2

 

4.375% senior unsecured notes due 2045
499.4

 
499.3

1.8% senior unsecured notes due 2049 (€750.0 million aggregate principal amount) (the “2049 Biopharma Euronotes”)
810.3

 

Other
197.2

 
66.7

Total debt
17,604.8

 
9,740.3

Less: currently payable
1,068.6

 
51.8

Long-term debt
$
16,536.2

 
$
9,688.5


XML 20 R37.htm IDEA: XBRL DOCUMENT v3.19.3
Commitments And Contingencies (Tables)
9 Months Ended
Sep. 27, 2019
Commitments and Contingencies Disclosure [Abstract]  
Warranty Accrual
The following is a rollforward of the Company’s accrued warranty liability ($ in millions):
Balance, December 31, 2018
$
77.4

Accruals for warranties issued during the period
46.6

Settlements made
(43.7
)
Effect of foreign currency translation
(1.2
)
Balance, September 27, 2019
$
79.1


XML 21 R18.htm IDEA: XBRL DOCUMENT v3.19.3
Defined Benefit Plans
9 Months Ended
Sep. 27, 2019
Retirement Benefits [Abstract]  
Defined Benefit Plans DEFINED BENEFIT PLANS
The following sets forth the components of the Company’s net periodic benefit (cost) of the noncontributory defined benefit pension plans ($ in millions):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
U.S. pension benefits:
 
 
 
 
 
 
 
Service cost
$
(1.6
)
 
$
(1.2
)
 
$
(4.8
)
 
$
(5.4
)
Interest cost
(22.1
)
 
(20.3
)
 
(66.6
)
 
(60.7
)
Expected return on plan assets
31.0

 
33.0

 
94.2

 
99.2

Amortization of actuarial loss
(6.7
)
 
(8.0
)
 
(19.2
)
 
(23.6
)
Amortization of prior service cost
(0.2
)
 
(0.2
)
 
(0.7
)
 
(0.7
)
Net periodic pension benefit
$
0.4


$
3.3


$
2.9


$
8.8

 
 
 
 
 
 
 
 
Non-U.S. pension benefits:
 
 
 
 
 
 
 
Service cost
$
(8.2
)
 
$
(8.6
)
 
$
(24.4
)
 
$
(26.2
)
Interest cost
(6.6
)
 
(6.3
)
 
(19.9
)
 
(19.6
)
Expected return on plan assets
10.9

 
11.6

 
32.7

 
35.6

Amortization of actuarial loss
(3.9
)
 
(1.5
)
 
(3.7
)
 
(4.5
)
Amortization of prior service credit
2.6

 
0.2

 
0.2

 
0.4

Curtailment gain recognized

 

 
1.1

 

Settlement loss recognized
0.1

 
1.2

 

 
0.8

Net periodic pension cost
$
(5.1
)
 
$
(3.4
)
 
$
(14.0
)
 
$
(13.5
)
The following sets forth the components of the Company’s net periodic benefit cost of the other postretirement employee benefit plans ($ in millions):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Service cost
$
(0.1
)
 
$

 
$
(0.3
)
 
$
(0.3
)
Interest cost
(1.3
)
 
(1.2
)
 
(3.8
)
 
(3.5
)
Amortization of prior service credit
0.6

 
0.6

 
1.6

 
1.8

Net periodic cost
$
(0.8
)
 
$
(0.6
)
 
$
(2.5
)
 
$
(2.0
)

The net periodic benefit cost of the noncontributory defined benefit pension plans and other postretirement employee benefit plans incurred during the three and nine-month periods ended September 27, 2019 and September 28, 2018 are reflected in the following captions in the accompanying Consolidated Condensed Statements of Earnings ($ in millions):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Service cost:
 
 
 
 
 
 
 
Cost of sales
$
(2.0
)
 
$
(1.6
)
 
$
(6.2
)
 
$
(7.0
)
Selling, general and administrative expenses
(7.9
)
 
(8.2
)
 
(23.3
)
 
(24.9
)
Total service cost
(9.9
)
 
(9.8
)
 
(29.5
)
 
(31.9
)
Other net periodic benefit costs:
 
 
 
 
 
 
 
Other income, net
4.4

 
9.1

 
15.9

 
25.2

Total
$
(5.5
)
 
$
(0.7
)
 
$
(13.6
)
 
$
(6.7
)

Employer Contributions
During 2019, the Company’s cash contribution requirements for its U.S. and non-U.S. defined benefit pension plans are forecasted to be approximately $10 million and $50 million, respectively. The ultimate amounts to be contributed depend upon, among other things, legal requirements, underlying asset returns, the plan’s funded status, the anticipated tax deductibility of the contribution, local practices, market conditions, interest rates and other factors.
XML 22 R14.htm IDEA: XBRL DOCUMENT v3.19.3
Goodwill
9 Months Ended
Sep. 27, 2019
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill GOODWILL
The following is a rollforward of the Company’s goodwill ($ in millions):
Balance, December 31, 2018
$
25,906.0

Attributable to 2019 acquisitions
214.9

Adjustments due to finalization of purchase price allocations
(6.9
)
Foreign currency translation and other
(389.2
)
Balance, September 27, 2019
$
25,724.8

The carrying value of goodwill by segment is summarized as follows ($ in millions):
 
September 27, 2019
 
December 31, 2018
Life Sciences
$
13,300.2

 
$
13,311.0

Diagnostics
6,829.9

 
6,925.6

Dental / Envista
3,283.2

 
3,325.5

Environmental & Applied Solutions
2,311.5

 
2,343.9

Total
$
25,724.8

 
$
25,906.0


The Company has not identified any “triggering” events which indicate an impairment of goodwill in the nine-month period ended September 27, 2019.
XML 23 R10.htm IDEA: XBRL DOCUMENT v3.19.3
Revenue (Notes)
9 Months Ended
Sep. 27, 2019
Revenue from Contract with Customer [Abstract]  
Revenue from Contract with Customer REVENUE
The following tables present the Company’s revenues disaggregated by geographical region and revenue type for the three and nine-month periods ended September 27, 2019 and September 28, 2018 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenue.
 
Life Sciences
 
Diagnostics
 
Dental / Envista
 
Environmental & Applied Solutions
 
Total
Three-month period ended September 27, 2019:
 
 
 
 
 
 
 
 
 
Geographical region:
 
 
 
 
 
 
 
 
 
North America
$
637.2

 
$
602.9

 
$
327.7

 
$
465.5

 
$
2,033.3

Western Europe
444.1

 
257.9

 
127.5

 
252.8

 
1,082.3

Other developed markets
149.2

 
108.4

 
45.6

 
32.5

 
335.7

High-growth markets (a)
465.1

 
632.7

 
158.5

 
329.7

 
1,586.0

Total
$
1,695.6

 
$
1,601.9

 
$
659.3

 
$
1,080.5

 
$
5,037.3

 
 
 
 
 
 
 
 
 
 
Revenue type:
 
 
 
 
 
 
 
 
 
Recurring
$
1,084.3

 
$
1,343.2

 
$
479.4

 
$
595.2

 
$
3,502.1

Nonrecurring
611.3

 
258.7

 
179.9

 
485.3

 
1,535.2

Total
$
1,695.6

 
$
1,601.9

 
$
659.3

 
$
1,080.5

 
$
5,037.3

 
 
 
 
 
 
 
 
 
 
Three-month period ended September 28, 2018:
 
 
 
 
 
 
 
 
 
Geographical region:
 
 
 
 
 
 
 
 
 
North America
$
584.0

 
$
574.0

 
$
339.8

 
$
439.7

 
$
1,937.5

Western Europe
447.1

 
262.3

 
137.2

 
257.5

 
1,104.1

Other developed markets
134.5

 
91.8

 
42.5

 
31.0

 
299.8

High-growth markets (a)
431.1

 
574.4

 
160.0

 
346.2

 
1,511.7

Total
$
1,596.7

 
$
1,502.5

 
$
679.5

 
$
1,074.4

 
$
4,853.1

 
 
 
 
 
 
 
 
 
 
Revenue type:
 
 
 
 
 
 
 
 
 
Recurring
$
1,030.9

 
$
1,273.3

 
$
478.2

 
$
571.1

 
$
3,353.5

Nonrecurring
565.8

 
229.2

 
201.3

 
503.3

 
1,499.6

Total
$
1,596.7

 
$
1,502.5

 
$
679.5

 
$
1,074.4

 
$
4,853.1




 
Life Sciences
 
Diagnostics
 
Dental / Envista
 
Environmental & Applied Solutions
 
Total
Nine-month period ended September 27, 2019:
 
 
 
 
 
 
 
 
 
Geographical region:
 
 
 
 
 
 
 
 
 
North America
$
1,878.1

 
$
1,836.3

 
$
966.4

 
$
1,403.0

 
$
6,083.8

Western Europe
1,363.7

 
828.5

 
443.7

 
774.1

 
3,410.0

Other developed markets
436.1

 
295.6

 
131.0

 
92.7

 
955.4

High-growth markets (a)
1,357.2

 
1,796.6

 
490.0

 
980.8

 
4,624.6

Total
$
5,035.1

 
$
4,757.0

 
$
2,031.1

 
$
3,250.6

 
$
15,073.8

 
 
 
 
 
 
 
 
 
 
Revenue type:
 
 
 
 
 
 
 
 
 
Recurring
$
3,264.4

 
$
4,047.9

 
$
1,489.3

 
$
1,770.2

 
$
10,571.8

Nonrecurring
1,770.7

 
709.1

 
541.8

 
1,480.4

 
4,502.0

Total
$
5,035.1

 
$
4,757.0

 
$
2,031.1

 
$
3,250.6

 
$
15,073.8

 
 
 
 
 
 
 
 
 
 
Nine-month period ended September 28, 2018:
 
 
 
 
 
 
 
 
 
Geographical region:
 
 
 
 
 
 
 
 
 
North America
$
1,642.4

 
$
1,760.1

 
$
977.2

 
$
1,308.7

 
$
5,688.4

Western Europe
1,346.5

 
861.4

 
483.3

 
785.5

 
3,476.7

Other developed markets
417.9

 
275.3

 
133.5

 
94.9

 
921.6

High-growth markets (a)
1,271.1

 
1,676.3

 
491.5

 
1,003.9

 
4,442.8

Total
$
4,677.9

 
$
4,573.1

 
$
2,085.5

 
$
3,193.0

 
$
14,529.5

 
 
 
 
 
 
 
 
 
 
Revenue type:
 
 
 
 
 
 
 
 
 
Recurring
$
3,057.3

 
$
3,892.8

 
$
1,513.5

 
$
1,702.7

 
$
10,166.3

Nonrecurring
1,620.6

 
680.3

 
572.0

 
1,490.3

 
4,363.2

Total
$
4,677.9

 
$
4,573.1

 
$
2,085.5

 
$
3,193.0

 
$
14,529.5


(a) The Company defines high-growth markets as developing markets of the world experiencing extended periods of accelerated growth in gross domestic product and infrastructure which include Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia). The Company defines developed markets as all markets that are not high-growth markets.
The Company sells equipment to customers as well as consumables, spare parts, software licenses and services, some of which customers purchase on a recurring basis. In most of the Company’s businesses, consumables are typically critical to the use of the equipment and are typically used on a one-time or limited basis, requiring frequent replacement in the customer’s operating cycle. Examples of these consumables include reagents used in diagnostic tests, filters used in filtration, separation and purification processes and cartridges for marking and coding equipment. Additionally, some of the Company’s consumables are used on a standalone basis, such as dental implants and water treatment solutions. The Company separates its goods and services between those sold on a recurring basis and those sold on a nonrecurring basis. Recurring revenue includes revenue from consumables, services, spare parts, software licenses recognized over time, software-as-a-service, sales-and-usage based royalties and OTLs. Nonrecurring revenue includes sales from equipment, software licenses recognized at a point in time and STLs. OTLs and STLs are included in the above revenue amounts. For the three-month periods ended September 27, 2019 and September 28, 2018, revenue accounted for under ASC 842 and ASC 840 was $108 million and $115 million, respectively. For the nine-month periods ended September 27, 2019 and September 28, 2018, revenue accounted for under ASC 842 and ASC 840 was $321 million and $308 million, respectively.
Remaining performance obligations related to Topic 606, Revenue from Contracts with Customers (“ASC 606”) represent the aggregate transaction price allocated to performance obligations with an original contract term greater than one year which are fully or partially unsatisfied at the end of the period. As of September 27, 2019, the aggregate amount of the transaction price allocated to remaining performance obligations was approximately $2.0 billion. The Company expects to recognize revenue on
approximately 39% of the remaining performance obligations over the next 12 months, 25% over the subsequent 12 months, and the remainder thereafter.
The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets) and deferred revenue, customer deposits and billings in excess of revenue recognized (contract liabilities) on the Consolidated Condensed Balance Sheets. Most of the Company’s long-term contracts are billed as work progresses in accordance with the contract terms and conditions, either at periodic intervals or upon achievement of certain milestones. Often this results in billing occurring subsequent to revenue recognition resulting in contract assets. Contract assets are generally classified as other current assets in the Consolidated Condensed Balance Sheets. The balance of contract assets as of September 27, 2019 and December 31, 2018 were $77 million and $82 million, respectively.
The Company often receives cash payments from customers in advance of the Company’s performance resulting in contract liabilities. These contract liabilities are classified as either current or long-term in the Consolidated Condensed Balance Sheets based on the timing of when the Company expects to recognize revenue. As of September 27, 2019 and December 31, 2018, contract liabilities were $801 million and $799 million, respectively, and are included within accrued expenses and other liabilities and other long-term liabilities in the accompanying Consolidated Condensed Balance Sheets. Revenue recognized during the nine-month periods ended September 27, 2019 and September 28, 2018 that was included in the contract liability balance on December 31, 2018 and at the date of adoption of ASC 606 on January 1, 2018 was $544 million and $568 million, respectively. Contract assets and liabilities are reported on the accompanying Consolidated Condensed Balance Sheets on a contract-by-contract basis.
XML 24 R81.htm IDEA: XBRL DOCUMENT v3.19.3
Net Earnings Per Share (Components of Basic and Diluted Earnings per Share) (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 27, 2019
Sep. 28, 2018
Numerator        
Net earnings $ 673.9 $ 663.7 $ 1,739.0 $ 1,904.1
Net earnings attributable to noncontrolling interest (5.9) 0.0 (5.9) 0.0
MCPS dividends (19.6) 0.0 (48.8) 0.0
Net earnings attributable to common stockholders 648.4 663.7 1,684.3 1,904.1
Adjustment for interest on convertible debentures 0.4 0.6 1.4 1.7
Net earnings attributable to common stockholders after assumed conversions (used in Diluted EPS) $ 648.8 $ 664.3 $ 1,685.7 $ 1,905.8
Denominator        
Weighted average common shares outstanding (used in Basic EPS) 718.8 701.4 714.7 700.1
Assumed exercise of dilutive options and vesting of dilutive RSUs and PSUs 9.1 6.9 8.9 7.3
Assumed conversion of the convertible debentures 1.4 2.3 1.6 2.5
Weighted average common shares outstanding (used in Diluted EPS) 729.3 710.6 725.2 709.9
Basic EPS $ 0.90 $ 0.95 $ 2.36 $ 2.72
Diluted EPS $ 0.89 $ 0.93 $ 2.32 $ 2.68
XML 25 R71.htm IDEA: XBRL DOCUMENT v3.19.3
Defined Benefit Plans (Components of Net Periodic Benefit Cost Reflected in the Consolidated Condensed Statement of Earnings) (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 27, 2019
Sep. 28, 2018
Defined Benefit Plan Disclosure [Line Items]        
Total service cost $ (9.9) $ (9.8) $ (29.5) $ (31.9)
Other income, net 4.4 9.1 15.9 25.2
Net periodic benefit (cost) (5.5) (0.7) (13.6) (6.7)
Cost of sales        
Defined Benefit Plan Disclosure [Line Items]        
Total service cost (2.0) (1.6) (6.2) (7.0)
Selling, general and administrative expenses        
Defined Benefit Plan Disclosure [Line Items]        
Total service cost $ (7.9) $ (8.2) $ (23.3) $ (24.9)
XML 26 R75.htm IDEA: XBRL DOCUMENT v3.19.3
Commitments And Contingencies (Narrative) (Details)
$ / shares in Units, $ in Millions
9 Months Ended
Sep. 27, 2019
USD ($)
$ / shares
Commitments and Contingencies Disclosure [Abstract]  
Loss contingency accrual, period increase $ 36
Loss contingency accrual, period increase, after-tax $ 29
Loss contingency accrual, period increase, per diluted share | $ / shares $ 0.04
XML 27 R79.htm IDEA: XBRL DOCUMENT v3.19.3
Stock Transactions And Stock-Based Compensation (Components of Stock-Based Compensation Program) (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 27, 2019
Sep. 28, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Pretax compensation expense $ 44.6 $ 38.2 $ 130.0 $ 111.6
Income tax benefit (9.2) (8.0) (27.1) (23.5)
Stock-based compensation expense, net of income taxes 35.4 30.2 102.9 88.1
Restricted stock units (“RSUs”)/performance stock units (“PSUs”)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Pretax compensation expense 27.6 24.0 79.8 69.6
Income tax benefit (5.7) (5.0) (16.6) (14.6)
Stock-based compensation expense, net of income taxes 21.9 19.0 63.2 55.0
Stock options        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Pretax compensation expense 17.0 14.2 50.2 42.0
Income tax benefit (3.5) (3.0) (10.5) (8.9)
Stock-based compensation expense, net of income taxes $ 13.5 $ 11.2 $ 39.7 $ 33.1
XML 28 R56.htm IDEA: XBRL DOCUMENT v3.19.3
Leases (Maturities of Lease Liabilities) (Details) - USD ($)
$ in Millions
Sep. 27, 2019
Jan. 01, 2019
Lessee, Operating Lease, Liability, Payment, Due [Abstract]    
Remainder of fiscal year $ 55.8  
Due in year two 197.3  
Due in year three 160.4  
Due in year four 140.6  
Due in year five 122.0  
Due thereafter 460.3  
Total operating lease payments 1,136.4  
Less: imputed interest 137.4  
Total operating lease liabilities $ 999.0 $ 1,012.0
XML 29 R52.htm IDEA: XBRL DOCUMENT v3.19.3
Leases (Lease Arrangements) (Narrative) (Details)
9 Months Ended
Sep. 27, 2019
Lessee, Lease, Description [Line Items]  
Lessee, operating lease, option to terminate, term 30 days
Maximum  
Lessee, Lease, Description [Line Items]  
Lessee, operating lease, renewal term 30 years
XML 30 R68.htm IDEA: XBRL DOCUMENT v3.19.3
Defined Benefit Plans (Narrative) (Details) - Defined benefit pension plans
$ in Millions
Sep. 27, 2019
USD ($)
U.S. pension benefits  
Defined Benefit Plan Disclosure [Line Items]  
Expected future employer contributions, current fiscal year $ 10
Non-U.S. pension benefits  
Defined Benefit Plan Disclosure [Line Items]  
Expected future employer contributions, current fiscal year $ 50
XML 31 R64.htm IDEA: XBRL DOCUMENT v3.19.3
Financing (Key Terms Of Offering) (Details) - Senior notes - EUR (€)
€ in Millions
Sep. 18, 2019
Sep. 27, 2019
Dec. 31, 2018
0.2% senior notes due 2026      
Debt Instrument [Line Items]      
Aggregate principal amount € 1,250.0 € 1,300.0 € 0.0
Interest rate of debt instrument 0.20% 0.20%  
Debt instrument, redemption price, percent 99.833%    
0.45% senior notes due 2028      
Debt Instrument [Line Items]      
Aggregate principal amount € 1,250.0 € 1,300.0 0.0
Interest rate of debt instrument 0.45% 0.45%  
Debt instrument, redemption price, percent 99.751%    
0.75% senior notes due 2031      
Debt Instrument [Line Items]      
Aggregate principal amount € 1,750.0 € 1,800.0 0.0
Interest rate of debt instrument 0.75% 0.75%  
Debt instrument, redemption price, percent 99.92%    
1.35% senior notes due 2039      
Debt Instrument [Line Items]      
Aggregate principal amount € 1,250.0 € 1,300.0 0.0
Interest rate of debt instrument 1.35% 1.35%  
Debt instrument, redemption price, percent 99.461%    
1.8% senior notes due 2049      
Debt Instrument [Line Items]      
Aggregate principal amount € 750.0 € 750.0 € 0.0
Interest rate of debt instrument 1.80% 1.80%  
Debt instrument, redemption price, percent 99.564%    
XML 32 R60.htm IDEA: XBRL DOCUMENT v3.19.3
Fair Value Measurements (Financial Assets and Liabilities Carried at Fair Value) (Details) - USD ($)
$ in Millions
Sep. 27, 2019
Dec. 31, 2018
Assets:    
Available-for-sale debt securities $ 35.7 $ 38.3
Investment in equity securities 314.4 148.9
Cross-currency swap derivative contracts 36.8  
Liabilities:    
Interest rate swap derivative contracts 64.0  
Deferred compensation plans 64.6 60.9
Quoted Prices in Active Market (Level 1)    
Assets:    
Available-for-sale debt securities 0.0 0.0
Investment in equity securities 0.0 0.0
Cross-currency swap derivative contracts 0.0  
Liabilities:    
Interest rate swap derivative contracts 0.0  
Deferred compensation plans 0.0 0.0
Significant Other Observable Inputs (Level 2)    
Assets:    
Available-for-sale debt securities 35.7 38.3
Investment in equity securities 0.0 0.0
Cross-currency swap derivative contracts 36.8  
Liabilities:    
Interest rate swap derivative contracts 64.0  
Deferred compensation plans 64.6 60.9
Significant Unobservable Inputs (Level 3)    
Assets:    
Available-for-sale debt securities 0.0 0.0
Investment in equity securities 314.4 148.9
Cross-currency swap derivative contracts 0.0  
Liabilities:    
Interest rate swap derivative contracts 0.0  
Deferred compensation plans $ 0.0 $ 0.0
XML 33 R43.htm IDEA: XBRL DOCUMENT v3.19.3
Revenue (Narrative) (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 27, 2019
Sep. 27, 2019
Sep. 28, 2018
Sep. 27, 2019
Sep. 28, 2018
Dec. 31, 2018
Revenue from Contract with Customer [Abstract]            
Revenue, OTLs and STLs   $ 108 $ 115 $ 321 $ 308  
Revenue, remaining performance obligation $ 2,000 2,000   2,000    
Revenue, remaining performance obligation, expected satisfaction in next 12 months, percent 39.00%          
Revenue, remaining performance obligation, expected satisfaction in subsequent 12 months, percent 25.00%          
Contract with customer, asset, net $ 77 77   77   $ 82
Contract with customer, liability $ 801 $ 801   801   $ 799
Contract with customer, liability, revenue recognized       $ 544 $ 568  
XML 34 R47.htm IDEA: XBRL DOCUMENT v3.19.3
Acquisitions (Pro Forma Financial Information) (Narrative) (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 27, 2019
Sep. 28, 2018
Dec. 31, 2018
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]          
Pro forma earnings, adjustments $ 673.9 $ 663.7 $ 1,739.0 $ 1,904.1  
IDT | Acquisition-related transaction costs          
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]          
Pro forma earnings, adjustments         $ 15.0
XML 35 R26.htm IDEA: XBRL DOCUMENT v3.19.3
General (Policies)
9 Months Ended
Sep. 27, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
New accounting standards
Accounting Standards Recently Adopted
In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842), which requires lessees to recognize a right-of-use (“ROU”) asset and a lease liability for all leases with terms greater than 12 months and also requires disclosures by lessees and lessors about the amount, timing and uncertainty of cash flows arising from leases. The accounting applied by a lessor is largely unchanged from that applied under the prior standard. Subsequent to the issuance of Topic 842, the FASB clarified the guidance through several ASUs; hereinafter the collection of lease guidance is referred to as “ASC 842”.
On January 1, 2019, the Company adopted ASC 842 using the modified retrospective method for all lease arrangements at the beginning of the period of adoption. Results for reporting periods beginning January 1, 2019 are presented under ASC 842, while prior period amounts were not adjusted and continue to be reported in accordance with the Company’s historic accounting under ASC 840, Leases (“ASC 840”). The standard had a material impact on the Company’s Consolidated Condensed Balance Sheet but did not have a significant impact on the Company’s consolidated net earnings and cash flows. The most significant impact was the recognition of ROU assets and lease liabilities for operating leases, while the accounting for finance leases remained substantially unchanged. For leases that commenced before the effective date of ASC 842, the Company elected the permitted practical expedients to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. The Company also elected to include leases with a term of 12 months or less in the recognized ROU assets and lease liabilities.
As a result of the cumulative impact of adopting ASC 842, the Company recorded operating lease ROU assets of $971 million and operating lease liabilities of $1,012 million as of January 1, 2019, primarily related to real estate and automobile leases, based on the present value of the future lease payments on the date of adoption. Refer to Note 5 for the additional disclosures required by ASC 842.
The Company determines if an arrangement is a lease at inception. For leases where the Company is the lessee, ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The ROU asset also consists of any prepaid lease payments, lease incentives received, costs which will be incurred in exiting a lease and the amount of any asset or liability recognized on business combinations relating to favorable or unfavorable lease terms. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as depreciation expense and interest expense using the accelerated interest
method of recognition. The Company has lease agreements which require payments for lease and non-lease components and has elected to account for these as a single lease component.
The Company leases Life Sciences, Diagnostics, and Environmental & Applied Solutions equipment to customers in both operating-type lease (“OTL”) and sales-type lease (“STL”) arrangements. Equipment lease revenue for OTL agreements is recognized on a straight-line basis over the life of the lease, and the costs of customer-leased equipment are recorded within property, plant and equipment, net in the accompanying Consolidated Condensed Balance Sheets and depreciated over the equipment’s estimated useful life. Depreciation expense associated with the leased equipment under OTL arrangements is reflected in cost of sales in the accompanying Consolidated Condensed Statements of Earnings. The OTLs are generally not cancellable until after an initial term and may or may not require the customer to purchase a minimum number of consumables or tests throughout the contract term. Certain of the Company’s lease contracts are customized for larger customers and often result in complex terms and conditions that typically require significant judgment in applying the criteria used to evaluate whether the arrangement should be considered an OTL or an STL. An STL results in earlier recognition of equipment revenue as compared to an OTL. Some of the Company’s leases include a purchase option for the customer to purchase the leased asset at the end of the lease arrangement for a purchase price equal to the asset’s fair market value at the time of the purchase. The Company manages its risk on the unguaranteed residual asset for leased equipment through the pricing and term of the leases. In certain geographies, equipment coming off OTL and STL arrangements after the initial lease term may be leased to other customers or used for spare parts.
For lease arrangements with lease and non-lease components where the Company is the lessor, the Company allocates the contract’s transaction price to the lease and non-lease components on a relative standalone selling price basis using the Company’s best estimate of the standalone selling price of each distinct product or service in the contract. The primary method used to estimate standalone selling price is the price observed in standalone sales to customers; however, when prices in standalone sales are not available the Company may use third-party pricing for similar products or services or estimate the standalone selling price. Allocation of the transaction price is determined at the inception of the lease arrangement. The Company’s leases primarily consist of leases with fixed lease payments. For those leases with variable lease payments, the variable lease payment is typically based upon use of the leased equipment or the purchase of consumables used with the leased equipment.
In August 2017, the FASB issued ASU No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities, which expands and refines hedge accounting for both financial and non-financial risk components, aligns the recognition and presentation of the effects of hedging instruments and hedge items in the financial statements and includes certain targeted improvements to ease the application of current guidance related to the assessment of hedge effectiveness. The ASU was effective for public entities for fiscal years beginning after December 15, 2018. In January 2019, the Company entered into approximately $1.9 billion of cross-currency swap derivative contracts to hedge its net investment in foreign operations against adverse changes in the exchange rates between the U.S. dollar and the Danish kroner, Japanese yen, euro and Swiss franc. In June 2019, the Company entered into interest rate swap agreements with a notional amount of $850 million which represents a portion of the amount of U.S. dollar-denominated bonds (with terms ranging from 10 to 30 years) the Company anticipates issuing to finance a portion of the acquisition of the Biopharma Business of General Electric Company (“GE”) Life Sciences (the “GE Biopharma Business” or “GE Biopharma”). These contracts effectively fixed the interest rate for a portion of the Company’s anticipated U.S. dollar-denominated debt issuance equal to the notional amount of the swaps to the rate specified in the interest rate swap agreements. Refer to Note 8 for additional disclosures about the Company’s debt issuances related to the pending GE Biopharma acquisition and Note 9 for additional disclosures about the Company’s hedging activities.
In addition to the cross-currency swaps entered into by the Company in January 2019, in September 2019, Envista entered into $650 million of cross-currency swap derivative contracts with respect to its senior unsecured term loan facility. These contracts effectively convert the senior unsecured term loan facility to an obligation denominated in euro and partially offset the impact of changes in currency rates on Envista’s euro-denominated net investments in foreign operations. In addition, Envista entered into $650 million of interest rate swap derivative contracts to convert the variable interest rate for the senior unsecured term loan facility to a fixed interest rate.
Except for the above accounting policy for leases that was updated as a result of adopting ASC 842, there have been no changes to the Company’s significant accounting policies described in the Annual Report on Form 10-K for the year ended December 31, 2018 that have a material impact on the Company’s Consolidated Condensed Financial Statements and the related Notes.
Accounting Standards Not Yet Adopted
In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which amends the impairment model by requiring entities to use a forward-looking approach
based on expected losses rather than incurred losses to estimate credit losses on certain types of financial instruments, including trade receivables. This may result in the earlier recognition of allowances for losses. The ASU is effective for public entities for fiscal years beginning after December 15, 2019, with early adoption permitted. The ASU will be adopted using a modified retrospective transition method, with the adoption impact recognized through a cumulative-effect adjustment to retained earnings in the period of adoption. In November 2018, April 2019 and May 2019, the FASB issued ASU No. 2018-19, Codification Improvements to Topic 326, Financial Instruments-Credit Losses, ASU No. 2019-04, Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments and ASU No. 2019-05, Financial Instruments-Credit Losses (Topic 326): Targeted Transition Relief which provided additional implementation guidance on the previously issued ASU. Management has not yet completed its assessment of the impact of the new standard on the Company’s financial statements. The Company is in the process of implementing changes to its accounting policies and processes for the new standard. Currently, the Company believes that the most notable impact of this ASU will relate to its processes around the assessment of the adequacy of its allowance for doubtful accounts on trade accounts receivable and the recognition of credit losses.
In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820), which modifies the disclosures on fair value measurements by removing the requirement to disclose the amount and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy and the policy for timing of such transfers. The ASU expands the disclosure requirements for Level 3 fair value measurements, primarily focused on changes in unrealized gains and losses included in other comprehensive income (loss). The ASU is effective for public entities for fiscal years beginning after December 15, 2019, with early adoption permitted. Management has not yet completed its assessment of the impact of the new standard on the Company’s financial statements.
In August 2018, the FASB issued ASU No. 2018-14, Disclosure Framework—Changes to the Disclosure Requirements for Defined Benefit Plans, which amends ASC 715, Compensation—Retirement Benefits, to add, remove, and clarify disclosure requirements related to defined benefit pension and other postretirement plans. The ASU is effective for public entities for fiscal years beginning after December 15, 2020, with early adoption permitted. Management has not yet completed its assessment of the impact of the new standard on the Company’s financial statements.
XML 36 R2.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Condensed Balance Sheets - USD ($)
$ in Millions
Sep. 27, 2019
Dec. 31, 2018
Current assets:    
Cash and equivalents $ 14,252.1 $ 787.8
Trade accounts receivable, net 3,467.1 3,489.6
Inventories:    
Finished goods 1,085.2 1,031.2
Work in process 335.0 313.9
Raw materials 603.5 565.0
Total inventories 2,023.7 1,910.1
Prepaid expenses and other current assets 610.8 906.3
Total current assets 20,353.7 7,093.8
Property, plant and equipment, net of accumulated depreciation of $3,023.3 and $2,828.3, respectively 2,519.6 2,511.2
Other long-term assets 1,787.1 648.4
Goodwill 25,724.8 25,906.0
Other intangible assets, net 11,145.9 11,673.1
Total assets 61,531.1 47,832.5
Current liabilities:    
Notes payable and current portion of long-term debt 1,068.6 51.8
Trade accounts payable 1,606.8 1,712.8
Accrued expenses and other liabilities 3,258.6 3,076.9
Total current liabilities 5,934.0 4,841.5
Other long-term liabilities 5,865.3 5,075.8
Long-term debt 16,536.2 9,688.5
Stockholders’ equity:    
Preferred stock, without par value, 15.0 million shares authorized; 1.65 million shares of 4.75% Mandatory Convertible Preferred Stock, Series A, issued and outstanding at September 27, 2019; no shares issued or outstanding at December 31, 2018 1,599.6 0.0
Common stock - $0.01 par value, 2.0 billion shares authorized; 835.0 million issued and 718.2 million outstanding at September 27, 2019; 817.9 million issued and 701.5 million outstanding at December 31, 2018 8.3 8.2
Additional paid-in capital 7,501.5 5,834.3
Retained earnings 26,481.2 25,163.0
Accumulated other comprehensive income (loss) (3,088.3) (2,791.1)
Total Danaher stockholders’ equity 32,502.3 28,214.4
Noncontrolling interests 693.3 12.3
Total stockholders’ equity 33,195.6 28,226.7
Total liabilities and stockholders’ equity $ 61,531.1 $ 47,832.5
XML 37 R6.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Condensed Statement Of Stockholders' Equity - USD ($)
$ in Millions
Total
Preferred stock
Common stock
Additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Noncontrolling interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Adoption of accounting standards         $ 154.5 $ (151.2)  
Balance, beginning of period at Dec. 31, 2017   $ 0.0 $ 8.1 $ 5,538.2 22,806.1 (1,994.2) $ 9.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of stock   0.0 0.0 0.0      
Sale of Envista Holdings Corporation Stock       0.0   0.0 0.0
Common stock-based award activity     0.1 194.0      
Common stock issued in connection with acquisitions       23.9      
Common stock issued in connection with LYONs’ conversions       16.1      
Net earnings $ 1,904.1       1,904.1    
Dividends declared         (336.0)    
Mandatory convertible preferred stock cumulative dividends         0.0    
Other comprehensive income (loss) (490.3)         (490.3)  
Change in noncontrolling interests             2.2
Balance, end of period at Sep. 28, 2018 27,685.2 0.0 8.2 5,772.2 24,528.7 (2,635.7) 11.8
Balance, beginning of period at Dec. 31, 2017   0.0 8.1 5,538.2 22,806.1 (1,994.2) 9.6
Balance, end of period at Dec. 31, 2018 28,226.7 0.0 8.2 5,834.3 25,163.0 (2,791.1) 12.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Adoption of accounting standards         0.0 0.0  
Balance, beginning of period at Jun. 29, 2018   0.0 8.2 5,706.1 23,977.2 (2,479.2) 12.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of stock   0.0 0.0 0.0      
Sale of Envista Holdings Corporation Stock       0.0   0.0 0.0
Common stock-based award activity     0.0 66.1      
Common stock issued in connection with acquisitions       0.0      
Common stock issued in connection with LYONs’ conversions       0.0      
Net earnings 663.7       663.7    
Dividends declared         (112.2)    
Mandatory convertible preferred stock cumulative dividends         0.0    
Other comprehensive income (loss) (156.5)         (156.5)  
Change in noncontrolling interests             (0.3)
Balance, end of period at Sep. 28, 2018 27,685.2 0.0 8.2 5,772.2 24,528.7 (2,635.7) 11.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Adoption of accounting standards         0.0 0.0  
Balance, beginning of period at Dec. 31, 2018 28,226.7 0.0 8.2 5,834.3 25,163.0 (2,791.1) 12.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of stock   1,599.6 0.1 1,443.1      
Sale of Envista Holdings Corporation Stock       (60.0)   26.1 676.7
Common stock-based award activity     0.0 253.2      
Common stock issued in connection with acquisitions       0.0      
Common stock issued in connection with LYONs’ conversions       30.9      
Net earnings 1,739.0       1,733.1    
Dividends declared         (366.1)    
Mandatory convertible preferred stock cumulative dividends         (48.8)    
Other comprehensive income (loss) (324.5)         (323.3)  
Change in noncontrolling interests             4.3
Balance, end of period at Sep. 27, 2019 33,195.6 1,599.6 8.3 7,501.5 26,481.2 (3,088.3) 693.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Adoption of accounting standards         0.0 0.0  
Balance, beginning of period at Jun. 28, 2019   1,599.6 8.3 7,482.6 25,955.0 (2,844.3) 12.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of stock   0.0 0.0 0.0      
Sale of Envista Holdings Corporation Stock       (60.0)   26.1 676.7
Common stock-based award activity     0.0 77.6      
Common stock issued in connection with acquisitions       0.0      
Common stock issued in connection with LYONs’ conversions       1.3      
Net earnings 673.9       668.0    
Dividends declared         (122.2)    
Mandatory convertible preferred stock cumulative dividends         (19.6)    
Other comprehensive income (loss) (271.3)         (270.1)  
Change in noncontrolling interests             4.6
Balance, end of period at Sep. 27, 2019 $ 33,195.6 $ 1,599.6 $ 8.3 $ 7,501.5 $ 26,481.2 $ (3,088.3) $ 693.3
XML 38 R22.htm IDEA: XBRL DOCUMENT v3.19.3
Stock Transactions And Stock-Based Compensation
9 Months Ended
Sep. 27, 2019
Share-based Payment Arrangement [Abstract]  
Stock Transactions And Stock-Based Compensation STOCK TRANSACTIONS AND STOCK-BASED COMPENSATION
Neither the Company nor any “affiliated purchaser” repurchased any shares of Company common stock during the nine-month period ended September 27, 2019. On July 16, 2013, the Company’s Board of Directors approved a repurchase program (the “Repurchase Program”) authorizing the repurchase of up to 20 million shares of the Company’s common stock from time to time on the open market or in privately negotiated transactions. As of September 27, 2019, 20 million shares remained available for repurchase pursuant to the Repurchase Program.
The following table summarizes the Company’s share activity (shares in millions):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Preferred stock - shares issued:
 
 
 
 
 
 
 
Balance, beginning of period
1.7

 

 

 

Issuance of MCPS

 

 
1.7

 

Balance, end of period
1.7

 

 
1.7

 

 
 
 
 
 
 
 
 
Common stock - shares issued:
 
 
 
 
 
 
 
Balance, beginning of period
834.0

 
816.0

 
817.9

 
812.5

Common stock-based award activity
1.0

 
1.2

 
4.1

 
4.0

Common stock issued in connection with acquisitions

 

 

 
0.2

Common stock issued in connection with LYONs’ conversions

 

 
0.9

 
0.5

Issuance of common stock

 

 
12.1

 

Balance, end of period
835.0

 
817.2

 
835.0

 
817.2


On March 1, 2019, the Company completed the underwritten public offering of 12.1 million shares of Danaher common stock at a price to the public of $123.00 per share (the “Common Stock Offering”), resulting in net proceeds of approximately $1.4 billion, after deducting expenses and the underwriters’ discount of $45 million. Simultaneously, the Company completed the underwritten public offering of 1.65 million shares of its 4.75% MCPS, Series A, without par value and with a liquidation preference of $1,000 per share (the “MCPS Offering”), resulting in net proceeds of approximately $1.6 billion, after deducting expenses and the underwriters’ discount of $50 million. The Company intends to use the net proceeds from the Common Stock
Offering and the MCPS Offering to fund a portion of the cash consideration payable for, and certain costs associated with, the GE Biopharma Acquisition. Pending completion of the GE Biopharma Acquisition, the Company has invested the net proceeds in short-term bank deposits and/or interest-bearing, investment-grade securities.
As a result of the dividend paid to shareholders of the Company’s common stock in July 2019, the Company triggered an anti-dilution adjustment pursuant to the terms of the MCPS and after giving affect to this adjustment, each share of MCPS will mandatorily convert on the mandatory conversion date, which is expected to be April 15, 2022, into between 6.6382 and 8.1318 shares of the Company’s common stock, subject to further anti-dilution adjustments. The number of shares of the Company’s common stock issuable upon conversion will be determined based on the average volume-weighted average price per share of the Company’s common stock over the 20 consecutive trading day period beginning on, and including, the 21st scheduled trading day immediately before April 15, 2022. Subject to certain exceptions, at any time prior to April 15, 2022, holders may elect to convert each share of the MCPS into 6.6382 shares of common stock, subject to further anti-dilution adjustments. In the event of a fundamental change, the MCPS will convert at the fundamental change rates specified in the certificate of designations, and the holders of MCPS would be entitled to a fundamental change make-whole dividend.
Holders of MCPS will be entitled to receive, when and if declared by the Company’s Board of Directors, cumulative dividends at the annual rate of 4.75% of the liquidation preference of $1,000 per share (equivalent to $47.50 annually per share), payable in cash or, subject to certain limitations, by delivery of shares of the Company’s common stock or any combination of cash and shares of the Company’s common stock, at the Company’s election. If declared, dividends on the MCPS will be payable quarterly on January 15, April 15, July 15 and October 15 of each year (commencing on July 15, 2019 to, and including, April 15, 2022), to the holders of record of the MCPS as they appear on the Company’s stock register at the close of business on the immediately preceding December 31, March 31, June 30 and September 30, respectively.
If the GE Biopharma Acquisition has not closed on or before 5:00 p.m. (New York City time) on August 25, 2020, the GE Biopharma Purchase Agreement is terminated or the Company’s Board of Directors, in its good faith judgment, determines that the GE Biopharma Acquisition will not occur, the Company has the option to redeem the shares of MCPS, in whole but not in part, subject to certain terms and conditions.
For a full description of the Company’s stock-based compensation programs, refer to Note 18 of the Company’s financial statements as of and for the year ended December 31, 2018 included in the Company’s 2018 Annual Report. As of September 27, 2019, approximately 46 million shares of the Company’s common stock were reserved for issuance under the 2007 Omnibus Incentive Plan.
In connection with the Envista IPO, Envista has adopted a stock-based compensation plan, which provides for grants of stock options, performance stock units (“PSUs”), restricted stock units (“RSUs”) and other stock-based awards denominated in shares of Envista common stock. Envista employees who participated in the Danaher stock compensation program prior to the IPO will continue to participate in such program solely with respect to outstanding compensation awards received prior to the Envista IPO, until the Distribution (at which time such awards will be converted into awards denominated in Envista common stock under the Envista stock compensation plan). From and after the Envista IPO, all equity compensation awarded to Envista associates will be awarded under the Envista stock compensation plan. Stock-based compensation expense for the Envista stock-based compensation plan is included in the Company’s consolidated stock-based compensation expense.
The following summarizes the components of the Company’s stock-based compensation expense ($ in millions):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
RSUs/PSUs:
 
 
 
 
 
 
 
Pretax compensation expense
$
27.6

 
$
24.0

 
$
79.8

 
$
69.6

Income tax benefit
(5.7
)
 
(5.0
)
 
(16.6
)
 
(14.6
)
RSU/PSU expense, net of income taxes
21.9

 
19.0

 
63.2

 
55.0

Stock options:
 
 
 
 
 
 
 
Pretax compensation expense
17.0

 
14.2

 
50.2

 
42.0

Income tax benefit
(3.5
)
 
(3.0
)
 
(10.5
)
 
(8.9
)
Stock option expense, net of income taxes
13.5

 
11.2

 
39.7

 
33.1

Total stock-based compensation:
 
 
 
 
 
 
 
Pretax compensation expense
44.6

 
38.2

 
130.0

 
111.6

Income tax benefit
(9.2
)
 
(8.0
)
 
(27.1
)
 
(23.5
)
Total stock-based compensation expense, net of income taxes
$
35.4

 
$
30.2

 
$
102.9

 
$
88.1


Stock-based compensation has been recognized as a component of selling, general and administrative expenses in the accompanying Consolidated Condensed Statements of Earnings. As of September 27, 2019, $192 million of total unrecognized compensation cost related to RSUs/PSUs is expected to be recognized over a weighted average period of approximately two years. As of September 27, 2019, $178 million of total unrecognized compensation cost related to stock options is expected to be recognized over a weighted average period of approximately three years. Future compensation amounts will be adjusted for any changes in estimated forfeitures.
XML 39 R65.htm IDEA: XBRL DOCUMENT v3.19.3
Hedging Transactions And Derivative Financial Instruments (Narrative) (Details) - USD ($)
$ in Millions
Sep. 27, 2019
Jun. 28, 2019
Jan. 31, 2019
Foreign currency contracts | Subsidiaries | Envista      
Derivative [Line Items]      
Derivative, notional amount $ 650.0    
Net investment hedging | Foreign currency contracts      
Derivative [Line Items]      
Derivative, notional amount 1,650.0   $ 1,900.0
Cash flow hedging | Interest rate swaps      
Derivative [Line Items]      
Derivative, notional amount 1,500.0    
Cash flow hedging | Interest rate swaps | Subsidiaries | Envista      
Derivative [Line Items]      
Derivative, notional amount 650.0    
U.S. dollar-denominated bonds | Net investment hedging | Foreign currency contracts      
Derivative [Line Items]      
Derivative, notional amount $ 1,000.0   $ 1,900.0
U.S. dollar-denominated bonds | Cash flow hedging | Interest rate swaps      
Derivative [Line Items]      
Derivative, notional amount   $ 850.0  
XML 40 R61.htm IDEA: XBRL DOCUMENT v3.19.3
Fair Value Measurements (Carrying Amounts and Fair Values of Financial Instruments) (Details) - USD ($)
$ in Millions
Sep. 27, 2019
Dec. 31, 2018
Assets:    
Available-for-sale debt securities $ 35.7 $ 38.3
Investment in equity securities 314.4 148.9
Cross-currency swap derivative contracts 36.8  
Liabilities:    
Interest rate swap derivative contracts 64.0  
Carrying Amount    
Assets:    
Available-for-sale debt securities 35.7 38.3
Investment in equity securities 314.4 148.9
Cross-currency swap derivative contracts 36.8 0.0
Liabilities:    
Interest rate swap derivative contracts 64.0 0.0
Notes payable and current portion of long-term debt 1,068.6 51.8
Long-term debt 16,536.2 9,688.5
Fair Value    
Assets:    
Available-for-sale debt securities 35.7 38.3
Investment in equity securities 314.4 148.9
Cross-currency swap derivative contracts 36.8 0.0
Liabilities:    
Interest rate swap derivative contracts 64.0 0.0
Notes payable and current portion of long-term debt 1,068.6 51.8
Long-term debt $ 17,045.5 $ 9,990.6
XML 41 R69.htm IDEA: XBRL DOCUMENT v3.19.3
Defined Benefit Plans (Components of Net Periodic Benefit Cost of Defined Benefit Pension Pans) (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 27, 2019
Sep. 28, 2018
Defined Benefit Plan Disclosure [Line Items]        
Service cost $ (9.9) $ (9.8) $ (29.5) $ (31.9)
Net periodic benefit (cost) (5.5) (0.7) (13.6) (6.7)
Defined benefit pension plans | U.S. pension benefits        
Defined Benefit Plan Disclosure [Line Items]        
Service cost (1.6) (1.2) (4.8) (5.4)
Interest cost (22.1) (20.3) (66.6) (60.7)
Expected return on plan assets 31.0 33.0 94.2 99.2
Amortization of actuarial loss (6.7) (8.0) (19.2) (23.6)
Amortization of prior service (cost) credit (0.2) (0.2) (0.7) (0.7)
Net periodic benefit (cost) 0.4 3.3 2.9 8.8
Defined benefit pension plans | Non-U.S. pension benefits        
Defined Benefit Plan Disclosure [Line Items]        
Service cost (8.2) (8.6) (24.4) (26.2)
Interest cost (6.6) (6.3) (19.9) (19.6)
Expected return on plan assets 10.9 11.6 32.7 35.6
Amortization of actuarial loss (3.9) (1.5) (3.7) (4.5)
Amortization of prior service (cost) credit 2.6 0.2 0.2 0.4
Curtailment gain recognized 0.0 0.0 1.1 0.0
Settlement loss recognized 0.1 1.2 0.0 0.8
Net periodic benefit (cost) $ (5.1) $ (3.4) $ (14.0) $ (13.5)
XML 42 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 43 R42.htm IDEA: XBRL DOCUMENT v3.19.3
General (Components of Accumulated Other Comprehensive Income) (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jan. 01, 2018
Sep. 27, 2019
Sep. 28, 2018
Sep. 27, 2019
Sep. 28, 2018
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]          
Beginning balance       $ (2,791.1)  
Total other comprehensive income (loss), net of income taxes   $ (271.3) $ (156.5) (324.5) $ (490.3)
Ending balance   (3,088.3)   (3,088.3)  
Foreign Currency Translation Adjustments          
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]          
Beginning balance $ (1,422.1) (2,155.4) (1,812.9) (2,098.1) (1,422.1)
Adoption of accounting standards (43.8)        
Increase (decrease)   (226.8) (162.4) (286.0) (509.4)
Income tax impact   (9.0) 0.0 (7.1) 0.0
Other comprehensive income (loss) before reclassifications, net of income taxes   (235.8) (162.4) (293.1) (509.4)
Increase (decrease)   0.0 0.0 0.0 0.0
Income tax impact   0.0 0.0 0.0 0.0
Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes   0.0 0.0 0.0 0.0
Total other comprehensive income (loss), net of income taxes   (235.8) (162.4) (293.1) (509.4)
Ending balance (1,465.9) (2,391.2) (1,975.3) (2,391.2) (1,975.3)
Pension & Postretirement Plan Benefit Adjustments          
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]          
Beginning balance (571.2) (681.1) (664.6) (691.1) (571.2)
Adoption of accounting standards (107.2)        
Increase (decrease)   0.0 0.0 0.0 0.0
Income tax impact   0.0 0.0 0.0 0.0
Other comprehensive income (loss) before reclassifications, net of income taxes   0.0 0.0 0.0 0.0
Increase (decrease)   7.5 7.7 20.7 25.8
Income tax impact   (1.7) (1.8) (4.9) (6.1)
Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes   5.8 5.9 15.8 19.7
Total other comprehensive income (loss), net of income taxes   5.8 5.9 15.8 19.7
Ending balance (678.4) (675.3) (658.7) (675.3) (658.7)
Unrealized Gain (Loss) on Available-For-Sale Securities Adjustments          
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]          
Beginning balance (0.9) (1.0) (1.7) (1.9) (0.9)
Adoption of accounting standards (0.2)        
Increase (decrease)   0.6 0.0 1.8 (0.8)
Income tax impact   (0.1) 0.0 (0.4) 0.2
Other comprehensive income (loss) before reclassifications, net of income taxes   0.5 0.0 1.4 (0.6)
Increase (decrease)   0.0 0.0 0.0 0.0
Income tax impact   0.0 0.0 0.0 0.0
Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes   0.0 0.0 0.0 0.0
Total other comprehensive income (loss), net of income taxes   0.5 0.0 1.4 (0.6)
Ending balance (1.1) (0.5) (1.7) (0.5) (1.7)
Cash Flow Hedge Adjustments          
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]          
Beginning balance 0.0 (6.8) 0.0 0.0 0.0
Adoption of accounting standards 0.0        
Increase (decrease)   (55.1) 0.0 (64.0) 0.0
Income tax impact   13.3 0.0 15.4 0.0
Other comprehensive income (loss) before reclassifications, net of income taxes   (41.8) 0.0 (48.6) 0.0
Increase (decrease)   0.0 0.0 0.0 0.0
Income tax impact   0.0 0.0 0.0 0.0
Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes   0.0 0.0 0.0 0.0
Total other comprehensive income (loss), net of income taxes   (41.8) 0.0 (48.6) 0.0
Ending balance 0.0 (48.6) 0.0 (48.6) 0.0
AOCI Including Portion Attributable to Noncontrolling Interest [Member]          
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]          
Beginning balance (1,994.2) (2,844.3) (2,479.2) (2,791.1) (1,994.2)
Adoption of accounting standards (151.2)        
Increase (decrease)   (281.3) (162.4) (348.2) (510.2)
Income tax impact   4.2 0.0 7.9 0.2
Other comprehensive income (loss) before reclassifications, net of income taxes   (277.1) (162.4) (340.3) (510.0)
Increase (decrease)   7.5 7.7 20.7 25.8
Income tax impact   (1.7) (1.8) (4.9) (6.1)
Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes   5.8 5.9 15.8 19.7
Total other comprehensive income (loss), net of income taxes   (271.3) (156.5) (324.5) (490.3)
Ending balance $ (2,145.4) (3,115.6) (2,635.7) (3,115.6) (2,635.7)
AOCI attributable to controlling interest          
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]          
Total other comprehensive income (loss), net of income taxes   (270.1) $ (156.5) (323.3) $ (490.3)
Ending balance   (3,088.3)   (3,088.3)  
AOCI attributable to noncontrolling interest          
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]          
Total other comprehensive income (loss), net of income taxes   (1.2)   (1.2)  
Ending balance   $ (27.3)   $ (27.3)  
XML 44 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3 html 473 387 1 false 111 0 false 10 false false R1.htm 0001000 - Document - Cover Page Sheet http://www.danaher.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1001000 - Statement - Consolidated Condensed Balance Sheets Sheet http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets Consolidated Condensed Balance Sheets Statements 2 false false R3.htm 1001001 - Statement - Consolidated Condensed Balance Sheets Consolidated Condensed Balance Sheets (Parenthetical) Sheet http://www.danaher.com/role/ConsolidatedCondensedBalanceSheetsConsolidatedCondensedBalanceSheetsParenthetical Consolidated Condensed Balance Sheets Consolidated Condensed Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - Consolidated Condensed Statements Of Earnings Sheet http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings Consolidated Condensed Statements Of Earnings Statements 4 false false R5.htm 1003000 - Statement - Consolidated Condensed Statements Of Comprehensive Income Sheet http://www.danaher.com/role/ConsolidatedCondensedStatementsOfComprehensiveIncome Consolidated Condensed Statements Of Comprehensive Income Statements 5 false false R6.htm 1004000 - Statement - Consolidated Condensed Statement Of Stockholders' Equity Sheet http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquity Consolidated Condensed Statement Of Stockholders' Equity Statements 6 false false R7.htm 1004001 - Statement - Consolidated Condensed Statement Of Stockholders' Equity Consolidated Condensed Statement Of Stockholders' Equity (Parenthetical) Sheet http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquityConsolidatedCondensedStatementOfStockholdersEquityParenthetical Consolidated Condensed Statement Of Stockholders' Equity Consolidated Condensed Statement Of Stockholders' Equity (Parenthetical) Statements 7 false false R8.htm 1005000 - Statement - Consolidated Condensed Statements Of Cash Flows Sheet http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows Consolidated Condensed Statements Of Cash Flows Statements 8 false false R9.htm 2101100 - Disclosure - General Sheet http://www.danaher.com/role/General General Notes 9 false false R10.htm 2103100 - Disclosure - Revenue (Notes) Notes http://www.danaher.com/role/RevenueNotes Revenue (Notes) Notes 10 false false R11.htm 2105100 - Disclosure - Acquisitions Sheet http://www.danaher.com/role/Acquisitions Acquisitions Notes 11 false false R12.htm 2106100 - Disclosure - Envista Initial Public Offering (Notes) Notes http://www.danaher.com/role/EnvistaInitialPublicOfferingNotes Envista Initial Public Offering (Notes) Notes 12 false false R13.htm 2108100 - Disclosure - Leases (Notes) Notes http://www.danaher.com/role/LeasesNotes Leases (Notes) Notes 13 false false R14.htm 2109100 - Disclosure - Goodwill Sheet http://www.danaher.com/role/Goodwill Goodwill Notes 14 false false R15.htm 2111100 - Disclosure - Fair Value Measurements Sheet http://www.danaher.com/role/FairValueMeasurements Fair Value Measurements Notes 15 false false R16.htm 2112100 - Disclosure - Financing Sheet http://www.danaher.com/role/Financing Financing Notes 16 false false R17.htm 2114100 - Disclosure - Hedging Transactions And Derivative Financial Instruments (Notes) Notes http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNotes Hedging Transactions And Derivative Financial Instruments (Notes) Notes 17 false false R18.htm 2115100 - Disclosure - Defined Benefit Plans Sheet http://www.danaher.com/role/DefinedBenefitPlans Defined Benefit Plans Notes 18 false false R19.htm 2117100 - Disclosure - Income Taxes Sheet http://www.danaher.com/role/IncomeTaxes Income Taxes Notes 19 false false R20.htm 2118100 - Disclosure - Nonoperating Income (Expense) Sheet http://www.danaher.com/role/NonoperatingIncomeExpense Nonoperating Income (Expense) Notes 20 false false R21.htm 2119100 - Disclosure - Commitments And Contingencies Sheet http://www.danaher.com/role/CommitmentsAndContingencies Commitments And Contingencies Notes 21 false false R22.htm 2120100 - Disclosure - Stock Transactions And Stock-Based Compensation Sheet http://www.danaher.com/role/StockTransactionsAndStockBasedCompensation Stock Transactions And Stock-Based Compensation Notes 22 false false R23.htm 2121100 - Disclosure - Net Earnings Per Share Sheet http://www.danaher.com/role/NetEarningsPerShare Net Earnings Per Share Notes 23 false false R24.htm 2122100 - Disclosure - Segment Information Sheet http://www.danaher.com/role/SegmentInformation Segment Information Notes 24 false false R25.htm 2123100 - Disclosure - Subsequent Event (Notes) Notes http://www.danaher.com/role/SubsequentEventNotes Subsequent Event (Notes) Notes 25 false false R26.htm 2201202 - Disclosure - General (Policies) Sheet http://www.danaher.com/role/GeneralPolicies General (Policies) Policies 26 false false R27.htm 2301301 - Disclosure - General (Tables) Sheet http://www.danaher.com/role/GeneralTables General (Tables) Tables http://www.danaher.com/role/General 27 false false R28.htm 2303301 - Disclosure - Revenue (Tables) Sheet http://www.danaher.com/role/RevenueTables Revenue (Tables) Tables http://www.danaher.com/role/RevenueNotes 28 false false R29.htm 2305301 - Disclosure - Acquisitions (Tables) Sheet http://www.danaher.com/role/AcquisitionsTables Acquisitions (Tables) Tables http://www.danaher.com/role/Acquisitions 29 false false R30.htm 2308301 - Disclosure - Leases (Tables) Sheet http://www.danaher.com/role/LeasesTables Leases (Tables) Tables http://www.danaher.com/role/LeasesNotes 30 false false R31.htm 2309301 - Disclosure - Goodwill (Tables) Sheet http://www.danaher.com/role/GoodwillTables Goodwill (Tables) Tables http://www.danaher.com/role/Goodwill 31 false false R32.htm 2311301 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.danaher.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.danaher.com/role/FairValueMeasurements 32 false false R33.htm 2312301 - Disclosure - Financing (Tables) Sheet http://www.danaher.com/role/FinancingTables Financing (Tables) Tables http://www.danaher.com/role/Financing 33 false false R34.htm 2314301 - Disclosure - Hedging Transactions And Derivative Financial Instruments (Tables) Sheet http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsTables Hedging Transactions And Derivative Financial Instruments (Tables) Tables http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNotes 34 false false R35.htm 2315301 - Disclosure - Defined Benefit Plans (Tables) Sheet http://www.danaher.com/role/DefinedBenefitPlansTables Defined Benefit Plans (Tables) Tables http://www.danaher.com/role/DefinedBenefitPlans 35 false false R36.htm 2317301 - Disclosure - Income Taxes (Tables) Sheet http://www.danaher.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.danaher.com/role/IncomeTaxes 36 false false R37.htm 2319301 - Disclosure - Commitments And Contingencies (Tables) Sheet http://www.danaher.com/role/CommitmentsAndContingenciesTables Commitments And Contingencies (Tables) Tables http://www.danaher.com/role/CommitmentsAndContingencies 37 false false R38.htm 2320301 - Disclosure - Stock Transactions And Stock-Based Compensation (Tables) Sheet http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationTables Stock Transactions And Stock-Based Compensation (Tables) Tables http://www.danaher.com/role/StockTransactionsAndStockBasedCompensation 38 false false R39.htm 2321301 - Disclosure - Net Earnings Per Share (Tables) Sheet http://www.danaher.com/role/NetEarningsPerShareTables Net Earnings Per Share (Tables) Tables http://www.danaher.com/role/NetEarningsPerShare 39 false false R40.htm 2322301 - Disclosure - Segment Information (Tables) Sheet http://www.danaher.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.danaher.com/role/SegmentInformation 40 false false R41.htm 2401403 - Disclosure - General (Narrative) (Details) Sheet http://www.danaher.com/role/GeneralNarrativeDetails General (Narrative) (Details) Details http://www.danaher.com/role/GeneralTables 41 false false R42.htm 2401404 - Disclosure - General (Components of Accumulated Other Comprehensive Income) (Details) Sheet http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails General (Components of Accumulated Other Comprehensive Income) (Details) Details http://www.danaher.com/role/GeneralTables 42 false false R43.htm 2403402 - Disclosure - Revenue (Narrative) (Details) Sheet http://www.danaher.com/role/RevenueNarrativeDetails Revenue (Narrative) (Details) Details http://www.danaher.com/role/RevenueTables 43 false false R44.htm 2403403 - Disclosure - Revenue (Disaggregation of Revenue by Geographical Region) (Details) Sheet http://www.danaher.com/role/RevenueDisaggregationOfRevenueByGeographicalRegionDetails Revenue (Disaggregation of Revenue by Geographical Region) (Details) Details http://www.danaher.com/role/RevenueTables 44 false false R45.htm 2403404 - Disclosure - Revenue (Disaggregation of Revenue by Revenue Type) (Details) Sheet http://www.danaher.com/role/RevenueDisaggregationOfRevenueByRevenueTypeDetails Revenue (Disaggregation of Revenue by Revenue Type) (Details) Details http://www.danaher.com/role/RevenueTables 45 false false R46.htm 2405402 - Disclosure - Acquisitions (Narrative) (Details) Sheet http://www.danaher.com/role/AcquisitionsNarrativeDetails Acquisitions (Narrative) (Details) Details http://www.danaher.com/role/AcquisitionsTables 46 false false R47.htm 2405403 - Disclosure - Acquisitions (Pro Forma Financial Information) (Narrative) (Details) Sheet http://www.danaher.com/role/AcquisitionsProFormaFinancialInformationNarrativeDetails Acquisitions (Pro Forma Financial Information) (Narrative) (Details) Details http://www.danaher.com/role/AcquisitionsTables 47 false false R48.htm 2405404 - Disclosure - Acquisitions (Fair Values Of The Assets Acquired And Liabilities) (Details) Sheet http://www.danaher.com/role/AcquisitionsFairValuesOfAssetsAcquiredAndLiabilitiesDetails Acquisitions (Fair Values Of The Assets Acquired And Liabilities) (Details) Details http://www.danaher.com/role/AcquisitionsTables 48 false false R49.htm 2405405 - Disclosure - Acquisitions (Pro Forma Financial Information) (Details) Sheet http://www.danaher.com/role/AcquisitionsProFormaFinancialInformationDetails Acquisitions (Pro Forma Financial Information) (Details) Details http://www.danaher.com/role/AcquisitionsTables 49 false false R50.htm 2405406 - Disclosure - Acquisitions (Pending Acquisition) (Narrative) (Details) Sheet http://www.danaher.com/role/AcquisitionsPendingAcquisitionNarrativeDetails Acquisitions (Pending Acquisition) (Narrative) (Details) Details http://www.danaher.com/role/AcquisitionsTables 50 false false R51.htm 2406401 - Disclosure - Envista Initial Public Offering (Narrative) (Details) Sheet http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails Envista Initial Public Offering (Narrative) (Details) Details http://www.danaher.com/role/EnvistaInitialPublicOfferingNotes 51 false false R52.htm 2408402 - Disclosure - Leases (Lease Arrangements) (Narrative) (Details) Sheet http://www.danaher.com/role/LeasesLeaseArrangementsNarrativeDetails Leases (Lease Arrangements) (Narrative) (Details) Details http://www.danaher.com/role/LeasesTables 52 false false R53.htm 2408403 - Disclosure - Leases (Components of Lease Expense) (Details) Sheet http://www.danaher.com/role/LeasesComponentsOfLeaseExpenseDetails Leases (Components of Lease Expense) (Details) Details http://www.danaher.com/role/LeasesTables 53 false false R54.htm 2408404 - Disclosure - Leases (Supplemental Cash Flow Information) (Details) Sheet http://www.danaher.com/role/LeasesSupplementalCashFlowInformationDetails Leases (Supplemental Cash Flow Information) (Details) Details http://www.danaher.com/role/LeasesTables 54 false false R55.htm 2408405 - Disclosure - Leases (Supplemental Balance Sheet Inofrmation) (Details) Sheet http://www.danaher.com/role/LeasesSupplementalBalanceSheetInofrmationDetails Leases (Supplemental Balance Sheet Inofrmation) (Details) Details http://www.danaher.com/role/LeasesTables 55 false false R56.htm 2408406 - Disclosure - Leases (Maturities of Lease Liabilities) (Details) Sheet http://www.danaher.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails Leases (Maturities of Lease Liabilities) (Details) Details http://www.danaher.com/role/LeasesTables 56 false false R57.htm 2409402 - Disclosure - Goodwill (Rollforward of Goodwill) (Details) Sheet http://www.danaher.com/role/GoodwillRollforwardOfGoodwillDetails Goodwill (Rollforward of Goodwill) (Details) Details http://www.danaher.com/role/GoodwillTables 57 false false R58.htm 2409403 - Disclosure - Goodwill (Goodwill by Segment) (Details) Sheet http://www.danaher.com/role/GoodwillGoodwillBySegmentDetails Goodwill (Goodwill by Segment) (Details) Details http://www.danaher.com/role/GoodwillTables 58 false false R59.htm 2411402 - Disclosure - Fair Value Measurements (Narrative) (Details) Sheet http://www.danaher.com/role/FairValueMeasurementsNarrativeDetails Fair Value Measurements (Narrative) (Details) Details http://www.danaher.com/role/FairValueMeasurementsTables 59 false false R60.htm 2411403 - Disclosure - Fair Value Measurements (Financial Assets and Liabilities Carried at Fair Value) (Details) Sheet http://www.danaher.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails Fair Value Measurements (Financial Assets and Liabilities Carried at Fair Value) (Details) Details http://www.danaher.com/role/FairValueMeasurementsTables 60 false false R61.htm 2411404 - Disclosure - Fair Value Measurements (Carrying Amounts and Fair Values of Financial Instruments) (Details) Sheet http://www.danaher.com/role/FairValueMeasurementsCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails Fair Value Measurements (Carrying Amounts and Fair Values of Financial Instruments) (Details) Details http://www.danaher.com/role/FairValueMeasurementsTables 61 false false R62.htm 2412402 - Disclosure - Financing (Narrative) (Details) Sheet http://www.danaher.com/role/FinancingNarrativeDetails Financing (Narrative) (Details) Details http://www.danaher.com/role/FinancingTables 62 false false R63.htm 2412403 - Disclosure - Financing (Components Of Debt) (Details) Sheet http://www.danaher.com/role/FinancingComponentsOfDebtDetails Financing (Components Of Debt) (Details) Details http://www.danaher.com/role/FinancingTables 63 false false R64.htm 2412404 - Disclosure - Financing (Key Terms Of Offering) (Details) Sheet http://www.danaher.com/role/FinancingKeyTermsOfOfferingDetails Financing (Key Terms Of Offering) (Details) Details http://www.danaher.com/role/FinancingTables 64 false false R65.htm 2414402 - Disclosure - Hedging Transactions And Derivative Financial Instruments (Narrative) (Details) Sheet http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails Hedging Transactions And Derivative Financial Instruments (Narrative) (Details) Details http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsTables 65 false false R66.htm 2414403 - Disclosure - Hedging Transactions And Derivative Financial Instruments (Summary of Notional Values and Pretax Impact in Fair Values of Net Investment Hedges) (Details) Sheet http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryOfNotionalValuesAndPretaxImpactInFairValuesOfNetInvestmentHedgesDetails Hedging Transactions And Derivative Financial Instruments (Summary of Notional Values and Pretax Impact in Fair Values of Net Investment Hedges) (Details) Details http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsTables 66 false false R67.htm 2414404 - Disclosure - Hedging Transactions And Derivative Financial Instruments (Derivative and Nonderivative Debt Instruments) (Details) Sheet http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeAndNonderivativeDebtInstrumentsDetails Hedging Transactions And Derivative Financial Instruments (Derivative and Nonderivative Debt Instruments) (Details) Details http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsTables 67 false false R68.htm 2415402 - Disclosure - Defined Benefit Plans (Narrative) (Details) Sheet http://www.danaher.com/role/DefinedBenefitPlansNarrativeDetails Defined Benefit Plans (Narrative) (Details) Details http://www.danaher.com/role/DefinedBenefitPlansTables 68 false false R69.htm 2415403 - Disclosure - Defined Benefit Plans (Components of Net Periodic Benefit Cost of Defined Benefit Pension Pans) (Details) Sheet http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfDefinedBenefitPensionPansDetails Defined Benefit Plans (Components of Net Periodic Benefit Cost of Defined Benefit Pension Pans) (Details) Details http://www.danaher.com/role/DefinedBenefitPlansTables 69 false false R70.htm 2415404 - Disclosure - Defined Benefit Plans (Components of Net Periodic Benefit Cost of Other Postretirement Benefit Pension Pans) (Details) Sheet http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfOtherPostretirementBenefitPensionPansDetails Defined Benefit Plans (Components of Net Periodic Benefit Cost of Other Postretirement Benefit Pension Pans) (Details) Details http://www.danaher.com/role/DefinedBenefitPlansTables 70 false false R71.htm 2415405 - Disclosure - Defined Benefit Plans (Components of Net Periodic Benefit Cost Reflected in the Consolidated Condensed Statement of Earnings) (Details) Sheet http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostReflectedInConsolidatedCondensedStatementOfEarningsDetails Defined Benefit Plans (Components of Net Periodic Benefit Cost Reflected in the Consolidated Condensed Statement of Earnings) (Details) Details http://www.danaher.com/role/DefinedBenefitPlansTables 71 false false R72.htm 2417402 - Disclosure - Income Taxes (Narrative) (Details) Sheet http://www.danaher.com/role/IncomeTaxesNarrativeDetails Income Taxes (Narrative) (Details) Details http://www.danaher.com/role/IncomeTaxesTables 72 false false R73.htm 2417403 - Disclosure - Income Taxes (Summary Of Danaher's Effective Income Tax Rate) (Details) Sheet http://www.danaher.com/role/IncomeTaxesSummaryOfDanahersEffectiveIncomeTaxRateDetails Income Taxes (Summary Of Danaher's Effective Income Tax Rate) (Details) Details http://www.danaher.com/role/IncomeTaxesTables 73 false false R74.htm 2418401 - Disclosure - Nonoperating Income (Expense) (Narrative) (Details) Sheet http://www.danaher.com/role/NonoperatingIncomeExpenseNarrativeDetails Nonoperating Income (Expense) (Narrative) (Details) Details http://www.danaher.com/role/NonoperatingIncomeExpense 74 false false R75.htm 2419402 - Disclosure - Commitments And Contingencies (Narrative) (Details) Sheet http://www.danaher.com/role/CommitmentsAndContingenciesNarrativeDetails Commitments And Contingencies (Narrative) (Details) Details http://www.danaher.com/role/CommitmentsAndContingenciesTables 75 false false R76.htm 2419403 - Disclosure - Commitments And Contingencies (Warranty Accrual) (Details) Sheet http://www.danaher.com/role/CommitmentsAndContingenciesWarrantyAccrualDetails Commitments And Contingencies (Warranty Accrual) (Details) Details http://www.danaher.com/role/CommitmentsAndContingenciesTables 76 false false R77.htm 2420402 - Disclosure - Stock Transactions And Stock-Based Compensation (Narrative) (Details) Sheet http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails Stock Transactions And Stock-Based Compensation (Narrative) (Details) Details http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationTables 77 false false R78.htm 2420403 - Disclosure - Stock Transactions And Stock-Based Compensation (Summary of Share Activity) (Details) Sheet http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationSummaryOfShareActivityDetails Stock Transactions And Stock-Based Compensation (Summary of Share Activity) (Details) Details http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationTables 78 false false R79.htm 2420404 - Disclosure - Stock Transactions And Stock-Based Compensation (Components of Stock-Based Compensation Program) (Details) Sheet http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationComponentsOfStockBasedCompensationProgramDetails Stock Transactions And Stock-Based Compensation (Components of Stock-Based Compensation Program) (Details) Details http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationTables 79 false false R80.htm 2421402 - Disclosure - Net Earnings Per Share (Narrative) (Details) Sheet http://www.danaher.com/role/NetEarningsPerShareNarrativeDetails Net Earnings Per Share (Narrative) (Details) Details http://www.danaher.com/role/NetEarningsPerShareTables 80 false false R81.htm 2421403 - Disclosure - Net Earnings Per Share (Components of Basic and Diluted Earnings per Share) (Details) Sheet http://www.danaher.com/role/NetEarningsPerShareComponentsOfBasicAndDilutedEarningsPerShareDetails Net Earnings Per Share (Components of Basic and Diluted Earnings per Share) (Details) Details http://www.danaher.com/role/NetEarningsPerShareTables 81 false false R82.htm 2422402 - Disclosure - Segment Information (Narrative) (Details) Sheet http://www.danaher.com/role/SegmentInformationNarrativeDetails Segment Information (Narrative) (Details) Details http://www.danaher.com/role/SegmentInformationTables 82 false false R83.htm 2422403 - Disclosure - Segment Information (Segment Results) (Details) Sheet http://www.danaher.com/role/SegmentInformationSegmentResultsDetails Segment Information (Segment Results) (Details) Details http://www.danaher.com/role/SegmentInformationTables 83 false false R84.htm 2423401 - Disclosure - Subsequent Event (Narrative) (Details) Sheet http://www.danaher.com/role/SubsequentEventNarrativeDetails Subsequent Event (Narrative) (Details) Details http://www.danaher.com/role/SubsequentEventNotes 84 false false All Reports Book All Reports dhr-2019927x10q.htm dhr-20190927.xsd dhr-20190927_cal.xml dhr-20190927_def.xml dhr-20190927_lab.xml dhr-20190927_pre.xml dhr-2019927xexx1012.htm dhr-2019927xexx1013.htm dhr-2019927xexx1014.htm dhr-2019927xexx1015.htm dhr-2019927xexx108.htm dhr-2019927xexx109.htm dhr-2019927xexx311.htm dhr-2019927xexx312.htm dhr-2019927xexx321.htm dhr-2019927xexx322.htm dhrlogofor8ksa26.jpg http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/country/2017-01-31 http://fasb.org/srt/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 true true XML 45 R46.htm IDEA: XBRL DOCUMENT v3.19.3
Acquisitions (Narrative) (Details)
$ in Millions
9 Months Ended
Sep. 27, 2019
USD ($)
Business
Business Combinations [Abstract]  
Number of businesses acquired | Business 5
Net cash consideration $ 331.1
Revenue reported by acquired entity for last annual period 72.0
Goodwill $ 214.9
XML 46 R3.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Condensed Balance Sheets Consolidated Condensed Balance Sheets (Parenthetical) - USD ($)
shares in Thousands, $ in Millions
Sep. 27, 2019
Dec. 31, 2018
Statement of Financial Position [Abstract]    
Property, plant and equipment, net of accumulated depreciation $ 3,023.3 $ 2,828.3
Preferred stock, dividend rate, percent 4.75%  
Preferred stock, no par value $ 0 $ 0
Preferred stock, shares authorized 15,000 0
Preferred stock, shares issued 1,650 0
Preferred stock, shares outstanding 1,650 0
Common stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 2,000,000 2,000,000
Common stock, shares issued 835,000 817,900
Common stock, shares outstanding 718,200 701,500
XML 47 R27.htm IDEA: XBRL DOCUMENT v3.19.3
General (Tables)
9 Months Ended
Sep. 27, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Components Of Accumulated Other Comprehensive Income (Loss) The changes in accumulated other comprehensive income (loss) by component are summarized below ($ in millions). Foreign currency translation adjustments generally relate to indefinite investments in non-U.S. subsidiaries, as well as the impact from the Company’s hedges of its net investment in foreign operations, including the Company’s cross-currency swap derivatives, net of any tax impacts.
 
Foreign Currency Translation Adjustments
 
Pension & Postretirement Plan Benefit Adjustments
 
Unrealized Gain (Loss) on Available-For-Sale Securities Adjustments
 
Cash Flow Hedge Adjustments
 
Total
 
For the Three-Month Period Ended September 27, 2019:
 
 
 
Balance, June 28, 2019
$
(2,155.4
)
 
$
(681.1
)
 
$
(1.0
)
 
$
(6.8
)
 
$
(2,844.3
)
 
Other comprehensive income (loss) before reclassifications:
 
 
 
 
 
 
 
 
 
 
(Decrease) increase
(226.8
)
 

 
0.6

 
(55.1
)
 
(281.3
)
 
Income tax impact
(9.0
)
 

 
(0.1
)
 
13.3

 
4.2

 
Other comprehensive income (loss) before reclassifications, net of income taxes
(235.8
)
 

 
0.5

 
(41.8
)
 
(277.1
)
 
Amounts reclassified from accumulated other comprehensive income (loss):
 
 
 
 
 
 
 
 
 
 
Increase

 
7.5

(a)

 

 
7.5

 
Income tax impact

 
(1.7
)
 

 

 
(1.7
)
 
Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes

 
5.8

 

 

 
5.8

 
Net current period other comprehensive income (loss), net of income taxes
(235.8
)
 
5.8

 
0.5

 
(41.8
)
 
(271.3
)
(b)
Balance, September 27, 2019
$
(2,391.2
)
 
$
(675.3
)
 
$
(0.5
)
 
$
(48.6
)
 
(3,115.6
)
 
Less: accumulated other comprehensive income attributable to noncontrolling interests
 
(27.3
)
 
Accumulated other comprehensive income attributable to controlling interests
 
$
(3,088.3
)
 
For the Three-Month Period Ended September 28, 2018:
 
 
 
Balance, June 29, 2018
$
(1,812.9
)
 
$
(664.6
)
 
$
(1.7
)
 
$

 
$
(2,479.2
)
 
Other comprehensive income (loss) before reclassifications:
 
 
 
 
 
 
 
 
 
 
Decrease
(162.4
)
 

 

 

 
(162.4
)
 
Income tax impact

 

 

 

 

 
Other comprehensive income (loss) before reclassifications, net of income taxes
(162.4
)
 

 

 

 
(162.4
)
 
Amounts reclassified from accumulated other comprehensive income (loss):
 
 
 
 
 
 
 
 
 
 
Increase

 
7.7

(a)

 

 
7.7

 
Income tax impact

 
(1.8
)
 

 

 
(1.8
)
 
Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes

 
5.9

 

 

 
5.9

 
Net current period other comprehensive income (loss), net of income taxes
(162.4
)
 
5.9

 

 

 
(156.5
)
 
Balance, September 28, 2018
$
(1,975.3
)
 
$
(658.7
)
 
$
(1.7
)
 
$

 
$
(2,635.7
)
 
(a) This accumulated other comprehensive income (loss) component is included in the computation of net periodic pension cost. Refer to Note 10 for additional details.
(b) Accumulated other comprehensive income (loss) for the three-month period ended September 27, 2019 consists of $270.1 million of accumulated other comprehensive loss attributable to controlling interest and $1.2 million of accumulated other comprehensive loss attributable to noncontrolling interest.
 
Foreign Currency Translation Adjustments
 
Pension & Postretirement Plan Benefit Adjustments
 
Unrealized Gain (Loss) on Available-For-Sale Securities Adjustments
 
Cash Flow Hedge Adjustments
 
Total
 
For the Nine-Month Period Ended September 27, 2019:
 
 
 
Balance, December 31, 2018
$
(2,098.1
)
 
$
(691.1
)
 
$
(1.9
)
 
$

 
$
(2,791.1
)
 
Other comprehensive income (loss) before reclassifications:
 
 
 
 
 
 
 
 
 
 
(Decrease) increase
(286.0
)
 

 
1.8

 
(64.0
)
 
(348.2
)
 
Income tax impact
(7.1
)
 

 
(0.4
)
 
15.4

 
7.9

 
Other comprehensive income (loss) before reclassifications, net of income taxes
(293.1
)
 

 
1.4

 
(48.6
)
 
(340.3
)
 
Amounts reclassified from accumulated other comprehensive income (loss):
 
 
 
 
 
 
 
 
 
 
Increase

 
20.7

(a)

 

 
20.7

 
Income tax impact

 
(4.9
)
 

 

 
(4.9
)
 
Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes

 
15.8

 

 

 
15.8

 
Net current period other comprehensive income (loss), net of income taxes
(293.1
)
 
15.8

 
1.4

 
(48.6
)
 
(324.5
)
(b)
Balance, September 27, 2019
$
(2,391.2
)
 
$
(675.3
)
 
$
(0.5
)
 
$
(48.6
)
 
(3,115.6
)
 
Less: accumulated other comprehensive income attributable to noncontrolling interests
 
(27.3
)
 
Accumulated other comprehensive income attributable to controlling interests
 
$
(3,088.3
)
 
For the Nine-Month Period Ended September 28, 2018:
 
 
 
Balance, December 31, 2017
$
(1,422.1
)
 
$
(571.2
)
 
$
(0.9
)
 
$

 
$
(1,994.2
)
 
Adoption of accounting standards
(43.8
)
 
(107.2
)
 
(0.2
)
 

 
(151.2
)
 
Balance, January 1, 2018
(1,465.9
)
 
(678.4
)
 
(1.1
)
 

 
(2,145.4
)
 
Other comprehensive income (loss) before reclassifications:
 
 
 
 
 
 
 
 
 
 
Decrease
(509.4
)
 

 
(0.8
)
 

 
(510.2
)
 
Income tax impact

 

 
0.2

 

 
0.2

 
Other comprehensive income (loss) before reclassifications, net of income taxes
(509.4
)
 

 
(0.6
)
 

 
(510.0
)
 
Amounts reclassified from accumulated other comprehensive income (loss):
 
 
 
 
 
 
 
 
 
 
Increase

 
25.8

(a)

 

 
25.8

 
Income tax impact

 
(6.1
)
 

 

 
(6.1
)
 
Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes

 
19.7

 

 

 
19.7

 
Net current period other comprehensive income (loss), net of income taxes
(509.4
)
 
19.7

 
(0.6
)
 

 
(490.3
)
 
Balance, September 28, 2018
$
(1,975.3
)
 
$
(658.7
)
 
$
(1.7
)
 
$

 
$
(2,635.7
)
 

(a) This accumulated other comprehensive income (loss) component is included in the computation of net periodic pension cost. Refer to Note 10 for additional details.
(b) Accumulated other comprehensive income (loss) for the nine-month period ended September 27, 2019 consists of $323.3 million of accumulated other comprehensive loss attributable to controlling interest and $1.2 million of accumulated other comprehensive loss attributable to noncontrolling interest.
XML 48 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 49 R23.htm IDEA: XBRL DOCUMENT v3.19.3
Net Earnings Per Share
9 Months Ended
Sep. 27, 2019
Earnings Per Share [Abstract]  
Net Earnings Per Share NET EARNINGS PER SHARE
Basic net earnings per share (“EPS”) is calculated by dividing net earnings attributable to common stockholders by the weighted average number of common shares outstanding for the applicable period. Diluted net EPS is computed based on the weighted average number of common shares outstanding increased by the number of additional shares that would have been outstanding had the potentially dilutive common shares (including subsidiary denominated equity) been issued and reduced by the number of shares the Company could have repurchased with the proceeds from the issuance of the potentially dilutive shares. For both the three and nine-month periods ended September 27, 2019 and the three-month period ended September 28, 2018no options to purchase shares were excluded from the diluted EPS calculation. For the nine-month period ended September 28, 2018, approximately one million options to purchase shares were not included in the diluted EPS calculation as the impact of their inclusion would have been anti-dilutive.
The impact of the MCPS calculated under the if-converted method was anti-dilutive, and as such 12 million shares and 9 million shares underlying the MCPS were excluded from the diluted EPS calculation for the three and nine-month periods ended September 27, 2019, respectively. The inclusion of Envista’s dilutive securities in the calculation of the Company’s net earnings attributable to common stockholders after assumed conversions did not significantly impact the Company’s diluted EPS for the three and nine-month periods ended September 27, 2019, respectively.
Information related to the calculation of net earnings per share is summarized as follows ($ and shares in millions, except per share amounts):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Numerator:
 
 
 
 
 
 
 
Net earnings
$
673.9

 
$
663.7

 
$
1,739.0

 
$
1,904.1

Net earnings attributable to noncontrolling interests
(5.9
)
 

 
(5.9
)
 

MCPS dividends
(19.6
)
 

 
(48.8
)
 

Net earnings attributable to common stockholders (used in Basis EPS)
648.4

 
663.7


1,684.3


1,904.1

Adjustment for interest on convertible debentures
0.4

 
0.6

 
1.4

 
1.7

Net earnings attributable to common stockholders after assumed conversions (used in Diluted EPS)
$
648.8

 
$
664.3


$
1,685.7


$
1,905.8

 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
Weighted average common shares outstanding (used in Basic EPS)
718.8

 
701.4

 
714.7

 
700.1

Incremental common shares from:
 
 
 
 
 
 
 
Assumed exercise of dilutive options and vesting of dilutive RSUs and PSUs
9.1

 
6.9

 
8.9

 
7.3

Assumed conversion of the convertible debentures
1.4

 
2.3

 
1.6

 
2.5

Weighted average common shares outstanding (used in Diluted EPS)
729.3

 
710.6

 
725.2

 
709.9

 
 
 
 
 
 
 
 
Basic EPS
$
0.90

 
$
0.95


$
2.36


$
2.72

Diluted EPS
$
0.89

 
$
0.93

 
$
2.32

 
$
2.68


XML 50 R7.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Condensed Statement Of Stockholders' Equity Consolidated Condensed Statement Of Stockholders' Equity (Parenthetical) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 27, 2019
Sep. 28, 2018
Statement of Stockholders' Equity [Abstract]        
Debt conversion, converted instrument, tax benefit $ 0.4 $ 0.0 $ 8.5 $ 4.2
XML 51 R32.htm IDEA: XBRL DOCUMENT v3.19.3
Fair Value Measurements (Tables)
9 Months Ended
Sep. 27, 2019
Fair Value Disclosures [Abstract]  
Financial Assets And Liabilities Carried At Fair Value
A summary of financial assets and liabilities that are measured at fair value on a recurring basis were as follows ($ in millions):
 
Quoted Prices in Active Market (Level 1)
 
Significant Other Observable Inputs (Level 2)
 
Significant Unobservable Inputs (Level 3)
 
Total
September 27, 2019:
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
Available-for-sale debt securities
$

 
$
35.7

 
$

 
$
35.7

Investment in equity securities

 

 
314.4

 
314.4

Cross-currency swap derivative contracts

 
36.8

 

 
36.8

Liabilities:
 
 
 
 
 
 
 
Interest rate swap derivative contracts

 
64.0

 

 
64.0

Deferred compensation plans

 
64.6

 

 
64.6

 
 
 
 
 
 
 
 
December 31, 2018:
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
Available-for-sale debt securities
$

 
$
38.3

 
$

 
$
38.3

Investment in equity securities

 

 
148.9

 
148.9

Liabilities:
 
 
 
 
 
 
 
Deferred compensation plans

 
60.9

 

 
60.9


Carrying Amounts And Fair Values Of Financial Instruments
The carrying amounts and fair values of the Company’s financial instruments were as follows ($ in millions):
 
September 27, 2019
 
December 31, 2018
 
Carrying Amount
 
Fair Value
 
Carrying Amount
 
Fair Value
Assets:
 
 
 
 
 
 
 
Available-for-sale debt securities
$
35.7

 
$
35.7

 
$
38.3

 
$
38.3

Investment in equity securities
314.4

 
314.4

 
148.9

 
148.9

Cross-currency swap derivative contracts
36.8

 
36.8

 

 

Liabilities:
 
 
 
 
 
 
 
Interest rate swap derivative contracts
64.0

 
64.0

 

 

Notes payable and current portion of long-term debt
1,068.6

 
1,068.6

 
51.8

 
51.8

Long-term debt
16,536.2

 
17,045.5

 
9,688.5

 
9,990.6


XML 52 R36.htm IDEA: XBRL DOCUMENT v3.19.3
Income Taxes (Tables)
9 Months Ended
Sep. 27, 2019
Income Tax Disclosure [Abstract]  
Summary Of Effective Income Tax Rate
The following table summarizes the Company’s effective tax rate:
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Effective tax rate
20.1
%
 
17.2
%
 
29.3
%
 
19.0
%

XML 53 R15.htm IDEA: XBRL DOCUMENT v3.19.3
Fair Value Measurements
9 Months Ended
Sep. 27, 2019
Fair Value Disclosures [Abstract]  
Fair Value Measurements FAIR VALUE MEASUREMENTS
Accounting standards define fair value based on an exit price model, establish a framework for measuring fair value where the Company’s assets and liabilities are required to be carried at fair value and provide for certain disclosures related to the valuation methods used within a valuation hierarchy as established within the accounting standards. This hierarchy prioritizes the inputs into three broad levels as follows. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in markets that are not active, or other observable characteristics for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from, or corroborated by, observable market data through correlation. Level 3 inputs are unobservable inputs based on the Company’s assumptions. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement in its entirety.
A summary of financial assets and liabilities that are measured at fair value on a recurring basis were as follows ($ in millions):
 
Quoted Prices in Active Market (Level 1)
 
Significant Other Observable Inputs (Level 2)
 
Significant Unobservable Inputs (Level 3)
 
Total
September 27, 2019:
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
Available-for-sale debt securities
$

 
$
35.7

 
$

 
$
35.7

Investment in equity securities

 

 
314.4

 
314.4

Cross-currency swap derivative contracts

 
36.8

 

 
36.8

Liabilities:
 
 
 
 
 
 
 
Interest rate swap derivative contracts

 
64.0

 

 
64.0

Deferred compensation plans

 
64.6

 

 
64.6

 
 
 
 
 
 
 
 
December 31, 2018:
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
Available-for-sale debt securities
$

 
$
38.3

 
$

 
$
38.3

Investment in equity securities

 

 
148.9

 
148.9

Liabilities:
 
 
 
 
 
 
 
Deferred compensation plans

 
60.9

 

 
60.9


Available-for-sale debt securities, which are included in other long-term assets in the accompanying Consolidated Condensed Balance Sheets, are measured at fair value using quoted prices reported by investment brokers and dealers based on the underlying terms of the security and comparison to similar securities traded on an active market. As of September 27, 2019, available-for-sale debt securities primarily include U.S. Treasury Notes and corporate debt securities, which are valued based on instruments with similar terms traded on an active market.
The Company’s investments in equity securities are classified as Level 3 in the fair value hierarchy because the Company estimates the fair value based on the measurement alternative and adjusts for impairments and observable price changes with a same or similar security from the same issuer within net earnings (the “Fair Value Alternative”). The investments in equity securities includes investments that the Company has made as a limited partner in a partnership for which the underlying investments are recorded on a fair value basis.
The cross-currency swap derivative contracts are used to partially hedge the Company’s net investments in foreign operations against adverse movements in exchange rates between the U.S. dollar and the Danish kroner, Japanese yen, euro and Swiss franc. Envista uses cross-currency swap derivative contracts to partially hedge its net investment in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. The cross-currency swap derivative contracts are classified as Level 2 in the fair value hierarchy as they are measured using the income approach with the relevant interest rates and foreign currency current exchange rates and forward curves as inputs. Refer to Note 9 for additional information.
In June 2019, the Company entered into interest rate swap agreements with a notional amount of $850 million which represents a portion of the amount of U.S. dollar-denominated bonds (with terms ranging from 10 to 30 years) the Company anticipates issuing to finance a portion of the GE Biopharma Acquisition. These contracts effectively fixed the interest rate for a portion of the Company’s anticipated U.S. dollar-denominated debt issuance equal to the notional amount of the swaps to the rate specified in the interest rate swap agreements. In September 2019, Envista entered into $650 million of interest rate swap derivative contracts to convert the variable interest rate for the Envista Term Loan Facility to a fixed interest rate. The interest rate swap derivative contracts are classified as Level 2 in the fair value hierarchy as they are measured using the income approach, based on the relevant interest rate yield curves. Refer to Note 8 and Note 9 for additional information.
The Company has established nonqualified contribution and deferred compensation programs that permit the Company to make tax-deferred contributions to officers and certain other employees, and also permit directors, officers and certain other employees to voluntarily defer taxation on a portion of their compensation. All amounts contributed or deferred under such plans are unfunded, unsecured obligations of the Company and are presented as a component of the Company’s compensation and benefits accrual included in other long-term liabilities in the accompanying Consolidated Condensed Balance Sheets. Non-director participants may choose among alternative earning rates for the amounts they defer, which are primarily based on investment options within the Company’s 401(k) program. Changes in the deferred compensation liability under these programs are recognized based on changes in the fair value of the participants’ accounts, which are based on the applicable earnings rates. Amounts voluntarily deferred by directors and amounts unilaterally contributed to participant accounts by the Company are deemed invested in the Company’s common stock and future distributions of such contributions (as well as future distributions of any voluntary deferrals allocated at any time to the Danaher common stock investment option) will be made solely in shares of Company common stock, and therefore are not reflected in the above amounts.
Fair Value of Financial Instruments
The carrying amounts and fair values of the Company’s financial instruments were as follows ($ in millions):
 
September 27, 2019
 
December 31, 2018
 
Carrying Amount
 
Fair Value
 
Carrying Amount
 
Fair Value
Assets:
 
 
 
 
 
 
 
Available-for-sale debt securities
$
35.7

 
$
35.7

 
$
38.3

 
$
38.3

Investment in equity securities
314.4

 
314.4

 
148.9

 
148.9

Cross-currency swap derivative contracts
36.8

 
36.8

 

 

Liabilities:
 
 
 
 
 
 
 
Interest rate swap derivative contracts
64.0

 
64.0

 

 

Notes payable and current portion of long-term debt
1,068.6

 
1,068.6

 
51.8

 
51.8

Long-term debt
16,536.2

 
17,045.5

 
9,688.5

 
9,990.6


As of September 27, 2019 and December 31, 2018, investments in non-marketable equity securities were categorized as Level 3, available-for-sale debt securities, cross-currency swap derivative contracts and interest rate swap derivative contracts were categorized as Level 2 and short and long-term borrowings were categorized as Level 1.
The fair value of long-term borrowings was based on quoted market prices. The difference between the fair value and the carrying amounts of long-term borrowings (other than the Company’s Liquid Yield Option Notes due 2021 (the “LYONs”)) is attributable to changes in market interest rates and/or the Company’s credit ratings subsequent to the incurrence of the borrowing. In the case of the LYONs, differences in the fair value from the carrying value are attributable to changes in the price of the Company’s common stock due to the LYONs’ conversion features. The fair values of borrowings with original maturities of one year or less, as well as cash and cash equivalents, trade accounts receivable, net and trade accounts payable approximate their carrying amounts due to the short-term maturities of these instruments.
XML 54 dhr-2019927x10q_htm.xml IDEA: XBRL DOCUMENT 0000313616 2019-01-01 2019-09-27 0000313616 dhr:FloatingRateSeniorNotesDue2022Member 2019-01-01 2019-09-27 0000313616 dhr:A0.75SeniorNotesDue2031Member 2019-01-01 2019-09-27 0000313616 us-gaap:PreferredStockMember 2019-01-01 2019-09-27 0000313616 dhr:A1.35SeniorNotesDue2039Member 2019-01-01 2019-09-27 0000313616 dhr:A1.7SeniorNotesDue2022Member 2019-01-01 2019-09-27 0000313616 dhr:A0.2SeniorNotesDue2026Member 2019-01-01 2019-09-27 0000313616 dhr:A0.45SeniorNotesDue2028Member 2019-01-01 2019-09-27 0000313616 dhr:A1.2SeniorNotesDue2027Member 2019-01-01 2019-09-27 0000313616 dhr:A1.8SeniorNotesDue2049Member 2019-01-01 2019-09-27 0000313616 dhr:A2.5SeniorNotesDue2025Member 2019-01-01 2019-09-27 0000313616 us-gaap:CommonStockMember 2019-01-01 2019-09-27 0000313616 2019-10-18 0000313616 2018-12-31 0000313616 2019-09-27 0000313616 2019-09-27 2019-09-27 0000313616 2018-06-30 2018-09-28 0000313616 2019-06-29 2019-09-27 0000313616 2018-01-01 2018-09-28 0000313616 us-gaap:RetainedEarningsMember 2018-01-01 2018-09-28 0000313616 us-gaap:AdditionalPaidInCapitalMember 2018-09-28 0000313616 us-gaap:PreferredStockMember 2018-09-28 0000313616 us-gaap:AdditionalPaidInCapitalMember 2019-09-27 0000313616 us-gaap:CommonStockMember 2019-09-27 0000313616 us-gaap:PreferredStockMember 2019-06-29 2019-09-27 0000313616 us-gaap:AdditionalPaidInCapitalMember 2019-06-29 2019-09-27 0000313616 us-gaap:PreferredStockMember 2018-01-01 2018-09-28 0000313616 us-gaap:NoncontrollingInterestMember 2019-06-29 2019-09-27 0000313616 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000313616 us-gaap:NoncontrollingInterestMember 2018-09-28 0000313616 us-gaap:CommonStockMember 2018-12-31 0000313616 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-09-27 0000313616 us-gaap:RetainedEarningsMember 2018-09-28 0000313616 us-gaap:NoncontrollingInterestMember 2017-12-31 0000313616 us-gaap:NoncontrollingInterestMember 2019-09-27 0000313616 us-gaap:CommonStockMember 2018-06-29 0000313616 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-09-27 0000313616 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 2018-09-28 0000313616 us-gaap:CommonStockMember 2018-09-28 0000313616 us-gaap:RetainedEarningsMember 2019-01-01 2019-09-27 0000313616 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 2018-09-28 0000313616 us-gaap:RetainedEarningsMember 2018-06-30 2018-09-28 0000313616 us-gaap:NoncontrollingInterestMember 2018-06-30 2018-09-28 0000313616 us-gaap:PreferredStockMember 2018-12-31 0000313616 2018-09-28 0000313616 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-09-28 0000313616 us-gaap:CommonStockMember 2017-12-31 0000313616 us-gaap:RetainedEarningsMember 2019-06-28 0000313616 us-gaap:RetainedEarningsMember 2018-06-29 0000313616 us-gaap:RetainedEarningsMember 2018-12-31 0000313616 us-gaap:PreferredStockMember 2019-09-27 0000313616 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-27 0000313616 us-gaap:AdditionalPaidInCapitalMember 2018-06-29 0000313616 us-gaap:AdditionalPaidInCapitalMember 2019-06-28 0000313616 us-gaap:RetainedEarningsMember 2019-09-27 0000313616 us-gaap:NoncontrollingInterestMember 2018-06-29 0000313616 us-gaap:PreferredStockMember 2017-12-31 0000313616 us-gaap:RetainedEarningsMember 2019-06-29 2019-09-27 0000313616 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-09-28 0000313616 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-29 0000313616 us-gaap:CommonStockMember 2019-01-01 2019-09-27 0000313616 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-29 2019-09-27 0000313616 us-gaap:RetainedEarningsMember 2017-12-31 0000313616 us-gaap:NoncontrollingInterestMember 2018-01-01 2018-09-28 0000313616 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-09-27 0000313616 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0000313616 us-gaap:CommonStockMember 2018-06-30 2018-09-28 0000313616 us-gaap:NoncontrollingInterestMember 2019-06-28 0000313616 us-gaap:NoncontrollingInterestMember 2018-12-31 0000313616 us-gaap:PreferredStockMember 2019-06-28 0000313616 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-28 0000313616 us-gaap:CommonStockMember 2019-06-28 0000313616 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-28 0000313616 us-gaap:CommonStockMember 2018-01-01 2018-09-28 0000313616 us-gaap:PreferredStockMember 2019-01-01 2019-09-27 0000313616 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0000313616 us-gaap:PreferredStockMember 2018-06-30 2018-09-28 0000313616 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000313616 us-gaap:CommonStockMember 2019-06-29 2019-09-27 0000313616 us-gaap:PreferredStockMember 2018-06-29 0000313616 2017-12-31 0000313616 srt:SubsidiariesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember dhr:EnvistaMember 2019-09-27 0000313616 2019-01-01 0000313616 us-gaap:AociAttributableToNoncontrollingInterestMember 2019-06-29 2019-09-27 0000313616 srt:MinimumMember dhr:U.S.DollarDenominatedBondsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2019-06-28 2019-06-28 0000313616 srt:SubsidiariesMember us-gaap:ForeignExchangeContractMember dhr:EnvistaMember 2019-09-27 0000313616 us-gaap:AociAttributableToNoncontrollingInterestMember 2019-01-01 2019-09-27 0000313616 srt:MaximumMember dhr:U.S.DollarDenominatedBondsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2019-06-28 2019-06-28 0000313616 dhr:U.S.DollarDenominatedBondsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2019-06-28 0000313616 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-01-31 0000313616 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-09-28 0000313616 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-12-31 0000313616 us-gaap:AccumulatedTranslationAdjustmentMember 2017-12-31 0000313616 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-01-01 2018-09-28 0000313616 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-09-28 0000313616 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-01-01 0000313616 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-01-01 0000313616 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0000313616 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-01-01 2018-09-28 0000313616 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-01-01 2018-09-28 0000313616 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0000313616 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-09-27 0000313616 us-gaap:AccumulatedTranslationAdjustmentMember 2019-09-27 0000313616 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-01-01 2018-01-01 0000313616 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-09-27 0000313616 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2019-01-01 2019-09-27 0000313616 us-gaap:AociAttributableToNoncontrollingInterestMember 2019-09-27 0000313616 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-12-31 0000313616 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-01-01 2018-09-28 0000313616 us-gaap:AccumulatedTranslationAdjustmentMember 2018-01-01 2018-09-28 0000313616 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-09-27 0000313616 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-09-28 0000313616 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2017-12-31 0000313616 us-gaap:AccumulatedTranslationAdjustmentMember 2018-01-01 2018-01-01 0000313616 us-gaap:AccumulatedTranslationAdjustmentMember 2018-09-28 0000313616 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2019-01-01 2019-09-27 0000313616 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-12-31 0000313616 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-01-01 2018-01-01 0000313616 us-gaap:AccumulatedTranslationAdjustmentMember 2018-01-01 0000313616 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-01-01 2018-01-01 0000313616 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-09-27 0000313616 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2017-12-31 0000313616 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2019-09-27 0000313616 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-09-28 0000313616 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-01-01 0000313616 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-01-01 2018-01-01 0000313616 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-12-31 0000313616 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-01-01 0000313616 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-09-27 0000313616 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-12-31 0000313616 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2019-09-27 0000313616 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2019-06-28 0000313616 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-06-29 2019-09-27 0000313616 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2019-06-29 2019-09-27 0000313616 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-06-30 2018-09-28 0000313616 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-06-29 2019-09-27 0000313616 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-06-30 2018-09-28 0000313616 us-gaap:AccumulatedTranslationAdjustmentMember 2019-06-29 2019-09-27 0000313616 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2019-06-29 2019-09-27 0000313616 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-06-30 2018-09-28 0000313616 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-06-30 2018-09-28 0000313616 us-gaap:AccumulatedTranslationAdjustmentMember 2018-06-30 2018-09-28 0000313616 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-06-29 0000313616 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-06-28 0000313616 us-gaap:AccumulatedTranslationAdjustmentMember 2018-06-29 0000313616 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-06-29 0000313616 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-06-29 0000313616 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-06-29 0000313616 us-gaap:AccumulatedTranslationAdjustmentMember 2019-06-28 0000313616 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-06-28 0000313616 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2019-06-28 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:DentalEnvistaMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:LifeSciencesMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:EnvironmentalAppliedSolutionsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:EnvironmentalAppliedSolutionsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:EnvironmentalAppliedSolutionsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:LifeSciencesMember 2018-06-30 2018-09-28 0000313616 dhr:OtherdevelopedmarketsMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:DiagnosticsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:EnvironmentalAppliedSolutionsMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:DentalEnvistaMember 2019-06-29 2019-09-27 0000313616 dhr:HighgrowthmarketsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:EnvironmentalAppliedSolutionsMember 2018-06-30 2018-09-28 0000313616 dhr:OtherdevelopedmarketsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:LifeSciencesMember 2018-06-30 2018-09-28 0000313616 dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:EnvironmentalAppliedSolutionsMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:DiagnosticsMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:EnvironmentalAppliedSolutionsMember 2018-06-30 2018-09-28 0000313616 dhr:RevenuefromContractwithCustomerMeasurementRecurringMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:DentalEnvistaMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:EnvironmentalAppliedSolutionsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:LifeSciencesMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:DentalEnvistaMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:DentalEnvistaMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:LifeSciencesMember 2019-06-29 2019-09-27 0000313616 srt:NorthAmericaMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:DentalEnvistaMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:DiagnosticsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:DentalEnvistaMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:DiagnosticsMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:LifeSciencesMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:EnvironmentalAppliedSolutionsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:DentalEnvistaMember 2018-06-30 2018-09-28 0000313616 dhr:RevenuefromContractwithCustomerMeasurementRecurringMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:DiagnosticsMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:DentalEnvistaMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:LifeSciencesMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:LifeSciencesMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:LifeSciencesMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:LifeSciencesMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:EnvironmentalAppliedSolutionsMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:DentalEnvistaMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:DiagnosticsMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:DiagnosticsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:DentalEnvistaMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:DiagnosticsMember 2019-06-29 2019-09-27 0000313616 dhr:HighgrowthmarketsMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:LifeSciencesMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:EnvironmentalAppliedSolutionsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:LifeSciencesMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:LifeSciencesMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:DiagnosticsMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:DiagnosticsMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:EnvironmentalAppliedSolutionsMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:DentalEnvistaMember 2019-06-29 2019-09-27 0000313616 srt:NorthAmericaMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:EnvironmentalAppliedSolutionsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:DentalEnvistaMember 2019-06-29 2019-09-27 0000313616 dhr:WesternEuropeMember 2018-06-30 2018-09-28 0000313616 dhr:WesternEuropeMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:DentalEnvistaMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:DiagnosticsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:DiagnosticsMember 2018-06-30 2018-09-28 0000313616 dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:DiagnosticsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:DiagnosticsMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:EnvironmentalAppliedSolutionsMember 2018-06-30 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:LifeSciencesMember 2019-06-29 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:DiagnosticsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:DentalEnvistaMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:LifeSciencesMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:EnvironmentalAppliedSolutionsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:DentalEnvistaMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:EnvironmentalAppliedSolutionsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:DiagnosticsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:EnvironmentalAppliedSolutionsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:LifeSciencesMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:EnvironmentalAppliedSolutionsMember 2018-01-01 2018-09-28 0000313616 dhr:RevenuefromContractwithCustomerMeasurementRecurringMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:EnvironmentalAppliedSolutionsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:DiagnosticsMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:EnvironmentalAppliedSolutionsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:LifeSciencesMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:LifeSciencesMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:DiagnosticsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:EnvironmentalAppliedSolutionsMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:EnvironmentalAppliedSolutionsMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:LifeSciencesMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:DentalEnvistaMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:DiagnosticsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:EnvironmentalAppliedSolutionsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:LifeSciencesMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:DiagnosticsMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:DentalEnvistaMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:LifeSciencesMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:LifeSciencesMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:EnvironmentalAppliedSolutionsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:LifeSciencesMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:DentalEnvistaMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:LifeSciencesMember 2019-01-01 2019-09-27 0000313616 dhr:HighgrowthmarketsMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:DentalEnvistaMember 2019-01-01 2019-09-27 0000313616 dhr:OtherdevelopedmarketsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:EnvironmentalAppliedSolutionsMember 2018-01-01 2018-09-28 0000313616 dhr:WesternEuropeMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:DentalEnvistaMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:DentalEnvistaMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:LifeSciencesMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:DiagnosticsMember 2018-01-01 2018-09-28 0000313616 dhr:OtherdevelopedmarketsMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:DentalEnvistaMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:DiagnosticsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:DentalEnvistaMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:DentalEnvistaMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:DiagnosticsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:DiagnosticsMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:LifeSciencesMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:DentalEnvistaMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementRecurringMember dhr:DiagnosticsMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:DentalEnvistaMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:DiagnosticsMember 2018-01-01 2018-09-28 0000313616 srt:NorthAmericaMember 2019-01-01 2019-09-27 0000313616 dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:LifeSciencesMember 2019-01-01 2019-09-27 0000313616 dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember dhr:LifeSciencesMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:DiagnosticsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:EnvironmentalAppliedSolutionsMember 2018-01-01 2018-09-28 0000313616 dhr:WesternEuropeMember 2019-01-01 2019-09-27 0000313616 us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-09-27 0000313616 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:OtherdevelopedmarketsMember dhr:EnvironmentalAppliedSolutionsMember 2018-01-01 2018-09-28 0000313616 us-gaap:OperatingSegmentsMember dhr:WesternEuropeMember dhr:DiagnosticsMember 2018-01-01 2018-09-28 0000313616 dhr:HighgrowthmarketsMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember dhr:EnvironmentalAppliedSolutionsMember 2018-01-01 2018-09-28 0000313616 srt:NorthAmericaMember 2018-01-01 2018-09-28 0000313616 dhr:RevenuefromContractwithCustomerMeasurementRecurringMember 2019-01-01 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:HighgrowthmarketsMember dhr:DentalEnvistaMember 2019-01-01 2019-09-27 0000313616 dhr:IDTMember us-gaap:AcquisitionRelatedCostsMember 2018-01-01 2018-12-31 0000313616 dhr:BiopharmaAcquisitionMember 2019-02-25 2019-02-25 0000313616 dhr:BiopharmaAcquisitionMember 2019-09-27 2019-09-27 0000313616 2018-01-01 2018-12-31 0000313616 dhr:BiopharmaAcquisitionMember 2019-02-25 0000313616 srt:SubsidiariesMember us-gaap:IPOMember dhr:EnvistaMember 2019-09-20 2019-09-20 0000313616 srt:SubsidiariesMember us-gaap:IPOMember dhr:EnvistaMember 2019-09-27 0000313616 us-gaap:SubsequentEventMember 2019-10-24 2019-10-24 0000313616 srt:SubsidiariesMember us-gaap:IPOMember dhr:EnvistaMember 2019-09-20 0000313616 srt:SubsidiariesMember dhr:EnvistaMember 2019-09-20 2019-09-27 0000313616 dhr:RedeemedNotesMember us-gaap:SeniorNotesMember us-gaap:SubsequentEventMember 2019-10-24 0000313616 dhr:A5.0SeniorNotesDue2020Member us-gaap:SeniorNotesMember us-gaap:SubsequentEventMember 2019-10-24 0000313616 dhr:A2.4SeniorNotesDue2020Member us-gaap:SeniorNotesMember us-gaap:SubsequentEventMember 2019-10-24 0000313616 srt:MaximumMember 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:DentalEnvistaMember 2018-12-31 0000313616 us-gaap:OperatingSegmentsMember dhr:EnvironmentalAppliedSolutionsMember 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:LifeSciencesMember 2018-12-31 0000313616 us-gaap:OperatingSegmentsMember dhr:DiagnosticsMember 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:LifeSciencesMember 2019-09-27 0000313616 us-gaap:OperatingSegmentsMember dhr:DiagnosticsMember 2018-12-31 0000313616 us-gaap:OperatingSegmentsMember dhr:EnvironmentalAppliedSolutionsMember 2018-12-31 0000313616 us-gaap:OperatingSegmentsMember dhr:DentalEnvistaMember 2019-09-27 0000313616 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-09-27 0000313616 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-09-27 0000313616 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2018-12-31 0000313616 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2018-12-31 0000313616 us-gaap:FairValueInputsLevel1Member 2019-09-27 0000313616 us-gaap:FairValueInputsLevel2Member 2019-09-27 0000313616 us-gaap:FairValueInputsLevel3Member 2018-12-31 0000313616 us-gaap:FairValueInputsLevel3Member 2019-09-27 0000313616 us-gaap:FairValueInputsLevel2Member 2018-12-31 0000313616 us-gaap:FairValueInputsLevel1Member 2018-12-31 0000313616 dhr:A0.2SeniorNotesDue2026Member us-gaap:SeniorNotesMember 2019-09-18 2019-09-18 0000313616 dhr:A1.8SeniorNotesDue2049Member us-gaap:SeniorNotesMember 2019-09-18 0000313616 dhr:A0.75SeniorNotesDue2031Member us-gaap:SeniorNotesMember 2019-09-18 0000313616 dhr:A0.45SeniorNotesDue2028Member us-gaap:SeniorNotesMember 2019-09-18 0000313616 dhr:A1.8SeniorNotesDue2049Member us-gaap:SeniorNotesMember 2019-09-18 2019-09-18 0000313616 dhr:A0.45SeniorNotesDue2028Member us-gaap:SeniorNotesMember 2019-09-18 2019-09-18 0000313616 dhr:A0.75SeniorNotesDue2031Member us-gaap:SeniorNotesMember 2019-09-18 2019-09-18 0000313616 dhr:A0.2SeniorNotesDue2026Member us-gaap:SeniorNotesMember 2019-09-18 0000313616 dhr:A1.35SeniorNotesDue2039Member us-gaap:SeniorNotesMember 2019-09-18 0000313616 dhr:A1.35SeniorNotesDue2039Member us-gaap:SeniorNotesMember 2019-09-18 2019-09-18 0000313616 dhr:A2.5SeniorNotesDue2025Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:EnvistaEuroTermLoanFacilityMember us-gaap:UnsecuredDebtMember 2019-09-27 0000313616 dhr:FloatingRateSeniorNotesDue2022Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:EnvistaTermLoanFacilityMember us-gaap:UnsecuredDebtMember 2019-09-27 0000313616 dhr:A5.0SeniorNotesDue2020Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:A0.2SeniorNotesDue2026Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:A1.35SeniorNotesDue2039Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:A0.5BondsDue2023Member us-gaap:BondsMember 2018-12-31 0000313616 dhr:A4.375SeniorNotesDue2045Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:A0.2SeniorNotesDue2026Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:A1.0SeniorNotesDue2019Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:A0.352SeniorNotesDue2021Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:USDollarDenominatedCommercialPaperMember us-gaap:CommercialPaperMember 2019-09-27 0000313616 dhr:EnvistaEuroTermLoanFacilityMember us-gaap:UnsecuredDebtMember 2018-12-31 0000313616 dhr:A5.0SeniorNotesDue2020Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:A0.45SeniorNotesDue2028Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:EnvistaTermLoanFacilityMember us-gaap:UnsecuredDebtMember 2018-12-31 0000313616 dhr:EuroDenominatedCommercialPaperMember us-gaap:CommercialPaperMember 2018-12-31 0000313616 dhr:OtherMember 2019-09-27 0000313616 dhr:A2.4SeniorNotesDue2020Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:A0.75SeniorNotesDue2031Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:A1.35SeniorNotesDue2039Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:A0.352SeniorNotesDue2021Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:A0.65SeniorNotesDue2032Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:OtherMember 2018-12-31 0000313616 dhr:A1.0SeniorNotesDue2019Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:A1.7SeniorNotesDue2022Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:A3.35SeniorNotesDue2025Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:A0.75SeniorNotesDue2031Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:A0.45SeniorNotesDue2028Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:ZeroCouponLYONSDue2021Member us-gaap:ConvertibleDebtMember 2018-12-31 0000313616 dhr:A3.35SeniorNotesDue2025Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:A1.2SeniorNotesDue2027Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:A2.5SeniorNotesDue2025Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:FloatingRateSeniorNotesDue2022Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:A1.7SeniorNotesDue2022Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:A0.3SeniorNotesDue2027Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:A1.8SeniorNotesDue2049Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:A0.5BondsDue2023Member us-gaap:BondsMember 2019-09-27 0000313616 dhr:USDollarDenominatedCommercialPaperMember us-gaap:CommercialPaperMember 2018-12-31 0000313616 dhr:ZeroCouponLYONSDue2021Member us-gaap:ConvertibleDebtMember 2019-09-27 0000313616 dhr:A1.2SeniorNotesDue2027Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:A1.125BondsDue2028Member us-gaap:BondsMember 2018-12-31 0000313616 dhr:A0.3SeniorNotesDue2027Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:A4.375SeniorNotesDue2045Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:A1.125BondsDue2028Member us-gaap:BondsMember 2019-09-27 0000313616 dhr:EuroDenominatedCommercialPaperMember us-gaap:CommercialPaperMember 2019-09-27 0000313616 dhr:A1.8SeniorNotesDue2049Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 dhr:A2.4SeniorNotesDue2020Member us-gaap:SeniorNotesMember 2018-12-31 0000313616 dhr:A0.65SeniorNotesDue2032Member us-gaap:SeniorNotesMember 2019-09-27 0000313616 srt:SubsidiariesMember us-gaap:IPOMember dhr:EnvistaMember 2019-09-01 2019-09-27 0000313616 dhr:BiopharmaEuronotesMember us-gaap:SeniorNotesMember 2019-09-18 2019-09-18 0000313616 dhr:ZeroCouponLYONSDue2021Member us-gaap:ConvertibleDebtMember 2019-01-01 2019-09-27 0000313616 us-gaap:RevolvingCreditFacilityMember dhr:A364DayFacilityMember us-gaap:ShortTermDebtMember 2019-08-27 0000313616 us-gaap:RevolvingCreditFacilityMember dhr:FiveYearFacilityMember us-gaap:LongTermDebtMember 2019-08-27 0000313616 srt:SubsidiariesMember dhr:EnvistaTermLoanFacilityMember us-gaap:UnsecuredDebtMember us-gaap:IPOMember dhr:EnvistaMember 2019-09-27 0000313616 us-gaap:RevolvingCreditFacilityMember dhr:SupersededCreditFacilityMember us-gaap:LongTermDebtMember 2019-08-27 0000313616 us-gaap:RevolvingCreditFacilityMember dhr:A364DayFacilityMember us-gaap:ShortTermDebtMember 2019-08-27 2019-08-27 0000313616 srt:SubsidiariesMember dhr:EnvistaEuroTermLoanFacilityMember us-gaap:UnsecuredDebtMember us-gaap:IPOMember dhr:EnvistaMember 2019-09-27 0000313616 srt:SubsidiariesMember us-gaap:RevolvingCreditFacilityMember dhr:EnvistaCreditFacilityMember us-gaap:LongTermDebtMember us-gaap:IPOMember dhr:EnvistaMember 2019-09-27 0000313616 dhr:A1.0SeniorNotesDue2019Member us-gaap:SeniorNotesMember 2019-07-08 2019-07-08 0000313616 dhr:EuroDenominatedCommercialPaperMember us-gaap:CommercialPaperMember 2019-09-27 2019-09-27 0000313616 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember dhr:A2020CreditFacilitiesMember us-gaap:LongTermDebtMember 2019-08-27 0000313616 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember dhr:A364DayFacilityMember us-gaap:ShortTermDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-08-27 2019-08-27 0000313616 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember dhr:FiveYearFacilityMember us-gaap:LongTermDebtMember 2019-08-27 2019-08-27 0000313616 us-gaap:RevolvingCreditFacilityMember dhr:A364DayFacilityMember us-gaap:ShortTermDebtMember us-gaap:EurodollarMember 2019-08-27 2019-08-27 0000313616 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember dhr:A2020CreditFacilitiesMember us-gaap:LongTermDebtMember 2019-08-27 0000313616 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember dhr:A364DayFacilityMember us-gaap:ShortTermDebtMember 2019-08-27 2019-08-27 0000313616 us-gaap:RevolvingCreditFacilityMember dhr:FiveYearFacilityMember us-gaap:LongTermDebtMember us-gaap:EurodollarMember 2019-08-27 2019-08-27 0000313616 us-gaap:RevolvingCreditFacilityMember dhr:A364DayFacilityMember us-gaap:ShortTermDebtMember us-gaap:FederalFundsEffectiveSwapRateMember 2019-08-27 2019-08-27 0000313616 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember dhr:FiveYearFacilityMember us-gaap:LongTermDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-08-27 2019-08-27 0000313616 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember dhr:FiveYearFacilityMember us-gaap:LongTermDebtMember 2019-08-27 2019-08-27 0000313616 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember dhr:A364DayFacilityMember us-gaap:ShortTermDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-08-27 2019-08-27 0000313616 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember dhr:A364DayFacilityMember us-gaap:ShortTermDebtMember 2019-08-27 2019-08-27 0000313616 us-gaap:RevolvingCreditFacilityMember dhr:FiveYearFacilityMember us-gaap:LongTermDebtMember us-gaap:FederalFundsEffectiveSwapRateMember 2019-08-27 2019-08-27 0000313616 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember dhr:FiveYearFacilityMember us-gaap:LongTermDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-08-27 2019-08-27 0000313616 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:NetInvestmentHedgingMember 2019-09-27 0000313616 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:NetInvestmentHedgingMember 2019-09-27 0000313616 us-gaap:LongTermDebtMember us-gaap:NetInvestmentHedgingMember 2019-09-27 0000313616 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-09-27 0000313616 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2019-09-27 0000313616 dhr:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2019-06-29 2019-09-27 0000313616 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2019-06-29 2019-09-27 0000313616 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2019-01-01 2019-09-27 0000313616 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-01-01 2019-09-27 0000313616 dhr:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2019-09-27 0000313616 dhr:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2019-01-01 2019-09-27 0000313616 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-06-29 2019-09-27 0000313616 dhr:U.S.DollarDenominatedBondsMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-01-31 0000313616 dhr:U.S.DollarDenominatedBondsMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-09-27 0000313616 country:US us-gaap:PensionPlansDefinedBenefitMember 2019-09-27 0000313616 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-09-27 0000313616 country:US us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 2018-09-28 0000313616 country:US us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-09-28 0000313616 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-09-28 0000313616 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-09-27 0000313616 country:US us-gaap:PensionPlansDefinedBenefitMember 2019-06-29 2019-09-27 0000313616 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-29 2019-09-27 0000313616 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 2018-09-28 0000313616 country:US us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-09-27 0000313616 us-gaap:CostOfSalesMember 2018-06-30 2018-09-28 0000313616 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-01-01 2018-09-28 0000313616 us-gaap:CostOfSalesMember 2018-01-01 2018-09-28 0000313616 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-06-30 2018-09-28 0000313616 us-gaap:CostOfSalesMember 2019-01-01 2019-09-27 0000313616 us-gaap:CostOfSalesMember 2019-06-29 2019-09-27 0000313616 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-06-29 2019-09-27 0000313616 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-09-27 0000313616 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-06-29 2019-09-27 0000313616 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-06-30 2018-09-28 0000313616 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-01-01 2018-09-28 0000313616 2017-01-01 2017-12-21 0000313616 2012-01-01 2015-12-31 0000313616 us-gaap:ForeignCountryMember 2013-01-01 2015-12-31 0000313616 us-gaap:ForeignCountryMember 2013-12-10 0000313616 us-gaap:ForeignCountryMember 2010-01-01 2012-12-31 0000313616 2017-12-22 2017-12-31 0000313616 us-gaap:EmployeeStockOptionMember 2018-06-30 2018-09-28 0000313616 us-gaap:EmployeeStockOptionMember 2019-06-29 2019-09-27 0000313616 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-09-27 0000313616 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-09-28 0000313616 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-09-28 0000313616 us-gaap:RestrictedStockUnitsRSUMember 2019-06-29 2019-09-27 0000313616 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-09-27 0000313616 us-gaap:RestrictedStockUnitsRSUMember 2018-06-30 2018-09-28 0000313616 us-gaap:PreferredStockMember 2019-03-01 0000313616 2013-07-16 0000313616 us-gaap:CommonStockMember 2019-03-01 2019-03-01 0000313616 us-gaap:PreferredStockMember 2019-03-01 2019-03-01 0000313616 us-gaap:EmployeeStockOptionMember 2019-09-27 2019-09-27 0000313616 srt:MaximumMember srt:ScenarioForecastMember us-gaap:PreferredStockMember 2022-04-15 0000313616 us-gaap:EmployeeStockOptionMember 2019-09-27 0000313616 us-gaap:RestrictedStockUnitsRSUMember 2019-09-27 2019-09-27 0000313616 us-gaap:CommonStockMember 2019-03-01 0000313616 srt:MinimumMember srt:ScenarioForecastMember us-gaap:PreferredStockMember 2022-04-15 0000313616 us-gaap:RestrictedStockUnitsRSUMember 2019-09-27 0000313616 us-gaap:CorporateNonSegmentMember 2018-06-30 2018-09-28 0000313616 us-gaap:CorporateNonSegmentMember 2019-06-29 2019-09-27 0000313616 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-09-27 0000313616 us-gaap:CorporateNonSegmentMember 2018-01-01 2018-09-28 0000313616 us-gaap:CorporateNonSegmentMember 2019-09-27 0000313616 us-gaap:CorporateNonSegmentMember 2018-12-31 shares pure iso4217:USD shares iso4217:USD iso4217:CHF iso4217:JPY iso4217:EUR dhr:Business_Segments dhr:Business iso4217:DKK false --12-31 Q3 2019 0000313616 0 4200000 400000 8500000 1 0.65 2828300000 3023300000 0 0 0.01 2000000000 2000000000 817900000 835000000 701500000 718200000 0.01005 0.01 0.00595 0.00585 0.01000 0.00500 0.01 0.005 0 30000000000 30800000000 0 540000000 53200000000 0 600000000 210000000 600000000 0 800000000 0 800000000 0 250000000 1300000000 30000000000 30800000000 1300000000 540000000 53200000000 1800000000 0 210000000 600000000 1300000000 800000000 750000000 800000000 600000000 250000000 0.002 0.00352 0.003 0.0045 0.005 0.0065 0.0075 0.01 0.01125 0.012 0.0135 0.017 0.018 0.025 0.0335 0.04375 0.050 0 0.00120 0.00125 0.00030 0.00040 2100000000 2700000000 0.0475 0 0 0 15000000 0 1650000 0 1650000 10-Q true 2019-09-27 false 001-08089 DANAHER CORPORATION DE 59-1995548 2200 Pennsylvania Avenue, N.W., Suite 800W 20037-1701 Washington, DC 202 828-0850 Common stock, $0.01 par value DHR NYSE 4.75% Mandatory Convertible Preferred Stock, Series A, without par value DHR.PRA NYSE Floating Rate Senior Notes due 2022 DHR F 06/30/22 NYSE 1.700% Senior Notes due 2022 DHR 1.7 01/04/22 NYSE 2.500% Senior Notes due 2025 DHR 2.5 07/08/25 NYSE 0.200% Senior Notes due 2026 DHR 0.2 03/18/26 NYSE 1.200% Senior Notes due 2027 DHR 1.2 06/30/27 NYSE 0.450% Senior Notes due 2028 DHR 0.45 03/18/28 NYSE 0.750% Senior Notes due 2031 DHR 0.75 09/18/31 NYSE 1.350% Senior Notes due 2039 DHR 1.35 09/18/39 NYSE 1.800% Senior Notes due 2049 DHR 1.8 09/18/49 NYSE Yes Yes Large Accelerated Filer false false false 718281174 14252100000 787800000 3467100000 3489600000 1085200000 1031200000 335000000.0 313900000 603500000 565000000.0 2023700000 1910100000 610800000 906300000 20353700000 7093800000 2519600000 2511200000 1787100000 648400000 25724800000 25906000000.0 11145900000 11673100000 61531100000 47832500000 1068600000 51800000 1606800000 1712800000 3258600000 3076900000 5934000000.0 4841500000 5865300000 5075800000 16536200000 9688500000 1599600000 0 8300000 8200000 7501500000 5834300000 26481200000 25163000000.0 -3088300000 -2791100000 32502300000 28214400000 693300000 12300000 33195600000 28226700000 61531100000 47832500000 5037300000 4853100000 15073800000 14529500000 2228900000 2162600000 6670000000.0 6378300000 2808400000 2690500000 8403800000 8151200000 1654700000 1558600000 5009900000 4798400000 318900000 301200000 951500000 911600000 834800000 830700000 2442400000 2441200000 4400000 9100000 15900000 25200000 26300000 41300000 70200000 123600000 30100000 2800000 72000000.0 6700000 843000000.0 801300000 2460100000 2349500000 169100000 137600000 721100000 445400000 673900000 663700000 1739000000.0 1904100000 5900000 0 5900000 0 668000000.0 663700000 1733100000 1904100000 19600000 0 48800000 0 648400000 663700000 1684300000 1904100000 0.90 0.95 2.36 2.72 0.89 0.93 2.32 2.68 718800000 701400000 714700000 700100000 729300000 710600000 725200000 709900000 673900000 663700000 1739000000.0 1904100000 -235800000 -162400000 -293100000 -509400000 -5800000 -5900000 -15800000 -19700000 500000 0 1400000 -600000 -41800000 0 -48600000 0 -271300000 -156500000 -324500000 -490300000 402600000 507200000 1414500000 1413800000 4700000 0 4700000 0 397900000 507200000 1409800000 1413800000 1599600000 0 0 0 0 0 1599600000 0 1599600000 0 1599600000 0 8300000 8200000 8200000 8100000 0 0 0 100000 0 0 100000 0 8300000 8200000 8300000 8200000 7482600000 5706100000 5834300000 5538200000 77600000 66100000 253200000 194000000.0 0 0 0 23900000 1300000 0 30900000 16100000 0 0 1443100000 0 -60000000.0 0 -60000000.0 0 7501500000 5772200000 7501500000 5772200000 25955000000.0 23977200000 25163000000.0 22806100000 0 0 0 154500000 668000000.0 663700000 1733100000 1904100000 122200000 112200000 366100000 336000000.0 19600000 0 48800000 0 26481200000 24528700000 26481200000 24528700000 -2844300000 -2479200000 -2791100000 -1994200000 0 0 0 -151200000 26100000 0 26100000 0 -270100000 -156500000 -323300000 -490300000 -3088300000 -2635700000 -3088300000 -2635700000 12000000.0 12100000 12300000 9600000 676700000 0 676700000 0 4600000 -300000 4300000 2200000 693300000 11800000 693300000 11800000 33195600000 27685200000 33195600000 27685200000 1739000000.0 1904100000 450300000 449400000 536600000 527500000 130000000.0 111600000 26300000 -128600000 169400000 255400000 -81500000 71500000 -225400000 -245600000 36300000 -398500000 2840400000 2784400000 331100000 2173300000 518400000 441300000 14100000 1600000 165500000 61100000 0 22100000 -28900000 0 -972000000.0 -2652000000.0 115000000.0 77300000 1443200000 0 1599600000 0 643400000 0 385000000.0 321200000 744100000 882100000 8137100000 0 680900000 503900000 -6000000.0 -16600000 11610500000 117700000 -14600000 -104200000 13464300000 145900000 787800000 630300000 14252100000 776200000 112900000 129000000.0 494800000 502000000.0 <span style="font-weight:bold;">GENERAL</span><div style="line-height:120%;padding-top:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The </span><span style="font-family:inherit;font-size:10pt;">Consolidated Condensed Financial Statements</span><span style="font-family:inherit;font-size:10pt;"> included herein have been prepared by Danaher Corporation (“Danaher” or the “Company”) without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In this quarterly report, the terms “Danaher” or the “Company” refer to Danaher Corporation, Danaher Corporation and its consolidated subsidiaries (including Envista Holdings Corporation (“Envista”), unless otherwise indicated or the context otherwise requires) or the consolidated subsidiaries of Danaher Corporation (including Envista, unless otherwise indicated or the context otherwise requires), as the context requires. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted pursuant to SEC rules and regulations; however, the Company believes that the disclosures are adequate to make the information presented not misleading. The Consolidated Condensed Financial Statements included herein should be read in conjunction with the financial statements as of and for the year ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and the Notes thereto included in the Company’s </span><span style="font-family:inherit;font-size:10pt;">2018 Annual Report on Form 10-K filed on February 21, 2019</span><span style="font-family:inherit;font-size:10pt;"> (the “2018 Annual Report” or “2018 Annual Report on Form 10-K”).</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In the opinion of the Company, the accompanying financial statements contain all adjustments (consisting of only normal recurring accruals) necessary to present fairly the financial position of the Company as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, its results of operations for the three and </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month periods ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">September 28, 2018</span><span style="font-family:inherit;font-size:10pt;"> and its cash flows for each of the </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month periods then ended.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Accounting Standards Recently Adopted</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842)</span><span style="font-family:inherit;font-size:10pt;">, which requires lessees to recognize a right-of-use (“ROU”) asset and a lease liability for all leases with terms greater than 12 months and also requires disclosures by lessees and lessors about the amount, timing and uncertainty of cash flows arising from leases. The accounting applied by a lessor is largely unchanged from that applied under the prior standard. Subsequent to the issuance of Topic 842, the FASB clarified the guidance through several ASUs; hereinafter the collection of lease guidance is referred to as “ASC 842”.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On January 1, 2019, the Company adopted ASC 842 using the modified retrospective method for all lease arrangements at the beginning of the period of adoption. Results for reporting periods beginning January 1, 2019 are presented under ASC 842, while prior period amounts were not adjusted and continue to be reported in accordance with the Company’s historic accounting under ASC 840, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Leases </span><span style="font-family:inherit;font-size:10pt;">(“ASC 840”). The standard had a material impact on the Company’s Consolidated Condensed Balance Sheet but did not have a significant impact on the Company’s consolidated net earnings and cash flows. The most significant impact was the recognition of ROU assets and lease liabilities for operating leases, while the accounting for finance leases remained substantially unchanged. For leases that commenced before the effective date of ASC 842, the Company elected the permitted practical expedients to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. The Company also elected to include leases with a term of 12 months or less in the recognized ROU assets and lease liabilities.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As a result of the cumulative impact of adopting ASC 842, the Company recorded operating lease ROU assets of </span><span style="font-family:inherit;font-size:10pt;"><span>$971 million</span></span><span style="font-family:inherit;font-size:10pt;"> and operating lease liabilities of </span><span style="font-family:inherit;font-size:10pt;"><span>$1,012 million</span></span><span style="font-family:inherit;font-size:10pt;"> as of January 1, 2019, primarily related to real estate and automobile leases, based on the present value of the future lease payments on the date of adoption. Refer to Note </span><span style="font-family:inherit;font-size:10pt;">5</span><span style="font-family:inherit;font-size:10pt;"> for the additional disclosures required by ASC 842.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company determines if an arrangement is a lease at inception. For leases where the Company is the lessee, ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The ROU asset also consists of any prepaid lease payments, lease incentives received, costs which will be incurred in exiting a lease and the amount of any asset or liability recognized on business combinations relating to favorable or unfavorable lease terms. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as depreciation expense and interest expense using the accelerated interest </span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">method of recognition. The Company has lease agreements which require payments for lease and non-lease components and has elected to account for these as a single lease component.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company leases Life Sciences, Diagnostics, and Environmental &amp; Applied Solutions equipment to customers in both operating-type lease (“OTL”) and sales-type lease (“STL”) arrangements. Equipment lease revenue for OTL agreements is recognized on a straight-line basis over the life of the lease, and the costs of customer-leased equipment are recorded within property, plant and equipment, net in the accompanying Consolidated Condensed Balance Sheets and depreciated over the equipment’s estimated useful life. Depreciation expense associated with the leased equipment under OTL arrangements is reflected in cost of sales in the accompanying Consolidated Condensed Statements of Earnings. The OTLs are generally not cancellable until after an initial term and may or may not require the customer to purchase a minimum number of consumables or tests throughout the contract term. Certain of the Company’s lease contracts are customized for larger customers and often result in complex terms and conditions that typically require significant judgment in applying the criteria used to evaluate whether the arrangement should be considered an OTL or an STL. An STL results in earlier recognition of equipment revenue as compared to an OTL. Some of the Company’s leases include a purchase option for the customer to purchase the leased asset at the end of the lease arrangement for a purchase price equal to the asset’s fair market value at the time of the purchase. The Company manages its risk on the unguaranteed residual asset for leased equipment through the pricing and term of the leases. In certain geographies, equipment coming off OTL and STL arrangements after the initial lease term may be leased to other customers or used for spare parts.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For lease arrangements with lease and non-lease components where the Company is the lessor, the Company allocates the contract’s transaction price to the lease and non-lease components on a relative standalone selling price basis using the Company’s best estimate of the standalone selling price of each distinct product or service in the contract. The primary method used to estimate standalone selling price is the price observed in standalone sales to customers; however, when prices in standalone sales are not available the Company may use third-party pricing for similar products or services or estimate the standalone selling price. Allocation of the transaction price is determined at the inception of the lease arrangement. The Company’s leases primarily consist of leases with fixed lease payments. For those leases with variable lease payments, the variable lease payment is typically based upon use of the leased equipment or the purchase of consumables used with the leased equipment.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2017, the FASB issued ASU No. 2017-12, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities, </span><span style="font-family:inherit;font-size:10pt;">which expands and refines hedge accounting for both financial and non-financial risk components, aligns the recognition and presentation of the effects of hedging instruments and hedge items in the financial statements and includes certain targeted improvements to ease the application of current guidance related to the assessment of hedge effectiveness. The ASU was effective for public entities for fiscal years beginning after December 15, 2018. In January 2019, the Company entered into approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$1.9 billion</span></span><span style="font-family:inherit;font-size:10pt;"> of cross-currency swap derivative contracts to hedge its net investment in foreign operations against adverse changes in the exchange rates between the U.S. dollar and the Danish kroner, Japanese yen, euro and Swiss franc. </span><span style="font-family:inherit;font-size:10pt;">In June 2019, the Company entered into interest rate swap agreements with a notional amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$850 million</span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">which represents a portion of the amount of U.S. dollar-denominated bonds (with terms ranging from</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;"><span>10</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>30</span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">years) the Company anticipates issuing to finance a portion of the</span><span style="font-family:inherit;font-size:10pt;"> acquisition of the Biopharma Business of General Electric Company (“GE”) Life Sciences (the “GE Biopharma Business” or “GE Biopharma”). </span><span style="font-family:inherit;font-size:10pt;">These contracts effectively fixed the interest rate for a portion of the Company’s anticipated U.S. dollar-denominated debt issuance equal to the notional amount of the swaps to the rate specified in the interest rate swap agreements</span><span style="font-family:inherit;font-size:10pt;">.</span><span style="font-family:inherit;font-size:10pt;"> Refer to Note </span><span style="font-family:inherit;font-size:10pt;">8</span><span style="font-family:inherit;font-size:10pt;"> for additional disclosures about the Company’s debt issuances related to the pending GE Biopharma acquisition and Note </span><span style="font-family:inherit;font-size:10pt;">9</span><span style="font-family:inherit;font-size:10pt;"> for additional disclosures about the Company’s hedging activities.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition to the cross-currency swaps entered into by the Company in January 2019, in September 2019</span><span style="font-family:inherit;font-size:10pt;">, Envista entered into </span><span style="font-family:inherit;font-size:10pt;"><span>$650 million</span></span><span style="font-family:inherit;font-size:10pt;"> of cross-currency swap derivative contracts with respect to its senior unsecured term loan facility. These contracts effectively convert the senior unsecured term loan facility to an obligation denominated in euro and partially offset the impact of changes in currency rates on Envista’s euro-denominated net investments in foreign operations. In addition, Envista entered into </span><span style="font-family:inherit;font-size:10pt;"><span>$650 million</span></span><span style="font-family:inherit;font-size:10pt;"> of interest rate swap derivative contracts to convert the variable interest rate for the senior unsecured term loan facility to a fixed interest rate.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Except for the above accounting policy for leases that was updated as a result of adopting ASC 842, there have been no changes to the Company’s significant accounting policies described in the Annual Report on Form 10-K for the year ended December 31, 2018 that have a material impact on the Company’s Consolidated Condensed Financial Statements and the related Notes.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Accounting Standards Not Yet Adopted</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, </span><span style="font-family:inherit;font-size:10pt;">which amends the impairment model by requiring entities to use a forward-looking approach </span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">based on expected losses rather than incurred losses to estimate credit losses on certain types of financial instruments, including trade receivables. This may result in the earlier recognition of allowances for losses. The ASU is effective for public entities for fiscal years beginning after December 15, 2019, with early adoption permitted. The ASU will be adopted using a modified retrospective transition method, with the adoption impact recognized through a cumulative-effect adjustment to retained earnings in the period of adoption. In November 2018, April 2019 and May 2019, the FASB issued ASU No. 2018-19, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Codification Improvements to Topic 326, Financial Instruments-Credit Losses,</span><span style="font-family:inherit;font-size:10pt;"> ASU No. 2019-04, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Codification Improvements to Topic 326, Financial Instruments-Credit Losses</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments</span><span style="font-family:inherit;font-size:10pt;"> and ASU No. 2019-05, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments-Credit Losses (Topic 326): Targeted Transition Relief </span><span style="font-family:inherit;font-size:10pt;">which provided additional implementation guidance on the previously issued ASU. Management has not yet completed its assessment of the impact of the new standard on the Company’s financial statements. The Company is in the process of implementing changes to its accounting policies and processes for the new standard. Currently, the Company believes that the most notable impact of this ASU will relate to its processes around the assessment of the adequacy of its allowance for doubtful accounts on trade accounts receivable and the recognition of credit losses.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU No. 2018-13, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurement (Topic 820)</span><span style="font-family:inherit;font-size:10pt;">, which modifies the disclosures on fair value measurements by removing the requirement to disclose the amount and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy and the policy for timing of such transfers. The ASU expands the disclosure requirements for Level 3 fair value measurements, primarily focused on changes in unrealized gains and losses included in other comprehensive income (loss). The ASU is effective for public entities for fiscal years beginning after December 15, 2019, with early adoption permitted. Management has not yet completed its assessment of the impact of the new standard on the Company’s financial statements.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU No. 2018-14, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Disclosure Framework—Changes to the Disclosure Requirements for Defined Benefit Plans</span><span style="font-family:inherit;font-size:10pt;">, which amends ASC 715, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation—Retirement Benefits</span><span style="font-family:inherit;font-size:10pt;">, to add, remove, and clarify disclosure requirements related to defined benefit pension and other postretirement plans. The ASU is effective for public entities for fiscal years beginning after December 15, 2020, with early adoption permitted. Management has not yet completed its assessment of the impact of the new standard on the Company’s financial statements.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Accumulated Other Comprehensive Income (Loss)</span><span style="font-family:inherit;font-size:10pt;">—Accumulated other comprehensive income (loss) refers to certain gains and losses that under U.S. GAAP are included in comprehensive income (loss) but are excluded from net earnings as these amounts are initially recorded as an adjustment to stockholders’ equity. The changes in accumulated other comprehensive income (loss) by component are summarized below ($ in millions). Foreign currency translation adjustments generally relate to indefinite investments in non-U.S. subsidiaries, as well as the impact from the Company’s hedges of its net investment in foreign operations, including the Company’s cross-currency swap derivatives, net of any tax impacts.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:31%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:3%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:3%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Foreign Currency Translation Adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Pension &amp; Postretirement Plan Benefit Adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized Gain (Loss) on Available-For-Sale Securities Adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash Flow Hedge Adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td colspan="16" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;font-weight:bold;">For the Three-Month Period Ended September 27, 2019:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Balance, June 28, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(2,155.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(681.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(6.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(2,844.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Other comprehensive income (loss) before reclassifications:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">(Decrease) increase</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(226.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(55.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(281.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Income tax impact</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(9.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>13.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Other comprehensive income (loss) before reclassifications, net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(235.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(41.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(277.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Amounts reclassified from accumulated other comprehensive income (loss):</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Increase</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>7.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:6pt;"><span style="font-family:inherit;font-size:6pt;">(a)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>7.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Income tax impact</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>5.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>5.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Net current period other comprehensive income (loss), net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(235.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>5.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(41.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(271.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:6pt;"><span style="font-family:inherit;font-size:6pt;">(b)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Balance, September 27, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(2,391.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(675.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(48.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(3,115.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td colspan="16" style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Less: accumulated other comprehensive income attributable to noncontrolling interests</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(27.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td colspan="16" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Accumulated other comprehensive income attributable to controlling interests</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(3,088.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td colspan="16" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;font-weight:bold;">For the Three-Month Period Ended September 28, 2018:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Balance, June 29, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1,812.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(664.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(2,479.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Other comprehensive income (loss) before reclassifications:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Decrease</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(162.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(162.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Income tax impact</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Other comprehensive income (loss) before reclassifications, net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(162.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(162.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Amounts reclassified from accumulated other comprehensive income (loss):</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Increase</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>7.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:6pt;"><span style="font-family:inherit;font-size:6pt;">(a)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>7.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Income tax impact</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>5.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>5.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Net current period other comprehensive income (loss), net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(162.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>5.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(156.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Balance, September 28, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1,975.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(658.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(2,635.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(a)</sup></span><span style="font-family:inherit;font-size:9pt;"> This accumulated other comprehensive income (loss) component is included in the computation of net periodic pension cost. Refer to Note </span><span style="font-family:inherit;font-size:9pt;">10</span><span style="font-family:inherit;font-size:9pt;"> for additional details.</span></div><div style="line-height:120%;padding-top:4px;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(b) </sup></span><span style="font-family:inherit;font-size:9pt;">Accumulated other comprehensive income (loss) for the three-month period ended </span><span style="font-family:inherit;font-size:9pt;">September 27, 2019</span><span style="font-family:inherit;font-size:9pt;"> consists of </span><span style="font-family:inherit;font-size:9pt;"><span>$270.1 million</span></span><span style="font-family:inherit;font-size:9pt;"> of accumulated other comprehensive loss attributable to controlling interest and </span><span style="font-family:inherit;font-size:9pt;"><span>$1.2 million</span></span><span style="font-family:inherit;font-size:9pt;"> of accumulated other comprehensive loss attributable to noncontrolling interest.</span></div><div style="line-height:120%;text-align:center;padding-left:12px;text-indent:-12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:31%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:3%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:3%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Foreign Currency Translation Adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Pension &amp; Postretirement Plan Benefit Adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized Gain (Loss) on Available-For-Sale Securities Adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash Flow Hedge Adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td colspan="16" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;font-weight:bold;">For the Nine-Month Period Ended September 27, 2019:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Balance, December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(2,098.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(691.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(2,791.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Other comprehensive income (loss) before reclassifications:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">(Decrease) increase</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(286.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(64.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(348.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Income tax impact</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(7.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>15.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>7.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Other comprehensive income (loss) before reclassifications, net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(293.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(48.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(340.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Amounts reclassified from accumulated other comprehensive income (loss):</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Increase</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>20.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:6pt;"><span style="font-family:inherit;font-size:6pt;">(a)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>20.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Income tax impact</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(4.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(4.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>15.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>15.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Net current period other comprehensive income (loss), net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(293.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>15.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(48.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(324.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:6pt;"><span style="font-family:inherit;font-size:6pt;">(b)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Balance, September 27, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(2,391.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(675.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(48.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(3,115.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td colspan="16" style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Less: accumulated other comprehensive income attributable to noncontrolling interests</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(27.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td colspan="16" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Accumulated other comprehensive income attributable to controlling interests</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(3,088.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td colspan="16" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;font-weight:bold;">For the Nine-Month Period Ended September 28, 2018:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Balance, December 31, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1,422.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(571.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(0.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1,994.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Adoption of accounting standards </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(43.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(107.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(151.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Balance, January 1, 2018</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1,465.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(678.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(2,145.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Other comprehensive income (loss) before reclassifications:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Decrease</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(509.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(510.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Income tax impact</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Other comprehensive income (loss) before reclassifications, net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(509.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(510.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Amounts reclassified from accumulated other comprehensive income (loss):</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Increase</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>25.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:6pt;"><span style="font-family:inherit;font-size:6pt;">(a)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>25.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Income tax impact</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(6.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(6.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>19.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>19.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Net current period other comprehensive income (loss), net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(509.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>19.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(490.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Balance, September 28, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1,975.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(658.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(2,635.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:4px;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(a)</sup></span><span style="font-family:inherit;font-size:9pt;"> This accumulated other comprehensive income (loss) component is included in the computation of net periodic pension cost. Refer to Note </span><span style="font-family:inherit;font-size:9pt;">10</span><span style="font-family:inherit;font-size:9pt;"> for additional details.</span></div><div style="line-height:120%;padding-top:4px;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(b) </sup></span><span style="font-family:inherit;font-size:9pt;">Accumulated other comprehensive income (loss) for the </span><span style="font-family:inherit;font-size:9pt;">nine</span><span style="font-family:inherit;font-size:9pt;">-month period ended </span><span style="font-family:inherit;font-size:9pt;">September 27, 2019</span><span style="font-family:inherit;font-size:9pt;"> consists of </span><span style="font-family:inherit;font-size:9pt;"><span>$323.3 million</span></span><span style="font-family:inherit;font-size:9pt;"> of accumulated other comprehensive loss attributable to controlling interest and </span><span style="font-family:inherit;font-size:9pt;"><span>$1.2 million</span></span><span style="font-family:inherit;font-size:9pt;"> of accumulated other comprehensive loss attributable to noncontrolling interest.</span></div> <div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Accounting Standards Recently Adopted</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842)</span><span style="font-family:inherit;font-size:10pt;">, which requires lessees to recognize a right-of-use (“ROU”) asset and a lease liability for all leases with terms greater than 12 months and also requires disclosures by lessees and lessors about the amount, timing and uncertainty of cash flows arising from leases. The accounting applied by a lessor is largely unchanged from that applied under the prior standard. Subsequent to the issuance of Topic 842, the FASB clarified the guidance through several ASUs; hereinafter the collection of lease guidance is referred to as “ASC 842”.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On January 1, 2019, the Company adopted ASC 842 using the modified retrospective method for all lease arrangements at the beginning of the period of adoption. Results for reporting periods beginning January 1, 2019 are presented under ASC 842, while prior period amounts were not adjusted and continue to be reported in accordance with the Company’s historic accounting under ASC 840, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Leases </span><span style="font-family:inherit;font-size:10pt;">(“ASC 840”). The standard had a material impact on the Company’s Consolidated Condensed Balance Sheet but did not have a significant impact on the Company’s consolidated net earnings and cash flows. The most significant impact was the recognition of ROU assets and lease liabilities for operating leases, while the accounting for finance leases remained substantially unchanged. For leases that commenced before the effective date of ASC 842, the Company elected the permitted practical expedients to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. The Company also elected to include leases with a term of 12 months or less in the recognized ROU assets and lease liabilities.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As a result of the cumulative impact of adopting ASC 842, the Company recorded operating lease ROU assets of </span><span style="font-family:inherit;font-size:10pt;"><span>$971 million</span></span><span style="font-family:inherit;font-size:10pt;"> and operating lease liabilities of </span><span style="font-family:inherit;font-size:10pt;"><span>$1,012 million</span></span><span style="font-family:inherit;font-size:10pt;"> as of January 1, 2019, primarily related to real estate and automobile leases, based on the present value of the future lease payments on the date of adoption. Refer to Note </span><span style="font-family:inherit;font-size:10pt;">5</span><span style="font-family:inherit;font-size:10pt;"> for the additional disclosures required by ASC 842.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company determines if an arrangement is a lease at inception. For leases where the Company is the lessee, ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The ROU asset also consists of any prepaid lease payments, lease incentives received, costs which will be incurred in exiting a lease and the amount of any asset or liability recognized on business combinations relating to favorable or unfavorable lease terms. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as depreciation expense and interest expense using the accelerated interest </span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">method of recognition. The Company has lease agreements which require payments for lease and non-lease components and has elected to account for these as a single lease component.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company leases Life Sciences, Diagnostics, and Environmental &amp; Applied Solutions equipment to customers in both operating-type lease (“OTL”) and sales-type lease (“STL”) arrangements. Equipment lease revenue for OTL agreements is recognized on a straight-line basis over the life of the lease, and the costs of customer-leased equipment are recorded within property, plant and equipment, net in the accompanying Consolidated Condensed Balance Sheets and depreciated over the equipment’s estimated useful life. Depreciation expense associated with the leased equipment under OTL arrangements is reflected in cost of sales in the accompanying Consolidated Condensed Statements of Earnings. The OTLs are generally not cancellable until after an initial term and may or may not require the customer to purchase a minimum number of consumables or tests throughout the contract term. Certain of the Company’s lease contracts are customized for larger customers and often result in complex terms and conditions that typically require significant judgment in applying the criteria used to evaluate whether the arrangement should be considered an OTL or an STL. An STL results in earlier recognition of equipment revenue as compared to an OTL. Some of the Company’s leases include a purchase option for the customer to purchase the leased asset at the end of the lease arrangement for a purchase price equal to the asset’s fair market value at the time of the purchase. The Company manages its risk on the unguaranteed residual asset for leased equipment through the pricing and term of the leases. In certain geographies, equipment coming off OTL and STL arrangements after the initial lease term may be leased to other customers or used for spare parts.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For lease arrangements with lease and non-lease components where the Company is the lessor, the Company allocates the contract’s transaction price to the lease and non-lease components on a relative standalone selling price basis using the Company’s best estimate of the standalone selling price of each distinct product or service in the contract. The primary method used to estimate standalone selling price is the price observed in standalone sales to customers; however, when prices in standalone sales are not available the Company may use third-party pricing for similar products or services or estimate the standalone selling price. Allocation of the transaction price is determined at the inception of the lease arrangement. The Company’s leases primarily consist of leases with fixed lease payments. For those leases with variable lease payments, the variable lease payment is typically based upon use of the leased equipment or the purchase of consumables used with the leased equipment.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2017, the FASB issued ASU No. 2017-12, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities, </span><span style="font-family:inherit;font-size:10pt;">which expands and refines hedge accounting for both financial and non-financial risk components, aligns the recognition and presentation of the effects of hedging instruments and hedge items in the financial statements and includes certain targeted improvements to ease the application of current guidance related to the assessment of hedge effectiveness. The ASU was effective for public entities for fiscal years beginning after December 15, 2018. In January 2019, the Company entered into approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$1.9 billion</span></span><span style="font-family:inherit;font-size:10pt;"> of cross-currency swap derivative contracts to hedge its net investment in foreign operations against adverse changes in the exchange rates between the U.S. dollar and the Danish kroner, Japanese yen, euro and Swiss franc. </span><span style="font-family:inherit;font-size:10pt;">In June 2019, the Company entered into interest rate swap agreements with a notional amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$850 million</span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">which represents a portion of the amount of U.S. dollar-denominated bonds (with terms ranging from</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;"><span>10</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>30</span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">years) the Company anticipates issuing to finance a portion of the</span><span style="font-family:inherit;font-size:10pt;"> acquisition of the Biopharma Business of General Electric Company (“GE”) Life Sciences (the “GE Biopharma Business” or “GE Biopharma”). </span><span style="font-family:inherit;font-size:10pt;">These contracts effectively fixed the interest rate for a portion of the Company’s anticipated U.S. dollar-denominated debt issuance equal to the notional amount of the swaps to the rate specified in the interest rate swap agreements</span><span style="font-family:inherit;font-size:10pt;">.</span><span style="font-family:inherit;font-size:10pt;"> Refer to Note </span><span style="font-family:inherit;font-size:10pt;">8</span><span style="font-family:inherit;font-size:10pt;"> for additional disclosures about the Company’s debt issuances related to the pending GE Biopharma acquisition and Note </span><span style="font-family:inherit;font-size:10pt;">9</span><span style="font-family:inherit;font-size:10pt;"> for additional disclosures about the Company’s hedging activities.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition to the cross-currency swaps entered into by the Company in January 2019, in September 2019</span><span style="font-family:inherit;font-size:10pt;">, Envista entered into </span><span style="font-family:inherit;font-size:10pt;"><span>$650 million</span></span><span style="font-family:inherit;font-size:10pt;"> of cross-currency swap derivative contracts with respect to its senior unsecured term loan facility. These contracts effectively convert the senior unsecured term loan facility to an obligation denominated in euro and partially offset the impact of changes in currency rates on Envista’s euro-denominated net investments in foreign operations. In addition, Envista entered into </span><span style="font-family:inherit;font-size:10pt;"><span>$650 million</span></span><span style="font-family:inherit;font-size:10pt;"> of interest rate swap derivative contracts to convert the variable interest rate for the senior unsecured term loan facility to a fixed interest rate.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Except for the above accounting policy for leases that was updated as a result of adopting ASC 842, there have been no changes to the Company’s significant accounting policies described in the Annual Report on Form 10-K for the year ended December 31, 2018 that have a material impact on the Company’s Consolidated Condensed Financial Statements and the related Notes.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Accounting Standards Not Yet Adopted</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, </span><span style="font-family:inherit;font-size:10pt;">which amends the impairment model by requiring entities to use a forward-looking approach </span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">based on expected losses rather than incurred losses to estimate credit losses on certain types of financial instruments, including trade receivables. This may result in the earlier recognition of allowances for losses. The ASU is effective for public entities for fiscal years beginning after December 15, 2019, with early adoption permitted. The ASU will be adopted using a modified retrospective transition method, with the adoption impact recognized through a cumulative-effect adjustment to retained earnings in the period of adoption. In November 2018, April 2019 and May 2019, the FASB issued ASU No. 2018-19, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Codification Improvements to Topic 326, Financial Instruments-Credit Losses,</span><span style="font-family:inherit;font-size:10pt;"> ASU No. 2019-04, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Codification Improvements to Topic 326, Financial Instruments-Credit Losses</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments</span><span style="font-family:inherit;font-size:10pt;"> and ASU No. 2019-05, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments-Credit Losses (Topic 326): Targeted Transition Relief </span><span style="font-family:inherit;font-size:10pt;">which provided additional implementation guidance on the previously issued ASU. Management has not yet completed its assessment of the impact of the new standard on the Company’s financial statements. The Company is in the process of implementing changes to its accounting policies and processes for the new standard. Currently, the Company believes that the most notable impact of this ASU will relate to its processes around the assessment of the adequacy of its allowance for doubtful accounts on trade accounts receivable and the recognition of credit losses.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU No. 2018-13, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurement (Topic 820)</span><span style="font-family:inherit;font-size:10pt;">, which modifies the disclosures on fair value measurements by removing the requirement to disclose the amount and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy and the policy for timing of such transfers. The ASU expands the disclosure requirements for Level 3 fair value measurements, primarily focused on changes in unrealized gains and losses included in other comprehensive income (loss). The ASU is effective for public entities for fiscal years beginning after December 15, 2019, with early adoption permitted. Management has not yet completed its assessment of the impact of the new standard on the Company’s financial statements.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU No. 2018-14, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Disclosure Framework—Changes to the Disclosure Requirements for Defined Benefit Plans</span><span style="font-family:inherit;font-size:10pt;">, which amends ASC 715, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation—Retirement Benefits</span><span style="font-family:inherit;font-size:10pt;">, to add, remove, and clarify disclosure requirements related to defined benefit pension and other postretirement plans. The ASU is effective for public entities for fiscal years beginning after December 15, 2020, with early adoption permitted. Management has not yet completed its assessment of the impact of the new standard on the Company’s financial statements.</span></div> 971000000 1012000000 1900000000 850000000 P10Y P30Y 650000000 650000000 The changes in accumulated other comprehensive income (loss) by component are summarized below ($ in millions). Foreign currency translation adjustments generally relate to indefinite investments in non-U.S. subsidiaries, as well as the impact from the Company’s hedges of its net investment in foreign operations, including the Company’s cross-currency swap derivatives, net of any tax impacts.<div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:31%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:3%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:3%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Foreign Currency Translation Adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Pension &amp; Postretirement Plan Benefit Adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized Gain (Loss) on Available-For-Sale Securities Adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash Flow Hedge Adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td colspan="16" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;font-weight:bold;">For the Three-Month Period Ended September 27, 2019:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Balance, June 28, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(2,155.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(681.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(6.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(2,844.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Other comprehensive income (loss) before reclassifications:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">(Decrease) increase</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(226.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(55.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(281.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Income tax impact</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(9.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>13.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Other comprehensive income (loss) before reclassifications, net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(235.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(41.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(277.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Amounts reclassified from accumulated other comprehensive income (loss):</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Increase</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>7.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:6pt;"><span style="font-family:inherit;font-size:6pt;">(a)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>7.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Income tax impact</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>5.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>5.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Net current period other comprehensive income (loss), net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(235.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>5.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(41.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(271.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:6pt;"><span style="font-family:inherit;font-size:6pt;">(b)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Balance, September 27, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(2,391.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(675.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(48.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(3,115.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td colspan="16" style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Less: accumulated other comprehensive income attributable to noncontrolling interests</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(27.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td colspan="16" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Accumulated other comprehensive income attributable to controlling interests</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(3,088.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td colspan="16" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;font-weight:bold;">For the Three-Month Period Ended September 28, 2018:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Balance, June 29, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1,812.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(664.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(2,479.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Other comprehensive income (loss) before reclassifications:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Decrease</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(162.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(162.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Income tax impact</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Other comprehensive income (loss) before reclassifications, net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(162.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(162.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Amounts reclassified from accumulated other comprehensive income (loss):</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Increase</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>7.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:6pt;"><span style="font-family:inherit;font-size:6pt;">(a)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>7.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Income tax impact</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>5.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>5.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Net current period other comprehensive income (loss), net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(162.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>5.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(156.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Balance, September 28, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1,975.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(658.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(2,635.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(a)</sup></span><span style="font-family:inherit;font-size:9pt;"> This accumulated other comprehensive income (loss) component is included in the computation of net periodic pension cost. Refer to Note </span><span style="font-family:inherit;font-size:9pt;">10</span><span style="font-family:inherit;font-size:9pt;"> for additional details.</span></div><div style="line-height:120%;padding-top:4px;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(b) </sup></span><span style="font-family:inherit;font-size:9pt;">Accumulated other comprehensive income (loss) for the three-month period ended </span><span style="font-family:inherit;font-size:9pt;">September 27, 2019</span><span style="font-family:inherit;font-size:9pt;"> consists of </span><span style="font-family:inherit;font-size:9pt;"><span>$270.1 million</span></span><span style="font-family:inherit;font-size:9pt;"> of accumulated other comprehensive loss attributable to controlling interest and </span><span style="font-family:inherit;font-size:9pt;"><span>$1.2 million</span></span><span style="font-family:inherit;font-size:9pt;"> of accumulated other comprehensive loss attributable to noncontrolling interest.</span></div><div style="line-height:120%;text-align:center;padding-left:12px;text-indent:-12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:31%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:3%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:3%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Foreign Currency Translation Adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Pension &amp; Postretirement Plan Benefit Adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized Gain (Loss) on Available-For-Sale Securities Adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash Flow Hedge Adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td colspan="16" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;font-weight:bold;">For the Nine-Month Period Ended September 27, 2019:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Balance, December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(2,098.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(691.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(2,791.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Other comprehensive income (loss) before reclassifications:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">(Decrease) increase</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(286.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(64.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(348.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Income tax impact</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(7.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>15.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>7.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Other comprehensive income (loss) before reclassifications, net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(293.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(48.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(340.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Amounts reclassified from accumulated other comprehensive income (loss):</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Increase</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>20.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:6pt;"><span style="font-family:inherit;font-size:6pt;">(a)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>20.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Income tax impact</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(4.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(4.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>15.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>15.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Net current period other comprehensive income (loss), net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(293.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>15.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(48.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(324.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:6pt;"><span style="font-family:inherit;font-size:6pt;">(b)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Balance, September 27, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(2,391.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(675.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(48.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(3,115.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td colspan="16" style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Less: accumulated other comprehensive income attributable to noncontrolling interests</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(27.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td colspan="16" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Accumulated other comprehensive income attributable to controlling interests</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(3,088.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td colspan="16" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;font-weight:bold;">For the Nine-Month Period Ended September 28, 2018:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Balance, December 31, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1,422.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(571.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(0.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1,994.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Adoption of accounting standards </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(43.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(107.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(151.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Balance, January 1, 2018</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1,465.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(678.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(2,145.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Other comprehensive income (loss) before reclassifications:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Decrease</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(509.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(510.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Income tax impact</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Other comprehensive income (loss) before reclassifications, net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(509.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(510.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Amounts reclassified from accumulated other comprehensive income (loss):</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Increase</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>25.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:6pt;"><span style="font-family:inherit;font-size:6pt;">(a)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>25.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Income tax impact</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(6.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(6.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>19.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>19.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Net current period other comprehensive income (loss), net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(509.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>19.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(490.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Balance, September 28, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1,975.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(658.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;"><span>(2,635.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:4px;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(a)</sup></span><span style="font-family:inherit;font-size:9pt;"> This accumulated other comprehensive income (loss) component is included in the computation of net periodic pension cost. Refer to Note </span><span style="font-family:inherit;font-size:9pt;">10</span><span style="font-family:inherit;font-size:9pt;"> for additional details.</span></div><div style="line-height:120%;padding-top:4px;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(b) </sup></span><span style="font-family:inherit;font-size:9pt;">Accumulated other comprehensive income (loss) for the </span><span style="font-family:inherit;font-size:9pt;">nine</span><span style="font-family:inherit;font-size:9pt;">-month period ended </span><span style="font-family:inherit;font-size:9pt;">September 27, 2019</span><span style="font-family:inherit;font-size:9pt;"> consists of </span><span style="font-family:inherit;font-size:9pt;"><span>$323.3 million</span></span><span style="font-family:inherit;font-size:9pt;"> of accumulated other comprehensive loss attributable to controlling interest and </span><span style="font-family:inherit;font-size:9pt;"><span>$1.2 million</span></span><span style="font-family:inherit;font-size:9pt;"> of accumulated other comprehensive loss attributable to noncontrolling interest.</span></div> -2155400000 -681100000 -1000000.0 -6800000 -2844300000 -226800000 0 600000 -55100000 -281300000 9000000.0 0 100000 -13300000 -4200000 -235800000 0 500000 -41800000 -277100000 0 -7500000 0 0 -7500000 0 -1700000 0 0 -1700000 0 -5800000 0 0 -5800000 -235800000 5800000 500000 -41800000 -271300000 -2391200000 -675300000 -500000 -48600000 -3115600000 -27300000 -3088300000 -1812900000 -664600000 -1700000 0 -2479200000 -162400000 0 0 0 -162400000 0 0 0 0 0 -162400000 0 0 0 -162400000 0 -7700000 0 0 -7700000 0 -1800000 0 0 -1800000 0 -5900000 0 0 -5900000 -162400000 5900000 0 0 -156500000 -1975300000 -658700000 -1700000 0 -2635700000 -270100000 -1200000 -2098100000 -691100000 -1900000 0 -2791100000 -286000000.0 0 1800000 -64000000.0 -348200000 7100000 0 400000 -15400000 -7900000 -293100000 0 1400000 -48600000 -340300000 0 -20700000 0 0 -20700000 0 -4900000 0 0 -4900000 0 -15800000 0 0 -15800000 -293100000 15800000 1400000 -48600000 -324500000 -2391200000 -675300000 -500000 -48600000 -3115600000 -27300000 -3088300000 -1422100000 -571200000 -900000 0 -1994200000 -43800000 -107200000 -200000 0 -151200000 -1465900000 -678400000 -1100000 0 -2145400000 -509400000 0 -800000 0 -510200000 0 0 -200000 0 -200000 -509400000 0 -600000 0 -510000000.0 0 -25800000 0 0 -25800000 0 -6100000 0 0 -6100000 0 -19700000 0 0 -19700000 -509400000 19700000 -600000 0 -490300000 -1975300000 -658700000 -1700000 0 -2635700000 -323300000 -1200000 <span style="font-weight:bold;">REVENUE</span><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following tables present the Company’s revenues disaggregated by geographical region and revenue type for the three and </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month periods ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">September 28, 2018</span><span style="font-family:inherit;font-size:10pt;"> ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenue.</span></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:31%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Life Sciences</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Diagnostics</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Dental / Envista</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Environmental &amp; Applied Solutions</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three-month period ended September 27, 2019:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Geographical region:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">North America</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>637.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>602.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>327.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>465.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,033.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Western Europe</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>444.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>257.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>127.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>252.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,082.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other developed markets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>149.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>108.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>45.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>335.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">High-growth markets </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(a)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>465.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>632.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>158.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>329.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,586.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,695.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,601.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>659.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,080.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,037.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue type:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Recurring</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,084.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,343.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>479.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>595.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,502.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nonrecurring</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>611.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>258.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>179.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>485.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,535.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,695.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,601.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>659.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,080.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,037.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three-month period ended September 28, 2018:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Geographical region:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">North America</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>584.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>574.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>339.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>439.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,937.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Western Europe</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>447.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>262.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>137.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>257.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,104.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other developed markets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>134.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>91.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>299.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">High-growth markets </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(a)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>431.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>574.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>160.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>346.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,511.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,596.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,502.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>679.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,074.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,853.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue type:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Recurring</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,030.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,273.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>478.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>571.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,353.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nonrecurring</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>565.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>229.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>201.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>503.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,499.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,596.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,502.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>679.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,074.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,853.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:4px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:31%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Life Sciences</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Diagnostics</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Dental / Envista</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Environmental &amp; Applied Solutions</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine-month period ended September 27, 2019:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Geographical region:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">North America</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,878.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,836.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>966.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,403.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,083.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Western Europe</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,363.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>828.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>443.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>774.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,410.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other developed markets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>436.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>295.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>131.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>92.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>955.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">High-growth markets </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(a)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,357.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,796.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>490.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>980.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,624.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,035.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,757.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,031.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,250.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15,073.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue type:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Recurring</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,264.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,047.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,489.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,770.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10,571.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nonrecurring</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,770.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>709.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>541.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,480.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,502.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,035.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,757.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,031.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,250.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15,073.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine-month period ended September 28, 2018:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Geographical region:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">North America</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,642.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,760.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>977.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,308.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,688.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Western Europe</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,346.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>861.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>483.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>785.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,476.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other developed markets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>417.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>275.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>133.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>94.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>921.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">High-growth markets </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(a)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,271.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,676.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>491.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,003.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,442.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,677.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,573.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,085.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,193.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14,529.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue type:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Recurring</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,057.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,892.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,513.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,702.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10,166.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nonrecurring</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,620.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>680.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>572.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,490.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,363.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,677.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,573.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,085.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,193.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14,529.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:4px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(a)</sup></span><span style="font-family:inherit;font-size:9pt;"> The Company defines high-growth markets as developing markets of the world experiencing extended periods of accelerated growth in gross domestic product and infrastructure which include Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia). The Company defines developed markets as all markets that are not high-growth markets. </span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company sells equipment to customers as well as consumables, spare parts, software licenses and services, some of which customers purchase on a recurring basis. In most of the Company’s businesses, consumables are typically critical to the use of the equipment and are typically used on a one-time or limited basis, requiring frequent replacement in the customer’s operating cycle. Examples of these consumables include reagents used in diagnostic tests, filters used in filtration, separation and purification processes and cartridges for marking and coding equipment. Additionally, some of the Company’s consumables are used on a standalone basis, such as dental implants and water treatment solutions. The Company separates its goods and services between those sold on a recurring basis and those sold on a nonrecurring basis. Recurring revenue includes revenue from consumables, services, spare parts, software licenses recognized over time, software-as-a-service, sales-and-usage based royalties and OTLs. Nonrecurring revenue includes sales from equipment, software licenses recognized at a point in time and STLs. OTLs and STLs are included in the above revenue amounts. For the three-month periods ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">September 28, 2018</span><span style="font-family:inherit;font-size:10pt;">, revenue accounted for under ASC 842 and ASC 840 was </span><span style="font-family:inherit;font-size:10pt;"><span>$108 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$115 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. For the </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month periods ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">September 28, 2018</span><span style="font-family:inherit;font-size:10pt;">, revenue accounted for under ASC 842 and ASC 840 was </span><span style="font-family:inherit;font-size:10pt;"><span>$321 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$308 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Remaining performance obligations related to </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Topic 606, Revenue from Contracts with Customers</span><span style="font-family:inherit;font-size:10pt;"> (“ASC 606”) represent the aggregate transaction price allocated to performance obligations with an original contract term greater than one year which are fully or partially unsatisfied at the end of the period. As of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, the aggregate amount of the transaction price allocated to remaining performance obligations was approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$2.0 billion</span></span><span style="font-family:inherit;font-size:10pt;">. The Company expects to recognize revenue on </span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">approximately </span><span style="font-family:inherit;font-size:10pt;"><span>39%</span></span><span style="font-family:inherit;font-size:10pt;"> of the remaining performance obligations over the next 12 months, </span><span style="font-family:inherit;font-size:10pt;"><span>25%</span></span><span style="font-family:inherit;font-size:10pt;"> over the subsequent 12 months, and the remainder thereafter.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets) and deferred revenue, customer deposits and billings in excess of revenue recognized (contract liabilities) on the Consolidated Condensed Balance Sheets. Most of the Company’s long-term contracts are billed as work progresses in accordance with the contract terms and conditions, either at periodic intervals or upon achievement of certain milestones. Often this results in billing occurring subsequent to revenue recognition resulting in contract assets. Contract assets are generally classified as other current assets in the Consolidated Condensed Balance Sheets. The balance of contract assets as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> were </span><span style="font-family:inherit;font-size:10pt;"><span>$77 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$82 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company often receives cash payments from customers in advance of the Company’s performance resulting in contract liabilities. These contract liabilities are classified as either current or long-term in the Consolidated Condensed Balance Sheets based on the timing of when the Company expects to recognize revenue. As of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, contract liabilities were </span><span style="font-family:inherit;font-size:10pt;"><span>$801 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$799 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively, and are included within accrued expenses and other liabilities and other long-term liabilities in the accompanying Consolidated Condensed Balance Sheets. Revenue recognized during the </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month periods ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">September 28, 2018</span><span style="font-family:inherit;font-size:10pt;"> that was included in the contract liability balance on </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and at the date of adoption of ASC 606 on January 1, 2018 was </span><span style="font-family:inherit;font-size:10pt;"><span>$544 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$568 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. Contract assets and liabilities are reported on the accompanying Consolidated Condensed Balance Sheets on a contract-by-contract basis.</span></div> <div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following tables present the Company’s revenues disaggregated by geographical region and revenue type for the three and </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month periods ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">September 28, 2018</span><span style="font-family:inherit;font-size:10pt;"> ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenue.</span></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:31%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Life Sciences</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Diagnostics</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Dental / Envista</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Environmental &amp; Applied Solutions</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three-month period ended September 27, 2019:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Geographical region:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">North America</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>637.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>602.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>327.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>465.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,033.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Western Europe</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>444.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>257.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>127.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>252.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,082.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other developed markets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>149.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>108.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>45.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>335.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">High-growth markets </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(a)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>465.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>632.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>158.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>329.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,586.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,695.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,601.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>659.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,080.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,037.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue type:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Recurring</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,084.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,343.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>479.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>595.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,502.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nonrecurring</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>611.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>258.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>179.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>485.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,535.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,695.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,601.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>659.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,080.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,037.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three-month period ended September 28, 2018:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Geographical region:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">North America</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>584.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>574.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>339.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>439.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,937.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Western Europe</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>447.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>262.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>137.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>257.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,104.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other developed markets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>134.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>91.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>299.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">High-growth markets </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(a)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>431.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>574.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>160.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>346.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,511.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,596.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,502.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>679.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,074.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,853.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue type:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Recurring</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,030.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,273.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>478.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>571.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,353.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nonrecurring</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>565.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>229.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>201.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>503.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,499.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,596.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,502.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>679.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,074.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,853.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:4px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:31%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Life Sciences</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Diagnostics</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Dental / Envista</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Environmental &amp; Applied Solutions</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine-month period ended September 27, 2019:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Geographical region:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">North America</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,878.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,836.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>966.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,403.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,083.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Western Europe</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,363.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>828.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>443.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>774.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,410.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other developed markets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>436.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>295.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>131.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>92.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>955.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">High-growth markets </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(a)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,357.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,796.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>490.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>980.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,624.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,035.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,757.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,031.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,250.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15,073.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue type:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Recurring</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,264.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,047.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,489.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,770.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10,571.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nonrecurring</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,770.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>709.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>541.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,480.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,502.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,035.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,757.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,031.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,250.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15,073.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine-month period ended September 28, 2018:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Geographical region:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">North America</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,642.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,760.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>977.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,308.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,688.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Western Europe</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,346.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>861.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>483.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>785.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,476.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other developed markets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>417.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>275.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>133.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>94.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>921.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">High-growth markets </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(a)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,271.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,676.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>491.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,003.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,442.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,677.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,573.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,085.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,193.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14,529.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue type:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Recurring</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,057.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,892.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,513.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,702.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10,166.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Nonrecurring</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,620.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>680.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>572.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,490.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,363.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,677.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,573.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,085.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,193.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14,529.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 637200000 602900000 327700000 465500000 2033300000 444100000 257900000 127500000 252800000 1082300000 149200000 108400000 45600000 32500000 335700000 465100000 632700000 158500000 329700000 1586000000.0 1695600000 1601900000 659300000 1080500000 5037300000 1084300000 1343200000 479400000 595200000 3502100000 611300000 258700000 179900000 485300000 1535200000 1695600000 1601900000 659300000 1080500000 5037300000 584000000.0 574000000.0 339800000 439700000 1937500000 447100000 262300000 137200000 257500000 1104100000 134500000 91800000 42500000 31000000.0 299800000 431100000 574400000 160000000.0 346200000 1511700000 1596700000 1502500000 679500000 1074400000 4853100000 1030900000 1273300000 478200000 571100000 3353500000 565800000 229200000 201300000 503300000 1499600000 1596700000 1502500000 679500000 1074400000 4853100000 1878100000 1836300000 966400000 1403000000.0 6083800000 1363700000 828500000 443700000 774100000 3410000000.0 436100000 295600000 131000000.0 92700000 955400000 1357200000 1796600000 490000000.0 980800000 4624600000 5035100000 4757000000.0 2031100000 3250600000 15073800000 3264400000 4047900000 1489300000 1770200000 10571800000 1770700000 709100000 541800000 1480400000 4502000000.0 5035100000 4757000000.0 2031100000 3250600000 15073800000 1642400000 1760100000 977200000 1308700000 5688400000 1346500000 861400000 483300000 785500000 3476700000 417900000 275300000 133500000 94900000 921600000 1271100000 1676300000 491500000 1003900000 4442800000 4677900000 4573100000 2085500000 3193000000.0 14529500000 3057300000 3892800000 1513500000 1702700000 10166300000 1620600000 680300000 572000000.0 1490300000 4363200000 4677900000 4573100000 2085500000 3193000000.0 14529500000 108000000 115000000 321000000 308000000 2000000000.0 0.39 0.25 77000000 82000000 801000000 799000000 544000000 568000000 <span style="font-weight:bold;">ACQUISITIONS</span><div style="line-height:120%;padding-top:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For a description of the Company’s acquisition activity for the year ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, reference is made to the financial statements as of and for the year ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and Note </span><span style="font-family:inherit;font-size:10pt;">3</span><span style="font-family:inherit;font-size:10pt;"> thereto included in the Company’s </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> Annual Report.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company continually evaluates potential acquisitions that either strategically fit with the Company’s existing portfolio or expand the Company’s portfolio into a new and attractive business area. The Company has completed a number of acquisitions that have been accounted for as purchases and have resulted in the recognition of goodwill in the Company’s financial statements. This goodwill arises because the purchase prices for these businesses reflect a number of factors including the future earnings and cash flow potential of these businesses, the multiple to earnings, cash flow and other factors at which similar businesses have been purchased by other acquirers, the competitive nature of the processes by which the Company acquired the businesses, avoidance of the time and costs which would be required (and the associated risks that would be encountered) to enhance the Company’s existing product offerings to key target markets and enter into new and profitable businesses and the complementary strategic fit and resulting synergies these businesses bring to existing operations.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company makes an initial allocation of the purchase price at the date of acquisition based upon its understanding of the fair value of the acquired assets and assumed liabilities. The Company obtains this information during due diligence and through other sources. In the months after closing, as the Company obtains additional information about these assets and liabilities, including through tangible and intangible asset appraisals, and learns more about the newly acquired business, it is able to refine the estimates of fair value and more accurately allocate the purchase price. Only items identified as of the acquisition date are considered for subsequent adjustment. The Company is continuing to evaluate certain pre-acquisition contingencies associated with its </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;"> acquisitions and is also in the process of obtaining valuations of acquired intangible assets and certain acquisition-related liabilities in connection with these acquisitions. The Company will make appropriate adjustments to the purchase price allocation prior to completion of the measurement period, as required.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During the </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month period ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">the Company acquired</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;"><span>five</span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">businesses for total consideration of </span><span style="font-family:inherit;font-size:10pt;"><span>$331 million</span></span><span style="font-family:inherit;font-size:10pt;"> in cash, net of cash acquired. The businesses acquired complement existing units of the Life Sciences, Diagnostics and Environmental &amp; Applied Solutions segments. The aggregate annual sales of these</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">businesses at the time of their acquisition, based on the companies’ revenues for their last completed fiscal year prior to the acquisition, were</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;"><span>$72 million</span></span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;">The Company preliminarily recorded an aggregate of</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;"><span>$215 million</span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">of goodwill related to these acquisitions.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following summarizes the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition for the acquisitions consummated during the </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month period ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> ($ in millions):</span></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:87%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Trade accounts receivable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventories</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property, plant and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>214.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other intangible assets, primarily customer relationships, trade names and technology</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>112.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Trade accounts payable</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other assets and liabilities, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net cash consideration</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>331.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Pro Forma Financial Information</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The unaudited pro forma information for the periods set forth below gives effect to the </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> acquisitions as if they had occurred as of January 1, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">. The pro forma information is presented for informational purposes only and is not necessarily indicative of the results of operations that actually would have been achieved had the acquisitions been consummated as of that time ($ in millions, except per share amounts):</span></div><div style="line-height:120%;padding-top:12px;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three-Month Period Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine-Month Period Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,037.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,873.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15,082.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14,685.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net earnings attributable to common stockholders</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>648.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>658.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,681.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,888.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diluted net earnings per share</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.89</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.93</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.32</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.66</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Acquisition-related transaction costs of </span><span style="font-family:inherit;font-size:10pt;"><span>$15 million</span></span><span style="font-family:inherit;font-size:10pt;"> associated with the IDT acquisition were excluded from pro forma earnings in </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Pending Acquisition</span></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On February 25, 2019, the Company entered into an Equity and Asset Purchase Agreement (the “GE Biopharma Purchase Agreement”) with GE to acquire the GE Biopharma Business for a cash purchase price of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$21.0 billion</span></span><span style="font-family:inherit;font-size:10pt;">, subject to certain adjustments, and the assumption of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$0.4 billion</span></span><span style="font-family:inherit;font-size:10pt;"> of pension liabilities (the “GE Biopharma Acquisition”). The GE Biopharma Business is a leading provider of instruments, consumables and software that support the research, discovery, process development and manufacturing workflows of biopharmaceutical drugs. Based on audited carve-out financial statements provided by GE, the GE Biopharma Business generated revenues of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$3.0 billion</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">. The Company expects to include the GE Biopharma Business within the Life Sciences segment. The GE Biopharma Acquisition is expected to provide additional sales and earnings growth opportunities for the Company’s Life Sciences segment by expanding the business’ geographic and product line diversity, including new product and service offerings that complement the Company’s current biologics workflow solutions. As a condition to obtaining certain regulatory approvals for the closing of the transaction, the Company will be required to divest certain of its existing product lines. In furtherance thereof, on October 18, 2019, the Company signed an agreement to sell certain of its product lines, contingent upon the Company closing the GE Biopharma Acquisition. These product lines had annual revenue in 2018 of </span><span style="font-family:inherit;font-size:10pt;"><span>$140 million</span></span><span style="font-family:inherit;font-size:10pt;">. Though </span><span style="font-family:inherit;font-size:10pt;">the timing of obtaining the regulatory approvals necessary to close the GE Biopharma Acquisition is uncertain, the Company continues to make progress with respect thereto and expects to close the transaction in the first quarter of 2020.</span><span style="font-family:inherit;font-size:10pt;"> </span></div><span style="font-family:inherit;font-size:10pt;">The Company expects to finance the GE Biopharma Acquisition with approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$3.0 billion</span></span><span style="font-family:inherit;font-size:10pt;"> of proceeds from the March 1, 2019 underwritten public offerings of its Common Stock and Mandatory Convertible Preferred Stock (“MCPS”), proceeds from the September 2019 issuance of debt, proceeds from the issuance of additional debt or other borrowings and available cash on hand. Refer to Note </span><span style="font-family:inherit;font-size:10pt;">8</span><span style="font-family:inherit;font-size:10pt;"> for additional information related to the issuance of debt and to Note </span><span style="font-family:inherit;font-size:10pt;">14</span> for additional information related to the March 1, 2019 public offerings. 5 331000000 72000000 215000000 <div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following summarizes the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition for the acquisitions consummated during the </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month period ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> ($ in millions):</span></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:87%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Trade accounts receivable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventories</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property, plant and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>214.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other intangible assets, primarily customer relationships, trade names and technology</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>112.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Trade accounts payable</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other assets and liabilities, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net cash consideration</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>331.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 8600000 8800000 3900000 214900000 112300000 2800000 14600000 331100000 The pro forma information is presented for informational purposes only and is not necessarily indicative of the results of operations that actually would have been achieved had the acquisitions been consummated as of that time ($ in millions, except per share amounts):<div style="line-height:120%;padding-top:12px;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three-Month Period Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine-Month Period Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,037.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,873.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15,082.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14,685.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net earnings attributable to common stockholders</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>648.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>658.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,681.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,888.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diluted net earnings per share</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.89</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.93</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.32</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.66</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 5037300000 4873400000 15082600000 14685800000 648400000 658100000 1681200000 1888500000 0.89 0.93 2.32 2.66 15000000 21000000000.0 400000000 3000000000.0 140000000 3000000000.0 <span style="font-weight:bold;">ENVISTA INITIAL PUBLIC OFFERING</span><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On September 20, 2019, Envista</span><span style="font-family:inherit;font-size:10pt;">, a subsidiary of the Company,</span><span style="font-family:inherit;font-size:10pt;"> completed an underwritten initial public offering </span><span style="font-family:inherit;font-size:10pt;">(the “Envista IPO”) </span><span style="font-family:inherit;font-size:10pt;">of </span><span style="font-family:inherit;font-size:10pt;"><span>30.8 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares of its common stock, which represents </span><span style="font-family:inherit;font-size:10pt;"><span>19.4%</span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">of Envista’s outstanding shares, at a public offering </span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">price of </span><span style="font-family:inherit;font-size:10pt;"><span>$22.00</span></span><span style="font-family:inherit;font-size:10pt;"> per share</span><span style="font-family:inherit;font-size:10pt;"> (the “IPO price”)</span><span style="font-family:inherit;font-size:10pt;">. Envista shares trade on the New York Stock Exchange under the symbol “NVST”.</span><span style="font-family:inherit;font-size:10pt;"> Envista realized net proceeds of </span><span style="font-family:inherit;font-size:10pt;"><span>$643 million</span></span><span style="font-family:inherit;font-size:10pt;"> from the Envista IPO, after deducting underwriting discounts and deal expenses.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In connection with the completion of the Envista IPO, through a series of equity and other transactions, the Company transferred its dental businesses to Envista. In exchange, Envista transferred consideration of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$2.0 billion</span></span><span style="font-family:inherit;font-size:10pt;"> to the Company, which consists primarily of the net proceeds from the Envista IPO and approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$1.3 billion</span></span><span style="font-family:inherit;font-size:10pt;"> of proceeds from Envista’s term debt financing.</span><span style="font-family:inherit;font-size:10pt;"> The excess of the net book value of the business transferred to Envista over the net proceeds from the IPO was </span><span style="font-family:inherit;font-size:10pt;"><span>$60 million</span></span><span style="font-family:inherit;font-size:10pt;"> and was recorded as a reduction to additional paid-in capital in the accompanying Consolidated Condensed Balance Sheet. Of the Company’s consolidated cash and cash equivalents as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$193 million</span></span><span style="font-family:inherit;font-size:10pt;"> is owned by Envista.</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Danaher continues to consolidate Envista, as the Company owns</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;"><span>80.6%</span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">of Envista’s outstanding common shares and retains control over Envista. The earnings attributable to the noncontrolling interest of Envista for the period from the Envista IPO until </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">were</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;"><span>$6 million</span></span><span style="font-family:inherit;font-size:10pt;">. As of</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, the noncontrolling interest of </span><span style="font-family:inherit;font-size:10pt;"><span>$681 million</span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">associated with Envista is reflected in noncontrolling interests in the accompanying Consolidated Condensed Balance Sheet. </span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Danaher intends to use a portion of the consideration received from Envista to redeem </span><span style="font-family:inherit;font-size:10pt;"><span>$882 million</span></span><span style="font-family:inherit;font-size:10pt;"> in aggregate principal amount of outstanding indebtedness in the fourth quarter of 2019</span><span style="font-family:inherit;font-size:10pt;"> (consisting of the Company’s </span><span style="font-family:inherit;font-size:10pt;"><span>2.4%</span></span><span style="font-family:inherit;font-size:10pt;"> senior unsecured notes due 2020 and </span><span style="font-family:inherit;font-size:10pt;"><span>5.0%</span></span><span style="font-family:inherit;font-size:10pt;"> senior unsecured notes due 2020. </span><span style="font-family:inherit;font-size:10pt;">The Company expects the make-whole premiums required in connection with the redemption will be </span><span style="font-family:inherit;font-size:10pt;"><span>$7 million</span></span><span style="font-family:inherit;font-size:10pt;"> (</span><span style="font-family:inherit;font-size:10pt;"><span>$5 million</span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">after-tax or</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;"><span>$0.01</span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">per diluted share). The Company intends to use the balance of the consideration it received from Envista for quarterly cash dividend payments to its shareholders.</span><span style="font-family:inherit;font-size:10pt;"> </span></div>The Company intends to make a tax-free distribution to its stockholders of all or a portion of its remaining equity interest in Envista, which may include one or more distributions effected as a dividend to all Danaher stockholders, one or more distributions in exchange for Danaher shares or other securities or any combination thereof (the “Distribution”). The Company has no obligation to pursue or consummate any further dispositions of its ownership interest in Envista, including through the Distribution, by any specified date or at all. If pursued, the Distribution may be subject to various conditions, including receipt of any necessary regulatory or other approvals, the existence of satisfactory market conditions and the receipt of an opinion of counsel to the effect that the separation, together with such Distribution, will be tax-free to Danaher and its stockholders for U.S. federal income tax purposes. 30800000 0.194 22.00 643000000 2000000000.0 1300000000 -60000000 193000000 0.806 -6000000 681000000 882000000 0.024 0.050 7000000 5000000 0.01 <span style="font-weight:bold;">LEASES</span><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company has operating leases for office space, warehouses, distribution centers, research and development facilities, manufacturing locations and certain equipment, primarily automobiles. Many leases include one or more options to renew, some of which include options to extend the leases for up to </span><span style="font-family:inherit;font-size:10pt;"><span>30 years</span></span><span style="font-family:inherit;font-size:10pt;">, and some leases include options to terminate the leases within </span><span style="font-family:inherit;font-size:10pt;"><span>30 days</span></span><span style="font-family:inherit;font-size:10pt;">. In certain of the Company’s lease agreements, the rental payments are adjusted periodically to reflect actual charges incurred for common area maintenance, utilities, inflation and/or changes in other indexes. The Company’s finance leases were not material as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> and for both the three and </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month periods then ended. ROU assets arising from finance leases are included in property, plant and equipment, net and the liabilities are included in notes payable and current portion of long-term debt and long-term debt in the accompanying Consolidated Condensed Balance Sheets.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The components of operating lease expense were as follows ($ in millions)</span><span style="font-family:Arial;font-size:10pt;">:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three-Month Period Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine-Month Period Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fixed operating lease expense </span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(a)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>58.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>178.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Variable operating lease expense</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total operating lease expense</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>72.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>216.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(a) </sup></span><span style="font-family:inherit;font-size:9pt;">Includes short-term leases and sublease income, both of which were immaterial.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Supplemental cash flow information related to the Company’s operating leases for the </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month period ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> was as follows ($ in millions):</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:87%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash paid for amounts included in the measurement of operating lease liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>177.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">ROU assets obtained in exchange for operating lease obligations</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>165.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents the lease balances within the Consolidated Condensed Balance Sheet, weighted average remaining </span><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">lease term and weighted average discount rates related to the Company’s operating leases as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> ($ in millions):</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:33%;"/><td style="width:54%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Lease Assets and Liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Classification</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating lease ROU assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other long-term assets</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>956.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating lease liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued expenses and other liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>182.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating lease liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other long-term liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>817.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total operating lease liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>999.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average remaining lease term</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average discount rate</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents the maturity of the Company’s operating lease liabilities as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> ($ in millions):</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:87%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Remainder of 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>55.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>197.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>160.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>140.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>122.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>460.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total operating lease payments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,136.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: imputed interest</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>137.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total operating lease liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>999.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, the Company had no additional significant operating or finance leases that had not yet commenced.</span></div> P30Y P30D <div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The components of operating lease expense were as follows ($ in millions)</span><span style="font-family:Arial;font-size:10pt;">:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three-Month Period Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine-Month Period Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fixed operating lease expense </span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(a)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>58.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>178.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Variable operating lease expense</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total operating lease expense</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>72.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>216.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(a) </sup></span><span style="font-family:inherit;font-size:9pt;">Includes short-term leases and sublease income, both of which were immaterial.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Supplemental cash flow information related to the Company’s operating leases for the </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month period ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> was as follows ($ in millions):</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:87%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash paid for amounts included in the measurement of operating lease liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>177.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">ROU assets obtained in exchange for operating lease obligations</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>165.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 58700000 178100000 13400000 38300000 72100000 216400000 177700000 165100000 <div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents the lease balances within the Consolidated Condensed Balance Sheet, weighted average remaining </span><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">lease term and weighted average discount rates related to the Company’s operating leases as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> ($ in millions):</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:33%;"/><td style="width:54%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Lease Assets and Liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Classification</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating lease ROU assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other long-term assets</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>956.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating lease liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued expenses and other liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>182.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating lease liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other long-term liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>817.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total operating lease liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>999.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average remaining lease term</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average discount rate</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 956100000 182000000.0 817000000.0 999000000.0 P7Y 0.031 <div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents the maturity of the Company’s operating lease liabilities as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> ($ in millions):</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:87%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Remainder of 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>55.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>197.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>160.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>140.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>122.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>460.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total operating lease payments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,136.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: imputed interest</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>137.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total operating lease liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>999.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 55800000 197300000 160400000 140600000 122000000.0 460300000 1136400000 137400000 999000000.0 <span style="font-weight:bold;">GOODWILL</span><div style="line-height:120%;padding-top:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following is a rollforward of the Company’s goodwill ($ in millions):</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:87%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance, December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25,906.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Attributable to 2019 acquisitions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>214.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Adjustments due to finalization of purchase price allocations</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency translation and other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(389.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance, September 27, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25,724.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The carrying value of goodwill by segment is summarized as follows ($ in millions):</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Life Sciences</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13,300.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13,311.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diagnostics</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,829.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,925.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dental / Envista</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,283.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,325.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Environmental &amp; Applied Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,311.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,343.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25,724.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25,906.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company has not identified any “triggering” events which indicate an impairment of goodwill in the </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month period ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">.</span></div> <div style="line-height:120%;padding-top:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following is a rollforward of the Company’s goodwill ($ in millions):</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:87%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance, December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25,906.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Attributable to 2019 acquisitions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>214.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Adjustments due to finalization of purchase price allocations</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency translation and other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(389.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance, September 27, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25,724.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The carrying value of goodwill by segment is summarized as follows ($ in millions):</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Life Sciences</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13,300.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13,311.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diagnostics</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,829.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,925.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dental / Envista</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,283.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,325.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Environmental &amp; Applied Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,311.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,343.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25,724.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25,906.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 25906000000.0 214900000 -6900000 -389200000 25724800000 13300200000 13311000000.0 6829900000 6925600000 3283200000 3325500000 2311500000 2343900000 25724800000 25906000000.0 <span style="font-weight:bold;">FAIR VALUE MEASUREMENTS</span><div style="line-height:120%;padding-top:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounting standards define fair value based on an exit price model, establish a framework for measuring fair value where the Company’s assets and liabilities are required to be carried at fair value and provide for certain disclosures related to the valuation methods used within a valuation hierarchy as established within the accounting standards. This hierarchy prioritizes the inputs into three broad levels as follows. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in markets that are not active, or other observable characteristics for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from, or corroborated by, observable market data through correlation. Level 3 inputs are unobservable inputs based on the Company’s assumptions. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement in its entirety.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">A summary of financial assets and liabilities that are measured at fair value on a recurring basis were as follows ($ in millions): </span></div><div style="line-height:120%;padding-top:12px;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices in Active Market (Level 1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Other Observable Inputs (Level 2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Unobservable Inputs (Level 3)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">September 27, 2019:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Available-for-sale debt securities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Investment in equity securities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>314.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>314.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cross-currency swap derivative contracts</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swap derivative contracts</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>64.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>64.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred compensation plans</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>64.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>64.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2018:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Available-for-sale debt securities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Investment in equity securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>148.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>148.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred compensation plans</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>60.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>60.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Available-for-sale debt securities</span><span style="font-family:inherit;font-size:10pt;">, which are included in other long-term assets in the accompanying Consolidated Condensed Balance Sheets, are measured at fair value using quoted prices reported by investment brokers and dealers based on the underlying terms of the security and comparison to similar securities traded on an active market. As of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, available-for-sale debt securities primarily include U.S. Treasury Notes and corporate debt securities, which are valued based on instruments with similar terms traded on an active market.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company’s investments in equity securities are classified as Level 3 in the fair value hierarchy because the Company estimates the fair value based on the measurement alternative and adjusts for impairments and observable price changes with a same or similar security from the same issuer within net earnings (the “Fair Value Alternative”). The investments in equity securities includes investments that the Company has made as a limited partner in a partnership for which the underlying investments are recorded on a fair value basis.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The </span><span style="font-family:inherit;font-size:10pt;">cross-currency swap derivative contracts</span><span style="font-family:inherit;font-size:10pt;"> are used to partially hedge the Company’s </span><span style="font-family:inherit;font-size:10pt;">net investments in foreign operations against adverse movements in exchange rates between the U.S. dollar and the Danish kroner, Japanese yen, euro and Swiss franc.</span><span style="font-family:inherit;font-size:10pt;"> Envista uses cross-currency swap derivative contracts to partially hedge its net investment in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. The cross-currency swap derivative contracts are classified as Level 2 in the fair value hierarchy as they are measured using the income approach with the relevant interest rates and foreign currency current exchange rates and forward curves as inputs. Refer to Note 9 for additional information.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In June 2019, the Company entered into interest rate swap agreements with a notional amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$850 million</span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">which represents a portion of the amount of U.S. dollar-denominated bonds (with terms ranging from</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;"><span>10</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>30</span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">years) the Company anticipates issuing to finance a portion of the</span><span style="font-family:inherit;font-size:10pt;"> GE Biopharma Acquisition. </span><span style="font-family:inherit;font-size:10pt;">These contracts effectively fixed the interest rate for a portion of the Company’s anticipated U.S. dollar-denominated debt issuance equal to the notional amount of the swaps to the rate specified in the interest rate swap agreements</span><span style="font-family:inherit;font-size:10pt;">.</span><span style="font-family:inherit;font-size:10pt;"> In September 2019, Envista entered into </span><span style="font-family:inherit;font-size:10pt;"><span>$650 million</span></span><span style="font-family:inherit;font-size:10pt;"> of interest rate swap derivative contracts to convert the variable interest rate for the Envista Term Loan Facility to a fixed interest rate. The interest rate swap derivative contracts are classified as Level 2 in the fair value hierarchy as they are measured using the income approach, based on the relevant interest rate yield curves. Refer to Note </span><span style="font-family:inherit;font-size:10pt;">8</span><span style="font-family:inherit;font-size:10pt;"> and Note </span><span style="font-family:inherit;font-size:10pt;">9</span><span style="font-family:inherit;font-size:10pt;"> for additional information.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company has established nonqualified contribution and deferred compensation programs that permit the Company to make tax-deferred contributions to officers and certain other employees, and also permit directors, officers and certain other employees to voluntarily defer taxation on a portion of their compensation. All amounts contributed or deferred under such plans are unfunded, unsecured obligations of the Company and are presented as a component of the Company’s compensation and benefits accrual included in other long-term liabilities in the accompanying Consolidated Condensed Balance Sheets. Non-director participants may choose among alternative earning rates for the amounts they defer, which are primarily based on investment options within the Company’s 401(k) program. Changes in the deferred compensation liability under these programs are recognized based on changes in the fair value of the participants’ accounts, which are based on the applicable earnings rates. Amounts voluntarily deferred by directors and amounts unilaterally contributed to participant accounts by the Company are deemed invested in the Company’s common stock and future distributions of such contributions (as well as future distributions of any voluntary deferrals allocated at any time to the Danaher common stock investment option) will be made solely in shares of Company common stock, and therefore are not reflected in the above amounts.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value of Financial Instruments</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The carrying amounts and fair values of the Company’s financial instruments were as follows ($ in millions):</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Available-for-sale debt securities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Investment in equity securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>314.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>314.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>148.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>148.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cross-currency swap derivative contracts</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swap derivative contracts</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>64.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>64.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Notes payable and current portion of long-term debt</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,068.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,068.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>51.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>51.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term debt</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,536.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17,045.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,688.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,990.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, investments in non-marketable equity securities were categorized as Level 3, available-for-sale debt securities, cross-currency swap derivative contracts and interest rate swap derivative contracts were categorized as Level 2 and short and long-term borrowings were categorized as Level 1.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The fair value of long-term borrowings was based on quoted market prices. The difference between the fair value and the carrying amounts of long-term borrowings (other than the Company’s Liquid Yield Option Notes due 2021 (the “LYONs”)) is attributable to changes in market interest rates and/or the Company’s credit ratings subsequent to the incurrence of the borrowing. In the case of the LYONs, differences in the fair value from the carrying value are attributable to changes in the price of the Company’s common stock due to the LYONs’ conversion features. The fair values of borrowings with original maturities of one year or less, as well as cash and cash equivalents, trade accounts receivable, net and trade accounts payable approximate their carrying amounts due to the short-term maturities of these instruments.</span></div> <div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">A summary of financial assets and liabilities that are measured at fair value on a recurring basis were as follows ($ in millions): </span></div><div style="line-height:120%;padding-top:12px;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices in Active Market (Level 1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Other Observable Inputs (Level 2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Unobservable Inputs (Level 3)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">September 27, 2019:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Available-for-sale debt securities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Investment in equity securities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>314.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>314.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cross-currency swap derivative contracts</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swap derivative contracts</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>64.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>64.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred compensation plans</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>64.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>64.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2018:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Available-for-sale debt securities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Investment in equity securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>148.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>148.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred compensation plans</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>60.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>60.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 0 35700000 0 35700000 0 0 314400000 314400000 0 36800000 0 36800000 0 64000000.0 0 64000000.0 0 64600000 0 64600000 0 38300000 0 38300000 0 0 148900000 148900000 0 60900000 0 60900000 850000000 P10Y P30Y 650000000 <div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The carrying amounts and fair values of the Company’s financial instruments were as follows ($ in millions):</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Available-for-sale debt securities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Investment in equity securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>314.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>314.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>148.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>148.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cross-currency swap derivative contracts</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swap derivative contracts</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>64.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>64.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Notes payable and current portion of long-term debt</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,068.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,068.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>51.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>51.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term debt</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,536.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17,045.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,688.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,990.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 35700000 35700000 38300000 38300000 314400000 314400000 148900000 148900000 36800000 36800000 0 0 64000000.0 64000000.0 0 0 1068600000 1068600000 51800000 51800000 16536200000 17045500000 9688500000 9990600000 <span style="font-weight:bold;">FINANCING</span><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, the Company was in compliance with all of its debt covenants. The components of the Company’s debt were as follows ($ in millions):</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. dollar-denominated commercial paper</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>72.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Euro-denominated commercial paper (€2.7 billion and €2.1 billion, respectively)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,933.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,377.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.0% senior unsecured notes due 2019 (€600.0 million aggregate principal amount) (the “2019 Euronotes”)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>687.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2.4% senior unsecured notes due 2020 </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>499.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>498.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">5.0% senior unsecured notes due 2020 (the “2020 Assumed Pall Notes”)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>382.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>386.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Zero-coupon LYONs due 2021</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.352% senior unsecured notes due 2021 (¥30.0 billion aggregate principal amount) (the “2021 Yen Notes”)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>277.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>273.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.7% senior unsecured notes due 2022 (€800.0 million aggregate principal amount) (the “2022 Euronotes”)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>872.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>913.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Floating rate senior unsecured notes due 2022 (€250.0 million aggregate principal amount) (the “Floating Rate 2022 Euronotes”)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>272.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>285.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Envista senior unsecured term loan facility due 2022 (the “Envista Term Loan Facility”)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>648.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Envista senior unsecured term loan facility due 2022 (€600.0 million aggregate principal amount) (the “Envista Euro Term Loan Facility”)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>655.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.5% senior unsecured bonds due 2023 (CHF 540.0 million aggregate principal amount) (the “2023 CHF Bonds”)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>546.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>550.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2.5% senior unsecured notes due 2025 (€800.0 million aggregate principal amount) (the “2025 Euronotes”)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>871.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>912.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">3.35% senior unsecured notes due 2025 </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>497.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>496.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.2% senior unsecured notes due 2026 (€1.3 billion aggregate principal amount) (the “2026 Biopharma Euronotes”)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,357.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.3% senior unsecured notes due 2027 (¥30.8 billion aggregate principal amount) (the “2027 Yen Notes”)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>284.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>279.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.2% senior unsecured notes due 2027 (€600.0 million aggregate principal amount) (the “2027 Euronotes”)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>651.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>682.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.45% senior unsecured notes due 2028 (€1.3 billion aggregate principal amount) (the “2028 Biopharma Euronotes”)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,355.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.125% senior unsecured bonds due 2028 (CHF 210.0 million aggregate principal amount) (the “2028 CHF Bonds”)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>216.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>218.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75% senior unsecured notes due 2031 (€1.8 billion aggregate principal amount) (the “2031 Biopharma Euronotes”)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,900.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.65% senior unsecured notes due 2032 (¥53.2 billion aggregate principal amount) (the “2032 Yen Notes”)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>491.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>483.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.35% senior unsecured notes due 2039 (€1.3 billion aggregate principal amount) (the “2039 Biopharma Euronotes”)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,349.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">4.375% senior unsecured notes due 2045 </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>499.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>499.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.8% senior unsecured notes due 2049 (€750.0 million aggregate principal amount) (the “2049 Biopharma Euronotes”)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>810.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>197.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>66.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total debt</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17,604.8</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,740.3</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: currently payable</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,068.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>51.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term debt</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,536.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,688.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For additional details regarding the Company’s debt financing, refer to Note </span><span style="font-family:inherit;font-size:10pt;">10</span><span style="font-family:inherit;font-size:10pt;"> of the Company’s financial statements as of and for the year ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> included in the Company’s </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> Annual Report.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company satisfies any short-term liquidity needs that are not met through operating cash flow and available cash primarily through issuances of commercial paper under its </span><span style="font-family:inherit;font-size:10pt;">U.S. dollar and euro-denominated</span><span style="font-family:inherit;font-size:10pt;"> commercial paper programs. Until August </span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">27, 2019, credit support for the commercial paper programs was generally provided by the Company’s </span><span style="font-family:inherit;font-size:10pt;"><span>$4.0 billion</span></span><span style="font-family:inherit;font-size:10pt;"> unsecured, multi-year revolving credit facility with a syndicate of banks that was scheduled to expire on July 10, 2020 (the “Superseded Credit Facility”), which was also available for working capital and other general corporate purposes. </span><span style="font-family:inherit;font-size:10pt;">During the duration of the Superseded Credit Facility, </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> borrowings were outstanding under the Superseded Credit Facility and the Company was in compliance with all covenants thereunder. Effective as of August 27, 2019, credit support for the Company’s U.S. dollar and euro-denominated commercial paper programs is provided by the 2020 Credit Facilities, as described below. In addition, the Company has also entered into reimbursement agreements with various commercial banks to support the issuance of letters of credit.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, borrowings outstanding under the Company’s euro-denominated commercial paper program had a weighted average annual interest rate of negative </span><span style="font-family:inherit;font-size:10pt;"><span>0.2%</span></span><span style="font-family:inherit;font-size:10pt;"> and a weighted average remaining maturity of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>42</span></span><span style="font-family:inherit;font-size:10pt;"> days. There were </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> borrowings outstanding under the Company’s U.S. dollar-denominated commercial paper program as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company repaid the</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;"><span>€600 million</span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">aggregate principal amount of the 2019 Euronotes and accrued interest upon their maturity on July 8, 2019 using proceeds from the issuance of euro-denominated commercial paper. The Company has classified </span><span style="font-family:inherit;font-size:10pt;">the </span><span style="font-family:inherit;font-size:10pt;"><span>2.4%</span></span><span style="font-family:inherit;font-size:10pt;"> senior unsecured notes due 2020 and the 2020 Assumed Pall Notes as short-term debt as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> since the Company plans to extinguish these obligations in the fourth quarter of 2019 (refer to Note 4 for additional information). The Company has classified approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$2.9 billion</span></span><span style="font-family:inherit;font-size:10pt;"> of its borrowings outstanding under the euro-denominated commercial paper program as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> as long-term debt in the accompanying Consolidated Condensed Balance Sheet as the Company had the intent and ability, as supported by availability under the 2020 Credit Facilities, to refinance these borrowings for at least one year from the balance sheet date. </span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Debt discounts, premiums and debt issuance costs totaled </span><span style="font-family:inherit;font-size:10pt;"><span>$86 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$19 million</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, respectively, and have been netted against the aggregate principal amounts of the related debt in the components of debt table above.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019 Debt Issuances</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Long-Term Indebtedness Related to the Pending GE Biopharma Acquisition</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On September 18, 2019, DH Europe Finance II S.a.r.l. (“Danaher International II”), a wholly-owned finance subsidiary of the Company, completed the underwritten public offering of senior unsecured notes due 2026, 2028, 2031, 2039 and 2049 (collectively the “Biopharma Euronotes”). The following summarizes the key terms of the offering (€ in millions):</span></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:21%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:18%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate Principal Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Stated Annual Interest Rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Issue Price (as % of Principal Amount)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Maturity Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Interest Payment Dates (in arrears)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2026 Biopharma Euronotes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">€</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,250.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.200</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>99.833</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">March 18, 2026</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">March 18</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2028 Biopharma Euronotes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">€</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,250.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.450</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>99.751</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">March 18, 2028</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">March 18</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2031 Biopharma Euronotes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">€</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,750.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.750</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>99.920</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 18, 2031</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 18</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2039 Biopharma Euronotes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">€</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,250.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.350</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>99.461</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 18, 2039</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 18</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2049 Biopharma Euronotes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">€</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>750.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.800</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>99.564</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 18, 2049</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 18</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Biopharma Euronotes are fully and unconditionally guaranteed by the Company. The Company received net proceeds from the Biopharma Euronotes, after underwriting discounts and commissions and offering expenses, of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>€6.2 billion</span></span><span style="font-family:inherit;font-size:10pt;"> (approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$6.8 billion</span></span><span style="font-family:inherit;font-size:10pt;"> based on currency exchange rates as of the date of the pricing of the notes). The Company plans to use the proceeds from the Biopharma Euronotes to fund a portion of the pending GE Biopharma Acquisition. Pending completion of the GE Biopharma Acquisition, the Company has invested the net proceeds in short-term bank deposits and/or interest-bearing, investment-grade securities.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Long-Term Indebtedness Related to Envista</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In September 2019, the Company received net cash distributions of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$2.0 billion</span></span><span style="font-family:inherit;font-size:10pt;"> from Envista as consideration for the Company’s contribution of assets to Envista in connection with the Envista IPO. Envista financed these cash payments through the issuance of common stock and proceeds from approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$1.3 billion</span></span><span style="font-family:inherit;font-size:10pt;"> of term debt, consisting of </span><span style="font-family:inherit;font-size:10pt;"><span>$650 million</span></span><span style="font-family:inherit;font-size:10pt;"> aggregate principal amount of borrowings under a three-year, senior unsecured term loan facility with variable interest rates and </span><span style="font-family:inherit;font-size:10pt;"><span>€600 million</span></span><span style="font-family:inherit;font-size:10pt;"> aggregate principal amount of borrowings under a three-year, senior unsecured term loan facility with variable interest rates (together, the “Envista Debt”). In addition, Envista entered into a revolving credit agreement with a syndicate of banks providing for a five-year </span><span style="font-family:inherit;font-size:10pt;"><span>$250 million</span></span><span style="font-family:inherit;font-size:10pt;"> senior unsecured revolving credit facility (the “Envista Credit </span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Facility”). Envista had </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> borrowings outstanding under the Envista Credit Facility as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">. As of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, Danaher owns </span><span style="font-family:inherit;font-size:10pt;"><span>80.6%</span></span><span style="font-family:inherit;font-size:10pt;"> of the common stock of Envista, and as a result, the Company consolidates Envista and therefore the Company’s Consolidated Condensed Balance Sheet as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> includes the Envista Debt. As of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, Envista was in compliance with all covenants under the Envista Credit Facility.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">364-Day and Five-Year Revolving Credit Facilities</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On August 27, 2019, the Company replaced the Superseded Credit Facility with a </span><span style="font-family:inherit;font-size:10pt;"><span>$5.0 billion</span></span><span style="font-family:inherit;font-size:10pt;"> unsecured revolving credit facility with a syndicate of banks that expires on August 27, 2024, subject to a one-year extension option at the request of the Company with the consent of the lenders (the “Five-Year Facility”). The Five-Year Facility also contains an expansion option permitting Danaher to request up to five increases of up to an aggregate additional </span><span style="font-family:inherit;font-size:10pt;"><span>$2.5 billion</span></span><span style="font-family:inherit;font-size:10pt;"> from lenders that elect to make such increase available, upon the satisfaction of certain conditions. At the same time, the Company entered into a </span><span style="font-family:inherit;font-size:10pt;"><span>$5.0 billion</span></span><span style="font-family:inherit;font-size:10pt;"> 364-day unsecured revolving credit facility with a syndicate of banks that expires on August 26, 2020 (the “Scheduled Termination Date”) (the “364-Day Facility” and together with the Five-Year Facility, the “2020 Credit Facilities”), to provide additional liquidity support for issuances under the Company’s U.S. dollar and euro-denominated commercial paper programs. The Company may elect, upon the payment of a fee equal to </span><span style="font-family:inherit;font-size:10pt;"><span>0.75%</span></span><span style="font-family:inherit;font-size:10pt;"> of the principal amount of the loans then outstanding and, upon the satisfaction of certain conditions, to convert any loans outstanding on the Scheduled Termination Date into term loans that are due and payable one year following the Scheduled Termination Date. The increase in the size of the Company’s commercial paper programs, as supported by the 2020 Credit Facilities, provides capacity for the Company to use proceeds from the commercial paper programs to fund a portion of the pending GE Biopharma Acquisition.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Borrowings under the Five-Year Facility bear interest as follows: (1) Eurocurrency Rate Committed Loans (as defined in the Five-Year Facility) bear interest at a variable rate equal to the London inter-bank offered rate plus a margin of between 58.5 and 100.0 basis points, depending on Danaher’s long-term debt credit rating; (2) Base Rate Committed Loans and Swing Line Loans (each as defined in the Five-Year Facility) bear interest at a variable rate equal to the highest of (a) the Federal funds rate (as published by the Federal Reserve Bank of New York from time to time) plus 50 basis points; (b) Bank of America’s “prime rate” as publicly announced from time to time and (c) the Eurocurrency Rate (as defined in the Five-Year Facility) plus 100 basis points; and (3) Bid Loans (as defined in the Five-Year Facility) bear interest at the rate bid by the particular lender providing such loan. In addition, Danaher is required to pay a per annum facility fee of between 4.0 and 12.5 basis points (depending on Danaher’s long-term debt credit rating) based on the aggregate commitments under the Five-Year Facility, regardless of usage.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Borrowings under the 364-Day Facility bear interest as follows: (1) Eurodollar Rate Loans (as defined in the 364-Day Facility) bear interest at a variable rate per annum equal to the London inter-bank offered rate plus a margin of between 59.5 and 100.5 basis points, depending on Danaher’s long-term debt credit rating; and (2) Base Rate Loans (as defined in the 364-Day Facility) bear interest at a variable rate per annum equal to the highest of (a) the Federal funds rate (as published by the Federal Reserve Bank of New York from time to time) plus 50 basis points, (b) Bank of America’s “prime rate” as publicly announced from time to time and (c) the Eurodollar Rate (as defined in the 364-Day Facility) plus 100 basis points, plus in each case a margin of up to 0.5 basis points depending on Danaher’s long-term debt credit rating. In addition, Danaher is required to pay a per annum facility fee of between 3.0 and 12.0 basis points (depending on Danaher’s long-term debt credit rating) based on the aggregate commitments under the 364-Day Facility, regardless of usage.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The 2020 Credit Facilities require the Company to maintain a consolidated leverage ratio (as defined in the facilities) of 0.65 to 1.00 or less. Borrowings under the 2020 Credit Facilities are prepayable at the Company’s option at any time in whole or in part without premium or penalty.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company’s obligations under the 2020 Credit Facilities are unsecured. The Company has unconditionally and irrevocably guaranteed the obligations of each of its subsidiaries in the event a subsidiary is named a borrower under either of the 2020 Credit Facilities. Each of the 2020 Credit Facilities contain customary representations, warranties, conditions precedent, events of default, indemnities and affirmative and negative covenants. The 2020 Credit Facilities are available for liquidity support for Danaher’s expanded U.S. dollar and euro commercial paper programs, as discussed above, and for general corporate purposes.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Guarantors of Debt</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company has guaranteed long-term debt and commercial paper issued by certain of its wholly-owned subsidiaries. The 2019 Euronotes, 2022 Euronotes, Floating Rate 2022 Euronotes, 2025 Euronotes and 2027 Euronotes were issued by DH Europe Finance S.a.r.l., formerly known as DH Europe Finance S.A. (“Danaher International”). The 2026 Biopharma Euronotes, 2028 Biopharma Euronotes, 2031 Biopharma Euronotes, 2039 Biopharma Euronotes and 2049 Biopharma Euronotes were issued by Danaher International II. The 2023 CHF Bonds and 2028 CHF Bonds were issued by DH Switzerland Finance S.A. (“Danaher Switzerland”). The 2021 Yen Notes, 2027 Yen Notes and 2032 Yen Notes were issued by DH Japan Finance S.A. (“Danaher Japan”). Each of Danaher International, Danaher International II, Danaher Switzerland and Danaher Japan are wholly-owned finance subsidiaries of Danaher Corporation. All of the outstanding and future securities issued by each of these entities, as well as the 2020 Assumed Pall Notes, are or will be fully and unconditionally guaranteed by the Company and these guarantees rank on parity with the Company’s unsecured and unsubordinated indebtedness.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">LYONs Redemption</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During the </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month period ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, holders of certain of the Company’s LYONs converted such LYONs into an aggregate of </span><span style="font-family:inherit;font-size:10pt;"><span>891 thousand</span></span><span style="font-family:inherit;font-size:10pt;"> shares of the Company’s common stock, par value </span><span style="font-family:inherit;font-size:10pt;"><span>$0.01</span></span><span style="font-family:inherit;font-size:10pt;"> per share. The Company’s deferred tax liability of </span><span style="font-family:inherit;font-size:10pt;"><span>$9 million</span></span><span style="font-family:inherit;font-size:10pt;"> associated with the book and tax basis difference in the converted LYONs was transferred to additional paid-in capital as a result of the conversions.</span></div> 0 72800000 2933200000 2377500000 0 687000000.0 499200000 498500000 382800000 386700000 34600000 56200000 277600000 273200000 872600000 913200000 272900000 285700000 648600000 0 655600000 0 546000000.0 550700000 871700000 912600000 497100000 496800000 1357500000 0 284400000 279900000 651500000 682000000.0 1355600000 0 216000000.0 218100000 1900700000 0 491100000 483400000 1349200000 0 499400000 499300000 810300000 0 197200000 66700000 17604800000 9740300000 1068600000 51800000 16536200000 9688500000 4000000000.0 0 0.002 P42D 0 600000000 0.024 2900000000 86000000 19000000 The following summarizes the key terms of the offering (€ in millions):<div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:21%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:18%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate Principal Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Stated Annual Interest Rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Issue Price (as % of Principal Amount)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Maturity Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Interest Payment Dates (in arrears)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2026 Biopharma Euronotes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">€</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,250.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.200</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>99.833</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">March 18, 2026</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">March 18</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2028 Biopharma Euronotes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">€</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,250.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.450</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>99.751</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">March 18, 2028</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">March 18</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2031 Biopharma Euronotes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">€</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,750.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.750</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>99.920</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 18, 2031</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 18</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2039 Biopharma Euronotes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">€</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,250.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.350</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>99.461</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 18, 2039</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 18</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2049 Biopharma Euronotes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">€</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>750.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.800</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>99.564</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 18, 2049</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 18</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div>The components of the Company’s debt were as follows ($ in millions):<div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. dollar-denominated commercial paper</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>72.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Euro-denominated commercial paper (€2.7 billion and €2.1 billion, respectively)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,933.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,377.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.0% senior unsecured notes due 2019 (€600.0 million aggregate principal amount) (the “2019 Euronotes”)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>687.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2.4% senior unsecured notes due 2020 </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>499.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>498.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">5.0% senior unsecured notes due 2020 (the “2020 Assumed Pall Notes”)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>382.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>386.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Zero-coupon LYONs due 2021</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.352% senior unsecured notes due 2021 (¥30.0 billion aggregate principal amount) (the “2021 Yen Notes”)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>277.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>273.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.7% senior unsecured notes due 2022 (€800.0 million aggregate principal amount) (the “2022 Euronotes”)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>872.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>913.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Floating rate senior unsecured notes due 2022 (€250.0 million aggregate principal amount) (the “Floating Rate 2022 Euronotes”)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>272.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>285.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Envista senior unsecured term loan facility due 2022 (the “Envista Term Loan Facility”)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>648.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Envista senior unsecured term loan facility due 2022 (€600.0 million aggregate principal amount) (the “Envista Euro Term Loan Facility”)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>655.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.5% senior unsecured bonds due 2023 (CHF 540.0 million aggregate principal amount) (the “2023 CHF Bonds”)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>546.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>550.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2.5% senior unsecured notes due 2025 (€800.0 million aggregate principal amount) (the “2025 Euronotes”)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>871.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>912.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">3.35% senior unsecured notes due 2025 </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>497.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>496.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.2% senior unsecured notes due 2026 (€1.3 billion aggregate principal amount) (the “2026 Biopharma Euronotes”)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,357.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.3% senior unsecured notes due 2027 (¥30.8 billion aggregate principal amount) (the “2027 Yen Notes”)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>284.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>279.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.2% senior unsecured notes due 2027 (€600.0 million aggregate principal amount) (the “2027 Euronotes”)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>651.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>682.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.45% senior unsecured notes due 2028 (€1.3 billion aggregate principal amount) (the “2028 Biopharma Euronotes”)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,355.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.125% senior unsecured bonds due 2028 (CHF 210.0 million aggregate principal amount) (the “2028 CHF Bonds”)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>216.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>218.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.75% senior unsecured notes due 2031 (€1.8 billion aggregate principal amount) (the “2031 Biopharma Euronotes”)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,900.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">0.65% senior unsecured notes due 2032 (¥53.2 billion aggregate principal amount) (the “2032 Yen Notes”)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>491.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>483.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.35% senior unsecured notes due 2039 (€1.3 billion aggregate principal amount) (the “2039 Biopharma Euronotes”)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,349.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">4.375% senior unsecured notes due 2045 </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>499.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>499.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.8% senior unsecured notes due 2049 (€750.0 million aggregate principal amount) (the “2049 Biopharma Euronotes”)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>810.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>197.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>66.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total debt</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17,604.8</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,740.3</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: currently payable</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,068.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>51.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term debt</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,536.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,688.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 1250000000.0 0.00200 0.99833 1250000000.0 0.00450 0.99751 1750000000.0 0.00750 0.99920 1250000000.0 0.01350 0.99461 750000000.0 0.01800 0.99564 6200000000 6800000000 2000000000.0 1300000000 650000000 600000000 250000000 0 0.806 5000000000.0 2500000000 5000000000.0 0.0075 891000 0.01 9000000 <span style="font-weight:bold;">HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS</span><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company uses </span><span style="font-family:inherit;font-size:10pt;">cross-currency swap derivative contracts</span><span style="font-family:inherit;font-size:10pt;"> to partially hedge its </span><span style="font-family:inherit;font-size:10pt;">net investments in foreign operations against adverse movements in exchange rates between the U.S. dollar and the Danish kroner, Japanese yen, euro and Swiss franc.</span><span style="font-family:inherit;font-size:10pt;"> The </span><span style="font-family:inherit;font-size:10pt;">cross-currency swap derivative contracts</span><span style="font-family:inherit;font-size:10pt;"> are agreements to exchange fixed-rate payments in one currency for fixed-rate payments in another currency. In January 2019, the Company entered into </span><span style="font-family:inherit;font-size:10pt;">cross-currency swap derivative contracts</span><span style="font-family:inherit;font-size:10pt;"> with respect to approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$1.9 billion</span></span><span style="font-family:inherit;font-size:10pt;"> of its U.S. dollar-denominated bonds and approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$1.0 billion</span></span><span style="font-family:inherit;font-size:10pt;"> of these derivative contracts remain outstanding as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">. These contracts effectively convert these U.S. dollar-denominated bonds to obligations denominated in Danish kroner, Japanese yen, euro and Swiss franc, and partially offset the impact of changes in currency rates on foreign currency denominated net investments. The changes in the spot rate of these instruments are recorded in accumulated other comprehensive income (loss) in stockholders’ equity, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in accumulated other comprehensive income (loss) in the Company’s Consolidated Condensed Statements of Stockholders’ Equity. Any ineffective portions of net investment hedges are reclassified from accumulated other comprehensive income (loss) into earnings during the period of change. The interest income or expense from these swaps are recorded in interest expense in the Company’s Consolidated Condensed Statements of Earnings consistent with the classification of interest expense attributable to the underlying debt. These instruments mature on dates ranging up to September 2028.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company has also issued foreign currency denominated long-term debt as partial hedges of its net investments in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro, Japanese yen and Swiss franc. These foreign currency denominated long-term debt issuances are designated and qualify as nonderivative hedging instruments. Accordingly, the foreign currency translation of these debt instruments is recorded in accumulated other comprehensive income (loss) in stockholders’ equity in the accompanying Consolidated Condensed Balance Sheets, offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in accumulated other comprehensive income (loss). Any ineffective portions of net investment hedges are reclassified from accumulated other comprehensive income (loss) into earnings during the period of change. These instruments mature on dates ranging from September 2025 to May 2032.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company has used interest rate swap agreements to hedge the variability in cash flows due to changes in benchmark interest rates related to a portion of the U.S. debt the Company anticipates issuing to fund the GE Biopharma Acquisition. The interest rate swap agreements are agreements in which the Company agrees to pay a fixed interest rate based on the rate specified in the agreement in exchange for receiving a floating interest rate from a third-party bank based upon a specified benchmark interest rate. </span><span style="font-family:inherit;font-size:10pt;">In June 2019, the Company entered into interest rate swap agreements with a notional amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$850 million</span></span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;">These contracts effectively fixed the interest rate for a portion of the Company’s anticipated U.S. dollar-denominated debt issuance equal to the notional amount of the swaps to the rate specified in the interest rate swap agreements</span><span style="font-family:inherit;font-size:10pt;">.</span><span style="font-family:inherit;font-size:10pt;"> The changes in the fair value of these instruments are recorded in accumulated other comprehensive income (loss) in stockholders’ equity and are subsequently reclassified to interest expense over the life of the related debt. </span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Envista uses cross-currency swap derivative contracts to partially hedge its net investments in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. The cross-currency swap derivative contracts are </span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">agreements to exchange fixed-rate payments in one currency for fixed-rate payments in another currency. In September 2019, Envista entered into cross-currency swap derivative contracts with respect to </span><span style="font-family:inherit;font-size:10pt;"><span>$650 million</span></span><span style="font-family:inherit;font-size:10pt;"> of the Envista Term Loan Facility and </span><span style="font-family:inherit;font-size:10pt;"><span>$650 million</span></span><span style="font-family:inherit;font-size:10pt;"> of these derivative contracts remain outstanding as of September 27, 2019. These contracts effectively convert the Envista Term Loan Facility to an obligation denominated in euro and partially offset the impact of changes in currency rates on foreign currency denominated net investments. The changes in the fair value of these instruments are recorded in accumulated other comprehensive income (loss) in equity, partially offsetting the foreign currency translation adjustment of Envista’s related net investment that is also recorded in accumulated other comprehensive income (loss). Any ineffective portions of net investment hedges are reclassified from accumulated other comprehensive income (loss) into earnings during the period of change. The interest income or expense from these swaps are recorded in interest expense, consistent with the classification of interest expense attributable to the underlying debt. These instruments mature on dates ranging from September 2020 to September 2022.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Envista issued the euro-denominated Envista Euro Credit Facility as a partial hedge of its net investments in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. This foreign currency denominated long-term debt issuance is designated and qualifies as a nonderivative hedging instrument. Accordingly, the foreign currency translation of this debt instrument is recorded in accumulated other comprehensive income (loss) in stockholders’ equity in the accompanying Consolidated Condensed Balance Sheet, offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in accumulated other comprehensive income (loss). Any ineffective portions of the net investment hedge is reclassified from accumulated other comprehensive income (loss) into earnings during the period of change. This debt matures in September 2022.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition to the cross-currency swaps entered into by the Company in January 2019, in September 2019</span><span style="font-family:inherit;font-size:10pt;">, Envista entered into </span><span style="font-family:inherit;font-size:10pt;"><span>$650 million</span></span><span style="font-family:inherit;font-size:10pt;"> of interest rate swap derivative contracts to convert the variable interest rate for the Envista Term Loan Facility to a fixed interest rate. The interest rate swap agreements are agreements in which Envista agrees to pay a fixed interest rate based on the rate specified in the agreement in exchange for receiving a floating interest rate from a third-party bank based upon a specified benchmark interest rate. These contracts effectively fixed the interest rate for the Envista Term Loan Facility. The changes in the fair value of these instruments are recorded in accumulated other comprehensive income (loss) in stockholders’ equity and are subsequently reclassified to interest expense over the life of the Envista Term Loan Facility.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the notional values as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive income (“OCI”) for the three and </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month periods then ended ($ in millions):</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gain (Loss) Recognized in OCI</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Three-Month Period Ended September 27, 2019:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,650.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>41.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency denominated debt</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,073.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>255.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swaps</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,500.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(55.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,223.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>241.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine-Month Period Ended September 27, 2019:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,650.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency denominated debt</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,073.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>263.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swaps</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,500.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(64.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,223.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>236.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gains or losses related to the foreign currency contracts and foreign currency denominated debt are classified as foreign currency translation adjustments in the schedule of changes in OCI in Note </span><span style="font-family:inherit;font-size:10pt;">1</span><span style="font-family:inherit;font-size:10pt;">, as these items are attributable to the Company’s hedges of its net investment in foreign operations. Gains or losses related to the interest rate swaps are classified as cash flow hedge adjustments in the schedule of changes in OCI in Note </span><span style="font-family:inherit;font-size:10pt;">1</span><span style="font-family:inherit;font-size:10pt;">. The Company did not reclassify any deferred gains or losses related to net investment hedges or cash flow hedges from accumulated other comprehensive income (loss) to earnings during the three or </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month periods ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">. In addition, the Company did not have any ineffectiveness related to net investment hedges or interest rate swaps during the three or </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month periods ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">. The cash inflows and outflows associated with the Company’s derivative contracts designated as net investment hedges are classified in all other investing activities in the accompanying Consolidated Condensed Statement of Cash Flows. The cash inflows and outflows associated with the Company’s derivative contracts designated as cash flow hedges are classified in cash flows from operating activities in the accompanying Consolidated Condensed Statement of Cash Flows.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company’s derivative instruments, as well as its nonderivative debt instruments designated and qualifying as net investment hedges, were classified as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> in the Company’s Consolidated Condensed Balance Sheet as follows ($ in millions):</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:87%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivative assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivative liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued expenses and other liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>64.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Nonderivative hedging instruments:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term debt</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,073.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amounts related to the Company’s derivatives expected to be reclassified from accumulated other comprehensive income (loss) to net earnings during the next 12 months are not significant.</span></div> 1900000000 1000000000.0 850000000 650000000 650000000 650000000 <div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the notional values as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive income (“OCI”) for the three and </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month periods then ended ($ in millions):</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gain (Loss) Recognized in OCI</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Three-Month Period Ended September 27, 2019:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,650.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>41.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency denominated debt</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,073.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>255.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swaps</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,500.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(55.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,223.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>241.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine-Month Period Ended September 27, 2019:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,650.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency denominated debt</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,073.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>263.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swaps</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,500.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(64.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,223.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>236.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the notional values as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive income (“OCI”) for the three and </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month periods then ended ($ in millions):</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gain (Loss) Recognized in OCI</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Three-Month Period Ended September 27, 2019:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,650.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>41.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency denominated debt</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,073.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>255.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swaps</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,500.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(55.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,223.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>241.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Nine-Month Period Ended September 27, 2019:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,650.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency denominated debt</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,073.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>263.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swaps</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,500.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(64.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,223.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>236.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 1650000000.0 41500000 8073600000 255200000 1500000000.0 -55100000 11223600000 241600000 1650000000.0 36800000 8073600000 263500000 1500000000.0 -64000000.0 11223600000 236300000 <div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company’s derivative instruments, as well as its nonderivative debt instruments designated and qualifying as net investment hedges, were classified as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> in the Company’s Consolidated Condensed Balance Sheet as follows ($ in millions):</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:87%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivative assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivative liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued expenses and other liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>64.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Nonderivative hedging instruments:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term debt</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,073.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 36800000 64000000.0 8073600000 <span style="font-weight:bold;">DEFINED BENEFIT PLANS</span><div style="line-height:120%;padding-top:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following sets forth the components of the Company’s net periodic benefit (cost) of the noncontributory defined benefit pension plans ($ in millions):</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three-Month Period Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine-Month Period Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">U.S. pension benefits:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Service cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(22.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(20.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(66.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(60.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected return on plan assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>94.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>99.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of actuarial loss</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(23.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of prior service cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic pension benefit</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Non-U.S. pension benefits:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Service cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(24.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(26.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected return on plan assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of actuarial loss</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of prior service credit</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Curtailment gain recognized</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Settlement loss recognized</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic pension cost</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following sets forth the components of the Company’s net periodic benefit cost of the other postretirement employee benefit plans ($ in millions):</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three-Month Period Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine-Month Period Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Service cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of prior service credit</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic cost</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The net periodic benefit cost of the noncontributory defined benefit pension plans and other postretirement employee benefit plans incurred during the three and </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month periods ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">September 28, 2018</span><span style="font-family:inherit;font-size:10pt;"> are reflected in the following captions in the accompanying Consolidated Condensed Statements of Earnings ($ in millions):</span></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three-Month Period Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine-Month Period Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Service cost:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Selling, general and administrative expenses</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(23.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(24.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total service cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(29.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(31.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Other n</span><span style="font-family:inherit;font-size:10pt;">et periodic benefit costs:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other income, net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Employer Contributions</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">the Company’s cash contribution requirements for its U.S. and non-U.S. defined benefit pension plans are forecasted to be approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$10 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$50 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. The ultimate amounts to be contributed depend upon, among other things, legal requirements, underlying asset returns, the plan’s funded status, the anticipated tax deductibility of the contribution, local practices, market conditions, interest rates and other factors.</span></div> <div style="line-height:120%;padding-top:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following sets forth the components of the Company’s net periodic benefit (cost) of the noncontributory defined benefit pension plans ($ in millions):</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three-Month Period Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine-Month Period Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">U.S. pension benefits:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Service cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(22.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(20.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(66.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(60.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected return on plan assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>94.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>99.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of actuarial loss</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(23.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of prior service cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic pension benefit</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Non-U.S. pension benefits:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Service cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(24.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(26.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected return on plan assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of actuarial loss</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of prior service credit</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Curtailment gain recognized</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Settlement loss recognized</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic pension cost</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div></div> 1600000 1200000 4800000 5400000 22100000 20300000 66600000 60700000 31000000.0 33000000.0 94200000 99200000 -6700000 -8000000.0 -19200000 -23600000 200000 200000 700000 700000 -400000 -3300000 -2900000 -8800000 8200000 8600000 24400000 26200000 6600000 6300000 19900000 19600000 10900000 11600000 32700000 35600000 -3900000 -1500000 -3700000 -4500000 -2600000 -200000 -200000 -400000 0 0 1100000 0 100000 1200000 0 800000 5100000 3400000 14000000.0 13500000 <div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following sets forth the components of the Company’s net periodic benefit cost of the other postretirement employee benefit plans ($ in millions):</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three-Month Period Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine-Month Period Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Service cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of prior service credit</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic cost</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 100000 0 300000 300000 1300000 1200000 3800000 3500000 -600000 -600000 -1600000 -1800000 800000 600000 2500000 2000000.0 <div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The net periodic benefit cost of the noncontributory defined benefit pension plans and other postretirement employee benefit plans incurred during the three and </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month periods ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">September 28, 2018</span><span style="font-family:inherit;font-size:10pt;"> are reflected in the following captions in the accompanying Consolidated Condensed Statements of Earnings ($ in millions):</span></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three-Month Period Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine-Month Period Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Service cost:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Selling, general and administrative expenses</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(23.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(24.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total service cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(29.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(31.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Other n</span><span style="font-family:inherit;font-size:10pt;">et periodic benefit costs:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other income, net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 2000000.0 1600000 6200000 7000000.0 7900000 8200000 23300000 24900000 9900000 9800000 29500000 31900000 -4400000 -9100000 -15900000 -25200000 5500000 700000 13600000 6700000 10000000 50000000 <span style="font-weight:bold;">INCOME TAXES</span><div style="line-height:120%;padding-top:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the Company’s effective tax rate:</span></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:45%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three-Month Period Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine-Month Period Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Effective tax rate</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The effective tax rate for </span><span style="font-family:inherit;font-size:10pt;">the three-month period ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">differs from the U.S. federal statutory rate of </span><span style="font-family:inherit;font-size:10pt;"><span>21.0%</span></span><span style="font-family:inherit;font-size:10pt;"> principally due to </span><span style="font-family:inherit;font-size:10pt;">the impact of earnings outside the United States which generally are taxed at rates lower than the U.S. federal rate. </span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The effective tax rate for </span><span style="font-family:inherit;font-size:10pt;">the </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month period ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">differs from the U.S. federal statutory rate of </span><span style="font-family:inherit;font-size:10pt;"><span>21.0%</span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">principally due to the impact of net discrete charges of</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;"><span>$227 million</span></span><span style="font-family:inherit;font-size:10pt;"> (</span><span style="font-family:inherit;font-size:10pt;"><span>$0.31</span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">per diluted share) related primarily to changes in estimates associated with prior period uncertain tax positions and audit settlements, net of the release of reserves for uncertain tax positions due to the expiration of statutes of limitation, release of valuation allowances associated with certain foreign tax credits, tax benefits resulting from changes in tax law and excess tax benefits from stock-based compensation. These discrete income tax charges increased the reported tax rate by</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;"><span>9.2%</span></span><span style="font-family:inherit;font-size:10pt;"> on a net basis. </span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company’s effective tax rates for both the three and</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month periods ended </span><span style="font-family:inherit;font-size:10pt;">September 28, 2018</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">were lower than the U.S. federal statutory rate of </span><span style="font-family:inherit;font-size:10pt;"><span>21.0%</span></span><span style="font-family:inherit;font-size:10pt;"> due principally to the impact of the Company’s earnings outside the United States which overall are taxed at rates lower than the U.S. federal rate. The effective tax rate for the three and nine-month periods ended </span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">September 28, 2018</span><span style="font-family:inherit;font-size:10pt;"> reflects a U.S. corporate income tax rate of</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;"><span>21.0%</span></span><span style="font-family:inherit;font-size:10pt;"> from the enactment of the Tax Cuts and Jobs Act (“TCJA”), partially offset by a new minimum tax on certain non-U.S. earnings as a result of the TCJA. The effective tax rate for the three-month period ended September 28, 2018 includes net tax benefits of </span><span style="font-family:inherit;font-size:10pt;"><span>$23 million</span></span><span style="font-family:inherit;font-size:10pt;"> (</span><span style="font-family:inherit;font-size:10pt;"><span>$0.03</span></span><span style="font-family:inherit;font-size:10pt;"> per diluted share) related primarily to the release of valuation allowances associated with certain foreign operating losses and excess tax benefits from stock-based compensation, which in aggregate reduced the reported tax rate by </span><span style="font-family:inherit;font-size:10pt;"><span>2.9%</span></span><span style="font-family:inherit;font-size:10pt;">. The effective tax rate for the nine-month period ended September 28, 2018 also includes these benefits, in addition to net tax benefits of </span><span style="font-family:inherit;font-size:10pt;"><span>$9 million</span></span><span style="font-family:inherit;font-size:10pt;"> (</span><span style="font-family:inherit;font-size:10pt;"><span>$0.01</span></span><span style="font-family:inherit;font-size:10pt;"> per diluted share) recorded in the second quarter of 2018 related to the release of reserves upon the expiration of statutes of limitation and excess tax benefits from stock-based compensation, which were partially offset by increases in estimates associated with prior period uncertain tax positions. </span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In the fourth quarter of 2018 and in the first quarter of 2019, the </span><span style="font-family:inherit;font-size:10pt;">Internal Revenue Service (“IRS”)</span><span style="font-family:inherit;font-size:10pt;"> proposed significant adjustments to the Company’s taxable income for the years 2012 through 2015 with respect to the deferral of tax on certain premium income related to the Company’s self-insurance programs. For income tax purposes, the recognition of premium income has been deferred in accordance with U.S. tax laws related to insurance. The IRS is challenging the deferral of premiums for certain types of insurance policies. The proposed adjustments would increase the Company’s taxable income over the 2012-2015 period by approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$2.7 billion</span></span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;">Management believes the positions the Company has taken in its U.S. tax returns are in accordance with the relevant tax laws, intends to vigorously defend these positions and is currently considering all of its alternatives. Due to the enactment of the TCJA in 2017 and the resulting reduction in the U.S. corporate tax rate for years after 2017, the Company revalued its deferred tax liabilities related to the temporary differences associated with this deferred premium income from </span><span style="font-family:inherit;font-size:10pt;"><span>35.0%</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>21.0%</span></span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;">If the Company is not successful in defending these assessments, the taxes owed to the IRS may be computed under the previous</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;"><span>35.0%</span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">statutory tax rate and the Company may be required to revalue the related deferred tax liabilities from</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;"><span>21.0%</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>35.0%</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">which in addition to any interest due on the amounts assessed, would require a charge to future earnings. The ultimate resolution of this matter is uncertain, could take many years and could result in a material adverse impact to the Company’s Consolidated Condensed Financial Statements, including its cash flows and effective tax rate.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Tax authorities in Denmark have raised significant issues related to interest accrued by certain of the Company’s subsidiaries. On December 10, 2013, the Company received assessments from </span><span style="font-family:inherit;font-size:10pt;">the Danish tax authority (“SKAT”)</span><span style="font-family:inherit;font-size:10pt;"> totaling approximately</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;"><span>DKK 1.7 billion</span></span><span style="font-family:inherit;font-size:10pt;"> including interest through </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> (approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$256 million</span></span><span style="font-family:inherit;font-size:10pt;"> based on the exchange rate as of</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">), imposing withholding tax relating to interest accrued in Denmark on borrowings from certain of the Company’s subsidiaries for the years 2004-2009. The Company appealed these assessments to the Danish National Tax Tribunal in 2014. The appeal is pending, awaiting the final outcome of other withholding tax cases brought to the Court of Justice of the European Union (“CJEU”). In February 2019, the CJEU decided several other cases related to Danish withholding tax on dividends and interest. In these cases, the CJEU ruled that the exemption of interest payments from withholding taxes provided in the applicable European Union (“EU”) directive should be denied where taxpayers use the directive for abusive or fraudulent purposes, and that it is up to the national courts to make this determination. SKAT has maintained a similar position related to withholding tax on interest accrued in Denmark on borrowings from certain of the Company’s subsidiaries with respect to tax years 2010-2012 and on August 27, 2019, the Company received assessments for these matters totaling approximately </span><span style="font-family:inherit;font-size:10pt;"><span>DKK 1.0 billion</span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">including interest through </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> (approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$152 million</span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">based on the exchange rate as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">). </span><span style="font-family:inherit;font-size:10pt;">The Company is appealing these assessments as well. </span><span style="font-family:inherit;font-size:10pt;"> The Company remains in discussions with SKAT on similar withholding tax matters for the years 2013-2015 and anticipates receiving additional assessments of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>DKK 735 million</span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">including interest through </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> (approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$108 million</span></span><span style="font-family:inherit;font-size:10pt;"> based on the exchange rate as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">). </span><span style="font-family:inherit;font-size:10pt;">Management believes the positions the Company has taken in Denmark are in accordance with the relevant tax laws and is vigorously defending its positions related to the received and anticipated assessments related to the 2004-2009, 2010-2012, and 2013-2015 years.</span><span style="font-family:inherit;font-size:10pt;"> The Company intends on pursuing this matter through the Danish High Court should the appeal to the Danish National Tax Tribunal be unsuccessful. The Company will continue to monitor decisions of both the Danish courts and the CJEU and evaluate the impact of these court rulings on the Company’s tax positions in Denmark. The ultimate resolution of this matter is uncertain, could take many years, and could result in a material adverse impact to the Company’s Consolidated Condensed Financial Statements, including its cash flow and effective tax rate.</span></div> <div style="line-height:120%;padding-top:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the Company’s effective tax rate:</span></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:45%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three-Month Period Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine-Month Period Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Effective tax rate</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 0.201 0.172 0.293 0.190 0.210 0.210 227000000 0.31 0.092 0.210 0.210 -23000000 -0.03 -0.029 -9000000 -0.01 2700000000 0.350 0.210 0.350 0.210 0.350 1700000000 256000000 1000000000.0 152000000 735000000 108000000 <span style="font-weight:bold;">NONOPERATING INCOME (EXPENSE)</span><div style="line-height:120%;padding-top:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company disaggregates the service cost component of net periodic benefit costs of the noncontributory defined benefit pension plans and other postretirement employee benefit plans and presents the other components of net periodic benefit cost in other income, net. These other components include the assumed rate of return on plan assets partially offset by amortization of actuarial losses and interest and aggregated to a gain of </span><span style="font-family:inherit;font-size:10pt;"><span>$4 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$16 million</span></span><span style="font-family:inherit;font-size:10pt;"> for the three and </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month periods ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, respectively, compared to a gain of </span><span style="font-family:inherit;font-size:10pt;"><span>$9 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$25 million</span></span><span style="font-family:inherit;font-size:10pt;"> for the three and </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month periods ended </span><span style="font-family:inherit;font-size:10pt;">September 28, 2018</span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div> 4000000 16000000 9000000 25000000 <span style="font-weight:bold;">COMMITMENTS AND CONTINGENCIES</span><div style="line-height:120%;padding-top:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For a description of the Company’s litigation and contingencies, refer to Note </span><span style="font-family:inherit;font-size:10pt;">17</span><span style="font-family:inherit;font-size:10pt;"> of the Company’s financial statements as of and for the year ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> included in the Company’s </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> Annual Report. The Company reviews the adequacy of its legal reserves on a quarterly basis and establishes reserves for loss contingencies that are both probable and reasonably estimable. During the </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month period ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, the Company recorded a provision of </span><span style="font-family:inherit;font-size:10pt;"><span>$36 million</span></span><span style="font-family:inherit;font-size:10pt;"> (</span><span style="font-family:inherit;font-size:10pt;"><span>$29 million</span></span><span style="font-family:inherit;font-size:10pt;"> after-tax or </span><span style="font-family:inherit;font-size:10pt;"><span>$0.04</span></span><span style="font-family:inherit;font-size:10pt;"> per diluted share) for </span><span style="font-family:inherit;font-size:10pt;">costs and estimated liabilities related to a legal contingency</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company generally accrues estimated warranty costs at the time of sale. In general, manufactured products are warranted against defects in material and workmanship when properly used for their intended purpose, installed correctly and appropriately maintained. Warranty periods depend on the nature of the product and range from the date of such sale up to the life of the product. The amount of the accrued warranty liability is determined based on historical information such as past experience, product failure rates or number of units repaired, estimated cost of material and labor and in certain instances estimated property damage. The accrued warranty liability is reviewed on a quarterly basis and may be adjusted as additional information regarding expected warranty costs becomes known.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following is a rollforward of the Company’s accrued warranty liability ($ in millions):</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:87%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance, December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>77.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accruals for warranties issued during the period</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>46.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Settlements made</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(43.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Effect of foreign currency translation</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance, September 27, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>79.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 36000000 29000000 0.04 <div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following is a rollforward of the Company’s accrued warranty liability ($ in millions):</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:87%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance, December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>77.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accruals for warranties issued during the period</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>46.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Settlements made</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(43.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Effect of foreign currency translation</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance, September 27, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>79.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 77400000 46600000 43700000 -1200000 79100000 <span style="font-weight:bold;">STOCK TRANSACTIONS AND STOCK-BASED COMPENSATION</span><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Neither the Company nor any “affiliated purchaser” repurchased any shares of Company common stock</span><span style="font-family:inherit;font-size:10pt;"> during the </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month period ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">. On July 16, 2013, the Company’s Board of Directors approved a repurchase program (the “Repurchase Program”) authorizing the repurchase of up to </span><span style="font-family:inherit;font-size:10pt;"><span>20 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares of the Company’s common stock from time to time on the open market or in privately negotiated transactions. As of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>20 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares remained available for repurchase pursuant to the Repurchase Program.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the Company’s share activity (shares in millions):</span></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:45%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three-Month Period Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine-Month Period Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Preferred stock - shares issued:</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, beginning of period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Issuance of MCPS</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, end of period</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Common stock - shares issued:</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, beginning of period</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>834.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>816.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>817.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>812.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Common stock-based award activity</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Common stock issued in connection with acquisitions</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Common stock issued in connection with LYONs’ conversions</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Issuance of common stock</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, end of period</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>835.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>817.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>835.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>817.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On March 1, 2019, the Company completed the underwritten public offering of </span><span style="font-family:inherit;font-size:10pt;"><span>12.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">shares of Danaher common stock at a price to the public of </span><span style="font-family:inherit;font-size:10pt;"><span>$123.00</span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">per share </span><span style="font-family:inherit;font-size:10pt;">(the “Common Stock Offering”), </span><span style="font-family:inherit;font-size:10pt;">resulting in net proceeds of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$1.4 billion</span></span><span style="font-family:inherit;font-size:10pt;">, after deducting expenses and the underwriters’ discount of </span><span style="font-family:inherit;font-size:10pt;"><span>$45 million</span></span><span style="font-family:inherit;font-size:10pt;">. Simultaneously, the Company completed the underwritten public offering of </span><span style="font-family:inherit;font-size:10pt;"><span>1.65 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares of its</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;"><span>4.75%</span></span><span style="font-family:inherit;font-size:10pt;"> MCPS, Series A, </span><span style="font-family:inherit;font-size:10pt;">without par value and with a liquidation preference of</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;"><span>$1,000</span></span><span style="font-family:inherit;font-size:10pt;"> per share</span><span style="font-family:inherit;font-size:10pt;"> (the “MCPS Offering”),</span><span style="font-family:inherit;font-size:10pt;"> resulting in net proceeds of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$1.6 billion</span></span><span style="font-family:inherit;font-size:10pt;">,</span><span style="font-family:inherit;font-size:10pt;"> after deducting expenses and the underwriters’ discount of </span><span style="font-family:inherit;font-size:10pt;"><span>$50 million</span></span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;"> The Company intends to use the net proceeds from the Common Stock </span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Offering and the MCPS Offering to fund a portion of the cash consideration payable for, and certain costs associated with, the GE Biopharma Acquisition. </span><span style="font-family:inherit;font-size:10pt;"> Pending completion of the GE Biopharma Acquisition, the Company has invested the net proceeds in short-term bank deposits and/or interest-bearing, investment-grade securities.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As a result of the dividend paid to shareholders of the Company’s common stock in July 2019, the Company triggered an anti-dilution adjustment pursuant to the terms of the MCPS and after giving affect to this adjustment, each share of MCPS will mandatorily convert on the mandatory conversion date, which is expected to be April 15, 2022, into between </span><span style="font-family:inherit;font-size:10pt;"><span>6.6382</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>8.1318</span></span><span style="font-family:inherit;font-size:10pt;"> shares of the Company’s common stock, subject to further anti-dilution adjustments. The number of shares of the Company’s common stock issuable upon conversion will be determined based on the average volume-weighted average price per share of the Company’s common stock over the </span><span style="font-family:inherit;font-size:10pt;"><span>20</span></span><span style="font-family:inherit;font-size:10pt;"> consecutive trading day period beginning on, and including, the 21st scheduled trading day immediately before April 15, 2022. Subject to certain exceptions, at any time prior to April 15, 2022, holders may elect to convert each share of the MCPS into </span><span style="font-family:inherit;font-size:10pt;"><span>6.6382</span></span><span style="font-family:inherit;font-size:10pt;"> shares of common stock, subject to further anti-dilution adjustments. In the event of a fundamental change, the MCPS will convert at the fundamental change rates specified in the certificate of designations, and the holders of MCPS would be entitled to a fundamental change make-whole dividend.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Holders of MCPS will be entitled to receive, when and if declared by the Company’s Board of Directors, cumulative dividends at the annual rate of </span><span style="font-family:inherit;font-size:10pt;"><span>4.75%</span></span><span style="font-family:inherit;font-size:10pt;"> of the liquidation preference of </span><span style="font-family:inherit;font-size:10pt;"><span>$1,000</span></span><span style="font-family:inherit;font-size:10pt;"> per share (equivalent to </span><span style="font-family:inherit;font-size:10pt;"><span>$47.50</span></span><span style="font-family:inherit;font-size:10pt;"> annually per share), payable in cash or, subject to certain limitations, by delivery of shares of the Company’s common stock or any combination of cash and shares of the Company’s common stock, at the Company’s election. If declared, dividends on the MCPS will be payable quarterly on January 15, April 15, July 15 and October 15 of each year (commencing on July 15, 2019 to, and including, April 15, 2022), to the holders of record of the MCPS as they appear on the Company’s stock register at the close of business on the immediately preceding December 31, March 31, June 30 and September 30, respectively.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If the GE Biopharma Acquisition has not closed on or before 5:00 p.m. (New York City time) on August 25, 2020, the GE Biopharma Purchase Agreement is terminated or the Company’s Board of Directors, in its good faith judgment, determines that the GE Biopharma Acquisition will not occur, the Company has the option to redeem the shares of MCPS, in whole but not in part, subject to certain terms and conditions.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For a full description of the Company’s stock-based compensation programs, refer to Note </span><span style="font-family:inherit;font-size:10pt;">18</span><span style="font-family:inherit;font-size:10pt;"> of the Company’s financial statements as of and for the year ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> included in the Company’s </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> Annual Report. As of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, approximately </span><span style="font-family:inherit;font-size:10pt;"><span>46 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares of the Company’s common stock were reserved for issuance under the 2007 Omnibus Incentive Plan.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In connection with the Envista IPO, Envista has adopted a stock-based compensation plan, which provides for grants of stock options, performance stock units (“PSUs”), restricted stock units (“RSUs”) and other stock-based awards denominated in shares of Envista common stock. Envista employees who participated in the Danaher stock compensation program prior to the IPO will continue to participate in such program solely with respect to outstanding compensation awards received prior to the Envista IPO, until the Distribution (at which time such awards will be converted into awards denominated in Envista common stock under the Envista stock compensation plan). From and after the Envista IPO, all equity compensation awarded to Envista associates will be awarded under the Envista stock compensation plan. Stock-based compensation expense for the Envista stock-based compensation plan is included in the Company’s consolidated stock-based compensation expense.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following summarizes the components of the Company’s stock-based compensation expense ($ in millions):</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three-Month Period Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine-Month Period Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSUs/PSUs:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pretax compensation expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>79.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>69.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income tax benefit</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(16.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU/PSU expense, net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>63.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>55.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock options:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pretax compensation expense</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>50.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income tax benefit</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock option expense, net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>39.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total stock-based compensation:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pretax compensation expense</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>44.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>130.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>111.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income tax benefit</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(27.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(23.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total stock-based compensation expense, net of income taxes</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>102.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>88.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock-based compensation has been recognized as a component of selling, general and administrative expenses in the accompanying Consolidated Condensed Statements of Earnings. As of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$192 million</span></span><span style="font-family:inherit;font-size:10pt;"> of total unrecognized compensation cost related to RSUs/PSUs is expected to be recognized over a weighted average period of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>two years</span></span><span style="font-family:inherit;font-size:10pt;">. As of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$178 million</span></span><span style="font-family:inherit;font-size:10pt;"> of total unrecognized compensation cost related to stock options is expected to be recognized over a weighted average period of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>three years</span></span><span style="font-family:inherit;font-size:10pt;">. Future compensation amounts will be adjusted for any changes in estimated forfeitures.</span></div> 20000000 20000000 <div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the Company’s share activity (shares in millions):</span></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:45%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three-Month Period Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine-Month Period Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Preferred stock - shares issued:</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, beginning of period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Issuance of MCPS</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, end of period</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Common stock - shares issued:</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, beginning of period</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>834.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>816.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>817.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>812.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Common stock-based award activity</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Common stock issued in connection with acquisitions</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Common stock issued in connection with LYONs’ conversions</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Issuance of common stock</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance, end of period</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>835.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>817.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>835.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>817.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 1700000 0 0 0 0 0 1700000 0 1700000 0 1700000 0 834000000.0 816000000.0 817900000 812500000 1000000.0 1200000 4100000 4000000.0 0 0 0 200000 0 0 900000 500000 0 0 12100000 0 835000000.0 817200000 835000000.0 817200000 12100000 123.00 1400000000 45000000 1650000 0.0475 1000 1600000000 50000000 6.6382 8.1318 20 6.6382 0.0475 1000 47.50 46000000 <div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following summarizes the components of the Company’s stock-based compensation expense ($ in millions):</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three-Month Period Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine-Month Period Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSUs/PSUs:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pretax compensation expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>79.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>69.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income tax benefit</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(16.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU/PSU expense, net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>63.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>55.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock options:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pretax compensation expense</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>50.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income tax benefit</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock option expense, net of income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>39.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total stock-based compensation:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pretax compensation expense</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>44.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>130.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>111.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income tax benefit</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(27.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(23.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total stock-based compensation expense, net of income taxes</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>102.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>88.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 27600000 24000000.0 79800000 69600000 5700000 5000000.0 16600000 14600000 21900000 19000000.0 63200000 55000000.0 17000000.0 14200000 50200000 42000000.0 3500000 3000000.0 10500000 8900000 13500000 11200000 39700000 33100000 44600000 38200000 130000000.0 111600000 9200000 8000000.0 27100000 23500000 35400000 30200000 102900000 88100000 192000000 P2Y 178000000 P3Y <span style="font-weight:bold;">NET EARNINGS PER SHARE</span><div style="line-height:120%;padding-top:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic net earnings per share (“EPS”) is calculated by dividing net earnings attributable to common stockholders by the weighted average number of common shares outstanding for the applicable period. Diluted net EPS is computed based on the weighted average number of common shares outstanding increased by the number of additional shares that would have been outstanding had the potentially dilutive common shares (including subsidiary denominated equity) been issued and reduced by the number of shares the Company could have repurchased with the proceeds from the issuance of the potentially dilutive shares. For both the three and </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month periods ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> and the three-month period ended </span><span style="font-family:inherit;font-size:10pt;">September 28, 2018</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> options to purchase shares were excluded from the diluted EPS calculation. For the </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month period ended </span><span style="font-family:inherit;font-size:10pt;">September 28, 2018</span><span style="font-family:inherit;font-size:10pt;">, approximately </span><span style="font-family:inherit;font-size:10pt;"><span>one million</span></span><span style="font-family:inherit;font-size:10pt;"> options to purchase shares were not included in the diluted EPS calculation as the impact of their inclusion would have been anti-dilutive.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The impact of the MCPS calculated under the if-converted method was anti-dilutive, and as such </span><span style="font-family:inherit;font-size:10pt;"><span>12 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares and </span><span style="font-family:inherit;font-size:10pt;"><span>9 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares underlying the MCPS were excluded from the diluted EPS calculation for the three and </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month periods ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, respectively. The inclusion of Envista’s dilutive securities in the calculation of the Company’s net earnings attributable to common stockholders after assumed conversions did not significantly impact the Company’s diluted EPS for the three and </span><span style="font-family:inherit;font-size:10pt;">nine</span><span style="font-family:inherit;font-size:10pt;">-month periods ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Information related to the calculation of net earnings per share is summarized as follows ($ and shares in millions, except per share amounts):</span></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three-Month Period Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine-Month Period Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Numerator:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>673.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>663.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,739.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,904.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net earnings attributable to noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">MCPS dividends</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(48.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net earnings attributable to common stockholders (used in Basis EPS)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>648.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>663.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,684.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,904.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Adjustment for interest on convertible debentures</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net earnings attributable to common stockholders after assumed conversions (used in Diluted EPS)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>648.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>664.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,685.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,905.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Denominator:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average common shares outstanding (used in Basic EPS)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>718.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>701.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>714.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>700.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Incremental common shares from:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Assumed exercise of dilutive options and vesting of dilutive RSUs and PSUs</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Assumed conversion of the convertible debentures</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average common shares outstanding (used in Diluted EPS)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>729.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>710.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>725.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>709.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic EPS</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.90</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.95</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.36</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.72</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diluted EPS</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.89</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.93</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.32</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.68</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 0 1000000000000 12000000 9000000 <div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Information related to the calculation of net earnings per share is summarized as follows ($ and shares in millions, except per share amounts):</span></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three-Month Period Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine-Month Period Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Numerator:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>673.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>663.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,739.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,904.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net earnings attributable to noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">MCPS dividends</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(48.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net earnings attributable to common stockholders (used in Basis EPS)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>648.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>663.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,684.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,904.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Adjustment for interest on convertible debentures</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net earnings attributable to common stockholders after assumed conversions (used in Diluted EPS)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>648.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>664.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,685.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,905.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Denominator:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average common shares outstanding (used in Basic EPS)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>718.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>701.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>714.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>700.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Incremental common shares from:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Assumed exercise of dilutive options and vesting of dilutive RSUs and PSUs</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Assumed conversion of the convertible debentures</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average common shares outstanding (used in Diluted EPS)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>729.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>710.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>725.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>709.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic EPS</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.90</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.95</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.36</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.72</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diluted EPS</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.89</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.93</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.32</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.68</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 673900000 663700000 1739000000.0 1904100000 5900000 0 5900000 0 19600000 0 48800000 0 648400000 663700000 1684300000 1904100000 400000 600000 1400000 1700000 648800000 664300000 1685700000 1905800000 718800000 701400000 714700000 700100000 9100000 6900000 8900000 7300000 1400000 2300000 1600000 2500000 729300000 710600000 725200000 709900000 0.90 0.95 2.36 2.72 0.89 0.93 2.32 2.68 <span style="font-weight:bold;">SEGMENT INFORMATION</span><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company operates and reports its results in </span><span style="font-family:inherit;font-size:10pt;"><span>four</span></span><span style="font-family:inherit;font-size:10pt;"> separate business segments consisting of the Life Sciences, Diagnostics, Dental/Envista and Environmental &amp; Applied Solutions segments. When determining the reportable segments, the Company </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">aggregated operating segments based on their similar economic and operating characteristics. Operating profit represents total revenues less operating expenses, excluding nonoperating income and expense, interest and income taxes. Operating profit amounts in the Other segment consist of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance. Intersegment amounts are not significant and are eliminated to arrive at consolidated totals.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Segment results are shown below ($ in millions):</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three-Month Period Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine-Month Period Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Sales:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Life Sciences</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,695.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,596.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,035.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,677.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diagnostics</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,601.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,502.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,757.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,573.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dental / Envista</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>659.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>679.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,031.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,085.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Environmental &amp; Applied Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,080.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,074.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,250.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,193.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,037.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,853.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15,073.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14,529.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Operating profit:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Life Sciences</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>342.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>312.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>995.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>875.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diagnostics</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>266.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>235.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>782.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>757.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dental / Envista</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>78.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>86.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>206.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>241.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Environmental &amp; Applied Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>256.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>254.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>761.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>732.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(108.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(57.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(302.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(166.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>834.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>830.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,442.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,441.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Segment identifiable assets are shown below ($ in millions):</span></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Life Sciences</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22,115.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22,122.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diagnostics</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14,175.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14,031.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dental / Envista</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,009.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,897.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Environmental &amp; Applied Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,741.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,637.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14,490.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,144.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>61,531.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>47,832.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 4 <div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Segment results are shown below ($ in millions):</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three-Month Period Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine-Month Period Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Sales:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Life Sciences</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,695.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,596.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,035.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,677.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diagnostics</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,601.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,502.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,757.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,573.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dental / Envista</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>659.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>679.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,031.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,085.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Environmental &amp; Applied Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,080.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,074.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,250.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,193.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,037.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,853.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15,073.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14,529.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Operating profit:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Life Sciences</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>342.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>312.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>995.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>875.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diagnostics</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>266.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>235.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>782.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>757.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dental / Envista</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>78.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>86.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>206.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>241.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Environmental &amp; Applied Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>256.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>254.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>761.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>732.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(108.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(57.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(302.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(166.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>834.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>830.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,442.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,441.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Segment identifiable assets are shown below ($ in millions):</span></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Life Sciences</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22,115.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22,122.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diagnostics</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14,175.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14,031.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dental / Envista</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,009.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,897.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Environmental &amp; Applied Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,741.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,637.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14,490.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,144.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>61,531.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>47,832.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 1695600000 1596700000 5035100000 4677900000 1601900000 1502500000 4757000000.0 4573100000 659300000 679500000 2031100000 2085500000 1080500000 1074400000 3250600000 3193000000.0 5037300000 4853100000 15073800000 14529500000 342500000 312800000 995500000 875600000 266000000.0 235100000 782000000.0 757400000 78700000 86100000 206400000 241800000 256500000 254300000 761300000 732500000 -108900000 -57600000 -302800000 -166100000 834800000 830700000 2442400000 2441200000 22115000000.0 22122400000 14175100000 14031100000 6009500000 5897300000 4741300000 4637300000 14490200000 1144400000 61531100000 47832500000 <span style="font-family:inherit;font-size:10pt;font-weight:bold;">SUBSEQUENT EVENTS</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On October 24, 2019, the Company will redeem the </span><span style="font-family:inherit;font-size:10pt;"><span>$500 million</span></span><span style="font-family:inherit;font-size:10pt;"> aggregate principal amount of </span><span style="font-family:inherit;font-size:10pt;"><span>2.4%</span></span><span style="font-family:inherit;font-size:10pt;"> Senior Notes due 2020 and the </span><span style="font-family:inherit;font-size:10pt;"><span>$375 million</span></span><span style="font-family:inherit;font-size:10pt;"> aggregate principal amount of </span><span style="font-family:inherit;font-size:10pt;"><span>5.0%</span></span><span style="font-family:inherit;font-size:10pt;"> 2020 Assumed Pall Notes, in each case at a redemption price equal to the outstanding principal amount and a make-whole premium as specified in the applicable indenture, plus accrued and unpaid interest. </span><span style="font-family:inherit;font-size:10pt;">The Company expects the make-whole premiums required in connection with the redemption will be </span><span style="font-family:inherit;font-size:10pt;"><span>$7 million</span></span><span style="font-family:inherit;font-size:10pt;"> (</span><span style="font-family:inherit;font-size:10pt;"><span>$5 million</span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">after-tax or</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;"><span>$0.01</span></span><span style="font-family:inherit;font-size:10pt;"> per diluted share). The payment of the make-whole premiums will be reflected as a loss on early extinguishment of borrowings in the Company’s fourth quarter financial statements, as the extinguishment is expected to occur in the fourth quarter. The Company is funding the redemption using a portion of the cash distribution it received in connection with the Envista IPO.</span></div> 500000000 0.024 375000000 0.050 7000000 5000000 0.01 XML 55 R11.htm IDEA: XBRL DOCUMENT v3.19.3
Acquisitions
9 Months Ended
Sep. 27, 2019
Business Combinations [Abstract]  
Acquisitions ACQUISITIONS
For a description of the Company’s acquisition activity for the year ended December 31, 2018, reference is made to the financial statements as of and for the year ended December 31, 2018 and Note 3 thereto included in the Company’s 2018 Annual Report.
The Company continually evaluates potential acquisitions that either strategically fit with the Company’s existing portfolio or expand the Company’s portfolio into a new and attractive business area. The Company has completed a number of acquisitions that have been accounted for as purchases and have resulted in the recognition of goodwill in the Company’s financial statements. This goodwill arises because the purchase prices for these businesses reflect a number of factors including the future earnings and cash flow potential of these businesses, the multiple to earnings, cash flow and other factors at which similar businesses have been purchased by other acquirers, the competitive nature of the processes by which the Company acquired the businesses, avoidance of the time and costs which would be required (and the associated risks that would be encountered) to enhance the Company’s existing product offerings to key target markets and enter into new and profitable businesses and the complementary strategic fit and resulting synergies these businesses bring to existing operations.
The Company makes an initial allocation of the purchase price at the date of acquisition based upon its understanding of the fair value of the acquired assets and assumed liabilities. The Company obtains this information during due diligence and through other sources. In the months after closing, as the Company obtains additional information about these assets and liabilities, including through tangible and intangible asset appraisals, and learns more about the newly acquired business, it is able to refine the estimates of fair value and more accurately allocate the purchase price. Only items identified as of the acquisition date are considered for subsequent adjustment. The Company is continuing to evaluate certain pre-acquisition contingencies associated with its 2019 acquisitions and is also in the process of obtaining valuations of acquired intangible assets and certain acquisition-related liabilities in connection with these acquisitions. The Company will make appropriate adjustments to the purchase price allocation prior to completion of the measurement period, as required.
During the nine-month period ended September 27, 2019, the Company acquired five businesses for total consideration of $331 million in cash, net of cash acquired. The businesses acquired complement existing units of the Life Sciences, Diagnostics and Environmental & Applied Solutions segments. The aggregate annual sales of these businesses at the time of their acquisition, based on the companies’ revenues for their last completed fiscal year prior to the acquisition, were $72 million. The Company preliminarily recorded an aggregate of $215 million of goodwill related to these acquisitions.
The following summarizes the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition for the acquisitions consummated during the nine-month period ended September 27, 2019 ($ in millions):
Trade accounts receivable
$
8.6

Inventories
8.8

Property, plant and equipment
3.9

Goodwill
214.9

Other intangible assets, primarily customer relationships, trade names and technology
112.3

Trade accounts payable
(2.8
)
Other assets and liabilities, net
(14.6
)
Net cash consideration
$
331.1


Pro Forma Financial Information
The unaudited pro forma information for the periods set forth below gives effect to the 2019 and 2018 acquisitions as if they had occurred as of January 1, 2018. The pro forma information is presented for informational purposes only and is not necessarily indicative of the results of operations that actually would have been achieved had the acquisitions been consummated as of that time ($ in millions, except per share amounts):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Sales
$
5,037.3

 
$
4,873.4

 
$
15,082.6

 
$
14,685.8

Net earnings attributable to common stockholders
648.4

 
658.1

 
1,681.2

 
1,888.5

Diluted net earnings per share
0.89

 
0.93

 
2.32

 
2.66


Acquisition-related transaction costs of $15 million associated with the IDT acquisition were excluded from pro forma earnings in 2018.
Pending Acquisition
On February 25, 2019, the Company entered into an Equity and Asset Purchase Agreement (the “GE Biopharma Purchase Agreement”) with GE to acquire the GE Biopharma Business for a cash purchase price of approximately $21.0 billion, subject to certain adjustments, and the assumption of approximately $0.4 billion of pension liabilities (the “GE Biopharma Acquisition”). The GE Biopharma Business is a leading provider of instruments, consumables and software that support the research, discovery, process development and manufacturing workflows of biopharmaceutical drugs. Based on audited carve-out financial statements provided by GE, the GE Biopharma Business generated revenues of approximately $3.0 billion in 2018. The Company expects to include the GE Biopharma Business within the Life Sciences segment. The GE Biopharma Acquisition is expected to provide additional sales and earnings growth opportunities for the Company’s Life Sciences segment by expanding the business’ geographic and product line diversity, including new product and service offerings that complement the Company’s current biologics workflow solutions. As a condition to obtaining certain regulatory approvals for the closing of the transaction, the Company will be required to divest certain of its existing product lines. In furtherance thereof, on October 18, 2019, the Company signed an agreement to sell certain of its product lines, contingent upon the Company closing the GE Biopharma Acquisition. These product lines had annual revenue in 2018 of $140 million. Though the timing of obtaining the regulatory approvals necessary to close the GE Biopharma Acquisition is uncertain, the Company continues to make progress with respect thereto and expects to close the transaction in the first quarter of 2020.
The Company expects to finance the GE Biopharma Acquisition with approximately $3.0 billion of proceeds from the March 1, 2019 underwritten public offerings of its Common Stock and Mandatory Convertible Preferred Stock (“MCPS”), proceeds from the September 2019 issuance of debt, proceeds from the issuance of additional debt or other borrowings and available cash on hand. Refer to Note 8 for additional information related to the issuance of debt and to Note 14 for additional information related to the March 1, 2019 public offerings.
XML 56 R19.htm IDEA: XBRL DOCUMENT v3.19.3
Income Taxes
9 Months Ended
Sep. 27, 2019
Income Tax Disclosure [Abstract]  
Income Taxes INCOME TAXES
The following table summarizes the Company’s effective tax rate:
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Effective tax rate
20.1
%
 
17.2
%
 
29.3
%
 
19.0
%

The effective tax rate for the three-month period ended September 27, 2019 differs from the U.S. federal statutory rate of 21.0% principally due to the impact of earnings outside the United States which generally are taxed at rates lower than the U.S. federal rate.
The effective tax rate for the nine-month period ended September 27, 2019 differs from the U.S. federal statutory rate of 21.0% principally due to the impact of net discrete charges of $227 million ($0.31 per diluted share) related primarily to changes in estimates associated with prior period uncertain tax positions and audit settlements, net of the release of reserves for uncertain tax positions due to the expiration of statutes of limitation, release of valuation allowances associated with certain foreign tax credits, tax benefits resulting from changes in tax law and excess tax benefits from stock-based compensation. These discrete income tax charges increased the reported tax rate by 9.2% on a net basis.
The Company’s effective tax rates for both the three and nine-month periods ended September 28, 2018 were lower than the U.S. federal statutory rate of 21.0% due principally to the impact of the Company’s earnings outside the United States which overall are taxed at rates lower than the U.S. federal rate. The effective tax rate for the three and nine-month periods ended
September 28, 2018 reflects a U.S. corporate income tax rate of 21.0% from the enactment of the Tax Cuts and Jobs Act (“TCJA”), partially offset by a new minimum tax on certain non-U.S. earnings as a result of the TCJA. The effective tax rate for the three-month period ended September 28, 2018 includes net tax benefits of $23 million ($0.03 per diluted share) related primarily to the release of valuation allowances associated with certain foreign operating losses and excess tax benefits from stock-based compensation, which in aggregate reduced the reported tax rate by 2.9%. The effective tax rate for the nine-month period ended September 28, 2018 also includes these benefits, in addition to net tax benefits of $9 million ($0.01 per diluted share) recorded in the second quarter of 2018 related to the release of reserves upon the expiration of statutes of limitation and excess tax benefits from stock-based compensation, which were partially offset by increases in estimates associated with prior period uncertain tax positions.
In the fourth quarter of 2018 and in the first quarter of 2019, the Internal Revenue Service (“IRS”) proposed significant adjustments to the Company’s taxable income for the years 2012 through 2015 with respect to the deferral of tax on certain premium income related to the Company’s self-insurance programs. For income tax purposes, the recognition of premium income has been deferred in accordance with U.S. tax laws related to insurance. The IRS is challenging the deferral of premiums for certain types of insurance policies. The proposed adjustments would increase the Company’s taxable income over the 2012-2015 period by approximately $2.7 billion. Management believes the positions the Company has taken in its U.S. tax returns are in accordance with the relevant tax laws, intends to vigorously defend these positions and is currently considering all of its alternatives. Due to the enactment of the TCJA in 2017 and the resulting reduction in the U.S. corporate tax rate for years after 2017, the Company revalued its deferred tax liabilities related to the temporary differences associated with this deferred premium income from 35.0% to 21.0%. If the Company is not successful in defending these assessments, the taxes owed to the IRS may be computed under the previous 35.0% statutory tax rate and the Company may be required to revalue the related deferred tax liabilities from 21.0% to 35.0%, which in addition to any interest due on the amounts assessed, would require a charge to future earnings. The ultimate resolution of this matter is uncertain, could take many years and could result in a material adverse impact to the Company’s Consolidated Condensed Financial Statements, including its cash flows and effective tax rate.
Tax authorities in Denmark have raised significant issues related to interest accrued by certain of the Company’s subsidiaries. On December 10, 2013, the Company received assessments from the Danish tax authority (“SKAT”) totaling approximately DKK 1.7 billion including interest through September 27, 2019 (approximately $256 million based on the exchange rate as of September 27, 2019), imposing withholding tax relating to interest accrued in Denmark on borrowings from certain of the Company’s subsidiaries for the years 2004-2009. The Company appealed these assessments to the Danish National Tax Tribunal in 2014. The appeal is pending, awaiting the final outcome of other withholding tax cases brought to the Court of Justice of the European Union (“CJEU”). In February 2019, the CJEU decided several other cases related to Danish withholding tax on dividends and interest. In these cases, the CJEU ruled that the exemption of interest payments from withholding taxes provided in the applicable European Union (“EU”) directive should be denied where taxpayers use the directive for abusive or fraudulent purposes, and that it is up to the national courts to make this determination. SKAT has maintained a similar position related to withholding tax on interest accrued in Denmark on borrowings from certain of the Company’s subsidiaries with respect to tax years 2010-2012 and on August 27, 2019, the Company received assessments for these matters totaling approximately DKK 1.0 billion including interest through September 27, 2019 (approximately $152 million based on the exchange rate as of September 27, 2019). The Company is appealing these assessments as well.  The Company remains in discussions with SKAT on similar withholding tax matters for the years 2013-2015 and anticipates receiving additional assessments of approximately DKK 735 million including interest through September 27, 2019 (approximately $108 million based on the exchange rate as of September 27, 2019). Management believes the positions the Company has taken in Denmark are in accordance with the relevant tax laws and is vigorously defending its positions related to the received and anticipated assessments related to the 2004-2009, 2010-2012, and 2013-2015 years. The Company intends on pursuing this matter through the Danish High Court should the appeal to the Danish National Tax Tribunal be unsuccessful. The Company will continue to monitor decisions of both the Danish courts and the CJEU and evaluate the impact of these court rulings on the Company’s tax positions in Denmark. The ultimate resolution of this matter is uncertain, could take many years, and could result in a material adverse impact to the Company’s Consolidated Condensed Financial Statements, including its cash flow and effective tax rate.
XML 57 R78.htm IDEA: XBRL DOCUMENT v3.19.3
Stock Transactions And Stock-Based Compensation (Summary of Share Activity) (Details) - shares
shares in Millions
3 Months Ended 9 Months Ended
Mar. 01, 2019
Sep. 27, 2019
Sep. 28, 2018
Sep. 27, 2019
Sep. 28, 2018
Preferred stock          
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Balance, beginning of period   1.7 0.0 0.0 0.0
Issuance of stock   0.0 0.0 1.7 0.0
Balance, end of period   1.7 0.0 1.7 0.0
Common stock          
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Balance, beginning of period   834.0 816.0 817.9 812.5
Common stock-based award activity   1.0 1.2 4.1 4.0
Common stock issued in connection with acquisitions   0.0 0.0 0.0 0.2
Common stock issued in connection with LYONs’ conversions   0.0 0.0 0.9 0.5
Issuance of stock 12.1 0.0 0.0 12.1 0.0
Balance, end of period   835.0 817.2 835.0 817.2
XML 58 R80.htm IDEA: XBRL DOCUMENT v3.19.3
Net Earnings Per Share (Narrative) (Details) - shares
shares in Millions
3 Months Ended 9 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 27, 2019
Sep. 28, 2018
Common stock        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share, amount 0.0 0.0 0.0 1,000,000.0
Preferred stock        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share, amount 12.0   9.0  
XML 59 R70.htm IDEA: XBRL DOCUMENT v3.19.3
Defined Benefit Plans (Components of Net Periodic Benefit Cost of Other Postretirement Benefit Pension Pans) (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 27, 2019
Sep. 28, 2018
Defined Benefit Plan Disclosure [Line Items]        
Service cost $ (9.9) $ (9.8) $ (29.5) $ (31.9)
Net periodic benefit (cost) (5.5) (0.7) (13.6) (6.7)
Other postretirement benefit plans        
Defined Benefit Plan Disclosure [Line Items]        
Service cost (0.1) 0.0 (0.3) (0.3)
Interest cost (1.3) (1.2) (3.8) (3.5)
Amortization of prior service (cost) credit 0.6 0.6 1.6 1.8
Net periodic benefit (cost) $ (0.8) $ (0.6) $ (2.5) $ (2.0)
XML 60 R74.htm IDEA: XBRL DOCUMENT v3.19.3
Nonoperating Income (Expense) (Narrative) (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 27, 2019
Sep. 28, 2018
Other Income and Expenses [Abstract]        
Other income, net $ 4.4 $ 9.1 $ 15.9 $ 25.2
XML 61 R84.htm IDEA: XBRL DOCUMENT v3.19.3
Subsequent Event (Narrative) (Details) - USD ($)
$ / shares in Units, $ in Millions
Oct. 24, 2019
Sep. 27, 2019
Subsequent event    
Subsequent Event [Line Items]    
Make-whole premiums $ 7  
Make-whole premiums, after-tax $ 5  
Make-whole premiums, per diluted share $ 0.01  
Senior notes | 2.4% senior notes due 2020    
Subsequent Event [Line Items]    
Interest rate of debt instrument   2.40%
Senior notes | 2.4% senior notes due 2020 | Subsequent event    
Subsequent Event [Line Items]    
Aggregate principal amount $ 500  
Interest rate of debt instrument 2.40%  
Senior notes | 5.0% senior notes due 2020    
Subsequent Event [Line Items]    
Interest rate of debt instrument   5.00%
Senior notes | 5.0% senior notes due 2020 | Subsequent event    
Subsequent Event [Line Items]    
Aggregate principal amount $ 375  
Interest rate of debt instrument 5.00%  
XML 62 R57.htm IDEA: XBRL DOCUMENT v3.19.3
Goodwill (Rollforward of Goodwill) (Details)
$ in Millions
9 Months Ended
Sep. 27, 2019
USD ($)
Goodwill [Roll Forward]  
Balance, December 31, 2018 $ 25,906.0
Attributable to 2019 acquisitions 214.9
Adjustments due to finalization of purchase price allocations (6.9)
Foreign currency translation and other (389.2)
Balance, September 27, 2019 $ 25,724.8
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.19.3
Leases (Components of Lease Expense) (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 27, 2019
Sep. 27, 2019
Leases [Abstract]    
Fixed operating lease expense $ 58.7 $ 178.1
Variable operating lease expense 13.4 38.3
Total operating lease expense $ 72.1 $ 216.4
XML 64 R40.htm IDEA: XBRL DOCUMENT v3.19.3
Segment Information (Tables)
9 Months Ended
Sep. 27, 2019
Segment Reporting [Abstract]  
Segment Results
Segment results are shown below ($ in millions):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Sales:
 
 
 
 
 
 
 
Life Sciences
$
1,695.6

 
$
1,596.7

 
$
5,035.1

 
$
4,677.9

Diagnostics
1,601.9

 
1,502.5

 
4,757.0

 
4,573.1

Dental / Envista
659.3

 
679.5

 
2,031.1

 
2,085.5

Environmental & Applied Solutions
1,080.5

 
1,074.4

 
3,250.6

 
3,193.0

Total
$
5,037.3

 
$
4,853.1

 
$
15,073.8

 
$
14,529.5

 
 
 
 
 
 
 
 
Operating profit:
 
 
 
 
 
 
 
Life Sciences
$
342.5

 
$
312.8

 
$
995.5

 
$
875.6

Diagnostics
266.0

 
235.1

 
782.0

 
757.4

Dental / Envista
78.7

 
86.1

 
206.4

 
241.8

Environmental & Applied Solutions
256.5

 
254.3

 
761.3

 
732.5

Other
(108.9
)
 
(57.6
)
 
(302.8
)
 
(166.1
)
Total
$
834.8

 
$
830.7

 
$
2,442.4

 
$
2,441.2


Segment identifiable assets are shown below ($ in millions):
 
September 27, 2019
 
December 31, 2018
Life Sciences
$
22,115.0

 
$
22,122.4

Diagnostics
14,175.1

 
14,031.1

Dental / Envista
6,009.5

 
5,897.3

Environmental & Applied Solutions
4,741.3

 
4,637.3

Other
14,490.2

 
1,144.4

Total
$
61,531.1

 
$
47,832.5


XML 65 R44.htm IDEA: XBRL DOCUMENT v3.19.3
Revenue (Disaggregation of Revenue by Geographical Region) (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 27, 2019
Sep. 28, 2018
Disaggregation of Revenue [Line Items]        
Sales $ 5,037.3 $ 4,853.1 $ 15,073.8 $ 14,529.5
North America        
Disaggregation of Revenue [Line Items]        
Sales 2,033.3 1,937.5 6,083.8 5,688.4
Western Europe        
Disaggregation of Revenue [Line Items]        
Sales 1,082.3 1,104.1 3,410.0 3,476.7
Other developed markets        
Disaggregation of Revenue [Line Items]        
Sales 335.7 299.8 955.4 921.6
High-growth markets        
Disaggregation of Revenue [Line Items]        
Sales 1,586.0 1,511.7 4,624.6 4,442.8
Operating segments | Life Sciences        
Disaggregation of Revenue [Line Items]        
Sales 1,695.6 1,596.7 5,035.1 4,677.9
Operating segments | Life Sciences | North America        
Disaggregation of Revenue [Line Items]        
Sales 637.2 584.0 1,878.1 1,642.4
Operating segments | Life Sciences | Western Europe        
Disaggregation of Revenue [Line Items]        
Sales 444.1 447.1 1,363.7 1,346.5
Operating segments | Life Sciences | Other developed markets        
Disaggregation of Revenue [Line Items]        
Sales 149.2 134.5 436.1 417.9
Operating segments | Life Sciences | High-growth markets        
Disaggregation of Revenue [Line Items]        
Sales 465.1 431.1 1,357.2 1,271.1
Operating segments | Diagnostics        
Disaggregation of Revenue [Line Items]        
Sales 1,601.9 1,502.5 4,757.0 4,573.1
Operating segments | Diagnostics | North America        
Disaggregation of Revenue [Line Items]        
Sales 602.9 574.0 1,836.3 1,760.1
Operating segments | Diagnostics | Western Europe        
Disaggregation of Revenue [Line Items]        
Sales 257.9 262.3 828.5 861.4
Operating segments | Diagnostics | Other developed markets        
Disaggregation of Revenue [Line Items]        
Sales 108.4 91.8 295.6 275.3
Operating segments | Diagnostics | High-growth markets        
Disaggregation of Revenue [Line Items]        
Sales 632.7 574.4 1,796.6 1,676.3
Operating segments | Dental / Envista        
Disaggregation of Revenue [Line Items]        
Sales 659.3 679.5 2,031.1 2,085.5
Operating segments | Dental / Envista | North America        
Disaggregation of Revenue [Line Items]        
Sales 327.7 339.8 966.4 977.2
Operating segments | Dental / Envista | Western Europe        
Disaggregation of Revenue [Line Items]        
Sales 127.5 137.2 443.7 483.3
Operating segments | Dental / Envista | Other developed markets        
Disaggregation of Revenue [Line Items]        
Sales 45.6 42.5 131.0 133.5
Operating segments | Dental / Envista | High-growth markets        
Disaggregation of Revenue [Line Items]        
Sales 158.5 160.0 490.0 491.5
Operating segments | Environmental & Applied Solutions        
Disaggregation of Revenue [Line Items]        
Sales 1,080.5 1,074.4 3,250.6 3,193.0
Operating segments | Environmental & Applied Solutions | North America        
Disaggregation of Revenue [Line Items]        
Sales 465.5 439.7 1,403.0 1,308.7
Operating segments | Environmental & Applied Solutions | Western Europe        
Disaggregation of Revenue [Line Items]        
Sales 252.8 257.5 774.1 785.5
Operating segments | Environmental & Applied Solutions | Other developed markets        
Disaggregation of Revenue [Line Items]        
Sales 32.5 31.0 92.7 94.9
Operating segments | Environmental & Applied Solutions | High-growth markets        
Disaggregation of Revenue [Line Items]        
Sales $ 329.7 $ 346.2 $ 980.8 $ 1,003.9
XML 66 R48.htm IDEA: XBRL DOCUMENT v3.19.3
Acquisitions (Fair Values Of The Assets Acquired And Liabilities) (Details)
$ in Millions
9 Months Ended
Sep. 27, 2019
USD ($)
Business Combinations [Abstract]  
Trade accounts receivable $ 8.6
Inventories 8.8
Property, plant and equipment 3.9
Goodwill 214.9
Other intangible assets, primarily customer relationships, trade names and technology 112.3
Trade accounts payable (2.8)
Other assets and liabilities, net (14.6)
Net cash consideration $ 331.1
XML 67 R67.htm IDEA: XBRL DOCUMENT v3.19.3
Hedging Transactions And Derivative Financial Instruments (Derivative and Nonderivative Debt Instruments) (Details) - Net investment hedging
$ in Millions
Sep. 27, 2019
USD ($)
Prepaid expenses and other current assets  
Derivatives, Fair Value [Line Items]  
Derivative assets $ 36.8
Accrued expenses and other liabilities  
Derivatives, Fair Value [Line Items]  
Derivative liabilities 64.0
Long-term debt  
Derivatives, Fair Value [Line Items]  
Nonderivative hedging instruments $ 8,073.6
XML 68 R63.htm IDEA: XBRL DOCUMENT v3.19.3
Financing (Components Of Debt) (Details)
€ in Millions, SFr in Millions, ¥ in Billions
Sep. 27, 2019
USD ($)
Sep. 27, 2019
CHF (SFr)
Sep. 27, 2019
JPY (¥)
Sep. 27, 2019
EUR (€)
Sep. 18, 2019
EUR (€)
Dec. 31, 2018
USD ($)
Dec. 31, 2018
CHF (SFr)
Dec. 31, 2018
JPY (¥)
Dec. 31, 2018
EUR (€)
Debt Instrument [Line Items]                  
Long-term debt $ 17,604,800,000         $ 9,740,300,000      
Less: currently payable 1,068,600,000         51,800,000      
Long-term debt excluding currently payable 16,536,200,000         9,688,500,000      
Other                  
Debt Instrument [Line Items]                  
Long-term debt 197,200,000         66,700,000      
Commercial paper | U.S. dollar-denominated commercial paper                  
Debt Instrument [Line Items]                  
Long-term debt 0         72,800,000      
Commercial paper | Euro-denominated commercial paper                  
Debt Instrument [Line Items]                  
Long-term debt 2,900,000,000     € 2,700.0   2,377,500,000     € 2,100.0
Senior notes | 1.0% senior notes due 2019                  
Debt Instrument [Line Items]                  
Long-term debt $ 0         687,000,000.0      
Interest rate of debt instrument 1.00% 1.00% 1.00% 1.00%          
Aggregate principal amount | €       € 0.0         600.0
Senior notes | 2.4% senior notes due 2020                  
Debt Instrument [Line Items]                  
Long-term debt $ 499,200,000         498,500,000      
Interest rate of debt instrument 2.40% 2.40% 2.40% 2.40%          
Senior notes | 5.0% senior notes due 2020                  
Debt Instrument [Line Items]                  
Long-term debt $ 382,800,000         386,700,000      
Interest rate of debt instrument 5.00% 5.00% 5.00% 5.00%          
Senior notes | 0.352% senior notes due 2021                  
Debt Instrument [Line Items]                  
Long-term debt $ 277,600,000         273,200,000      
Interest rate of debt instrument 0.352% 0.352% 0.352% 0.352%          
Aggregate principal amount | ¥     ¥ 30.0         ¥ 30.0  
Senior notes | 1.7% senior notes due 2022                  
Debt Instrument [Line Items]                  
Long-term debt $ 872,600,000         913,200,000      
Interest rate of debt instrument 1.70% 1.70% 1.70% 1.70%          
Aggregate principal amount | €       € 800.0         800.0
Senior notes | Floating rate senior notes due 2022                  
Debt Instrument [Line Items]                  
Long-term debt $ 272,900,000         285,700,000      
Aggregate principal amount | €       € 250.0         250.0
Senior notes | 2.5% senior notes due 2025                  
Debt Instrument [Line Items]                  
Long-term debt $ 871,700,000         912,600,000      
Interest rate of debt instrument 2.50% 2.50% 2.50% 2.50%          
Aggregate principal amount | €       € 800.0         800.0
Senior notes | 3.35% senior notes due 2025                  
Debt Instrument [Line Items]                  
Long-term debt $ 497,100,000         496,800,000      
Interest rate of debt instrument 3.35% 3.35% 3.35% 3.35%          
Senior notes | 0.2% senior notes due 2026                  
Debt Instrument [Line Items]                  
Long-term debt $ 1,357,500,000         0      
Interest rate of debt instrument 0.20% 0.20% 0.20% 0.20% 0.20%        
Aggregate principal amount | €       € 1,300.0 € 1,250.0       0.0
Senior notes | 0.3% senior notes due 2027                  
Debt Instrument [Line Items]                  
Long-term debt $ 284,400,000         279,900,000      
Interest rate of debt instrument 0.30% 0.30% 0.30% 0.30%          
Aggregate principal amount | ¥     ¥ 30.8         30.8  
Senior notes | 1.2% senior notes due 2027                  
Debt Instrument [Line Items]                  
Long-term debt $ 651,500,000         682,000,000.0      
Interest rate of debt instrument 1.20% 1.20% 1.20% 1.20%          
Aggregate principal amount | €       € 600.0         600.0
Senior notes | 0.45% senior notes due 2028                  
Debt Instrument [Line Items]                  
Long-term debt $ 1,355,600,000         0      
Interest rate of debt instrument 0.45% 0.45% 0.45% 0.45% 0.45%        
Aggregate principal amount | €       € 1,300.0 € 1,250.0       0.0
Senior notes | 0.75% senior notes due 2031                  
Debt Instrument [Line Items]                  
Long-term debt $ 1,900,700,000         0      
Interest rate of debt instrument 0.75% 0.75% 0.75% 0.75% 0.75%        
Aggregate principal amount | €       € 1,800.0 € 1,750.0       0.0
Senior notes | 0.65% senior notes due 2032                  
Debt Instrument [Line Items]                  
Long-term debt $ 491,100,000         483,400,000      
Interest rate of debt instrument 0.65% 0.65% 0.65% 0.65%          
Aggregate principal amount | ¥     ¥ 53.2         ¥ 53.2  
Senior notes | 1.35% senior notes due 2039                  
Debt Instrument [Line Items]                  
Long-term debt $ 1,349,200,000         0      
Interest rate of debt instrument 1.35% 1.35% 1.35% 1.35% 1.35%        
Aggregate principal amount | €       € 1,300.0 € 1,250.0       0.0
Senior notes | 4.375% senior notes due 2045                  
Debt Instrument [Line Items]                  
Long-term debt $ 499,400,000         499,300,000      
Interest rate of debt instrument 4.375% 4.375% 4.375% 4.375%          
Senior notes | 1.8% senior notes due 2049                  
Debt Instrument [Line Items]                  
Long-term debt $ 810,300,000         0      
Interest rate of debt instrument 1.80% 1.80% 1.80% 1.80% 1.80%        
Aggregate principal amount | €       € 750.0 € 750.0       0.0
Unsecured debt | Envista term loan facility                  
Debt Instrument [Line Items]                  
Long-term debt $ 648,600,000         0      
Unsecured debt | Envista euro term loan facility                  
Debt Instrument [Line Items]                  
Long-term debt 655,600,000         0      
Aggregate principal amount | €       € 600.0         € 0.0
Convertible debt | Zero-coupon LYONs due 2021                  
Debt Instrument [Line Items]                  
Long-term debt $ 34,600,000         56,200,000      
Interest rate of debt instrument 0.00% 0.00% 0.00% 0.00%          
Bonds | 0.5% senior bonds due 2023                  
Debt Instrument [Line Items]                  
Long-term debt $ 546,000,000.0         550,700,000      
Interest rate of debt instrument 0.50% 0.50% 0.50% 0.50%          
Aggregate principal amount | SFr   SFr 540         SFr 540    
Bonds | 1.125% senior bonds due 2028                  
Debt Instrument [Line Items]                  
Long-term debt $ 216,000,000.0         $ 218,100,000      
Interest rate of debt instrument 1.125% 1.125% 1.125% 1.125%          
Aggregate principal amount | SFr   SFr 210         SFr 210    
XML 70 R29.htm IDEA: XBRL DOCUMENT v3.19.3
Acquisitions (Tables)
9 Months Ended
Sep. 27, 2019
Business Combinations [Abstract]  
Fair Values Of The Assets Acquired And Liabilities Assumed
The following summarizes the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition for the acquisitions consummated during the nine-month period ended September 27, 2019 ($ in millions):
Trade accounts receivable
$
8.6

Inventories
8.8

Property, plant and equipment
3.9

Goodwill
214.9

Other intangible assets, primarily customer relationships, trade names and technology
112.3

Trade accounts payable
(2.8
)
Other assets and liabilities, net
(14.6
)
Net cash consideration
$
331.1


Results Of Operations If Acquisition Was Consummated The pro forma information is presented for informational purposes only and is not necessarily indicative of the results of operations that actually would have been achieved had the acquisitions been consummated as of that time ($ in millions, except per share amounts):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Sales
$
5,037.3

 
$
4,873.4

 
$
15,082.6

 
$
14,685.8

Net earnings attributable to common stockholders
648.4

 
658.1

 
1,681.2

 
1,888.5

Diluted net earnings per share
0.89

 
0.93

 
2.32

 
2.66


XML 71 R9.htm IDEA: XBRL DOCUMENT v3.19.3
General
9 Months Ended
Sep. 27, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
General GENERAL
The Consolidated Condensed Financial Statements included herein have been prepared by Danaher Corporation (“Danaher” or the “Company”) without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In this quarterly report, the terms “Danaher” or the “Company” refer to Danaher Corporation, Danaher Corporation and its consolidated subsidiaries (including Envista Holdings Corporation (“Envista”), unless otherwise indicated or the context otherwise requires) or the consolidated subsidiaries of Danaher Corporation (including Envista, unless otherwise indicated or the context otherwise requires), as the context requires. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted pursuant to SEC rules and regulations; however, the Company believes that the disclosures are adequate to make the information presented not misleading. The Consolidated Condensed Financial Statements included herein should be read in conjunction with the financial statements as of and for the year ended December 31, 2018 and the Notes thereto included in the Company’s 2018 Annual Report on Form 10-K filed on February 21, 2019 (the “2018 Annual Report” or “2018 Annual Report on Form 10-K”).
In the opinion of the Company, the accompanying financial statements contain all adjustments (consisting of only normal recurring accruals) necessary to present fairly the financial position of the Company as of September 27, 2019 and December 31, 2018, its results of operations for the three and nine-month periods ended September 27, 2019 and September 28, 2018 and its cash flows for each of the nine-month periods then ended.
Accounting Standards Recently Adopted
In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842), which requires lessees to recognize a right-of-use (“ROU”) asset and a lease liability for all leases with terms greater than 12 months and also requires disclosures by lessees and lessors about the amount, timing and uncertainty of cash flows arising from leases. The accounting applied by a lessor is largely unchanged from that applied under the prior standard. Subsequent to the issuance of Topic 842, the FASB clarified the guidance through several ASUs; hereinafter the collection of lease guidance is referred to as “ASC 842”.
On January 1, 2019, the Company adopted ASC 842 using the modified retrospective method for all lease arrangements at the beginning of the period of adoption. Results for reporting periods beginning January 1, 2019 are presented under ASC 842, while prior period amounts were not adjusted and continue to be reported in accordance with the Company’s historic accounting under ASC 840, Leases (“ASC 840”). The standard had a material impact on the Company’s Consolidated Condensed Balance Sheet but did not have a significant impact on the Company’s consolidated net earnings and cash flows. The most significant impact was the recognition of ROU assets and lease liabilities for operating leases, while the accounting for finance leases remained substantially unchanged. For leases that commenced before the effective date of ASC 842, the Company elected the permitted practical expedients to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. The Company also elected to include leases with a term of 12 months or less in the recognized ROU assets and lease liabilities.
As a result of the cumulative impact of adopting ASC 842, the Company recorded operating lease ROU assets of $971 million and operating lease liabilities of $1,012 million as of January 1, 2019, primarily related to real estate and automobile leases, based on the present value of the future lease payments on the date of adoption. Refer to Note 5 for the additional disclosures required by ASC 842.
The Company determines if an arrangement is a lease at inception. For leases where the Company is the lessee, ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The ROU asset also consists of any prepaid lease payments, lease incentives received, costs which will be incurred in exiting a lease and the amount of any asset or liability recognized on business combinations relating to favorable or unfavorable lease terms. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as depreciation expense and interest expense using the accelerated interest
method of recognition. The Company has lease agreements which require payments for lease and non-lease components and has elected to account for these as a single lease component.
The Company leases Life Sciences, Diagnostics, and Environmental & Applied Solutions equipment to customers in both operating-type lease (“OTL”) and sales-type lease (“STL”) arrangements. Equipment lease revenue for OTL agreements is recognized on a straight-line basis over the life of the lease, and the costs of customer-leased equipment are recorded within property, plant and equipment, net in the accompanying Consolidated Condensed Balance Sheets and depreciated over the equipment’s estimated useful life. Depreciation expense associated with the leased equipment under OTL arrangements is reflected in cost of sales in the accompanying Consolidated Condensed Statements of Earnings. The OTLs are generally not cancellable until after an initial term and may or may not require the customer to purchase a minimum number of consumables or tests throughout the contract term. Certain of the Company’s lease contracts are customized for larger customers and often result in complex terms and conditions that typically require significant judgment in applying the criteria used to evaluate whether the arrangement should be considered an OTL or an STL. An STL results in earlier recognition of equipment revenue as compared to an OTL. Some of the Company’s leases include a purchase option for the customer to purchase the leased asset at the end of the lease arrangement for a purchase price equal to the asset’s fair market value at the time of the purchase. The Company manages its risk on the unguaranteed residual asset for leased equipment through the pricing and term of the leases. In certain geographies, equipment coming off OTL and STL arrangements after the initial lease term may be leased to other customers or used for spare parts.
For lease arrangements with lease and non-lease components where the Company is the lessor, the Company allocates the contract’s transaction price to the lease and non-lease components on a relative standalone selling price basis using the Company’s best estimate of the standalone selling price of each distinct product or service in the contract. The primary method used to estimate standalone selling price is the price observed in standalone sales to customers; however, when prices in standalone sales are not available the Company may use third-party pricing for similar products or services or estimate the standalone selling price. Allocation of the transaction price is determined at the inception of the lease arrangement. The Company’s leases primarily consist of leases with fixed lease payments. For those leases with variable lease payments, the variable lease payment is typically based upon use of the leased equipment or the purchase of consumables used with the leased equipment.
In August 2017, the FASB issued ASU No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities, which expands and refines hedge accounting for both financial and non-financial risk components, aligns the recognition and presentation of the effects of hedging instruments and hedge items in the financial statements and includes certain targeted improvements to ease the application of current guidance related to the assessment of hedge effectiveness. The ASU was effective for public entities for fiscal years beginning after December 15, 2018. In January 2019, the Company entered into approximately $1.9 billion of cross-currency swap derivative contracts to hedge its net investment in foreign operations against adverse changes in the exchange rates between the U.S. dollar and the Danish kroner, Japanese yen, euro and Swiss franc. In June 2019, the Company entered into interest rate swap agreements with a notional amount of $850 million which represents a portion of the amount of U.S. dollar-denominated bonds (with terms ranging from 10 to 30 years) the Company anticipates issuing to finance a portion of the acquisition of the Biopharma Business of General Electric Company (“GE”) Life Sciences (the “GE Biopharma Business” or “GE Biopharma”). These contracts effectively fixed the interest rate for a portion of the Company’s anticipated U.S. dollar-denominated debt issuance equal to the notional amount of the swaps to the rate specified in the interest rate swap agreements. Refer to Note 8 for additional disclosures about the Company’s debt issuances related to the pending GE Biopharma acquisition and Note 9 for additional disclosures about the Company’s hedging activities.
In addition to the cross-currency swaps entered into by the Company in January 2019, in September 2019, Envista entered into $650 million of cross-currency swap derivative contracts with respect to its senior unsecured term loan facility. These contracts effectively convert the senior unsecured term loan facility to an obligation denominated in euro and partially offset the impact of changes in currency rates on Envista’s euro-denominated net investments in foreign operations. In addition, Envista entered into $650 million of interest rate swap derivative contracts to convert the variable interest rate for the senior unsecured term loan facility to a fixed interest rate.
Except for the above accounting policy for leases that was updated as a result of adopting ASC 842, there have been no changes to the Company’s significant accounting policies described in the Annual Report on Form 10-K for the year ended December 31, 2018 that have a material impact on the Company’s Consolidated Condensed Financial Statements and the related Notes.
Accounting Standards Not Yet Adopted
In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which amends the impairment model by requiring entities to use a forward-looking approach
based on expected losses rather than incurred losses to estimate credit losses on certain types of financial instruments, including trade receivables. This may result in the earlier recognition of allowances for losses. The ASU is effective for public entities for fiscal years beginning after December 15, 2019, with early adoption permitted. The ASU will be adopted using a modified retrospective transition method, with the adoption impact recognized through a cumulative-effect adjustment to retained earnings in the period of adoption. In November 2018, April 2019 and May 2019, the FASB issued ASU No. 2018-19, Codification Improvements to Topic 326, Financial Instruments-Credit Losses, ASU No. 2019-04, Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments and ASU No. 2019-05, Financial Instruments-Credit Losses (Topic 326): Targeted Transition Relief which provided additional implementation guidance on the previously issued ASU. Management has not yet completed its assessment of the impact of the new standard on the Company’s financial statements. The Company is in the process of implementing changes to its accounting policies and processes for the new standard. Currently, the Company believes that the most notable impact of this ASU will relate to its processes around the assessment of the adequacy of its allowance for doubtful accounts on trade accounts receivable and the recognition of credit losses.
In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820), which modifies the disclosures on fair value measurements by removing the requirement to disclose the amount and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy and the policy for timing of such transfers. The ASU expands the disclosure requirements for Level 3 fair value measurements, primarily focused on changes in unrealized gains and losses included in other comprehensive income (loss). The ASU is effective for public entities for fiscal years beginning after December 15, 2019, with early adoption permitted. Management has not yet completed its assessment of the impact of the new standard on the Company’s financial statements.
In August 2018, the FASB issued ASU No. 2018-14, Disclosure Framework—Changes to the Disclosure Requirements for Defined Benefit Plans, which amends ASC 715, Compensation—Retirement Benefits, to add, remove, and clarify disclosure requirements related to defined benefit pension and other postretirement plans. The ASU is effective for public entities for fiscal years beginning after December 15, 2020, with early adoption permitted. Management has not yet completed its assessment of the impact of the new standard on the Company’s financial statements.
Accumulated Other Comprehensive Income (Loss)—Accumulated other comprehensive income (loss) refers to certain gains and losses that under U.S. GAAP are included in comprehensive income (loss) but are excluded from net earnings as these amounts are initially recorded as an adjustment to stockholders’ equity. The changes in accumulated other comprehensive income (loss) by component are summarized below ($ in millions). Foreign currency translation adjustments generally relate to indefinite investments in non-U.S. subsidiaries, as well as the impact from the Company’s hedges of its net investment in foreign operations, including the Company’s cross-currency swap derivatives, net of any tax impacts.
 
Foreign Currency Translation Adjustments
 
Pension & Postretirement Plan Benefit Adjustments
 
Unrealized Gain (Loss) on Available-For-Sale Securities Adjustments
 
Cash Flow Hedge Adjustments
 
Total
 
For the Three-Month Period Ended September 27, 2019:
 
 
 
Balance, June 28, 2019
$
(2,155.4
)
 
$
(681.1
)
 
$
(1.0
)
 
$
(6.8
)
 
$
(2,844.3
)
 
Other comprehensive income (loss) before reclassifications:
 
 
 
 
 
 
 
 
 
 
(Decrease) increase
(226.8
)
 

 
0.6

 
(55.1
)
 
(281.3
)
 
Income tax impact
(9.0
)
 

 
(0.1
)
 
13.3

 
4.2

 
Other comprehensive income (loss) before reclassifications, net of income taxes
(235.8
)
 

 
0.5

 
(41.8
)
 
(277.1
)
 
Amounts reclassified from accumulated other comprehensive income (loss):
 
 
 
 
 
 
 
 
 
 
Increase

 
7.5

(a)

 

 
7.5

 
Income tax impact

 
(1.7
)
 

 

 
(1.7
)
 
Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes

 
5.8

 

 

 
5.8

 
Net current period other comprehensive income (loss), net of income taxes
(235.8
)
 
5.8

 
0.5

 
(41.8
)
 
(271.3
)
(b)
Balance, September 27, 2019
$
(2,391.2
)
 
$
(675.3
)
 
$
(0.5
)
 
$
(48.6
)
 
(3,115.6
)
 
Less: accumulated other comprehensive income attributable to noncontrolling interests
 
(27.3
)
 
Accumulated other comprehensive income attributable to controlling interests
 
$
(3,088.3
)
 
For the Three-Month Period Ended September 28, 2018:
 
 
 
Balance, June 29, 2018
$
(1,812.9
)
 
$
(664.6
)
 
$
(1.7
)
 
$

 
$
(2,479.2
)
 
Other comprehensive income (loss) before reclassifications:
 
 
 
 
 
 
 
 
 
 
Decrease
(162.4
)
 

 

 

 
(162.4
)
 
Income tax impact

 

 

 

 

 
Other comprehensive income (loss) before reclassifications, net of income taxes
(162.4
)
 

 

 

 
(162.4
)
 
Amounts reclassified from accumulated other comprehensive income (loss):
 
 
 
 
 
 
 
 
 
 
Increase

 
7.7

(a)

 

 
7.7

 
Income tax impact

 
(1.8
)
 

 

 
(1.8
)
 
Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes

 
5.9

 

 

 
5.9

 
Net current period other comprehensive income (loss), net of income taxes
(162.4
)
 
5.9

 

 

 
(156.5
)
 
Balance, September 28, 2018
$
(1,975.3
)
 
$
(658.7
)
 
$
(1.7
)
 
$

 
$
(2,635.7
)
 
(a) This accumulated other comprehensive income (loss) component is included in the computation of net periodic pension cost. Refer to Note 10 for additional details.
(b) Accumulated other comprehensive income (loss) for the three-month period ended September 27, 2019 consists of $270.1 million of accumulated other comprehensive loss attributable to controlling interest and $1.2 million of accumulated other comprehensive loss attributable to noncontrolling interest.
 
Foreign Currency Translation Adjustments
 
Pension & Postretirement Plan Benefit Adjustments
 
Unrealized Gain (Loss) on Available-For-Sale Securities Adjustments
 
Cash Flow Hedge Adjustments
 
Total
 
For the Nine-Month Period Ended September 27, 2019:
 
 
 
Balance, December 31, 2018
$
(2,098.1
)
 
$
(691.1
)
 
$
(1.9
)
 
$

 
$
(2,791.1
)
 
Other comprehensive income (loss) before reclassifications:
 
 
 
 
 
 
 
 
 
 
(Decrease) increase
(286.0
)
 

 
1.8

 
(64.0
)
 
(348.2
)
 
Income tax impact
(7.1
)
 

 
(0.4
)
 
15.4

 
7.9

 
Other comprehensive income (loss) before reclassifications, net of income taxes
(293.1
)
 

 
1.4

 
(48.6
)
 
(340.3
)
 
Amounts reclassified from accumulated other comprehensive income (loss):
 
 
 
 
 
 
 
 
 
 
Increase

 
20.7

(a)

 

 
20.7

 
Income tax impact

 
(4.9
)
 

 

 
(4.9
)
 
Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes

 
15.8

 

 

 
15.8

 
Net current period other comprehensive income (loss), net of income taxes
(293.1
)
 
15.8

 
1.4

 
(48.6
)
 
(324.5
)
(b)
Balance, September 27, 2019
$
(2,391.2
)
 
$
(675.3
)
 
$
(0.5
)
 
$
(48.6
)
 
(3,115.6
)
 
Less: accumulated other comprehensive income attributable to noncontrolling interests
 
(27.3
)
 
Accumulated other comprehensive income attributable to controlling interests
 
$
(3,088.3
)
 
For the Nine-Month Period Ended September 28, 2018:
 
 
 
Balance, December 31, 2017
$
(1,422.1
)
 
$
(571.2
)
 
$
(0.9
)
 
$

 
$
(1,994.2
)
 
Adoption of accounting standards
(43.8
)
 
(107.2
)
 
(0.2
)
 

 
(151.2
)
 
Balance, January 1, 2018
(1,465.9
)
 
(678.4
)
 
(1.1
)
 

 
(2,145.4
)
 
Other comprehensive income (loss) before reclassifications:
 
 
 
 
 
 
 
 
 
 
Decrease
(509.4
)
 

 
(0.8
)
 

 
(510.2
)
 
Income tax impact

 

 
0.2

 

 
0.2

 
Other comprehensive income (loss) before reclassifications, net of income taxes
(509.4
)
 

 
(0.6
)
 

 
(510.0
)
 
Amounts reclassified from accumulated other comprehensive income (loss):
 
 
 
 
 
 
 
 
 
 
Increase

 
25.8

(a)

 

 
25.8

 
Income tax impact

 
(6.1
)
 

 

 
(6.1
)
 
Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes

 
19.7

 

 

 
19.7

 
Net current period other comprehensive income (loss), net of income taxes
(509.4
)
 
19.7

 
(0.6
)
 

 
(490.3
)
 
Balance, September 28, 2018
$
(1,975.3
)
 
$
(658.7
)
 
$
(1.7
)
 
$

 
$
(2,635.7
)
 

(a) This accumulated other comprehensive income (loss) component is included in the computation of net periodic pension cost. Refer to Note 10 for additional details.
(b) Accumulated other comprehensive income (loss) for the nine-month period ended September 27, 2019 consists of $323.3 million of accumulated other comprehensive loss attributable to controlling interest and $1.2 million of accumulated other comprehensive loss attributable to noncontrolling interest.
XML 72 R25.htm IDEA: XBRL DOCUMENT v3.19.3
Subsequent Event (Notes)
9 Months Ended
Sep. 27, 2019
Subsequent Events [Abstract]  
Subsequent Events SUBSEQUENT EVENTS
On October 24, 2019, the Company will redeem the $500 million aggregate principal amount of 2.4% Senior Notes due 2020 and the $375 million aggregate principal amount of 5.0% 2020 Assumed Pall Notes, in each case at a redemption price equal to the outstanding principal amount and a make-whole premium as specified in the applicable indenture, plus accrued and unpaid interest. The Company expects the make-whole premiums required in connection with the redemption will be $7 million ($5 million after-tax or $0.01 per diluted share). The payment of the make-whole premiums will be reflected as a loss on early extinguishment of borrowings in the Company’s fourth quarter financial statements, as the extinguishment is expected to occur in the fourth quarter. The Company is funding the redemption using a portion of the cash distribution it received in connection with the Envista IPO.
XML 73 R1.htm IDEA: XBRL DOCUMENT v3.19.3
Cover Page - shares
9 Months Ended
Sep. 27, 2019
Oct. 18, 2019
Entity Information [Line Items]    
Document type 10-Q  
Document quarterly report true  
Document period end date Sep. 27, 2019  
Document transition report false  
Entity file number 001-08089  
Entity registrant name DANAHER CORPORATION  
Amendment flag false  
Document fiscal year focus 2019  
Document fiscal period focus Q3  
Current fiscal year end date --12-31  
Entity central index key 0000313616  
Entity incorporation, state code DE  
Entity tax identification number 59-1995548  
Entity address, address line one 2200 Pennsylvania Avenue, N.W., Suite 800W  
Entity address, city Washington,  
Entity address, state DC  
Entity address, postal zip code 20037-1701  
City area code 202  
Local phone number 828-0850  
Entity current reporting status Yes  
Entity interactive data current Yes  
Entity filer category Large Accelerated Filer  
Entity small business false  
Entity emerging growth company false  
Entity shell company false  
Entity common stock, shares outstanding   718,281,174
Common stock    
Entity Information [Line Items]    
Title of 12(b) security Common stock, $0.01 par value  
Trading symbol DHR  
Security exchange name NYSE  
Preferred stock    
Entity Information [Line Items]    
Title of 12(b) security 4.75% Mandatory Convertible Preferred Stock, Series A, without par value  
Trading symbol DHR.PRA  
Security exchange name NYSE  
Floating rate senior notes due 2022    
Entity Information [Line Items]    
Title of 12(b) security Floating Rate Senior Notes due 2022  
Trading symbol DHR F 06/30/22  
Security exchange name NYSE  
1.7% senior notes due 2022    
Entity Information [Line Items]    
Title of 12(b) security 1.700% Senior Notes due 2022  
Trading symbol DHR 1.7 01/04/22  
Security exchange name NYSE  
2.5% senior notes due 2025    
Entity Information [Line Items]    
Title of 12(b) security 2.500% Senior Notes due 2025  
Trading symbol DHR 2.5 07/08/25  
Security exchange name NYSE  
0.2% senior notes due 2026    
Entity Information [Line Items]    
Title of 12(b) security 0.200% Senior Notes due 2026  
Trading symbol DHR 0.2 03/18/26  
Security exchange name NYSE  
1.2% senior notes due 2027    
Entity Information [Line Items]    
Title of 12(b) security 1.200% Senior Notes due 2027  
Trading symbol DHR 1.2 06/30/27  
Security exchange name NYSE  
0.45% senior notes due 2028    
Entity Information [Line Items]    
Title of 12(b) security 0.450% Senior Notes due 2028  
Trading symbol DHR 0.45 03/18/28  
Security exchange name NYSE  
0.75% senior notes due 2031    
Entity Information [Line Items]    
Title of 12(b) security 0.750% Senior Notes due 2031  
Trading symbol DHR 0.75 09/18/31  
Security exchange name NYSE  
1.35% senior notes due 2039    
Entity Information [Line Items]    
Title of 12(b) security 1.350% Senior Notes due 2039  
Trading symbol DHR 1.35 09/18/39  
Security exchange name NYSE  
1.8% senior notes due 2049    
Entity Information [Line Items]    
Title of 12(b) security 1.800% Senior Notes due 2049  
Trading symbol DHR 1.8 09/18/49  
Security exchange name NYSE  
XML 74 R5.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Condensed Statements Of Comprehensive Income - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 27, 2019
Sep. 28, 2018
Statement of Comprehensive Income [Abstract]        
Net earnings $ 673.9 $ 663.7 $ 1,739.0 $ 1,904.1
Other comprehensive income (loss), net of income taxes:        
Foreign currency translation adjustments (235.8) (162.4) (293.1) (509.4)
Pension and postretirement plan benefit adjustments 5.8 5.9 15.8 19.7
Unrealized gain (loss) on available-for-sale securities adjustments 0.5 0.0 1.4 (0.6)
Cash flow hedge adjustments (41.8) 0.0 (48.6) 0.0
Total other comprehensive income (loss), net of income taxes (271.3) (156.5) (324.5) (490.3)
Comprehensive income 402.6 507.2 1,414.5 1,413.8
Less: comprehensive income attributable to noncontrolling interests (4.7) 0.0 (4.7) 0.0
Comprehensive income attributable to Danaher $ 397.9 $ 507.2 $ 1,409.8 $ 1,413.8
XML 75 R21.htm IDEA: XBRL DOCUMENT v3.19.3
Commitments And Contingencies
9 Months Ended
Sep. 27, 2019
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies COMMITMENTS AND CONTINGENCIES
For a description of the Company’s litigation and contingencies, refer to Note 17 of the Company’s financial statements as of and for the year ended December 31, 2018 included in the Company’s 2018 Annual Report. The Company reviews the adequacy of its legal reserves on a quarterly basis and establishes reserves for loss contingencies that are both probable and reasonably estimable. During the nine-month period ended September 27, 2019, the Company recorded a provision of $36 million ($29 million after-tax or $0.04 per diluted share) for costs and estimated liabilities related to a legal contingency.
The Company generally accrues estimated warranty costs at the time of sale. In general, manufactured products are warranted against defects in material and workmanship when properly used for their intended purpose, installed correctly and appropriately maintained. Warranty periods depend on the nature of the product and range from the date of such sale up to the life of the product. The amount of the accrued warranty liability is determined based on historical information such as past experience, product failure rates or number of units repaired, estimated cost of material and labor and in certain instances estimated property damage. The accrued warranty liability is reviewed on a quarterly basis and may be adjusted as additional information regarding expected warranty costs becomes known.
The following is a rollforward of the Company’s accrued warranty liability ($ in millions):
Balance, December 31, 2018
$
77.4

Accruals for warranties issued during the period
46.6

Settlements made
(43.7
)
Effect of foreign currency translation
(1.2
)
Balance, September 27, 2019
$
79.1


XML 76 R17.htm IDEA: XBRL DOCUMENT v3.19.3
Hedging Transactions And Derivative Financial Instruments (Notes)
9 Months Ended
Sep. 27, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Hedging Transactions and Derivative Financial Instruments HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS
The Company uses cross-currency swap derivative contracts to partially hedge its net investments in foreign operations against adverse movements in exchange rates between the U.S. dollar and the Danish kroner, Japanese yen, euro and Swiss franc. The cross-currency swap derivative contracts are agreements to exchange fixed-rate payments in one currency for fixed-rate payments in another currency. In January 2019, the Company entered into cross-currency swap derivative contracts with respect to approximately $1.9 billion of its U.S. dollar-denominated bonds and approximately $1.0 billion of these derivative contracts remain outstanding as of September 27, 2019. These contracts effectively convert these U.S. dollar-denominated bonds to obligations denominated in Danish kroner, Japanese yen, euro and Swiss franc, and partially offset the impact of changes in currency rates on foreign currency denominated net investments. The changes in the spot rate of these instruments are recorded in accumulated other comprehensive income (loss) in stockholders’ equity, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in accumulated other comprehensive income (loss) in the Company’s Consolidated Condensed Statements of Stockholders’ Equity. Any ineffective portions of net investment hedges are reclassified from accumulated other comprehensive income (loss) into earnings during the period of change. The interest income or expense from these swaps are recorded in interest expense in the Company’s Consolidated Condensed Statements of Earnings consistent with the classification of interest expense attributable to the underlying debt. These instruments mature on dates ranging up to September 2028.
The Company has also issued foreign currency denominated long-term debt as partial hedges of its net investments in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro, Japanese yen and Swiss franc. These foreign currency denominated long-term debt issuances are designated and qualify as nonderivative hedging instruments. Accordingly, the foreign currency translation of these debt instruments is recorded in accumulated other comprehensive income (loss) in stockholders’ equity in the accompanying Consolidated Condensed Balance Sheets, offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in accumulated other comprehensive income (loss). Any ineffective portions of net investment hedges are reclassified from accumulated other comprehensive income (loss) into earnings during the period of change. These instruments mature on dates ranging from September 2025 to May 2032.
The Company has used interest rate swap agreements to hedge the variability in cash flows due to changes in benchmark interest rates related to a portion of the U.S. debt the Company anticipates issuing to fund the GE Biopharma Acquisition. The interest rate swap agreements are agreements in which the Company agrees to pay a fixed interest rate based on the rate specified in the agreement in exchange for receiving a floating interest rate from a third-party bank based upon a specified benchmark interest rate. In June 2019, the Company entered into interest rate swap agreements with a notional amount of $850 million. These contracts effectively fixed the interest rate for a portion of the Company’s anticipated U.S. dollar-denominated debt issuance equal to the notional amount of the swaps to the rate specified in the interest rate swap agreements. The changes in the fair value of these instruments are recorded in accumulated other comprehensive income (loss) in stockholders’ equity and are subsequently reclassified to interest expense over the life of the related debt.
Envista uses cross-currency swap derivative contracts to partially hedge its net investments in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. The cross-currency swap derivative contracts are
agreements to exchange fixed-rate payments in one currency for fixed-rate payments in another currency. In September 2019, Envista entered into cross-currency swap derivative contracts with respect to $650 million of the Envista Term Loan Facility and $650 million of these derivative contracts remain outstanding as of September 27, 2019. These contracts effectively convert the Envista Term Loan Facility to an obligation denominated in euro and partially offset the impact of changes in currency rates on foreign currency denominated net investments. The changes in the fair value of these instruments are recorded in accumulated other comprehensive income (loss) in equity, partially offsetting the foreign currency translation adjustment of Envista’s related net investment that is also recorded in accumulated other comprehensive income (loss). Any ineffective portions of net investment hedges are reclassified from accumulated other comprehensive income (loss) into earnings during the period of change. The interest income or expense from these swaps are recorded in interest expense, consistent with the classification of interest expense attributable to the underlying debt. These instruments mature on dates ranging from September 2020 to September 2022.
Envista issued the euro-denominated Envista Euro Credit Facility as a partial hedge of its net investments in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. This foreign currency denominated long-term debt issuance is designated and qualifies as a nonderivative hedging instrument. Accordingly, the foreign currency translation of this debt instrument is recorded in accumulated other comprehensive income (loss) in stockholders’ equity in the accompanying Consolidated Condensed Balance Sheet, offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in accumulated other comprehensive income (loss). Any ineffective portions of the net investment hedge is reclassified from accumulated other comprehensive income (loss) into earnings during the period of change. This debt matures in September 2022.

In addition to the cross-currency swaps entered into by the Company in January 2019, in September 2019, Envista entered into $650 million of interest rate swap derivative contracts to convert the variable interest rate for the Envista Term Loan Facility to a fixed interest rate. The interest rate swap agreements are agreements in which Envista agrees to pay a fixed interest rate based on the rate specified in the agreement in exchange for receiving a floating interest rate from a third-party bank based upon a specified benchmark interest rate. These contracts effectively fixed the interest rate for the Envista Term Loan Facility. The changes in the fair value of these instruments are recorded in accumulated other comprehensive income (loss) in stockholders’ equity and are subsequently reclassified to interest expense over the life of the Envista Term Loan Facility.
The following table summarizes the notional values as of September 27, 2019 and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive income (“OCI”) for the three and nine-month periods then ended ($ in millions):
 
Notional Amount
 
Gain (Loss) Recognized in OCI
For the Three-Month Period Ended September 27, 2019:
 
 
 
Foreign currency contracts
$
1,650.0

 
$
41.5

Foreign currency denominated debt
8,073.6

 
255.2

Interest rate swaps
1,500.0

 
(55.1
)
Total
$
11,223.6

 
$
241.6

For the Nine-Month Period Ended September 27, 2019:
 
 
 
Foreign currency contracts
$
1,650.0

 
$
36.8

Foreign currency denominated debt
8,073.6

 
263.5

Interest rate swaps
1,500.0

 
(64.0
)
Total
$
11,223.6

 
$
236.3


Gains or losses related to the foreign currency contracts and foreign currency denominated debt are classified as foreign currency translation adjustments in the schedule of changes in OCI in Note 1, as these items are attributable to the Company’s hedges of its net investment in foreign operations. Gains or losses related to the interest rate swaps are classified as cash flow hedge adjustments in the schedule of changes in OCI in Note 1. The Company did not reclassify any deferred gains or losses related to net investment hedges or cash flow hedges from accumulated other comprehensive income (loss) to earnings during the three or nine-month periods ended September 27, 2019. In addition, the Company did not have any ineffectiveness related to net investment hedges or interest rate swaps during the three or nine-month periods ended September 27, 2019. The cash inflows and outflows associated with the Company’s derivative contracts designated as net investment hedges are classified in all other investing activities in the accompanying Consolidated Condensed Statement of Cash Flows. The cash inflows and outflows associated with the Company’s derivative contracts designated as cash flow hedges are classified in cash flows from operating activities in the accompanying Consolidated Condensed Statement of Cash Flows.
The Company’s derivative instruments, as well as its nonderivative debt instruments designated and qualifying as net investment hedges, were classified as of September 27, 2019 in the Company’s Consolidated Condensed Balance Sheet as follows ($ in millions):
Derivative assets:
 
Prepaid expenses and other current assets
$
36.8

 
 
Derivative liabilities:
 
Accrued expenses and other liabilities
64.0

 
 
Nonderivative hedging instruments:
 
Long-term debt
8,073.6


Amounts related to the Company’s derivatives expected to be reclassified from accumulated other comprehensive income (loss) to net earnings during the next 12 months are not significant.
XML 77 R13.htm IDEA: XBRL DOCUMENT v3.19.3
Leases (Notes)
9 Months Ended
Sep. 27, 2019
Leases [Abstract]  
Leases LEASES
The Company has operating leases for office space, warehouses, distribution centers, research and development facilities, manufacturing locations and certain equipment, primarily automobiles. Many leases include one or more options to renew, some of which include options to extend the leases for up to 30 years, and some leases include options to terminate the leases within 30 days. In certain of the Company’s lease agreements, the rental payments are adjusted periodically to reflect actual charges incurred for common area maintenance, utilities, inflation and/or changes in other indexes. The Company’s finance leases were not material as of September 27, 2019 and for both the three and nine-month periods then ended. ROU assets arising from finance leases are included in property, plant and equipment, net and the liabilities are included in notes payable and current portion of long-term debt and long-term debt in the accompanying Consolidated Condensed Balance Sheets.
The components of operating lease expense were as follows ($ in millions):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 27, 2019
Fixed operating lease expense (a)
$
58.7

 
$
178.1

Variable operating lease expense
13.4

 
38.3

Total operating lease expense
$
72.1

 
$
216.4

(a) Includes short-term leases and sublease income, both of which were immaterial.
Supplemental cash flow information related to the Company’s operating leases for the nine-month period ended September 27, 2019 was as follows ($ in millions):
Cash paid for amounts included in the measurement of operating lease liabilities
$
177.7

ROU assets obtained in exchange for operating lease obligations
165.1


The following table presents the lease balances within the Consolidated Condensed Balance Sheet, weighted average remaining
lease term and weighted average discount rates related to the Company’s operating leases as of September 27, 2019 ($ in millions):
Lease Assets and Liabilities
Classification
 
Assets:
 
 
Operating lease ROU assets
Other long-term assets
$
956.1

 
 
 
Liabilities:
 
 
Current:
 
 
Operating lease liabilities
Accrued expenses and other liabilities
$
182.0

Long-term:
 
 
Operating lease liabilities
Other long-term liabilities
817.0

Total operating lease liabilities
 
$
999.0

 
 
 
Weighted average remaining lease term
7 years

Weighted average discount rate
3.1
%

The following table presents the maturity of the Company’s operating lease liabilities as of September 27, 2019 ($ in millions):
Remainder of 2019
$
55.8

2020
197.3

2021
160.4

2022
140.6

2023
122.0

Thereafter
460.3

Total operating lease payments
1,136.4

Less: imputed interest
137.4

Total operating lease liabilities
$
999.0


As of September 27, 2019, the Company had no additional significant operating or finance leases that had not yet commenced.
ZIP 78 0000313616-19-000148-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000313616-19-000148-xbrl.zip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�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

"'$;)^"[8-_;-?I.![97 )IM$&P8<9(ARXZVF4!FMC!'0 M*LZ%= :(#&QO&A^."=YHL?J,:QG7C@;7&&P25(1%.-99T!1(RAW4Q@K,.*%" M&81\I\LQ[1;7ME/*FLN-%LK/N)9Q[7AP#3>X1@@%..B@2CA'E7=::&\85])R M (E _Y^]-VUNX\C2A?\*0C,]84=0ZMP7.UY'Y.K1#5M26^J9F$\=$%$D<0T" M&"R2>7_]FUD+JD" *PID 4A'M)H :LGEG"?/?A*NO6I$,I4TR6\)YQ+./0OG M:)TB014-:JH%F$M+!=;*&N2%4P(0@1WR)!'V]^ M^3 9S^ZW_)]V=7[&0:VU(2V)1\@H$?G?*4R<0.\X@4?(6JURU$,%"94>4J&@EDXX8K@&Q&HL.IN1V07@ MV8<^J^^H2=)X:=$J9"Y =7 MB#Q!9X+.!)VO#)T"@E0D_."*A"?H3-"9H/.UH1.#5,#[" IX)S!-8)K ]+7! ME,A47/O(,*R;$?UW%+5$8-J=8IZGLB!I$1)5)*I(5)&H(E%%HHI$%:TLR'%% M$.4?UXN$?[F:9=G;Z_##56\:[ID,>MEXD UZG[/I(K?$%&N#Q%DO*#9BUT+B MQVYK.(+YI;T\GOFEO3R>^:6]/)[YG=M-N]Q*2U:_9Y'+6GU[%J?9FV>5P M,DY=6 Y1^>H*%!SS(ISLQ-/NI]U/NW^:$T^[?USFM5B.;;:XZJGK\.MY/Q6& M/(1L801Y70#7$A^^Q\X#BRDB5F)B!( <:84-$G _T2*BE;H%J["[IN*1WQU_ MS2FS),QN9-A10=Z!8R@V>0+FB@1:70,M65>S!9I+2(V'5CKJ@=>((H.ADL9: MP3D_4=#:1VH;Y0FS$F8ES'H69B&(Z\Q:AS3SS.4=5* QTGOI#<*&6R>5WE-I MNNYCUEYRRC"6[T1"K81:";6>@5JX1BV,@:/(L5A!BB*-)*/>LZ 7:D8L17M* M)N@\:KU0Q;J 8FU6[4THEE#L=%",UA6A8CHI84ABC6\XFTRP5NMS"U:PN= G#=T@2 MR10,#&Z4EL)R0PPD3F*AY6'*)E&\*.F@((-NV*X)X:TV2NI>Z0[H&0AL*^HNGT#JAHQ78* 3ER<\>Q!2)_7(0?PF9_RT:!% :] MZ_[LSVPQWY&_#YJ-62-B#BJD@=#2:4$]-\I#&2X3$!CK'#E0/VY$@'S?5]M> M[GHW;*80D^-PP)R __8T$$'4D1W:6N6PHT@*2[4'.A8O)X8)+0PQ[N0181\& M3PE35%K"@^[@ 0%UC(1Q&%OA)**844"DI-@@(XWQ G*]M0V\(#P8"_&2H*2 MA) 0H4.(@&I$(,19[CUBF$4P,$)8ICC3 DL/!#C0+)OV$.%E#(T8IOR;A! = M0@A2=XNSL=TY@1AZ&%MK,JT](EASS:B1GN\_6.+9;-Z&!T >28[)R817_F=X MU=LP@>^+J\H\V*O6XQGL5QAUC^/PIGQMJS9"A'X6^,!?+IX\\L/_1_# MJY?3.RCE\0Z(M>8&F^T+CM)!01AN!&PYIBA WEI&+9-*.N D]PI +9P]X("M M2*X%M7;*JDF"1-*J:^2Y%-Q9429Y1D\6F$0CZ<30@$?$AQ\TM4A(CB37"M* M4,29 X[ZVAV8]E6I@"1<2KB4<&D#ERBHE38L$,"$"J0IH=)I#81%2!+K$$88 M'K!9IP5066$_W MU)#ZT8;M.^"DEZQ^+'%OGZ91*.A-0D^KDU34ZE232BK)&2"(S! M5'##E:**RJUD$)[#J7DBC 94'>?8-I&".Z9H'B/0;@'@V'=3%VXC7)5&H (5[Z4 M"[?3#39?<$'2(B2J2%21J")11:**1!6)*EI9D..*(,H_?B^6[NMD- B/*/6= MWN)FFOVT(T4.9W,GO939O<'HR2?V3GR]DL MO/2%"/KU(NF?Y5=X:'=$8Y/?&('_/^O/E+/?:KHB]*X'8 (-W M\JCS5#J%GX&OQ'!*DJ:F"HO%:8RR)O,&BT@[W9'TM?%SOU4 M[.8BM1=,V)FPL[/8V>B1&.1,RQ 36A)'M1*2*QS^\L8XJ9U)2OOKQF)3WG(I MT82E"4L3EK:(I8U.D#Y(/H S[XE3U,D@AR(OC;, 4X,UV'\GR/8!L8V*66>8 MXB/O!'M:G*$ M!LI3JJF# MU%H'C#MV0:I),=UP@%!&6^T^\1 A=U:".@)!*:%-1!LNZMZ4*&AKCB JI*%6 M*.D=0]Q)@<.W=K_I68>.-OOP&" D7[0L: *;!#;[!1M9!W9X!H2FP#L'!478 M*N ,!5@IXCDE>/]ZS2&#S5Y,[&%YVG5/)KA)$OKSVQ'":X>7VK-&@Y.B+!3_?AYZ#A!=>15MP)JIS2P%-+M?$".0.% MM9AQ9=@+1%KM!2-:B7HB4KYCJ6'G 478=ZNR^5V+>80U?W;Q71U",2 ,&$RU MT ^O%GHW63 Y_Q,^)WQN%Y\%2/76#Z[>>C$[PG."Y57B&4*:Z\4=0-[Z;/)D .P%V NQV 1N+5)O^5' R=]_]?=$/ M4ZB^;^/9C_]F'E[U]ZM9.9NG#;'_E/'U MKF:1=_]M[H6$Q%B$'(O)6EY1@Q"C$''&I(/F6=[82+&]R44OPDR4P%9+T5]? MCMM[=FN3<_3[$C;O"J,UM\)"LDL1[O>>38:E;_^?V_ F_QS MF,EY]7G+0GP97F?SWH?L>^^/R75_0XZ[[L\NA^-B>/WE8E)]48B%^3??AX/% MU4\Q]@-(S.G?JE,A'!6C_G2>_53]L;%=;U91%G48$7AS=Q!&\28,__;SFXVC MK?CMOI^>>5MZ6>=?]JKYDUTM<[J/>-\GA"AM@)]XZF+$&_)/ZZ738ZQ%KPJV M./&@RU.E@88_-U' :5) ;HSL_;U7>HT2&9PD&:R9IGO_T;^>_MPK+=2]E8DZ MT<9)TL9=PD+\K(< ME+LVICE=?\013SSM?MK]M/NG.?&N[/X3W$Z)-!)I=( TCJO"VQ;1\M=L^7#CDEL@XY!4Y9:*0 ''K*-=" 8XB=UEA2*-">6LS(?^#_V;TF MU2H_H"GBYW?'7W-:+DFY*V43!!>IZ\'16AH2-!X\--)&N3X &*'2=VBE5E'%#,2& XHEE- ;@C T MX9,1:O_Z]5,!KXW*3V= X':[=W4.HHXKHN3-+_^=S1?9;-QSR]EDFIUPL7DJ M&Y4YD08.IJ 3995RNXO=[HKC #/<:KWESLHO M1R"FG 06,%#7&;,JJ#96,LV4H0XRI8V700$BF CF]U6VIOM8L ]+N4"BU=*1 M"0@2$.P&!*@.)L <:CN0\'+6$(Y)ZW&&25H2-"P M&S2P.JX&608),!X+)RGP5 (IN7 >,010ON'AB?S=PL>,7-L(9;_&5[U-BSQ]\55967M5=-^!KL M2ICUS_VJQUJ%]:!IX(4.M)#D( M@3/A7T.])\)[!2"56##"K3UI/-E/[04N6;OVW00G"4Y>%4X0:8HGDDMML8" M6@BU#!<:&]0@; 3 ^]>$N@PG^XE+E>T&NB0X27#RNG!":CCQ"EO)A0: 0,HI M5P!CJBE1#@%OY0'[GW>'DQ>RX K0;@)M@I?NP\M!PP?#==HL9-0C0;CT)$@C M5#$&PT>&PN56N_W'QCT+ UKI#<\0:57+Z+[Q]=#C7^]J4_8T1,4!40>396P" MO8LP<.=B/J&O1E<*>3RT/KM4^GC>D9P+3=D-]GD^7KLF#RA"=\3OC<*CY+4*=S&,NUXLYB2C1% M$$F!J>*&.<^,#K<S2#)7A.\)S@^53A&=7A%UISIZV42D%* MC??".8T]DEAR0*WO;%CI:WLI4)"?89*?$T G@$X W3I DT;&HHD"LR<4>AF3 MBJ2WWCOBC'$ "=K9>):N^7WP&:)@CW$J"; 38"? /E7 9G4 8FSSQ#DEE#)! M-4>*4P\M0#"(U-!PND_ ;B.>CYX!WG*-Z2,#RE=-G[@-C%4J@@A7OI2[O0L- M6U]PWJTQ\<_UY/_6,K:?)'=KZ]:?+V>YHW=%NMV(=,=GB)%6"SIUUD-[Z""> M@*U[P(9 G6NCJ='*$X:14A1((00'V@%LM42&&I& [45#Q 'A[V3"M81K"=>> M@6NHSE$A&&A%K22 (4J0T51:J[UQB&EE56=C[%X?U_93TON,"/D.)V1+R):0 M[1G(1GBCD"_P&/N@AWI#B08:,PT9Q)P(13'8:S#:02/;RP0EPS/.0:NU.!/2 M):0[':1CC3P)PI61@ J!(66&*>%H[/)$H/1:XOT;W=J'JS8 !IQ1#EN-YNU^ MV.UA1WZ\^>7#9#R[W_S?6EV]8^QD0)! M2V>":504.FP"[ @I8;08*T )$AI M1X_=9-4DI6Z8XPN1I]4F*L^E\<[*2D?KI4W0]0!T80!KW)ZG3IX=>&KGT8W#F0>TSX3[B5<.N <0N!NL8QDU91HJ5DDE(N M@OCE%+ 22^@]HSSAUDL;U"EI5P5,R)60ZVB0B]3(Y:@&003#R@I!L:4:(HFH M\I0((IU(RF('#.9$@':[\R4L.THL.TJLHG60J<8F()773#A!O0^ !8FSUFD@ MH:%H_X7;]@(XK<1%48".O"7XL46[=ZM4_/$5X-G;K%\: 5)A=\/K_![)ZOX MG'K 0L+.T\). G JRGYP1=D3=";H3-#YVM")4"J8?H %TQ-X)O!,X/G:X$E0 M*F9^!,7,$Y@F,$U@^MI@RF J-'YL(-;-Q(8["GPB,.U.8=-369"T"(DJ$E4D MJDA4D:@B446BBE86Y+B"B/*/ZP73/PS'V=OK\/U5;QINF0QZV7B0#7J?L^DB MM\042X/$62\H-F+7FNK';FLX@OFEO3R>^:6]/)[YI;T\GOF=S%YVTVSW$H+5 MK]GDOPZWD_U<<\B'QA+NI*P-@*9(GFP!I!D?324:^HLE(R9XW#^XD6 M$:W4-EB%W345C_SN^&M.F25A=B/'#IXQ@E++F4. Z01;W8,M >JROL12;3W5 MW&A.L6-*,F"E8=YY"($V)PI;^TAO@V><@58S-!)J)=0Z'=1"M$X2,Y &N8H8 M3C!%U&NEH$$ >">(%@:=*FKM);-,P<8H!A#H!%^S=U/16,6BGKQ(0X#I/3B<15O/GEO[/Y(IN->VXYFTRS5/!R M"U?SNN EUQ03!KB'U%('G11< TB(XY@18 ]4.HD"1DD'!1ETQ8(=UOH=/>HB MFIV"EU1']R5A1=8]S9T3F'BB$6.("L@51PYQI941RGIYH'ZQW6%E'Q9FP6"[ MM;L3IB1,Z0BF2%C[V@&GS%NF-.>*0NR$]];JH'E(9A5#>^K<= "8LA?[+Q&X MU6;A"542JG0&57"-*E 1001 D&-(#10:$(=!@!G/(138GBJJO(Q]E@N:]*&$ M,L>),K0.N/'8(: <\UI(2CW45 040DIZ !!\A6-IW= 12OU] AG[3:E[1Q[ M'UM \L=%^"%L]K=L%$AAT+ONS_[,%O,=^?N@V9C7;"P]$I()$!B94(V\!IKY M("TH+CSR?D_=,5Y"6,CW?;7MY:YWPVI*('\GC\$%W-- !%E'=QC-2:P0 M287 E#FBJ%)2(,TAYA)9>.J(L ^#)^*T5=-$ H0$"+L @6P#I/P%%(./0>& M4ZI,$!\P9QAJ'>1](/R>ZL<>$"#LQ5H),6[5CI @(4'";I" FY! ,+?8&L@= M#7]H*@E4 208C2VC3EY&>!E3HR1)BT@(T2&$H(W.<.G@\VCQX#YNWP9@(MMITH_NVP$,/L?S/\*JW80+?%U>5@;!7K<-2% F/,#."H\H$U@;3Q6W&BF %?0''%X1R;6@UD[9->$9XOOLW?8$&NZL M,).\HR<+39(T4NB@0";\0BFB6C!%M68>0LVX(X0J/1 VIE6;<\*JX\2J MH\0B6C>HEI8Q*@%WA@&*%=(>("4U!-I1"\1K1[_> 2AM""MGA*!VF[%VCL6/ M+0+VRR0<"JEI]'.KFYQ*TV@*>2,U40$"'0+4&TVM(9)J0JU$&EN ->QLNO-K M1_:>,=YN;.^!]JH^ 9]^PLZ$G35VRCJG0D.$+$'<"(,IPU@P(9PP7')C#,?B M\+%S'R9ZY86B_ MA1':<-4&=1K))!%V-8?A-LQ5^0 B7/E27MQ.]]Q\P05)BY"H(E%%HHI$%8DJ M$E4DJFAE08XKB"C_^+U8NJ^3T2 \HE1X>HN;:?;3CA1Q[(:$(YA?VLOCF5_: MR^.97]K+XYG?R>QE-VUR>S!*_I&=+V>S\-(7(NC7"Z9_EF/AH=T]@*P0TF@] MQXRP$&C#A3=4>:Z@E-@8Q#14AOM.MY[[-)L,EN>+C[//V>S;\#Q;^5S+05XT M!OF],.+T>;C9; \_#!L]E@#TB*.";:.D&U MAT>N^K@N<^@K'QF9#'GN:7L#-AYP%C)VTV$D2Q9HOC$ML\ M+5ER8QEARF*IE'J!:IL'BYW[J=U]1F&[U;L3>B;T3.C9)GHV&B8Z 9PU 5"Q M%=1JIK&T# @&B1"$8Y[0\Y6KSG" CKSI6D+3A*:'C*;-QI!*",XU<]@(:IC7 M'%G)/>20(4_D_M&T?4AL \3 &60M5R#M'(H=5\S+FU\^3,:S^QTXK57O>\Z* M=(;[.5QQ/R6 4D*"#.4M#3JH=AA;0B7QQ&M&.ET^M 7@:%),-[P@\(PAT&HW MBH=(N;-"U!'(2@EO(MY(4.MN3A$-A%+0$4J!41Q#K +T&&FT.7J7ZTYXLP_' M 1/@1KDW0";/9B M::<<[3%1/\%-@IN7AAM4PPTUGB/@L ):4<6]QL AXX7DQ%/3W7H>78";ES)- M$YGDG9,#H(,&&"(:\HS"0"GND'!!J8+"8P>]"O*-=U")@S#5;J)$*[4H,4"A]MVJ7?1NLF"* $CXG/"Y77R6 M*-5>/[C:Z]WDP 3/"9X3/+<*SQS"5-_] .N[=Y,'$T G@$X W2Y 8YAJR!]! M#?EN\F0"[ 38";#;!6P*4IWZDP'*W(/W]T4_3*'ZOI5GAP6/^SH<+_O%BC>F M-PIGY]NJ5"H"?UMC'1+XY/;\US )HNJ*X3B@Z>*GM_DW]:CD4Y>HNF$YO6/O MP[A^WAAT?3^;+M[\\D/_Q[ $R^EJ(9[Z_MZ7JZQG)M?AMIM [!=1P.A=A?>] M+9IM]\INV[W^//S\+1M-IF%-5M].+GJ+\(#OD]EHT,O^"I),]++$*\)296&E M!KWXW6207]H/1#F*PD[XNGS\'!U:-%L#>M'"@]_KC0?CU8M:?+V;A M\W(67G,U/(^W1'[.>B[\DLW&/;><3:;963Z0W\-9-RI^.NNIBUE8SK/>;U&Z MZJD !>%C_EPU'_9[/T3W>WY7]M=Y-LUA*0SR__3C$N97!0"9A;WH__BNMW6= MR@4)LVFL4G\T6GU<7/7#1,+(QY/%ME5]UULGX,>2:TV-+3N<&Y.<9Z/1O)?] M[W(XC8)E;S'IG9>(FL_S>_@]_G]@N/GR.K+R_*P7WAAF&_Y9Q ^3B\7W^'DT M/,_& 7OS59T7<1'Y[]=97/%B6^N'3Y>S\ZO^//P6]J&W"H7H?>W/AV')>N_' MO>O)?%$17SG@__@W@2#_>=[[6HK)\16-P>7[L+B91@X;W?3.PP+$/^.\XE.6 M\ZQZ8#WG.-[UV\)E@V)+V7^TWG8U]EP%]^Z^IP30OFN0<4R_:]A?JN1]*^#P!-!M.<#-<;? M%U>S+'M['6#M:G7N%*?0T\_'$A(_AY,AUZ +Y0?QLUX0%N6SGY=/L+71B'PT MXMG/.ZL7\_P\KF98JLC:09 ,=*0^FYX@J#@,\[]!X+'Y\X=?Z +__J RP.M* M%MHZB@$5#$E!,;722*(M%.&#MPRN:J@-KF8_K2PIL8#[;UD@;#4>?(YDNOJB MU!7F6Q0 ^0_\CWL5 /;HQ.C-*F.]L#"C\,"%R>>QZR]JZQF70#ICG>-, M4,"] ,I19+ABD# %47OK+UI;?[BI>[6U_I%AYM,L/#2(?C<-Z'GV$\=!6'GV MS0GK#A[K&O4B*<<<$\NH-X(R S6R @:^@\98@W"[6'>_L>.QO(;19HC%06&= M *A1KQ,S+HQ2#F*JE54>*02]AUQ*%_ZO5:QK:?WW>-;_+/\&??XRJ8]B'7 6/ M(O#EY2P+4P["[JP_GI=4/9T%:3N:'B;GU1K\79%/7!7(WMS.%T=FLY"VVB&O4#BSM[D!KCV=&?!OWYK\"HB\ _ M^T>R1O5,HQUFCG!(%*.8&&&IAXXC'D0Y+_E=E8=73/:IGM7'U:1NX=C[XARY M!\3$"L3D_:$@6[R*O:_M@-@MU3_:*"/3YGM8ZJ4KN2 LZB,,RI7E^38,-NQQ M0?,-/'3+OGZ/+??9J C1K0'G_U[-JH=,@X;_]FM@Z3_?]B_"D'[JC[[W;^;A M57^_FI6S>=H0^T\97R_HXX$N_FWNA83$6(0<4]1)KZA!B%&(.&/20?,L8V4T MDT1^C5 <[5^KI>BO+\?M/;NUJ3DC?0F;]SD;93GQO16!F8!&4FN,J3). ^8, M=Q)CH+R#\BU^8&OW<0*VBB8/@@FJ^T9[*2WV7"J#.;5$:BLUL+$'!! ,>-<4 MBQX%)"YGPBR(2_'8*$8P' $J1EK:Y?\)XL27[Y.7W5VT:1#8>7<+ M,62U<_/EUWEIZV_L7V$@KDA@4%P;X#AB\2X"]9Y\/XOA=2330+?5D5@>DH6G M(#^2QY>5,V!^%?.+2\R,\O=\.5I$MT1^810&"ST[-P%GPV\1K\_"CI:_UE_. M>S^LA-#^?)XMYC_FKQAD%]ELEE^:C^9LY3,)/TTG\V%I]U^-*[PZ^O+F\RU3 MB/;G^C6C83_<-8P6[Q_CN5^X):HXK7!I^#"(]NM!3_='.<-^OLIREUWO]WN< M3Z-)W*8H2%>O*BS9U8K,HZ_TS^A7"7)G[E@)8X[K-!OD+UGY)->D\G+%PY#R MG0B$E0TC(45QNY"O@XXRC#+'M\ :43I?3J,SXOQJ&!8A]X6$\9YGLT6@PJ@> M!BTUR/:YT3V08IS^<&,#&!]S:S_ BL_Y-OBJ7 MV3AHT;D[;A2^'A8J1)A /KGXZMP+5]PP?-HN17K^6GX9)W_[]=W21G:S==C M2O5@,-S14M;['C!J__H*:>2@,LN,E4%; 8)Z;S6$D#@EH?#$*DYNZRO;XGQB M>,_B0[9XLIKR6%L+WRS8?%BF+E(KB$AB *U1Q@I'@=32<\RE,< ;3#RF.RZX M^ =I8<'%9KF"[MFV]AR&, %SZC%>!$_$H&7RK$&_; M\=040+?C=>-@+$!TGFW],\' M_,]685ZK<),HA1=R^6R9%8&-J_BU0C9=0\+ZVQ7>-7^O@E>"E)_C5H2SQTJQ M?VPJ,8-E+I GI_,A.)V+$-#H#+@=R[2!OS>UNC+NS#E1\$;AU(G$FH?Q#B:K M:-G2616'_'_ZXV5_=M,K7_DBWG,A:@,61Q8&: /.$4"E8<(!!Q0AP"KG(=K( M\[H7UU86KHKM]NE$IX0<^/'2*%=A.1#0,B$5D=3J\)\5VGD+8TL-AS:R-W;> MAM9\Z92]F"]]BSDD;--M\7J632>S12T*/_T$*4)2*ZAY^_7F[0IVBM#471(H M6M!TMB1QY/_T:S6QMIPQ^0? MOQ=O^#H9#<(C/GS\XGKXW4[!!^M/7#VJ(,H/RSR%X6X@6F>L*ETT:$M?A^-\ M/^UP?CZ:Q#J#T=^E1Y/S/]]L<7])S)"'WL8VM50A):4E'CL4X#5(C1R\K7.U M>.!O3HU"0H6+O=<4,!P=1-XSQ)DL^#704S90BR>_![[I98%UI]&[&B2Q;=NT MOF+*_..?[S^___+^XX?/*[):6[W'.P$?,[I=)H>>X$-LA6;?_!*#%?L!&N?G ML^'J"-]F)^B?_^]R."_LNA$)OT7QY*(,= M)I5GOV&WM5'CP+FCH!_%(_*58].:]KH*5*)3(_O6'RWS/)/I)$8H1")L<%:9 M'U::S6*NV2*[+/.,+H:+VA=T>\FSOX;SW' 7YWX1A(!)-+8%+;5R-VZ8_5;7 M#<=A2_N]5XQ%2D*&^'VW!E;I/3=GLY5 M/SXL9L^LA]GVZ\2N0MK)+RR,D#5U-1U*X?$Q-^=[D,#N(KYMS)V/?3BO[^W/ MAO,\J>>\'[.\\J"T*L4LC^V:5R@PSQK98Q%2(IBOS3?ZL2>S2INK]/"+99Z? M&"!DO.X?C0GXCXMWM4T MOI;/*0BN.9_^M\EPT#1"K_)\SB?S&"^9/^K[9#D*H\K*9+GHG*VH-TC$D["G MD2K"SOU9TM7JA@#R.5F%>W[,UVM\E;_M?DXILTHG%^&8R/7 MV:).X QCR(.W"DZI^"3<'C@R#SAJK',UX((U\O(;0?]=,7+.Q/&:VM(^OQEG ML\LHWV]0V]?"JC.IQUSF \;\M>[@VW7_SWSF87V&!: 5<9$-86*=N3:L!PW1 MHC#TY[[JZ,O/(_'SE+_2XI_S5G\XZT4@7='3BO(:JE/X,\AW@TWW1>U(^1J= MW_/"U3T<%WI@'$1I3QN$%PS"K9>Y$%%L[6RRO+PJ^68^"=/*ROS3G&>C%2R\ M/<9R]*)8'9YR%F%NL>6M_54RY-J[^U\GRT5)"]L5P;,UJ"D&%%;HNY7B:G. M14QOH,KK_#3+<7"U*_$=Q<-CL$ 1G58%RVZAAQAS, Z7#&,AG"!V1VA<^?T; M&UR22$XVN:\I\$&X>E8>)XUXA/[@_R[GBS+KM+GEPWEU'%>L51[(JU"(:4R/ M;+RMN#R20*Z#UT"4G\611G<1=W8Q:C;/V7S;8Z;Y?%(=C"58QQ4L2"[.N)AM M$6%V4>_U;8HISZMR21IO>EN%U-^R9H=5&A=:SDI&F:_MVFW>RX_AB!Q%2'2@ M@WQ75_LVKX3UV]!18TOX(I[1DTH.:>#-=5TZOS1*YVQ8'2P=<^[:3IGONV:] MWR'D<9MP\GR&VU?D)92^$(R\\H9;P"E33DLG+#8:8TX]PQO^N ^Y M,/KQ0J]D!U7.]C$VZNJNNR(IP9J)].T\.X]FTN^3V6">C=_\*.8 M_A8CG6D._TO,0RFB(.%>\_CP'CW<\<@(JLQ9$#J*0,2HUU0L6H7J-<3JZJ"J MY>I:*(XS70D*L;!_KZKL?]9KU)'.C[2UNGB]_^A?3W_NE>7Q>JOZ>+UY64ZO M'$@C(Z@P,11U#BK5[76)O)2EB[HC^8B&L^;!>[8>.U.X"\*I72I$57#,2N$- M=X_Z\T5#N;\81GHIS&&K,_>64':6QXF\&K8^R(^2UKD+FE$B.70(ZIB[((32 MR'#&$7)2F(UFJA4_JGJV*Q]4X8S1-Q7?6]3V@M"=2R(,^[/PBVY16<698Q856G%6Y.+SI(/ W5XDF3:.ZNX M(H11I+GVE%FKHC.3R%%Y.@NW\O,D>NK\-1\/\*H^?*C#1HV)!JRT]I MCUA9^&Y'191FOGMLBI5#;\UB4M35*E[;K?BYKBG@O1_^O5?D",6S8_[C3^U8 M3TIHWB2NQ@/7"FZ"6_4VX^?F&\?Q,!RMOQ,419 +._UY-AJ5O^9:;?P<9G)> M?=ZR*%^"6#WO?+2?5%48$Y_^;[<+"X"E>' MU2@KK\8,N?YTGOU4_;%A4WJS:F:XZM9)WMS=ZK!XA>!_^[FZZ/9O\)Z?[ONM M_NET.BS.8J3 ECS%6^?[OMK%WKE^W2Q3O4,5ZEGBST>/;<#"-^/GMVGPL/70;X%,N'SQ8W M9[V\E' 1 E(5M-V185M=FZYPLJ@YV0K& 4#"^:" *HH%$(!!;1W!PF+_F)CD M9W-RM6^?XJZ%*URU9WOC;-QNN]]T\.YYGI4U]G1/70YJ7N54&T4X$$',#;P* MM/::4NH QH8Q:_9MRWYT8T!(6N6S[K/3H9^@'_, N8VPHK/H0+PNO$"KPCVY M'R!:EJZ&TQB"FBO@D?#*<,KL_&H+B?/^_7/7'%63L[02&$+W#Z0P^H#/XEH5MVK^Y MV[QV%"?R#P\Q,6D'FP%>VH=7YNU'5XVTBG_N%Z XM-L$EM"7?=[?I6: M_+Y.^'O]/,[EN+\;]X9Y^%I,E!^4-9-7"8V-LEBO,]@8UKU3 M 9E&+'P@[YRZ&R1];U2C1@)P@"3FAE* K4*&8FLI\X9Y:E CJM%![;7@EFJ& M\H(R&B+E8>Q_1;PR]M[0SP??LU%)YDN1-+F% X;S7MEPITPU;?P8N'FZG$TG M,1=C$K-8RU3,V-]WG,4,S,+<.1P/\A:JWU9)RU5Q[9B@NA%% MBGNS@$)>OWN0D]5&3&-^23.PL4J@C<&1,4%D/9+OK&QS'#F[-[^**;5E \T8 MXW>[1DX3IAX.W'W$\C\1[1Z,!3SH2,*6P@0A>S!.D-!]Q@FV]-.IOZRC^IYX MJIA1W% $(C]@XN$/F7C6Q-Q-0;952\]&*+GUHZV/SDEA>YJ>KX2! 8QLB9MK\NAY@/&,>M?[=0I<7OBD>CET.4 ?]P[0!%=PCBB@D1FF$D9%6 M:LX-Q2WADF@+E\B9X/C=9L^2/>!2-[W9";02:)TF:/$Z2%$CQJB6DEJ%*6)8 M45 :< -\%()BKB@GK=\2K7%4T*(=YLEV0^0ITXF"L .1\N813%NZF>K M7(E3S%A_D$U%S:9$*V.E"#^R($S"<*0 3[06@!BJP:/Z;%1E M+S?FD7I:=5>3;]$=W8UNLRUX)XZ[P%NG>+BK)^=1\BH"=12,E9!9CJ@%BE%H MC)** 44@"M=ZK!YSI#Z=5[=I@+OQJDR!,8E7CY)741T9@L,)*B'70#!,M2.! M314/+.L\QEZHO9VK&W+P+KR*WN$V](L50%/7'#;1<8X&*XN-,^0P*M_ZN\ M]E];^$?]-9S_:W U^]=[^^7W/,UA=?6'R7B6Q2@; MIOJK6ZW3H]!M=77CQP=12JQ02CY0?_T=V,2IK^W@U%EOOOSZ?\O:4>=!9.@' MN.FOX'A^5E0!+UH!+J^G50OO%Z8+60>>,,XAEQ!A:CEUCDEG.7#62DFEYN9. MJ:Z-&KWAS#K?*-.;%^E+V;(DV:((4][]*R?? M^>1B\;V?@V!_$0A^&CM'5U6@PCE[?G76&PSGYU%3BVUG9I-8.2HL[K=L-,E; MF.2/N>Z/EQ>Q.%3>K_+[9/9G5.MR$>YK-=3S;)E+W;W!;'D96YCKJO]W5>;M MO#_[EKV=+!>]BU5%NODBD$@^^&I2@][7F[ &9_?@]F4VCM 6+EUU$7\%QJQ% M2P&8DH*+F,5'A8""6H4@A 02([AY3"3GKJV].X[D>(] _HIB8L&P*QGGK[#Z M@9##>3(6AYOW*Q18"=1!__T>Y*-)#@-Q4R-$5746RVE$-(+\Y_GV847F M#._M%_)HO.UK.:/ROL"=@]=Y&-ZH$ RWC;8\G2(>C2:7P_/Y"J9B^/"R M:.[="\)FE/@FXV*5XLI-OL:3/PZD$@)FV>4RZ%R3(,SFF/(MT/IJEO-7XUXBS90/A\*HX_?EB]9X(WHNXC1:&=.OE:^\\ M*PL;7L8;EM/)>.VIUFC;SW$E8 #' M M0T'EB1(:@B!:AVL(A\Z"6-N140O91I\#.YQ/)X&3?IU-EM/W%&26)2 _ M5C44[XO!)_='.OM?]/W,*#,1?(FT4=Z:YK!^9*%=!!TV\ MKM_=M%.5^'PQG 6N_=^@W2X*D0L!!-X]_[S:L[FNA>[V>+?N]N0Y-H0[3M)" M5'R +O(M7I/_UOT$>T,62!MI 2+H9Y1J[A65V L"O*#<&>J"'D]HLU/"IRAG M9X-Y-'S]]A%(ML_&GY=30\_U@=?),+DV=A?(Y)&(%B?P__RUDHJ/>Y MD3O(^9]F6:':YQW@MRS"3OBO)U,@OB8)'\$P;=KZBC,(B%"5V%K\.I\$<<=F3%#Y/%#A6V M=ZAQG=OIZFDT2R2OW N3C8GGL\UM.+L.'9(5P6V ]=.AI05\)D]:E'62ODW% M[S8GU7N\:(2 ,4MCK +"78:,^L%T!(!8'$W(8'_+W?";OX M%D/^AX]?7(^\>RXI;GGBZE'/*JS^N9'>5YCD(Z=$\38(1,M9=F])=6PP@4@R MSD'\'T9 >>/!]VR4 M5-]]C]Z[/]Y_^+7)[6NUR!]9 MA/PQ ]YEONC-R_MT/X[7#J)*[73C;T%[[>]@A>]'._Q\.!A&-:#4JDLY\.SY M1T9A+5@46O#:*3Z,9H^\>OX:#C[_=&B:>,OEZ+W_]''EDGKV@W=7C>^47X&$ MF&84UV'3"(;CA5+DI)'>L"C:.AW.&\FIAGZSJTTL5??Q(L>/P!^!*,*'&.DQ MCV)G;,SYI5:DMLN:#1>!C!I5$#H'V?!?OV67_5%A]5P)FN6REG[T^6SQK^C@ MBEGA\9S++XZNBGAY_/%S15#ARUN^]]5/-XT)K+G>P]9MR+!YX/W\>5UWP):4 M^=9\[<7 *D&TF;-]UOM^-3R/BF_90F*^;V(BM96%>&H=@=1R X@!0 1)1FNG M/0Y_0BMO$]/OP_$DO/GF?>XEGB\^?A^' ^EJ./V4S6+]R?YEIF^B"RJ,;#8) M2S>^+"[9YGPZ*,H:+XLO:LIZ_\&O2"L@_;WF(+G%H_6WG8EJ%\ JUW-EEITL M%_-%:2TNB#4@?A#+[X3?>XPBE61X6[+;+%;ZP/G8PG'84 F* >?_7LVJATP# MR;[].LOZ?[[M7X0A_=0??>_?S*-P>C4K9_.T(?:?,K[>U2Q2U[_-O9"0&(N0 M8XHZ&61F@Q"C$''&I(/F69::7$L,FVTB[P5D62U%?WTY;N]9"Y(3VDURPJ\@ M.:TB2O9FC2H!F-8]Z@PDC&EFN:!<6AXNX": M.+[N&H.*WH%-,]3."+N1S/?T1S2ESC#Q(FZIDCEW<0)4(FPI6BSRKMFE*RBV M$?J?R>S/TH+E_CJ_ZH\OLT+ SJ^8WUP'':L:V(?_^ORE'-,.]O+5D *.GZN-XN1S;RIUB3CE2VTH9(%T2.>Q6<3<9I8Z59A@_Y($P>6_X M:#439_U8#0-[^\S]NKC8M3KHZJ+97<,C!M8[*+JUGNS^M'E_JP M4!.R.NZRL (W_%WS=9?:H@X;S+6+&# 6EJ3R]Q>NMO*%A;\9: MR]T7#-BI>+C6=3%PL<@,HH X:K4-_Q*CF*#2"R\%:+IJ(B-,"D9H:+3SK0&6 M>2_KNUTP1\?HCX[CW&?T3VGDKDQ&I=J;$]L\#W (8\@[(98LLG9V;$.)PAOR MHK3):]49:0^%!U3X0)&0.^VHTH9;38&G2&Y+4]@\7TZ;W."60O6MQGFN4<]M MC3<<,->%[ZF,*1M-X)+$WX#QCDA P:JK]-[NM&H,I> M]'Y\'F3#>1:9H*:U0KRJF.+.J@TUE5:QJ,6-$5$FXZC?KJ?FK'QNG_K#P?NQ MZ4^'X5Q\D'K7#(8Q0BM\=[]XM+]8GV*;(\Z%/0]B]7FLMYFW;8U"=BX<%<%Q M#0?C-,SV[3 ((L5\J^"8_OEY@;Q1@FKB0_PPB,+3H*?[H]PI^_DJRV)@X\\.W="QQ'F?T2Q)9![;L;,F\ON2*@/]#!ZNAOC91BGD20"PYD +3=6 M0NAC&H C4!N!H02$&F1N,TZ,^5#C0?P_5R^F6IC^;!;W[K\BF-SBD5+?/Y@# MXM%A=%L*-K3+6L- H]_'12Q[)2*W%3#VTLJ'[8_[45-8"[%K\&HUP;/(F4T% M(JS _!6LT(_R5K!&3*CPR!K-D+;.02NY$L09Q0,?>:Z#9G"?L6SEG_AXL7): MJ*AD/NC^6H5:M>4-$&!+2?GN>@,J9U5A9HI(/\MB7&=^#L0#OA!9:@4SEX3N M*E><2S9KLD%,-/^VVCY;GCR0FV;X:_SUT ME@7=IA8"!2<."^\E1,A12IT5%@0&(1H8#C<2V]:JYZD&)7R9;)N_]X:TPNQ69:K-::/>?V7E[. D8N\OL/X?#CMCWK] M?#/R3*6&6#H<1]M=-BB2KLL$H$E,PUO/ -I%HONAM$XW\@AOVT+VK/V01MZ* M!0QZS0C2RFFO)48B'$N628P%YAL&YW5BK ZG/\+:YO:S0:T2M47G"KTC#9*U MRRP:KKM!\)L:&WZLOH;V$KPUSZ<:!CB/)8:BKSS.NC=89GG:6JYH[9NX&I#) MM4*<$.VTA%0RB@T+Q.4 %,QBO!%5^@K$1=^!(R0NNL7EMG?B"MK#LY^]-?TO M?!=S.=]^OYJ,(G1GU\/E];S.J1YN]XM'T: LV%*E8>];3* UH!)@(?9*4F 4 M]B0V4U5!3.#6D" S;)9I^=2_R0M@%%X[]U<\%I;#^57\,J_ZM4U[O9?47^L4 MY_L[PW_8]P:R.ED%".<1HAA 90D64'JDO93*"LD"EIFU3,Z'-J\P!O;_.IA- MW&-EN.=K7W$1WR[Z?_4FL^Y:M%BMZVOH- K?.J.L#VQOO+.!A#2!S!B+_)-( M*!QZ9=7-+3&9+T-)N]7'!@_V27K!S8RQEX.RPT)N?/[Q5AF76_II[EPO-?*M M&NIP<8>2&HW-I%T\:&Q07NFAWPO(\/9BEL4",_/"&ESZK_.E;>0XYF%G02+("_\U[ [Q MNB!=E/4JRB"YE;$PB!DK'U<17G3=OUG5^)F,L_B\Z\EL_?WS7G9Q41B&7&,50&XJHK, M6ORP;;SG5C&R:LVOPA3&L5C.:'C9KU9WNIS-E_EPB[IC,5HJ?V%9MB9.8#HI M6]]4RSRIW&3;U[>N"U2%+\:!-D=X%IVJ>9F;B'D7P["^N1LR3G815S8&(UZ4 M@QN<;=R?;UX0"1OE_[[U9\/)/==3B'=?]V9_9HO'*5;W!M??U)M- E 65QNC4>3:J_%T% M>175D?+8ZVS:+S IO'MRF>7CR87B^3+0[/H:5H+QBG7"0RN*B@/9X)Q(.T#7OPLU+%?XLQOUE9[6A\^5N,MYK?FQ\.(;4!V*VDQE :#4K: MHB!#@R"A "5A(S^&_ M.?79?=XU#?PQX]IE6D]) ]]3X=_;1\2D(H]8JG)>%I>;7%S$#*CP\/,L $\N MZ 3):GZV?EP7N7OAVZHT91F&7Y>B#-!9UM4\NU62,I!@OP;1JL99/,?S.\\: M8<#]Y6)R/?DZ'.4UUGZ/(R_'NNU GTR+Q^8.AW'V_:PWCZ 7P+@0!%;WU->% M5<<'_T)9M=W^%[C([#/Z) LG(C_M[_:WB]O*YTB(9:\#;()3\- MEK.;L+E(>RYB:5!1GWNT.H48F. M&,6),EXZ1PGQRC/O-<746X@\8$T5<=ON?,SGLYA\J2:S99^::+YE*P;]FZT[ M$;[?>2.*C)!&M<%M7HY\Z>LBA:7,-"L2358J4JQ?6Q1F#J)>$;D3"\V.;@JN MS+VOO0@%X:8@'\\NBUU?YB'0%[ETFH<:A>?T>U'&#_P9U;FS7@">"D^&XXM1 M >2!@/X>;\HE[5SL+B2[Z!GZ*P>-+UNF4M4IJZ@I%K@?3Q:]*!//8KV)_FZ9 M:JV'%44^B8OS=5):38.\G66[^0>"]O3\B*.W88_"4(H-SHV_ <'#FN+ M-M]^3&'E#O281YOE)TQ9;;2A0HXF\:A=!?_'JVY]]=P0@-O99\\4W\(*17-2 MGKU]K]S&*=#$!<'#VB".:2@Q=H8(KYC2$C/=D-L\]=XI290 CHKPGQ*(@1@\ MR23W &\(7J\=A/"E3)LK OMSY^^ZR%*E_!4!_J.R;U_3()<=7O4WX>#Q57X,VS1UY@H,(L-=$;]Z3S[ MJ?IC8ZO>K%JUKKHRB3=W-W(M7L'QWWZN+KK]&[SGI_M^:_VGQ]WVZ&:UQ]1W M"^^A$_03^N^6Q3_JL8NG3E9LU[R_Q)/Q[>_Y\5047^^Y>#!M7XZTW0>^W1\B MW#YJMQ.7;VNT5IP1Y4S@]*]>+N'T_@WD_QTL63P@@2<02-2PE1JZV;>^!?KP MP[]B@Y<[Y.>GZX&R',=R>LG^?(_7@$T7;W[YH1]%\^7T.2TBG[/.K]=6 M\M^?,<,'2:S+C4X+&QJC;*5^*D*@1-X2P E52&I$)564 H4=E'K#RKEN08O: M\)U9X8_-Y+XODD:\VXR(NF57.^@&IIT"M!<^ !.0'#R0\$80//+:>,2AIIS* MV##9J0 F@"*M)&4;92@>"R3WMWUY+)! +MX]&$)UT$CRJHK4'N;Y7_W9L*B2 MN5TZ>D"H?K"!^1Z$ZJYPI:RMRX(093FBU @9_E'"&(M^1O[,"3#VQI9P_Y(SC+$]^AC(-&\ !U%!G&I::$ @ 5AXXZ$DY"J) S MS^6[=@Y#++:4]SI"ONNFV6 ?+KE)]/8_Z:!\PH[BL*.#R3*>Q;MPZ9V+7+XM M]\.]//$\2W1_:'UVD>V?MQPO#'68U*5 ,4?"( ^Q -29('T #C0B #A+,,%W MNM'W*5IPU*ZX_^P-?UWB3F:'A'P)^5I%/EK''P+(F:?1=NHY=0)IA3E7! &+ M- J:UA.1KQWA#D&V1ZWJ\*$O%PK_G@?ZK+Y_4K("N3>L2CYUN&VY;'KK/ING M#J!HS!R[E%]-9HLBY*X*"8SAP''+HU!9I*R<%3&/JQCN/-)K>%U%:NY2ZWT/ MI/!Y.2W[GL?PUIA$F#'0J+C05Q[X[Z.^'P M/?)@^)[@G8BH.W1].);HS:LM%RU>KXN6%,UXY+PN1F#EY2S'A6U1K(UPYN2_ M.D[_E0!U5QHHE$?$2H9BBH^B6EB"+!,.:*:4H/?[KZH*!/OU8?$C]X8?FP^K MD7,Q^1JS> KP6?:M%.$GI>C4&7[YGL^#RO);?7P_G*^CF-364J H,Q1+$@"?$> PY4AQ M0TPC7\S;SK%];>?J25V^,HGS$ MJ$+"7O7#725_5O5=5DF@A1;U<&;66:\("HTE/@*A]R^S1A61YV>2/DQ?W>^/ M2F]-(/5'_:6%_JB/J@GP\&,>P\F[ ,&3&]3O@?4+SLY-07FCF]N,6G7[ZX6S M-)L_V8;2M73>9*BH)$OZH*$"WY-G2$DGC!@OJR.TE121"Z0]529J!Z[[[<7- M$*^_"&84M*;AQ;"H2-+!'+J7=%F>B-5N"QD47/#3/FQ3ATH,3\H;.]9%Z.@1 M\.R)?KQE JK-1IU'_.?/.2\(4Y?W>/9\]Q*QT4V#^V-GVGW[GL2U085II2S5 MV'KHJ$1:*F$94-RZH%=2O=$._E:%K75KW_8J6RV8[R1E+QM1UGTC_*N>+Z6. MA:)"]:H!8R>R"(Q]1(47%N:1/ M'B*R=X(#UB<*.DOIMQ7*EP]E>H5)J_/SV3(;5&E/A?6TJ#OZ\O/OI )Y./HA M!'BMS"^"BCGCJ*4("ND-8]Z&_QBSVK'[%<15<$<)_WO3$*% 6SJ&'6J QRD( M!+]5UJ\X6S],QN=[/EX%Y.EX/:CC=7M5@MV YV@/G)28G!*3=X-UV"@_ M@S&CTB@'I=2<2HNH$<9 K(B,/RNN-J.;*Z= MH+PD:=8N:0%0AZ[\.! M1@A17"DAK:(82RG<1I6A]1.MV@%5;, ?U?KG/\:N7_"NH^[.]FO\4=W7CB8= M1WD26H)%P]9!VXQG2T7 M^(^POI^RV?ECC 5!;,R;(-8B)EY)F&_1_44.6PW7VJ30+CB!_O:RZ9GKZ7*M MM*X)!0B* M0,-* * 4\#X0-2,8DLXE7+:1?!:SQS9V[,%,SNMR_>_J-7F/*2,?2*7A8 MIR!.I^ F.V)0LR,&1'F#O=0&4BB]\)("$\UTV#-!-WIJ/HD=A]_V> BB=D/8 MTR&X]QB[\'V6EW]+?;GNYDW4X$UFH O\(C#F%%NK@&,06B@\LHA[]US>5'$/ M]LZ@)$BIJ777,9VGVX-DIR5A=>FD/8@@2-PP#5%@@=6.(*"0!00['B/F6]BR/8_7]';]G$+?JGWO!ZNESDI;_#&9'-%R>LM>*& MLXSW7$>M3OFHZ2TC)26<3_B29S2,HXI+6/_K0]>.P)-=2N6ZZP9C-:[Z@]Z MXTDO+D.DSH#H\S#WO%AP[..T0O?)K'-!LIZXXNK_J*\?=&[R1:!BZZ# M3'^>#=YM[L=&:X [=V0_]);_T\_19&X-QQ0")! BU%L9!"6!@U9##0;4VKQ: M=[]QXZ.(A[61Z9%_7*\<]N'C%]=C[YY//JL[GQ5@^NMD,O@^'(UBM/%H$OM[ MW1M(ZKTFPG$L#&*4>B2AD]QBZKU13$+>""1%8>$!@99Q ZDS6E /I#?(*0 ] M1^S>>O\/OF>S\__Q_E\/Y\'0[-1;2>3Z7;S;.\P M!P[^[W*^R#UPO<$R9\*HW8^&_Z\0[(-0.UW.SJ]RYVE0=;)>/PC YZWT43W( M>*4?'N);V8BAET&APH'!&'&46J&M(I@RQ2$E4*D[=>Q/Y8JK\]SQ$F;:V*:= M&3B:=<)W]W(R:Y6/']SH;F7__G@*1Z^?S()0/^X5Y>7.;WJ+67\\'^6,766D4%PPH;X;'D!DNPD;1?<7.YTJ9NRW^U4XU^F:W MIC=(C;Y;:/3]*-?,PX]YA-=I9Z_(LUP\Y_W9["9Z>+[U1\M\#5=//P>UIF[^[F:>FG ^C!W=E> M"'O(H'F"<%X>5_7JI=& M;P MD NA[P/\[L3L%7ESI2)-PZ!-PB=3",$)(X)*B$ M07DEWFE'F <"4PL)1>J)P3 'CEL0IB"<@ZIT8(?]R_%D'B9PPM$VG#:*_A I M+.5"$:HH@U X:S!7%ALI,,)/-%J_##LW-K$U;F9G LGCB.+2.-_%0W<_7"H13;6^#LJR80-5]$>]O_?<^-MP MONB?8AS=0ZPN:U8GRG"JF7>&>0J\%U9#ZRD+O$^5H:B3!W*^Q>7^ML;L^ P) MG.P"1VL7.&F6%[#N2D5-.,J=,-8Y3%U@5K61(T.^%VN7_/^S]^;-;2-) M^O!707AF(MP1DJ8.U.6.G8BJ C#CC1Z[UW;/&_W[9P(B(0MKBM0 I-W:3_]F M%0 "/'23$D1A=KM;)''4D?GD69G/<42DK9E8^J*'N3MTD9\Y_X[[VM7^(NCG M.7#,U\R5WO!?X)^#[+LOM/#C/!^=!_ET#&0PS^ 65\DZS0M_L*1[WB2?^I)B M#R[Y-X4%>?#-QQ?PS7EPZW*GE>6#+DDB::(X#!AF(>&8&0T M,E0(8TSH:Y?UJ[*D>'!ER2U/?%RIR018X5_N[%5;:[*\N=@D5Q83:84*$8LM MU1$5WNF C2;6TF[7=D3O#@-]S#R?H?AB6PL%;DNGX[08 MER"ZS^#5P1D03'U:[S0M :9@4>#QV1_YO"Y:L^.8$?7"1I:6ODM1]V _7!&AK4<>T+#, 9%71)5=*Y[0Z M3>CEPKS[9'?C93'[#H+#OWX$.D$*:#]N*1X>-$GGU7/<$-R-U7Y?9//S&EFY9SI,@^'*>EYW[8?%FL!NP M#54C^WQZN8!IYU,_IB*#]2YF*:P!"+9)V3D%"8_ZQ7T7X.8>MS3_6_D6Z\Y[UJ'TM9#<*IQ943SUR=_A"*L'LM,R*[]6! MR_/4*8U [#X?R+_#;XQ[9'>>5T?P_-%DX1AJV>DB*( T8)Q7>389NQHNW[-J M7B.@/*!Z>.JWTK^X7ICEN$!5A#'YJ4U'^64ZF5P!*\PN_,6C65',0)_T='<* M;^X,N)IA,$[GJ=O[V>+KN;\^JVJ9+/>"=O=B,>T\H?Y^R:+7,-;BXM)[7.&) MNBXUG3<4L+(PRYM&$_C15ZKV]-\A\Y:4EJB7ZM5*H #9UI7']L](JWM;:XK;R70.-'#Z-?.[H M61^]JORQU1O?5WIC32-DH)&!1G[KVA6K]$$'^M@-?3PDX6AOFW]=AL4K23'9 MQ@[;/>KO'DL=KS8B?< 3'W9_V/UA]U_GQ(?=/ZSC)5M4@=#Q M#VJNASZ_82\/9WZO9B]?46.D[VD^<>ZEX[-9<5RF$Q4WE"?47X(Q$#' UP-4 5_V$*Z8Z<*4H$L*Z@E[,1E;)2$282LU"S*CL M,5S10;<:P&H JX,'*]&"%4T(2ZP-$Z05BV-E"."4EA$6.#0DWBA(]CBP&A2A MO14-ZZ_'Z?WT>U;U>';YD>X4T?SJ5G?3@=<+J_A0=7J$4"YX$IHP 3[4B!@$ M1@]/XD03:WB$U_DP]LO8\EOR_4/^:ITOO=4##D#B$H(D(;2I(P M9C;41IL8%/HDMC%B.D;]8,1'.!8&1AP8L;>,2,F2$4V(3&09QPQ'3$DJL2^= M&]E813%$.D+*(LPY908CB2(AJ-(1 M23#A:L.E=7=>'!CG-28AV&)6EL?N%'(V'8$Q^".]K [PI_[PG",4MX^/M0T/ MK)I\Q9:B94N=$)G(&+F:M"S4H106S$5L0J:X@@LW"M#,B@Q&;.MUM_4R^S3+ M+<5I7JT]V3^GT&MV.+]N=E=MT@Z3H/:J,)(Q3U@24\V9LBRFH!430O%&:ZC> ML?L.P^%\M^59!X8?&+X?#(\1;C-?8L:)#;GEB(0LQD:QF-$X(HQ&D8[UAE>X M=QP_1)0'?A_X_69^IRV_&QRR,&$HP@HS%5(MX]ARR37BQG!F]\+O@SC>6U"V MIP:X_[AZU*Y3=VTX;W?P\QOV\G#F-^SEXSEZW%UO^]6MAT\W??1C'$G M&DP2C(1%-N$,LY!R)21+PHA0$8HX4LN^:^/SXEVSY)]@Q3_#@C>ZS=7@X^ZS MCCV8P*^6T5GKY#:G>2M?7)$1?-)N2]D NLXE,- T-T2 K6:ACQ 4R*M0F M-$JP%\"F.S6$^<"H Z/VAE%#V2JUA@D9)J&TC#$ND4:1U%2@6!!FX>H7P*@] M-6,'-AW8]'%LRELV3;C15L0:$4F9(58*QF,:)BS1&J'-XF$[8M-!^/6\ESOQ>S5[VTW9_.;W'#CF_Y=5.?-C]8?>'W7^=$Q]V M_^!2QWK3$6WO,WU(O?L7%/9CG9Y!*C12*HR-Y89I$BE!8QM192(=:1I'.ZQK M+_\G')+B22==CYAS!"C5' 4*L:,41'""!LME2$&L8TZQ/U! MDAV66Y,G=,"2 4L&+'D EH@V&2A5]YI)$1XK(W5W$3",)E$BA*4((LH1H3$"7]@SX37X6WHWXG9P>G]:IFZ M4X8J$6#_@YSEAG F$-618(9'VB"C:"(V"K0^#U/WM#O8P-0#4_>&J3LEIRP5 MH=28@ D..K:A4G.*31PR,,\-?W#+O_Y8X&NJ. [EB1KX>N#K0^1KT2DE1T-D M612&-$:,@3;.8T&EB6,3"\GI0[N6[<8>/GPF//BT_*%F^FMRAPY[>3CS&_;R M<.;W:O;R]7B>]U?,[2!U7B%:KW.<:+!E>1@1(YBA1E.=H)!K&PJ-L-W(>]M% MN8O!)3U8N8.5^Z02Q(S)^ 5P_ X+QJ$# M-ZH'GG^M/"]QZ]GBB*G0:(RPTDP9J03BB>2QBHBTW.REEFM_W-F#E!\X_E5P M/&TY/DI"A!%2!DG,0F(ECB@7(:9$$:'W4\9N-X[N@Q?)WB[_Z]PEUS7?[^39 MU9)]6%S +:.5R4WR:7;<5-]@NG<_%G?O1Q\%/\[ST7F0%EF0 M3T>3Q1AL_7P:S.9P0S"9N9EDQ460^C/X[A?X(4A'SAV03J]@IH&=3*@D7IGO.? MQ[SZ16\=9G^=EK,OF5%&:33,:P!K 3\?9JZ]\VJH0$U M9L7$#\P-O QF9_[[>JVN_)U^]$5>NGMF09G#&J5%9SF#>9&.JV?">CI&^0Z# M3XMOV?PD"+1_Z(.7_'-V.>_4$"+"UQ!2C]C"]%;Z<*L*XX?G-+L<_';R^23X M4O@=N0H^P-J7]=H4L/*N0][:,[JDXO=MW*Y\/BWGQ<+M4!G\R.?GRS6M]N"& MY=SD- =^^7215NCDOZY8TO^Y'5A&F>M5L08\&[RY U;$8FW _M_G1?.0R_1K M=GP*J_KM.#V#(;U+)S_2JQ)>]=?SHI[-_8:8WF=\P7GA!,2?RD0J'-J(D)AK M%JM$,TL(9Y@(SE6,[4/F_L61F"-]U]S:;?5R*=+5Y5C?L[5-]=+U"VS>YVR2 M>2%TG'!E,2C,0H6(@06M(RH8:-$@3C6QEAZ32BC"([*QGM_[=GH+96R@]AZ$ MUA= (5O!IE>6Q<]E!]G*K9F]GME&2QT!8#CP*GM &RCNP.AYH_8'I]DH7929 MOZ!^90#O 0AP7+YVVPI\U@CML3:= %/J^Z8#AG2\?\N2A@H@$R0PT/SHAJX M^VUV6F;%=T\@'L"#T7DZ_9K5: T#"I1 />M8>U5<%;,+BJ =E?D9;D N>-N M@OE-LWF0I<44=J8,WKJ+W,(1]+.S8@)OQ@2Z':3_$?_\$T"T6^M;U[9&PM5= MF)^#;.JNVSFL^07 EUO[-)C ^+V42HOY%$8*#TZ;#^5Y?ND7I\+)-6G4?8G; MU2(#I&U0<6T_\G(-%Y]:XW#K]V"!-"IF97E<*;.CJ]L;K=[[!7[]%HYJ07J[ MQ<_3"4BV\VS\=87FEVSVX#=!64EF__(LHK9O @>SR:.(1P3N>^B=)J7Y\&W8@84=13\ M=PI#SN"95]GT*,@6Q?L_+>>K6L@SNNFW;%CV' MKU?7Z@F6RJU&S>MW'OMU>$INQ-/4@^;5J@Y;::USCS2@4 ) 7%X6LQ0XWV.> M^Z$ "?4]]8O1:3U<(6:S.,M!U];?^BK4U_Y(B[&[Y+O[RJV6<]_ [#\YZ])M MB=/@ N7QQP&"6^YT M=5]B!\>F9(>3\-_GLQS;RN>[0JF?SB.+,#II%O-FE. MOQ99UM$MTV ZJZ>77H#Y.7^4.EXY /Y\JP= B#:;S9T<<1TFB$@8V/R:1L+8 M4(22)E2&&V='HR4E?J@'KOVXM]:K)TM?G3L.]GZI6'LWWOB\^+=CA!NRNLO+C=>YO7ML^Y5->?EMQ"*XW>;O#,\J_ P__ @QGKOX!W ^$ M\BF;5/P-$G#EZ38MSY/)[$=]W:V.1GY'3X9DFTWA MCG"?RQYM"X/RP^^,Y* M[H/E"@M:R?G &;&.G&HKM*77#J =C]M]#$[=1@9O*PCQQA. O%L[KRD]PZ16 M'&2U"V23.R1K#V98C85K+I@PRI2.9"0TTC%8'Y(Q$FUIF]20V!>8[\A5KUEP!GO@G(SK0/OP0?\]#DP^ MNSQ/89T"/0*CL?2Z%*A:#WXH:*AE5PG-SLXR[P0#_?DL_R,;UUID5_/Q>MRZ M^%BW:]I5&5\K4+P7SRV97RBP@D%M@I5SC]NB1GE+'(BQ;*ZIU+!+$+Q>8:ZU MY!NUM >OTV-,&5 OEX[56L=LK)L5_7+?>J)"80?.A&7P3RPM$HQ)%,O($*IX MS+0E:$NDZ!YZ(OWW.,O__4OV-9W$0 ;SJR5,U?.N\<2A7-=%[R_.LW()@9\7 MIV4^SM,"OGPQ./9H#9+O4X,$1MK"(=<9T_#!!=@\8WV';?!>M$TT<#\W).W$ M7?#+#,8%A.8#B>Y!:8TF*_)[#$'_?RAP=Y^FO7?UGSE<+^ 0'GY3EL,#"7DS<5*7D:RT\7'C:K^-W6 MW.)B]K5(+VI/["40>K[JD 42N$B_9<$\_>.X\XCVX9ZI9F=G^:B)%,(?\W09 MUSJ\Q%M+Q;>U+.FO>,\P(D\ZR G^[R />B[[,)0'056QM7-)K^44W% M>W9713CP3G>V+IHX:>1OV<[",4?1+I!W(P?E JQ+GWI=.4"G9^[[\1'\Y;W: M[B98^:^UJVU59ZBF6CCWO#=.*]Y._6AFTZR5_NLZQLKFN(><9M/LS#G\TM&H M6'A:O#YN/&D/9CT\> RK]&$V/6XVI_(^.KW'K=E%>A6,SF>STEO7\,ANV**. M'M2NM 9%F^7VD.47N1O;;$.EG?#FTJTYNZQ6MPY1;%NQ$.&WWWYJ"!D&;^M8 M2'W]=KIO5NJJWNVY5QJ7W-"$#+Y.@?QZB'Z+7 KT)WV M"B0#4D_RD1=$RP",7T-'L/7J;1!^447KESQ4D5Q]-0ALD/ @+YS3N$OGC3>Y M&N)R:.Y)*^1;N(4#!7-<[T:KC&ZA6" $ +'9Z%OE/EW,%^YV$)TM1L#R>(9: M18ZWP!0_,L>2Y;6WN>$TDV^F#B "A#>9C3PA W!YI,I!Z-5Z=)1.4\<:*X/; MH*N?@*[@Y:=9%7("ULA\R#XHP2#)RBKX6BU(]T%'C4^\R)Q;V2\6*/= ,&&,.P%9P( MC61TW%8]%CSDB$M!D2$LHJ'"2DFX.PXE8XK:-R H1^FE2V,H%ME]P],[DMNC MM"@\##=?N\Z=.;9JLO@%5F88^;PQ$_612__I?;] ;_QG&/6H^ M;UGC+\#G9? A^Q%\FEVD&ZF8/_+Q_!S^A(F=NI!OX=+E)F!C9^^:/S;R#=XL MSYN_X1M^NNFWG?_TVE_6T\/X\KXX(N^>,RQN MRQFNV**>![[\(_!*8? GY/^WV]3A.E?LD3/?(K]N2>Q[I6>!7\?>;^\+^7)* M<>R3^V_MS[('"KC'2NR-)FRC7546TRO'@==*!<[>J!;(6QT#%;Q**ABP8*"" MNV#!T.5SZ/4V=/H;=G_8_6'WA]T?=G_H\KE']7CO,SWL+CB$X+8+CL8HB9'+ MTB6<$4,UQ80DVG*N#2)$[K +CLM]VU+^Y)_MT47CCM"MI9%5]M>G^EAY988M M[X[R,:#*@"H#JO0051AOCW FB4FP84RIF"6*&)-0 M);A.K$J8T1N-1G;?_K-OZLJ!- 4<@&4 EB<'%M$%%AJ)T%J&%6$XU$8EE% 9 MQAKS)-IL2_;$P/+4ZLJ!H,IK*?A^0TF_H0?I_7%!=>K$8JHCSDPL63;H42$X8V(93&,=-8:*%U3(F,-:=1 M3';Z1 MR9]8C!\^AQ]<-H6]9[75!S+]B^9MWO*VL8H3@A0/-66Q$LKJ,(ZEC"+7N8GQ MC>/"59E.6Z]O4V',9ZMNX<27:Z+S$WD(GKI7X/]_'3PKV]PBBQ(64FYDB$)F M.)?(#9I[:X!X8=&+9'#!NB-F='Z5B$7+*$,,80PEI&0AA# M<&Q,)-%&@>3',VQ/#>A]]D<;.';@V,=Q+&DYEC%B1,@(DE*SF(2::!/%"2$\ M-C81&UEVS\.Q^Q:Q!\FNK_=(X2]M\;GA7.%PMFC8_6'WA]T?=G_8_<,JL%8A&,<6$"8NDBD*C"$-<$;8F8BRRDEDCM>(ZQMPB+AC#B7YF5AVM] MDYJZ@7"GXTS;B,55V!GR/CKY;127M(.T'859"1B,>"14R8 MD EI)(^MH* 0Z"=E]*=.\1ZX?.#RP^7RL&U$+B,9&HLBFXB8Q8DVRF)!XY 3 M86(6;K1?O3.7]]3P7F-TAG>:(#IP^<#EO>%RWG*YY=A8);4-L68TC(V)8VE# MBZDBBO&'*^U]M-E?&XL?7(SZEUT:Y"^:A67+PHPSJY!.%$6&19&4B= DX3:, MM:$4;91-<(OXY7#,;G[$*#\AA^!^&]SDA\&= H4=8QDQR43,28092[0,$8W" M1"4@=J.8TJ?DSJ>VE<41"MD)&UAS8,W>L":A;5$Q$)+4<(8YT0S%L59A3*TA M6!"BXV2CV.!=6?-E&+CJB$LY,.? G#UBSK!E3N**!'$0DXJ'3%"EJ9"$$6%C M"4IMM%$J:)_,^<1R4QTIA7;J8WY>"_2OOC5X\_U.GKW2N_[IN[]KW]N]&=.] M;[^EU?&]G^?CUP^^^^;FN_=^W%&0+VN=EJ[8*6S4\45:?,NJ#O$;M4^KSO- [2,O@E^YY- GH4I+>VNSD*1G3_PZH?:,3 ML__W>=$\Y#+]FAV?%EGZ[3@]@R&]2R<_TJL27O77\Z*>S?V&F-YG?,%YX=#V M3V4B%0YM1$C,-8M5HIDE!-0[(CA7,;8/F?L73[/ [.Z,KJ/HY5*DJ\NQOF=K MF^IEW1?8O,_9)/-P?IQP93&15J@0L=A2'5'!)(\U-MJ5SSJFMVSM/I#MRWD6 MG(%L"[X[X;::!-.E;J#FT[0$LH:I_68_LFP:S%??X!C(?35J6KRF7O,MKWWUVQE<7L ]:?4L.[N 25[Y+"SQ M,S!9#@ S#G[/L\DX^'CI%[_*]AG#ZP@B.'CK[G,W$/3S+[]__%#ZO_'//_T4 MY 2\WF1GRXJM)K/@A&\Z6OFH:R>X@J$>%3YZZS8.IA1D8US?YT?>[DX+0'_ M7)H1/-C=D$]KV/)K[;Y93A66\/VT7IMR^;,?[U%G8?W UA;UK)A=K*YJO=B M23=,S]WAMZ]YV<9T9A<7,T=0L]$WOYSU+):+"%F!X/>H,[.Y+T@J,AT=>#P8^EVN)P7"R\-[P+\^P3R+9I4WT2->KRH23W6 MEDD4,V8MTQ;%3#$DA92&&1,;2A7GYDT7PU^GC+JK<.&[D"W^XVJ%@0\?O\2! M/'FHZKKEBO,E(!!+*Q MGM_[/?A-D(%5>>D8M@"+=\LJKG71?O]!?[#O/_Q]225KQM1=]9>[#.TQ,R/W M4'\ZCUV:_[+RCKE#V.A@(;9#)EY,\=1J$EZ(I"$88=.Z$E#.41K/OV31U MTB<([J*5PM*'2!"J!66 29J8*(P1PZ$*N>;B&-VXJ[?>CBL=TXT:!'NMZ&W3 M-?S@O14%\SR;32:S'Z#\_=FK8?ED B\K?WJW18:NR(\=S!<_7@OOW+[BGD,- MU>;3,2R%_]Q]_M3YB":K;T"5OZY2WT:@!=6__M<;MS'P&:8_:CYO(:XO^05H M)Q^R'\&GV46ZX;?\D8_GY_ G3 S4,S",72[#)+TLLW?-'QN,]F:99+#T4LHW MUZ<@5*\0]"\_-Q>M_X9O^.FFWW;^T]UN>V":QY1;NE9'VX'+^\Y4;E0?GNW;GZ?PV\A#IG, M."9M"5+XP% 8)DJ$#%,J):*)CJ,8U/4HB3;20KO1MUN25=PE[Y<^$1]G&Y\7 M__[M<^1)+VHISRX)[U='=U5\;?D<]\HF$?7+U66V&D[?=FO?CGGV+V&T5Q#7 MIUI> X"]! "C;(]N3(J])6O@90'86FZ! M($/.^_XT]#W,,UX4LQO5L> M2";*PY_)B0A.*\^(#VXLO\;-UT=!D967SO'Q M/9M<_?0:,XUJI C;TZP"6:L5EA%!(1,:2\(L09%2)I0FD3*TB&G_H5H+J^"8SMGUH2DD;9*1$(3%I+08,DP0S@6V-C$J-W+]I? L52( MP\CF?34.%WR"_A*4V32?%4 /J$-Y/NTDZN"U5*Z R>? M<%GDTU%^"=I E9KPTTIVBW^$HU[_U";-93@4NXDOG0-U6MHH5+'4(5;,,&RP M-9932:B@EL5[<'YH((7/GA!\IE*TR-Q]]\&5SMV#LV-P=@P'X&_@]>[Q/!5* M:@B2RJB0::$40DP1(622R,3@^_+Z'72)GO#Z>E%8*79:%;9_['YHC@%R$MZB M/1 4O%Z#09"6R8F*F:*1"HDE(-"9BBQ-++*121*AY$8IFQT(=-B==28GZ+F9 M/%1J,.H/34*_9![MG/=++&?6:D(YU2SA4@*3Q@+%7%"F8G7C8=P'"N*>\NB! M',I]-68\N]6,!T&\:I3#%[HL@1S'P:\N7_/#8)W?#!2\!0I AXB$&"""(J9C M9"S\PXCFUF*B+-Z#,&>;&OOS P65AQ[*ZQ5P]%7\'R2[RS83R1BI)0XCBI!E MEB'-&9/2BBC2DB;1QAF.'>@%/65W?B(.FMT/S4#_?UDQ@[5=7 *!^P.2RP.H MKU?CEZCE;,PCCDU"8VLP"TVHC+;":(YD)!B1R>X%N=L1ZS?$[%D'0"<8HCH5$4<(0(8J!CJ\3!+QOD$5\#V9\;QE^MYFU_6/X0S/D\8FX M384@RSP]^< \/7C$KO/T7C)TR!8ZD,!1R(1E,9:,1<@P)#2-#0FEB45,]I*. M)S: @SPW<$A!!B?!HLR\'>4:@0F5 MBI-]5/JI]LUM6P]@9UT[8&S(/!AGL^EX&9:@P5O[CR1@X0,S#VC@;C?N MD8,K 2/:0@>1H",H9D6D)3-*&98@3JR-&$8B-/LX:PC[[7>B'R>^JK>S)J6*AD!$5 M"7-E_I2)N056CW2L$Q/OP1703WY7>+>IQ/WC]T-S ] 3>@<=XA5;!QBW;$Y! M% M#<4)=ZU^JE1*QY4ZD8]?N,=Z#6'?[TS\^#Y4XP8=@*@PV_(%P*6VKY+-^C1R:U%!?C2H,0ID,QCV=\(6UF)+K#17L30ZPC*$WZU0"2C[,4<)C2C?QYE! MH(D-:.'/#2WXB++=M@7IGZK?*[#IJ])PF!POVK*@(HY%0@1%G&EIM=92"<_Q M%+-(8+J7B$ ?.'X([[]DNQZ=T-LT"=$I3R0?HDF(G9M&@H5K0L"&/&3>$ MZ<0P8IC$,J8VB1)L&8[W<9K05279 WQW&H"D>%)> @6R. G. PF)=U>Y"AB MAB&F,'9_1)(B@R6E6L4&4[2/%CW]9%*A=GK4M_\R_*6["?#M;@+QZ 9_\(C! M/7 72*$MI B#B9%(X 3'+(J-DBR6H8Y=%H"1>A\! KS%6'AV2.$,#\Z!P3EP MF/S.VG*C/&3*4B9BD43 X50+B1ARQ4,X"XG>1ZBAG_PNR=#E[X7Y!\);X_[R ML:$&N<=0PXN&$-&!$!XI0H3D-L12*L9BZB,*[DR1Q=%^7 7A9K12/C>&N)#" M;@\.]E8Y>$TZP(OF4]56"Y5,1(1&Q(;(QDDL;"(CSZ$)8A)"O-Z@(H\AJ0T68 M4)U$$4=:[,=5 *30.6MT+RC9[5DC@G=["+!_!D.O<*6ORL%A&X!<9M;@.*.6^ A M>0/P@,$ML!4XPA8X3**HQ5C C[$T/$E$%!N.E8YQ%"5[RB 0&^8&??:V)OA( MH0,YESRX!0Z$3WE;^TM2+*U%!NDH5$A*B90)#;81BD.,T#[:"/>$3P>WP$MV M"Z 3?JN@)TV"(*,GY"&"G@S]"^^$)[+%$Q.96"&*M+62$:*-%J%E'"0_XH:R M?50.<*2P@2?/7HD\5/C ;8=>04Q?]82#9/@0M:7 I,(ZYPOUC^$-S%N#;:P=0]<@< GC X"S8BB&DTYH@C!)& M*9@;L2:@*"AAL(M-RD@2;M!]JY;=+9:P>>*9JN?&$'Q$0W48C=(&9\&!\&G8 MRGJ+(A5SY4)^BKB>(5QSSZ>)8=CJ/70;Z@N?#LZ"E^PL"$_HK6&!\-%5@@Y3 MU>%Z"YBVN_<.O^'/:A,H@Y.0<<)=02$2M&&4N8-(:9&$D9$?@0ZCT(_!YS/#UHCC\\ZU[> M)O);XUX\J&^Q?\1@WF]#$89:%&&)8%1(;1*;&!FC",-_JUP K2W:0^=!,!OD M!H8\NW4O,=HIAO16.7A-.L"+9E+2*0$L%<.)3B*B*-$,)3$*0QW%"E/)*=E# MW\&>,.E@VK]DT_XCB.-B4..W\';8\C;3,2OV+2OHO8P^92''3XEP)((A"[53%BJ"#7:T!@8EC%! M]U"&?[=\ROF!=\LX-!OYRVP.INT8:.,9M.#363'."G\%OOPC*&>3?!S\"?G_ M]8<]9A(*URI%-$B%8:!)C5"*D29#!PBA^7V\8B-%=R$9QQ%&XTSK9#]N8 MYQ:1KTD2'BR[<40[3:@X3ZS4"'16AA&(Q-"$6FN3B 19_H!H\RXZQ!R)<+=> MG'YRVZX-2-1;&?A+5I;O@M&B*$ QFEP%E^E5>CK)'JNK5KM:3VUS8P]2E^6D MY5Z52(8CE5 91RS$QD2*1P9K@9"AQF[HLHYK;;4)^Y.51XC+W39X>N@V]U:, M#I;FJ^7>L"T$24PB=1)K'7(0NY@H@VT8NI+0TD8*;YS[OIE[=R-Z&=Z'EON" M6/?0K$^GL!T[Y_X-%N@]MI#"%HYG"Y#=RSU\.CUY5VORYWTNPXNW#CK):-(B MG5 F(\0-0S(V@I'8*$62F!M,;PPJ?YA-1_M6-?@1HWRW7NO;MKF?EL0KL-L' MD!I J@6I3OZ*CP+'EPV>43T>3A1M1/MTZM0<_^7'#TE.@ MW4GP*;N<%?.35?*^%S'O(EK5+DM0 D.59WD&V^L^G3"[S IX"-#\*"W/ Z"))OP-+."2H MOK\L "L+&-?RQKPL%T!EF2>KT>SB(BL\R5VF\$0 9<"W()\_8L=^._E\ K@Y MF0"5NA%EBV)V#&K,[ +(>YZ-'[Z;&Z.]+&9?B_2B/ F"WP"G)H%>?%V4\_6C M,-MPK &\=5+HH-8(^"\KUF!]@U1V0!D$K0W8__N\:!YRF7[-CD^++/UVG)[! MD-ZEDQ_I50FO^NMY4<_F?D-,[S.^X+QP8OI/92)!([ 1(3'7+%:)9I80SC 1 M+A4'VP=QA:=5($7KE 0 O.52I*O+L;YG:YOJ%9DOL'F?LTGF]8#C*!:*A(B3 M!&.F$FJXCHAB\$'@R'!S3"K5!!Z1C?7\WK?36RAC'R!"A$=J=12,B@QP(B@7 MEP[;EL+A6AX)?H D^9I- 38F+DY0S+[G#K!/KW8+V)6:^>?;]$S1*=.HI6O< M$BF-;<18 HJF=96<9*QE;$VX6<4)5OKCF?4+ _()X"7_TS_R"\6%V96%+,? ML.HVO81?YE>KVF=M(7^^S-P*10!'2!+AOERFFJP^=B5A\U/V?3;Y[AZ^^NK5 MG,]K. HN%I-Y?NSUEZ)9RX:0S^KU"'[D\_, .IJ.@8-?>[!X32=?JN% MH2/CC1<3H%Y0X[(_+G,0D$!C_[T PL;(<0A!*T<=VL4/JM4/FN5O#CL< M!3_.\]&Y?SPLWJPC2!UK_9@5WRIA>YF[I!,GV&8N^ZAA*2"S AC1G[I8P%]E MYJ32P_6S1='HL^-%42%/Y>CQW+MK4Q+VZS,*#8HU$()*XB@)A142:MA M,5D<1WQ+_[8.T[YFID1+GD0K/'D,7.+X$BAM7&;3-W^;SFZS;._/BZ<-/((X MR!S3+.9@:DR][52I?C=3F*?[CKCP[ (J/TB=RTGNU,J:?2>.(;YGL&QSQ[?P M+O]X8(GX[,P)V.]9;=G4*MNM@FU=0-VF9MX@"?-R0_QYQ%B=+&CG1VZ,XZP< M%?FINS8#+1NF\'ZZM$*/5E;CO $/KSEZ:P@ JLCRB],%+*BCFR#]6F2U:>>7 MZCNHY[-%V1UNC7:SY1JX=S1ZNUNS23:'YU<:O!_S,YLVV@_EP63Y.;N<=ZS1 MAA0>_+RC+IUO)_%U:KHS]< >@Y$%W.-6-'/V%J#_5R#FRM+,_<8#/1>UY)JZ MDWB.VO<-S6'KMQ,AQ>ZD*R:@IRL4*1Y*1 P7-I92;]&G.J=4_K]Z8KJ:U_MZ M/I]@.@_+I7?'"J-V8>UR77]URWJ?\S);;^T +8"G_Z+%6KK$6J?KWZ H2VA MCK\\&FV]/;Y)*D5VD>931X\P')#S *O.PW,)% 8Z+"P2:#&[H98/L!5%/MHD M%M9V0L":J@C)A$F1@#U'%8NHBL,XTF&22+3,4X.]O(E0_EE/)9W_.LN=3?4E MOUBCF*B6\Q%2:^+]N4AG7?R"JC5.KT ?7E)#O8*/E[SP7*<0?G&BL)*]^P8$ MUDG]95;1A,44:\Z41F"]QBH"^\K*1,?)?3/S[\#UOWV.O&A^&L[OJ8IU-]'3 M463N)H'2?DG;'KE5B^PRS;V"^O#]>R1;UB?R;^7.3BZ 48F*.9)AA"CC3&I# M9&@MPF&82&4V<@$^P2ROO ;Y\6R30RN4)2O6U/\N)G?!6XU/T/J15KRS(ZV@ M8JTX)_A=C^6@+1?O6NN;,*> M9[-% 3;]?Q9I 7-T4_,L_'8UYAQZIT8GD)U/J[V$3S_=S*D[M1)N=]++-B.> M(IMHC4C,73MUFBB)1!BRT$AB#6=[:(GR=);C0_WFY$3MSV\.Q./BL+?JDW=W M7?2-V6 \DY4DVH:-0$Y6Y.]F:H&_7)Z-GQM\@*F6\)=))U[Z?3[/,H\CJXZX M"HER'U.L9.]I[2-W*%3YU2KW7^WHK_R;[;)>YQ'T#KTJ4R.K@:"S19ZQY\$D M2T&ZSZ9ULL929I_6@R[]H-V4.D&"!^C/>\BQ<0P4C/-RY'09F.]ED5WDBXM* M@:DVJ5$\1K/2>7?=*=S'*!%W!2/5"3Y$V@ 214JQA)"M3(AIDQQK4D2(7RS M(O ;_ C;#T,81_5$?ZUFJ:=C?VD]0^LF^"&[?Y[M775;N7F:9V>JK=NO_>]) M&\7%!O['+2<"P6_(*BVL1,9&<2BXC38"0KO?DYO3"N^Z)W@+IN]L3_J&P(^A MD1WGD+G,O/*RB@U-'$[#V,[3[P":638-IB[D 2C^-_0=4<:] ]VG^;_[V<1HLV33 LHEJ1O_POH#++$AJW>'] M^^#S27I2G$Q.?"%'EZ<0I=/4)15X4W6:UN;!^_=MED(:_#B?3297Q[,?4UBB M1A$I%Z=E/L[3XFHMN?2HBLUF?CWA:[_\/V#DH!@%EPLP849P!U@G;H7AUIMM M/.YS*_RD*GZGRO-I58UR! -K^#?H9%_<4&/2J3^KL8H55*]#!K]_V8A9?:Y3 M0"H76"M'2I?$92:ST;V^7]9I=9^RV ]@4V6N+;!*V=24'-_[DR'ZG/WC5.G M"DQ6WXFJ,SF57!AEDTG]JX\HN,^ERRZK/V]!!Q?\*H,/V8_@T^PBW3C! WO[ M-9]6PTL7\UGS174@R'_S(Q_/S^%J6(WZT('CKO2RS-XU?VR@UYOE^ M !5YW\60V]4UO=11?UWJJ-KKJ*_SK.'.:AB\5(*H @_-P90F)!&XF,1 $:^2 M(IP=Y^$!U/BW:1G\Q2EYZVAQ33'V0R>.5TD032I5$+U:4'B5^[X4!K]6Z1U^ M_\O@+9AV:5%D:5%N0X%74RO;N1^VM:MX(@YYOH(Z34K1'JIAO8"Z3HKBMLJ_ MCA76+ X5XE2R6'!"#2<2)5%D0[11D-02/R"II>NOY$X7EG1*FT G9R/_@ M^TJ8NGN=..+ZP1QT*>->@5VOA.,AUG93G6X $:(J81IIHDTH8V8D48 !1B?* M BALK.?D"\68AYJ&26102"575@"26&FCR)!P(Z-ME=T_9>/LXM*]Q)ONU\%(=(@P MHM2)I$_23W# D0%'=F6G/WCJ_TR+T7D=RR>\[TLP[/T^]KYO!6V?(I7%I7H\ MH\>EQXZ5EZ/Q@+[?UL66G(5*:ZE%9+@T)G*9&IQ(0B+*6"2?P7\2;G1+)O+P M'"B]]9,X1LE^Q\.%;)P/\]YO].Y(-P2VP46T:B"%-DXT2BVE.#^@?O[;V56Z?4]F>FPD\_D+WA2K\G3.!(H'E(W7EOJ!D&B+1^ MI$%&13Q,5"BQ 9T"5:X'&BGGB'@&UX/8T%@H?G[7@QAR-P9O^>%$7 F2;:4K MI33ED4PB&2,;*@Z0,F+@A+< M#64@9;6BB0F-(1%*>.R/J#J'B.52;!3->WJ'2&]Q1*D3108@&8"D=Q/?BT6^ M7HV!XKXOP[#_^]K_UYG%0=60Q?'"LSAPV%;SIAPG FF.(L04C['$)/2NE- * M$8GPR5TI^(1NZCI[JQL\9'$,WO^7Q+E,=LZO@=F"DYA;K4.L"4(^XQPL&&E% M(G=6O[BWO/PHN\4-;"U?&'C'AD9X,.93A&)#D%2-))YS! ME:*8<:U"MKA?@K3(@K/%9'+E6[(LIC#JIL,D M?/=UD18I;$75]*[3(6:MX621C;+\NVO\DLVW=)W=\N*C(#USW2Z7K65@ =H. M4E/R'[ M:WGY]DG;FQ(B.P>LM0FQB!*)$57(6)Q0 WLODDC%480W[-F7O/3K]F@5%6GLJ]]&O MTWH/W64+WT69U3?= =;<#6<+USDT<,U"'0$U[[RE(1F\ONE95C??ZMQ\W4U' M:PU,74_A[UG9].U:0>-\VFVD?)I.O\%V7L[*O(+;O\Z*98OQX],L=4A[5#_. MD=CQUR(=9X'O\.6[FO:OZ9V_?#>[DZ;S(3Q=5N^E="\O;H5+ACIB,%3.8,!3&+'*MO5AH-9=,)=*UA6Z@$D#L MW6> E=G9Y_EL].T+J!]E]?C2]?3-81/]?OH?0!_(QD"[#:Z>=7!U=D=<=2U[ M 5?'6?[O7[*OZ20&K6U^U?:3K@BA1M&RF/^[VUK87PR\X"]W/WYN6NKE&\B[ M_.G*S>]C-;\5^'W_Z\<==IG>]!7N#'8] M8KXR!VU-T9W\ZX0Y>N:Q\6/_NK MEM3HB;$L,]\*>/DH@"BX:%IUA M^Y'/?-7WY,ZP/H&3SJ>YB.*[[*7N"OZR: M(+@&>&"U?*UN7[8>AGJ@,,N.74OYH\U&K9ZH M)[#BP5F]Y!7L?H>]\WTL&Y6PT:5[[HU$IV4Y)>A[-<.]2R&*NCXO97WT/K(AT8H*3AGPH_LJ M0:'=*,GP"UA+'\^LG^:2P%/0LQ87IMDVF[KNN/.K9^/1U>&ML,BG9JO6IG ? M)K_QUJJ]-RAH:_=WV?]+S?[/*MK(/D7;!H]NL,B25=]NX<%JA8,[>.(;E_VZ M5;\9@7ASL]6_B\3(]9/%_M_G19N<^34[/BVR]-NQ]YB_2R<_TJL27O77\Z*> MS?V&F-YG? %@*-#+G\I$*AS:B)"8:Q:K1#-+"&>8",Y5C.V#@A(>: 'C3R*A2(AXB3!F*F$&JXCL+?@@\"1X>:8WMB-_-;;PULH MXRG\00V8= 1/PPOGZ:/UM%L% F[3,1!2BL4Z(1'8JT(3Q, @X582J6,IQ480 MI"L0!L!_!L#O)HR@%<0_!O!UJ/]C5HP!D-_\;3J[+5GD 7[[5EF;+>:P6)7C MNU+\< TE8;E\#]UF5S1G'L3JEI&<96"Q2R1!@6;A37Z5!OFX#U\>SCCVE6E.?Y MI7;2KN/_W>[7BI BPOV]J_PHB4[X!L'_92<.)*#K%?\C?%?3^9$WK(&XG5E0 M+B;S5<_^J$6XLO6[3KWK$\3SK,BV.ER[P.@^C%W4?!R8=.+=H9_/LVS>-XX" MZV@T68Q=)*T# PX&^\AKS?A^^,A;%;C+_>)6)MQD M]]SP#KY^7MZ-:_B-IJ MKV'*P^,HO:I6SY%?XJS/WYWUN128:W/*UT_X/+?.]'$:Z,77!9CUS?:O!]$N M)VD=50@^+RX!B[*Q8Y\U052;Z'NWNCM-+ T3+))@:L<<[&PA:(038U5HF6MB M*3:JH3[Q=J_W!\W/T[G+A\I! M;+@\B!7:)N%14"Y._Q=LFL"[G&;3VED$&PVRP,?A?!IT $]Q!%]D_UDXEUGM>Z#ANW7#IY MYMXS8$ M@&YTO"3)(OZ?YQ#D\CH N@5PFL<#P0++,P M2Z?US.MK+T#-RR^R58&UYE7>.U&S-BR#N;/N0RYC%EDNE$$1 Z*.-8VT,'HC M&/DB!9(&K0>4G@<2]6>7"":V(C,^C\VR\F,";W$K! MBGK*<[ORYUW\MTHMR+3_Q E; PTT'3NKT%Y]<$YQE60#R$9X#<]BW M'X"UP2&+. M9' HDI$(QR+A(VB0"7* $61MU1=TJS]G&5 );]3M@*KPIR9K3 M6;=F!YSY/-GS;+KBRH/_W$O.>4X;^7V?!XZ^J^=V M'UD_ZWJTJ&3@,K!;@Y [X3!>9%6V5WI5A1RF6> 5X3/@1"]W;GETS7Q+89[7 M\X*%6E.6.^ENUS#RD?.YU+C1'JS8#D1'#?K \VK)N)Y?U^0H;^8G7SN"1V0I M]\N:-^M!_^V('[A\YC:@#\M?[7OY+GB+?_+9V\L$ZW"VM,S=@=W[QA/06 M;AEG9S#%<;/UFV_Y:?TU\/]M.H'+(FCQV#T!%-ZQPU)W_;'/Q_8G7)S ]4D. MDX7S!UZDQ=?<[\]I-O^1 9LQ><(\-6.$3I#+@<]+V$=X#I#+.&NVT%.N-Y66 M)#EQ><_+/+9&FKNTS>G7GX.WY*? ..+>N@3NA9\]IS@UKEF7+ 45=Q^+@T7R[P M9>K."BZ<"E-9/YVT%&_S./1=SX)IS'88I3/;\Z)*M =$=BCD\G6F(,]:U=*I M+QVB#X'2/#M@TG^I_;\B)M6ZR3P)\_F52;Q3;AR%+@;BO'$G1YP M_H8R_9J]!(A<5Z'O )"USNJ)\UJ26G_N';B^W?K=@*/J@"/;'3AZCEH!R"=8 MA!Z X-'3@F"7RNZTM%L!\*CZ&F[R\FGDW2\=8JG\@NOT\7#R.-DIU-$6ZM S M0=WZ.K\$H/MRK1+=[,*ZUGP!)H@W0])NA'4,0@VLD+0Z0YC/MM'AV?+9/[GE M0">^<'6$[N@1FH6O.0 MN..0ZP?:'5_EA7-HC6"=5PZXN[=TWPW[ZM$#_NN.2):=1**&#(!.I@[,E[]= M.9YW[@UG6E5)+LT9]R#+O6.J-K2VS\=E<-7OO&'2=:0D&"W*^>S"O14(!T2+ M2Z&HC>D?:>'FY2W(ULAV! $X#-<=56/WLP3:3GW*00[CO)C6"^NLP[.SW'D; M7%S%?9XZR' ?EC'M>L5OV)REU]N;K=O]9NM YJ,_+NBZS5EVBUWM2@@L2@=U MZ2F,LDJL<"_YFDV]0!S-BLM9)707\%>Y<9"U_QFC9,@8?8Z,T>=/^=R2D_'W M"L!FA6=EYU3L+<)[0.X [IJ^TI3\6.%MYU*OE-K&95C#L9-YDZOCV0\GE;O8 MO(0DK+K51@"B2/=S C:J#R=[57/]5_C,ND528&CPE>A\!;B>=487_GMY6'\S+>7[MU8@VW##MZ_;T=, _N/!-0B9[K4 M:RH[7VVNZ6?09/X/UJY*-KIAJ3H7;BX4#GX'M?K#!B6=KS:'\=^I M(_L;!^ OZ29BUV)\ZZ(<7;M6[2_=J;M_5E[D1>L*"]2GH5?5E,[[;2WVJDH3 M>C)I=(PUIST8EG/0I3IU'CI+D;6Z"5A469UK[>7NCPP>F9:MVJ+A+J<'_>J2 MX.JU=Z.>N=@,L[I2!ZI29O0?U??O_XP=6K:,H8]FFX;_X6+8HFHO+@L-,4!O[@FX\OX)MS M9VKG,] :O2[9HZQ1X%N?,M()A%T30ZKVN0Z+>4$'#%A]6>5[=%.;'G\4_=8P MK^H<^;!1%$:QB4*!&:-"81SKF"4Q-@3;A&T[D]O&=6TSI39,^AG$2U:^]V"# MUPZ%U.'>W[]$MT5G_U]6S.S,!1[=,GWVE3?)O5JHUD/+0='<&J,M_3A7\C;H M,D1+;\XM5YO-2 )GJI> 1X\_/N<'=E,XLLD\/W)(&7Q/)XM'<.A=$X94V\J* M<"YEPA$F1C)IB0XCH942KC5=B,Q&PI#U8ZZ."*3%QZ*J^OPO-^Y?L\(3S/;3 M0ZLY-NVU=SD LQE61[>VD+G_9CGEUF_8JM-BN5U@E&>%=QRF?X#9G)Y6KL(G M*#<1=AHF,V9D0B.JC;1,V%AI9;GE5'/-8R7M>B['C0S^)?W#@!%^EL_CJH!? MCYG\H>=CU1Z/OY?E#"PC)P:6"L[I;%:5L7%44KF*Q[F/DSA=L/92M>*CDASN ML,*\+I]4NZ8[J4V7:3X^=LZE]-)5TNH>2FD/L32[?"??R3Y](5MJ;_I_I9ZL M2T&LC4E($3*(81X"'6,EM08"MIK9Z$W7<7!7M8F#UK0/I>[#QR]QH$X>RN!; MGKA\5$63'Q8^?',=UVU*["+_[AU^+0N6>CK^1S;^"FNA@;Z_>P,@RLO19%:" M8NT\*F8"T"XRX.9+Y[\K%MFVS5M=QW_$T=_??_A[\.63 M_O!9VR_O 70"_2$*HOC3^W_I+^__%0?)^P_Z@WVO?PG>?_C\Y=-O_XP_?/F\ MI,R5#;B[3^HN4WG,2I![N+3X_AU$"Y>W_V"$'!6SLCQ>IE&4/])+@/"&AJOR M8T!J. M1X]=]]%Z30OSX-OQ6SJ*IEX9X(SIJ^R MZ5'E7J_S?$J71Y9.1R@?H I?-B:(G M*Y?'><9H>Q0.&T9BP0S\U[ XXC($[92'"9@72&N\I?U#LPP?9I6>K@PYVD[K[D0P83:2"GOGB'-?BV*, [K,'GT+8#:RN)\Z=+M_+3 MDF78JBU1C",,>@I*&%A.3('TE3*.<"C"D%BM'D:6RY(8 S'>DQCW>$IFZ07? MAK" D1?>J]?UK??K['KE=BB[@\[ <'0ZO6.:)A._FN/-+ >"H)LWT;T@G]Y? MXSBJ,_4;/6MV=E9F53I,#N)RY,W0BBBK0_>-P*LTH%FK0RU_Z0YI3>>JW2^= MY_F\_LM95?>MW>>\I6^O.12NM/2XFF,Z&BTN%E7QZ%KR@V0OLG-WR+8ZE#J[ MR(*W8"25/_E"W,ZE5;N!:Y>/R_SSF5;K,Y\WOO2-:7DCON(L4 [_=U%-Z3H' M8%%7MUY=@.J,1%Y69W ?-:E[E*#PCKR+)@'E\Y;5B/UJN% 5Z$=@EC2TV1Q8 M\#>N3<5KY,O=F:1EF9_E3=KA?:?CU,&TF/KLK7$;T*AC"DL27!X,J9,[Z\?, MBJ9+Q?(X!OSI5+)-ZEG>V]SQF+6,FS'7-6J7Y02]XZ9>DU':G/G8>'$^J@YXU0LI[ 4#:\VU!BK;$\O9GG<'45:S?LNF83[S/#]H"C/U25E7"C MO\X]W"4NYV>^1-/4$>=2+)Y7_TZJ0]DW@AO'7'KQM$A/)]D MNQ:.KXQS8N![I>"L7<$'#^0%;SQJ;G_3*]\GD?/L6=1 M5FZ MO)L9<>O^BDJUY-;JNH8014;\DY[4+5<\[#2'WET1RI;Q>84*._\(BV^ MK9>V+=J^%QL' BMT<4RWFH4QS]UAT'F='N)WKCY3.+^A7\FZM-PZP36_C$]P MSD?GJP-POY=M5KUWQ*P]=R7CO7J3L^P]N3:LO2RYV\58Y]FIFFEXQ=TM:)4K MMOK\BN3A.7DQ/G;(?U5U5:G>Z\^^IIU77K/\L"0/5N*=4VDQS6[S*-V\W/49 M_FEM@7:.]^[;S=K"+]YR]"I^?6R,QGMRU\&[77UIIRWH<-IB#ZWQG >%L+QKUV) MX/0Q@'-(\1OOJ]J"AO6Z/R$6-GM?@8JG^@<#QA[P8?M1@J<<0:>(4 /26RRV M;KMN$.VEWL)E_UCGJ^:O/K)!66P3^QM C,?HEB&8&>KWC, MM"7('(:>_S+C!_NV'K9XS:_SCW9M@.WM/)X8=JK(NA!)[>:.L:N(?P-8/%^NLP=^WBV+%S]:U9X-@=M MZ,;C7!PI2Q&-E4*$Q3126NG$$(PH$0EEW>-9CUV' &Z(@]BO;EQ[./K6.A79%?9U520NG=W#?.-98AEB"1D)*\=J,FN M:;Z\![[4Y6(^VO?+G@8-!/HVU8]SF>ZN6D9=RKVJF?'VSVZ*M1 O?WK7O*)# ML@V%.FI\AQH*=;54IM7G+DU/':Y,5JG:70-D6]'=*)M,ZE_]L7SWN71ES^O/ M6Z;U);^ G7!E33_- +36I_E7O]]+_>2!?/FX_=OXKEK_5HJE<(^I>?FXO6?\,W_'33;SO_Z6ZW;9FC M/RP/:F"]3*>S^7QV\?/*YCMXZNYL]W-U_/N+5X(_@?K\=0H7>P4:)-:6-;LS1)RFHV]? M"Z"LL0/>6?'N3Z-1!@;"OE=J;Z6WDEIJ?W%2^_B?7G3^6KF[8B\T-T-6[QY+ M=$^YAD_,>:]VXL/N/ZN:L0=#*ED/$FR2CRT2'2F$>848),D)C$TN&XB2*.)8[.\G]HD]BLSOZAO$19VC+ M:>PUO_ ]J&KOI+XE&O1:E.$!EWJ&2R%N/:D,\$A3JXA/=[,RPA(EL<(QXHG M&Q44/SJ7E.UZI-Y[A]1OTR*#N8".WT#$QVF+(*4N\M+Y2GU$M])N3>:"X%_2 M/[97[?N?E:I]KP+50KREN? +A+178LMM4=#6C_K6\[S M18"(/$*"GO =XLBU5-A;G>E@+=Q7#QZB+=FF$\*-PF&(-&=$"&D2&L::*AE: M%*V"QW5:B^/73XAG M] 5\5 L^*%$ .I*(,**,BM @2SBU@C#+$\WBIW3G]"N][^XN'(9VZ\*YC?1Z MJZZ\*JWD!>/#VUL 0N*VFTF$.*%86&V19$(JJ6PL$AKCF"I,8_UR_"H]AA>7 M907?W8@SH)/MZ[/K81STSH]:#F>5B&4G4K-1DK&%(I,C!!3.I*:F"1B MQ!70P))&JXUM&LA,I^,54_,NRN$N="]\1,B.G40/)H;G)?S!Q32@XH"*.T5% MII:H*"C%DI$846R9Y$HF2%-+$FJYU)J$=_'1W:8!KT'HPU3B77B_0CP@ZJOQ MG=V0R/G!'5!XDCS.0Y>*]CEP>AO&L'!("7U1*:&]5:8.0&=Z%1PO MZ)+C*>+$(L(5,YSQ6!M*8AU32\' $@G#SYG'>6?%XJ#P@G Z'$1Y43ZII\_C M/,3L0SZ3VBUI(R\',=*CZ'J+LFB/.P'8!U@%ND+T:3ZE2QZ>-E/!Y+DA!&50^[G MG3.5>IF0] I\20-D#9#50A83[?$D)2-F3!03%C*E#$ 83Q!+DCB)H]BJ?B1F M_KZ;Q$S*3^@ =UY3^ZLOB]Q\OY-GKY16W_SRS5"-WM%FZ)EFN(/]J;_JM MC7@ZO66GXYM;(?GF,ZY^?Z=@?[JE?=+VWC[+0N)E769^K<;X1_O>_0?4@NSA M=;SQ(YJSI&73#F&>7=0=*+:T_5KO3527,M_:R6I[(ZN3(+AEES9[8Y1;%GZM MG/K+6>NZ,T738?T)WI MFMY,5;EY>$9[TTJ@:J;K<,Z1^M%*:Z5FG\_3[UF0KK;/R&4MFKOD0U'JXOV%U:D%:6R<0# M[G5M>/;25[?SN!6'TN'V]@G?7!\.5]$KXM<@N4["GZB:)M5I;F;3>#S.O*6(H4=Z+_(C;G-6XZZR63$<6C<"$WZKQ=,AA*"*^J5L0W#UOIF)MN1$VB5ELK0RY M373"8H&M31B[7K?XI5WDQRH8L)6^K_2OZ96S;$'!J#>W\XX7I&#L.HNR=VG= MO>IGVT<%XY#F_4H$RA8%8R5]Q_M(G?>TXV,=O"NO0O=\\[=?9FY(67'QRD^J MN_!6IQ208I0GV%(FF*18A8QIA&.,$,5&X]T=5;]5@7#[\P6VYX4=-#V@@^E/ ME%WWW.&Z*CE](S_K^@A>Z>V347WM:=8F-;GXVL.2D%SP;ELBTA3F&V 2^)R3 M*N? I=>X,""\;I1.YW?)!MAG=/__9^_-F]M&LGS1K\+P=+^HBI#=N2]5;VY$ MKG/=TV5[+/>[M_^:@$1(XA1%J@G2+O6G?YD 2( B)6Z@Q 5]ZWK$#4!FGO,[ M^SE+3CC_)\F!)@/,>F M]9H0:JR1Q'$GJ8#02N$1?5=AT( M:3)Z.>1.)$5(8P>9M)0S)Z0 BCE/E()2(UX+N7-)B8/4(1$/30KI#/&46XVL M0=2C ML#B:5=-=[X/HL1^X5M?N(5_HE2*5OCP_IO+.\.(7X66;#E@_2;KGW4['Q7/Y$$#7E-TTX MNBS/!GGQD)1V@%M /-B6I591Y M"05'TML7#VGE?18/:75&RCHGOPOAH V2.QJ!B"*7HT@QB(@O9;'BA_27*HRF[1: MB=ATZ6*Y O4M9GLOZ3U^GM6/9W;XS_2=/S3WU*$V8-\'$2SNQ7:U@7NCF149 MJF>*%RVIK$$J(B<5T9+**ZSUP$GAK5%C@^UIZ>0@(>-\@ZQ__W#Y8>:W*/T8 MAQY8/5Q^.QS:.52@:4FC)8V6-%K2:$GC_-)X+M/1]]YUC,5DSR3QO%[B3EL' ME3_V"WUB*1 H%:C6DYIH[BV!1FA!#61*$*F)MDY[8)U::!,['WZ-$=F2 &)\ M]=E1J,\$>B\?8I'Q:"[]*,]:'CW^]]\OFXL.[][@L-&$HD4N/02B7]:)]0R\ M+BTZ'1HZD0J=! =&*"RI4Y)JB@4%F&NKI;0(>L]V12=Q(NB$6G1JT>DP#NK4 MT8E5Z$2L=I!Q"S2A5).@0FELF>"(VYC2Y1O0G9Y/DCL:="*-5H:WZ-2B4XM. MSZ*3J*I0.1?,":,5\3C $5"(.X@!U (13(!I0' M=U"==N7Z*LR0H$IIAX8;[[FSP! J+5' 2^6QXAQ8)]P:F#'=[I-V!R'T ;Y& M,?KQP,E!H3T:!3%B^_V*SXQ#OM%& A:N.1 368(QK^GZ+(:X&M9-A#(;3BWBV9 MQ?X4+*:[_#7?Y,\YSR[M#7PZ?@\,&VW"MW=&..,IG>? SQ" 2OHS12Q1'A-' M-(70:Z@MQPH82"33ZR2R;<30I^&)P+AEZ):A#XBA:\Y$&C1X*SG5#D(J-!#> M*Z&=:IJA3\-:E_(T&/IL\@W4_3 LZU]%B[;A39P\.4E&O:2?3]9M?7C+0(+5 M0H@(4\^]"$8XH00ZB3$E#FOG=&Q'M]"@<1$DZ@?P^28? OVW?*;Q<9OEL>-H M>.]EUU[KV6L# RVH%* B0*V,A%'$A"#>>,J8ULP+H)!U@C'D-&\65([(-; . MJ(C7&;S1@DH+*@A9U%93)Y2&!DJJO-50.437R%;84%,Y%FMF M'5"!S9HU+:JTJ'+$J()@+0,;!D5% . @H,C9H+H@+332DBA$B6Q<53DE5$'- M#OXX 50YM=2&I]Z5AU%O..ID*WN0G(2S=360D"K!02DOK+:2HP^$/K9PU M3 -L@&5KY&+/ \F7N-.UBC S2KN]TRWQ &U-?1MX.6HL8!46$ (9D0:PF V) M@Q:A.5':.\V-QHZL4:B^)18=*2.4A M]]XSS@Q=(T]J>[W@6&R-%[&@R1!+BP4M%KPR%B!0-;#1V& *B4,*.+9= M9GP\N\?;]>U_RT8[*_=G)3V]M$];;<_IL3Y5ORX';IM8>.VAOO>X6G5MT M?AF="9^ALY5,.NJ\#I!-M03: &N09MP9Y\,?#:+S$3G1UD%GW&SSDQ:=6W1N MT;E%9X@8K77FA8) K10PF!J!)3<(4.*!]9HQTB0Z'Y%;<6G5MT M;M&Y672N=28F6B" 2%"3B:%0.*F!D$9PA2-&NS5J?#;1G4\)G46CO=1/#9T/ M:@3Y73&1$X'PS=<*7+W.0-B#6?'^,T[C=-Q#G;A;>GWYY^>_KGN?#V]$^M5JV=C#V_D&/(CB6L2L#2Q'M% M+%)$2>J0$Q9'AV4<0(N5HFM4T#4\&GOZ33\;' MMVAU<&@E*K3RA$N" 530<8H@%,P#XQ!G6G+B,'CU4=G'@59-]@MHT:I%JQ:M MGD4K"BJT M T0(JUJ[<4VPDI89IQ5Y_]/8QH F4S59+M7#2PLG1P@D#576\M$Z%=[67 MCE+ K )2">DID]1IB=:H\&EZ%/>1P$EKZYQT2E [F?LY\$"B\I, ) SEGDOM M@_9!M<>*,2V4A\QSM(8NLM_1W$1@"X_/26TX:OZNMXIC 3#7'&I#J8+42O?6D[J/@K]AHZI"R]\M?^_&WS7/9)#1F& CE"".,JRE MTM)X!ZD3QEIGWGIP]S'P-T:-]I9M^;OE[]WXN^8KY !!AY77,O TY$X*I;CQ MF!/.+=!KC*C:[QSOH^!O>AKR^VQ2'=JQWAL[!#FHQ1<(A8X)Y#TE5 (CI<<& M&H& ),#HMQ[K?3"0L5X#S3;HT 8=6HS),095&$, #?]Q[CP,?SDH#10!7!CV M4"EFUK []CKE^Z@P!GZ@+<:T&--B3,286@XG,\!8IRW E-DM=2: XXM%EQZ MQQH>SWN\KHWU])@F71PMQK08<\08PZKX"-+&:Z4EQ9Q1QYBF5%/M''(*8LW6 MR!/?ZPCPH\(8TNHQIYU1L6(@>#Z [HS]MEQ4>16 4J>(=\1H3#5 VG/#B<:"'Y4$(-.PY/;1FI.@^-%+0T3(NX1(TPHJ2ET0"-NA>7.(F^H@T)@3QC$PH1O:G>+<>W'-]R_)8<7_-(2HJ],U1RR0/'8R^ @5QQPK$V%EAU.#.\CXSCFVRU MT^9G['L#S&0T3GK]2#N=VZ0WZ(S2Z^'M('RC>XX.QY4(4L_7Q$A[1JU"% 8P M01I:Z"4U1#(&)5C#2O@ZV^M/Z3BZ&Z.WT4[2;\/:L9Q6HD8=.OZ5CH;=)+N+ MDDD@B'Y]#9?CP2H1;93B9$%#5!,V)2%<&"$(P(HZ825TQE,(PEM&$.3W"!K' MZUQH0:,%C7,##0FJP8^242&Y0XH#1!'7&GL(/#-4:.>97\,[L8NF<:36RHM9 M6K!%C18U3A$U4(4:&G+N%>2">T\9$4(PB"U$ 3,P0I[N5]4X =0X+U7CU#(< M+M/QN)\33%YJTJ!C8V[\[^(2=LMWSVFX"MVC*V<;XMRH?NYMN;@OK M+:QO!^NUQA:$"DLLMS@@.R6&*@^%Q$!!*B!3ZS3HVD1;/SW'"20?0(OK+:ZW MN-[B^IOC>JVQ"$><> .P%YY2$P=D(P-$K#XVV"&^1E1]$W7]!'$=-]NEZ-QQ M/?>\_V6[_FER'RY_G3_LU*&?_[G\X:_3.)WL MR>+Z@33>WZ7YUD$$_MS$ZA!]LKS\W[O1]"(/R6WZ_FJ4)K^_3V["(_V2]'\D MCUFXU5_N1N5J-GO$9)/GZ]R-(MW_6^:%A,18A!Q3U$FOJ$&(48@X8])!L\W: MO\7SBRV=3 2!06T\5C*_'4_/[,DAY]#U+1S>9=I/<]YZ3R1%2&,'F;24,R>D M (K%(;H*2HWX>_1N&B$L*6-##7,!13Z/PRJ_!$P;S;Y7@[]G@&4>-2^O[]+N MI)]^O@EH64/)+-^HN$#='U[__F[9>CEE6&)K:?C/6""U(80ZJ@7D'%OT'E0E M&HH12[Q2'@.*J5<2M MM /< N*Y5A0SJP16Q HA@5;*2/,>OEN"#=_NT@#:_:"2A25TXG""B.'CNTXX MRD .]T'81*J,%!K?,>&=9/"8YT+P7[/.H!X5NRJ.*X^*37\PC"31>9BCB4YZ M_] ?/J;I[!=Q/%S6^>E/G=Z@$S:B'YXL^_F7>538Z @6-[#V\SF]#DP/K#<( M"FGQNG[]091H_?D[@$*OS;&W^GKY>O=IUOF4 M_NA\'=XG"UKPCUYW?!?^# LKQ4X08/WD(4M_F?ZQ0&/O9E'8668#9.^>#](6 M]R#TS[^^6Q"XY?U?^.BESQK_Z-QO=J"I_F)3*!/K)^7P0TK**?6@'5>>O_I1 M8,K5L-^-LC\H%NG[W\('=YW",.BX $+/5#R<34;6>1S^IRACUCK[,^1__ 8D ML,%.[(TH+M.'<:X6%[N$^$4G*N%G#@@M-134(')J$"TUM-308D-+#6MBP]ED MZ%Y.VZ%OEY1[[M&>DP_F8"BKNBCEF3;:6DDD)0!))QSRF@*OG49\C;JH6O/( M3?-HF_&;'EJ%\XF'6PX*/0\IC-[BYG'CYDK8Q!5L LB,U\ 'M(R)3>'/V%Y" M>\D)1)CK76'SQ3S5MX+--VDL\[:,T+:J:D'PK$!PM?)(JTP@"(2-23\0:4Z5 MQ5H0A\,7%3#0 [A&5]"5RN.^@^X-*(^X51Y;Y;'%S18W7\9-7FF/1"*FL34" M&DF1P0I;12S%W@K)[#IC6U9JCRUNGA1N'FCH<^LU?HS>X#0;O^"C/(EN9:MA M059-UIGV#FN$! GJ%.9<0& %%%IPR!P6:TR"G6[K$3OC8*.XL!7['Z1F= (* MT'EP-($51PO!G)'2 R(LI8XJY#&6DD+,O<=J#0-I!4#CZ;'*"ZE,_8TG2 M0YS[V -+#@II#E6[.$\LD956@B71DAIG(,!48:8X="+6 M5DO+M6=K="'>?LYSBR4MEK182.HE,)SC6*I.->*"$>X"KW,%+!=F M?UAR,+Z,=; $MEC28DF+)LDQ8(6^.9 MHEYPQ2!$"EL@ *?>K>$J;F;^P($XC?4%JCE\K_(9Q(E:J#M!J!,5U%DE M,9$68^P-U<9J+ATS4L:7WI$UXMS-].0_&*C;GW'80ET+=2W4O2[4A;^J! ! M34SED1X@"C&2.HXB,4'1 XHPND;:;3-]Z@\$ZM#K=B=NH:Z%NA;J]@EU"%:1 M ,LA=1P@@1EE*%87$*^541!@'_YYK=;M!P-UKSI@XWB@;DE+]49\@T_:KZ_5 M<_OYQMB+U)G97G;='V:349J]V"([5M\A#SVV2%"I5$S4QQ ) @D1%,E:BVRL MK##0,^*AI-!8P231"G(7S*# 17*W%MD-'&#L7+VR_738Y[B_H][59#PN:CQ=#G(M&E G@^Y&#:M[@^O):!0NUYV,PO+R.XYC4]?\2E,BV'AE@_"( M6__X_?TP]A0M=B7KI+&IZ/:/LJ+IW,;7VVUC5C0]V^)I1FEGE-Y$]@B[U!OD M)UBU0P_T'=DFFWZ27%\7_<_CAR:.X>CWNDG\:7@1])0L_'4Y#F_<3WNFNV04 M3O.VT=[F+[67FW)3[8)SZLD!=CN_3T:WO4'Q>$G@TND;A;C(WVD;HKYW:Y!Q-ET1-Y@>\Z[7?*!TU';9[TEE19R M6CHZ",A9K>R$-1U]G6:]=_LONQ+4?O?B<%FNS6-O2:,EC98T6M)H26/W'5I/ M\9C? G"P"H8I@X)9TD^S5U+7#S+)XYAR."2I=&Y#70Y2OIYOG#2O>\->MEX%$CL>]I)_XA9V\]Y<ADFQJ\I3G_Q_%Z:M!5\V=O2N/OD$XD8?0 ML>9X<*@-&+30\ARTX I:O,%*8T0]LX!ZCP0'E&%A'9=.8-W$J*]#AQ;1J"74 M0DL++6<,+;7IJQP!A0R P!%&N=2*2&\T$TIBP>$ZPX4:=Z2\-K0@W.P4P19; M6FPY7VRI32CUDC/ JQX+BG34@FG?%!8%-?A?X:\@1/EU;&%M";1/EPS1Y*( M^VTX3OK5@)2W&5-Z%*.-,:PU4](*:V.A#6:/HT0'P)" 2D) @!)/I6S&E=( M>\M&N7LK)CV\,<-G$+QI^15#5.MN@K1S2@/F.*>8 @F HAP$WE746K6SZU,T MQZ]O/G.PY=>67]^$7TG%KW$0$ 96(: -19I(XX4S4D!'K)-P9\5\VG-I=_59 MOOU(P99A6X9]$X:MI5-B0IAV+,A61ZED4$K*B862&H*10$T(V&88%L-6(SZ* MJM.=5_K"O)"\#V-GL'4CL>?:T&4'7LMZN/EDI[SP]O3;TV]/_SP7WI[^:=65 M%II#+P_D7,1^M'N.P1URJ&V5?8!8->@78A+3#[$TUE/.A!;<*H6=LAP!*=9H MR9WO?+0.LIW]Y>O,MB,?R"N&Q?9.M]N.PSQV]&EYL>1%40VW%( 3C_*Z 4N) M48(!;;UT1EN& 5W#5G^1%S?SA:_#B_(#;'FQY<53X44,2#6J G-"C&-:0$>E M$,HR23T#7B/A&%VCC&>57-S ;;;6S%?ZJODB+3.VS+A?9D05,P)B$0[*J6)& M!R;$ @>)Z(P@'A)"E=A=,#;,C(B^:M+YFS'C ;JG]Y6+=2@3JY[=S+<-7NQE MSM5*PCGZ4!TF5=*K M;K2[7HNE+9:V6-IBZ5982F"5/2^D4U(!(BS45$@@A.8* N:CU>^\;GS^=2.- M!%NUM.F$WOV/MJXM[!6&0.]L9I?^^][ )(/G!%V(@@^?OYA/@DR])Q^#B<]"!\$N$THMT, M2V_B=Z/BDHPGY>?)("@OO8=\IOPX"5I*VIV$Y[[J]7OCQSB_)'ZI#K_A(<)) M]SL/^:9=I^$Z]\GH]S36GPRZO9R@+CJ].,8NS<+#A"MG.=L4*[D)OQJ.L@^+ M4CW>I#>8)(7B]9+(W$^<-_\GR;DQ X8H 103@C#*M-!:",-Y &3('<4V7. O MR:;2G>U) _GT^9OK0/AA6V!::TK><=&?,@5'29^9;\80.B](=9P)UO MX69_=N],OEY#YP]^/G&YL, MDD ]F;NY*7!M=LA? X=_BVK^BV>L,=9<(B&M@U1II()I"*RE4')I .2U,S8. M.RX!,M"$,XYM'8E$W%(&I14,RX5#>E4&C$/CH^K8[P]_1,S-+9Q.EN]3^%+6 M6:;$IM-=RS$V8N(OVUD(<0DOC0N=+JIVO3G/#)C^OAO3\W:=[-\G5F6 M&8PL\%PZ3W$/0O_\Z[L%$[^\/WKAL^T^.ITKKDZ0.L&T17I(:8M[&QW\[6Z4 MIN]_"Q_<=0J?7,=%/?+,&PUMF?)0*\1>+RXEX<^*SQMYY9WY+* MT9#*\V/I6U)I2>6@4.5 IRBW=-08Y*RMT1Q[W8=;<$^\=6[,0:0\/!^H@4*" ME/&JNX#C2@OK76S;3:%6@@!K)904.:^<7Q@_LMR-9@KW7MB+SP_I*'<4KM5K M8# I8B)5% 3/@B#OTJT5 @8 MBC!U6DI.+!4&6VN$9$PUROT+>?@[<#_DS99OMMS? <5.*=&<*( M)T@:&1B;*JD(!9!Y#SWU1"VDY^PJWO_1F'B7S0[N.:[A&2T/GSL/HTI(BH@Z;%M*-\3"4C8X@/@$>/LG/Q4X.;W9-WER%-[16 V&@!4)@+HF@U&&I@;>>2VMB-B=9F-"S M'&^^I@%;KGO]7I%<.?;%RBZG"YO[\G:^@H^?_-KJ!%P"17]^@D6;G_[#J#>( M28C]_F.G.TEC9N1.!-^[?PC/%H\[34:#F#K9&4[&6:^;%B02]B)0?SX&+>O\ MN.M=WTW'?X<'B)GA@??"%Y)I^F*0T'D29GB4!1*+WZA2[]XFWW]?P+'UC\.> MIUO_N$6JUT J7FE&-)@UFB*)I8? 6,P$\AHAXK3C<>[IJR'5*I7I[9%JZU\N M@;AYI!JDXTZWEUV/TG#\UW?)Z#8 S_#F#1YU99E"04"B$G7.( PP9P!J1A'U M2BM)C*%"*D2M6FCH4Y'"',WDO$U.#JI M]B'3A;7]'-GE/;S HK Y#$+ M.+!X8._ PX/(P[U!)\V*TH\L5F@,KWOYEW_THI +,FXT%763P76PV)+P@RC" M'X9944V15T\DDVYOW,G2\;@_+?R(B%$6:(0'2),L%QNC-,[23(O*N.>N6$.@ M](^'7F''QE\78BA'GDZ_=]\;)T7-1^T&WY-^F<.>Q!SH)-QB<5W3V]X4!4#Y M[0.TA37$NI/PHJS*R^+SQLJ8P6TA&&N[%K_63W[DRT__"'?)YG^9?S\;#Z]_ M?W\5GBW&O>]CD5_^<$7137CB&:86+=.+)RGA-;PU2O.?%IOX,!Q-ZV!R*7SU M^&;PNXKY):KRY0W50%-"N1#Q+R4$0X*S8'T8X\&:CHWU "!&Y??LLI1+0A*[ M"^Y(KCG'!%+I98>@L*^N$2AX^&H8^&EFQD=N> .B;$ZASYK6Z)_D;[SBI@2C M,'W1-GQMI5[ FE)/();2$T-B13%VR#(1E'JJ(7' _\Z2OT:PG_2!ZS6(=R-RI7L]DC)IL\ M7R=L>"#C?\N\D) 8BY!CBCKI%34(,0H19TPZ:+82"WF)52"X&&6(2MYL*Y+Y M[7AZ9@U4%Z(-"NF:$H.-0WDXF[C@H(\6S'0]' 6=+IG7_DHL/E353J!*M=/8 M.@&D508@ 0$B"$?/#-.*P?#&5JK=5B!^^)Z9F5LM'81K1A-IBMQA81TS&1=V MU%^'5UE'!5C_*2(Y K]^,W]5^9_PUY\O.@_):-S+A<#PYB86TU\]YGKCC\Y] M;]"[G]SG%!0.;6K@S-J-S.1!$JFOL&IF3Q#NL2:6+W-^/L,FD:;[DVZ0(U&O MG3.-=MD\C;*Q3#@/-'(Z9T)CK0(U(,RXX9 M>X3WX);8P/];"BR43 M:':68*L%Q(**OT(^A/4-*R$QSMUA4]*ZR,FF6S1LB73]%C($5]U7O9'.*0P\ M9QP&]9E9Y *Q .,<(]XNQ*!VER$;A!#6&A%VQ"*$X-DY(&2!58 )+Q7D089+ M#R+3 H80L8"]M@C9/)*PI@C90TAAJ0BYCEG,W=R?'5@XBSO1[?QS$O3,\.W M8SFG3B7-HGR9N?-C4ZBU'?:["93S/,*;WB@;/_F"+)II;4TZ'Z-S99#T.U_3[^E@D@9('WWO7:=1*,I*3[/Y-L7#13+,GOJ:LK'%SNF"AM MZ*DX>@PF3Q97CZ+I,IS?4GK/#T6;*T?_.^-\@FHZAJQ27=CI+[2$Y^.*I;^0^345QLV>8L\F%8\Y1K MGMSS+MAL5VDZ*!^S8-?D.K)N?I=\1;F55\:DLOICSIZFE.#AK#J]+ :9^OUT M<)LW"7JR!>7]"P?_C#\>'PH^KBUOV.]=]]*LO/+L .N']F,XZ7=GK+G. 4:/ M9/Z]>';O\S,KF35:NZ_4 [.0/+12%Q&FE'$.%5.:*N<5P[$2I@_X+7@;:#>!G MPR;,]N@%94',Y(]X:D9+J 'JQK_]+1DDMWE8.;!!OY=^+]M850'C M&E7EW#).?@_L$HAVUGLUUU:+SH.YJWL)!TU%V_>(.U-.*GH%#KHY^GSOW0X# MDF0Q22:PRZ!;:JWSL?#(7$7+RO"]<'K1_9XWO(UN]L@_T=?3SQ$U:B>1>VPM MX+W@'S)_5?%QPR'S_/K% E/.,.:?"=Z2=YR,?#Z4P0,"E.\TRAL29Y!EBXU,<=WO=HEG^!;+O7W M;/BQ6N:K4-#"@#W 0PHL5Y('7F8&8$$]D?OW6D8NYO]%:ES\):HD3W[1C#L3 MT[VX,W=)@5WSP"KH9=IABIFF#AE*??C<8.8)-,!(COE"@\=7.+!/Z8^]'-=^ MO,^[@._'N?AB!+?!<-S))M=1>[^9]"/L%&!8:A(!#V.CURPK\X!RD$C^B+K# MCPHVHA9RGSP6+6;O'W*C)&\56R![@*)> -J##8)PW,+)(>2M5BD,,SDW%9%3 MBBVIK.Q*G!-@*>BF$C\IFAL_(^^B=#I8.A2P1B-&I+2.DD9<9FO,9-WL=^%FY]VEP]7'K8 MGTSM_%PK#N]'=3S\-?-%782#BC>(9DSX/#Q6J;@/NN4G90 W+B!>("PR6.Y) M-UC.V2PSZ!D7A8G]\/N];HYZX44W'42;W0<[=1 IH4@/*H5WX9Z/DCW:!/FP MBU@07(:$%F(!'W9PFC61MQ@>(YF,[X:C KK#]MAT$/N_!ZLP/.8HZ3WU+_6R M;)(^\9>4%!#LPU&TAJX>9SZ09Y*MLLE5,/)ZR:CPA7R.M[W.0QX="/)H!WYJ M:5VG8=^Z=4UI1S,H7MXF@UXXH7%M&QYG/KK+_U3?=G?2C>,,[MR8K3MBWDP^ MVO_\S\X*T)6@,OTH5U82@I!2C@H+M <.4&ID/9Q: MN)]>U5DH0347!1@:5"Z#M HZF6-: 4.9C'+WZ5\G69P!,]T#-QD-PUT',0\Z[-A4,)J_NK]/!6-X MNH^#CD^O1I/HTJQB9_%+.7?D$VK2/&FZ?*;B&6H:1+D-3Y\UW#(H1.$"T9M< M1.R*$RUN6NQJ?K':+4>38L>3<;RS)Y4.Q*>>51J>=E=KGM>Q6#1H!==NW=ID34>'B#6#D_* $_U MDTA9R=4DBW^'/V]&R:0;5A04KRH 5ACL88&]<:X%/TS/<3"EH^MXH#F5W4>- MN'0FA\5/\3+L8%1O/:P9/>TUU"U895,"J*%55( @RU ;&UUZ\LPIIL'VT25UEK2?TDR%E&RNF4;GOO-M;$E\[R: MTL:V_F6KQBW2+ZK1KS:*4\N(DHQJ:H03RGCF#&2*!-(^0OK=>FHA72Q[;$S+ MV_J7J]3#PZ'BGW>)P7R;#\ 4NM/2<$M<]H^TW_\PWV=M\R/Y-B=RHDS-W2FQ M7'F297FL.Y=HN=@-!S 5M$^%ZE0>+63EX"*S(R\>GPWYRTKQE@NN&:_,+3 < MZJN+-%)9=C3HQ4PY0+F7E#BH&(8:60BP<5H3NT=(P'.)'^&YXWMQ$_\7:. MC,,ARITDU0ZI6E,[:Y/LK&F^U4)BUC1B4=UW(8=Y:D;-":!YL^K);V:.D8O* M9BO,UTJ>Y?+MP_9T,B=XIZEG<2SX9)1-"I%?Q8RF@%;SO?SO7GA=.$!*5O6<=,$ZWXRJ-([GOB ?@1VF(WYS WR86"[(-LC%Q5J0:#E64^(\DZE_3Z+ MS$?'1AY *LJ3TL5Z]N@)R1UHN['=J\ M8BEY[.Z 25"7**5> >TT]D1P!$1X:^MYQ8TGVNQ+$ &M6&W3K(+#) ^L-%9P+ MS2G$3IF@,Q#'P(LS?U?>9^.!QI\^?_K\Q7U5WSY^^H]..=WX)_=_O[A/EVX6 MU-QVPO$:C_LFPWRGV!MLKUDA95:6ZQ1E&-?#;)RGT0T'9>)P+)2>\?^L/' M-*U^-_O^0RP.RJ,#X7:EJWSZC-F+#QGAM?A!D2&<-Q.;M&6>HL%S1H]I0MQ8Y/P\&LQ'=9 ME<'RSKS;JM5D?TIU/(2];W;52,!212BA@'AGC=>*0FC#9CN"$(:4+4Q1VFBS MFVD9"?<8BUULZG.*_;IV-9\NID&>H)_U'R]RG$I&KPT16-0:?0N E./.N ( M FKN!!00VR#='/5D>ZK=K-/%VQ0GOP9$U.J3.=?(,(<)Y8IZAE2P"9V@F'"J M'9,[X/%F)>$OYFNT$/&V?:#F(6(=V^V@.J#QM@/:QAW0WM;^YD%'-,8R9X-R M:)B4"A(%O+24!N5%D:WM[_W9V_AP[.U@?]WWBN+<8&\7$W9NTT$L?%[3X!9" M&8XE#/\?4(]1[#MN#!,*>T&EYS6#&V"CM- L]LNE&$A)*98*6 ,X!SI0[4L& M]\K[;&QP!PO[MX_??G.?OEUVU"?;,9\_1=O;?3(?W>6N!O<:C_OJ!G+ZSI91("_B?[98>?3<+Q#XP7(MY?%SSSWSB$73A[LWB M**E>=I>'QVOMTZ-?8I[PBCRZ&$')7? /H^%5+K'B96+_A>$@O'PL>Z.$#_+2 M\]$TY_( =+7#L^:>Y-X5[7*2(J4R*_%A?P8&Q8P% Z.*VPK&= S=8L8Y91!* M)2G@DB@)I!%N86S3WP*-5"+K4<6\QJ1ODM'H,;SU_\4RR"_YSG\L.W0$ILW_ M[SZ]%'B/7HH]=J,J#H/6NE$9"2' R!,8QXI@S8"D#D$@!$4>@7H0??E!+-][ M%?7F+[-/HCL__/L^IW6'$T[KGP6?GH;0R&MC %I!1[)""$AMB' [* MO_ $;7L>3QJ"OXB!'GR4T, M.Q0]4H:QL4O1K::\5)0\T8,8RU/3F[R3=%"%JC!T.(@?P]'OX3K97>\AIN'I_\]TB5-/2S>-Y1S3:/T@R8MA2TVT7%&AC.3I+[.FR-TR6I--KN_R MG:E5 ?1[-T\O,:TAR7.0II]-4_9GVSZEQ#QG;>F!<-;^P"ZA.@M.,B"&:NN$4<2,%Q M;-JI;,WP1MI)Q0%2!@+*#=8$.2"#Q4TL!T[J!YSYMX+)/+3GW+T*&1^]O,OC:)J[>=S YK!-&NC%_-?BM?UZP\BR?7G M[P"*0;[Y0-W )?U^^6DN1./K\-S7T]=+MO1;+Q+FI_1'Y^LP8./3I_W1ZX[O MPI]A85=1O1_%PT!C!!_C0P=G?23'*!?=CAL,(1ZFYUX=EOW M/H/Z3UNL<"41'/3T]%SS9Z *S0NEO!>,:X,D54A+*C7B3G@. ,5T(?YAI3K?Q.'MG=26C27?"'SF.0L<*,B\^U\E112. MME)XYBU%8K^0;J=;>5LQAI8+PFAE#OK9*$ M .*$0 A;[]%Z;/A_9MO],=_M;=P@ZW(F81\6G5';<^;A,^":TO]P.?.R&C(: M#)ANNB/G-:H-O19+_K2*)TG%DYXR[ V",965&A5X$F)*I0CO!I;4"RDIRWGR M2]EB8*^\B)>TK-F#E%PDVEV.MBFZ_ODDW$RZ":CKAITW1^% M=V\Y,T\+Z,JM_U;M_'\DO4'TC._,YNN,N8!+1NENS^XGR-6G:ZFOB--N@O*% MRZ9<*'[XH],=3J*CZ-] _K]F;?GR;KE;*MPJK^>:W>DP#?U5^[.+)V"[[7AE M^T14N=!&.L6L<$1Y2A'B$GH+C!/ (J(<71CCM+:;((!C$VX"^6'EW)]7.?JW M)?,7;9R_Y&[@Z?N-7/MI^MJ!54]29 *I,LX,YU0KK\-]K66$4\\L@> LS?) MX61O5BF:GV],;9K4UR(V;6+P*@_3ZQ@6G)HY+T:55( 6#7&L <)4?OML_K/S M[:OZ=*G,MX^?/Q59G?G;[[6Z=#'#\[=83JGBI[LF>*ZS@%W6O\E0Z+V4"P=Z M3WMY.6(]36R0QW0?.V4OO>3F)F_07<3:K^\"G8W*[GHQ4ER^U7&QZ^']?0Q*QZ%HVV=^=-LLOY?G8WP>=/XZZ3]V(%O2KWD63=7#,M1J\PZ' MPU%69$?DC21JASD=_-7Y*5ZEI(.OUZRIK8X_\W"%6L:5L$GVR6^+6G$UU3B6\6^RZBGSLIE M[DM,!HIY+GE24)$T,PPBJA-[6*3C3CXS+@XL_%XDWPS2V^&X@)+<75(\?^PY MK@ZKBB'TT_ MR5Y6ORP):B]FTCL&J#90"^^D==(;88@ HJ9^*86!50K&(%0@'":0 H3IH(IQ M03PQ!Y;44V2X9)/[.,_[7VFV%$7R XS="7K?\RR>\D ;2.5YHB*5%85'G=L3 M-O*V-R@>+PC9X?2-P@F6O]-0^@]$*_-_"'TAD0=MEQMT%E?<,@S2C%\TCB.- MK9=^N>MU UDWP?7SS3F?B7+058'+.>_.HINFT2C( A:(39F_J9MB#]D-LWS-J_2V-XC1L1AE M?*GBZ6@3LU<$'#FKXN,<:&Z9E1AQ3[$@BB@M$8J-T3$C!"_$N'*M:6DM4Q$V M1+/1)K,1 .Z?D][XT%4F .$4*">@J0EQ@CJXW'0@&)C=^0T<1;,MJ_TM&PFV1W\50%@NC7 MEL]:/GM+/I.HUMC>2$28)@! RB54@F!F+0XBC4BE^,9\1EH^:_FLY;/(9Z+6 MI0)8@ 2$ *!*5)<:R"--X'-%&?0+93BKN SWO)96T6_Y0Y$HLJ'ZP5[[C?S MY?*M71F'PJVUV3J"+W)KY*F"68NFND5.0\'$ MG](?^4?/5-;^US=[FJQ\>*UJSME#=W[\C"OIBXA&#A&#X[0FBZ60Q D&*448 M,2<66B=OS<^BY>>6GUM^W@L_TRJYGWDH2;!9&<2:2B D<$$LB3#8KFG5%(<B:<-W"Q1'M5@.D-F7ROPKOE\9;'CXC'@]7="O*6R5LF/VDFK\7$6D%^TCQ^ MF+5.3U%@VK^$/S32@^7X4]I?<4/:36BIHJ6*EBI:JFBIXNP+I/*7\S73IM[C ML>&"Z5.WL$Y@?>U9GL[ZVK,\G?6=S5D>I@5_^*7)IYA; T%MF!2QPGB(I$=( M4XR%5-I[1I QT&JT.)JQ\:+E0C-JW#?9T>%96^6R<:T"5 M51QH2AD*?PA+@3*$8LT$$WNOI=X;S_(/LN79EF=/A&P.YTX+: M(& =@L XKC''P)!-^XQL7I>]-YY%'^A)\^S)#4BN^X_?7Q5SP7[$H5/3@1_G MU3T!0E0;IL>=UUHX"BVA(/P-E500.B"P=G;# LYJYE]]*F!3U=E[8FC8J-I\ ML)+VU 7J43-D;5 <=-9Y)305!E/IN6:.!XZ5FG+"E-X30VY57KTWAFQRA'G+ MD"U#;LZ0I):##1RU BGI*4(&44!=YA[A3GD=(G#J"D)N7DYY9X8DC0Z0;ME MR)8A-V?(6M3%!-Y#FFMB): &<^4)MXKZH+1RC^QF/0HVD9 'Q) GH;*>3V>P MN0RF(G$I#I<,1#8H!G!V?O3&=\$>#<24]?+YLZU/J>3\6N]:BZ'QB$CO(8K^ M7ZTAT,PJ1)D+&O*B3^DESE>US3XT$_6\FAFT3N*S8NA:DUR-I.0:4P>TH!X( M+37$1FD$-0>(TB89^DU-W):A6X8^589&]6Z\4"''-*+"<6JE%DIXY 0( AM8 M[#8SEE=+Z+?3R%N&;AGZ9!FZ%A]2%CHE69#/@%/EF5*.>&XXD,!JP#=S1Z^6 MT =C8H-&G="'Q]$G'>1]P<3^VS\^?\IRR.:_Q@_#HK,MS>VC9G',*P>W<,I) M3[!WCA*'M$2<(LH=9XXRO#BIXB46-[,M_7Q3_#WN7?73R_0Z?'7<:ZY7]S$( M\H.5UZ I-H$NU=QUMQTN),U:UMN;KGY3;D9X:JT M2$(FK3+*24 % BLQS:QX\"LZGUP;SM'Z@ [TX=_*A'N-'$V2&SO M":+ (4F4ET0S#9SBPL&]SY_86X,KVFRSG.-L37_N_NXS9G)6R75++4.22:ZU MI5(CX1$'FDC &>7:V;W/G]AC=YU&D[A:)F^9_*B87,!6DK=,WC+Y23-Y+1K6 M2O*39O+<6/_+. E/.GV_D6L7^_II1B,N=3;W0D[W0]_/.'/C8]D^\,L)X0$>K#) M( E?FLNCZ"3C3M)Y"+2>=L;#G*QFE+0K ?UI)07!RKOB-<-0 N>Q8U0:)I6B MFFKH+.#2T!=ULB_Q\0,%Y>_-$\W'UR":2=:M[EY1#IH1#EA!./@#6*FWO2+) M/ 0BR3P?A5 U5_3EPL#@%!)AZ M*ZG"0JC8F,,%^:@X86PA[_)+\AB/+/M\,Q..D1+,,!N_A2!\2@%LW78\BPF6 M3\^L'PR2(>3K/]XR,H1KAH[** !X(18ZT2P1(3$1$$#H:$DO,_= M(B#41] ^;YF-LS>0D^N20@4*4CO.D((@3EPP M7DF@I;&"]][W730_1H.-2@=O5$11 MT<1[M*)C%U\DBC_O3 V_F2^7%YW+\&F@";6#7A%K8X>3H$XDH\[WI#])<_E2 M-*7J]'MAT[IY8[2@;\0M2HOTY#>CO]52B50]*;CE%ANO _((RK44T@4US!'B MDK,"BOU6+_S);^]N TC,Z-UA7Y[X ^U"Y9YKS]I>H:\Z1I!O@K,JSD-P;%Z+I+"<4,V!8$8#9H+@Y=@QM%#,_P8J^(;4LZX6 M3A>QK3DM?'OJ^593UWMA-P<;#SB1+<]J90Z2;P-Q3_;YR'RQZ:^.Q] :3 MI #P_.W"K9O_N=PY'36G=/3$>;W@WVW G8O$DP?._[T;32_R$/2W]U>C-/G] M?2$A,18AQQ1UTBMJ$&(4 M(LZ8=-!LL_9OT3'IF3PXU9_%OX? NTW[1O2185(!H MB&U09'!@;"\MM,1[Z'QX8J]X5$#+2Z1=-=[XYW@%9>S%\S\U3J=(.B?\(YO< M!&R-SMKA*-^6L+/Q:]=)=A<7FP738%3JIA/MPNY? H/'9R\M\]I#/W>W>8O^ M+LD"3'Q/LZE1/P<083W97=B+]X%O[CM7R>#W@)0/PW"A7!K]93C*,2;H/./W M5VD2=_&BO%R$Y?>WHZ2;=K)9Z>J'>59][?-7X:E+!6VZ2]W2W@L'VNM&"LA5 MR[MA/YQT-OU2N5FEK,WFO?MAC_XZ"=K<0BBI""Z/1[W;V[!#@:P&X;]Q[WVW MUY_D!Y5T_V=2;%3G83**@G \#1#$_9[>OKA.)-7BKTAMA8YP&QX^4G,@X.OR MI[VL=MF+3II(*LEU3C'#SE7:40_A0AU(8SP-H4@!^?OC'VDZV+OISRLE M%SML&2/$ XRHL4Y:$IN7(.:,E-8N6%ZU\NKG'4)_#SI%59.]8(DA]%^HKJ,0 M2..;_YV-QO_]-1G=;'+U/R5(WDQ&XQBC?0Z,LP^= M7(LNW&_Q\NO?*.\$ERL&D[#%=03-83=@93>-V!ZD7;=3C 8K83<)7PR::N?[ ML#^Y3]__R$5AE!KE^T7\N H;KO,P,6,J_]:^F4I4H3GB-&700>8(HT@IC9Q@ MRDLN@'2,+?2IL>G5^.,@&X\F<>]K+/8M*,Y9%,3AO:A!C'O?TV]!GP@2SP;] M'1Z*3_;C)[\F'Z ]>,.NJ\WIC(O="<+ZL2Q$J0]6'Q1Z:F]PW9]TBKH8["H8JNI IS^<9T^Y"TW+_+, MAZ!DCGOW.0$'=3%\\:FV,%6V[L,]<_LAOUJIE,PK,#.=/=-J2W&!,XL=)OW-]%T_EHJ+2'/.GE!QX(7ZP^(-.,"G# MLV7QJ&]Z11O1W.J,!'33NPZ?QGMUTZQW.TBFG%5:L#5+I;CE<-*/;-\)=^B- M^X6*ONPQ [O]'L1,^'UE!+VQ>?:_GZZE%)GUI02B30/615LD'12 %K?FNI]$ M$^OJ<:E0U,,X?3.F9_7"[X-M$S;P>G(_Z264"( U4\ PA>-!+Z8GO<3,=M@/&*?N8Y#GS0(ENZ1@$OYA2?6\\E:A!=G33?I 'H\<-;;[AJ%,F M1UWU"@&=*QKQQE% ;6*FE@+HZ9>F;O6H@E3B[J(FN4HK>G^*@!: IK M8OJ3(H<^[.J">3&OYX=3*7V;-94E2.-A(9EG#Y]D\>_'&"J/-RW7]71#BHT? M!>LFBX[0,0$6[@89[B11&&P47YT XK*K"R,OB>+FWK*^_V6*JP?KZF,0H:)([* M=E*.9Q!:;!OBA<38)4>]R2RJE0I=/=]<6QUL,X$=B"%\+'CT=6*,K='"BH7Q M<;7D;Y,\!%6C7[A_OJ99.OJ>=@.;^LEX,DJG:3#+*Y]?SA->.VM\2;)3\UG" M*Y6E'\%8B8(TWX"-).D\_'+YXO9BRB"DFX00-&M_P+JAE5.8ZV!T*.&E^4; M%; X@EM43@N]<^IF#:IO?O!Q$XN/(L%DG9_*',X6JS]N\B,(\2P0X6 X%?=YIL"4"*8+KA]\ )+IV^G]0W_XF(;O M!B&;R]7>=>]A>IFX?=,RNN+YELFDRIT>9LRS-2X@>U"^>/-RGV,_]U M%H1[P([\O$JM+OYD.!F'!ZPR*F9W+5=<>I^Z\W>?.^Q@G@6M-U]$+^[S5>%' M_"GH+L61YL[P_&'*BT[5]=)1F.]"=-HMW>1E6UMCG.G'RS8ND-7/X11B1F>G MRB%86$ PICII;B8NV8+""3?]_BS+I5K$]%MK/U(,(CS'"67FXTR(SUWJ.=:) M>N@JR1JC)K'&.IDQP0NW?X(XAY\0)Y\\<)L0]RH)<3&C;:ZT_;G.H0LAT%X6 MS;2@!WR^63X?7HU&T6>?*[?ZL?I.F4VK(M/%I]7]/ E[\>$)5%;)H*H(X2FS M4"AJ+: *(.F0\?Q];0(?UPXP1S"4AHKP*XJ-AXPI0ZEP5K_K!(LB>8C$/9JD M;Y#%%V/S-\-^?_@CPG0VN;]/1N'CPKR[GKFV-K9VIFCSTY\B;)2J4?;S+XV: M B??YU^Z>EG\(6/7OJL\8_._68'VKI3;(HB8F7G MGQGI\G7H'.Q(@^L__$CWNO^Q*,^UDD]-;>'OZ[>FWIW^>"V]/ M?TL?PN'.SOTR2L?)'TOC"*^D$>]]B7_:82%','%,X-H<;Z@4XIH3[2TEV AN ML&=>.8<-)8O]S%6_/XSE.=WE43M7$,+JZ;Y%_.[Q(9U+Q_XZR]/( ^1_CUD: M0;EH:;X\:3)Z&A=)T[.-P_2$?!]?#^[03?2)7Z2"]Z8U7N,+0CH&S MHYR"_M,JEI>PJB+73@4]0<4YZ.$SQS5FR$.&%*58*KK04,F5U167Z>A[[SI= MSOC?DC]T<3ZQ'."(G!;T ]_;8+8MJ*MBK4,0A#^W#O<6939 F=H %08\1$HK M"RF@FEEEC<"0<&*H=80L](??&\H6Y1I4>:L4(96*&.)0UY9)!FB M% (MN0/,4HP=EPS3A8XX^]1EWMZ\@:Q1\Z:%F19FSAAF>-6#5F!$B'&,0 *I MI%QB[9VV$@-NK$(+7?3VJTG@/V4SK^ M?!, YE"]+@A^D*\((6UXYPC4B"/FZ,!6E;(0+ ]F!;)&<405QXH*Y630&S!Q MUOKF.?H@/!Q0OJJ+H^7H$^7H\IIY/XKU3_VUV;WFZ#1Y% 4SB(FB2'$%H.+" M0LLY]\ O-%YN0H"_O0W \(>57?6;M &VHHH6"UHLV#\6U-R14>*K(M26W+TMK3;T^_/?WV M]-O3;TM2-[,9CMGC!VG-AT\5EEI:HXFC!"MM%>6*"*Z<=IXNM''?;YGG+/@8 M%;7/N9[6G)>/M\5:QP!"9\.%M2 ]QH!!)9CAPE&'@>;$<6 M!0Q@*19R@?9; M-KE7+B2-.M]:+FRY<##A>B6HT/!9IH0SWQ3E)!M";*2:8U=TH RQ=J?/9;UK=/+B3H M-#32MJ2OS4_=)#\5H5H,&GL5>-T&YJ:&.D<4@Y8ZCZ&2B%.@#JND;Y]P@#\L M3GIN4U/;#/@68;9 F%ID&Z"@U4/ L->0&BT%M1A;1#3 5%MY8.5\^T68MI2O M19@681I!&%XA#'$4<2T38L2KEM^< ,*<6@5? M/8NO+>/;SN&*894" "U2&!I#O=442B&\A5C*H.$HKY%:L(]>IXQOKUK*Z[I: MVO#($:@01\W-N%(4".7 0*P,$XY"I32#7CJ)A4-&.]Q\3<^;>S4@?-5ZGI:; M3Y2;CZ)D!]<NV/#S( M/ V93M M?1N.DW[X1:"C]U>16N<2^MLZOK:6ISW]]O3;TV]/OSW]MH[O?+*F":6 OP1D<+-<--6+05/2TW'0XWT7I72>\,)X10[D60 M141RQ26@7GJL );-<5/AGVXD0 Q.HS2G9:<38:=:A#>P#\$< L\$H59:+<([ MQA(I+8/8+%3,[%@@UTB$%IZ&KM=6NK4IG!NE<%)::_+ ,&0<*T:MI<;I. ]; M6!UY6 @O7F\20V,FG'S=1JK'GXK9NN5:I'@.*6KM8)A PC)$%4:*0HJ%4A)! MH0Q$Q!']>O4DC9FGHJT\:Y&B18IFD*)>%D(UX(@2Z+2E #(!N58<&6FY<8J0 M5ZX\:V*\"G_=U(X6*EJH.%FH8+4R#^)D,#VPL,,R\%>SDS;(OBL T(! <"Z0XG5_UT/S4D3>W1G_:YT@, P9482$#5 MX0]20P%VC#%%#9"*0XF=QMA:S3#=,A*QLM2MB?@>_4#VAG5+#KB-6+Q59E8+ M,L<(,E16R0,8.TLHA40Y"@W6''D5S#&-/("8+]AD#57@-0$RS;8%;4'FK$#F M;:LDW@J!CJ):B'%1E?L;HXRP0 GM*,="**P<,Y(PJ; ^ZH:;*2Y$-IC[X\E MQW^8=3\M>+7@=5;@)45MY#@3SFMO)5+482T9<5@ZYXQ$@.OF>Y4TYJP28H]^ M[:/!KMP!]9=Q$IYT^GXCUR[V]=/D/OSD>FYQ_=X@?7^7YK@&$?CS'%O R 0- M+/?R.0_479)UKM)TT!FEU\/;0?A)MQ/>2O)O#0?I(/=+96D_/.;M1>H)>-1^%*W].I+ROK] :=\5W:2:[C)9+!8_AAQPP'^0%'2H\O MNO&KW<[E.+QQ'VZ2Q;NX9#0(7\X^=#HJ?V.ZAYLO-WT8YZ6\!88C?M&)4*--@):\O^\B7\T^EE.1-9-B--TX>'D;#/\(BQVG_<5>"^W_G &<) MN55Q%T Q%=B$P^664@^U4H)K9+&5+N9UOAJY?W">!DMU_=(" M&5D&RMV(L49F[[/T^I?N9/0CB*4L';S[7^,?P\YCFHRR!?#>DMND:L3:T<7%0T);5QQ$?%;QA7GD[ M@4(246(PEC0HY0I:&PX:!6AS7(KMPLH' F\O$..+T'8W2M.]@9N?C">C=)ZR MDOOA)&IY/P(Q1\I)NO\SB=L7'S,HDX^=Z[MD<%LHCV%?_%JV8=% M?3IN7&\P20I#Y26->C_V0OY/DM->9K& =""$#6:$@ $(,APA26VP#M!P@7^ MDM1^N);RSYK0_?.7!5O^_^Q]:7/;R+7H7T$YF92GBE*P-99Q)558Y_IFQO:U M-"^53[<@LB4A)@$&("7K_OIW3G=C(RG)(D$))#N5."*61B]G7T$UFTY@B$^? M+R-%(^?;(N&&(>NANGCYJ*EM!>6$X \8PM#M$M[Q02_^]H[M+OZ\H%/*".(9 MB8BM!WH N!P06[,]-=)]*W ]4+5C-]#.&D': )7;L0/7CV(#)6I?"X'+ ,.Q M/91R5(Y\ $. QXL7?P=PEP)9GZ."6BSIIJ-9V??H4HF\KY\^?OKU0OD2?54N M_LO[&M5 M8J(#%96X'R;_=!V6Z;^[I4A]MW?@=P"\&!,!!60@7Q$*1$VE/=_ M^9.CZ^J'Z,L%^TO[\#.R)N"OXR7G7%+9EVCRP,2-0L MSSB;NX4SHD6)+Z/VNL;(@%4#745&5KV%LP$Y;KDH%Z .X\>0F#'5=SZ?IF/V M%<[_@"J&Z72)X^&$8.ILRD AV36NE^?9]E].LW%!V2AB_LU+>#QXTAB'PE]< MW"8+Y3Y?3B>@_H/FSO3_]FBWR80-,L\7H)NGR72*.PKS1SV_.XGW\.7IDKU5 M+J]*V/2D@(=IEL_2C)T&_<\R73S\S+^2EN42EY9-0'B8+,>;)ES/DBH!MR# M-^O)%G2^+(!;X%KOT\4MGVB1CRF=E,IUD<_8%?Q0DHTI$WL>6PK_$K(L.+BK M7 S&N2-.<6LN".!&MW[Y#+87IL(A!V2N;$(G75OTFRL,;'?JO>I,F,^W/]W& M85-UMM=M=MRZ9TS IFTX*B5&XUVW3#TR8]LQG2@B8:PYF%/L!7%,#%75-F0_ M EA6$'E!QTN814K+Z#NB%9U448M M/##GZ]7>:7')*OGBUC7IK:(X6-0F??* MCD 9,.1FXN2:5L.QY8=LRTSB!(RN)T0*LD MW\>&,DP$(48B7#$-&$)0 7QB &@_."S:B_KV*#JU:L@:E@>B2$!,FQ 2FYJO M:VH8.:$!>EV@6>L1<7M"IY62DGM!I\?L!&OH!)]J[ (]XY7R'$IE^4+A7!\@ M5!C['T$J="4P;@QL?+P0O#@M^.LE/K JAB1P?&?5^9VO*5ROZC2Y7)VY\GO0 M6A\L=PE8RFE&>GTV1IM @9=G='$+.'R/CI3V>D;<;U*"J#2^W3L.-2R)N)9F M6PZ)=$L%1 (%R(MCD*%CRPAM5=,&S9*^%/2:%H6PX.Z"1FOFMCTZ$@3"["1% M_M@Y6ZT$;F)ZL6I$1(]\0C3/\;0@=D([C")=!_KYBN?\#\GI^Y@9 M'9@R3V=-)EXF?M2ZXQ"UCR%Y*F"[T08-$#M] )F-T>B:FZ 3.;M+09%%TX!F M?RA;REX-X!73:F^_(/!"X:S??K'Y(+E>H"$M!W##4 ME0FS?V^+:I!YU8/;.M M[,T7XULZ64[I.DMCEDLT8ZJ$S4B0:@Y&I9%?]G1OH$TP4J+MAX.4)&"\2D-8CP M./W\RPXZQ#H56-^>UH"=L$ZU>C_%8"?^N_W%#/=HVOVFRL-:.8,9T^E4W/W; M.W15P&]8R;CZO>%(+M,9[,LG>J]\S6?)6A L[.A-FO'I)%':,.)-(';)&2A42I9P$ID&R#9!$J>OCQ]>?KR].7IO[E980_IY)]: MGHQ7$HD'6?/A$"IB\;@9I]6;3O6CT+%TU]54DQB&YIO$5=W TF(W#M7UBC-? MBOPZ7?R6E^4^*^I9MM%K-1E9#^:-6)G$[M?'[E:OO"#T;5.-8EOW"0D-VU$C MS=+T2'=-0HQ@K5G!D]C=6RD[RS+.;8G=$KLE=K\8N]U6[[[(#8BK^T'@.B:Q M+2M%ZR'0^"=&Q%#O=8A7.:?.D?P49S /C5LTF^UUL-OOS$H$C#83CV'B-// MH;35H'1DQ1BA[@)B:YH1:,!RO0JE#=U9BZ;O Z6W5ZO_CQ;Y)"EO\7 =7=,_ MO 9&#U88EPAZJ CZ+--UFI)F!@K$0>A96J#Z.O$=4[4XAGK$!@5X3TRW']%9 M,EV)TR>"T\^@M*:J+4$ZT.+ T2R;A)A1%L2 MF[>:Y:>S$FDTF^RJX@X9 9]CJIJJ-QCH:Y;C.Y%JJY9*(B-PB&5K:F08MF]$ MNK;!DMPN6!!6V\FQLJYY\)$E>.]3B]7<QGE*_''(6/@L$K;L29Y* MG, )S"CR8^*JAAMIQ-,T;"8>J=@U4O)48- Z.>YVM6HRV:8>0! M4_/TP A)$,0><535-C7?]GW#5-7^^5H_BJ+IG*^70Y=\36+A4+#P621T&KX6 M^%AZVO5LP_")';E>%-HZ,3T2FK9+#+U_OC9 S6[X"MQ1^S@WU:MZORQY%4>L M?%-BK:E'*-+;6&J&W?]-X+G6,N.8+@FB*-9-DVC$\ T'RY0"-U;-P+!\:ZW4 M8M>,D4V[#:54.%4?%2A/M-=X8&&ZO+;P? X1A=GX;%&D8*CL^0>36&TG: M<;Q !\74-'V;A)'AQZ[GPI]$#PWB6';_R#W8<&.)W(/B^T^L6^+VX[AM-CE M5N"IFN;8MAT$Q MM7S>)2[38TVW;=]2ULOV],.Z^@A$MQSPW)'9+[);8W<)N MJ\D!\NTH#!TM\ S;(ZIF.L3R0M>Q/-.-@9-'>^'<0PTU/C#L/C;OJ\=ZWZ'Y MAI5UKD*-%=: D;402%%AG] K> 1[WYVP"4US&AS6'0=4:D_S;-T@L>[[ID%T M"X1PS0[*2K34:- M%4:J2ES;5T.=.+[C.<2) )D8QLD'DD\V@V/]*8S ME0N(0VQ;C70G();I>9%EZ;'IV:&O X=:ZV.])3_J28J4_$CBT8#PR&SP2/.= M( H#U]0"BP0&^D;U(,#_\W0S#-:LJEORH[[PZ"B*-DB'Z,L;^-2NTK!IS+-5 M/'^G)J@!BO8D7^*,=BD*.E"=?IL\]6?WYUF8/'3+E=Z*WM(UW26.8>B!&9/( M5QW+-5W--'7/5SW5V,%R)-89JV!D5]AU1T0])(22.?H9&. MU?CE#3MT07#48CLF?APZZ+6#7YH=1I;AK?6][(-&]NB9[]EW)VGDJTBH_<'[ MM@N7-%+2R"=II*&VO"<>]B>,C$B+ A(2WR%F%)NVIVJ!&WK>FK6J)SFROP@' MTF_\DJ22DDI**BFI)%!)W6CU:+6U2'4#,_1"X@6!YSF^K9FA:041T<*U7*F> M),G^(D6(U+>'&DJRJE^+1K Z=GU]+9_"<;'OU9YQL>_UI,\ MXQ/Q1[*?W2YQ(T#D&Z30I:*OER42Z2#&?5K?VZV_(1+X3$L>,/2,D+N"5%CJ^;OIAJ :N$?E](]9:#,4NB*7* M$'>)6$-"+%-K5072/-.W-#VV=:(3S7,#P_!\HJMJ1#Q]S:W4 \?Z5W\)6$>"6%:#6)KA$@<0R'=,GSAN[.H^\8ACV)&O6YK6.V*M^6IWXEBJ["!V M0,;;=W__F(T+5G?YMA^:/HEU$@.&^;'I M$CV,-.(:JO9J?*TW:Y4C<4WBVH!P36_AFF,YL:G;<>";Q'6(;P=A;!+@:*%% MS&C-"+POOM:?9;C7A/"CL0L/7RULR@6AXK>XI?NIZ-I-RUK/KSK*9KEVRY\: M6:'KQ;X1FI%+5.)ZQ';!]SLD,@-?5QU5M2(2!F88.6N-F/;" MYWO#>?V'ZD7O"5UZ*N:T2%4Z7&TAD0$AN>9AAF0* Z(J<>>%UB1 M:NFZYUB::ZX9UQ^)^A3GLA;\N>\4(-U]Y8*/@ZS%(RWQ$JT!K8U6[V0CBG55 M]TU?M8CE^)[J&5$012 =Q&;H_&@P]PO0NM<$)*W?7C42K25:'RY:DZ:"O1^I MH:H%:J!Y*HDLTS/=0%--W0ACRS&T>"_'$ MAFY9(;$LE5BNYGEN#$\ZMA4:NANN19/UPJU[3+YR>PUH.5"T'F;JUB%47SN5 M#9&;(*%"0H6$"@D5$BID :^_U\6X7DE'VON"MND9<$">1;?50-XV43.)0]_S M-1*:NJ/I&C%5 U1\V]'68_(CT3?R"RVJ:. ?JP^V+"?5.VWE1*]U$_69GM>N M>@SQOR=@,Y#X/BQ\U]56G4#/,VW+T_PP\%UBV;9O8%P!L35=-XS066MT_Z/X MOJGUVX[XWF>0P$GA^Y!:#4E\?P-\;^4!Z5@15+-#5[4C8KN^#_\CCJNKH>O; MD;;6*O<%_'VM0<\N^*Z?&WTZ"B6^']#Z)+[OB.^FVJH=$0:A%9B:1V)BJ8YK M6J$6!(X9VP8)U#7'X@OX>\_X;O?I093.@GUO0"M@[Y7(PML%;F[5,W"'EH"# M(22MU*+0 .)A^[&K^@;Q7.*ZMF5$NNF:KAW8IOT<(7FR VK/JH+3J]=R Y(E59%415*5'JF*VP1):[9GP U7LQV+!#%0%43IHM$[%G?!,_+6K85$U7Q0QDD<1P[V1@D-)W0C#?YKPP!_ M35HO/CK5-@9:?42WL)_=IJV?/E]&BF:=*]5Z=A^R'JIS*H]SZ2X^7M ;3('^ M2N=Y@76'P[0<3_-R6=!+>-N?YN-O[]@^X\\+.J4,;S U0S4T58L"V8^F&ZNF@VUA$4RV+HSY %YUXBQ=_ M1WNG4$#_.:):L:2;#JF[71?1K[]'GRZ5CY_BSU]_]RX_?OY4P]8*7'.060'_ M;39#VVV-^KN7 >X>:,[E+56"? :O/2CYG!;)@O**U 4#G%))X7\%+9=3_#O; M%KR?YT @OMJ4Z"T&% =.X$>F%WHQ"33'L>&"37PU0)79TUQ^6?YO\U+#B0"D'N%%9R4=(S^ZSXM)2;-W?[_.E\5SS.C%>Z>4 M=)[@T2A78IIPA4\3EU:F=65Q+##W6WI-E8MQ2K,Q+4=*F"8W60Y/C/$'JXKP MURB[@W<2=M#X=Y%GHHG)7Y+9_(/BS>?3E$Z4BQP+E6,%\^I[YXKRSUN:P>8L M:#%+D>6SCQ;UKM>/CM@- 5R;),>G0'\/H)[RD4"AL=SX#*HP[5P^@C$%V@;.&[[)]ADWZ7-^;%_EU MNL - C1B1[;(<:<+>D>!;I3*%,^S&8M^G].LQ).CW\?3)1( !8"I>2#-QOF, MLAF(9T=P#3Y.RP6[*AY8)-_IQJDD,Y!N.#KC"7V&?XKJU"IX0F!:9LD4^ 3N M&%PNX( 1!,< 2YQ$Y.Q%]IMO6I:+]RJA8"@J."WRX!7-)K$.DROA%XG4Y3 MUDP=YK/(X4J!=?<3/D_,N!%WX$3*\^?D(W:9"RVK -R"US'%.7YXAK;W -"& MMC)A]N]M40TRAUT_NRIH\NTLN88I_9),[Y.'$N6FVT*LYF533%XR/^6V0,KZ MIS)V7,T,0EV/+(]$;NR10-=!1M!!P0!!+MB*;S%H =@)D+0#$-1;D72W8_7, MMA.FQK=TLIS2S]>K8M7'C',#@ __0=Q\4L!RO="--=V-G<@AH$AY*M&(JQJQ M;@>Q:QLM 2N(X;' ]37=\8CK>F[DF5H0.[[CFI&)12U6)*0>))J7B"2:WD^H MN-BV6LQ M"UO\_M,N:+3_%YY_VL8US]WK!CE^D,^,,G>J]\ MS8$ KL[V/ITL;N%/6*C()02%=9K,2_I+]2A6<'T^HL7PF, ME)[]#C=NE2_P2HY"^X1.!A* ]U9)^:=Q^)^0Q_S0V;\I_@^VD=H>@. %M'!O M8'%!YPN*!@^^2[H]4E!Z/7&2(*&!0X/#H,&1T# :-BNS,?)$(X7;(^$HP'# MT>,DYT2"Q#?M43*EI6P"?HCE(09#6XYX$TYVX4,Y_>'R7@D:$C1.H7A,QU;AF6'1/,\WPTP/HZ-,KDM_A;,3W$; D28 &1H#,5I"<&@0&<8#H>![QB.V;6J3IH15K,3$U MLA:EW0\!<@Z? !'7.K725QX&-# M0)> 3A:ZNF^$JN%K:TT'>I. #IL F2/+MGOM=_"VZ7''[U_"(D1U)L>N_4J. MJV4H(PJNJCR71/^+U!C8KB!HP9[(@JO:9=IP4*?9AE5 MZ[<'RN!R:0=%(P;;SN@8R4.K+*CKNI'N6;JAAQ8)M<")0BUT=,-2+3-TW;74 MPL.SFNR'/!"UY^;%DCQ(\C 0\M"J(AJ$MN_946@0TR>ZIKN.03P[L*+8"GQX MX_!M&OL@#^;()O9YGVT*)'F0Y&$HY*%5&]37=#TT=3MP H-8AN%8CA,Y@>W: M01#8QEJ]K<.S..R'/!#;Z-7B.3SR<&S1*;Q:A/)71=2+V)$P'#+^.PW^QZ G MV*9!8BNRB!.:KJNY9J2%NN,;)+36F@HYYA^Y&N T[X'R.T$@6/YEAT[\5J][P.T".P'IVVW5XN MQ&F)T[O@M*:V2ECZOAWYH>MZGD9($,=.%/E&K+N&:ZLDC*TCT./W@M3Z2#4T M&9P@T7I :&TT:!T#A[; 1,! M'S5X].@ 5!U5.@"EA?\X*8;=!!6"BD#L*/1#@SC$-0(O5'W5);[FJY'IJ]KA MFP->C6+8YKDI*8:D&,=(,5RKB3@,,$@@-HD6N\1P'#<.XS@RHR"(5-TA^Y,Q M7DTI>1V*88QTHO::&BHIAJ080Z$8FM90#)>$7N2Z:ABJ$=$BS8D#U;- YB#8 MK=C8DW7R-FDV0=M8ISZ.?2TP(X.8FN]KMN-%GFW'3D0BC>S3BM-3 MQJ?=:_S#LU#PMH!]PBX92<,D#6MH6"MTU%,#+5!=S];CF+B^XSI^;&NN:WNF MY5KZ_I)5^Z%AYL@A/<=P2AHF:9BD88.G8:TF]F'H@]!%3$(LA_BV[MDDUD)5 MUPS7U@)[?W+86M/8[4S2((C9QGFO'6,E$9-$3!*QP1.Q5KQO%*K$,#2=D, C M4>QY#H';6AAI=F"!<+9/XUL?1,P<$;W?R-L#)6+#C 1:)7.B1YR.#>%>R\ ^ MZ,KBK[@A_R=N%+6YD?GSOA PCK,QRC"5,)G9 $:FQI;DRTP/%< M0HAC$<.V7<]9=_'6XM?';)S/Z&]Y61YCRQ?#E*4#CS>J5]*P@Z=A9JM\LN5Z M5D0B:N;CFNZJNO;Q%8MQ_%,S;0BV[2,*%#]K>6PP^[[X+K]EH"0-$S2,$G# M^J1AK90'E>AJ8!B1Z9DJ,8GMAHX5P',@D!';.JI,H\AV#Z+8;^(;C68'C;*EB'7H'&MVR M>LWD'*P0<@2RQFF@K-TD;.NVZL2V2]38T$ALA&[L$2V,(]U2/3M:+R,U/*O( M7E!6]K&4*#LHE'5)(T ;AN8$#@D-QR?PEQ<:1NPXEA6ZMD4<<_A&@'V@K.WH MDLM*E!T.RA*M0=G(#R/'L4/-L RB!A[\U'W7,)W0BCW-VQ)E#[U["K96ZK., MVO UVT./_.BY=\I1ED,B1H/WNAH12R5^H!-0B!W-!=W8\ /BZH$>>\%:3\8! M*L1[J=IL.^?V4=NZ!D4(ALK=CQ/]B=EDE;O$)J9G6I&ADS#07 \$^2@,-=V/ M/%T/#T"YW@OZ.]:1]TR3Z'^RZ&\W49.:XZA$=US34#VBFKI/8L>+#-4!\=\W MS>W-X8?>LT&U9/EDB?_'B?]N@__$,XEKQH$3@U3@1Z$3.[JKAA%H_'9H!VO% M4 >H]>\'_TWMR$,.C\W5_1H=6PX9ZRVMP7I'-URB1KY/4/B/8\<-8MMU5%_U M=,W0U[HN#D_G?YT2QSJQCJ-ODS38'PD2&WJKE%(4:UYHQH;C 1[[?N3 OP:) M7-NS2'0 FOMK(;$IVQ]+)!X0$I,FTE0'.5N+_2 T38_$F@N<63-4N&*XEA[[ M!^ H?QTDMBU-(K%$X@$AL=T@L6';ANL&AA=J&C$-TS%,'Q3JT 11.@[M W"= MOQ(2&_WF(@]?=SYT9_KG!=S8U8;6*7"Y7L+R(&UL[Y^E#VZ+R9M6K.K$-2S= M(H9G>8[AN<0GH:_%:NBX^U:W@[R8YS B_91G O5?AM,E["!<>[HTJNJB_RKD@]C]II9)ZB&IQ^E2#Z-%/>+0='S+MZS >7$<"PO##1;-4PM MM&-_[Q[^5Z$>AMISA1!)/B3Y.%WR05HEB1S?#'60/S33(%&,76>"(-(,)XX< ME;A[#Q!X'=W%ZCG:[_C)Q[&%#\C.J+M5 #F59C:V[33!4T%@Z<2/O,@!VNB MAD;BP-*TP/ "+PK6.G*]Q*[31PBS8:)1VKDL:Q6Q2?UTD,-/J M>A]CMQ8S33-Z)CJ@@23]4P?<-03N'I8GS)P DO!O>IWB>I2D+.FB5)*"*N5M M?I\I5Q0HH_+^STJ:*3#>%".U?OYEAYFW#FH,'Z;%AK6T!NS0.[5Z/\UPTNQW M^XL90N^T^TV5TWMV7,J83J?B[M_>J>_8;UC)N/J]8?\NTQDME4_T7OF:SY(U M[C!+BILTX]-+EHN\NL"9#;MRGTX6M[^X[KFENH9-?JK >IQ/I\F\I+]4?WQ8 M!>)WM>VS=B4X[QZWC/(/V<9/']ZM82"_ISUQZZE[O=_ZL=?>U/H[U.90SUG] M]VP)7T-:YZ6;@2^P7]U&A1=TOF N%[Y+NCU24,0^32'QY*$AI.,6,!@: P9G M*P\1K/3@(V0'U6CL /6)'2K''X0>X>J-+YW$$5PD81";!O&-R(T=*[2]*'(L M-0JUM4*V'I/Y5E2'C]R\<\0R0CT, CMP/3U>L_P^2@V=_S$/G!KJ/9N8AXD1VV=3H:!X M(/*@[+C!\)PTUM. )H[FFTZGD/L*/9"HL>F98>F&0>AN68]?7NI9Q^%A#5S M!**?K-A_(%+*:6"IW90!#@/-"X)(M0P[)*&J.EHZLSAAYKJ:Z8;>G%$3,>%OU42JW9D68YE:FOI0 /@ MQGLI\&>-5-65'3F/ULQPTA@/Z-E4^/:-.":>'1#3\(GAZWX(C-T/G-C5;6(2 M;X"BQIA,W"(EC$]>QHRC6 M;-<( E6UURIZOCU;?YV20^;(-F7EL*-CV@>-MJ0IQ.MZKN8&@1W;OD_LF+A> M$+JNZ7B:16)"!F@#?RVTM8Q^>?7 6?*AJ^&R4-BVU*#=C,.,5#,FENF[(0EL MR]-BRS1#-PYC,P2BT#<3WSFW_FE+FNFJ>XQ*?@%\#)9E2P7\9-'>;<*" LW4 M'(M$?AA&Q#(B)]#4R+84J*&0)4UKWO#CVR%KN^%/22!\& M>VU$>G;-/7MR@Q4JX^/ESJL:<\2-PZ/)XT6R9B[_AF?EK.8)#QT_F&K[-^ M]D_"(+-4$Q"S#7=,B.J:AN&ZVK7I)E=:8E#M6K-T3&9+6B\^.O4V"EI]Y'BR MG]VTFD^?+R-%L\^5:CV[#UD/U3FEQXLE=!'R8GE5TO\L03F([M "> GO^--\ M_.T=VUW\>4&GE&'1F:^'EN:H8:"&MJ8'L1%%L6L[D:=[D6]:X9G:B!4F<=W8 M3CA2%K=4"?(9C/6@W*?3J5+0":4S=GW++:\XUY\?95U$ WBD M1'.;;'_?-"T5Y%Y=-6R+:,3QL2^/:@2&%X?16KGMD%XM/F8E@!MJTC $]6:@ MCBZZO(P+PN;%'#A2,@U!^]94W<2+M5[>':BVN'OZN7E!LS0O/N4+6H9+JJNZ MNF*X_RW/;A:TF.$8EP]SVE'X6V^OVON[2+[^9O?^LV8"ZT=]\>IZ]D^5Q;[" MD5]\XDIRBY->[0M)S@*2W>JN&JJ7%O@64#I 1 MQ1_=\:TH!*W*<(SUMC#=\_^(^9NT7'R%A3"WS.0++3"K,[FAIP!: #'L0@-= M1@U<9_K3*14;#% _[0Q6?*D*6ZLR65(%]TI1DFSR*A1*;S1SP_,])W9-U;-5 MR]-UG80Z4"C-P&:^D;,6P[=W"D7.U:&"T;84RK#7=87CH%"MVO"Z[7NZ;9I^ MY+L:<2UB!!90J BT+BLTC#4E[0THU(!!:P<*M2G[=7<*Q0@2*-*PA1/E2P(2 M%%OV"$O$T&1\JXR3DBK)0DF8:#6;,_@ $!Q3!18*0+C(&2W+EXMR 80-I,!U M"$6"ERBSY!L]N[_-IPC#=)8N9TI2*B6>\#4&:,$G<:0$(P3&K,0++PVS+.A( MF4^7I9*,QR"A3]AXRVR>I/@2AZAS97LDN&Q)D?0[S&=1LIFL3[B$7?C/,BWX M; %>,RY4@_"YN&7OM':)":17^R?S1D/F3374C-ASB1IX1HP&V-CS?=\. ].* MO6 MINM+\L!B-3Y?(R)$WS'.8YF6MW@QR,M5ZTKX/%*^%?%=KPG:&^E]O^\# M-!O'GNI$,3!G0\4VO8:CN;'NQZ[KA8YK =6M-0D@=,\?GG<-N'&9?#^80]PC M_]SZS00W\6R1?%?RX@T^_X,@1!IKB:]%ONYJ1A1X80QH'\11""#DFYH5!*$> MOPB$@#V'Z70)C/KB-BGH6T 23$%\NX$HO08H]4F 4L_59[T_+S_,.2V4"=\5 MI<2I_0S?C\;*H/M,=5JRS8I;PXO62\_P5WH>Q@#>PKGE>L-]B1T": MN(6M YDMO5IR0%[ :V.:WCW.4D54O_+QR^?SY\S+3]FM]F@^YI=7K<+KM96> ML:SU,$-#7]DB]N]M40TR!TG[[*J@R;:Y'CKQK#7[JVY"4+4VX+I =_*F/'U4R@8WID>21R M8X\$NFX13;*)]C)?[XR?L4 M?/1^4X+/G\*/E]4S7Z.+/WZ[9(]\_A)]]?#&Q1K(O]ZJW_W]]R0#H$5*51.[ M,"W'R[)$,H&Z@)J595E=R(OJ&E#E>JJ;2#VGG@FP^@)G=@>$ MO,BY71P6CSH7N\A GM/R6;W+72)?+ZG:(K8U*>X&T[YR^#Z,5'*J7:Z4$WU1 MJ<[-E5$?J=VIK$/6I@J:IL.]W<(_^Y)XJY<1ZVYX@V:J>W#'?,RXV(7H]95.688 (DJ<%_=),3G[+<^_X:4Z/6!3VE7'ZRQ!Y4A! MY3/,XBZE]Q( 3A0 -K)>"0TG"@V_I?]9IB"8/3"Q+$CF*>;J HR 3+.Y(*J$ MBU. BP"NXB04;SQ&KP%*#U&Y2$'(>!XJ?E0EZ:O@_K_R)1;57TXG3"$ P9I) MQ8U6,LUA^K4)XU%9FGE&EH -($QOE.,31C;Q,9"WV%@/-"D4FJ'XO;4)Z^F* MS%MX)V%^W,N-27UTD:,#:3Q=3AJWSNH6X =!<^G8O;@E)V9>OE9P!Q6[]\ M-H,KMZB5I?FDW/5@GRF\_O*3[1XC #D_J_/M+ )]H=\?V92BP12A[3XMF:<0 M: ><\TA!)V:#2H60/:KI%QS4"GH-FCOH*\)\B,0FKV63%ZQNCT9%88;SPLAT M+"_V#&P6:H6.9=IN$-F:&6NA$:Z9X=[6(/4I_OSU=V8T4KY&O\$?GWY5+C\K M5NYSB_H>(F\ MCW*"%7T?WR;9#:-\LY2Q$S[JLD W0HDP/*5)B5[Z>WHU3DJT[ ,<5W,#'CJ% M*\@W"T !-&1-4V#QW)+%'!:W<%JTX-_CLQW#QY89XA BP(AUC1&VIFNATD^% M2M]L5F67PH4),C^C2<:0B1O\_\@8:V,TN52N*7P5^5NSXFER7YXKBC?M<#T^ MIP7L@P*[O,@+)AA<)^,%LHNT97O >3X^P8H-I8(9Y\N%,DUG('&REUM?Q.": M I_[!6U]_Q;6+%Q&0>]HMJ0CYB/)V+;#$]?IHOI_A;>)@>OH)41@$7\RHV') M]Y-Y/C!7!E^'82JSY!7-*(Z17X$P)8R2C#T)OXJ(-Q"K01B8UO+S/"^Y?1-@ MBN^8F'I'F( 3*9< -Q]:)KZ:F\ZGB?A@N<"9W^"97#,8Q;B+%DUL;V5GWQK; M3P*D%.,^\/MY538".1L[+@!-!-,2B>]D.1:#8NQ& ;\ 'M!AA&9)!A@C)0/! M'-:#C_()HA4!P'L"YS'-YV)' &[G=)$R:R:,1+.;Q6V)&P*'\HTNZCT"B![# MOO$?)>>.E8B!,20W?)EY3S-SO+K:_;G-%VPOYN#:OO RM6/M?N64P]NQ\)X*]]M1NI*4,688?@#.T(\BGS"(WP0V?'(;Y;3 M%J@GC;P/YYW!WV,.7!\J*!1OY,4#1@N'!;EAS4X #U( MD%4TU@OJBM.ZR>'Z!US6DOM>2P5(![(DAE";'\9]P#ML[2UL!HH+R#:9,#9# M[S@M+CHHQY^I?!^(.@@"\- 5X$6L)I\FM\\*.5R M?(MBN6 V8I15'TBS%:MWN!:V>G6\Z2*?[)K#!::[>@W)XNHU[B)?NRHTU+41 M."5>O;P 5D'7KL).K;V? ^<'U7;].CHH@:ZOWL#C15F@NHQGW(S%P(I.VC=+ M@*@IJ)*U4%,B#1< 7ZDCR%[YMG'I0328>WB2YR93Y+0WMTJ6+[@X_NC#[ -( M %#)2[F4Q2#B/B\F+Y'#]Z%EQ$]/^RI!Q1/Y> OW5DG,+)E07!1R[H;_(D9, M'^)P;;=K02D>W0GD<%0% @ K"9-Q,ZC1RIT&_'8=,HB MBH;FL:TLG:]K7U6/W;SZ3\JP$I$ J>V4+C@&01ODM$KZ>/0S.*DKD!J75\@OA4FF%H,J$?W1USGF9)@: :(KH$8* MG 3&02I1$9/1(Z95IO6@5,SBV5=CRX;G>9"8L2_,8#2[K4],Z!7H]XQC+@OV M"YYA!+2@C.WC+2;H5I=X'">GVL\!/;"2STMD^<#5N91>;@"QL&8(.(& M,U>P632Z>#TQY!?P+?RS-C"PFYL1 F8ZP8!+IIB7C1YPG:13_#A#/J -#XWG M8IR#%I TNL$<[V*0*!/K6W/EB)A,X$A+_"SG@"L6"[;0#;CX+.X-+Q5EJ%_069(R@S#:,8$"5/E:**U6@=UHW,XHMQ1A MLW)A.D-J\5>X6-O/0/5)LI)'\3-!'TT8!=,P.<$%:MA^I!9XKF@M\S"%C1$V MKCX!I>HH&"CJX*8UH@TC6M5(R?@6S1.UV9#IQ<*&^SP5DQAPG!A01QK7RM[- M-+^JS7T/(Z$ XE27:'/IF$N+.UK+N2VSO7@$(6\C5ZU5Y:V9J@3'XP3'"Q@L MO89I9(NNA05H&AK7F<^3^0=* !5F5ZY-,W^<7YP#O,'%E#D8A/>Q1HJ.C@F<0@<:5ZZ*RM"\SX!#M4!$N.G*[258!NT(% MJ&<=:)= ?:) C0H3=T4)>"F7S"J65KEVG%RRC(3[VQ1-R,(7Q1WGS)%8MCV) M9>72&BF3G)LZ"U2?RJXCLV.:'3^,,3D=!)('"8DG"HD@[UXG8R'_E;1Q00N7 M/D D6LD*M#,S$!!J-5K<.%%CBCE&;S#NW@(O $AA7YB X)QQ,T-S4?BT60@' MR+^8,BN^]M3X+-M45"V J3#O.^4V+^[K?Q1!)(B?*(BWB.V$SBLG/PJPE?K$ M]*2'MGC!7=KY;$8+%$33_Q/" [N\+!"P(B 08(,!B#[);O#9Y MA$[7GK8%'=\ROS'SA*59EM^QKTA /6% Q9B6105L+'2#62B!IS^K(E7T$6VD MC#Y>,7MI@:96YH? X*.KARJ, @DE6@KR!XK";G)32=7UAQ!%,A!?)4">*$!6 M$:4"6BK H-R?WO)RP:\[6J:;&Z#_A!U07&+BB6+B MYXY4VT4^5/M$, U&2(_:42D(R%R!%,QAF55A-2.D]2PRA]4K23#4[CJYRSD& M"N3E0KJ0>UJ6C3I^XQD+1]M;7;O"\<.M^3V:JB#!^U3 ^_(I(ETE/8F+W-J6 M+!I[,P-)%B=ZDZ,!A-'_HJ;^+("V9* F'H*-'2EER[#8L@3"S &4,:VF42\Q MT!L3%!@B/4'9)&P0/]*YC+@ M2*C,]5QD=)&$:11#6K#+BKG52L&H#7\CY=] 9A?*':]YV@[8;7(]>+X-X,!M M.B^?!$9)6244=J0%#->:[-F5S<2=WRR)3B<0,KOFGZ$0*JQ)B?]0-R$$ES3#'K:T;54#W M4'FG6R5,1R+7I*I[^T2X6Y/NR0T4NJI9S>-8ZQ"KJ][1=@7"NO*@N%=7"13E M+F ,TOT$"PSN9'\W1C56!7'!LO6X\_ *#1F+Y#OW:S:Q=A(+3A0+OE3YB&OB M12.]MFGP\S5^]X$@6P$_Q^Y6UA439V0HGD2/%U@T.GP!9(QBR0MDIQDS)F.. MP/B691 V?I21R*YHJES4?F] C <,VN-IV0E@#/S_79H+_Q% -+M8.6B8L^<) M@:81FQH/BP1B"<3K)HQV(9#-01J@SJ%';UE6=6V*M/R&$(D9JD6>(0PETU%E MM&;O)M=T\=#F#[Q""!^Y!FLAJ4LXEG"\,QR_S"'_X?'4N!=XKQ_-/NV";A-E MW75Y'UQRG"F3XV1RG*0YK0"UU1I7#<%@MJ?&S]0-#2AE]H,$HW;UAK50[G$. MVL7_50&,+ QW?(LUAIK([IL\G[!,]48A3T$2RVY2%C8&K%"*1"<+5_$SA MS3Z4@K6$HB;HM8D%0MBHRV"*Y*F\%!(T;@HR/V8M'&/))'RT;1[$K.M6]2PA M5#=@QRMN"NLZ5F3*ZD%'594_C,-C-?] 2!=U$,>B4C?S0J99>R*L4*=H@\=H MYKQ(>90?%D"3(-TG2/.?^/@O6/@P'?,KW1+"APCU#(R3^TXUU!G &A!) 6;C MQD7SI*[(P%&X/"7PG2@]_2==-4XDREU2I)2'V2.MO%ESLK#*ISSXLZ["U2J$ M6H5V NP53=6@VG/QHQ8V:563P-I]XR-+0!49U#D6HLI8I90)]@=?T%9$$/=J MP"7L?+KD=7J!SRX>F"N$NHT*,WW\/:7 E95UIJM("6_7A$ZS M?R^+ARJ+FY4];?PQ1=5T1J'H;!G7MC6;RO/8)YB+R2 ]H;D:*RN) MN[P(,_8(P A2+ *+\4Y8 B'EI;6YTP8]Z#*_^]0A7"09WN0P'^::8_4-16V8 M"D1!\& 5:;$(05J.I^CS8)5N17W#S?!=H0F'4-I*A*+?Q]-ER8/WJKNID&\: MVO\@:AJ@ZX7=$S6WYJR!-P;[8Q7"*LSDJ:E(^#Y1^ XI-Y\CZ"VS=CD75C$3 M*7,EGU20C28*YMH#H6 NI.Y.88P6W6PW;"CSZ\4]]H ?B5IT]*9V6K-6$B/I MN);@O#NYAE-8L@8X!2._LU9)@AI$4XRUOX6I3-&0B]12%)?EU0^_5WE]HU:= MFDE: #!.'SA6U+]HQM+'>4\9@*I9V9I!6YX8K25H/U]UH2WS2* ^4:#VA*MS MW#4>=Q.<.8:P*5ZS8M-<;9O&R 3S._@[@JLJB06#. M9]A&;-$N92#*U71KXTN8.U&8XW;HVOK\[V6YJ+HNM<36<8*'O'BH9(JZ'5X3 M6%,%SG1?;%H3\LB;:S0VM(4749RQZ5[2K7S'"SJ.UKW8+DTF3;G8<$1^#I"?"F MR%5@?9JFR0-_$TY2$/BQS-<]76QK.;]9DDE>M&R)C.8WH=$(X*(LC"AKNE9U MM&U5,55G%/V+!&BVSRDIV#W<8#0-B!%IA M@E&0-UE;=F;R+$ON7B[HNB+72B&OJ-]=U:A&UMN20-@2+Y CUN$\51_7$:M] MSV8GFL]R5BMX=J>E8=4S<*V.@;0F2)![41^'#6T;>)_U?\#%23ZKVWN+WJZ3 MY:QNJ,E3G=#KAFG7?\CF"Q(2?U2W$D$*&(-0><> IM69FT(! 94H93I#NW-Y M*VOYF;QF[,R*R7;)(H'W\_DM;>Q/O"/U:+4;'@?A*U;;,,V7)4P"6^[1B837 M$X77SZQIXS6K6B*ZJ^CMI42ZJ M8?GM>KBZ* _.>>L5__?N#ZD_^!,]S\LY3;[!R2.6EQ6H3%BGXVLQ,P0.;!@T7G+O MR[S Z11TBO8*C$2]&@/C BT EC1J+' -$^N4FT'[":^O!_<>&%7"CO'8W.4[ M=LJH:BFPY/1%8Z.\>JB"H)"!39/[42L(E_6CITJ7#@TM29S()/$7)XF_-N=@ M,297TRH,%<,!YQ/1][N@=RD+[GMX'-NP_C-E0+_2'!G[OK3DP%'5_9@+>*+K M4;=Q'4.>>_CD^1I<[Q-.Q?:O85*BI)._O2L]W;8#VU?5,(A(K*E^H-MJ:$6Q M&^N>KZOOVH>ZUZFRG]U,JL__+_KZ_SY&__SQ#6L#D=4'#&V8U:\@CQ7)=+M) M,1S#*>O/N50GAAN8W13('8BW\(*+>.DP=!()T(;I\BM=8D=.RF[>3L\K2 M0/N9%XEYAVXQ8#"[H9WR'_"5=++2ZZC=:.E]TTFTJD?2"EI$\],28P P(7*1 M5QB&KZ#?AN5>8JQLB@U#@&/-\JL4E2!1E>V.K62E)AJ/ +Z!B?.N3C\SAQ?Z M:A_9+%9EOHI'$/T5Z'=XI*Q,M_0NGR[KUI"=G8&Q,8CM3)33;@8I6"-GNY!4?5>YU1=3.NB(%1'/I^FD$R^\.N$J9Z0*!!(>""[(5*Z, MM<^9ZJ"B$7P7?M3-0:I&E50>IWKYZ;55KE=5Y-:4AQ&ZP((Z._Y E M]_,V7567+M%F%N4+W*:FH#H[@PF[VA1Y[&YW#><"1M>/ D[W1E2L3B<837+] M,.J4:F<36= ;7@B]56V]7<2]EN[J/EYW5:CY-;-:+?C)(J_87'&*G3E.C[+2 MZ]A^B6T,3O.&V2#$?!+=MAI\9X7MPDK/?)M.KG4^3+F]N5H^')VO7<.$6:8]UFW*T.91+U M E(.:UW$K\KN<[1DA2H6*X&D&/E<4J9'K;#]CO_\[)K98UHI6UTJN)EF,#J5 M%Q.,7]1V]KC2W M@1/[%07XTL10L@5^7BY0EGO+Z;[[>\CC+G!+M]9K><":4-JWUX[A9':8 M)A*FAPXTE[>LZ#4/UEKD-UQ_K0L5K\N-7#"8=#K)8#U7)CX(=I2B9,LDG*8U M.K<&51!WAO([,NS:32R,:LR"/H;@><8,L>,<+=KMC^ZR MBV0GLO"^P@]F@Z_[G@C[8C-384Q$];Y]3]"WZBYS8N**Q3/"NONU"<_X7+/8 MZAVV93_#5H('2VY966OUS=78C+#EJ!U7H\I;BWZ MAY9@_@B3;"E7*GG#)+FCZ,0HATP>E2EKT9S"P<)SO %I1?Y*U,YO&*U3@MLT M2P Z_FL#,!04+>8\09VIAM_3&2\3L?6T#&T'6O6(U+[(,8J1H[R(33]9J-R$ MY^LDT9LYJO&V@DATEPF4 MWN78C7.R/:49<2%R!Y%LAX\#3G)YAC=NV2#1C%9]- A<93*CM4#*_9039OKH MR$*5M-=!S#$AVHUO@9A,._-S:BK2P);#C M._AJBVLL;@M*=XN;Z(_PE4.C?+MMS.IL>%3)]N+BJ%'=/N6+'5B5OOV&""$Z M&?-VA0\(1T'M$(*S@Q\33"^9*'$=S'71"A=Y6R/HY094 014@')EK*I?0WLE M7CP)!L#[=YG1GRW;!)EV.@5ZM!MZ]J3T_%D[MY6K'2.VR5 M-;BML$B#ROS]*H_L [+Z>@+/,"* M'VA]$4^9PSY^D;G(CO],=V7 PLRT2+Z?5?:2JO7.BNL6#^$'3QVS5GAGC,OD M>^,@Q:-AU4J8U?BA/GH!"2M'O_62)I0;3+>G%UN FS1B/P9> PL7\UH1@NQ@ MZZ;-++IAJGQ97DW3L?(9XVU@-L.SG @K;[E 7]3-0SMUJ*Q2$-IQD' IV M:D*,83;8"YW%=QBNPYN^9#1XD:TW&%5M\KDCJ,LVP16 MJ00[CS:Z3\EEY3Y8+% M3[8B8]KS%!F6W/K+R^GV9%3<06;L#H-7RV8I""Q@&*$9670M M;W?8UD@)T^0F Q::CANYJ&YXKOPEF<\!2(15KW?DB+-J,?87PTK"ZOJG@B>*=@:]F9*VOW(,(\ 8[\6=;WQD:W]:3N$&<#ZJ6 MGU'5\O,KRL%O*[5_QB2Z%756A-X_UJ)T>QY35^#:@<2P^G%T(@H#H&!=!3+T M9$+4=@O[V<5X8^P4!'X:EL'=8]6>C?@!P"KYMNT\>?O:NWU.=&B9M'_\HU[7UZ;D8M@JN1BU2BZ^%\X MO\!"C%5%I>V6U$N5#JQNRF)_ZZG#I+&\E*(;C$!9(^4N9T2:@?\=;5(@NY4G MZ[7Q'6&5HKH%)RNW23IK0U>S?^S1NA(4[%85 UN'J'ZH[F#'.F9H18[.T\V2 M">Y6,[E_K):[7&8+H)*?QXN\*E>&=$%,"AYG^ML?O![F%:49M@\3L2K)#;(K M5K6PF)6M;SPZ]Z:L XR,LTW*;V*J\ T<(.GT(F>+Z;CXQ(*00RTPN[_>A+JR M#I\,JP&!!FF M;>M)E7S$JE&"E(?5.X1\ A^JYP1R?LZR+RLC/E8 Y*W>ZV8HG% Q71R&XITW MAW"=:R1Q\W^O%S>M7*3H^"&4)--6F5:_]%= <)$DZ6 FX*M MY(![8U^DJE-!M7NL=Q';O+J=$6Z7$*G^^(9C)JW6*_V@W.;W M );%J*(472 3I46G9=ZN1"\L?QT\V=9\U)-\\%P9M,@CD14YIF-[Q-8-)U3- MV U#U[),X@;1#Y=!>XT"9%^CBS]^N[Q0/L?*YR_15^_RX^=/%V^XNQNF^"G/ MSG[UO"_*[\ 9D&R_K57N(\)S6M;5+X6@..:LJE.,7O/0)R] M)N@X2W1NYY3F N[_VMB*$;EJ WQCC?ZYH:-\]'$R'8OZ2.CV%$E&.==9<%8C MEDS%N@_CO5^ZN_GF1:!-YRV*0%>EIU\,#?NI MT#F(J*70@V&Z(C/B#7V3#I M814$E[#0#RQTV6UM@5H425:*8G[/P<)K4]FO':HJA("B555.5+=;S:%H1RRQ M'M0;(H-6*.:&87G^;UU3>/0H'L%82&-Y#GOCI^,FW23+6&0B!BD*$;,=#S2M M"LHE,]0'6-NRV@[T[(Q6%XZ5-\L%FP@KNZ3@,96L!'+EBJ:\5:EH%6/C MLBLR-*%P"\:SGJ.R 7A0ZF^S'5'"KRXU!6KKXI[23+*:XR4OW#L#QW,F(DV: MD.L*E-[7,H?R-'/Z67(G"3X[@(_"PMT8M601?YQF+:H8*#0 PNI6'3""=',Z MSD,OV/.#8XW!6OVM\K9J^M(B]6EC386U<3,#+XC/K-OS:3+F83VL_V"!'6NH MX&&B9LA(M%%^8.]==;RQR#U3F">K-[I(%YA\)]2=LO'_8P<"844303# :7Y/ MLN2&?_J*3C&T5O1%X*]5X7*U%M5J1[)1GQ*;@ 9>6'J)G7"OE]UR"S!;7I$. M2W? I&[I=([?J2KV*DMTJG!H$<.)^LJPBR',]Q;-*2MU$;GAAIMT.*OF^Y.R M3@\PQ]47*TAN=6GG-EZT=;8OLC[5*;.(3RK+<.7^%D5D5\>>4Q TNIO+U,QE M2%3[@G.ZL80[;740)%NMB'2[W2\ M9.6. 8J+!2_OS(+3T@Q#:5GS[0++8,PV90$,*B#7E@&Y@P_([5;#08Y"N;Q: M=7G;K" )ZV:#2%>4]PE^3"!&DLFH"MJ !4IV"F46^72$#[8:+]WE^/ZT\G-@ M7D5^58X12UL$JJ8_G$2M5?C9N*9D-5^%ZPLITI8Z92ME3<>JE35.*N 'L(.C MRD_).,F2M3AZ9F2>&W+'L[02),;CIKG-&L]G/6VXJM -#!9%VAF-JW>&D;?G MMT?PL&]TE3HWQ>3;Y JU%JRCO=C2J]Z3B?FR';F2EJV$QU6#(X=&[!\PHXUF MV]7X61(C MH4Y?1MCPG,$/5V/;F1Z"G34I,1>L ]Z>0QM68D 1N;\*'OTKXY-;.DTV#+Y+ MP.MJBX^U]G7L 8P+R?CO]:6WOO?LV^T)98@7T^Z41,.\%^E?3ZE;*[/ERI6F MPDY 3W^6_OK'>/*V3\$Y;]4TM]Z][3R!/W MMKOU8R,^KSX",B_RV8I2"$?2/J/V;_Y\YU+!SE;GY]@"#8S8NI[F][_%[_\:3RF("?L>XO[:H5UV:I\ M+%3G]VB4^'D+#.MU+P0(,X:\!K^/;@O;N3[VQ3Q7][$#SI3AU ML$CX)E"!7N6 M*_8/J=I6M':8\+B]3GOTY',/%L/74%*W(J(_N-9#@=W3L%2VFY+5ILHJAFHK M*71+%&(MV20*[<2CJH#BE7"Y M/8:\?*[C/+_P=)HO32C4,&-?>CB%SZLY1+.DN,&B&CN7"I]L/<(.G1#5[3_* MZO(H\SRMZP%L7YG-/M^E\>QJ4[N]5BW=M8'!3CU"-.OPO=I\;?]DB>&G.'DWERJG>M)G\]CMM'E^(W MV.)M2<2+I_K4"VLIKYQ==<*961V.Z^0NQ\B=AZ80Y]7#+_M<@LSC'$XBWAX$ M)>Q83]^LR& KUX)'M_-6O045I:176_QTVC:493Y.64X#2[ 2.<\"B3;&MXNF M IAO5"H++/B'&4MO4VFTKG+5A/!728N/E(^LRWH_LT/K6W,'- 2;*6> =57J MN.AGS[/(LDF5#5C2XJ[*(>"-[M,F7X[GU_%, 9'JM?7Z#[ZI_=GV'[9[DN=[ MS5J5\IB4QP:PQ83#45\B\KD'5>4$QX:7U!"#8LBB: MRI4=9OF&0F65I5WU@FDUAOLU:K65:P4[[H)[EL0]B7N[120<$#;5[3N_?&9F MAJK24$,E?7GW7N]./ZVWJ0X79(?&M?H]Z#K_$(C^5DG)O_0AOP(C_#=K>'9OAZV/_< M#\NB).U)4D0_:@^?T,Y/PLFW-Y?=Z,7^NA>[&W?V\/4H&;R=O7,'AAW"TC7UV^<;%F[)Q0("PP@US%O[\ZR0M@(I,L;[[Y-_+B@R(*KF\ MS]2JW:;DO8]:AAM6'^A]NU C?JYL%X1\8FKM\1/E!BAR5F$TS..*=B;]OEU[ M<,IE)6&X6:TG.P79B7;Z<9<_8WNW%&DDEGMD9?%9O>%R.;X5LP'R1D4SNH*1 MN6YARR?6L7B8(S P9:FJ8KBVI)\/P0DRM&JZSLJ$937=O_=;35V !4.BM43K7=": M]_JNK%EOA-);O]GP>^RT,F,(.$V3JZJ[> LI$V5*;P AN7?D!HWY;V+QUDD_ M&/ML.S:)LD>*LA=="S0S/]\DP) 9KRMSU!5Y1YE-EEM D@6V#]HE2FZ 07([ M[RO[V:W7T33AH3N=+=OR MR(]M\[$W;5/T.&_9JI'*#Y8"M]^@J*_<:)-I9X)G3Y1@B"A86-^@X2&-X2&[8I;G@SA>,'V2#@:,!P]3G). MH]+W;^DU52Y8HV6Z33>;K6H+/[9G>U_MG[=8X;,G_+8=(T:62\ZM/M>U]U,0 M,8;]G\0!,=*)N%[8E*9T$RGT!I>8:6UF^!PN4IV'$ MO,Q!DMSYV PXMDF^Q)3?7>#TP,(UGMN"8<=S8-"4O9T)=^N%#Y;#'+.58D!X MO%U&Q]$B^7;;T:-GT2';>1:WWY6WA0!)'@9-'DZ/ KR"C0+XO&V<;Y,9*_F\ M1&2)R(-!9'-$]"V]VH>'R)U*9"N=!JH/O$GKSCC'OAK76/E*5#>]20K\ZL8N M(&55,^R&YC=%,K]E/3K@'7RUU7%R@>5N6"'%K6N[]=?*J!Q:E\/=-J;O5I@C M93[%5JMPC->TP-J6G_+M^S&\^[N^_;Y4Q:O'HCXN@E.09TRJ9G7GX,<$:]Q. ME#C-DFR< O1=+. 6JZ?W@NZ1^T%U]D^BI)._O2M5R]14BYBNYH7$L#17\TED M6K%F6W9DJ3X,T'0=^5$J8,WW4YKPMX]QI%P$'Z-/072Q7?&^7J;&^Q6L4IU. M9GY=I3"_OL;"DXER5>3)I.DO5-"2)L7X%J IGU8MB?#E18K579< Z0!GY6(Y M>6#0AC4DQ\K5,ITRLG\$MW@!M8K/&<([]RR5I(\0U)X9%IR4O3)FS&V* OG?"V4M?I M=,$K6(_:U:QQT#D0;NP(Q2XLZ/@V Z9Y@[,0"'E5E8\?TR7CQR/E.L\G[.4K M"DPZN:&X'1-^+Z%%#@<_QFOIN,CIE(X719ZE8[X(T74*ZTDNRT6!2%S"$WE1 MGBO; =_>:G9V0>^"K:1#?<)DD>PRZ:OO\S!X)V-6Q9G.SPB]P-@W9( M4/D!4)&E,R6H' A5D:4SCP..3KUT)FLE\M8UD XP&.=P8VWV4&Q3AM(,39B0 MN'NDN-M[#4^)NQ)W)>Z^ N[NH32HQ%V)NQ)W7P%W]U!Q=)BX>U0U"C[/*89* M\&B*ZW1QE)G?ABF+1PZ-"QPZ2&GZ5E'Z$J0D2#VR--?=KHJ/!"D)4H\LS;&W MLV(.7+8Z=(="2.<%':/*]AV'2N$&"E'FN2XA2D)4C]6Y M+7LKE5>"E 2IQT"*D,,J8WP:5KU55ZJ28/K^3YB=7CX>07RL*H&N;L5)GUUE M9>S342FB4TOR$T._WZ% \'FH_* M6MEVBO8-ZJXY4$9@G,$I@E,$M@WB,P]]IP_G" ^:E6)U4 1/5[ MP]1$T;;NU/?1O\%85:S9O[=%-<@\N:%G5P5-OITEUS"E7Y+I??)0PJ?^>EN( MU;QLBLE+YJ?<%O3Z;^_^5,:.JYE!J.N1Y9'(C3T2Z+I%--VV+#?2@FW6?LG* MOX/\'\ =;)U1;T7RPV?62T'^;EV]("^H\I7>T6Q)E5^+_'YQNV4SD0V#*[), M?SW;URO3_WR5?LM^HD[\EA7\=Q[Q3:M2#Y8#OTJMST>9UM[*>?[$=R>X92UD M'JM;K]15/Y6J<"Q_[ZX\YRUK"H:M6 E4O"CMG1*>%%8*7]D7/)V&]9*U=1?= MYVZ87*"\_]7SOCQ26__U](@W+BEE;66;[U?)>-L:5!QEI%)]H@A@#T#+'BH" M'%7PTV^T+%DONA08XQB[__WR!M[60T+S(UC?R9QEKU*<.E@D]L;_6:9EBC[H M;=H%')@%^+TV .EL[V?ZLY2]CAB$C0'(5V\#PMM(3\.EO,&R*&@V?E#H]S$W M2Q0)MBU^);GB->(DMP'48<+C]CKML9//8<*><401DKNJDX=N:60NR$*X("M3 M8Y9G9UN;&SM&;F/^79GD2[3K5A:"8S+'6-N)"SMOT5'8:Z30+%$(+9I;*8T2 MA9Z+/=HJV*.O*7\ITC%5TFQP9EL_?+9C/E6Y\Q%6BJ4.5>W'NV9'K$O'F^T_9'@EB9,'+F>TC'"!DO< M&.>S>9XAV.37\&--7CGO)\ZI5XF*@Q;,=Y:.B[P"T2V66EPMEEOP[+ZKI*[BII3*%T[EZ4(+;-$O8K/\[P2\*/&>+Z8S(GH$7 M/N4%7/-F<'&F,,PL*;[114TV!K CYXH2TAG.\QKV B=U MM2QQ)\J__,G1-?N#@M*#,GX ED$7Q0-;TCQ!WH41;<"(JD)0K4VLZ..DVNYD M.A6[?4/SFR*9WZ;P& X%6'[6VI6A@LW B!&<6@L=\>2NT^FB8%EA(^!&&'/" M,\3PM CKP$JV84%'=]F(#C:JG5*'1EN("@SO&,4 M%+9<%#2[X31VPQ$*5!\OITDQ?:A$PDWH_]29P@%^S :([*,*?E'ZV(#%#9P+ MH-O$?L8)#)*..]RG&K.DQ1TJV[!-%,$1OKBZ8^,UR+[.D<32["X%PHDJN?@2 M#$BSLDM)^:<8_P9ZPR;5W#S?*O% N\@"1'%> MI+ (&!T0F:)! )]LO8UT]V-XB6-X\.R4A28CG,$U8)YWZ02%F2O94!-:J>P@FL 46U$:!?)[BN&YKE,SSG,>S2)7(K_2BM="^K#,QK3 @4?L49:CD#TPXV7* M3AM&FB7?*)X<''PISA?^0@J/[Q04'F$$X3M>*KO?!D4T*Y,Q_YR@RVD!FN5_ MEL#\@&[#RG155\^W5[Z4/^8P.'X2-J>[C-:4.!W9L"%^)>[@PL04?TNOJ7(Q M3BGL3EF1*B =E\_L)O\> "Y\4%#/78BG6$:-@ANGM4Y:5\7L&K'&E4[4)Z5E MTGVE9XUO@3L!6++O<16L17Q'+,U1 2EHL01N/:.3%*0@/+8I/5LBQ+0L$BA4 MW-%I/F>+3#.0L):,B]?&C-;(*!DOF.X]I>SY3=LW9@$S"]1_\1/ &.[SXANS M:97Y=,F8Z9[I1S>IJ"F>_H473_]"BVO,'(7S?5LZME;6G2>3EML3LUH&W![1 MMW[34K?_*&=J\SS-%@>F8J*&R:U1G"!MM$XA\KZ-<>I-.37SB4PH* V,G/RR MA*,K\+LPUN5M6DPJ_K3E\IX:?]O]?FK,'0#ER:EBWN(>QETJ3:@K./^2.E@M\O;!\4 M#HG#;MQYAR,_VR%H1>U)WGHN&NAMPR"D#"%EB$.3(9:9E").6(I ^U6;JR*C MG:1H^KBC"KV^1I/>VT51 +-CG@G45RL;%D#/#IS(?#U&-*0R>.9JN+$L@_?Z M9?!.R\2F:7NPL0W *2>->L=AU/L7ZH^+_&P"VN*A"<\/^Y^[M&Q)F51:MIAE M2^&!>#]DW-J;J6KTHW:J%UO7!A3_^H:JQB[6+9V\CE(A*=Z14KQ6T,A90:>, M*+3C9#C%F% @*#!Q^#)+V1#VZ^LD+8!Z3)<86?+O944'6(3+'?R)$4% C1#Y MZW#+$AAT-NF&W&C.+DA@O!(.#-?"*P7* 0N4TLQYT@3VU,R)I1$T,, MBGM!DQO^5R= &;,O[[% 0RON6407W^;E/ 5V@FD(MP]E"NK\_V?OW9O;1H[U MX:^"XM%W+A;URC LKM K,6/?KR=FOQ]S>L*>=LRE/SH8]>K \@^VU@=%F M[9BKQV@WLW'=+]9<9E-[HET,Q^-!"SVQPZ=>0L\Z^^/B_W=O.1& MEP'/.6C/;,#BC FB58GF4_F \EZ,?K9D&)RH[-"D\@Q2Z1.I]#6I:%*INE39 M87LT'568CC:+G-/ (B MJVX>/^\>53_GU8K&+?&2EV@ _/*DV>QVIJA2$U(Z.E2L2:IDDNK5\Y0 5-RJ M.O2XWAH\K!48EO$38C $FW.(C]4G,+OU[DNX?\F!%EEF66?^D_9P3X.:.YJ: M-34?#35W<]T+:FK6U%Q-:CY1V7Q4T4KU6KQDT[F:=-O)56)V.-2I PE5I\!N MKLB4ID!-@5H&:@H\#@KLYLKZ.1P*/(W8JWK5?=IQUU:Y66R'0^C:M3]&8BXU MK4@3LR;F?1)SJ"I9[&I5MA%WOOK%[YD;, M^)6ZRN7LOY#Q<2.]SIU6HC'> !G/"?]>^(M[A32NK/!^%:#( MC?+NQ; @?^*[,^+=*#>!GALQ9*0A44?Y>]BY;)2T.J8F-?Q%'2K3]&00CKKQ M4O1T&H&O&P_;I?'6LZ+9[+M?A\.O&X#97\\$W3,>4;<"]NE^ 8RT)W:BI-\N M%T+O2$C_J')E/K$@2#<1_["'R[E#8O C6-_)G&6IEENCLDP\PH[?[N318#\F MW"#VK1#,N'VKKU?(V*R <:;MKRJ)YP,CX%8%3"QM1146P!A3]T5,73K/KN>> MY7:@4V&;%AB^4R_"2$61N,V>O8E^/E)_[DX>,8&_V&!L38TI6^!NP:G,@23.! <"$X+LQ<6/$5:7:9A.0$_&]^^C4+8>C@J?#YS MD?B'"JP*#O*"2^6*[GI-W;Y$H(@=7'@.FT0.4-+4MNY<+P"+(D@$T&:Q@[V7 MX6E@E?^" $I1*["9;X,S@XP M.S!W@@VLR:^!U\%9A'OW3'OSK>67 X[HV:SVS&; MO6YW,#9'N6[L*7?!FP';P6Z[85*?8JT9U)O.;"_6U-*W04';:#V[4C6GM6O- M^,W"KR*]IK0U")FKF$H56K>F]Y8[8>A:66"(@<0B;8QD/ =][#G>74SM0-.I M&:R8 YD3HL_1G&J*+B<9:(=H.#Q;M^-S2RN<\RDIDE +O&KZ!NG$HP2;ZRO' MYOK*_!EFEP+U%9A7"5RUAAK&$TZ#_"<7ZX/<7\@_MMEHY!^56SA+SP:AN.9S MIZB[:L3-E3DFIJG60I5F<'GANLI![LE)F=S5$;4K6-=7;+2IMN]WG(5(3M=KFY MV,WR2<V ]SQ^Y]G N$IA60 C!I M=H9!S7 9/;=E_]8W[AY8WHL">/\A=D*F[)XYWA(_4Y/.1\#\>WO"C2$>U,'= MC*TIV+40G^?[';E2#+'XHPO[1^%@0SBW_:GQ9V3Y8!'FW]Z"4KL R9]50 ]O MNP$X?'-IRO9G+C5?P%JJ@/.AS;-RS+-$,FH#31MH6R=ZM6]U7MNHRW>V48K: M4T4BL\(ZFE?,WA7W8-KD+609E:5RBQA&)?!Z!M0^_<=%H7K7Z[-S8'S4&[<=%NF7VJ/;9V#7EURS#A,H)S%^//-\-/QL_&^/._ MKJYOAOD"JX@ATVK4^R"Q'4?I&;7[8H,YF%H!N9@AF5Y@'<(7 MO,GWFO$PMR=SD$5+>()\P/Q.SJ#>_FD/5CLL2Y!#G$?B12'\Z"(QBL77#"LT MK+5#7?JH2(NIZ%\[@ UC?(L&I\_/ROZQOZI_FQOM]8_+6]B!PX1H9&4:PV!>=B MVH2X,)*KO_KZI8;1:2^ZF\-9@YEDB$:$;!!;B T;HV^077, M[B/_"Q 'NB;(+%.NV^4-$VZN)P>D:S14UH$]):N?[[C/P)B*153JB]82%/@/ M>P&& /@0!6BNWC!NBTH%X7F)E4M)0,M!ZS2YW1/;C'883'_"V#0P9KZW6-U\ MVN"REFC66\67"#-/SWA54(3,7\ 9WX;&S'8M%]VM>O[AC&]LAM3E&9^]L(#K MWRY\J-9DPH\5A=P(CA0S5VDC,\!?; MI6LYCN-X"V)U],^ZB!9]@$"V7")!) MZ5(NH^23!W#X\7]A&&'F\X,$)V'.*!U)?&P>+9 H@ XP?>[?N#4.LTC5W?KX M==<2T7C7NR<' <:?S%U^54[#)[FWPG\$(SJ@(T\+0QN1.^7''SS?F3[ #LF= M\G%&%@SJ65/P$E&GP"^$P,3S@XG>DL.*\I=<6#X\=U\#D4F(,G8*DQ&9;I@T M1;$S.6?*!Y6+00^)CF7.G*4<"R,M()N)8H-X]^)<4J!:H CAL#%WCI?,*;]* M!'R")>+=.V&2XL#]Y'@B3$D)$WXY+ ).(\((4>2+(43:I)P=S,?!G0X> V R M3 N+9QT?+1%-XB(2==%^!=XL?$ 27)U)BF8P]<*;(M--D 8F>*+QK$LM.'HYQ;GL6NG#30N8/;%HE<._$4F%^< $!R.!%1U]2^L_EN67=D MM%E?X87.#63D!+O?33@F*=+FTW8VNXJ2_RH;'7DVN+$ M^2CQ,:&=,%'VZ2/&4^5VB_'H/9\YZP.@E^_YG ]1*?HV$BF/':#_+R(UOA=: M/F:R^+@M"[3&D:"35VHH*FBKK+OXKF;"DGL;$-5L(K))220IB:5XUONTY;*\ M3+Z]/\?R]YHYC"*JB5ZZL!(73V.AO1X6FKD=#*V=$_ L)QB:'BS/8'L%A]L< M4<\%7_5,,(;>'J"\7A^X:Q/TVVF61)[8X1-.V[/._KCX_]U;3@18<\$# \&& MJO"8(%J5 /;+5S7Z8O2SY3K_1&6')I5GD$J?2"5/LVM-*B=&*ON6*CMLCZ:C M"M/19I%S&HBRUYM[)I7.11OW:K^X%V]? MRINH GWO]W+0966UPQ$H@0.GJ'XWEY6B*4I3U,8*K&Z]K4E*DU2) M)-4VZWDN"2MN61WZ5<(%%GEA$JQ24W$:[9'-1KD=(BHK^X[9?3]6XASD4K^: M-C5MOH(F'^12Y)HX-7&^"G&6&K&ON/EY(%;F<(&EC?\KP\JL*-DUT-2LJ;F*U-RH-S4U:VH^$FHVZ]W3 MI.:CBE6J-^(EF\X5I=M<@:;#H4X=1Z@^!>:Y[=84J"E0RT!-@<="@<=)]VW+55;@;;X1"Z=NV/D9A+!=_0Q*R)61.S)F9-S)J8"]G3LI.9^/TT M[C'&$R#DSQE3$UAMZ:F_1!>T]NH-#_UW[LN/+*T[=G;K,^O[F36#*7VPG ?K M,8"A?I[[8C6[3=':97[&W&>S7][\);CL#\SVZ*+9''>'G?'@U/%.34\&(> ;+T5/IQ&]O/&H M#1IU-!:MH]]-&3;-8N^-=[\.AU\W@.N_GD>Q9URI=ZURB\9S^1O[1:)ZKUWK M4R7^?"5)1T_\1Y7^] F;^V'#1QM4XR0$[_7#'NY;#XG%CV!])W.6I=IQC


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end
XML 79 R30.htm IDEA: XBRL DOCUMENT v3.19.3
Leases (Tables)
9 Months Ended
Sep. 27, 2019
Leases [Abstract]  
Lessee, Lease Costs
The components of operating lease expense were as follows ($ in millions):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 27, 2019
Fixed operating lease expense (a)
$
58.7

 
$
178.1

Variable operating lease expense
13.4

 
38.3

Total operating lease expense
$
72.1

 
$
216.4

(a) Includes short-term leases and sublease income, both of which were immaterial.
Supplemental cash flow information related to the Company’s operating leases for the nine-month period ended September 27, 2019 was as follows ($ in millions):
Cash paid for amounts included in the measurement of operating lease liabilities
$
177.7

ROU assets obtained in exchange for operating lease obligations
165.1


Lessee, Assets and Liabilities
The following table presents the lease balances within the Consolidated Condensed Balance Sheet, weighted average remaining
lease term and weighted average discount rates related to the Company’s operating leases as of September 27, 2019 ($ in millions):
Lease Assets and Liabilities
Classification
 
Assets:
 
 
Operating lease ROU assets
Other long-term assets
$
956.1

 
 
 
Liabilities:
 
 
Current:
 
 
Operating lease liabilities
Accrued expenses and other liabilities
$
182.0

Long-term:
 
 
Operating lease liabilities
Other long-term liabilities
817.0

Total operating lease liabilities
 
$
999.0

 
 
 
Weighted average remaining lease term
7 years

Weighted average discount rate
3.1
%

Lessee, Operating Lease, Liability, Maturity
The following table presents the maturity of the Company’s operating lease liabilities as of September 27, 2019 ($ in millions):
Remainder of 2019
$
55.8

2020
197.3

2021
160.4

2022
140.6

2023
122.0

Thereafter
460.3

Total operating lease payments
1,136.4

Less: imputed interest
137.4

Total operating lease liabilities
$
999.0


JSON 80 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "dhr-2019927x10q.htm": { "axisCustom": 0, "axisStandard": 29, "contextCount": 473, "dts": { "calculationLink": { "local": [ "dhr-20190927_cal.xml" ] }, "definitionLink": { "local": [ "dhr-20190927_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "dhr-2019927x10q.htm" ] }, "labelLink": { "local": [ "dhr-20190927_lab.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-doc-2019-01-31.xml", "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "dhr-20190927_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-ref-2019-01-31.xml" ] }, "schema": { "local": [ "dhr-20190927.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd", "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-parts-codification-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 569, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2019-01-31": 84, "http://www.danaher.com/20190927": 6, "http://xbrl.sec.gov/dei/2019-01-31": 5, "total": 95 }, "keyCustom": 28, "keyStandard": 359, "memberCustom": 46, "memberStandard": 53, "nsprefix": "dhr", "nsuri": "http://www.danaher.com/20190927", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "span", "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001000 - Document - Cover Page", "role": "http://www.danaher.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2103100 - Disclosure - Revenue (Notes)", "role": "http://www.danaher.com/role/RevenueNotes", "shortName": "Revenue (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2105100 - Disclosure - Acquisitions", "role": "http://www.danaher.com/role/Acquisitions", "shortName": "Acquisitions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2106100 - Disclosure - Envista Initial Public Offering (Notes)", "role": "http://www.danaher.com/role/EnvistaInitialPublicOfferingNotes", "shortName": "Envista Initial Public Offering (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2108100 - Disclosure - Leases (Notes)", "role": "http://www.danaher.com/role/LeasesNotes", "shortName": "Leases (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2109100 - Disclosure - Goodwill", "role": "http://www.danaher.com/role/Goodwill", "shortName": "Goodwill", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2111100 - Disclosure - Fair Value Measurements", "role": "http://www.danaher.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2112100 - Disclosure - Financing", "role": "http://www.danaher.com/role/Financing", "shortName": "Financing", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2114100 - Disclosure - Hedging Transactions And Derivative Financial Instruments (Notes)", "role": "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNotes", "shortName": "Hedging Transactions And Derivative Financial Instruments (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2115100 - Disclosure - Defined Benefit Plans", "role": "http://www.danaher.com/role/DefinedBenefitPlans", "shortName": "Defined Benefit Plans", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2117100 - Disclosure - Income Taxes", "role": "http://www.danaher.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001000 - Statement - Consolidated Condensed Balance Sheets", "role": "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets", "shortName": "Consolidated Condensed Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q3", "decimals": "-5", "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2118100 - Disclosure - Nonoperating Income (Expense)", "role": "http://www.danaher.com/role/NonoperatingIncomeExpense", "shortName": "Nonoperating Income (Expense)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2119100 - Disclosure - Commitments And Contingencies", "role": "http://www.danaher.com/role/CommitmentsAndContingencies", "shortName": "Commitments And Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2120100 - Disclosure - Stock Transactions And Stock-Based Compensation", "role": "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensation", "shortName": "Stock Transactions And Stock-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2121100 - Disclosure - Net Earnings Per Share", "role": "http://www.danaher.com/role/NetEarningsPerShare", "shortName": "Net Earnings Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2122100 - Disclosure - Segment Information", "role": "http://www.danaher.com/role/SegmentInformation", "shortName": "Segment Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2123100 - Disclosure - Subsequent Event (Notes)", "role": "http://www.danaher.com/role/SubsequentEventNotes", "shortName": "Subsequent Event (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2201202 - Disclosure - General (Policies)", "role": "http://www.danaher.com/role/GeneralPolicies", "shortName": "General (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2301301 - Disclosure - General (Tables)", "role": "http://www.danaher.com/role/GeneralTables", "shortName": "General (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2303301 - Disclosure - Revenue (Tables)", "role": "http://www.danaher.com/role/RevenueTables", "shortName": "Revenue (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2305301 - Disclosure - Acquisitions (Tables)", "role": "http://www.danaher.com/role/AcquisitionsTables", "shortName": "Acquisitions (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q3", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001001 - Statement - Consolidated Condensed Balance Sheets Consolidated Condensed Balance Sheets (Parenthetical)", "role": "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheetsConsolidatedCondensedBalanceSheetsParenthetical", "shortName": "Consolidated Condensed Balance Sheets Consolidated Condensed Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2308301 - Disclosure - Leases (Tables)", "role": "http://www.danaher.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2309301 - Disclosure - Goodwill (Tables)", "role": "http://www.danaher.com/role/GoodwillTables", "shortName": "Goodwill (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2311301 - Disclosure - Fair Value Measurements (Tables)", "role": "http://www.danaher.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2312301 - Disclosure - Financing (Tables)", "role": "http://www.danaher.com/role/FinancingTables", "shortName": "Financing (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2314301 - Disclosure - Hedging Transactions And Derivative Financial Instruments (Tables)", "role": "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsTables", "shortName": "Hedging Transactions And Derivative Financial Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2315301 - Disclosure - Defined Benefit Plans (Tables)", "role": "http://www.danaher.com/role/DefinedBenefitPlansTables", "shortName": "Defined Benefit Plans (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "dhr:SummaryOfDanahersEffectiveIncomeTaxRateTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2317301 - Disclosure - Income Taxes (Tables)", "role": "http://www.danaher.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "dhr:SummaryOfDanahersEffectiveIncomeTaxRateTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2319301 - Disclosure - Commitments And Contingencies (Tables)", "role": "http://www.danaher.com/role/CommitmentsAndContingenciesTables", "shortName": "Commitments And Contingencies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2320301 - Disclosure - Stock Transactions And Stock-Based Compensation (Tables)", "role": "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationTables", "shortName": "Stock Transactions And Stock-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2321301 - Disclosure - Net Earnings Per Share (Tables)", "role": "http://www.danaher.com/role/NetEarningsPerShareTables", "shortName": "Net Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002000 - Statement - Consolidated Condensed Statements Of Earnings", "role": "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings", "shortName": "Consolidated Condensed Statements Of Earnings", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2322301 - Disclosure - Segment Information (Tables)", "role": "http://www.danaher.com/role/SegmentInformationTables", "shortName": "Segment Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2401403 - Disclosure - General (Narrative) (Details)", "role": "http://www.danaher.com/role/GeneralNarrativeDetails", "shortName": "General (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R42": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2018Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2401404 - Disclosure - General (Components of Accumulated Other Comprehensive Income) (Details)", "role": "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails", "shortName": "General (Components of Accumulated Other Comprehensive Income) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember", "decimals": "-5", "lang": null, "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-6", "first": true, "lang": null, "name": "dhr:OperatingtypeLeaseAndSalestypeLeaseRevenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2403402 - Disclosure - Revenue (Narrative) (Details)", "role": "http://www.danaher.com/role/RevenueNarrativeDetails", "shortName": "Revenue (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-6", "first": true, "lang": null, "name": "dhr:OperatingtypeLeaseAndSalestypeLeaseRevenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2403403 - Disclosure - Revenue (Disaggregation of Revenue by Geographical Region) (Details)", "role": "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByGeographicalRegionDetails", "shortName": "Revenue (Disaggregation of Revenue by Geographical Region) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:DisaggregationOfRevenueTableTextBlock", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD_srt_StatementGeographicalAxis_srt_NorthAmericaMember", "decimals": "-5", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2403404 - Disclosure - Revenue (Disaggregation of Revenue by Revenue Type) (Details)", "role": "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByRevenueTypeDetails", "shortName": "Revenue (Disaggregation of Revenue by Revenue Type) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:DisaggregationOfRevenueTableTextBlock", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD_srt_ProductOrServiceAxis_dhr_RevenuefromContractwithCustomerMeasurementRecurringMember", "decimals": "-5", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfBusinessesAcquired", "reportCount": 1, "unique": true, "unitRef": "Business", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405402 - Disclosure - Acquisitions (Narrative) (Details)", "role": "http://www.danaher.com/role/AcquisitionsNarrativeDetails", "shortName": "Acquisitions (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfBusinessesAcquired", "reportCount": 1, "unique": true, "unitRef": "Business", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405403 - Disclosure - Acquisitions (Pro Forma Financial Information) (Narrative) (Details)", "role": "http://www.danaher.com/role/AcquisitionsProFormaFinancialInformationNarrativeDetails", "shortName": "Acquisitions (Pro Forma Financial Information) (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2018Q4YTD_us-gaap_BusinessAcquisitionAxis_dhr_IDTMember_us-gaap_NonrecurringAdjustmentAxis_us-gaap_AcquisitionRelatedCostsMember", "decimals": "-6", "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationAcquiredReceivablesFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405404 - Disclosure - Acquisitions (Fair Values Of The Assets Acquired And Liabilities) (Details)", "role": "http://www.danaher.com/role/AcquisitionsFairValuesOfAssetsAcquiredAndLiabilitiesDetails", "shortName": "Acquisitions (Fair Values Of The Assets Acquired And Liabilities) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationAcquiredReceivablesFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405405 - Disclosure - Acquisitions (Pro Forma Financial Information) (Details)", "role": "http://www.danaher.com/role/AcquisitionsProFormaFinancialInformationDetails", "shortName": "Acquisitions (Pro Forma Financial Information) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003000 - Statement - Consolidated Condensed Statements Of Comprehensive Income", "role": "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfComprehensiveIncome", "shortName": "Consolidated Condensed Statements Of Comprehensive Income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405406 - Disclosure - Acquisitions (Pending Acquisition) (Narrative) (Details)", "role": "http://www.danaher.com/role/AcquisitionsPendingAcquisitionNarrativeDetails", "shortName": "Acquisitions (Pending Acquisition) (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2018Q4YTD", "decimals": "-6", "lang": null, "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOrSaleOfEquity", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406401 - Disclosure - Envista Initial Public Offering (Narrative) (Details)", "role": "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "shortName": "Envista Initial Public Offering (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "I2019Q4SpecialDate10242019_us-gaap_DebtInstrumentAxis_dhr_RedeemedNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember", "decimals": "-6", "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "dhr:LesseeOperatingLeaseOptiontoTerminateTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408402 - Disclosure - Leases (Lease Arrangements) (Narrative) (Details)", "role": "http://www.danaher.com/role/LeasesLeaseArrangementsNarrativeDetails", "shortName": "Leases (Lease Arrangements) (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "dhr:LesseeOperatingLeaseOptiontoTerminateTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408403 - Disclosure - Leases (Components of Lease Expense) (Details)", "role": "http://www.danaher.com/role/LeasesComponentsOfLeaseExpenseDetails", "shortName": "Leases (Components of Lease Expense) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408404 - Disclosure - Leases (Supplemental Cash Flow Information) (Details)", "role": "http://www.danaher.com/role/LeasesSupplementalCashFlowInformationDetails", "shortName": "Leases (Supplemental Cash Flow Information) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408405 - Disclosure - Leases (Supplemental Balance Sheet Inofrmation) (Details)", "role": "http://www.danaher.com/role/LeasesSupplementalBalanceSheetInofrmationDetails", "shortName": "Leases (Supplemental Balance Sheet Inofrmation) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q3", "decimals": "-5", "lang": null, "name": "us-gaap:OperatingLeaseLiabilityCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408406 - Disclosure - Leases (Maturities of Lease Liabilities) (Details)", "role": "http://www.danaher.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails", "shortName": "Leases (Maturities of Lease Liabilities) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2018Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409402 - Disclosure - Goodwill (Rollforward of Goodwill) (Details)", "role": "http://www.danaher.com/role/GoodwillRollforwardOfGoodwillDetails", "shortName": "Goodwill (Rollforward of Goodwill) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:ScheduleOfGoodwillTextBlock", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": "-5", "lang": null, "name": "us-gaap:GoodwillPurchaseAccountingAdjustments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:ScheduleOfGoodwillTextBlock", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409403 - Disclosure - Goodwill (Goodwill by Segment) (Details)", "role": "http://www.danaher.com/role/GoodwillGoodwillBySegmentDetails", "shortName": "Goodwill (Goodwill by Segment) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q3_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_dhr_LifeSciencesMember", "decimals": "-5", "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q3_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411402 - Disclosure - Fair Value Measurements (Narrative) (Details)", "role": "http://www.danaher.com/role/FairValueMeasurementsNarrativeDetails", "shortName": "Fair Value Measurements (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R6": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004000 - Statement - Consolidated Condensed Statement Of Stockholders' Equity", "role": "http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquity", "shortName": "Consolidated Condensed Statement Of Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411403 - Disclosure - Fair Value Measurements (Financial Assets and Liabilities Carried at Fair Value) (Details)", "role": "http://www.danaher.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails", "shortName": "Fair Value Measurements (Financial Assets and Liabilities Carried at Fair Value) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q3", "decimals": "-5", "lang": null, "name": "us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411404 - Disclosure - Fair Value Measurements (Carrying Amounts and Fair Values of Financial Instruments) (Details)", "role": "http://www.danaher.com/role/FairValueMeasurementsCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails", "shortName": "Fair Value Measurements (Carrying Amounts and Fair Values of Financial Instruments) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q3_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember", "decimals": "-5", "lang": null, "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LongTermDebt", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412402 - Disclosure - Financing (Narrative) (Details)", "role": "http://www.danaher.com/role/FinancingNarrativeDetails", "shortName": "Financing (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2018Q4", "decimals": "-6", "lang": null, "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LongTermDebt", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412403 - Disclosure - Financing (Components Of Debt) (Details)", "role": "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "shortName": "Financing (Components Of Debt) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q3_us-gaap_DebtInstrumentAxis_dhr_OtherMember", "decimals": "-5", "lang": null, "name": "us-gaap:LongTermDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "I2019Q3SpecialDate09182019_us-gaap_DebtInstrumentAxis_dhr_A0.2SeniorNotesDue2026Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "eur", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412404 - Disclosure - Financing (Key Terms Of Offering) (Details)", "role": "http://www.danaher.com/role/FinancingKeyTermsOfOfferingDetails", "shortName": "Financing (Key Terms Of Offering) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "D2019Q3SpecialDate09182019_us-gaap_DebtInstrumentAxis_dhr_A0.2SeniorNotesDue2026Member_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember", "decimals": "INF", "lang": null, "name": "us-gaap:DebtInstrumentRedemptionPricePercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q3_dei_LegalEntityAxis_dhr_EnvistaMember_srt_ConsolidatedEntitiesAxis_srt_SubsidiariesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414402 - Disclosure - Hedging Transactions And Derivative Financial Instruments (Narrative) (Details)", "role": "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails", "shortName": "Hedging Transactions And Derivative Financial Instruments (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R66": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q3", "decimals": "-5", "first": true, "lang": null, "name": "dhr:DerivativeandNonderivativeNotionalAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414403 - Disclosure - Hedging Transactions And Derivative Financial Instruments (Summary of Notional Values and Pretax Impact in Fair Values of Net Investment Hedges) (Details)", "role": "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryOfNotionalValuesAndPretaxImpactInFairValuesOfNetInvestmentHedgesDetails", "shortName": "Hedging Transactions And Derivative Financial Instruments (Summary of Notional Values and Pretax Impact in Fair Values of Net Investment Hedges) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "lang": null, "name": "dhr:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesAndNonderivativesArisingDuringPeriodBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_NetInvestmentHedgingMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414404 - Disclosure - Hedging Transactions And Derivative Financial Instruments (Derivative and Nonderivative Debt Instruments) (Details)", "role": "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeAndNonderivativeDebtInstrumentsDetails", "shortName": "Hedging Transactions And Derivative Financial Instruments (Derivative and Nonderivative Debt Instruments) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_NetInvestmentHedgingMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q3_us-gaap_RetirementPlanSponsorLocationAxis_country_US_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2415402 - Disclosure - Defined Benefit Plans (Narrative) (Details)", "role": "http://www.danaher.com/role/DefinedBenefitPlansNarrativeDetails", "shortName": "Defined Benefit Plans (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q3_us-gaap_RetirementPlanSponsorLocationAxis_country_US_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2415403 - Disclosure - Defined Benefit Plans (Components of Net Periodic Benefit Cost of Defined Benefit Pension Pans) (Details)", "role": "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfDefinedBenefitPensionPansDetails", "shortName": "Defined Benefit Plans (Components of Net Periodic Benefit Cost of Defined Benefit Pension Pans) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD_us-gaap_RetirementPlanSponsorLocationAxis_country_US_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-5", "lang": null, "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": null, "groupType": "statement", "isDefault": "false", "longName": "1004001 - Statement - Consolidated Condensed Statement Of Stockholders' Equity Consolidated Condensed Statement Of Stockholders' Equity (Parenthetical)", "role": "http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquityConsolidatedCondensedStatementOfStockholdersEquityParenthetical", "shortName": "Consolidated Condensed Statement Of Stockholders' Equity Consolidated Condensed Statement Of Stockholders' Equity (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R70": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2415404 - Disclosure - Defined Benefit Plans (Components of Net Periodic Benefit Cost of Other Postretirement Benefit Pension Pans) (Details)", "role": "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfOtherPostretirementBenefitPensionPansDetails", "shortName": "Defined Benefit Plans (Components of Net Periodic Benefit Cost of Other Postretirement Benefit Pension Pans) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember", "decimals": "-5", "lang": null, "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2415405 - Disclosure - Defined Benefit Plans (Components of Net Periodic Benefit Cost Reflected in the Consolidated Condensed Statement of Earnings) (Details)", "role": "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostReflectedInConsolidatedCondensedStatementOfEarningsDetails", "shortName": "Defined Benefit Plans (Components of Net Periodic Benefit Cost Reflected in the Consolidated Condensed Statement of Earnings) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "lang": null, "name": "us-gaap:DefinedBenefitPlanOtherCosts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "D2017Q4SpecialDateNewIncomeTaxRate", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417402 - Disclosure - Income Taxes (Narrative) (Details)", "role": "http://www.danaher.com/role/IncomeTaxesNarrativeDetails", "shortName": "Income Taxes (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "D2017Q4SpecialDateNewIncomeTaxRate", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "dhr:SummaryOfDanahersEffectiveIncomeTaxRateTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417403 - Disclosure - Income Taxes (Summary Of Danaher's Effective Income Tax Rate) (Details)", "role": "http://www.danaher.com/role/IncomeTaxesSummaryOfDanahersEffectiveIncomeTaxRateDetails", "shortName": "Income Taxes (Summary Of Danaher's Effective Income Tax Rate) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "dhr:SummaryOfDanahersEffectiveIncomeTaxRateTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OtherNonoperatingIncome", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2418401 - Disclosure - Nonoperating Income (Expense) (Narrative) (Details)", "role": "http://www.danaher.com/role/NonoperatingIncomeExpenseNarrativeDetails", "shortName": "Nonoperating Income (Expense) (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R75": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2419402 - Disclosure - Commitments And Contingencies (Narrative) (Details)", "role": "http://www.danaher.com/role/CommitmentsAndContingenciesNarrativeDetails", "shortName": "Commitments And Contingencies (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2018Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2419403 - Disclosure - Commitments And Contingencies (Warranty Accrual) (Details)", "role": "http://www.danaher.com/role/CommitmentsAndContingenciesWarrantyAccrualDetails", "shortName": "Commitments And Contingencies (Warranty Accrual) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2018Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "I2013Q3ShareRepurchaseProgram", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420402 - Disclosure - Stock Transactions And Stock-Based Compensation (Narrative) (Details)", "role": "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails", "shortName": "Stock Transactions And Stock-Based Compensation (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "I2013Q3ShareRepurchaseProgram", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfStockByClassTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420403 - Disclosure - Stock Transactions And Stock-Based Compensation (Summary of Share Activity) (Details)", "role": "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationSummaryOfShareActivityDetails", "shortName": "Stock Transactions And Stock-Based Compensation (Summary of Share Activity) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfStockByClassTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420404 - Disclosure - Stock Transactions And Stock-Based Compensation (Components of Stock-Based Compensation Program) (Details)", "role": "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationComponentsOfStockBasedCompensationProgramDetails", "shortName": "Stock Transactions And Stock-Based Compensation (Components of Stock-Based Compensation Program) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005000 - Statement - Consolidated Condensed Statements Of Cash Flows", "role": "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows", "shortName": "Consolidated Condensed Statements Of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": "-5", "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2421402 - Disclosure - Net Earnings Per Share (Narrative) (Details)", "role": "http://www.danaher.com/role/NetEarningsPerShareNarrativeDetails", "shortName": "Net Earnings Per Share (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2421403 - Disclosure - Net Earnings Per Share (Components of Basic and Diluted Earnings per Share) (Details)", "role": "http://www.danaher.com/role/NetEarningsPerShareComponentsOfBasicAndDilutedEarningsPerShareDetails", "shortName": "Net Earnings Per Share (Components of Basic and Diluted Earnings per Share) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "lang": null, "name": "us-gaap:InterestOnConvertibleDebtNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "Business_Segments", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2422402 - Disclosure - Segment Information (Narrative) (Details)", "role": "http://www.danaher.com/role/SegmentInformationNarrativeDetails", "shortName": "Segment Information (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "Business_Segments", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2422403 - Disclosure - Segment Information (Segment Results) (Details)", "role": "http://www.danaher.com/role/SegmentInformationSegmentResultsDetails", "shortName": "Segment Information (Segment Results) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember", "decimals": "-5", "lang": null, "name": "us-gaap:OperatingIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "D2019Q4SpecialDate10242019_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:PaymentsOfDebtExtinguishmentCosts", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2423401 - Disclosure - Subsequent Event (Narrative) (Details)", "role": "http://www.danaher.com/role/SubsequentEventNarrativeDetails", "shortName": "Subsequent Event (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R9": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101100 - Disclosure - General", "role": "http://www.danaher.com/role/General", "shortName": "General", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dhr-2019927x10q.htm", "contextRef": "FD2019Q3YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 111, "tag": { "country_US": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "UNITED STATES", "terseLabel": "U.S. pension benefits" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2017-01-31", "presentation": [ "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfDefinedBenefitPensionPansDetails", "http://www.danaher.com/role/DefinedBenefitPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City area code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current fiscal year end date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document fiscal period focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document fiscal year focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document period end date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r400" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document quarterly report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r401" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document transition report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]", "terseLabel": "Cover Page [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity address, address line one" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity address, city" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity address, postal zip code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity address, state" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r402" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity central index key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity common stock, shares outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity current reporting status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/FairValueMeasurementsNarrativeDetails", "http://www.danaher.com/role/FinancingNarrativeDetails", "http://www.danaher.com/role/GeneralNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r402" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity emerging growth company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity file number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r402" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity filer category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity incorporation, state code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]", "terseLabel": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r403" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity interactive data current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r402" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity registrant name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r402" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity shell company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r402" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity small business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r402" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity tax identification number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/FairValueMeasurementsNarrativeDetails", "http://www.danaher.com/role/FinancingNarrativeDetails", "http://www.danaher.com/role/GeneralNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local phone number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r398" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r399" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security exchange name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dhr_A0.2SeniorNotesDue2026Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "0.2% Senior Notes Due 2026 [Member]", "label": "0.2% Senior Notes Due 2026 [Member]", "terseLabel": "0.2% senior notes due 2026" } } }, "localname": "A0.2SeniorNotesDue2026Member", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/CoverPage", "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingKeyTermsOfOfferingDetails" ], "xbrltype": "domainItemType" }, "dhr_A0.352SeniorNotesDue2021Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "0.352% Senior Notes Due 2021 [Member]", "label": "0.352% Senior Notes Due 2021 [Member]", "terseLabel": "0.352% senior notes due 2021" } } }, "localname": "A0.352SeniorNotesDue2021Member", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/FinancingComponentsOfDebtDetails" ], "xbrltype": "domainItemType" }, "dhr_A0.3SeniorNotesDue2027Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "0.3% Senior Unsecured Notes Due 2027 [Member]", "label": "0.3% Senior Notes Due 2027 [Member]", "terseLabel": "0.3% senior notes due 2027" } } }, "localname": "A0.3SeniorNotesDue2027Member", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/FinancingComponentsOfDebtDetails" ], "xbrltype": "domainItemType" }, "dhr_A0.45SeniorNotesDue2028Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "0.45% Senior Notes Due 2028 [Member]", "label": "0.45% Senior Notes Due 2028 [Member]", "terseLabel": "0.45% senior notes due 2028" } } }, "localname": "A0.45SeniorNotesDue2028Member", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/CoverPage", "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingKeyTermsOfOfferingDetails" ], "xbrltype": "domainItemType" }, "dhr_A0.5BondsDue2023Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "0.5% Bonds Due 2023 [Member]", "label": "0.5% Bonds Due 2023 [Member]", "terseLabel": "0.5% senior bonds due 2023" } } }, "localname": "A0.5BondsDue2023Member", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/FinancingComponentsOfDebtDetails" ], "xbrltype": "domainItemType" }, "dhr_A0.65SeniorNotesDue2032Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "0.65% Senior Notes Due 2032 [Member]", "label": "0.65% Senior Notes Due 2032 [Member]", "terseLabel": "0.65% senior notes due 2032" } } }, "localname": "A0.65SeniorNotesDue2032Member", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/FinancingComponentsOfDebtDetails" ], "xbrltype": "domainItemType" }, "dhr_A0.75SeniorNotesDue2031Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "0.75% Senior Notes Due 2031 [Member]", "label": "0.75% Senior Notes Due 2031 [Member]", "terseLabel": "0.75% senior notes due 2031" } } }, "localname": "A0.75SeniorNotesDue2031Member", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/CoverPage", "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingKeyTermsOfOfferingDetails" ], "xbrltype": "domainItemType" }, "dhr_A1.0SeniorNotesDue2019Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "1.0% Senior Notes Due 2019 [Member]", "label": "1.0% Senior Notes Due 2019 [Member]", "terseLabel": "1.0% senior notes due 2019" } } }, "localname": "A1.0SeniorNotesDue2019Member", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhr_A1.125BondsDue2028Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "1.125% Bonds Due 2028 [Member]", "label": "1.125% Bonds Due 2028 [Member]", "terseLabel": "1.125% senior bonds due 2028" } } }, "localname": "A1.125BondsDue2028Member", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/FinancingComponentsOfDebtDetails" ], "xbrltype": "domainItemType" }, "dhr_A1.2SeniorNotesDue2027Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "1.2% Senior Notes Due 2027 [Member]", "label": "1.2% Senior Notes Due 2027 [Member]", "terseLabel": "1.2% senior notes due 2027" } } }, "localname": "A1.2SeniorNotesDue2027Member", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/CoverPage", "http://www.danaher.com/role/FinancingComponentsOfDebtDetails" ], "xbrltype": "domainItemType" }, "dhr_A1.35SeniorNotesDue2039Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "1.35% Senior Notes Due 2039 [Member]", "label": "1.35% Senior Notes Due 2039 [Member]", "terseLabel": "1.35% senior notes due 2039" } } }, "localname": "A1.35SeniorNotesDue2039Member", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/CoverPage", "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingKeyTermsOfOfferingDetails" ], "xbrltype": "domainItemType" }, "dhr_A1.7SeniorNotesDue2022Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "1.7% Senior Notes Due 2022 [Member]", "label": "1.7% Senior Notes Due 2022 [Member]", "terseLabel": "1.7% senior notes due 2022" } } }, "localname": "A1.7SeniorNotesDue2022Member", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/CoverPage", "http://www.danaher.com/role/FinancingComponentsOfDebtDetails" ], "xbrltype": "domainItemType" }, "dhr_A1.8SeniorNotesDue2049Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "1.8% Senior Notes Due 2049 [Member]", "label": "1.8% Senior Notes Due 2049 [Member]", "terseLabel": "1.8% senior notes due 2049" } } }, "localname": "A1.8SeniorNotesDue2049Member", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/CoverPage", "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingKeyTermsOfOfferingDetails" ], "xbrltype": "domainItemType" }, "dhr_A2.4SeniorNotesDue2020Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "2.4% Senior Notes Due 2020 [Member]", "label": "2.4% Senior Notes Due 2020 [Member]", "terseLabel": "2.4% senior notes due 2020" } } }, "localname": "A2.4SeniorNotesDue2020Member", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingNarrativeDetails", "http://www.danaher.com/role/SubsequentEventNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhr_A2.5SeniorNotesDue2025Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "2.5% Senior Notes Due 2025 [Member]", "label": "2.5% Senior Notes Due 2025 [Member]", "terseLabel": "2.5% senior notes due 2025" } } }, "localname": "A2.5SeniorNotesDue2025Member", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/CoverPage", "http://www.danaher.com/role/FinancingComponentsOfDebtDetails" ], "xbrltype": "domainItemType" }, "dhr_A2020CreditFacilitiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "2020 Credit Facilities", "label": "2020 Credit Facilities [Member]", "terseLabel": "2020 credit facilities" } } }, "localname": "A2020CreditFacilitiesMember", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhr_A3.35SeniorNotesDue2025Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "3.35% Senior Notes Due 2025 [Member]", "label": "3.35% Senior Notes Due 2025 [Member]", "terseLabel": "3.35% senior notes due 2025" } } }, "localname": "A3.35SeniorNotesDue2025Member", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/FinancingComponentsOfDebtDetails" ], "xbrltype": "domainItemType" }, "dhr_A364DayFacilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "364-Day Facility [Member]", "label": "364-Day Facility [Member]", "terseLabel": "364-day facility" } } }, "localname": "A364DayFacilityMember", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhr_A4.375SeniorNotesDue2045Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "4.375% Senior Unsecured Notes Due 2045 [Member]", "label": "4.375% Senior Notes Due 2045 [Member]", "terseLabel": "4.375% senior notes due 2045" } } }, "localname": "A4.375SeniorNotesDue2045Member", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/FinancingComponentsOfDebtDetails" ], "xbrltype": "domainItemType" }, "dhr_A5.0SeniorNotesDue2020Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "5.0% Senior Notes 2020 [Member]", "label": "5.0% Senior Notes Due 2020 [Member]", "terseLabel": "5.0% senior notes due 2020" } } }, "localname": "A5.0SeniorNotesDue2020Member", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/SubsequentEventNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhr_BiopharmaAcquisitionMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Biopharma Acquisition [Member]", "label": "Biopharma Acquisition [Member]", "terseLabel": "Biopharma Acquisition" } } }, "localname": "BiopharmaAcquisitionMember", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/AcquisitionsPendingAcquisitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhr_BiopharmaEuronotesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Biopharma Euronotes [Member]", "label": "Biopharma Euronotes [Member]", "terseLabel": "Biopharma euronotes" } } }, "localname": "BiopharmaEuronotesMember", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssetsAndLiabilitiesNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets And Liabilities, Net", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets And Liabilities, Net", "negatedTerseLabel": "Other assets and liabilities, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssetsAndLiabilitiesNet", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/AcquisitionsFairValuesOfAssetsAcquiredAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "dhr_CumulativeEffectofNewAccountingPrincipleinPeriodofAdoptionIncreaseDecreasetoAOCI": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Cumulative Effect of New Accounting Principle in Period of Adoption, Increase (Decrease) to AOCI.", "label": "Cumulative Effect of New Accounting Principle in Period of Adoption, Increase (Decrease) to AOCI", "terseLabel": "Adoption of accounting standards" } } }, "localname": "CumulativeEffectofNewAccountingPrincipleinPeriodofAdoptionIncreaseDecreasetoAOCI", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "dhr_DebtConversionConvertedInstrumentTaxBenefitExpense": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Debt Conversion, Converted Instrument, Tax Benefit (Expense)", "label": "Debt Conversion, Converted Instrument, Tax Benefit (Expense)", "terseLabel": "Debt conversion, converted instrument, tax benefit" } } }, "localname": "DebtConversionConvertedInstrumentTaxBenefitExpense", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquityConsolidatedCondensedStatementOfStockholdersEquityParenthetical", "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "dhr_DebtInstrumentCovenantsConversionFeePercent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Covenants, Conversion Fee, Percent", "label": "Debt Instrument, Covenants, Conversion Fee, Percent", "terseLabel": "Debt instrument, leverage ratio, maximum" } } }, "localname": "DebtInstrumentCovenantsConversionFeePercent", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "percentItemType" }, "dhr_DebtInstrumentCovenantsLeverageRatio": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Covenants, Leverage Ratio", "label": "Debt Instrument, Covenants, Leverage Ratio", "terseLabel": "Leverage ratio" } } }, "localname": "DebtInstrumentCovenantsLeverageRatio", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "pureItemType" }, "dhr_DentalEnvistaMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Dental [Member]", "label": "Dental / Envista [Member]", "terseLabel": "Dental / Envista" } } }, "localname": "DentalEnvistaMember", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/GoodwillGoodwillBySegmentDetails", "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByGeographicalRegionDetails", "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByRevenueTypeDetails", "http://www.danaher.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "dhr_DerivativeandNonderivativeNotionalAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Derivative and Nonderivative, Notional Amount", "label": "Derivative and Nonderivative, Notional Amount", "terseLabel": "Derivative and nonderivative, notional amount" } } }, "localname": "DerivativeandNonderivativeNotionalAmount", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryOfNotionalValuesAndPretaxImpactInFairValuesOfNetInvestmentHedgesDetails" ], "xbrltype": "monetaryItemType" }, "dhr_DiagnosticsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Diagnostics [Member]", "label": "Diagnostics [Member]", "terseLabel": "Diagnostics" } } }, "localname": "DiagnosticsMember", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/GoodwillGoodwillBySegmentDetails", "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByGeographicalRegionDetails", "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByRevenueTypeDetails", "http://www.danaher.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "dhr_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPerDilutedShareAmount": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Per Diluted Share Amount", "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Per Diluted Share Amount", "terseLabel": "Net tax benefits, impact, per diluted share" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPerDilutedShareAmount", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "perShareItemType" }, "dhr_EnvironmentalAppliedSolutionsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Environmental & Applied Solutions [Member]", "label": "Environmental & Applied Solutions [Member]", "terseLabel": "Environmental & Applied Solutions" } } }, "localname": "EnvironmentalAppliedSolutionsMember", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/GoodwillGoodwillBySegmentDetails", "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByGeographicalRegionDetails", "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByRevenueTypeDetails", "http://www.danaher.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "dhr_EnvistaCreditFacilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Envista Credit Facility [Member]", "label": "Envista Credit Facility [Member]", "terseLabel": "Envista credit facility" } } }, "localname": "EnvistaCreditFacilityMember", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhr_EnvistaEuroTermLoanFacilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Envista Euro Term Loan Facility [Member]", "label": "Envista Euro Term Loan Facility [Member]", "terseLabel": "Envista euro term loan facility" } } }, "localname": "EnvistaEuroTermLoanFacilityMember", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhr_EnvistaMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Envista [Member]", "label": "Envista [Member]", "terseLabel": "Envista" } } }, "localname": "EnvistaMember", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/FairValueMeasurementsNarrativeDetails", "http://www.danaher.com/role/FinancingNarrativeDetails", "http://www.danaher.com/role/GeneralNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhr_EnvistaTermLoanFacilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Envista Term Loan Facility", "label": "Envista Term Loan Facility [Member]", "terseLabel": "Envista term loan facility" } } }, "localname": "EnvistaTermLoanFacilityMember", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhr_EuroDenominatedCommercialPaperMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Euro-Denominated Commercial Paper [Member]", "label": "Euro-Denominated Commercial Paper [Member]", "terseLabel": "Euro-denominated commercial paper" } } }, "localname": "EuroDenominatedCommercialPaperMember", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhr_FiveYearFacilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Five-Year Facility [Member]", "label": "Five-Year Facility [Member]", "terseLabel": "Five-year facility" } } }, "localname": "FiveYearFacilityMember", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhr_FloatingRateSeniorNotesDue2022Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Floating Rate Senior Notes Due 2022 Member [Member]", "label": "Floating Rate Senior Notes Due 2022 [Member]", "terseLabel": "Floating rate senior notes due 2022" } } }, "localname": "FloatingRateSeniorNotesDue2022Member", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/CoverPage", "http://www.danaher.com/role/FinancingComponentsOfDebtDetails" ], "xbrltype": "domainItemType" }, "dhr_ForeignCurrencyDenominatedDebtMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign Currency Denominated debt [Member]", "label": "Foreign Currency Denominated Debt [Member]", "terseLabel": "Foreign currency denominated debt" } } }, "localname": "ForeignCurrencyDenominatedDebtMember", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryOfNotionalValuesAndPretaxImpactInFairValuesOfNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "dhr_HighgrowthmarketsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The Company defines high-growth markets as developing markets of the world experiencing extended periods of accelerated growth in gross domestic product and infrastructure which includes Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia).", "label": "High-growth markets [Member]", "terseLabel": "High-growth markets" } } }, "localname": "HighgrowthmarketsMember", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "dhr_IDTMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "IDT", "label": "IDT [Member]", "terseLabel": "IDT" } } }, "localname": "IDTMember", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/AcquisitionsProFormaFinancialInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhr_IncomeTaxExaminationAmountofPotentialAdditionalTaxAssessments": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Income Tax Examination, Amount of Potential Additional Tax Assessments", "label": "Income Tax Examination, Amount of Potential Additional Tax Assessments", "terseLabel": "Income tax examination, amount of potential additional tax assessments" } } }, "localname": "IncomeTaxExaminationAmountofPotentialAdditionalTaxAssessments", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "dhr_IncomeTaxExaminationAmountofTaxAssessments": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Income tax assessment received imposing withholding tax and interest related to accrued interest on borrowings.", "label": "Income Tax Examination, Amount of Tax Assessments", "terseLabel": "Income tax examination, amount of tax assessments" } } }, "localname": "IncomeTaxExaminationAmountofTaxAssessments", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "dhr_IncomeTaxExaminationSelfinsuranceProgramsProposedAdjustmentstoTaxableIncome": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Income Tax Examination, Self-insurance Programs, Proposed Adjustments to Taxable Income", "label": "Income Tax Examination, Self-insurance Programs, Proposed Adjustments to Taxable Income", "terseLabel": "Income tax examination, proposed adjustments to taxable income" } } }, "localname": "IncomeTaxExaminationSelfinsuranceProgramsProposedAdjustmentstoTaxableIncome", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "dhr_InterestRateSwapLiabilityFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Interest Rate Swap, Liability, Fair Value Disclosure", "label": "Interest Rate Swap, Liability, Fair Value Disclosure", "terseLabel": "Interest rate swap derivative contracts" } } }, "localname": "InterestRateSwapLiabilityFairValueDisclosure", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails", "http://www.danaher.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails" ], "xbrltype": "monetaryItemType" }, "dhr_LesseeAssetsandLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lessee, Assets and Liabilities[Table Text Block]", "label": "Lessee, Assets and Liabilities [Table Text Block]", "terseLabel": "Lessee, Assets and Liabilities" } } }, "localname": "LesseeAssetsandLiabilitiesTableTextBlock", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "dhr_LesseeOperatingLeaseOptiontoTerminateTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lessee, Operating Lease, Option to Terminate, Term", "label": "Lessee, Operating Lease, Option to Terminate, Term", "terseLabel": "Lessee, operating lease, option to terminate, term" } } }, "localname": "LesseeOperatingLeaseOptiontoTerminateTerm", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/LeasesLeaseArrangementsNarrativeDetails" ], "xbrltype": "durationItemType" }, "dhr_LifeSciencesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Life Sciences [Member]", "label": "Life Sciences [Member]", "terseLabel": "Life Sciences" } } }, "localname": "LifeSciencesMember", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/GoodwillGoodwillBySegmentDetails", "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByGeographicalRegionDetails", "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByRevenueTypeDetails", "http://www.danaher.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "dhr_LineofCreditFacilityAdditionalBorrowingCapacity": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Line of Credit Facility Additional Borrowing Capacity", "label": "Line of Credit Facility, Additional Borrowing Capacity", "terseLabel": "Additional borrowing capacity expansion" } } }, "localname": "LineofCreditFacilityAdditionalBorrowingCapacity", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "dhr_LongtermDebtWeightedAverageMaturityatPointinTime": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Long-term Debt, Weighted Average Maturity, at Point in Time", "label": "Long-term Debt, Weighted Average Maturity, at Point in Time", "terseLabel": "Weighted average maturity of long-term debt, at point in time" } } }, "localname": "LongtermDebtWeightedAverageMaturityatPointinTime", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "durationItemType" }, "dhr_LossContingencyAccrualPeriodIncreaseDecreaseAftertax": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Loss Contingency Accrual, Period Increase (Decrease), After-tax", "label": "Loss Contingency Accrual, Period Increase (Decrease), After-tax", "terseLabel": "Loss contingency accrual, period increase, after-tax" } } }, "localname": "LossContingencyAccrualPeriodIncreaseDecreaseAftertax", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "dhr_LossContingencyAccrualPeriodIncreaseDecreasePerDilutedShare": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency Accrual, Period Increase (Decrease), Per Diluted Share", "label": "Loss Contingency Accrual, Period Increase (Decrease), Per Diluted Share", "terseLabel": "Loss contingency accrual, period increase, per diluted share" } } }, "localname": "LossContingencyAccrualPeriodIncreaseDecreasePerDilutedShare", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "perShareItemType" }, "dhr_NonderivativeHedgingInstruments": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Nonderivative Hedging Instruments", "label": "Nonderivative Hedging Instruments", "terseLabel": "Nonderivative, notional amount", "verboseLabel": "Nonderivative hedging instruments" } } }, "localname": "NonderivativeHedgingInstruments", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeAndNonderivativeDebtInstrumentsDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryOfNotionalValuesAndPretaxImpactInFairValuesOfNetInvestmentHedgesDetails" ], "xbrltype": "monetaryItemType" }, "dhr_OperatingtypeLeaseAndSalestypeLeaseRevenues": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of operating-type lease and sales-type lease revenues.", "label": "Operating-type Lease And Sales-type Lease, Revenues", "terseLabel": "Revenue, OTLs and STLs" } } }, "localname": "OperatingtypeLeaseAndSalestypeLeaseRevenues", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/RevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "dhr_OtherComprehensiveIncomeLossUnrealizedGainLossonNonderivativesArisingDuringPeriodBeforeTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Nonderivatives Arising During Period, Before Tax", "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Nonderivatives Arising During Period, Before Tax", "terseLabel": "Nonderivative, gain (loss) recognized in OCI" } } }, "localname": "OtherComprehensiveIncomeLossUnrealizedGainLossonNonderivativesArisingDuringPeriodBeforeTax", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryOfNotionalValuesAndPretaxImpactInFairValuesOfNetInvestmentHedgesDetails" ], "xbrltype": "monetaryItemType" }, "dhr_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesAndNonderivativesArisingDuringPeriodBeforeTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Other Comprehensive Income Unrealized Gain Loss On Derivatives And Nonderivatives Arising During Period Before Tax", "label": "Other Comprehensive Income Unrealized Gain Loss On Derivatives And Nonderivatives Arising During Period Before Tax", "terseLabel": "Derivative and nonderivative, gain (loss) recognized in OCI" } } }, "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesAndNonderivativesArisingDuringPeriodBeforeTax", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryOfNotionalValuesAndPretaxImpactInFairValuesOfNetInvestmentHedgesDetails" ], "xbrltype": "monetaryItemType" }, "dhr_OtherMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Other [Member]", "label": "Other [Member]", "terseLabel": "Other" } } }, "localname": "OtherMember", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/FinancingComponentsOfDebtDetails" ], "xbrltype": "domainItemType" }, "dhr_OtherdevelopedmarketsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Other developed markets [Member]", "label": "Other developed markets [Member]", "terseLabel": "Other developed markets" } } }, "localname": "OtherdevelopedmarketsMember", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "dhr_PaymentsOfDebtExtinguishmentCostsAfterTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Payments Of Debt Extinguishment Costs, After-Tax", "label": "Payments Of Debt Extinguishment Costs, After-Tax", "terseLabel": "Make-whole premiums, after-tax" } } }, "localname": "PaymentsOfDebtExtinguishmentCostsAfterTax", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/SubsequentEventNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "dhr_PaymentsOfDebtExtinguishmentCostsPerDilutedShare": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Payments Of Debt Extinguishment Costs, Per Diluted Share", "label": "Payments Of Debt Extinguishment Costs, Per Diluted Share", "terseLabel": "Make-whole premiums, per diluted share" } } }, "localname": "PaymentsOfDebtExtinguishmentCostsPerDilutedShare", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/SubsequentEventNarrativeDetails" ], "xbrltype": "perShareItemType" }, "dhr_ProceedsfromUnderwrittenPublicOfferingsofCommonStockandMandatoryConvertiblePreferredStockProceedsfromIssuanceofDebtandAvailableCash": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Proceeds from Underwritten Public Offerings of Common Stock and Mandatory Convertible Preferred Stock, Proceeds from Issuance of Debt, and Available Cash", "label": "Proceeds from Underwritten Public Offerings of Common Stock and Mandatory Convertible Preferred Stock, Proceeds from Issuance of Debt, and Available Cash", "terseLabel": "Proceeds from issuance of common stock and preferred stock, proceeds from issuance of debt and available cash" } } }, "localname": "ProceedsfromUnderwrittenPublicOfferingsofCommonStockandMandatoryConvertiblePreferredStockProceedsfromIssuanceofDebtandAvailableCash", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/AcquisitionsPendingAcquisitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "dhr_RedeemedNotesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Redeemed Notes [Member]", "label": "Redeemed Notes [Member]", "terseLabel": "Redeemed notes" } } }, "localname": "RedeemedNotesMember", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhr_RevenueRemainingPerformanceObligationExpectedSatisfactioninTheNext12MonthsPercent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Revenue, Remaining Performance Obligation, Expected Satisfaction in The Next 12 Months, Percent", "label": "Revenue, Remaining Performance Obligation, Expected Satisfaction in The Next 12 Months, Percent", "terseLabel": "Revenue, remaining performance obligation, expected satisfaction in next 12 months, percent" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedSatisfactioninTheNext12MonthsPercent", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/RevenueNarrativeDetails" ], "xbrltype": "percentItemType" }, "dhr_RevenueRemainingPerformanceObligationExpectedSatisfactioninYearTwoPercent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Revenue, Remaining Performance Obligation, Expected Satisfaction in Year Two, Percent", "label": "Revenue, Remaining Performance Obligation, Expected Satisfaction in Year Two, Percent", "terseLabel": "Revenue, remaining performance obligation, expected satisfaction in subsequent 12 months, percent" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedSatisfactioninYearTwoPercent", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/RevenueNarrativeDetails" ], "xbrltype": "percentItemType" }, "dhr_RevenuefromContractwithCustomerMeasurementNonrecurringMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Revenue from Contract with Customer, Measurement, Nonrecurring [Member]", "label": "Revenue from Contract with Customer, Measurement, Nonrecurring [Member]", "terseLabel": "Nonrecurring revenue" } } }, "localname": "RevenuefromContractwithCustomerMeasurementNonrecurringMember", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByRevenueTypeDetails" ], "xbrltype": "domainItemType" }, "dhr_RevenuefromContractwithCustomerMeasurementRecurringMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Revenue from Contract with Customer, Measurement, Recurring [Member]", "label": "Revenue from Contract with Customer, Measurement, Recurring [Member]", "terseLabel": "Recurring revenue" } } }, "localname": "RevenuefromContractwithCustomerMeasurementRecurringMember", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByRevenueTypeDetails" ], "xbrltype": "domainItemType" }, "dhr_SaleofStockTransactionsConsiderationTransferedandProceedsfromIssuanceofDebt": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sale of Stock Transactions, Consideration Transfered and Proceeds from Issuance of Debt", "label": "Sale of Stock Transactions, Consideration Transfered and Proceeds from Issuance of Debt", "terseLabel": "Consideration transfered and proceeds from issuance of debt" } } }, "localname": "SaleofStockTransactionsConsiderationTransferedandProceedsfromIssuanceofDebt", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "dhr_SummaryOfDanahersEffectiveIncomeTaxRateTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Summary Of Danaher's Effective Income Tax Rate [Table Text Block]", "label": "Summary Of Danaher's Effective Income Tax Rate [Table Text Block]", "terseLabel": "Summary Of Effective Income Tax Rate" } } }, "localname": "SummaryOfDanahersEffectiveIncomeTaxRateTableTextBlock", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "dhr_SupersededCreditFacilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Superseded Credit Facility [Member]", "label": "Superseded Credit Facility [Member]", "terseLabel": "Superseded credit facility" } } }, "localname": "SupersededCreditFacilityMember", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhr_U.S.DollarDenominatedBondsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "U.S. Dollar-Denominated Bonds [Member]", "label": "U.S. Dollar-Denominated Bonds [Member]", "terseLabel": "U.S. dollar-denominated bonds" } } }, "localname": "U.S.DollarDenominatedBondsMember", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsNarrativeDetails", "http://www.danaher.com/role/GeneralNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhr_USDollarDenominatedCommercialPaperMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "US Dollar Denominated Commercial Paper [Member]", "label": "US Dollar-Denominated Commercial Paper [Member]", "terseLabel": "U.S. dollar-denominated commercial paper" } } }, "localname": "USDollarDenominatedCommercialPaperMember", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhr_WesternEuropeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Western Europe [Member]", "label": "Western Europe [Member]", "terseLabel": "Western Europe" } } }, "localname": "WesternEuropeMember", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "dhr_ZeroCouponLYONSDue2021Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Zero-Coupon LYONS Due 2021 [Member]", "label": "Zero-Coupon LYONS Due 2021 [Member]", "terseLabel": "Zero-coupon LYONs due 2021" } } }, "localname": "ZeroCouponLYONSDue2021Member", "nsuri": "http://www.danaher.com/20190927", "presentation": [ "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r396" ], "lang": { "en-US": { "role": { "label": "Consolidated Entities [Axis]", "terseLabel": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/FairValueMeasurementsNarrativeDetails", "http://www.danaher.com/role/FinancingNarrativeDetails", "http://www.danaher.com/role/GeneralNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Consolidated Entities [Domain]", "terseLabel": "Consolidated Entities [Domain]" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/FairValueMeasurementsNarrativeDetails", "http://www.danaher.com/role/FinancingNarrativeDetails", "http://www.danaher.com/role/GeneralNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r126", "r133" ], "lang": { "en-US": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.danaher.com/role/GoodwillGoodwillBySegmentDetails", "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByGeographicalRegionDetails", "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByRevenueTypeDetails", "http://www.danaher.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.danaher.com/role/GoodwillGoodwillBySegmentDetails", "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByGeographicalRegionDetails", "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByRevenueTypeDetails", "http://www.danaher.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsNarrativeDetails", "http://www.danaher.com/role/FinancingNarrativeDetails", "http://www.danaher.com/role/GeneralNarrativeDetails", "http://www.danaher.com/role/LeasesLeaseArrangementsNarrativeDetails", "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsNarrativeDetails", "http://www.danaher.com/role/FinancingNarrativeDetails", "http://www.danaher.com/role/GeneralNarrativeDetails", "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NorthAmericaMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "North America [Member]", "terseLabel": "North America" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r136", "r208", "r211", "r391", "r392" ], "lang": { "en-US": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByRevenueTypeDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByRevenueTypeDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsNarrativeDetails", "http://www.danaher.com/role/FinancingNarrativeDetails", "http://www.danaher.com/role/GeneralNarrativeDetails", "http://www.danaher.com/role/LeasesLeaseArrangementsNarrativeDetails", "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsNarrativeDetails", "http://www.danaher.com/role/FinancingNarrativeDetails", "http://www.danaher.com/role/GeneralNarrativeDetails", "http://www.danaher.com/role/LeasesLeaseArrangementsNarrativeDetails", "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Forecast [Member]", "terseLabel": "Scenario, forecast" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r137", "r208", "r212", "r393", "r394", "r395" ], "lang": { "en-US": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByGeographicalRegionDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r175", "r360" ], "lang": { "en-US": { "role": { "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_SubsidiariesMember": { "auth_ref": [ "r229", "r357", "r358" ], "lang": { "en-US": { "role": { "label": "Subsidiaries [Member]", "terseLabel": "Subsidiaries" } } }, "localname": "SubsidiariesMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/FairValueMeasurementsNarrativeDetails", "http://www.danaher.com/role/FinancingNarrativeDetails", "http://www.danaher.com/role/GeneralNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]" } } }, "localname": "AOCIAttributableToParentNetOfTaxRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities.", "label": "Accounts Payable and Accrued Liabilities [Member]", "terseLabel": "Accrued expenses and other liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeAndNonderivativeDebtInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableTradeCurrent": { "auth_ref": [ "r7", "r27" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Trade, Current", "terseLabel": "Trade accounts payable" } } }, "localname": "AccountsPayableTradeCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r4", "r16", "r139", "r140", "r209" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Trade accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r30" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued expenses and other liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r52", "r58", "r60", "r228", "r294" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "terseLabel": "Pension & Postretirement Plan Benefit Adjustments" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r25", "r167" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "terseLabel": "Property, plant and equipment, net of accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheetsConsolidatedCondensedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember": { "auth_ref": [ "r58", "r293" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, including portion attributable to noncontrolling interest.", "label": "Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]", "terseLabel": "Cash Flow Hedge Adjustments" } } }, "localname": "AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": { "auth_ref": [ "r49", "r50", "r51", "r58", "r60" ], "lang": { "en-US": { "role": { "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.", "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]", "terseLabel": "Unrealized Gain (Loss) on Available-For-Sale Securities Adjustments" } } }, "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r55", "r57", "r58" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "terseLabel": "Accumulated other comprehensive income (loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets", "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r54", "r58", "r60", "r294" ], "lang": { "en-US": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated other comprehensive income (loss)", "verboseLabel": "AOCI attributable to controlling interest" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquity", "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r47", "r58", "r60", "r294" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Foreign Currency Translation Adjustments" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AcquisitionRelatedCostsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Category of acquisition-related costs allocated to (included in) reported pro forma earnings (supplemental pro forma information).", "label": "Acquisition-related Costs [Member]", "terseLabel": "Acquisition-related transaction costs" } } }, "localname": "AcquisitionRelatedCostsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/AcquisitionsProFormaFinancialInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r17" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "verboseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquity", "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentForAmortization": { "auth_ref": [ "r96", "r165" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.", "label": "Amortization", "terseLabel": "Amortization" } } }, "localname": "AdjustmentForAmortization", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Noncash items:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r246", "r252", "r256" ], "calculation": { "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationComponentsOfStockBasedCompensationProgramDetails": { "order": 1.0, "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Pretax compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationComponentsOfStockBasedCompensationProgramDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": { "auth_ref": [], "calculation": { "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationComponentsOfStockBasedCompensationProgramDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Expense, after Tax", "totalLabel": "Stock-based compensation expense, net of income taxes" } } }, "localname": "AllocatedShareBasedCompensationExpenseNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationComponentsOfStockBasedCompensationProgramDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r121" ], "lang": { "en-US": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive securities excluded from computation of earnings per share, amount" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/NetEarningsPerShareNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/NetEarningsPerShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AociAttributableToNoncontrollingInterestMember": { "auth_ref": [ "r54", "r58", "r294" ], "lang": { "en-US": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Noncontrolling Interest [Member]", "terseLabel": "AOCI attributable to noncontrolling interest" } } }, "localname": "AociAttributableToNoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": { "auth_ref": [ "r54", "r58", "r60", "r294" ], "lang": { "en-US": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]", "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]" } } }, "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r130", "r368", "r382" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets", "verboseLabel": "Identifiable assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets", "http://www.danaher.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r6", "r43" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets:" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "auth_ref": [ "r142", "r143", "r149" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale", "terseLabel": "Available-for-sale debt securities" } } }, "localname": "AvailableForSaleSecuritiesDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails", "http://www.danaher.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r248", "r254" ], "lang": { "en-US": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationComponentsOfStockBasedCompensationProgramDetails", "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeAndNonderivativeDebtInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r307", "r310" ], "lang": { "en-US": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeAndNonderivativeDebtInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BondsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt security, in which the authorized issuer owes the holder a debt and is obliged to repay the principal and interest (the coupon).", "label": "Bonds [Member]", "terseLabel": "Bonds" } } }, "localname": "BondsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingComponentsOfDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/AcquisitionsPendingAcquisitionNarrativeDetails", "http://www.danaher.com/role/AcquisitionsProFormaFinancialInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r273", "r274" ], "lang": { "en-US": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/AcquisitionsPendingAcquisitionNarrativeDetails", "http://www.danaher.com/role/AcquisitionsProFormaFinancialInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/AcquisitionsPendingAcquisitionNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted": { "auth_ref": [ "r270", "r271" ], "lang": { "en-US": { "role": { "documentation": "The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisition, Pro Forma Earnings Per Share, Diluted", "terseLabel": "Diluted net earnings per share" } } }, "localname": "BusinessAcquisitionProFormaEarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/AcquisitionsProFormaFinancialInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]", "terseLabel": "Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]" } } }, "localname": "BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/AcquisitionsProFormaFinancialInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable": { "auth_ref": [ "r272" ], "lang": { "en-US": { "role": { "documentation": "Schedule of the nature and amount of any material, nonrecurring adjustments directly attributable to the business combination(s) included in the reported pro forma revenue and earnings (supplemental pro forma information).", "label": "Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table]", "terseLabel": "Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table]" } } }, "localname": "BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/AcquisitionsProFormaFinancialInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [ "r270", "r271" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.", "label": "Business Acquisition, Pro Forma Information [Table Text Block]", "terseLabel": "Results Of Operations If Acquisition Was Consummated" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total revenue reported by the acquired entity for its previous full fiscal year before the business acquisition.", "label": "Business Acquisition, Revenue Reported by Acquired Entity for Last Annual Period", "terseLabel": "Revenue reported by acquired entity for last annual period", "verboseLabel": "Pending acquisition, revenue for last annual period" } } }, "localname": "BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/AcquisitionsNarrativeDetails", "http://www.danaher.com/role/AcquisitionsPendingAcquisitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "auth_ref": [ "r270", "r271" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisition, Pro Forma Net Income (Loss)", "terseLabel": "Net earnings attributable to common stockholders" } } }, "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/AcquisitionsProFormaFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "auth_ref": [ "r270", "r271" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Business Acquisition, Pro Forma Revenue", "terseLabel": "Sales" } } }, "localname": "BusinessAcquisitionsProFormaRevenue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/AcquisitionsProFormaFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAcquiredReceivablesFairValue": { "auth_ref": [ "r276" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value of acquired receivable from business combination, excluding certain loans and debt securities acquired in transfer.", "label": "Business Combination, Acquired Receivable, Fair Value", "terseLabel": "Trade accounts receivable" } } }, "localname": "BusinessCombinationAcquiredReceivablesFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/AcquisitionsFairValuesOfAssetsAcquiredAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r279", "r280", "r281" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Net cash consideration", "verboseLabel": "Pending acquisition, purchase price" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/AcquisitionsFairValuesOfAssetsAcquiredAndLiabilitiesDetails", "http://www.danaher.com/role/AcquisitionsNarrativeDetails", "http://www.danaher.com/role/AcquisitionsPendingAcquisitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r282" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "verboseLabel": "Acquisitions" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/Acquisitions" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "auth_ref": [ "r277" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable", "negatedTerseLabel": "Trade accounts payable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/AcquisitionsFairValuesOfAssetsAcquiredAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r277" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "terseLabel": "Other intangible assets, primarily customer relationships, trade names and technology" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/AcquisitionsFairValuesOfAssetsAcquiredAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r275", "r277" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "terseLabel": "Inventories" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/AcquisitionsFairValuesOfAssetsAcquiredAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": { "auth_ref": [ "r277" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other", "terseLabel": "Pending acquisition, pension liabilities to be assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/AcquisitionsPendingAcquisitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r275", "r277" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "terseLabel": "Property, plant and equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/AcquisitionsFairValuesOfAssetsAcquiredAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "auth_ref": [ "r333", "r334" ], "lang": { "en-US": { "role": { "documentation": "Measured as reported on the statement of financial position (balance sheet).", "label": "Reported Value Measurement [Member]", "terseLabel": "Carrying Amount" } } }, "localname": "CarryingReportedAmountFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r24", "r98" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Ending balance of cash and equivalents", "periodStartLabel": "Beginning balance of cash and equivalents", "terseLabel": "Cash and equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets", "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows", "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease": { "auth_ref": [], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.", "label": "Cash and Cash Equivalents, Period Increase (Decrease)", "totalLabel": "Net change in cash and equivalents" } } }, "localname": "CashAndCashEquivalentsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r303" ], "lang": { "en-US": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Cash flow hedging" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsNarrativeDetails", "http://www.danaher.com/role/GeneralNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryOfNotionalValuesAndPretaxImpactInFairValuesOfNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_CommercialPaperMember": { "auth_ref": [ "r183" ], "lang": { "en-US": { "role": { "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.", "label": "Commercial Paper [Member]", "terseLabel": "Commercial paper" } } }, "localname": "CommercialPaperMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r173", "r176" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r35" ], "lang": { "en-US": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock, Capital Shares Reserved for Future Issuance", "terseLabel": "Common shares reserved for issuance under the 2007 Omnibus Incentive Plan, shares" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common stock", "verboseLabel": "Common stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquity", "http://www.danaher.com/role/CoverPage", "http://www.danaher.com/role/NetEarningsPerShareNarrativeDetails", "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails", "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationSummaryOfShareActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheetsConsolidatedCondensedBalanceSheetsParenthetical", "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheetsConsolidatedCondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheetsConsolidatedCondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r15", "r192" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheetsConsolidatedCondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r15" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock - $0.01 par value, 2.0 billion shares authorized; 835.0 million issued and 718.2 million outstanding at September 27, 2019; 817.9 million issued and 701.5 million outstanding at December 31, 2018" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r63", "r65", "r66" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income attributable to Danaher" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r63", "r65", "r286", "r287", "r297" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "negatedTerseLabel": "Less: comprehensive income attributable to noncontrolling interests" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r63", "r65", "r285", "r297" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Comprehensive income" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerAssetNet": { "auth_ref": [ "r203", "r205", "r209" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "Contract with Customer, Asset, after Allowance for Credit Loss", "terseLabel": "Contract with customer, asset, net" } } }, "localname": "ContractWithCustomerAssetNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/RevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r203", "r204", "r209" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "terseLabel": "Contract with customer, liability" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/RevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r210" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "terseLabel": "Contract with customer, liability, revenue recognized" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/RevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r185" ], "lang": { "en-US": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]", "terseLabel": "Convertible debt" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": { "auth_ref": [ "r13", "r14", "r193", "r196" ], "lang": { "en-US": { "role": { "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.", "label": "Convertible Preferred Stock, Shares Issued upon Conversion", "terseLabel": "Convertible preferred stock, shares issued upon conversion" } } }, "localname": "ConvertiblePreferredStockSharesIssuedUponConversion", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r135" ], "lang": { "en-US": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Corporate, Non-Segment [Member]", "terseLabel": "Other" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r73" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "negatedLabel": "Cost of sales" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of sales" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostReflectedInConsolidatedCondensedStatementOfEarningsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Costs and Expenses [Abstract]", "terseLabel": "Operating costs:" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.", "label": "Cumulative Effect of New Accounting Principle in Period of Adoption", "terseLabel": "Adoption of accounting standards" } } }, "localname": "CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "auth_ref": [ "r101", "r102" ], "lang": { "en-US": { "role": { "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.", "label": "Debt Conversion, Converted Instrument, Shares Issued", "terseLabel": "Shares issued under debt conversion, shares" } } }, "localname": "DebtConversionConvertedInstrumentSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtCurrent": { "auth_ref": [ "r29" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.danaher.com/role/FinancingComponentsOfDebtDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.", "label": "Debt, Current", "terseLabel": "Less: currently payable", "verboseLabel": "Notes payable and current portion of long-term debt" } } }, "localname": "DebtCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets", "http://www.danaher.com/role/FinancingComponentsOfDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r188" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "verboseLabel": "Financing" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/Financing" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r10", "r11", "r12", "r369", "r370", "r381" ], "lang": { "en-US": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/FairValueMeasurementsNarrativeDetails", "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingKeyTermsOfOfferingDetails", "http://www.danaher.com/role/FinancingNarrativeDetails", "http://www.danaher.com/role/GeneralNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails", "http://www.danaher.com/role/SubsequentEventNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Debt instrument, basis spread on variable rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days", "terseLabel": "Convertible preferred stock, threshold consecutive trading days" } } }, "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r339", "r341" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Aggregate principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingKeyTermsOfOfferingDetails", "http://www.danaher.com/role/FinancingNarrativeDetails", "http://www.danaher.com/role/SubsequentEventNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r32" ], "lang": { "en-US": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest rate of debt instrument" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingKeyTermsOfOfferingDetails", "http://www.danaher.com/role/FinancingNarrativeDetails", "http://www.danaher.com/role/SubsequentEventNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingKeyTermsOfOfferingDetails", "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r33" ], "lang": { "en-US": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/FairValueMeasurementsNarrativeDetails", "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingKeyTermsOfOfferingDetails", "http://www.danaher.com/role/FinancingNarrativeDetails", "http://www.danaher.com/role/GeneralNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails", "http://www.danaher.com/role/SubsequentEventNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r379" ], "lang": { "en-US": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument, Redemption Price, Percentage", "terseLabel": "Debt instrument, redemption price, percent" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingKeyTermsOfOfferingDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r33", "r107", "r193", "r197", "r198", "r199", "r338", "r339", "r341", "r380" ], "lang": { "en-US": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingKeyTermsOfOfferingDetails", "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": { "auth_ref": [ "r186", "r340" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.", "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net", "terseLabel": "Debt discounts, premiums and debt issuance costs" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).", "label": "Deferred Compensation Liability, Classified, Noncurrent", "terseLabel": "Deferred compensation plans" } } }, "localname": "DeferredCompensationLiabilityClassifiedNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "auth_ref": [ "r225", "r238", "r242" ], "calculation": { "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfDefinedBenefitPensionPansDetails": { "order": 4.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Gain (Loss)", "terseLabel": "Amortization of actuarial loss" } } }, "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfDefinedBenefitPensionPansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": { "auth_ref": [ "r226", "r239", "r242" ], "calculation": { "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfDefinedBenefitPensionPansDetails": { "order": 5.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)", "negatedTerseLabel": "Amortization of prior service (cost) credit" } } }, "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfDefinedBenefitPensionPansDetails", "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfOtherPostretirementBenefitPensionPansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]", "terseLabel": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfDefinedBenefitPensionPansDetails", "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfOtherPostretirementBenefitPensionPansDetails", "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostReflectedInConsolidatedCondensedStatementOfEarningsDetails", "http://www.danaher.com/role/DefinedBenefitPlansNarrativeDetails", "http://www.danaher.com/role/DefinedBenefitPlansTables" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear": { "auth_ref": [ "r241" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of contributions received and expected to be received by defined benefit plan from employer in current fiscal year.", "label": "Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year", "terseLabel": "Expected future employer contributions, current fiscal year" } } }, "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DefinedBenefitPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "auth_ref": [ "r224", "r237", "r242" ], "calculation": { "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfDefinedBenefitPensionPansDetails": { "order": 3.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets", "terseLabel": "Expected return on plan assets" } } }, "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfDefinedBenefitPensionPansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanInterestCost": { "auth_ref": [ "r218", "r223", "r236", "r242" ], "calculation": { "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfDefinedBenefitPensionPansDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.", "label": "Defined Benefit Plan, Interest Cost", "negatedTerseLabel": "Interest cost" } } }, "localname": "DefinedBenefitPlanInterestCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfDefinedBenefitPensionPansDetails", "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfOtherPostretirementBenefitPensionPansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "auth_ref": [ "r221", "r234", "r242" ], "calculation": { "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfDefinedBenefitPensionPansDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostReflectedInConsolidatedCondensedStatementOfEarningsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "negatedTerseLabel": "Net periodic benefit (cost)", "negatedTotalLabel": "Net periodic benefit (cost)" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfDefinedBenefitPensionPansDetails", "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfOtherPostretirementBenefitPensionPansDetails", "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostReflectedInConsolidatedCondensedStatementOfEarningsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanOtherCosts": { "auth_ref": [], "calculation": { "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostReflectedInConsolidatedCondensedStatementOfEarningsDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of defined benefit plan cost (credit), classified as other.", "label": "Defined Benefit Plan, Other Cost (Credit)", "negatedTerseLabel": "Other income, net" } } }, "localname": "DefinedBenefitPlanOtherCosts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostReflectedInConsolidatedCondensedStatementOfEarningsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments": { "auth_ref": [ "r227", "r240" ], "calculation": { "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfDefinedBenefitPensionPansDetails": { "order": 6.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment", "terseLabel": "Curtailment gain recognized" } } }, "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfDefinedBenefitPensionPansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": { "auth_ref": [ "r227", "r240" ], "calculation": { "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfDefinedBenefitPensionPansDetails": { "order": 7.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement", "terseLabel": "Settlement loss recognized" } } }, "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfDefinedBenefitPensionPansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanServiceCost": { "auth_ref": [ "r217", "r222", "r235", "r242" ], "calculation": { "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfDefinedBenefitPensionPansDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 }, "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostReflectedInConsolidatedCondensedStatementOfEarningsDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Service Cost", "negatedLabel": "Total service cost", "negatedTerseLabel": "Service cost" } } }, "localname": "DefinedBenefitPlanServiceCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfDefinedBenefitPensionPansDetails", "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfOtherPostretirementBenefitPensionPansDetails", "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostReflectedInConsolidatedCondensedStatementOfEarningsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r96", "r166" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r44", "r45", "r332" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "terseLabel": "Derivative assets" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeAndNonderivativeDebtInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsNarrativeDetails", "http://www.danaher.com/role/GeneralNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryOfNotionalValuesAndPretaxImpactInFairValuesOfNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r308", "r309", "r312", "r315" ], "lang": { "en-US": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsNarrativeDetails", "http://www.danaher.com/role/GeneralNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryOfNotionalValuesAndPretaxImpactInFairValuesOfNetInvestmentHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r323" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "Hedging Transactions and Derivative Financial Instruments" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r305", "r308", "r312" ], "lang": { "en-US": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsNarrativeDetails", "http://www.danaher.com/role/GeneralNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeAndNonderivativeDebtInstrumentsDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryOfNotionalValuesAndPretaxImpactInFairValuesOfNetInvestmentHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r305", "r308", "r312", "r315", "r316", "r319", "r321" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]", "terseLabel": "Derivative Instruments, Gain (Loss) [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryOfNotionalValuesAndPretaxImpactInFairValuesOfNetInvestmentHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryOfNotionalValuesAndPretaxImpactInFairValuesOfNetInvestmentHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r44", "r45", "r332" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Derivative liabilities" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeAndNonderivativeDebtInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r300", "r302" ], "lang": { "en-US": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "terseLabel": "Derivative, notional amount", "verboseLabel": "Derivatives, notional amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsNarrativeDetails", "http://www.danaher.com/role/GeneralNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryOfNotionalValuesAndPretaxImpactInFairValuesOfNetInvestmentHedgesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r109", "r299", "r301", "r302", "r305", "r306", "r311", "r312", "r317", "r318", "r321" ], "lang": { "en-US": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeTermOfContract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Derivative, Term of Contract", "terseLabel": "Derivative, term of contract" } } }, "localname": "DerivativeTermOfContract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsNarrativeDetails", "http://www.danaher.com/role/GeneralNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DerivativesFairValueLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivatives, Fair Value [Line Items]", "terseLabel": "Derivatives, Fair Value [Line Items]" } } }, "localname": "DerivativesFairValueLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeAndNonderivativeDebtInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByGeographicalRegionDetails", "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByRevenueTypeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByGeographicalRegionDetails", "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByRevenueTypeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r208" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Disaggregation of Revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r257" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "terseLabel": "Stock Transactions And Stock-Based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": { "auth_ref": [ "r248", "r254" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of share-based payment arrangement.", "label": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]", "terseLabel": "Components Of Stock-Based Compensation Program" } } }, "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": { "auth_ref": [ "r1" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Revenue", "verboseLabel": "Pending divestiture, revenue" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/AcquisitionsPendingAcquisitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsCommonStockCash": { "auth_ref": [ "r200" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.", "label": "Dividends, Common Stock, Cash", "negatedLabel": "Dividends declared" } } }, "localname": "DividendsCommonStockCash", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPreferredStockCash": { "auth_ref": [ "r200", "r378" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.", "label": "Dividends, Preferred Stock, Cash", "negatedTerseLabel": "Mandatory convertible preferred stock cumulative dividends" } } }, "localname": "DividendsPreferredStockCash", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Net earnings per common share:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r71", "r111", "r115", "r118", "r119", "r120", "r123", "r376", "r389" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic", "verboseLabel": "Basic EPS" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings", "http://www.danaher.com/role/NetEarningsPerShareComponentsOfBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r71", "r111", "r115", "r118", "r119", "r120", "r123", "r376", "r389" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted", "verboseLabel": "Diluted EPS" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings", "http://www.danaher.com/role/NetEarningsPerShareComponentsOfBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareReconciliationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share Reconciliation [Abstract]", "terseLabel": "Numerator" } } }, "localname": "EarningsPerShareReconciliationAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/NetEarningsPerShareComponentsOfBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r124" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Net Earnings Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/NetEarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": { "auth_ref": [ "r335" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.", "label": "Effect of Exchange Rate on Cash and Cash Equivalents", "terseLabel": "Effect of exchange rate changes on cash and equivalents" } } }, "localname": "EffectOfExchangeRateOnCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r108", "r260", "r261" ], "lang": { "en-US": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/IncomeTaxesSummaryOfDanahersEffectiveIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r260", "r261", "r265" ], "lang": { "en-US": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Federal statutory income tax rate, percent" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.", "label": "Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent", "terseLabel": "Net tax benefits, impact, percent" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r253" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "verboseLabel": "Total unrecognized compensation cost" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r253" ], "lang": { "en-US": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Weighted average period for cost to be recognized" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": { "auth_ref": [ "r252" ], "calculation": { "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationComponentsOfStockBasedCompensationProgramDetails": { "order": 2.0, "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Expense, Tax Benefit", "negatedTerseLabel": "Income tax benefit" } } }, "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationComponentsOfStockBasedCompensationProgramDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r251" ], "lang": { "en-US": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]", "terseLabel": "Stock options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationComponentsOfStockBasedCompensationProgramDetails", "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r192" ], "lang": { "en-US": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquity", "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails", "http://www.danaher.com/role/NetEarningsPerShareNarrativeDetails", "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails", "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationSummaryOfShareActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquitySecuritiesFvNi": { "auth_ref": [ "r330" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Equity Securities, FV-NI", "terseLabel": "Investment in equity securities" } } }, "localname": "EquitySecuritiesFvNi", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails", "http://www.danaher.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "auth_ref": [ "r332" ], "lang": { "en-US": { "role": { "documentation": "Measured as an estimate of fair value.", "label": "Estimate of Fair Value Measurement [Member]", "terseLabel": "Fair Value" } } }, "localname": "EstimateOfFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EurodollarMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest rate based on U.S. dollar denominated deposits at foreign banks or foreign branches of U.S. banks.", "label": "Eurodollar [Member]", "terseLabel": "Eurocurrency rate" } } }, "localname": "EurodollarMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAdjustmentToInventoryMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fair value adjustment to acquisition-date inventory allocated (included) to (in) reported pro forma earnings (supplemental pro forma information).", "label": "Fair Value Adjustment to Inventory [Member]", "terseLabel": "Fair value adjustment to inventory" } } }, "localname": "FairValueAdjustmentToInventoryMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/AcquisitionsProFormaFinancialInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r324", "r325", "r326", "r328" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]" } } }, "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "auth_ref": [ "r324", "r333", "r334" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value, by Balance Sheet Grouping [Table]", "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]" } } }, "localname": "FairValueByBalanceSheetGroupingTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "auth_ref": [ "r324", "r333" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]", "terseLabel": "Carrying Amounts And Fair Values Of Financial Instruments" } } }, "localname": "FairValueByBalanceSheetGroupingTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r219", "r220", "r242", "r325", "r362" ], "lang": { "en-US": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementBasisAxis": { "auth_ref": [ "r324", "r329" ], "lang": { "en-US": { "role": { "documentation": "Information by measurement basis.", "label": "Measurement Basis [Axis]", "terseLabel": "Measurement Basis [Axis]" } } }, "localname": "FairValueByMeasurementBasisAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.", "label": "Fair Value Measurement [Domain]", "terseLabel": "Fair Value Measurement [Domain]" } } }, "localname": "FairValueDisclosureItemAmountsDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r327" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r219", "r220", "r242", "r325", "r363" ], "lang": { "en-US": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Quoted Prices in Active Market (Level 1)" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r219", "r220", "r242", "r325", "r364" ], "lang": { "en-US": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Significant Other Observable Inputs (Level 2)" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r219", "r220", "r242", "r325", "r365" ], "lang": { "en-US": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Significant Unobservable Inputs (Level 3)" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "auth_ref": [ "r307", "r311", "r319" ], "lang": { "en-US": { "role": { "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]" } } }, "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeAndNonderivativeDebtInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FederalFundsEffectiveSwapRateMember": { "auth_ref": [ "r320" ], "lang": { "en-US": { "role": { "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg.", "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]", "terseLabel": "Federal funds rate" } } }, "localname": "FederalFundsEffectiveSwapRateMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r144", "r145", "r146", "r147", "r148", "r150", "r151", "r152", "r153" ], "lang": { "en-US": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]", "terseLabel": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]", "terseLabel": "Assets:" } } }, "localname": "FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]", "terseLabel": "Liabilities:" } } }, "localname": "FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Tax Authority [Member]", "terseLabel": "Foreign tax authority" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.", "label": "Foreign Currency Contract, Asset, Fair Value Disclosure", "terseLabel": "Cross-currency swap derivative contracts" } } }, "localname": "ForeignCurrencyContractAssetFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails", "http://www.danaher.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignExchangeContractMember": { "auth_ref": [ "r219", "r314" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.", "label": "Foreign Exchange Contract [Member]", "terseLabel": "Foreign currency contracts" } } }, "localname": "ForeignExchangeContractMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GeneralNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryOfNotionalValuesAndPretaxImpactInFairValuesOfNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignPlanMember": { "auth_ref": [ "r231" ], "lang": { "en-US": { "role": { "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Foreign Plan [Member]", "terseLabel": "Non-U.S. pension benefits" } } }, "localname": "ForeignPlanMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfDefinedBenefitPensionPansDetails", "http://www.danaher.com/role/DefinedBenefitPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r155", "r156" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Balance, September 27, 2019", "periodStartLabel": "Balance, December 31, 2018", "terseLabel": "Goodwill", "verboseLabel": "Total goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets", "http://www.danaher.com/role/GoodwillGoodwillBySegmentDetails", "http://www.danaher.com/role/GoodwillRollforwardOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAcquiredDuringPeriod": { "auth_ref": [ "r157" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.", "label": "Goodwill, Acquired During Period", "terseLabel": "Goodwill", "verboseLabel": "Attributable to 2019 acquisitions" } } }, "localname": "GoodwillAcquiredDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/AcquisitionsFairValuesOfAssetsAcquiredAndLiabilitiesDetails", "http://www.danaher.com/role/AcquisitionsNarrativeDetails", "http://www.danaher.com/role/GoodwillRollforwardOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillDisclosureTextBlock": { "auth_ref": [ "r162" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for goodwill.", "label": "Goodwill Disclosure [Text Block]", "verboseLabel": "Goodwill" } } }, "localname": "GoodwillDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/Goodwill" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r158" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "verboseLabel": "Foreign currency translation and other" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GoodwillRollforwardOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GoodwillGoodwillBySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillPurchaseAccountingAdjustments": { "auth_ref": [ "r159", "r269" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Purchase Accounting Adjustments", "terseLabel": "Adjustments due to finalization of purchase price allocations" } } }, "localname": "GoodwillPurchaseAccountingAdjustments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GoodwillRollforwardOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill [Roll Forward]" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GoodwillRollforwardOfGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r72" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r305" ], "lang": { "en-US": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsNarrativeDetails", "http://www.danaher.com/role/GeneralNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeAndNonderivativeDebtInstrumentsDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryOfNotionalValuesAndPretaxImpactInFairValuesOfNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]", "terseLabel": "IPO" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r69", "r111", "r367", "r374", "r390" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Earnings before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r169" ], "lang": { "en-US": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostReflectedInConsolidatedCondensedStatementOfEarningsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostReflectedInConsolidatedCondensedStatementOfEarningsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r262" ], "lang": { "en-US": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r268" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Tax Examination [Line Items]", "terseLabel": "Income Tax Examination [Line Items]" } } }, "localname": "IncomeTaxExaminationLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExaminationTable": { "auth_ref": [ "r263", "r264" ], "lang": { "en-US": { "role": { "documentation": "A summary of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the Increase or Decrease in the liability from the prior period, and any penalties and interest that have been incurred or accrued.", "label": "Income Tax Examination [Table]", "terseLabel": "Income Tax Examination [Table]" } } }, "localname": "IncomeTaxExaminationTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r105", "r129", "r267" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": { "auth_ref": [ "r260", "r261" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount", "terseLabel": "Net tax benefits, impact, amount" } } }, "localname": "IncomeTaxReconciliationOtherReconcilingItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r100" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Cash income tax payments" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r95" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Change in trade accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r95" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Change in trade accounts receivable, net" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r95" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Change in inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r95" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.", "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities", "terseLabel": "Change in accrued expenses and other liabilities" } } }, "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r95" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Change in prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquity", "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationSummaryOfShareActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": { "auth_ref": [ "r117", "r122" ], "calculation": { "http://www.danaher.com/role/NetEarningsPerShareComponentsOfBasicAndDilutedEarningsPerShareDetails": { "order": 3.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities", "terseLabel": "Assumed conversion of the convertible debentures" } } }, "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/NetEarningsPerShareComponentsOfBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r116", "r122" ], "calculation": { "http://www.danaher.com/role/NetEarningsPerShareComponentsOfBasicAndDilutedEarningsPerShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements", "verboseLabel": "Assumed exercise of dilutive options and vesting of dilutive RSUs and PSUs" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/NetEarningsPerShareComponentsOfBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r163", "r164" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Other intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r68", "r128", "r337", "r340", "r377" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestOnConvertibleDebtNetOfTax": { "auth_ref": [ "r114" ], "calculation": { "http://www.danaher.com/role/NetEarningsPerShareComponentsOfBasicAndDilutedEarningsPerShareDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The after-tax amount of interest recognized in the period associated with any convertible debt.", "label": "Interest on Convertible Debt, Net of Tax", "terseLabel": "Adjustment for interest on convertible debentures" } } }, "localname": "InterestOnConvertibleDebtNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/NetEarningsPerShareComponentsOfBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r90", "r93", "r100" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash interest payments" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r313" ], "lang": { "en-US": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap [Member]", "terseLabel": "Interest rate swap agreements", "verboseLabel": "Interest rate swaps" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsNarrativeDetails", "http://www.danaher.com/role/GeneralNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryOfNotionalValuesAndPretaxImpactInFairValuesOfNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r39" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Inventory, Finished Goods, Gross", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryGross": { "auth_ref": [ "r42" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Inventory, Gross", "totalLabel": "Total inventories" } } }, "localname": "InventoryGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNetAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Inventory, Net [Abstract]", "terseLabel": "Inventories:" } } }, "localname": "InventoryNetAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r41" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Raw Materials, Gross", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r40" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Inventory, Work in Process, Gross", "terseLabel": "Work in process" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r75", "r127" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "terseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r353", "r355" ], "calculation": { "http://www.danaher.com/role/LeasesComponentsOfLeaseExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "totalLabel": "Total operating lease expense" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/LeasesComponentsOfLeaseExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r353" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Lessee, Lease Costs" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/LeasesLeaseArrangementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r346" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]", "terseLabel": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/LeasesLeaseArrangementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r354" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Lessee, Operating Lease, Liability, Maturity" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r354" ], "calculation": { "http://www.danaher.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Payments, Due", "totalLabel": "Total operating lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r354" ], "calculation": { "http://www.danaher.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Due after Year Five", "terseLabel": "Due thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r354" ], "calculation": { "http://www.danaher.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Five", "terseLabel": "Due in year five" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r354" ], "calculation": { "http://www.danaher.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Four", "terseLabel": "Due in year four" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r354" ], "calculation": { "http://www.danaher.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Three", "terseLabel": "Due in year three" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r354" ], "calculation": { "http://www.danaher.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Two", "terseLabel": "Due in year two" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r354" ], "calculation": { "http://www.danaher.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease having an initial or remaining lease term in excess of one year due in remainder of fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year", "terseLabel": "Remainder of fiscal year" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r354" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "terseLabel": "Less: imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "auth_ref": [ "r345" ], "lang": { "en-US": { "role": { "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Renewal Term", "terseLabel": "Lessee, operating lease, renewal term" } } }, "localname": "LesseeOperatingLeaseRenewalTerm", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/LeasesLeaseArrangementsNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r356" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/LeasesNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r21", "r372", "r386" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r31" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities, Fair Value Disclosure [Abstract]", "terseLabel": "Liabilities:" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r12", "r370", "r381" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-term Line of Credit", "terseLabel": "Line of credit facility, amount outstanding" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.", "label": "Line of Credit Facility, Commitment Fee Percentage", "terseLabel": "Per annum fee" } } }, "localname": "LineOfCreditFacilityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r28" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Line of credit" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate (LIBOR) [Member]", "terseLabel": "LIBOR" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r12", "r187", "r370", "r383" ], "calculation": { "http://www.danaher.com/role/FinancingComponentsOfDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt", "terseLabel": "Long-term debt", "totalLabel": "Long-term debt" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.", "label": "Long-term Debt, Fair Value", "terseLabel": "Long-term debt" } } }, "localname": "LongTermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.", "label": "Long-term Debt [Member]", "terseLabel": "Long-term debt" } } }, "localname": "LongTermDebtMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeAndNonderivativeDebtInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r33" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 }, "http://www.danaher.com/role/FinancingComponentsOfDebtDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt", "verboseLabel": "Long-term debt excluding currently payable" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets", "http://www.danaher.com/role/FinancingComponentsOfDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r33" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingKeyTermsOfOfferingDetails", "http://www.danaher.com/role/FinancingNarrativeDetails", "http://www.danaher.com/role/SubsequentEventNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r33", "r184" ], "lang": { "en-US": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingKeyTermsOfOfferingDetails", "http://www.danaher.com/role/FinancingNarrativeDetails", "http://www.danaher.com/role/SubsequentEventNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongtermDebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.", "label": "Long-term Debt, Weighted Average Interest Rate, at Point in Time", "terseLabel": "Weighted average interest rate of long-term debt, interest rate" } } }, "localname": "LongtermDebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease": { "auth_ref": [ "r174" ], "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in loss contingency liability.", "label": "Loss Contingency Accrual, Period Increase (Decrease)", "terseLabel": "Loss contingency accrual, period increase" } } }, "localname": "LossContingencyAccrualCarryingValuePeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r38", "r371", "r385" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Noncontrolling interests" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets", "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.", "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners", "terseLabel": "Ownership percentage by noncontrolling owners" } } }, "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_MinorityInterestPeriodIncreaseDecrease": { "auth_ref": [ "r284" ], "lang": { "en-US": { "role": { "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.", "label": "Noncontrolling Interest, Period Increase (Decrease)", "terseLabel": "Change in noncontrolling interests" } } }, "localname": "MinorityInterestPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]", "terseLabel": "Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]" } } }, "localname": "MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/CommitmentsAndContingenciesWarrantyAccrualDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r92" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net operating cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r92" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net operating cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r92", "r94", "r97" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net operating cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r61", "r64", "r70", "r97", "r122", "r375", "r388" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net earnings attributable to Danaher stockholders" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r61", "r64", "r290", "r296" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 }, "http://www.danaher.com/role/NetEarningsPerShareComponentsOfBasicAndDilutedEarningsPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "negatedLabel": "Net earnings attributable to noncontrolling interest", "negatedTerseLabel": "Less: net earnings attributable to noncontrolling interests", "verboseLabel": "Net earnings attributable to noncontrolling interest" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings", "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/NetEarningsPerShareComponentsOfBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r111", "r113" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.danaher.com/role/NetEarningsPerShareComponentsOfBasicAndDilutedEarningsPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net earnings attributable to common stockholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings", "http://www.danaher.com/role/NetEarningsPerShareComponentsOfBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r113", "r114" ], "calculation": { "http://www.danaher.com/role/NetEarningsPerShareComponentsOfBasicAndDilutedEarningsPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "totalLabel": "Net earnings attributable to common stockholders after assumed conversions (used in Diluted EPS)" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/NetEarningsPerShareComponentsOfBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentHedgingMember": { "auth_ref": [ "r304" ], "lang": { "en-US": { "role": { "documentation": "Hedges of a net investment in a foreign operation.", "label": "Net Investment Hedging [Member]", "terseLabel": "Net investment hedging" } } }, "localname": "NetInvestmentHedgingMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GeneralNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeAndNonderivativeDebtInstrumentsDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails", "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryOfNotionalValuesAndPretaxImpactInFairValuesOfNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "New accounting standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GeneralPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": { "auth_ref": [ "r201", "r288", "r292" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.", "label": "Noncontrolling Interest, Increase from Subsidiary Equity Issuance", "terseLabel": "Sale of Envista Holdings Corporation Stock" } } }, "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquity", "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r283" ], "lang": { "en-US": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Noncontrolling interests" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Nonoperating income (expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings" ], "xbrltype": "stringItemType" }, "us-gaap_NonrecurringAdjustmentAxis": { "auth_ref": [ "r272" ], "lang": { "en-US": { "role": { "documentation": "Information about material and nonrecurring adjustment directly attributable to the business combination(s) included in the reported pro forma revenue and earnings (supplemental pro forma information).", "label": "Nonrecurring Adjustment [Axis]", "terseLabel": "Nonrecurring Adjustment [Axis]" } } }, "localname": "NonrecurringAdjustmentAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/AcquisitionsProFormaFinancialInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NonrecurringAdjustmentDomain": { "auth_ref": [ "r272" ], "lang": { "en-US": { "role": { "documentation": "Material, nonrecurring adjustment(s) allocated (included) to (in) reported pro forma revenue and earnings (supplemental pro forma information).", "label": "Nonrecurring Adjustment [Domain]", "terseLabel": "Nonrecurring Adjustment [Domain]" } } }, "localname": "NonrecurringAdjustmentDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/AcquisitionsProFormaFinancialInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NumberOfBusinessesAcquired": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The number of businesses acquired by the entity during the period.", "label": "Number of Businesses Acquired", "terseLabel": "Number of businesses acquired" } } }, "localname": "NumberOfBusinessesAcquired", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of segments reported" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "terseLabel": "Operating profit", "totalLabel": "Operating profit" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings", "http://www.danaher.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r347", "r355" ], "calculation": { "http://www.danaher.com/role/LeasesComponentsOfLeaseExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Fixed operating lease expense" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/LeasesComponentsOfLeaseExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]", "terseLabel": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]" } } }, "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r343" ], "calculation": { "http://www.danaher.com/role/LeasesSupplementalBalanceSheetInofrmationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Total operating lease liabilities", "totalLabel": "Total operating lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GeneralNarrativeDetails", "http://www.danaher.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails", "http://www.danaher.com/role/LeasesSupplementalBalanceSheetInofrmationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r343" ], "calculation": { "http://www.danaher.com/role/LeasesSupplementalBalanceSheetInofrmationDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liabilities, accrued expenses and other liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/LeasesSupplementalBalanceSheetInofrmationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r343" ], "calculation": { "http://www.danaher.com/role/LeasesSupplementalBalanceSheetInofrmationDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liabilities, other long-term liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/LeasesSupplementalBalanceSheetInofrmationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r344", "r349" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Cash paid for amounts included in the measurement of operating lease liabilities" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/LeasesSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r342" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease ROU assets", "verboseLabel": "Operating lease ROU assets, other long term assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GeneralNarrativeDetails", "http://www.danaher.com/role/LeasesSupplementalBalanceSheetInofrmationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r352", "r355" ], "lang": { "en-US": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/LeasesSupplementalBalanceSheetInofrmationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r351", "r355" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/LeasesSupplementalBalanceSheetInofrmationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r126", "r133" ], "lang": { "en-US": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GoodwillGoodwillBySegmentDetails", "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByGeographicalRegionDetails", "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByRevenueTypeDetails", "http://www.danaher.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r2", "r298" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "verboseLabel": "General" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/General" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r26" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other long-term assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": { "auth_ref": [ "r58" ], "calculation": { "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax", "terseLabel": "Increase (decrease)" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "auth_ref": [ "r58", "r67" ], "calculation": { "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax", "totalLabel": "Other comprehensive income (loss) before reclassifications, net of income taxes" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": { "auth_ref": [ "r56", "r266" ], "calculation": { "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax", "negatedTerseLabel": "Income tax impact" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": { "auth_ref": [ "r48", "r55" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfComprehensiveIncome": { "order": 4.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax", "terseLabel": "Cash flow hedge adjustments" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r46", "r336" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "verboseLabel": "Foreign currency translation adjustments" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r62", "r65", "r67", "r192" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Other comprehensive income (loss)", "totalLabel": "Total other comprehensive income (loss), net of income taxes" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquity", "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfComprehensiveIncome", "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]", "terseLabel": "Other comprehensive income (loss), net of income taxes:" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r53", "r55" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "negatedTerseLabel": "Pension and postretirement plan benefit adjustments" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax": { "auth_ref": [ "r48", "r55", "r322" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).", "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax", "terseLabel": "Derivative, gain (loss) recognized in OCI" } } }, "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryOfNotionalValuesAndPretaxImpactInFairValuesOfNetInvestmentHedgesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "auth_ref": [ "r49", "r55" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfComprehensiveIncome": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.", "label": "Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax", "terseLabel": "Unrealized gain (loss) on available-for-sale securities adjustments" } } }, "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncomeAndExpensesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Income and Expenses [Abstract]" } } }, "localname": "OtherIncomeAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": { "auth_ref": [ "r214", "r258" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.", "label": "Other Income and Other Expense Disclosure [Text Block]", "terseLabel": "Nonoperating Income (Expense)" } } }, "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/NonoperatingIncomeExpense" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r34" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other long-term liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncome": { "auth_ref": [ "r76" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income", "terseLabel": "Other income, net" } } }, "localname": "OtherNonoperatingIncome", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings", "http://www.danaher.com/role/NonoperatingIncomeExpenseNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": { "auth_ref": [ "r216", "r230", "r231", "r243" ], "lang": { "en-US": { "role": { "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.", "label": "Other Postretirement Benefits Plan [Member]", "terseLabel": "Other postretirement benefit plans" } } }, "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfOtherPostretirementBenefitPensionPansDetails", "http://www.danaher.com/role/DefinedBenefitPlansTables" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [ "r79", "r82", "r110" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.", "label": "Payments for (Proceeds from) Other Investing Activities", "negatedTerseLabel": "All other investing activities" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtExtinguishmentCosts": { "auth_ref": [ "r88" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.", "label": "Payment for Debt Extinguishment or Debt Prepayment Cost", "terseLabel": "Make-whole premiums" } } }, "localname": "PaymentsOfDebtExtinguishmentCosts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/SubsequentEventNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividends": { "auth_ref": [ "r86" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.", "label": "Payments of Dividends", "negatedLabel": "Payment of dividends" } } }, "localname": "PaymentsOfDividends", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r89" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "terseLabel": "Payments of stock issuance costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r80" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedTerseLabel": "Cash paid for acquisitions" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInvestments": { "auth_ref": [ "r82" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.", "label": "Payments to Acquire Investments", "negatedTerseLabel": "Payments for purchases of investments" } } }, "localname": "PaymentsToAcquireInvestments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r81" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Payments for additions to property, plant and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "auth_ref": [ "r244" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for pension and other postretirement benefits.", "label": "Pension and Other Postretirement Benefits Disclosure [Text Block]", "terseLabel": "Defined Benefit Plans" } } }, "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DefinedBenefitPlans" ], "xbrltype": "textBlockItemType" }, "us-gaap_PensionPlansDefinedBenefitMember": { "auth_ref": [ "r215", "r230", "r231", "r243" ], "lang": { "en-US": { "role": { "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.", "label": "Pension Plan [Member]", "terseLabel": "Defined benefit pension plans" } } }, "localname": "PensionPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfDefinedBenefitPensionPansDetails", "http://www.danaher.com/role/DefinedBenefitPlansNarrativeDetails", "http://www.danaher.com/role/DefinedBenefitPlansTables" ], "xbrltype": "domainItemType" }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "auth_ref": [ "r331" ], "lang": { "en-US": { "role": { "documentation": "Measured at fair value for financial reporting purposes.", "label": "Portion at Fair Value Measurement [Member]", "terseLabel": "Portion at Fair Value Measurement [Member]" } } }, "localname": "PortionAtFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockDividendRatePerDollarAmount": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The amount per share used to calculated dividend payments on preferred stock.", "label": "Preferred Stock, Dividend Rate, Per-Dollar-Amount", "terseLabel": "Preferred stock, annual liquidation preference, per share" } } }, "localname": "PreferredStockDividendRatePerDollarAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockDividendRatePercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The percentage rate used to calculate dividend payments on preferred stock.", "label": "Preferred Stock, Dividend Rate, Percentage", "terseLabel": "Preferred stock, dividend rate, percent" } } }, "localname": "PreferredStockDividendRatePercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheetsConsolidatedCondensedBalanceSheetsParenthetical", "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_PreferredStockDividendsIncomeStatementImpact": { "auth_ref": [], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 }, "http://www.danaher.com/role/NetEarningsPerShareComponentsOfBasicAndDilutedEarningsPerShareDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.", "label": "Preferred Stock Dividends, Income Statement Impact", "negatedLabel": "MCPS dividends", "negatedTerseLabel": "Mandatory convertible preferred stock dividends" } } }, "localname": "PreferredStockDividendsIncomeStatementImpact", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings", "http://www.danaher.com/role/NetEarningsPerShareComponentsOfBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockLiquidationPreference": { "auth_ref": [ "r14", "r103", "r106", "r193", "r194" ], "lang": { "en-US": { "role": { "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.", "label": "Preferred Stock, Liquidation Preference Per Share", "terseLabel": "Preferred stock, liquidation preference per share" } } }, "localname": "PreferredStockLiquidationPreference", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Preferred stock" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquity", "http://www.danaher.com/role/CoverPage", "http://www.danaher.com/role/NetEarningsPerShareNarrativeDetails", "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails", "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationSummaryOfShareActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockNoParValue": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, No Par Value", "verboseLabel": "Preferred stock, no par value" } } }, "localname": "PreferredStockNoParValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheetsConsolidatedCondensedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheetsConsolidatedCondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheetsConsolidatedCondensedBalanceSheetsParenthetical", "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheetsConsolidatedCondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r14" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, without par value, 15.0 million shares authorized; 1.65 million shares of 4.75% Mandatory Convertible Preferred Stock, Series A, issued and outstanding at September 27, 2019; no shares issued or outstanding at December 31, 2018" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r5", "r22", "r23" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.", "label": "Prepaid Expenses and Other Current Assets [Member]", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpensesAndOtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeAndNonderivativeDebtInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r83" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Common stock, proceeds from issuance", "verboseLabel": "Proceeds from the sale of common stock, net of issuance costs" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows", "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfDebt": { "auth_ref": [ "r84" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.", "label": "Proceeds from Issuance of Debt", "terseLabel": "Proceeds from term debt" } } }, "localname": "ProceedsFromIssuanceOfDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r84" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from Issuance of Long-term Debt", "terseLabel": "Proceeds from borrowings (maturities longer than 90 days)" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock": { "auth_ref": [ "r83" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.", "label": "Proceeds from Issuance of Preferred Stock and Preference Stock", "terseLabel": "Proceeds from the sale of preferred stock, net of issuance costs", "verboseLabel": "Preferred stock, proceeds from the issuance" } } }, "localname": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows", "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": { "auth_ref": [ "r83", "r255" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.", "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised", "terseLabel": "Proceeds from the issuance of common stock in connection with stock-based compensation" } } }, "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "auth_ref": [ "r83" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.", "label": "Proceeds from Issuance or Sale of Equity", "terseLabel": "Proceeds from the sale of Envista Holdings Corporation Common Stock, net of issuance costs" } } }, "localname": "ProceedsFromIssuanceOrSaleOfEquity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows", "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r85", "r89", "r110" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds from (Payments for) Other Financing Activities", "terseLabel": "All other financing activities" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess": { "auth_ref": [ "r84", "r87", "r99" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.", "label": "Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less", "terseLabel": "Net proceeds from borrowings (maturities of 90 days or less)" } } }, "localname": "ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": { "auth_ref": [], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.", "label": "Proceeds from Sale and Maturity of Marketable Securities", "terseLabel": "Proceeds from sale of investments" } } }, "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "auth_ref": [ "r78" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Proceeds from Sale of Property, Plant, and Equipment", "terseLabel": "Proceeds from sales of property, plant and equipment" } } }, "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrual": { "auth_ref": [ "r180", "r181", "r373" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.", "label": "Standard and Extended Product Warranty Accrual", "periodEndLabel": "September 27, 2019", "periodStartLabel": "December 31, 2018" } } }, "localname": "ProductWarrantyAccrual", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/CommitmentsAndContingenciesWarrantyAccrualDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualPayments": { "auth_ref": [ "r177" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.", "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments", "negatedTerseLabel": "Settlements made" } } }, "localname": "ProductWarrantyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/CommitmentsAndContingenciesWarrantyAccrualDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualWarrantiesIssued": { "auth_ref": [ "r178" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued.", "label": "Standard and Extended Product Warranty Accrual, Increase for Warranties Issued", "terseLabel": "Accruals for warranties issued during the period" } } }, "localname": "ProductWarrantyAccrualWarrantiesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/CommitmentsAndContingenciesWarrantyAccrualDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r61", "r64", "r91", "r130", "r134", "r285", "r289", "r291", "r296", "r297" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 }, "http://www.danaher.com/role/NetEarningsPerShareComponentsOfBasicAndDilutedEarningsPerShareDetails": { "order": 3.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net earnings", "totalLabel": "Net earnings", "verboseLabel": "Pro forma earnings, adjustments" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/AcquisitionsProFormaFinancialInformationNarrativeDetails", "http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquity", "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows", "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfComprehensiveIncome", "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings", "http://www.danaher.com/role/NetEarningsPerShareComponentsOfBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r8", "r9", "r168", "r387" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property, plant and equipment, net of accumulated depreciation of $3,023.3 and $2,828.3, respectively" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "auth_ref": [ "r58", "r60" ], "calculation": { "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails": { "order": 1.0, "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "negatedTerseLabel": "Increase (decrease)" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "auth_ref": [ "r58", "r60", "r67" ], "calculation": { "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax", "negatedTotalLabel": "Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAociCurrentPeriodTax": { "auth_ref": [ "r56", "r59", "r266" ], "calculation": { "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails": { "order": 2.0, "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).", "label": "Reclassification from AOCI, Current Period, Tax", "terseLabel": "Income tax impact" } } }, "localname": "ReclassificationFromAociCurrentPeriodTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r87" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Repayments of Debt", "terseLabel": "Repayment of debt" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r87" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-term Debt", "negatedTerseLabel": "Net repayments of borrowings (maturities longer than 90 days)" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r259", "r397" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "negatedLabel": "Research and development expenses" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted stock units (\u201cRSUs\u201d)/performance stock units (\u201cPSUs\u201d)" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationComponentsOfStockBasedCompensationProgramDetails", "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r18", "r200", "r384" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "verboseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanSponsorLocationAxis": { "auth_ref": [ "r231", "r233" ], "lang": { "en-US": { "role": { "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Axis]", "terseLabel": "Retirement Plan Sponsor Location [Axis]" } } }, "localname": "RetirementPlanSponsorLocationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfDefinedBenefitPensionPansDetails", "http://www.danaher.com/role/DefinedBenefitPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanSponsorLocationDomain": { "auth_ref": [ "r231", "r233" ], "lang": { "en-US": { "role": { "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Domain]", "terseLabel": "Retirement Plan Sponsor Location [Domain]" } } }, "localname": "RetirementPlanSponsorLocationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfDefinedBenefitPensionPansDetails", "http://www.danaher.com/role/DefinedBenefitPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTypeAxis": { "auth_ref": [ "r215", "r216", "r230", "r231", "r243" ], "lang": { "en-US": { "role": { "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Axis]", "terseLabel": "Retirement Plan Type [Axis]" } } }, "localname": "RetirementPlanTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfDefinedBenefitPensionPansDetails", "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfOtherPostretirementBenefitPensionPansDetails", "http://www.danaher.com/role/DefinedBenefitPlansNarrativeDetails", "http://www.danaher.com/role/DefinedBenefitPlansTables" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanTypeDomain": { "auth_ref": [ "r215", "r216", "r230", "r231", "r243" ], "lang": { "en-US": { "role": { "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Domain]", "terseLabel": "Retirement Plan Type [Domain]" } } }, "localname": "RetirementPlanTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfDefinedBenefitPensionPansDetails", "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfOtherPostretirementBenefitPensionPansDetails", "http://www.danaher.com/role/DefinedBenefitPlansNarrativeDetails", "http://www.danaher.com/role/DefinedBenefitPlansTables" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r207", "r208" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Sales" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings", "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByGeographicalRegionDetails", "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByRevenueTypeDetails", "http://www.danaher.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r213" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue from Contract with Customer" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/RevenueNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r206" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Revenue, remaining performance obligation" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/RevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving credit facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r350", "r355" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "ROU assets obtained in exchange for operating lease obligations" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/LeasesSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]", "terseLabel": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of Stock, Number of Shares Issued in Transaction", "terseLabel": "Number of shares issued in transaction" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction.", "label": "Sale of Stock, Percentage of Ownership after Transaction", "terseLabel": "Sale of stock, ownership after transaction, percent" } } }, "localname": "SaleOfStockPercentageOfOwnershipAfterTransaction", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "IPO price" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r58" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Components Of Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GeneralTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r121" ], "lang": { "en-US": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/NetEarningsPerShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r273", "r274" ], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/AcquisitionsPendingAcquisitionNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r33", "r107", "r193", "r197", "r198", "r199", "r338", "r339", "r341", "r380" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "terseLabel": "Components Of Debt" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r230", "r231", "r232", "r233", "r242" ], "lang": { "en-US": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfDefinedBenefitPensionPansDetails", "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostOfOtherPostretirementBenefitPensionPansDetails", "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostReflectedInConsolidatedCondensedStatementOfEarningsDetails", "http://www.danaher.com/role/DefinedBenefitPlansNarrativeDetails", "http://www.danaher.com/role/DefinedBenefitPlansTables" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock": { "auth_ref": [ "r230", "r231", "r232", "r233", "r242" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.", "label": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]", "terseLabel": "Schedule of Defined Benefit Plans Disclosures" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DefinedBenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "auth_ref": [ "r308", "r312", "r316" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "terseLabel": "Derivative Instruments, Gain (Loss) [Table Text Block]" } } }, "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "auth_ref": [ "r311" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value" } } }, "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r122" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "verboseLabel": "Components Of Basic And Diluted Earnings Per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/NetEarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r324", "r325" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Financial Assets And Liabilities Carried At Fair Value" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r160", "r161" ], "lang": { "en-US": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GoodwillGoodwillBySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r160", "r161" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Rollforward Of Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GoodwillTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "auth_ref": [ "r221" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.", "label": "Schedule of Net Benefit Costs [Table Text Block]", "terseLabel": "Schedule of Net Benefit Costs" } } }, "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DefinedBenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": { "auth_ref": [ "r300" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.", "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]", "terseLabel": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]" } } }, "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r182" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "Schedule of Product Warranty Liability [Table Text Block]", "terseLabel": "Warranty Accrual" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r278" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Fair Values Of The Assets Acquired And Liabilities Assumed" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r125", "r130", "r131", "r132", "r160" ], "lang": { "en-US": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r125", "r130", "r131", "r132", "r160" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Segment Results" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r248", "r254" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationComponentsOfStockBasedCompensationProgramDetails", "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTextBlock": { "auth_ref": [ "r13", "r14", "r15", "r104", "r189", "r190", "r191", "r193", "r194", "r195", "r197", "r198", "r199", "r200" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.", "label": "Schedule of Stock by Class [Table Text Block]", "terseLabel": "Summary of Share Activity" } } }, "localname": "ScheduleOfStockByClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GoodwillGoodwillBySegmentDetails", "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByGeographicalRegionDetails", "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByRevenueTypeDetails", "http://www.danaher.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r138" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "verboseLabel": "Segment Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/SegmentInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r74", "r154" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "negatedLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [ "r77" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/DefinedBenefitPlansComponentsOfNetPeriodicBenefitCostReflectedInConsolidatedCondensedStatementOfEarningsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeniorNotesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.", "label": "Senior Notes [Member]", "terseLabel": "Senior notes" } } }, "localname": "SeniorNotesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingKeyTermsOfOfferingDetails", "http://www.danaher.com/role/FinancingNarrativeDetails", "http://www.danaher.com/role/SubsequentEventNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r95" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationComponentsOfStockBasedCompensationProgramDetails", "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r245", "r249" ], "lang": { "en-US": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationComponentsOfStockBasedCompensationProgramDetails", "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r192" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "periodEndLabel": "Balance, end of period", "periodStartLabel": "Balance, beginning of period" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationSummaryOfShareActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share", "terseLabel": "Common stock issued, price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShortTermDebtMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt arrangement having an initial term within one year or the normal operating cycle, if longer.", "label": "Short-term Debt [Member]", "terseLabel": "Short-term debt" } } }, "localname": "ShortTermDebtMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShorttermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount of short-term debt existing as of the balance sheet date.", "label": "Short-term Debt, Fair Value", "terseLabel": "Notes payable and current portion of long-term debt" } } }, "localname": "ShorttermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FairValueMeasurementsCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r179" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the standard and extended product warranty accrual.", "label": "Standard and Extended Product Warranty Accrual, Foreign Currency Translation Gain (Loss)", "terseLabel": "Effect of foreign currency translation" } } }, "localname": "StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/CommitmentsAndContingenciesWarrantyAccrualDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r0", "r130", "r160", "r170", "r171", "r172", "r391" ], "lang": { "en-US": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/GoodwillGoodwillBySegmentDetails", "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByGeographicalRegionDetails", "http://www.danaher.com/role/RevenueDisaggregationOfRevenueByRevenueTypeDetails", "http://www.danaher.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r13", "r14", "r15", "r192" ], "lang": { "en-US": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r37", "r192" ], "lang": { "en-US": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]", "verboseLabel": "Statement, Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquity", "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/GeneralComponentsOfAccumulatedOtherComprehensiveIncomeDetails", "http://www.danaher.com/role/NetEarningsPerShareNarrativeDetails", "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails", "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationSummaryOfShareActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquity", "http://www.danaher.com/role/FairValueMeasurementsNarrativeDetails", "http://www.danaher.com/role/GeneralNarrativeDetails", "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationSummaryOfShareActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquity", "http://www.danaher.com/role/FairValueMeasurementsNarrativeDetails", "http://www.danaher.com/role/GeneralNarrativeDetails", "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationSummaryOfShareActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r14", "r15", "r200" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock Issued During Period, Shares, Acquisitions", "terseLabel": "Common stock issued in connection with acquisitions" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationSummaryOfShareActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r36", "r192", "r193", "r200" ], "lang": { "en-US": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "terseLabel": "Common stock issued in connection with LYONs\u2019 conversions" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationSummaryOfShareActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r14", "r15", "r192", "r200" ], "lang": { "en-US": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuance of stock" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails", "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationSummaryOfShareActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r14", "r15", "r192", "r200" ], "lang": { "en-US": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Common stock-based award activity" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationSummaryOfShareActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r37", "r192", "r200" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock Issued During Period, Value, Acquisitions", "terseLabel": "Common stock issued in connection with acquisitions" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r37", "r192", "r200" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "terseLabel": "Common stock issued in connection with LYONs\u2019 conversions" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r14", "r15", "r192", "r200" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of stock" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r14", "r15", "r200", "r247", "r250" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Common stock-based award activity" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.", "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased", "terseLabel": "Stock repurchase program, authorized shares to be repurchased, shares" } } }, "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.", "label": "Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased", "terseLabel": "Stock repurchase program, remaining number of shares authorized to be repurchased, shares" } } }, "localname": "StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/StockTransactionsAndStockBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r15", "r19", "r20", "r141" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total Danaher stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r283", "r284", "r295" ], "calculation": { "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balance, end of period", "periodStartLabel": "Balance, beginning of period", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets", "http://www.danaher.com/role/ConsolidatedCondensedStatementOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r202" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Envista Initial Public Offering" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/SubsequentEventNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/SubsequentEventNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r359" ], "lang": { "en-US": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/SubsequentEventNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r359" ], "lang": { "en-US": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/SubsequentEventNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r359" ], "lang": { "en-US": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/SubsequentEventNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r361" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/SubsequentEventNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Different names of stock transactions and the different attributes of each transaction.", "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]", "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]", "terseLabel": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails", "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary, Sale of Stock [Line Items]", "terseLabel": "Subsidiary, Sale of Stock [Line Items]" } } }, "localname": "SubsidiarySaleOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/EnvistaInitialPublicOfferingNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosures:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r366" ], "lang": { "en-US": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]", "terseLabel": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnsecuredDebtMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.", "label": "Unsecured Debt [Member]", "terseLabel": "Unsecured debt" } } }, "localname": "UnsecuredDebtMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingComponentsOfDebtDetails", "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VariableLeaseCost": { "auth_ref": [ "r348", "r355" ], "calculation": { "http://www.danaher.com/role/LeasesComponentsOfLeaseExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.", "label": "Variable Lease, Cost", "terseLabel": "Variable operating lease expense" } } }, "localname": "VariableLeaseCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/LeasesComponentsOfLeaseExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/FinancingNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r114", "r120" ], "calculation": { "http://www.danaher.com/role/NetEarningsPerShareComponentsOfBasicAndDilutedEarningsPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-US": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted", "totalLabel": "Weighted average common shares outstanding (used in Diluted EPS)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings", "http://www.danaher.com/role/NetEarningsPerShareComponentsOfBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Average common stock and common equivalent shares outstanding:", "verboseLabel": "Denominator" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings", "http://www.danaher.com/role/NetEarningsPerShareComponentsOfBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r112", "r120" ], "calculation": { "http://www.danaher.com/role/NetEarningsPerShareComponentsOfBasicAndDilutedEarningsPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic", "verboseLabel": "Weighted average common shares outstanding (used in Basic EPS)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/ConsolidatedCondensedStatementsOfEarnings", "http://www.danaher.com/role/NetEarningsPerShareComponentsOfBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 10 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(d)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(n)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1377-109256" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1500-109256" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1930-109256" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258" }, "r124": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8475-108599" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9031-108599" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599" }, "r138": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4531-111522" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118954083&loc=d3e26610-111562" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919244-210447" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919253-210447" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919258-210447" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919230-210447" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118942338&loc=SL82898722-210454" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922888-210455" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922895-210455" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922900-210455" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118942371&loc=SL82922954-210456" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267" }, "r162": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/subtopic&trid=2144439" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r173": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14615-108349" }, "r176": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(2))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(3))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(5)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4852-112606" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870" }, "r188": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770" }, "r202": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130531-203044" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130532-203044" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130533-203044" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130556-203045" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046" }, "r213": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r214": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "610", "URI": "http://asc.fasb.org/topic&trid=49130413" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942" }, "r244": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=SL79508275-113901" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r257": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r258": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "720", "URI": "http://asc.fasb.org/topic&trid=2122503" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=117331294&loc=d3e36027-109320" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e39076-109324" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324" }, "r268": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e961-128460" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(4)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868840&loc=d3e2207-128464" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r282": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569655-111683" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4590271-111686" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686" }, "r298": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579240-113959" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(iii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624181-113959" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41641-113959" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41678-113959" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=116861445&loc=SL5629052-113961" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=118875152&loc=SL5864739-113975" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109977999&loc=d3e76258-113986" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109978405&loc=d3e80720-113993" }, "r323": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13433-108611" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13467-108611" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13476-108611" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b,c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918643-209977" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971" }, "r356": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888251" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r361": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6589523&loc=d3e617274-123014" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r398": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r399": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r400": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-13" }, "r401": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1-" }, "r402": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r403": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e640-108580" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724391-108580" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e557-108580" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118951672&loc=d3e1436-108581" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6935-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3098-108585" } }, "version": "2.1" } XML 81 R34.htm IDEA: XBRL DOCUMENT v3.19.3
Hedging Transactions And Derivative Financial Instruments (Tables)
9 Months Ended
Sep. 27, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments, Gain (Loss) [Table Text Block]
The following table summarizes the notional values as of September 27, 2019 and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive income (“OCI”) for the three and nine-month periods then ended ($ in millions):
 
Notional Amount
 
Gain (Loss) Recognized in OCI
For the Three-Month Period Ended September 27, 2019:
 
 
 
Foreign currency contracts
$
1,650.0

 
$
41.5

Foreign currency denominated debt
8,073.6

 
255.2

Interest rate swaps
1,500.0

 
(55.1
)
Total
$
11,223.6

 
$
241.6

For the Nine-Month Period Ended September 27, 2019:
 
 
 
Foreign currency contracts
$
1,650.0

 
$
36.8

Foreign currency denominated debt
8,073.6

 
263.5

Interest rate swaps
1,500.0

 
(64.0
)
Total
$
11,223.6

 
$
236.3


Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]
The following table summarizes the notional values as of September 27, 2019 and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive income (“OCI”) for the three and nine-month periods then ended ($ in millions):
 
Notional Amount
 
Gain (Loss) Recognized in OCI
For the Three-Month Period Ended September 27, 2019:
 
 
 
Foreign currency contracts
$
1,650.0

 
$
41.5

Foreign currency denominated debt
8,073.6

 
255.2

Interest rate swaps
1,500.0

 
(55.1
)
Total
$
11,223.6

 
$
241.6

For the Nine-Month Period Ended September 27, 2019:
 
 
 
Foreign currency contracts
$
1,650.0

 
$
36.8

Foreign currency denominated debt
8,073.6

 
263.5

Interest rate swaps
1,500.0

 
(64.0
)
Total
$
11,223.6

 
$
236.3


Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
The Company’s derivative instruments, as well as its nonderivative debt instruments designated and qualifying as net investment hedges, were classified as of September 27, 2019 in the Company’s Consolidated Condensed Balance Sheet as follows ($ in millions):
Derivative assets:
 
Prepaid expenses and other current assets
$
36.8

 
 
Derivative liabilities:
 
Accrued expenses and other liabilities
64.0

 
 
Nonderivative hedging instruments:
 
Long-term debt
8,073.6


XML 83 R38.htm IDEA: XBRL DOCUMENT v3.19.3
Stock Transactions And Stock-Based Compensation (Tables)
9 Months Ended
Sep. 27, 2019
Share-based Payment Arrangement [Abstract]  
Summary of Share Activity
The following table summarizes the Company’s share activity (shares in millions):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Preferred stock - shares issued:
 
 
 
 
 
 
 
Balance, beginning of period
1.7

 

 

 

Issuance of MCPS

 

 
1.7

 

Balance, end of period
1.7

 

 
1.7

 

 
 
 
 
 
 
 
 
Common stock - shares issued:
 
 
 
 
 
 
 
Balance, beginning of period
834.0

 
816.0

 
817.9

 
812.5

Common stock-based award activity
1.0

 
1.2

 
4.1

 
4.0

Common stock issued in connection with acquisitions

 

 

 
0.2

Common stock issued in connection with LYONs’ conversions

 

 
0.9

 
0.5

Issuance of common stock

 

 
12.1

 

Balance, end of period
835.0

 
817.2

 
835.0

 
817.2


Components Of Stock-Based Compensation Program
The following summarizes the components of the Company’s stock-based compensation expense ($ in millions):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
RSUs/PSUs:
 
 
 
 
 
 
 
Pretax compensation expense
$
27.6

 
$
24.0

 
$
79.8

 
$
69.6

Income tax benefit
(5.7
)
 
(5.0
)
 
(16.6
)
 
(14.6
)
RSU/PSU expense, net of income taxes
21.9

 
19.0

 
63.2

 
55.0

Stock options:
 
 
 
 
 
 
 
Pretax compensation expense
17.0

 
14.2

 
50.2

 
42.0

Income tax benefit
(3.5
)
 
(3.0
)
 
(10.5
)
 
(8.9
)
Stock option expense, net of income taxes
13.5

 
11.2

 
39.7

 
33.1

Total stock-based compensation:
 
 
 
 
 
 
 
Pretax compensation expense
44.6

 
38.2

 
130.0

 
111.6

Income tax benefit
(9.2
)
 
(8.0
)
 
(27.1
)
 
(23.5
)
Total stock-based compensation expense, net of income taxes
$
35.4

 
$
30.2

 
$
102.9

 
$
88.1


XML 84 R59.htm IDEA: XBRL DOCUMENT v3.19.3
Fair Value Measurements (Narrative) (Details) - Interest rate swap agreements - Cash flow hedging - USD ($)
$ in Millions
Jun. 28, 2019
Sep. 27, 2019
Derivative, notional amount   $ 1,500.0
Envista | Subsidiaries    
Derivative, notional amount   $ 650.0
U.S. dollar-denominated bonds    
Derivative, notional amount $ 850.0  
U.S. dollar-denominated bonds | Minimum    
Derivative, term of contract 10 years  
U.S. dollar-denominated bonds | Maximum    
Derivative, term of contract 30 years  
XML 85 R55.htm IDEA: XBRL DOCUMENT v3.19.3
Leases (Supplemental Balance Sheet Inofrmation) (Details) - USD ($)
$ in Millions
Sep. 27, 2019
Jan. 01, 2019
Leases [Abstract]    
Operating lease ROU assets, other long term assets $ 956.1 $ 971.0
Operating lease liabilities, accrued expenses and other liabilities 182.0  
Operating lease liabilities, other long-term liabilities 817.0  
Total operating lease liabilities $ 999.0 $ 1,012.0
Weighted average remaining lease term 7 years  
Weighted average discount rate 3.10%  
XML 86 R51.htm IDEA: XBRL DOCUMENT v3.19.3
Envista Initial Public Offering (Narrative) (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
1 Months Ended 3 Months Ended 9 Months Ended
Oct. 24, 2019
Sep. 27, 2019
Sep. 27, 2019
Sep. 20, 2019
Sep. 27, 2019
Sep. 27, 2019
Sep. 28, 2018
Sep. 27, 2019
Sep. 28, 2018
Dec. 31, 2018
Dec. 31, 2017
Subsidiary, Sale of Stock [Line Items]                      
Proceeds from the sale of Envista Holdings Corporation Common Stock, net of issuance costs               $ 643.4 $ 0.0    
Cash and equivalents   $ 14,252.1 $ 14,252.1   $ 14,252.1 $ 14,252.1 $ 776.2 14,252.1 776.2 $ 787.8 $ 630.3
Sale of stock, ownership after transaction, percent   80.60%                  
Net earnings attributable to noncontrolling interest           5.9 0.0 5.9 0.0    
Noncontrolling interests   $ 693.3 $ 693.3   $ 693.3 $ 693.3   $ 693.3   $ 12.3  
Subsequent event                      
Subsidiary, Sale of Stock [Line Items]                      
Make-whole premiums $ 7.0                    
Make-whole premiums, after-tax $ 5.0                    
Make-whole premiums, per diluted share $ 0.01                    
Senior notes | Redeemed notes | Subsequent event                      
Subsidiary, Sale of Stock [Line Items]                      
Aggregate principal amount $ 882.0                    
Senior notes | 2.4% senior notes due 2020                      
Subsidiary, Sale of Stock [Line Items]                      
Interest rate of debt instrument   2.40% 2.40%   2.40% 2.40%   2.40%      
Senior notes | 2.4% senior notes due 2020 | Subsequent event                      
Subsidiary, Sale of Stock [Line Items]                      
Aggregate principal amount $ 500.0                    
Interest rate of debt instrument 2.40%                    
Senior notes | 5.0% senior notes due 2020                      
Subsidiary, Sale of Stock [Line Items]                      
Interest rate of debt instrument   5.00% 5.00%   5.00% 5.00%   5.00%      
Senior notes | 5.0% senior notes due 2020 | Subsequent event                      
Subsidiary, Sale of Stock [Line Items]                      
Aggregate principal amount $ 375.0                    
Interest rate of debt instrument 5.00%                    
Subsidiaries | Envista                      
Subsidiary, Sale of Stock [Line Items]                      
Net earnings attributable to noncontrolling interest     $ (6.0)                
Subsidiaries | Envista | IPO                      
Subsidiary, Sale of Stock [Line Items]                      
Number of shares issued in transaction       30.8              
Ownership percentage by noncontrolling owners       19.40%              
IPO price       $ 22.00              
Proceeds from the sale of Envista Holdings Corporation Common Stock, net of issuance costs       $ 643.0              
Consideration transfered and proceeds from issuance of debt       2,000.0              
Proceeds from term debt       $ 1,300.0 $ 1,300.0            
Cash and equivalents   $ 193.0 193.0   193.0 $ 193.0   $ 193.0      
Noncontrolling interests   $ 681.0 $ 681.0   $ 681.0 681.0   681.0      
Additional paid-in capital                      
Subsidiary, Sale of Stock [Line Items]                      
Sale of Envista Holdings Corporation Stock           $ (60.0) $ 0.0 $ (60.0) $ 0.0    
XML 87 R82.htm IDEA: XBRL DOCUMENT v3.19.3
Segment Information (Narrative) (Details)
9 Months Ended
Sep. 27, 2019
Business_Segments
Segment Reporting [Abstract]  
Number of segments reported 4
XML 88 R72.htm IDEA: XBRL DOCUMENT v3.19.3
Income Taxes (Narrative) (Details)
$ / shares in Units, kr in Millions, $ in Millions
3 Months Ended 9 Months Ended 12 Months Ended 36 Months Ended 48 Months Ended
Dec. 31, 2017
Sep. 27, 2019
Sep. 28, 2018
USD ($)
$ / shares
Sep. 27, 2019
USD ($)
$ / shares
Sep. 28, 2018
USD ($)
$ / shares
Dec. 21, 2017
Dec. 31, 2015
USD ($)
Dec. 31, 2015
DKK (kr)
Dec. 31, 2012
USD ($)
Dec. 31, 2012
DKK (kr)
Dec. 31, 2015
USD ($)
Dec. 10, 2013
USD ($)
Dec. 10, 2013
DKK (kr)
Income Tax Examination [Line Items]                          
Federal statutory income tax rate, percent 21.00% 21.00% 21.00% 21.00% 21.00% 35.00%              
Net tax benefits, impact, amount     $ (23) $ 227 $ (9)                
Net tax benefits, impact, per diluted share | $ / shares     $ (0.03) $ 0.31 $ (0.01)                
Net tax benefits, impact, percent     (2.90%) 9.20%                  
Income tax examination, proposed adjustments to taxable income                     $ 2,700    
Foreign tax authority                          
Income Tax Examination [Line Items]                          
Income tax examination, amount of tax assessments                       $ 256 kr 1,700
Income tax examination, amount of potential additional tax assessments             $ 108 kr 735 $ 152 kr 1,000      
XML 89 R76.htm IDEA: XBRL DOCUMENT v3.19.3
Commitments And Contingencies (Warranty Accrual) (Details)
$ in Millions
9 Months Ended
Sep. 27, 2019
USD ($)
Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]  
December 31, 2018 $ 77.4
Accruals for warranties issued during the period 46.6
Settlements made (43.7)
Effect of foreign currency translation (1.2)
September 27, 2019 $ 79.1
XML 90 R16.htm IDEA: XBRL DOCUMENT v3.19.3
Financing
9 Months Ended
Sep. 27, 2019
Debt Disclosure [Abstract]  
Financing FINANCING
As of September 27, 2019, the Company was in compliance with all of its debt covenants. The components of the Company’s debt were as follows ($ in millions):
 
September 27, 2019
 
December 31, 2018
U.S. dollar-denominated commercial paper
$

 
$
72.8

Euro-denominated commercial paper (€2.7 billion and €2.1 billion, respectively)
2,933.2

 
2,377.5

1.0% senior unsecured notes due 2019 (€600.0 million aggregate principal amount) (the “2019 Euronotes”)

 
687.0

2.4% senior unsecured notes due 2020
499.2

 
498.5

5.0% senior unsecured notes due 2020 (the “2020 Assumed Pall Notes”)
382.8

 
386.7

Zero-coupon LYONs due 2021
34.6

 
56.2

0.352% senior unsecured notes due 2021 (¥30.0 billion aggregate principal amount) (the “2021 Yen Notes”)
277.6

 
273.2

1.7% senior unsecured notes due 2022 (€800.0 million aggregate principal amount) (the “2022 Euronotes”)
872.6

 
913.2

Floating rate senior unsecured notes due 2022 (€250.0 million aggregate principal amount) (the “Floating Rate 2022 Euronotes”)
272.9

 
285.7

Envista senior unsecured term loan facility due 2022 (the “Envista Term Loan Facility”)
648.6

 

Envista senior unsecured term loan facility due 2022 (€600.0 million aggregate principal amount) (the “Envista Euro Term Loan Facility”)
655.6

 

0.5% senior unsecured bonds due 2023 (CHF 540.0 million aggregate principal amount) (the “2023 CHF Bonds”)
546.0

 
550.7

2.5% senior unsecured notes due 2025 (€800.0 million aggregate principal amount) (the “2025 Euronotes”)
871.7

 
912.6

3.35% senior unsecured notes due 2025
497.1

 
496.8

0.2% senior unsecured notes due 2026 (€1.3 billion aggregate principal amount) (the “2026 Biopharma Euronotes”)
1,357.5

 

0.3% senior unsecured notes due 2027 (¥30.8 billion aggregate principal amount) (the “2027 Yen Notes”)
284.4

 
279.9

1.2% senior unsecured notes due 2027 (€600.0 million aggregate principal amount) (the “2027 Euronotes”)
651.5

 
682.0

0.45% senior unsecured notes due 2028 (€1.3 billion aggregate principal amount) (the “2028 Biopharma Euronotes”)
1,355.6

 

1.125% senior unsecured bonds due 2028 (CHF 210.0 million aggregate principal amount) (the “2028 CHF Bonds”)
216.0

 
218.1

0.75% senior unsecured notes due 2031 (€1.8 billion aggregate principal amount) (the “2031 Biopharma Euronotes”)
1,900.7

 

0.65% senior unsecured notes due 2032 (¥53.2 billion aggregate principal amount) (the “2032 Yen Notes”)
491.1

 
483.4

1.35% senior unsecured notes due 2039 (€1.3 billion aggregate principal amount) (the “2039 Biopharma Euronotes”)
1,349.2

 

4.375% senior unsecured notes due 2045
499.4

 
499.3

1.8% senior unsecured notes due 2049 (€750.0 million aggregate principal amount) (the “2049 Biopharma Euronotes”)
810.3

 

Other
197.2

 
66.7

Total debt
17,604.8

 
9,740.3

Less: currently payable
1,068.6

 
51.8

Long-term debt
$
16,536.2

 
$
9,688.5


For additional details regarding the Company’s debt financing, refer to Note 10 of the Company’s financial statements as of and for the year ended December 31, 2018 included in the Company’s 2018 Annual Report.
The Company satisfies any short-term liquidity needs that are not met through operating cash flow and available cash primarily through issuances of commercial paper under its U.S. dollar and euro-denominated commercial paper programs. Until August
27, 2019, credit support for the commercial paper programs was generally provided by the Company’s $4.0 billion unsecured, multi-year revolving credit facility with a syndicate of banks that was scheduled to expire on July 10, 2020 (the “Superseded Credit Facility”), which was also available for working capital and other general corporate purposes. During the duration of the Superseded Credit Facility, no borrowings were outstanding under the Superseded Credit Facility and the Company was in compliance with all covenants thereunder. Effective as of August 27, 2019, credit support for the Company’s U.S. dollar and euro-denominated commercial paper programs is provided by the 2020 Credit Facilities, as described below. In addition, the Company has also entered into reimbursement agreements with various commercial banks to support the issuance of letters of credit.
As of September 27, 2019, borrowings outstanding under the Company’s euro-denominated commercial paper program had a weighted average annual interest rate of negative 0.2% and a weighted average remaining maturity of approximately 42 days. There were no borrowings outstanding under the Company’s U.S. dollar-denominated commercial paper program as of September 27, 2019.
The Company repaid the €600 million aggregate principal amount of the 2019 Euronotes and accrued interest upon their maturity on July 8, 2019 using proceeds from the issuance of euro-denominated commercial paper. The Company has classified the 2.4% senior unsecured notes due 2020 and the 2020 Assumed Pall Notes as short-term debt as of September 27, 2019 since the Company plans to extinguish these obligations in the fourth quarter of 2019 (refer to Note 4 for additional information). The Company has classified approximately $2.9 billion of its borrowings outstanding under the euro-denominated commercial paper program as of September 27, 2019 as long-term debt in the accompanying Consolidated Condensed Balance Sheet as the Company had the intent and ability, as supported by availability under the 2020 Credit Facilities, to refinance these borrowings for at least one year from the balance sheet date.
Debt discounts, premiums and debt issuance costs totaled $86 million and $19 million as of September 27, 2019 and December 31, 2018, respectively, and have been netted against the aggregate principal amounts of the related debt in the components of debt table above.
2019 Debt Issuances
Long-Term Indebtedness Related to the Pending GE Biopharma Acquisition
On September 18, 2019, DH Europe Finance II S.a.r.l. (“Danaher International II”), a wholly-owned finance subsidiary of the Company, completed the underwritten public offering of senior unsecured notes due 2026, 2028, 2031, 2039 and 2049 (collectively the “Biopharma Euronotes”). The following summarizes the key terms of the offering (€ in millions):
 
Aggregate Principal Amount
 
Stated Annual Interest Rate
 
Issue Price (as % of Principal Amount)
 
Maturity Date
 
Interest Payment Dates (in arrears)
2026 Biopharma Euronotes
1,250.0

 
0.200
%
 
99.833
%
 
March 18, 2026
 
March 18
2028 Biopharma Euronotes
1,250.0

 
0.450
%
 
99.751
%
 
March 18, 2028
 
March 18
2031 Biopharma Euronotes
1,750.0

 
0.750
%
 
99.920
%
 
September 18, 2031
 
September 18
2039 Biopharma Euronotes
1,250.0

 
1.350
%
 
99.461
%
 
September 18, 2039
 
September 18
2049 Biopharma Euronotes
750.0

 
1.800
%
 
99.564
%
 
September 18, 2049
 
September 18

The Biopharma Euronotes are fully and unconditionally guaranteed by the Company. The Company received net proceeds from the Biopharma Euronotes, after underwriting discounts and commissions and offering expenses, of approximately €6.2 billion (approximately $6.8 billion based on currency exchange rates as of the date of the pricing of the notes). The Company plans to use the proceeds from the Biopharma Euronotes to fund a portion of the pending GE Biopharma Acquisition. Pending completion of the GE Biopharma Acquisition, the Company has invested the net proceeds in short-term bank deposits and/or interest-bearing, investment-grade securities.
Long-Term Indebtedness Related to Envista
In September 2019, the Company received net cash distributions of approximately $2.0 billion from Envista as consideration for the Company’s contribution of assets to Envista in connection with the Envista IPO. Envista financed these cash payments through the issuance of common stock and proceeds from approximately $1.3 billion of term debt, consisting of $650 million aggregate principal amount of borrowings under a three-year, senior unsecured term loan facility with variable interest rates and €600 million aggregate principal amount of borrowings under a three-year, senior unsecured term loan facility with variable interest rates (together, the “Envista Debt”). In addition, Envista entered into a revolving credit agreement with a syndicate of banks providing for a five-year $250 million senior unsecured revolving credit facility (the “Envista Credit
Facility”). Envista had no borrowings outstanding under the Envista Credit Facility as of September 27, 2019. As of September 27, 2019, Danaher owns 80.6% of the common stock of Envista, and as a result, the Company consolidates Envista and therefore the Company’s Consolidated Condensed Balance Sheet as of September 27, 2019 includes the Envista Debt. As of September 27, 2019, Envista was in compliance with all covenants under the Envista Credit Facility.
364-Day and Five-Year Revolving Credit Facilities
On August 27, 2019, the Company replaced the Superseded Credit Facility with a $5.0 billion unsecured revolving credit facility with a syndicate of banks that expires on August 27, 2024, subject to a one-year extension option at the request of the Company with the consent of the lenders (the “Five-Year Facility”). The Five-Year Facility also contains an expansion option permitting Danaher to request up to five increases of up to an aggregate additional $2.5 billion from lenders that elect to make such increase available, upon the satisfaction of certain conditions. At the same time, the Company entered into a $5.0 billion 364-day unsecured revolving credit facility with a syndicate of banks that expires on August 26, 2020 (the “Scheduled Termination Date”) (the “364-Day Facility” and together with the Five-Year Facility, the “2020 Credit Facilities”), to provide additional liquidity support for issuances under the Company’s U.S. dollar and euro-denominated commercial paper programs. The Company may elect, upon the payment of a fee equal to 0.75% of the principal amount of the loans then outstanding and, upon the satisfaction of certain conditions, to convert any loans outstanding on the Scheduled Termination Date into term loans that are due and payable one year following the Scheduled Termination Date. The increase in the size of the Company’s commercial paper programs, as supported by the 2020 Credit Facilities, provides capacity for the Company to use proceeds from the commercial paper programs to fund a portion of the pending GE Biopharma Acquisition.
Borrowings under the Five-Year Facility bear interest as follows: (1) Eurocurrency Rate Committed Loans (as defined in the Five-Year Facility) bear interest at a variable rate equal to the London inter-bank offered rate plus a margin of between 58.5 and 100.0 basis points, depending on Danaher’s long-term debt credit rating; (2) Base Rate Committed Loans and Swing Line Loans (each as defined in the Five-Year Facility) bear interest at a variable rate equal to the highest of (a) the Federal funds rate (as published by the Federal Reserve Bank of New York from time to time) plus 50 basis points; (b) Bank of America’s “prime rate” as publicly announced from time to time and (c) the Eurocurrency Rate (as defined in the Five-Year Facility) plus 100 basis points; and (3) Bid Loans (as defined in the Five-Year Facility) bear interest at the rate bid by the particular lender providing such loan. In addition, Danaher is required to pay a per annum facility fee of between 4.0 and 12.5 basis points (depending on Danaher’s long-term debt credit rating) based on the aggregate commitments under the Five-Year Facility, regardless of usage.
Borrowings under the 364-Day Facility bear interest as follows: (1) Eurodollar Rate Loans (as defined in the 364-Day Facility) bear interest at a variable rate per annum equal to the London inter-bank offered rate plus a margin of between 59.5 and 100.5 basis points, depending on Danaher’s long-term debt credit rating; and (2) Base Rate Loans (as defined in the 364-Day Facility) bear interest at a variable rate per annum equal to the highest of (a) the Federal funds rate (as published by the Federal Reserve Bank of New York from time to time) plus 50 basis points, (b) Bank of America’s “prime rate” as publicly announced from time to time and (c) the Eurodollar Rate (as defined in the 364-Day Facility) plus 100 basis points, plus in each case a margin of up to 0.5 basis points depending on Danaher’s long-term debt credit rating. In addition, Danaher is required to pay a per annum facility fee of between 3.0 and 12.0 basis points (depending on Danaher’s long-term debt credit rating) based on the aggregate commitments under the 364-Day Facility, regardless of usage.
The 2020 Credit Facilities require the Company to maintain a consolidated leverage ratio (as defined in the facilities) of 0.65 to 1.00 or less. Borrowings under the 2020 Credit Facilities are prepayable at the Company’s option at any time in whole or in part without premium or penalty.
The Company’s obligations under the 2020 Credit Facilities are unsecured. The Company has unconditionally and irrevocably guaranteed the obligations of each of its subsidiaries in the event a subsidiary is named a borrower under either of the 2020 Credit Facilities. Each of the 2020 Credit Facilities contain customary representations, warranties, conditions precedent, events of default, indemnities and affirmative and negative covenants. The 2020 Credit Facilities are available for liquidity support for Danaher’s expanded U.S. dollar and euro commercial paper programs, as discussed above, and for general corporate purposes.
Guarantors of Debt
The Company has guaranteed long-term debt and commercial paper issued by certain of its wholly-owned subsidiaries. The 2019 Euronotes, 2022 Euronotes, Floating Rate 2022 Euronotes, 2025 Euronotes and 2027 Euronotes were issued by DH Europe Finance S.a.r.l., formerly known as DH Europe Finance S.A. (“Danaher International”). The 2026 Biopharma Euronotes, 2028 Biopharma Euronotes, 2031 Biopharma Euronotes, 2039 Biopharma Euronotes and 2049 Biopharma Euronotes were issued by Danaher International II. The 2023 CHF Bonds and 2028 CHF Bonds were issued by DH Switzerland Finance S.A. (“Danaher Switzerland”). The 2021 Yen Notes, 2027 Yen Notes and 2032 Yen Notes were issued by DH Japan Finance S.A. (“Danaher Japan”). Each of Danaher International, Danaher International II, Danaher Switzerland and Danaher Japan are wholly-owned finance subsidiaries of Danaher Corporation. All of the outstanding and future securities issued by each of these entities, as well as the 2020 Assumed Pall Notes, are or will be fully and unconditionally guaranteed by the Company and these guarantees rank on parity with the Company’s unsecured and unsubordinated indebtedness.
LYONs Redemption
During the nine-month period ended September 27, 2019, holders of certain of the Company’s LYONs converted such LYONs into an aggregate of 891 thousand shares of the Company’s common stock, par value $0.01 per share. The Company’s deferred tax liability of $9 million associated with the book and tax basis difference in the converted LYONs was transferred to additional paid-in capital as a result of the conversions.
XML 91 R12.htm IDEA: XBRL DOCUMENT v3.19.3
Envista Initial Public Offering (Notes)
9 Months Ended
Sep. 27, 2019
Equity [Abstract]  
Envista Initial Public Offering ENVISTA INITIAL PUBLIC OFFERING
On September 20, 2019, Envista, a subsidiary of the Company, completed an underwritten initial public offering (the “Envista IPO”) of 30.8 million shares of its common stock, which represents 19.4% of Envista’s outstanding shares, at a public offering
price of $22.00 per share (the “IPO price”). Envista shares trade on the New York Stock Exchange under the symbol “NVST”. Envista realized net proceeds of $643 million from the Envista IPO, after deducting underwriting discounts and deal expenses.
In connection with the completion of the Envista IPO, through a series of equity and other transactions, the Company transferred its dental businesses to Envista. In exchange, Envista transferred consideration of approximately $2.0 billion to the Company, which consists primarily of the net proceeds from the Envista IPO and approximately $1.3 billion of proceeds from Envista’s term debt financing. The excess of the net book value of the business transferred to Envista over the net proceeds from the IPO was $60 million and was recorded as a reduction to additional paid-in capital in the accompanying Consolidated Condensed Balance Sheet. Of the Company’s consolidated cash and cash equivalents as of September 27, 2019$193 million is owned by Envista.
Danaher continues to consolidate Envista, as the Company owns 80.6% of Envista’s outstanding common shares and retains control over Envista. The earnings attributable to the noncontrolling interest of Envista for the period from the Envista IPO until September 27, 2019 were $6 million. As of September 27, 2019, the noncontrolling interest of $681 million associated with Envista is reflected in noncontrolling interests in the accompanying Consolidated Condensed Balance Sheet.
Danaher intends to use a portion of the consideration received from Envista to redeem $882 million in aggregate principal amount of outstanding indebtedness in the fourth quarter of 2019 (consisting of the Company’s 2.4% senior unsecured notes due 2020 and 5.0% senior unsecured notes due 2020. The Company expects the make-whole premiums required in connection with the redemption will be $7 million ($5 million after-tax or $0.01 per diluted share). The Company intends to use the balance of the consideration it received from Envista for quarterly cash dividend payments to its shareholders.
The Company intends to make a tax-free distribution to its stockholders of all or a portion of its remaining equity interest in Envista, which may include one or more distributions effected as a dividend to all Danaher stockholders, one or more distributions in exchange for Danaher shares or other securities or any combination thereof (the “Distribution”). The Company has no obligation to pursue or consummate any further dispositions of its ownership interest in Envista, including through the Distribution, by any specified date or at all. If pursued, the Distribution may be subject to various conditions, including receipt of any necessary regulatory or other approvals, the existence of satisfactory market conditions and the receipt of an opinion of counsel to the effect that the separation, together with such Distribution, will be tax-free to Danaher and its stockholders for U.S. federal income tax purposes.
XML 92 R39.htm IDEA: XBRL DOCUMENT v3.19.3
Net Earnings Per Share (Tables)
9 Months Ended
Sep. 27, 2019
Earnings Per Share [Abstract]  
Components Of Basic And Diluted Earnings Per Share
Information related to the calculation of net earnings per share is summarized as follows ($ and shares in millions, except per share amounts):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Numerator:
 
 
 
 
 
 
 
Net earnings
$
673.9

 
$
663.7

 
$
1,739.0

 
$
1,904.1

Net earnings attributable to noncontrolling interests
(5.9
)
 

 
(5.9
)
 

MCPS dividends
(19.6
)
 

 
(48.8
)
 

Net earnings attributable to common stockholders (used in Basis EPS)
648.4

 
663.7


1,684.3


1,904.1

Adjustment for interest on convertible debentures
0.4

 
0.6

 
1.4

 
1.7

Net earnings attributable to common stockholders after assumed conversions (used in Diluted EPS)
$
648.8

 
$
664.3


$
1,685.7


$
1,905.8

 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
Weighted average common shares outstanding (used in Basic EPS)
718.8

 
701.4

 
714.7

 
700.1

Incremental common shares from:
 
 
 
 
 
 
 
Assumed exercise of dilutive options and vesting of dilutive RSUs and PSUs
9.1

 
6.9

 
8.9

 
7.3

Assumed conversion of the convertible debentures
1.4

 
2.3

 
1.6

 
2.5

Weighted average common shares outstanding (used in Diluted EPS)
729.3

 
710.6

 
725.2

 
709.9

 
 
 
 
 
 
 
 
Basic EPS
$
0.90

 
$
0.95


$
2.36


$
2.72

Diluted EPS
$
0.89

 
$
0.93

 
$
2.32

 
$
2.68


XML 93 R31.htm IDEA: XBRL DOCUMENT v3.19.3
Goodwill (Tables)
9 Months Ended
Sep. 27, 2019
Goodwill and Intangible Assets Disclosure [Abstract]  
Rollforward Of Goodwill
The following is a rollforward of the Company’s goodwill ($ in millions):
Balance, December 31, 2018
$
25,906.0

Attributable to 2019 acquisitions
214.9

Adjustments due to finalization of purchase price allocations
(6.9
)
Foreign currency translation and other
(389.2
)
Balance, September 27, 2019
$
25,724.8

The carrying value of goodwill by segment is summarized as follows ($ in millions):
 
September 27, 2019
 
December 31, 2018
Life Sciences
$
13,300.2

 
$
13,311.0

Diagnostics
6,829.9

 
6,925.6

Dental / Envista
3,283.2

 
3,325.5

Environmental & Applied Solutions
2,311.5

 
2,343.9

Total
$
25,724.8

 
$
25,906.0


XML 94 R35.htm IDEA: XBRL DOCUMENT v3.19.3
Defined Benefit Plans (Tables)
9 Months Ended
Sep. 27, 2019
Defined Benefit Plan Disclosure [Line Items]  
Schedule of Defined Benefit Plans Disclosures
The net periodic benefit cost of the noncontributory defined benefit pension plans and other postretirement employee benefit plans incurred during the three and nine-month periods ended September 27, 2019 and September 28, 2018 are reflected in the following captions in the accompanying Consolidated Condensed Statements of Earnings ($ in millions):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Service cost:
 
 
 
 
 
 
 
Cost of sales
$
(2.0
)
 
$
(1.6
)
 
$
(6.2
)
 
$
(7.0
)
Selling, general and administrative expenses
(7.9
)
 
(8.2
)
 
(23.3
)
 
(24.9
)
Total service cost
(9.9
)
 
(9.8
)
 
(29.5
)
 
(31.9
)
Other net periodic benefit costs:
 
 
 
 
 
 
 
Other income, net
4.4

 
9.1

 
15.9

 
25.2

Total
$
(5.5
)
 
$
(0.7
)
 
$
(13.6
)
 
$
(6.7
)

Defined benefit pension plans  
Defined Benefit Plan Disclosure [Line Items]  
Schedule of Net Benefit Costs
The following sets forth the components of the Company’s net periodic benefit (cost) of the noncontributory defined benefit pension plans ($ in millions):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
U.S. pension benefits:
 
 
 
 
 
 
 
Service cost
$
(1.6
)
 
$
(1.2
)
 
$
(4.8
)
 
$
(5.4
)
Interest cost
(22.1
)
 
(20.3
)
 
(66.6
)
 
(60.7
)
Expected return on plan assets
31.0

 
33.0

 
94.2

 
99.2

Amortization of actuarial loss
(6.7
)
 
(8.0
)
 
(19.2
)
 
(23.6
)
Amortization of prior service cost
(0.2
)
 
(0.2
)
 
(0.7
)
 
(0.7
)
Net periodic pension benefit
$
0.4


$
3.3


$
2.9


$
8.8

 
 
 
 
 
 
 
 
Non-U.S. pension benefits:
 
 
 
 
 
 
 
Service cost
$
(8.2
)
 
$
(8.6
)
 
$
(24.4
)
 
$
(26.2
)
Interest cost
(6.6
)
 
(6.3
)
 
(19.9
)
 
(19.6
)
Expected return on plan assets
10.9

 
11.6

 
32.7

 
35.6

Amortization of actuarial loss
(3.9
)
 
(1.5
)
 
(3.7
)
 
(4.5
)
Amortization of prior service credit
2.6

 
0.2

 
0.2

 
0.4

Curtailment gain recognized

 

 
1.1

 

Settlement loss recognized
0.1

 
1.2

 

 
0.8

Net periodic pension cost
$
(5.1
)
 
$
(3.4
)
 
$
(14.0
)
 
$
(13.5
)
Other postretirement benefit plans  
Defined Benefit Plan Disclosure [Line Items]  
Schedule of Net Benefit Costs
The following sets forth the components of the Company’s net periodic benefit cost of the other postretirement employee benefit plans ($ in millions):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Service cost
$
(0.1
)
 
$

 
$
(0.3
)
 
$
(0.3
)
Interest cost
(1.3
)
 
(1.2
)
 
(3.8
)
 
(3.5
)
Amortization of prior service credit
0.6

 
0.6

 
1.6

 
1.8

Net periodic cost
$
(0.8
)
 
$
(0.6
)
 
$
(2.5
)
 
$
(2.0
)

XML 95 R54.htm IDEA: XBRL DOCUMENT v3.19.3
Leases (Supplemental Cash Flow Information) (Details)
$ in Millions
9 Months Ended
Sep. 27, 2019
USD ($)
Leases [Abstract]  
Cash paid for amounts included in the measurement of operating lease liabilities $ 177.7
ROU assets obtained in exchange for operating lease obligations $ 165.1
XML 96 R50.htm IDEA: XBRL DOCUMENT v3.19.3
Acquisitions (Pending Acquisition) (Narrative) (Details) - USD ($)
$ in Millions
9 Months Ended 12 Months Ended
Sep. 27, 2019
Feb. 25, 2019
Sep. 27, 2019
Dec. 31, 2018
Business Acquisition [Line Items]        
Pending acquisition, purchase price     $ 331.1  
Pending acquisition, revenue for last annual period     $ 72.0  
Pending divestiture, revenue       $ 140.0
Biopharma Acquisition        
Business Acquisition [Line Items]        
Pending acquisition, purchase price   $ 21,000.0    
Pending acquisition, pension liabilities to be assumed   400.0    
Pending acquisition, revenue for last annual period   $ 3,000.0    
Proceeds from issuance of common stock and preferred stock, proceeds from issuance of debt and available cash $ 3,000.0      
XML 97 R58.htm IDEA: XBRL DOCUMENT v3.19.3
Goodwill (Goodwill by Segment) (Details) - USD ($)
$ in Millions
Sep. 27, 2019
Dec. 31, 2018
Goodwill [Line Items]    
Total goodwill $ 25,724.8 $ 25,906.0
Operating segments | Life Sciences    
Goodwill [Line Items]    
Total goodwill 13,300.2 13,311.0
Operating segments | Diagnostics    
Goodwill [Line Items]    
Total goodwill 6,829.9 6,925.6
Operating segments | Dental / Envista    
Goodwill [Line Items]    
Total goodwill 3,283.2 3,325.5
Operating segments | Environmental & Applied Solutions    
Goodwill [Line Items]    
Total goodwill $ 2,311.5 $ 2,343.9
XML 98 R83.htm IDEA: XBRL DOCUMENT v3.19.3
Segment Information (Segment Results) (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 27, 2019
Sep. 28, 2018
Dec. 31, 2018
Segment Reporting Information [Line Items]          
Sales $ 5,037.3 $ 4,853.1 $ 15,073.8 $ 14,529.5  
Operating profit 834.8 830.7 2,442.4 2,441.2  
Identifiable assets 61,531.1   61,531.1   $ 47,832.5
Other          
Segment Reporting Information [Line Items]          
Operating profit (108.9) (57.6) (302.8) (166.1)  
Identifiable assets 14,490.2   14,490.2   1,144.4
Life Sciences | Operating segments          
Segment Reporting Information [Line Items]          
Sales 1,695.6 1,596.7 5,035.1 4,677.9  
Operating profit 342.5 312.8 995.5 875.6  
Identifiable assets 22,115.0   22,115.0   22,122.4
Diagnostics | Operating segments          
Segment Reporting Information [Line Items]          
Sales 1,601.9 1,502.5 4,757.0 4,573.1  
Operating profit 266.0 235.1 782.0 757.4  
Identifiable assets 14,175.1   14,175.1   14,031.1
Dental / Envista | Operating segments          
Segment Reporting Information [Line Items]          
Sales 659.3 679.5 2,031.1 2,085.5  
Operating profit 78.7 86.1 206.4 241.8  
Identifiable assets 6,009.5   6,009.5   5,897.3
Environmental & Applied Solutions | Operating segments          
Segment Reporting Information [Line Items]          
Sales 1,080.5 1,074.4 3,250.6 3,193.0  
Operating profit 256.5 $ 254.3 761.3 $ 732.5  
Identifiable assets $ 4,741.3   $ 4,741.3   $ 4,637.3
XML 99 R73.htm IDEA: XBRL DOCUMENT v3.19.3
Income Taxes (Summary Of Danaher's Effective Income Tax Rate) (Details)
3 Months Ended 9 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 27, 2019
Sep. 28, 2018
Income Tax Disclosure [Abstract]        
Effective tax rate 20.10% 17.20% 29.30% 19.00%
XML 100 R77.htm IDEA: XBRL DOCUMENT v3.19.3
Stock Transactions And Stock-Based Compensation (Narrative) (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 9 Months Ended
Sep. 27, 2019
Mar. 01, 2019
Sep. 27, 2019
Sep. 28, 2018
Sep. 27, 2019
Sep. 28, 2018
Apr. 15, 2022
Dec. 31, 2018
Jul. 16, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Stock repurchase program, authorized shares to be repurchased, shares                 20,000,000
Stock repurchase program, remaining number of shares authorized to be repurchased, shares 20,000,000   20,000,000   20,000,000        
Common stock, proceeds from issuance         $ 1,443.2 $ 0.0      
Preferred stock, shares issued 1,650,000   1,650,000   1,650,000     0  
Preferred stock, dividend rate, percent 4.75%                
Preferred stock, proceeds from the issuance         $ 1,599.6 $ 0.0      
Common shares reserved for issuance under the 2007 Omnibus Incentive Plan, shares 46,000,000   46,000,000   46,000,000        
Restricted stock units (“RSUs”)/performance stock units (“PSUs”)                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Total unrecognized compensation cost $ 192.0   $ 192.0   $ 192.0        
Weighted average period for cost to be recognized 2 years                
Stock options                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Total unrecognized compensation cost $ 178.0   $ 178.0   $ 178.0        
Weighted average period for cost to be recognized 3 years                
Preferred stock                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Issuance of stock     0 0 1,700,000 0      
Payments of stock issuance costs   $ 50.0              
Preferred stock, shares issued   1,650,000              
Preferred stock, dividend rate, percent   4.75%              
Preferred stock, liquidation preference per share   $ 1,000              
Preferred stock, proceeds from the issuance   $ 1,600.0              
Convertible preferred stock, threshold consecutive trading days   20              
Preferred stock, annual liquidation preference, per share   $ 47.50              
Preferred stock | Scenario, forecast | Minimum                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Convertible preferred stock, shares issued upon conversion             6.6382    
Preferred stock | Scenario, forecast | Maximum                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Convertible preferred stock, shares issued upon conversion             8.1318    
Common stock                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Issuance of stock   12,100,000 0 0 12,100,000 0      
Common stock issued, price per share   $ 123.00              
Common stock, proceeds from issuance   $ 1,400.0              
Payments of stock issuance costs   $ 45.0              
XML 101 R49.htm IDEA: XBRL DOCUMENT v3.19.3
Acquisitions (Pro Forma Financial Information) (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 9 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 27, 2019
Sep. 28, 2018
Business Combinations [Abstract]        
Sales $ 5,037.3 $ 4,873.4 $ 15,082.6 $ 14,685.8
Net earnings attributable to common stockholders $ 648.4 $ 658.1 $ 1,681.2 $ 1,888.5
Diluted net earnings per share $ 0.89 $ 0.93 $ 2.32 $ 2.66
XML 102 R41.htm IDEA: XBRL DOCUMENT v3.19.3
General (Narrative) (Details) - USD ($)
$ in Millions
Jun. 28, 2019
Sep. 27, 2019
Jan. 31, 2019
Jan. 01, 2019
Operating lease ROU assets   $ 956.1   $ 971.0
Total operating lease liabilities   999.0   $ 1,012.0
Foreign currency contracts | Subsidiaries | Envista        
Derivative, notional amount   650.0    
Net investment hedging | Foreign currency contracts        
Derivative, notional amount   1,650.0 $ 1,900.0  
Cash flow hedging | Interest rate swap agreements        
Derivative, notional amount   1,500.0    
Cash flow hedging | Interest rate swap agreements | Subsidiaries | Envista        
Derivative, notional amount   650.0    
U.S. dollar-denominated bonds | Net investment hedging | Foreign currency contracts        
Derivative, notional amount   $ 1,000.0 $ 1,900.0  
U.S. dollar-denominated bonds | Cash flow hedging | Interest rate swap agreements        
Derivative, notional amount $ 850.0      
U.S. dollar-denominated bonds | Cash flow hedging | Interest rate swap agreements | Minimum        
Derivative, term of contract 10 years      
U.S. dollar-denominated bonds | Cash flow hedging | Interest rate swap agreements | Maximum        
Derivative, term of contract 30 years      
XML 103 R45.htm IDEA: XBRL DOCUMENT v3.19.3
Revenue (Disaggregation of Revenue by Revenue Type) (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 27, 2019
Sep. 28, 2018
Disaggregation of Revenue [Line Items]        
Sales $ 5,037.3 $ 4,853.1 $ 15,073.8 $ 14,529.5
Recurring revenue        
Disaggregation of Revenue [Line Items]        
Sales 3,502.1 3,353.5 10,571.8 10,166.3
Nonrecurring revenue        
Disaggregation of Revenue [Line Items]        
Sales 1,535.2 1,499.6 4,502.0 4,363.2
Operating segments | Life Sciences        
Disaggregation of Revenue [Line Items]        
Sales 1,695.6 1,596.7 5,035.1 4,677.9
Operating segments | Life Sciences | Recurring revenue        
Disaggregation of Revenue [Line Items]        
Sales 1,084.3 1,030.9 3,264.4 3,057.3
Operating segments | Life Sciences | Nonrecurring revenue        
Disaggregation of Revenue [Line Items]        
Sales 611.3 565.8 1,770.7 1,620.6
Operating segments | Diagnostics        
Disaggregation of Revenue [Line Items]        
Sales 1,601.9 1,502.5 4,757.0 4,573.1
Operating segments | Diagnostics | Recurring revenue        
Disaggregation of Revenue [Line Items]        
Sales 1,343.2 1,273.3 4,047.9 3,892.8
Operating segments | Diagnostics | Nonrecurring revenue        
Disaggregation of Revenue [Line Items]        
Sales 258.7 229.2 709.1 680.3
Operating segments | Dental / Envista        
Disaggregation of Revenue [Line Items]        
Sales 659.3 679.5 2,031.1 2,085.5
Operating segments | Dental / Envista | Recurring revenue        
Disaggregation of Revenue [Line Items]        
Sales 479.4 478.2 1,489.3 1,513.5
Operating segments | Dental / Envista | Nonrecurring revenue        
Disaggregation of Revenue [Line Items]        
Sales 179.9 201.3 541.8 572.0
Operating segments | Environmental & Applied Solutions        
Disaggregation of Revenue [Line Items]        
Sales 1,080.5 1,074.4 3,250.6 3,193.0
Operating segments | Environmental & Applied Solutions | Recurring revenue        
Disaggregation of Revenue [Line Items]        
Sales 595.2 571.1 1,770.2 1,702.7
Operating segments | Environmental & Applied Solutions | Nonrecurring revenue        
Disaggregation of Revenue [Line Items]        
Sales $ 485.3 $ 503.3 $ 1,480.4 $ 1,490.3
XML 104 R66.htm IDEA: XBRL DOCUMENT v3.19.3
Hedging Transactions And Derivative Financial Instruments (Summary of Notional Values and Pretax Impact in Fair Values of Net Investment Hedges) (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 27, 2019
Sep. 27, 2019
Jan. 31, 2019
Derivative Instruments, Gain (Loss) [Line Items]      
Derivative and nonderivative, notional amount $ 11,223.6 $ 11,223.6  
Derivative and nonderivative, gain (loss) recognized in OCI 241.6 236.3  
Net investment hedging | Foreign currency contracts      
Derivative Instruments, Gain (Loss) [Line Items]      
Derivatives, notional amount 1,650.0 1,650.0 $ 1,900.0
Derivative, gain (loss) recognized in OCI 41.5 36.8  
Net investment hedging | Foreign currency denominated debt      
Derivative Instruments, Gain (Loss) [Line Items]      
Nonderivative, notional amount 8,073.6 8,073.6  
Nonderivative, gain (loss) recognized in OCI 255.2 263.5  
Cash flow hedging | Interest rate swaps      
Derivative Instruments, Gain (Loss) [Line Items]      
Derivatives, notional amount 1,500.0 1,500.0  
Derivative, gain (loss) recognized in OCI $ (55.1) $ (64.0)  
XML 105 R62.htm IDEA: XBRL DOCUMENT v3.19.3
Financing (Narrative) (Details)
$ / shares in Units, shares in Thousands, € in Millions
1 Months Ended 3 Months Ended 9 Months Ended
Sep. 27, 2019
USD ($)
$ / shares
Sep. 20, 2019
USD ($)
Sep. 18, 2019
USD ($)
Sep. 18, 2019
EUR (€)
Aug. 27, 2019
USD ($)
Jul. 08, 2019
EUR (€)
Sep. 27, 2019
USD ($)
$ / shares
Sep. 27, 2019
USD ($)
$ / shares
Sep. 28, 2018
USD ($)
Sep. 27, 2019
USD ($)
$ / shares
shares
Sep. 28, 2018
USD ($)
Sep. 27, 2019
EUR (€)
Dec. 31, 2018
USD ($)
$ / shares
Dec. 31, 2018
EUR (€)
Debt Instrument [Line Items]                            
Long-term debt $ 17,604,800,000           $ 17,604,800,000 $ 17,604,800,000   $ 17,604,800,000     $ 9,740,300,000  
Debt discounts, premiums and debt issuance costs $ 86,000,000           $ 86,000,000 $ 86,000,000   $ 86,000,000     $ 19,000,000  
Sale of stock, ownership after transaction, percent 80.60%                          
Common stock, par value | $ / shares $ 0.01           $ 0.01 $ 0.01   $ 0.01     $ 0.01  
Debt conversion, converted instrument, tax benefit               $ 400,000 $ 0 $ 8,500,000 $ 4,200,000      
Subsidiaries | Envista | IPO                            
Debt Instrument [Line Items]                            
Proceeds from term debt   $ 1,300,000,000         $ 1,300,000,000              
Consideration transfered and proceeds from issuance of debt   $ 2,000,000,000.0                        
Revolving credit facility | Superseded credit facility | Long-term debt                            
Debt Instrument [Line Items]                            
Line of credit         $ 4,000,000,000.0                  
Line of credit facility, amount outstanding         0                  
Revolving credit facility | Envista credit facility | Long-term debt | Subsidiaries | Envista | IPO                            
Debt Instrument [Line Items]                            
Line of credit $ 250,000,000           250,000,000 250,000,000   250,000,000        
Line of credit facility, amount outstanding $ 0           $ 0 $ 0   $ 0        
Revolving credit facility | Five-year facility | Long-term debt                            
Debt Instrument [Line Items]                            
Line of credit         5,000,000,000.0                  
Additional borrowing capacity expansion         $ 2,500,000,000                  
Revolving credit facility | Five-year facility | Long-term debt | Minimum                            
Debt Instrument [Line Items]                            
Per annum fee         0.04%                  
Revolving credit facility | Five-year facility | Long-term debt | Maximum                            
Debt Instrument [Line Items]                            
Per annum fee         0.125%                  
Revolving credit facility | Five-year facility | Long-term debt | LIBOR | Minimum                            
Debt Instrument [Line Items]                            
Debt instrument, basis spread on variable rate         0.585%                  
Revolving credit facility | Five-year facility | Long-term debt | LIBOR | Maximum                            
Debt Instrument [Line Items]                            
Debt instrument, basis spread on variable rate         1.00%                  
Revolving credit facility | Five-year facility | Long-term debt | Federal funds rate                            
Debt Instrument [Line Items]                            
Debt instrument, basis spread on variable rate         0.50%                  
Revolving credit facility | Five-year facility | Long-term debt | Eurocurrency rate                            
Debt Instrument [Line Items]                            
Debt instrument, basis spread on variable rate         1.00%                  
Revolving credit facility | 364-day facility | Short-term debt                            
Debt Instrument [Line Items]                            
Line of credit         $ 5,000,000,000.0                  
Debt instrument, leverage ratio, maximum         0.75%                  
Revolving credit facility | 364-day facility | Short-term debt | Minimum                            
Debt Instrument [Line Items]                            
Per annum fee         0.03%                  
Revolving credit facility | 364-day facility | Short-term debt | Maximum                            
Debt Instrument [Line Items]                            
Per annum fee         0.12%                  
Revolving credit facility | 364-day facility | Short-term debt | LIBOR | Minimum                            
Debt Instrument [Line Items]                            
Debt instrument, basis spread on variable rate         0.595%                  
Revolving credit facility | 364-day facility | Short-term debt | LIBOR | Maximum                            
Debt Instrument [Line Items]                            
Debt instrument, basis spread on variable rate         1.005%                  
Revolving credit facility | 364-day facility | Short-term debt | Federal funds rate                            
Debt Instrument [Line Items]                            
Debt instrument, basis spread on variable rate         0.50%                  
Revolving credit facility | 364-day facility | Short-term debt | Eurocurrency rate                            
Debt Instrument [Line Items]                            
Debt instrument, basis spread on variable rate         1.00%                  
Revolving credit facility | 2020 credit facilities | Long-term debt | Minimum                            
Debt Instrument [Line Items]                            
Leverage ratio         0.65                  
Revolving credit facility | 2020 credit facilities | Long-term debt | Maximum                            
Debt Instrument [Line Items]                            
Leverage ratio         1                  
Commercial paper | Euro-denominated commercial paper                            
Debt Instrument [Line Items]                            
Weighted average interest rate of long-term debt, interest rate 0.20%           0.20% 0.20%   0.20%   0.20%    
Weighted average maturity of long-term debt, at point in time 42 days                          
Long-term debt $ 2,900,000,000           $ 2,900,000,000 $ 2,900,000,000   $ 2,900,000,000   € 2,700 $ 2,377,500,000 € 2,100
Commercial paper | U.S. dollar-denominated commercial paper                            
Debt Instrument [Line Items]                            
Long-term debt 0           0 0   0     72,800,000  
Senior notes | 1.0% senior notes due 2019                            
Debt Instrument [Line Items]                            
Long-term debt $ 0           $ 0 $ 0   $ 0     687,000,000.0  
Repayment of debt | €           € 600                
Interest rate of debt instrument 1.00%           1.00% 1.00%   1.00%   1.00%    
Aggregate principal amount | €                       € 0   600
Senior notes | 2.4% senior notes due 2020                            
Debt Instrument [Line Items]                            
Long-term debt $ 499,200,000           $ 499,200,000 $ 499,200,000   $ 499,200,000     498,500,000  
Interest rate of debt instrument 2.40%           2.40% 2.40%   2.40%   2.40%    
Senior notes | Biopharma euronotes                            
Debt Instrument [Line Items]                            
Proceeds from term debt     $ 6,800,000,000 € 6,200                    
Unsecured debt | Envista term loan facility                            
Debt Instrument [Line Items]                            
Long-term debt $ 648,600,000           $ 648,600,000 $ 648,600,000   $ 648,600,000     0  
Unsecured debt | Envista term loan facility | Subsidiaries | Envista | IPO                            
Debt Instrument [Line Items]                            
Aggregate principal amount 650,000,000           650,000,000 650,000,000   650,000,000        
Unsecured debt | Envista euro term loan facility                            
Debt Instrument [Line Items]                            
Long-term debt 655,600,000           655,600,000 655,600,000   655,600,000     0  
Aggregate principal amount | €                       € 600   € 0
Unsecured debt | Envista euro term loan facility | Subsidiaries | Envista | IPO                            
Debt Instrument [Line Items]                            
Aggregate principal amount | €                       € 600    
Convertible debt | Zero-coupon LYONs due 2021                            
Debt Instrument [Line Items]                            
Long-term debt $ 34,600,000           $ 34,600,000 $ 34,600,000   $ 34,600,000     $ 56,200,000  
Interest rate of debt instrument 0.00%           0.00% 0.00%   0.00%   0.00%    
Shares issued under debt conversion, shares | shares                   891        
Debt conversion, converted instrument, tax benefit                   $ 9,000,000        
XML 106 R24.htm IDEA: XBRL DOCUMENT v3.19.3
Segment Information
9 Months Ended
Sep. 27, 2019
Segment Reporting [Abstract]  
Segment Information SEGMENT INFORMATION
The Company operates and reports its results in four separate business segments consisting of the Life Sciences, Diagnostics, Dental/Envista and Environmental & Applied Solutions segments. When determining the reportable segments, the Company 
aggregated operating segments based on their similar economic and operating characteristics. Operating profit represents total revenues less operating expenses, excluding nonoperating income and expense, interest and income taxes. Operating profit amounts in the Other segment consist of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance. Intersegment amounts are not significant and are eliminated to arrive at consolidated totals.
Segment results are shown below ($ in millions):
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Sales:
 
 
 
 
 
 
 
Life Sciences
$
1,695.6

 
$
1,596.7

 
$
5,035.1

 
$
4,677.9

Diagnostics
1,601.9

 
1,502.5

 
4,757.0

 
4,573.1

Dental / Envista
659.3

 
679.5

 
2,031.1

 
2,085.5

Environmental & Applied Solutions
1,080.5

 
1,074.4

 
3,250.6

 
3,193.0

Total
$
5,037.3

 
$
4,853.1

 
$
15,073.8

 
$
14,529.5

 
 
 
 
 
 
 
 
Operating profit:
 
 
 
 
 
 
 
Life Sciences
$
342.5

 
$
312.8

 
$
995.5

 
$
875.6

Diagnostics
266.0

 
235.1

 
782.0

 
757.4

Dental / Envista
78.7

 
86.1

 
206.4

 
241.8

Environmental & Applied Solutions
256.5

 
254.3

 
761.3

 
732.5

Other
(108.9
)
 
(57.6
)
 
(302.8
)
 
(166.1
)
Total
$
834.8

 
$
830.7

 
$
2,442.4

 
$
2,441.2


Segment identifiable assets are shown below ($ in millions):
 
September 27, 2019
 
December 31, 2018
Life Sciences
$
22,115.0

 
$
22,122.4

Diagnostics
14,175.1

 
14,031.1

Dental / Envista
6,009.5

 
5,897.3

Environmental & Applied Solutions
4,741.3

 
4,637.3

Other
14,490.2

 
1,144.4

Total
$
61,531.1

 
$
47,832.5


XML 107 R20.htm IDEA: XBRL DOCUMENT v3.19.3
Nonoperating Income (Expense)
9 Months Ended
Sep. 27, 2019
Other Income and Expenses [Abstract]  
Nonoperating Income (Expense) NONOPERATING INCOME (EXPENSE)
The Company disaggregates the service cost component of net periodic benefit costs of the noncontributory defined benefit pension plans and other postretirement employee benefit plans and presents the other components of net periodic benefit cost in other income, net. These other components include the assumed rate of return on plan assets partially offset by amortization of actuarial losses and interest and aggregated to a gain of $4 million and $16 million for the three and nine-month periods ended September 27, 2019, respectively, compared to a gain of $9 million and $25 million for the three and nine-month periods ended September 28, 2018, respectively.
XML 108 R4.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Condensed Statements Of Earnings - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 27, 2019
Sep. 28, 2018
Income Statement [Abstract]        
Sales $ 5,037.3 $ 4,853.1 $ 15,073.8 $ 14,529.5
Cost of sales (2,228.9) (2,162.6) (6,670.0) (6,378.3)
Gross profit 2,808.4 2,690.5 8,403.8 8,151.2
Operating costs:        
Selling, general and administrative expenses (1,654.7) (1,558.6) (5,009.9) (4,798.4)
Research and development expenses (318.9) (301.2) (951.5) (911.6)
Operating profit 834.8 830.7 2,442.4 2,441.2
Nonoperating income (expense):        
Other income, net 4.4 9.1 15.9 25.2
Interest expense (26.3) (41.3) (70.2) (123.6)
Interest income 30.1 2.8 72.0 6.7
Earnings before income taxes 843.0 801.3 2,460.1 2,349.5
Income taxes (169.1) (137.6) (721.1) (445.4)
Net earnings 673.9 663.7 1,739.0 1,904.1
Less: net earnings attributable to noncontrolling interests (5.9) 0.0 (5.9) 0.0
Net earnings attributable to Danaher stockholders 668.0 663.7 1,733.1 1,904.1
Mandatory convertible preferred stock dividends (19.6) 0.0 (48.8) 0.0
Net earnings attributable to common stockholders $ 648.4 $ 663.7 $ 1,684.3 $ 1,904.1
Net earnings per common share:        
Basic $ 0.90 $ 0.95 $ 2.36 $ 2.72
Diluted $ 0.89 $ 0.93 $ 2.32 $ 2.68
Average common stock and common equivalent shares outstanding:        
Basic 718.8 701.4 714.7 700.1
Diluted 729.3 710.6 725.2 709.9
EXCEL 109 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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v3.19.3
Revenue (Tables)
9 Months Ended
Sep. 27, 2019
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
The following tables present the Company’s revenues disaggregated by geographical region and revenue type for the three and nine-month periods ended September 27, 2019 and September 28, 2018 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenue.
 
Life Sciences
 
Diagnostics
 
Dental / Envista
 
Environmental & Applied Solutions
 
Total
Three-month period ended September 27, 2019:
 
 
 
 
 
 
 
 
 
Geographical region:
 
 
 
 
 
 
 
 
 
North America
$
637.2

 
$
602.9

 
$
327.7

 
$
465.5

 
$
2,033.3

Western Europe
444.1

 
257.9

 
127.5

 
252.8

 
1,082.3

Other developed markets
149.2

 
108.4

 
45.6

 
32.5

 
335.7

High-growth markets (a)
465.1

 
632.7

 
158.5

 
329.7

 
1,586.0

Total
$
1,695.6

 
$
1,601.9

 
$
659.3

 
$
1,080.5

 
$
5,037.3

 
 
 
 
 
 
 
 
 
 
Revenue type:
 
 
 
 
 
 
 
 
 
Recurring
$
1,084.3

 
$
1,343.2

 
$
479.4

 
$
595.2

 
$
3,502.1

Nonrecurring
611.3

 
258.7

 
179.9

 
485.3

 
1,535.2

Total
$
1,695.6

 
$
1,601.9

 
$
659.3

 
$
1,080.5

 
$
5,037.3

 
 
 
 
 
 
 
 
 
 
Three-month period ended September 28, 2018:
 
 
 
 
 
 
 
 
 
Geographical region:
 
 
 
 
 
 
 
 
 
North America
$
584.0

 
$
574.0

 
$
339.8

 
$
439.7

 
$
1,937.5

Western Europe
447.1

 
262.3

 
137.2

 
257.5

 
1,104.1

Other developed markets
134.5

 
91.8

 
42.5

 
31.0

 
299.8

High-growth markets (a)
431.1

 
574.4

 
160.0

 
346.2

 
1,511.7

Total
$
1,596.7

 
$
1,502.5

 
$
679.5

 
$
1,074.4

 
$
4,853.1

 
 
 
 
 
 
 
 
 
 
Revenue type:
 
 
 
 
 
 
 
 
 
Recurring
$
1,030.9

 
$
1,273.3

 
$
478.2

 
$
571.1

 
$
3,353.5

Nonrecurring
565.8

 
229.2

 
201.3

 
503.3

 
1,499.6

Total
$
1,596.7

 
$
1,502.5

 
$
679.5

 
$
1,074.4

 
$
4,853.1




 
Life Sciences
 
Diagnostics
 
Dental / Envista
 
Environmental & Applied Solutions
 
Total
Nine-month period ended September 27, 2019:
 
 
 
 
 
 
 
 
 
Geographical region:
 
 
 
 
 
 
 
 
 
North America
$
1,878.1

 
$
1,836.3

 
$
966.4

 
$
1,403.0

 
$
6,083.8

Western Europe
1,363.7

 
828.5

 
443.7

 
774.1

 
3,410.0

Other developed markets
436.1

 
295.6

 
131.0

 
92.7

 
955.4

High-growth markets (a)
1,357.2

 
1,796.6

 
490.0

 
980.8

 
4,624.6

Total
$
5,035.1

 
$
4,757.0

 
$
2,031.1

 
$
3,250.6

 
$
15,073.8

 
 
 
 
 
 
 
 
 
 
Revenue type:
 
 
 
 
 
 
 
 
 
Recurring
$
3,264.4

 
$
4,047.9

 
$
1,489.3

 
$
1,770.2

 
$
10,571.8

Nonrecurring
1,770.7

 
709.1

 
541.8

 
1,480.4

 
4,502.0

Total
$
5,035.1

 
$
4,757.0

 
$
2,031.1

 
$
3,250.6

 
$
15,073.8

 
 
 
 
 
 
 
 
 
 
Nine-month period ended September 28, 2018:
 
 
 
 
 
 
 
 
 
Geographical region:
 
 
 
 
 
 
 
 
 
North America
$
1,642.4

 
$
1,760.1

 
$
977.2

 
$
1,308.7

 
$
5,688.4

Western Europe
1,346.5

 
861.4

 
483.3

 
785.5

 
3,476.7

Other developed markets
417.9

 
275.3

 
133.5

 
94.9

 
921.6

High-growth markets (a)
1,271.1

 
1,676.3

 
491.5

 
1,003.9

 
4,442.8

Total
$
4,677.9

 
$
4,573.1

 
$
2,085.5

 
$
3,193.0

 
$
14,529.5

 
 
 
 
 
 
 
 
 
 
Revenue type:
 
 
 
 
 
 
 
 
 
Recurring
$
3,057.3

 
$
3,892.8

 
$
1,513.5

 
$
1,702.7

 
$
10,166.3

Nonrecurring
1,620.6

 
680.3

 
572.0

 
1,490.3

 
4,363.2

Total
$
4,677.9

 
$
4,573.1

 
$
2,085.5

 
$
3,193.0

 
$
14,529.5


XML 111 R8.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Condensed Statements Of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Cash flows from operating activities:    
Net earnings $ 1,739.0 $ 1,904.1
Noncash items:    
Depreciation 450.3 449.4
Amortization 536.6 527.5
Stock-based compensation expense 130.0 111.6
Change in trade accounts receivable, net (26.3) 128.6
Change in inventories (169.4) (255.4)
Change in trade accounts payable (81.5) 71.5
Change in prepaid expenses and other assets 225.4 245.6
Change in accrued expenses and other liabilities 36.3 (398.5)
Net operating cash provided by operating activities 2,840.4 2,784.4
Cash flows from investing activities:    
Cash paid for acquisitions (331.1) (2,173.3)
Payments for additions to property, plant and equipment (518.4) (441.3)
Proceeds from sales of property, plant and equipment 14.1 1.6
Payments for purchases of investments (165.5) (61.1)
Proceeds from sale of investments 0.0 22.1
All other investing activities 28.9 0.0
Net operating cash used in investing activities (972.0) (2,652.0)
Cash flows from financing activities:    
Proceeds from the issuance of common stock in connection with stock-based compensation 115.0 77.3
Proceeds from the sale of common stock, net of issuance costs 1,443.2 0.0
Proceeds from the sale of preferred stock, net of issuance costs 1,599.6 0.0
Proceeds from the sale of Envista Holdings Corporation Common Stock, net of issuance costs 643.4 0.0
Payment of dividends (385.0) (321.2)
Net proceeds from borrowings (maturities of 90 days or less) 744.1 882.1
Proceeds from borrowings (maturities longer than 90 days) 8,137.1 0.0
Net repayments of borrowings (maturities longer than 90 days) (680.9) (503.9)
All other financing activities (6.0) (16.6)
Net operating cash provided by financing activities 11,610.5 117.7
Effect of exchange rate changes on cash and equivalents (14.6) (104.2)
Net change in cash and equivalents 13,464.3 145.9
Beginning balance of cash and equivalents 787.8 630.3
Ending balance of cash and equivalents 14,252.1 776.2
Supplemental disclosures:    
Cash interest payments 112.9 129.0
Cash income tax payments $ 494.8 $ 502.0